data_2orc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2orc _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.8 mm-40 . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 4.7 ttt180 -79.4 72.12 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.541 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 10.7 mm -84.86 157.73 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.382 -0.824 . . . . 0.0 109.168 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 10.9 p -65.32 -174.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 111.216 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.507 ' CD1' HD12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -91.35 -35.3 14.49 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.527 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.2 tmtp? -81.78 -69.63 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.684 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -42.53 -55.57 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.563 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.541 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 10.1 t80 -44.0 -56.22 4.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . . . -54.91 -35.67 64.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.466 -0.771 . . . . 0.0 110.382 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ttp -66.8 -35.11 79.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.881 . . . . 0.0 110.586 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -78.45 -24.73 45.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.184 -0.947 . . . . 0.0 110.343 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -111.09 -77.36 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.014 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.35 158.85 19.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.429 ' OE1' ' HA ' ' A' ' 16' ' ' GLN . 2.4 tp60 -74.03 -30.62 62.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -24.23 41.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -52.15 8.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.175 -0.953 . . . . 0.0 108.758 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.459 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.5 m -58.31 -27.17 63.85 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.47 -53.81 8.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -9.19 45.44 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.774 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.87 -44.81 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' A' ' 42' ' ' LEU . 14.3 mt -79.57 -28.97 41.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 42.02 4.45 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.2 t -129.96 179.44 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -1.161 . . . . 0.0 109.696 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -75.15 154.8 37.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.326 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -26.59 64.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 m -71.26 -50.57 31.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.905 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.58 -17.89 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.181 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -78.25 -61.3 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.699 0.761 . . . . 0.0 109.214 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.584 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.8 OUTLIER -54.71 -14.28 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.664 -0.648 . . . . 0.0 110.501 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.511 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 10.6 tttt -93.57 -39.98 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.576 -1.327 . . . . 0.0 108.964 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.24 -8.66 57.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.185 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.527 ' CG2' ' HG2' ' A' ' 8' ' ' LYS . 8.3 mt -118.56 -47.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.424 -0.798 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.584 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.8 t-80 -72.95 -11.17 60.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.957 -1.089 . . . . 0.0 110.01 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -76.34 -88.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.962 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.04 46.45 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.69 -170.03 2.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.526 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 13.8 ptpt -148.64 87.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.686 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.584 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 22.8 mt -118.21 171.83 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.86 . . . . 0.0 110.739 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 28.2 m-85 -154.02 110.03 3.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.484 -0.76 . . . . 0.0 109.701 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.502 ' CD2' HD22 ' A' ' 23' ' ' LEU . 3.8 mp -86.14 128.71 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 111.327 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 1.6 m -93.74 105.87 17.88 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.496 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 7.2 mt -91.61 134.22 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 110.916 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.651 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.8 m-20 -53.85 -18.66 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.66 -0.65 . . . . 0.0 110.512 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.651 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 91.01 -19.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -2.33 56.44 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.34 0.52 25.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 50' ' ' VAL . 2.1 t -72.46 -175.18 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -1.138 . . . . 0.0 110.139 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.473 HG12 HD21 ' A' ' 23' ' ' LEU . 19.8 t -156.11 130.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.457 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 8.0 t80 -128.0 76.16 1.67 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 109.345 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -48.54 130.29 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 110.998 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.81 84.94 2.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 109.758 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.511 ' CB ' HG12 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -79.0 147.12 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.333 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.0 t -138.71 86.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.82 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 56' A ASP . 7.2 ttpp -97.12 91.48 5.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 110.106 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.556 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -4.38 73.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.28 0.562 . . . . 0.0 112.373 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 157.0 -23.94 0.47 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.3 tt0 -178.92 128.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.109 -1.23 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.44 ' O ' ' CG2' ' A' ' 56' D VAL . 3.6 m -100.21 129.33 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.655 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.431 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -134.72 158.45 75.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 110.517 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 58' ' ' PHE . 11.2 Cg_exo -72.71 -59.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.263 1.665 . . . . 0.0 110.327 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER 56.35 109.99 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 110.072 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.423 ' C ' ' HA ' ' A' ' 58' ' ' PHE . 20.2 Cg_exo -62.94 133.61 14.05 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.497 0.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 110.169 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.6 mm100 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.25 0.548 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 18.6 ttt180 -79.53 74.54 6.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 109.626 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.591 HG23 ' CD1' ' A' ' 10' ' ' TYR . 2.9 mt -90.87 146.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.676 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.06 -178.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.768 0.794 . . . . 0.0 111.3 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . 13.1 tp -92.34 -49.97 5.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.16 -64.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.598 -0.688 . . . . 0.0 109.306 178.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -43.72 -53.26 5.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.108 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.591 ' CD1' HG23 ' A' ' 5' ' ' ILE . 1.9 t80 -46.46 -55.18 7.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 109.707 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.85 -37.34 42.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.612 0.72 . . . . 0.0 109.584 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.468 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -55.35 -41.14 72.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 110.415 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -38.77 54.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.52 -67.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 110.007 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 168.65 155.08 9.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.29 -33.85 70.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -1.156 . . . . 0.0 109.878 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -85.23 -7.55 58.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.151 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -53.9 5.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.472 HG21 ' N ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -66.71 -34.1 77.1 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.421 -0.8 . . . . 0.0 109.051 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' N ' HG21 ' A' ' 19' ' ' THR . . . -76.44 -23.55 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 17' ' ' THR . 2.3 mmtt -71.04 -43.79 67.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.002 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 3.8 m-20 -70.09 -28.79 65.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.458 ' CD2' HG13 ' A' ' 50' ' ' VAL . 22.0 mt -79.45 -27.51 41.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 26.96 31.45 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 23' ' ' LEU . 7.0 m -135.82 156.13 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.475 ' O ' HD11 ' A' ' 30' ' ' ILE . 96.1 m-85 -64.93 172.18 3.04 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 110.073 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -75.72 -23.37 56.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.172 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -62.85 -46.52 87.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.844 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.69 66.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.853 . . . . 0.0 109.949 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.549 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.5 mp -67.03 -49.88 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' LYS . 25.5 m-20 -57.22 -58.94 6.02 Favored 'General case' 0 C--O 1.194 -1.833 0 O-C-N 121.358 -0.839 . . . . 0.0 110.007 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -49.76 -23.87 2.04 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 119.588 -1.945 . . . . 0.0 109.107 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' O ' HD12 ' A' ' 40' ' ' ILE . . . -76.7 -40.19 49.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.558 -0.714 . . . . 0.0 109.935 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.582 ' CD1' ' HB2' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -95.12 -40.47 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.405 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -60.69 -58.27 9.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.917 -1.115 . . . . 0.0 108.407 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.45 15.1 16.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.932 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 40' ' ' ILE . . . -152.12 93.39 0.14 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 9.8 mmm-85 -86.77 168.86 13.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -1.064 . . . . 0.0 110.82 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER 71.29 66.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.303 -0.873 . . . . 0.0 110.439 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.614 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 17.2 mt -125.45 163.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.5 m-85 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 4.4 mp -140.88 116.87 10.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.534 ' OG1' ' CB ' ' A' ' 51' ' ' TYR . 2.3 p -88.01 101.67 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.555 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.584 HD12 ' CE2' ' A' ' 10' ' ' TYR . 5.5 mt -94.78 124.44 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.047 -1.033 . . . . 0.0 110.314 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.476 ' ND2' ' CB ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -85.43 -177.25 6.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -0.969 . . . . 0.0 110.26 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.36 0.16 17.79 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -101.14 -4.45 27.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.692 . . . . 0.0 110.166 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.84 -15.06 61.55 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.476 ' CB ' ' ND2' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -48.86 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -1.193 . . . . 0.0 109.589 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.458 HG13 ' CD2' ' A' ' 23' ' ' LEU . 45.7 t -80.8 105.78 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 111.063 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CB ' ' OG1' ' A' ' 43' ' ' THR . 0.2 OUTLIER -88.26 90.71 8.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 109.083 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 58' ' ' PHE . . . -89.08 140.48 29.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 110.124 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 56' E LYS . 0.2 OUTLIER -152.61 136.73 16.47 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.889 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' D VAL . 8.7 mt-10 -98.1 111.83 24.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 56' C GLU . 2.6 p -109.82 132.69 57.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.245 -0.91 . . . . 0.0 110.186 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 56' A ASP . 13.8 ttpp -160.24 110.41 1.82 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.677 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.479 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 38.6 t70 61.26 11.42 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.609 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 128.91 -44.92 1.18 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.455 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' C GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.8 mt-10 -60.9 98.2 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.241 -1.152 . . . . 0.0 110.93 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.532 ' O ' ' CG2' ' A' ' 56' D VAL . 4.8 m -107.19 61.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.833 . . . . 0.0 110.088 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -58.93 174.9 0.36 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.97 -1.081 . . . . 0.0 110.557 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 56' E LYS . 2.0 Cg_endo -88.98 -79.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.35 2.033 . . . . 0.0 110.215 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 0.6 OUTLIER 59.91 122.31 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.282 -0.886 . . . . 0.0 109.865 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -77.78 128.91 17.52 Favored 'Cis proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.326 -0.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.383 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 C--O 1.216 -0.694 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 40.0 ttp180 -125.16 79.84 1.83 Allowed 'General case' 0 C--N 1.283 -2.292 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.573 HG23 ' CD1' ' A' ' 10' ' ' TYR . 24.2 mt -84.75 135.59 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.383 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -49.46 -176.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.068 0.937 . . . . 0.0 111.833 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.591 HD23 ' CE2' ' A' ' 58' ' ' PHE . 2.8 tp -94.4 -37.21 11.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.506 ' HD2' ' N ' ' A' ' 9' ' ' ASP . 1.4 tmtt? -83.84 -65.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.278 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.506 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 8.3 m-20 -46.84 -45.58 20.31 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.585 ' HB2' ' O ' ' A' ' 6' ' ' THR . 13.3 t80 -55.4 -50.98 68.33 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.719 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -26.14 63.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.767 -0.583 . . . . 0.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -21.63 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -101.32 -6.15 24.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -77.52 0.59 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.1 143.25 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -65.1 -31.99 73.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 110.097 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -80.4 -10.82 59.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.118 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -90.97 -36.65 13.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.342 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -26.94 60.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.42 -39.09 23.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.813 . . . . 0.0 110.699 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.6 tmtt? -65.08 -34.68 79.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 109.956 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 7.7 m-20 -71.46 -38.38 71.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 110.023 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.478 HD12 ' CE2' ' A' ' 58' ' ' PHE . 21.1 mt -80.7 -7.59 59.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 110.407 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 35.42 90.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -134.44 175.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.22 -1.165 . . . . 0.0 109.9 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -82.36 146.19 29.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 110.378 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.545 ' HA ' ' CD1' ' A' ' 30' ' ' ILE . 2.2 mt-30 -53.35 -24.6 12.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.364 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -64.16 -57.54 9.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.93 -30.9 4.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.135 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.545 ' CD1' ' HA ' ' A' ' 27' ' ' GLN . 45.2 mt -70.0 -55.48 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.035 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.0 OUTLIER -59.99 -7.76 1.94 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 111.378 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -91.26 -34.45 14.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.574 -1.329 . . . . 0.0 108.266 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.472 ' O ' HD12 ' A' ' 40' ' ' ILE . . . -86.16 -15.84 39.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.543 HD13 ' CG2' ' A' ' 30' ' ' ILE . 10.6 mt -95.46 -48.11 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.513 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 18.8 t60 -68.09 -55.9 10.81 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.229 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.11 13.44 18.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.492 ' O ' HD13 ' A' ' 40' ' ' ILE . . . -141.63 83.78 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 8.0 mmm-85 -90.43 77.14 6.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.524 ' CE ' ' HB2' ' A' ' 56' ' ' LYS . 2.9 pttm 177.18 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.568 -0.708 . . . . 0.0 109.126 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.603 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 5.4 mt -103.17 161.66 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.748 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.603 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 37.6 m-85 -157.47 131.31 8.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.397 -0.814 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.532 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 2.0 mp -124.54 118.3 26.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 0.0 110.353 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.516 ' OG1' ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -89.27 102.65 15.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.064 -1.022 . . . . 0.0 109.429 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.3 mt -89.29 43.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.962 -1.086 . . . . 0.0 109.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 49.4 p-10 -105.45 -151.53 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.704 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 68.92 6.34 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.143 -0.973 . . . . 0.0 108.799 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.704 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 120.61 -53.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.47 29.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 33.6 t -78.01 156.37 30.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.541 -0.976 . . . . 0.0 110.181 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.439 ' O ' HG11 ' A' ' 50' ' ' VAL . 24.8 t -110.82 98.35 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 110.484 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.516 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 5.5 m-85 -96.9 89.85 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.467 ' HB3' HD22 ' A' ' 42' ' ' LEU . . . -89.71 122.73 33.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.181 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 56' E LYS . 0.5 OUTLIER -160.21 137.49 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.937 . . . . 0.0 110.582 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.439 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.45 178.52 4.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.835 . . . . 0.0 109.673 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 54' ' ' GLU . 83.9 t -152.06 111.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.965 . . . . 0.0 110.462 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HB2' ' CE ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.49 122.4 41.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.094 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.0 t0 50.98 -90.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -142.52 54.87 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.5 tt0 -162.19 97.03 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.136 . . . . 0.0 110.351 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.412 ' CG1' HG21 ' A' ' 55' ' ' VAL . 11.1 m -92.62 165.29 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 9.5 ptpt -165.68 148.53 6.7 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.076 -1.015 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.0 Cg_exo -76.76 73.76 5.16 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.959 1.505 . . . . 0.0 111.211 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CE2' HD23 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -45.62 132.93 6.39 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.846 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 79.0 Cg_endo -92.61 79.15 0.13 OUTLIER 'Cis proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.827 -1.739 . . . . 0.0 110.816 0.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.555 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 1.1 p . . . . . 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 110.645 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.233 0.539 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.22 94.77 4.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.993 0.901 . . . . 0.0 111.011 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.582 HD13 ' CE1' ' A' ' 10' ' ' TYR . 2.2 mt -90.3 -173.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.663 -0.648 . . . . 0.0 109.766 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.76 -179.09 5.43 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.288 -0.883 . . . . 0.0 111.608 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -91.4 -43.01 10.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.56 -63.79 1.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.406 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.485 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -44.25 -50.77 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.582 ' CE1' HD13 ' A' ' 5' ' ' ILE . 5.3 t80 -57.39 -51.64 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.358 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -49.03 -26.08 2.39 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 109.605 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 tpt -71.83 -52.65 16.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.036 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.94 -21.03 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.636 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.95 -75.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 109.611 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 173.5 142.58 3.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.481 ' NE2' ' HG2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.42 -36.06 75.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -1.232 . . . . 0.0 109.701 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -78.72 -16.5 57.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.76 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -78.59 -51.24 10.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 0.0 109.256 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.3 m -64.7 -23.82 67.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -83.82 -25.82 30.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.285 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.55 -27.27 41.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.74 -27.95 26.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.846 . . . . 0.0 110.218 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.7 mt -80.02 -8.13 59.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.66 29.71 72.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.7 m -151.48 150.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 110.107 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.527 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 9.3 p90 -66.68 169.33 7.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.957 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.481 ' HG2' ' NE2' ' A' ' 16' ' ' GLN . 9.4 mp0 -65.3 -32.07 73.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 111.349 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.527 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -46.6 -48.37 19.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.972 -1.08 . . . . 0.0 110.773 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.44 70.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.55 HG22 HD13 ' A' ' 34' ' ' ILE . 2.8 mp -72.11 -32.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.79 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 6.8 t-20 -65.88 -23.77 66.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -36.84 12.84 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.423 -1.423 . . . . 0.0 108.047 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB3' ' CD1' ' A' ' 40' ' ' ILE . . . -71.14 -14.77 62.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.55 HD13 ' CB ' ' A' ' 7' ' ' LEU . 5.7 mt -112.48 -54.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 5.2 t-160 -56.19 -15.63 4.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -85.23 29.14 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.755 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . 43.52 44.11 6.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.32 -172.0 3.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -1.112 . . . . 0.0 111.07 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' O ' ' CG2' ' A' ' 55' ' ' VAL . 15.3 mttt -135.02 83.87 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.539 -0.725 . . . . 0.0 109.053 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.589 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 27.0 mt -114.4 165.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 111.372 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.2 m-85 -159.67 177.51 10.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.641 . . . . 0.0 109.388 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.41 111.78 5.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.062 . . . . 0.0 109.706 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.52 HG23 ' ND2' ' A' ' 45' ' ' ASN . 9.3 m -75.53 99.42 4.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.448 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.578 HD12 ' CE2' ' A' ' 10' ' ' TYR . 55.7 mt -86.99 59.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 111.364 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.52 ' ND2' HG23 ' A' ' 43' ' ' THR . 39.7 p30 -103.4 -123.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.997 -1.064 . . . . 0.0 109.711 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 40.65 29.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.107 -0.996 . . . . 0.0 109.969 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.561 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 41.8 t0 72.78 64.35 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.384 0.612 . . . . 0.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 -12.21 41.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.545 ' HB2' ' CB ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -59.1 159.47 7.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.955 -1.321 . . . . 0.0 109.068 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 38.2 t -127.69 127.87 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 111.19 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 30.0 m-85 -124.64 159.03 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -143.62 137.2 28.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.802 -1.186 . . . . 0.0 111.112 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 56' E LYS . 1.1 mp0 -142.56 143.91 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 110.165 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE2' ' CD1' ' A' ' 58' ' ' PHE . 1.0 OUTLIER -84.01 167.55 16.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.669 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 39' ' ' LYS . 3.0 t -139.24 128.56 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.994 -1.066 . . . . 0.0 110.216 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 56' A ASP . 0.0 OUTLIER -146.92 170.16 17.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.518 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 60.8 t0 -40.57 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 53.31 59.12 10.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 7.6 tt0 -172.49 88.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.197 -1.178 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' D VAL . . . . . . . . . . . . . 6.2 m -97.07 140.38 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 0.0 109.952 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -119.0 172.6 4.15 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.071 -1.018 . . . . 0.0 110.69 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 58' ' ' PHE . 1.2 Cg_endo -87.6 24.94 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.354 2.036 . . . . 0.0 110.564 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.525 ' CD1' ' OE2' ' A' ' 54' ' ' GLU . 62.4 t80 -30.64 123.62 0.32 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.873 -0.517 . . . . 0.0 111.304 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.8 Cg_endo -80.17 108.03 1.16 Allowed 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.396 -1.918 . . . . 0.0 110.551 0.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.016 -1.052 . . . . 0.0 110.063 179.548 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.293 0.568 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -78.76 92.18 4.78 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.131 0.967 . . . . 0.0 111.029 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.555 HD11 ' CD1' ' A' ' 10' ' ' TYR . 18.3 mt -90.74 154.86 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.983 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.54 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -50.78 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.281 1.039 . . . . 0.0 111.413 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' A' ' 34' ' ' ILE . 4.0 tp -92.91 -39.99 10.85 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 9' ' ' ASP . 1.1 mmmp? -90.64 -63.42 1.27 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.3 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.3 t70 -44.63 -44.89 9.29 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.555 ' CD1' HD11 ' A' ' 5' ' ' ILE . 8.7 t80 -56.46 -57.39 12.52 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.501 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.32 -21.01 4.96 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 ttm -78.43 -46.8 18.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.774 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -78.04 -10.85 59.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -69.42 0.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 133.06 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -58.86 -24.02 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.445 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -78.75 -26.8 44.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.041 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -76.35 -56.39 4.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 108.672 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.408 ' O ' HD13 ' A' ' 23' ' ' LEU . 1.1 t -60.21 -30.75 69.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 16' ' ' GLN . . . -64.2 -43.61 94.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -19.48 56.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -73.7 -26.4 60.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.47 HD23 HD22 ' A' ' 42' ' ' LEU . 9.4 mt -82.93 -52.24 6.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.25 28.89 1.05 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.65 162.46 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -1.155 . . . . 0.0 110.015 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.76 -175.11 0.37 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.399 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -22.87 37.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 110.618 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' ALA . 23.5 t -74.58 -72.1 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 110.279 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.82 -27.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.307 -0.87 . . . . 0.0 109.349 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -68.61 -61.69 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.546 -0.721 . . . . 0.0 109.566 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.569 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 0.5 OUTLIER -46.56 -18.26 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.563 -0.711 . . . . 0.0 111.032 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -89.76 -40.86 12.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.438 -1.414 . . . . 0.0 108.588 178.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -7.04 53.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.517 -0.74 . . . . 0.0 109.136 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.531 ' CD1' HD13 ' A' ' 7' ' ' LEU . 15.8 mt -111.33 -54.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.636 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.538 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 67.2 t60 -61.16 -14.99 28.84 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -64.16 -9.01 14.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.629 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 34.12 60.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 153.69 31.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.55 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.544 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER -86.3 58.97 5.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.506 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 4.9 mt -93.25 167.83 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 111.093 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 68.0 m-85 -155.88 167.75 29.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 4.6 mp -142.79 105.35 4.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.835 -1.166 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 1.3 m -78.59 93.1 4.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.587 -0.695 . . . . 0.0 109.197 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 44' ' ' ILE . 27.8 mt -96.76 117.68 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.303 -0.873 . . . . 0.0 110.509 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.572 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER -81.76 -173.48 4.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.266 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.66 0.34 17.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.72 0.71 52.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.122 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' SER . . . 85.16 -14.11 51.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -45.28 162.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -1.205 . . . . 0.0 109.928 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.51 ' CG2' ' OD2' ' A' ' 22' ' ' ASP . 80.9 t -138.72 114.94 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -101.04 80.39 2.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 109.382 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 41' ' ' PHE . . . -80.42 89.68 5.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.701 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -102.47 167.5 9.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.765 . . . . 0.0 109.687 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 56' D VAL . 0.8 OUTLIER -135.08 156.93 48.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.076 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.58 105.23 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 56' A ASP . 11.3 ttpp -123.65 103.24 8.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 56' A ASP . 51.6 t0 59.09 23.77 12.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.915 . . . . 0.0 110.449 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 109.62 -36.5 4.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 42.5 mt-10 -63.04 104.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 34.0 m -106.4 157.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.122 -0.986 . . . . 0.0 110.46 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' E LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.26 167.54 2.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.962 . . . . 0.0 110.575 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.57 175.97 10.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 121.875 1.716 . . . . 0.0 110.411 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 59' ' ' PRO . 13.4 t80 -167.82 146.04 3.89 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 110.364 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.566 ' HA ' ' CD2' ' A' ' 58' ' ' PHE . 59.1 Cg_endo -91.89 48.41 1.34 Allowed 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.115 -2.035 . . . . 0.0 110.455 0.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.235 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.422 0.629 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 9.3 ttt180 -79.18 80.11 5.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.546 ' CD1' HD13 ' A' ' 44' ' ' ILE . 2.6 mt -86.02 164.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.523 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -70.34 -178.6 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.134 0.969 . . . . 0.0 112.367 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.536 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . 3.5 tp -92.55 -40.36 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.547 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.44 -65.92 0.97 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.487 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -43.42 -48.54 7.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.564 ' CB ' ' O ' ' A' ' 6' ' ' THR . 12.6 t80 -54.03 -57.32 11.48 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.829 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.6 -27.37 4.47 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 109.912 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.79 77.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -15.04 58.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.229 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.71 -87.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 179.47 48.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.504 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.2 tp60 -90.2 -28.66 18.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -1.096 . . . . 0.0 110.509 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 6.1 t -87.03 -24.93 24.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.242 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -73.71 -59.08 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.955 . . . . 0.0 108.75 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.512 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.1 m -60.0 -32.27 70.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.552 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . . . -76.45 -20.63 56.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.129 -0.982 . . . . 0.0 110.336 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.45 -46.93 68.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.104 -0.997 . . . . 0.0 110.912 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.08 -6.41 53.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.105 -0.997 . . . . 0.0 112.221 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.566 ' CD2' ' CD2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -162.72 36.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.639 -1.288 . . . . 0.0 109.882 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . -160.82 67.25 0.26 Allowed Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 59' ' ' PRO 0.254 38.3 t -75.12 -2.26 3.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.734 0.778 . . . . 0.0 109.5 -178.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -134.32 82.54 1.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 26' ' ' TYR . 1.6 tt0 -36.14 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.617 -0.677 . . . . 0.0 111.369 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 26' ' ' TYR . 36.1 p -76.61 -55.44 5.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.977 -1.077 . . . . 0.0 109.211 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 26' ' ' TYR . . . -57.45 -17.79 15.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.328 -0.857 . . . . 0.0 108.901 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.528 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -74.31 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.623 -0.673 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.6 m-20 -62.24 -9.63 8.45 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.52 -0.737 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 2.3 ttpt -93.25 -38.15 11.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.866 -1.146 . . . . 0.0 108.086 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -82.5 -8.29 59.62 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.547 ' CG2' ' HG2' ' A' ' 8' ' ' LYS . 22.7 mt -108.89 -48.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.573 -0.704 . . . . 0.0 109.585 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 3.5 t60 -70.96 -28.65 64.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.867 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -65.46 -33.43 75.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.52 59.72 0.83 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.33 -176.02 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 26.9 tttt -117.21 71.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 40' ' ' ILE . 10.4 mt -115.95 166.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.472 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 91.8 m-85 -149.39 173.2 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.295 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.566 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 3.6 mp -143.32 147.96 35.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.007 -1.058 . . . . 0.0 111.455 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 94.9 m -112.63 105.52 13.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.583 -0.698 . . . . 0.0 109.191 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.546 HD13 ' CD1' ' A' ' 5' ' ' ILE . 2.5 mt -83.04 -134.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.316 -0.865 . . . . 0.0 111.164 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 2.1 p-10 34.77 -146.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.932 -0.48 . . . . 0.0 111.497 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.655 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 56.27 23.07 6.78 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.655 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 26.8 t70 100.19 35.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 123.752 0.821 . . . . 0.0 109.28 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.62 7.25 57.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -67.63 104.28 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -1.175 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.88 125.78 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.463 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 7.8 m-85 -112.29 158.86 19.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.803 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 23' ' ' LEU . . . -139.34 97.01 3.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 56' E LYS . 29.1 mt-10 -111.99 126.09 54.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.808 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' O ' HG21 ' A' ' 55' ' ' VAL . 1.7 mt-10 -82.04 161.61 22.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 54' ' ' GLU . 5.6 t -142.33 121.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.463 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -147.71 142.72 27.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 15.9 t70 56.21 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.919 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -157.8 36.21 0.54 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.69 132.01 12.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -1.175 . . . . 0.0 110.182 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -101.14 169.71 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.158 -0.964 . . . . 0.0 110.557 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 3.9 mttm -145.24 175.67 2.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 6.2 Cg_exo -81.57 -163.0 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.21 1.94 . . . . 0.0 110.433 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 179.07 113.41 0.19 Allowed Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.305 -0.872 . . . . 0.0 110.329 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.486 ' HG3' HG22 ' A' ' 25' ' ' VAL . 46.0 Cg_endo -77.85 108.18 1.14 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.117 -2.035 . . . . 0.0 110.734 -0.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 63.4 p . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 121.412 0.625 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.38 68.64 6.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 110.503 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.483 HG23 ' HA ' ' A' ' 10' ' ' TYR . 8.6 mt -91.79 139.35 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 17.7 p -51.22 -174.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.023 -1.048 . . . . 0.0 110.943 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.551 ' CD2' ' CG1' ' A' ' 34' ' ' ILE . 3.6 tp -91.42 -36.48 13.77 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -82.87 -68.79 0.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.725 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.441 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.2 OUTLIER -44.99 -54.2 6.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CB ' ' O ' ' A' ' 6' ' ' THR . 1.2 t80 -47.01 -55.24 8.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.277 -0.889 . . . . 0.0 110.232 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.46 61.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.529 -0.732 . . . . 0.0 110.162 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.3 ttm -67.67 -32.79 73.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.472 ' NH1' ' HG2' ' A' ' 13' ' ' ARG . 30.6 mtt-85 -83.52 -27.3 29.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.5 -65.3 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.0 141.34 3.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.441 ' OE1' HG22 ' A' ' 30' ' ' ILE . 1.0 OUTLIER -58.5 -35.79 72.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.019 -1.283 . . . . 0.0 109.998 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -79.72 -16.52 55.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.125 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.93 -57.65 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.452 ' O ' HD22 ' A' ' 23' ' ' LEU . 3.0 m -49.83 -34.45 19.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.85 82.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.743 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -82.06 -4.72 57.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.728 . . . . 0.0 110.041 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' HB3' HG23 ' A' ' 50' ' ' VAL . 7.7 m-20 -84.44 -38.6 19.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.013 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -116.74 14.03 15.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.18 -0.95 . . . . 0.0 110.435 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.88 37.87 91.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.529 HG22 ' CD1' ' A' ' 23' ' ' LEU . 22.1 t -108.88 120.79 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -1.12 . . . . 0.0 110.062 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -45.72 166.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.464 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -71.51 -27.71 63.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.154 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 30' ' ' ILE . 29.3 t -70.66 -61.61 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.724 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -45.32 -26.18 0.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.153 -0.967 . . . . 0.0 109.114 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.555 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -66.06 -66.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.582 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 71.0 m-80 -61.67 -7.25 3.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.545 -0.722 . . . . 0.0 110.468 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -35.93 15.22 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.863 -1.148 . . . . 0.0 108.116 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.98 -10.95 51.93 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.551 ' CG1' ' CD2' ' A' ' 7' ' ' LEU . 35.0 mt -103.66 -43.35 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 52.1 t-80 -74.93 -56.31 4.88 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.901 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.62 -4.17 55.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.955 . . . . 0.0 111.118 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -123.53 69.06 0.46 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.213 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -65.07 -170.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.243 . . . . 0.0 110.266 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 55.15 68.9 0.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 108.872 -179.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.604 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 2.8 mt -120.26 151.01 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.87 . . . . 0.0 110.444 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 90.5 m-85 -158.82 128.0 5.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.651 -0.656 . . . . 0.0 110.203 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.547 ' CD1' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -120.95 133.59 55.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 m -108.04 100.76 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.939 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 5.8 mt -82.05 -173.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.898 . . . . 0.0 110.025 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER 82.7 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.248 0.547 . . . . 0.0 111.927 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.688 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 64.33 17.66 10.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 30.2 t70 110.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.948 0.899 . . . . 0.0 109.067 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.51 79.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -70.85 109.1 4.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.839 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 22' ' ' ASP . 25.3 t -79.5 109.53 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 110.23 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 5.9 m-85 -95.21 143.94 26.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 108.937 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -127.21 86.86 2.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.113 . . . . 0.0 110.916 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.31 151.66 20.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.857 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -130.9 160.1 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 110.168 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 23.3 t -150.24 84.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.416 -0.802 . . . . 0.0 109.9 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 56' A ASP . 5.2 ttmt -94.16 101.76 13.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.141 -0.975 . . . . 0.0 109.609 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 56' ' ' LYS . 38.4 t70 -13.61 80.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.378 0.608 . . . . 0.0 112.049 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.08 -27.44 0.8 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.81 132.42 0.12 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.018 -1.284 . . . . 0.0 110.807 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 56' E LYS . 12.5 m -96.98 165.89 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.425 ' HB2' ' CD ' ' A' ' 57' ' ' PRO . 10.6 ptpt -175.53 171.8 1.15 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.847 -1.158 . . . . 0.0 110.813 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 60' ' ' SER . 3.7 Cg_exo -76.83 -173.18 1.65 Allowed 'Trans proline' 0 C--N 1.299 -2.078 0 O-C-N 124.53 1.805 . . . . 0.0 110.485 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 39.0 t80 178.91 114.79 0.19 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 110.865 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -79.5 107.13 0.99 Allowed 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.372 -1.928 . . . . 0.0 109.886 -0.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 12.5 p . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.508 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 . . . . . 0 C--O 1.214 -0.764 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -126.55 90.48 3.18 Favored 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.617 -0.677 . . . . 0.0 109.455 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.573 HD11 ' CE1' ' A' ' 10' ' ' TYR . 1.1 mt -90.28 151.57 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.612 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 3.0 p -84.31 -166.16 1.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.767 0.794 . . . . 0.0 111.376 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.541 HD11 ' CD1' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.06 -28.41 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -81.65 -82.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.816 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.1 m-20 -41.69 -56.03 2.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.456 -0.778 . . . . 0.0 110.058 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.573 ' CE1' HD11 ' A' ' 5' ' ' ILE . 1.4 t80 -49.6 -50.63 41.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.409 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 7' ' ' LEU . . . -56.29 -32.49 64.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 110.37 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -36.56 84.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.313 -0.867 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -38.07 44.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.132 -0.98 . . . . 0.0 110.147 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -99.23 -80.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.996 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.59 44.19 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.41 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 14.3 mm100 -88.72 -31.03 18.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.242 -1.151 . . . . 0.0 110.053 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.8 m -83.18 -26.13 31.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -56.55 4.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 108.797 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 2.1 m -55.55 -30.64 61.13 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -64.0 -55.86 19.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.896 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -84.66 11.58 8.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.461 -0.774 . . . . 0.0 109.787 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 3.0 m-20 -90.23 -43.28 10.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.416 -0.802 . . . . 0.0 110.58 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.596 ' CD1' ' CG2' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -94.63 -22.25 18.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.504 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 115.75 58.19 0.34 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.596 ' CG2' ' CD1' ' A' ' 23' ' ' LEU . 3.1 t -152.53 161.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.269 . . . . 0.0 110.166 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -77.8 177.6 8.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.467 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.04 -50.13 30.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 110.272 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.5 p -62.3 -60.32 3.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.59 -29.47 0.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.964 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -65.8 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.603 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.587 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 2.7 m-20 -57.13 -7.45 0.52 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.473 -0.767 . . . . 0.0 111.208 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 -41.87 15.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.73 -1.231 . . . . 0.0 107.762 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.451 ' O ' ' HB1' ' A' ' 36' ' ' ALA . . . -70.44 -45.28 66.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.489 HG12 ' CB ' ' A' ' 7' ' ' LEU . 10.5 mt -66.54 -46.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -42.87 -36.58 1.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.634 178.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 33' ' ' ALA . . . -67.91 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.758 -0.589 . . . . 0.0 109.727 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . 129.14 -16.24 5.77 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.337 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.698 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -39.97 81.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' GLY . 6.6 ptpt 9.69 69.06 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.512 0.672 . . . . 0.0 112.736 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.581 ' O ' ' CD2' ' A' ' 41' ' ' PHE . 29.5 mt -80.77 167.48 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 109.126 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 40' ' ' ILE . 27.6 m-85 -158.29 150.55 21.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.877 -1.14 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.574 HD11 ' N ' ' A' ' 42' ' ' LEU . 4.5 mp -138.97 122.05 16.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.807 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.587 ' O ' ' CG2' ' A' ' 43' ' ' THR . 1.0 OUTLIER -102.27 109.48 21.16 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.475 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.554 ' CG2' ' O ' ' A' ' 49' ' ' SER . 2.0 mt -98.48 152.23 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 110.126 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.426 ' OD1' ' C ' ' A' ' 44' ' ' ILE . 2.9 m-20 -136.09 -171.81 2.97 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.999 -1.063 . . . . 0.0 110.391 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.76 -4.22 30.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -156.67 16.91 0.31 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -93.4 -6.19 62.92 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.351 -1.899 . . . . 0.0 108.351 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.572 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 72.1 m 54.24 -92.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.572 ' CG2' ' O ' ' A' ' 49' ' ' SER . 8.4 t -161.21 98.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.28 -0.888 . . . . 0.0 110.475 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 24.1 t80 -86.8 138.18 31.8 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 58' ' ' PHE . . . -120.8 93.92 4.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.543 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 17.2 pt-20 -111.41 137.45 49.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 110.369 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -89.47 162.84 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.28 -0.888 . . . . 0.0 108.963 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.48 ' O ' ' CG ' ' A' ' 39' ' ' LYS . 6.1 t -135.77 143.41 36.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.892 -1.13 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 56' B GLY . 2.6 tppt? -159.96 169.54 23.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 109.35 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 56' ' ' LYS . 36.9 t70 -29.57 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.379 0.609 . . . . 0.0 111.232 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 46.71 61.6 4.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.21 99.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.123 -1.222 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 56' E LYS . 16.5 m -107.17 153.41 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.132 -0.98 . . . . 0.0 109.681 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.504 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -144.03 175.7 2.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 110.604 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 60' ' ' SER . 1.9 Cg_endo -87.79 -174.21 1.16 Allowed 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.092 1.862 . . . . 0.0 109.611 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 28.5 t80 174.39 113.78 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 110.434 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 60' ' ' SER . 1.9 Cg_endo -80.06 110.7 1.98 Allowed 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.513 -1.87 . . . . 0.0 110.325 -0.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.524 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 16.3 m . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.538 -0.726 . . . . 0.0 110.867 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 43' ' ' THR . 30.1 mm-40 . . . . . 0 C--O 1.214 -0.786 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . 0.255 0.3 OUTLIER -89.53 66.89 7.45 Favored 'General case' 0 C--N 1.282 -2.364 0 O-C-N 121.559 -0.713 . . . . 0.0 109.348 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 22.0 mt -87.24 155.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.221 -0.924 . . . . 0.0 111.242 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 1.1 m -65.99 -173.37 0.18 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.149 0.976 . . . . 0.0 111.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.532 ' CD2' HG12 ' A' ' 34' ' ' ILE . 3.3 tp -93.23 -39.32 11.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.522 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.7 tmtm? -90.22 -61.81 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.113 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 52.2 t0 -46.42 -44.99 17.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.915 . . . . 0.0 108.641 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CE2' HD13 ' A' ' 44' ' ' ILE . 3.0 t80 -55.52 -58.56 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.49 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.04 -14.6 17.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.457 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 tpt -90.52 -24.41 20.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 0.0 110.182 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.73 -21.0 21.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -107.22 -55.41 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.31 140.89 3.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -59.91 -35.68 75.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -11.29 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.486 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -52.47 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.76 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.498 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 3.0 m -60.66 -34.56 74.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.532 ' CB ' ' HG3' ' A' ' 27' ' ' GLN . . . -78.43 -19.66 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -79.78 -51.08 9.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.493 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 57.0 p30 -70.86 -18.13 62.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 29.2 mt -79.81 -31.98 40.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 34.5 22.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.35 169.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.231 -1.159 . . . . 0.0 110.03 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.422 ' O ' HD11 ' A' ' 30' ' ' ILE . 12.8 m-85 -72.2 145.74 47.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.493 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.532 ' HG3' ' CB ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -66.2 -16.77 64.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' ALA . 20.2 m -71.1 -61.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.06 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -41.2 -36.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.606 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.527 ' CG2' HD13 ' A' ' 34' ' ' ILE . 1.3 mp -68.1 -55.11 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.308 -0.87 . . . . 0.0 110.528 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.4 OUTLIER -54.21 -13.65 0.91 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -38.86 11.71 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.563 -1.336 . . . . 0.0 108.253 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -10.89 59.75 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.532 HG12 ' CD2' ' A' ' 7' ' ' LEU . 16.5 mt -111.52 -51.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.0 110.0 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -60.49 -19.72 57.74 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.464 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.69 -84.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 109.883 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.63 38.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 152.28 20.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -1.119 . . . . 0.0 110.889 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -100.51 69.03 1.4 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.825 . . . . 0.0 109.512 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.546 ' C ' ' CD1' ' A' ' 41' ' ' PHE . 15.5 mt -89.64 164.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.864 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 71.7 m-85 -144.62 163.98 32.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 3.2 mp -144.35 141.55 29.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 110.692 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 2.8 m -118.76 102.96 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.785 . . . . 0.0 109.395 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.579 HD13 ' CE2' ' A' ' 10' ' ' TYR . 19.3 mt -118.89 100.01 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 111.167 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -107.81 -167.09 1.21 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.826 -1.171 . . . . 0.0 110.525 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.89 -2.23 7.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' ASN . 11.3 t70 -144.69 7.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.616 -0.678 . . . . 0.0 109.401 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -91.07 -7.83 65.41 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.554 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER 47.81 -92.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' A' ' 48' ' ' GLY . 2.4 t -161.57 95.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.146 -0.971 . . . . 0.0 109.963 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -100.11 134.78 42.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.608 -0.682 . . . . 0.0 109.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.84 130.5 53.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 110.206 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -137.32 104.66 5.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.96 . . . . 0.0 110.692 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -79.36 150.82 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.373 -0.83 . . . . 0.0 109.868 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.34 132.17 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -153.51 151.38 29.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -40.68 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.206 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.32 -65.84 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -171.91 -179.56 2.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -1.051 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -100.48 149.09 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.172 -0.955 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.534 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -122.99 179.4 1.03 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 56' E LYS . 5.6 Cg_endo -90.62 -170.94 0.4 Allowed 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.014 1.809 . . . . 0.0 110.269 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.499 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 40.5 t80 176.49 109.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.207 -0.933 . . . . 0.0 111.03 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -81.68 99.33 0.26 Allowed 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.843 -1.732 . . . . 0.0 109.682 -0.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.53 ' CA ' ' HB2' ' A' ' 57' ' ' PRO . 13.7 m . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.856 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 43' ' ' THR . 5.2 mm-40 . . . . . 0 C--O 1.213 -0.857 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.94 75.8 0.94 Allowed 'General case' 0 C--N 1.281 -2.387 0 O-C-N 121.764 -0.585 . . . . 0.0 109.92 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 10' ' ' TYR . 1.5 mt -90.67 148.51 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.735 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.589 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 1.3 p -90.95 169.23 11.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 112.296 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.572 HD11 ' N ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -61.5 -25.88 67.55 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -81.43 -83.43 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.489 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 8' ' ' LYS . 75.7 m-20 -41.05 -54.6 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.971 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.589 ' CB ' ' O ' ' A' ' 6' ' ' THR . 43.7 t80 -51.12 -58.27 6.56 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.66 -23.36 11.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.522 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -34.19 52.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.635 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -91.67 -12.85 32.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -123.46 -49.95 1.89 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.276 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.18 134.81 2.86 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.42 ' OE1' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -60.9 -32.22 71.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.211 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -84.06 -11.45 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 110.192 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -51.94 7.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.204 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.458 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -65.6 -31.61 72.74 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.425 -0.797 . . . . 0.0 108.893 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -75.68 -26.29 57.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.607 -0.683 . . . . 0.0 109.773 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -27.98 61.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' OD1' ' HG ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -82.94 -27.55 30.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 110.305 -179.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.472 ' HG ' ' OD1' ' A' ' 22' ' ' ASP . 25.9 mt -80.66 -10.8 59.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.965 . . . . 0.0 110.103 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 48.08 75.29 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.22 153.1 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.343 -1.092 . . . . 0.0 110.033 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.469 ' O ' HD13 ' A' ' 30' ' ' ILE . 31.8 m-85 -66.75 157.55 32.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.122 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -64.65 -11.66 37.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.26 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.9 t -75.96 -62.31 1.64 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.87 -35.91 4.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.234 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.54 ' CG2' ' CD1' ' A' ' 34' ' ' ILE . 3.7 mt -74.77 -48.15 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -55.11 -13.65 1.3 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.753 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -93.32 -38.94 11.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 108.385 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.32 -7.66 57.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.54 ' CD1' ' CG2' ' A' ' 30' ' ' ILE . 13.1 mt -110.89 -53.35 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.566 -0.709 . . . . 0.0 109.495 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.549 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 83.7 t60 -52.5 -31.3 34.53 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.196 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.17 -43.0 13.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.461 -0.774 . . . . 0.0 109.659 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.52 55.75 16.46 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HD2' ' H ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -85.14 39.86 0.79 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.189 -1.183 . . . . 0.0 111.153 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.5 OUTLIER 72.74 101.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.383 -0.823 . . . . 0.0 111.176 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.564 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 6.6 mt -145.61 159.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 99.4 m-85 -154.08 160.86 42.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.918 -1.114 . . . . 0.0 111.218 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.568 ' CD2' ' CD1' ' A' ' 7' ' ' LEU . 4.7 mp -143.47 114.72 7.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.53 -0.731 . . . . 0.0 110.3 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 51' ' ' TYR . 54.0 m -89.28 100.62 13.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.844 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.483 HD11 ' O ' ' A' ' 49' ' ' SER . 3.7 mm -79.91 74.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 0.0 110.21 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.468 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 3.3 p30 -44.31 167.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 110.397 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -8.97 2.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -78.6 7.0 7.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.02 11.95 46.99 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 44' ' ' ILE . 42.6 m -84.7 -173.06 4.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -1.165 . . . . 0.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 42' ' ' LEU . 70.8 t -138.42 101.34 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.062 -1.024 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CB ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -78.71 77.87 5.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.016 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.46 86.05 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 110.537 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 56' E LYS . 37.1 mt-10 -102.41 108.0 19.18 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' O ' ' CB ' ' A' ' 56' D VAL . 0.0 OUTLIER -79.52 176.01 10.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.39 -0.819 . . . . 0.0 109.705 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 54' ' ' GLU . 15.5 t -142.31 110.49 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.859 . . . . 0.0 110.364 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 27.2 ttmt -128.92 154.64 46.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' A ASP . . . . . . . . . . . . . 48.0 m-20 -47.83 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 146.55 -52.14 0.57 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.95 168.97 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.453 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 27.0 m -81.98 -177.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.8 mttm -148.54 172.07 5.6 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.248 -0.908 . . . . 0.0 110.389 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 1.6 Cg_endo -85.45 -47.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.947 1.764 . . . . 0.0 110.27 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 56.31 95.82 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.249 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 6.4 Cg_exo -70.1 157.21 93.24 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.835 -2.152 . . . . 0.0 110.284 0.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.7 m . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 110.281 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.154 0.502 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -82.95 66.82 8.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 4.8 tp -87.13 173.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 41' ' ' PHE . 5.1 p -77.29 -172.7 2.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.296 1.045 . . . . 0.0 111.108 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.538 ' CD2' HG12 ' A' ' 34' ' ' ILE . 1.4 tp -90.2 -34.65 15.73 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -85.37 -69.78 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.621 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -41.66 -49.17 4.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.247 -0.908 . . . . 0.0 109.111 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 1.6 t80 -50.15 -59.61 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.583 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -48.09 -31.07 5.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 109.449 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.438 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.71 -53.47 55.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.627 -0.67 . . . . 0.0 109.813 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -59.31 -31.19 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.789 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.46 ' CD2' ' HE3' ' A' ' 18' ' ' LYS . 5.0 m-85 -106.76 -81.06 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.253 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 162.87 -176.46 39.15 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.453 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -85.14 -27.5 26.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.096 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 m -85.88 -16.37 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.46 ' HE3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -89.59 -39.92 12.94 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.288 -0.883 . . . . 0.0 108.969 179.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.5 m -71.68 -26.32 62.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.552 -0.718 . . . . 0.0 109.266 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -83.7 -39.21 20.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 110.443 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -62.74 -32.39 73.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -80.67 -31.53 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.041 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.9 mt -89.19 -7.87 54.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.394 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.14 49.79 50.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.43 147.48 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -1.195 . . . . 0.0 109.937 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -59.39 163.54 3.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.262 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -26.11 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 t -83.47 -51.48 7.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.878 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.428 ' O ' ' HB1' ' A' ' 33' ' ' ALA . . . -47.99 -23.74 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -81.01 -68.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.774 . . . . 0.0 109.726 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.573 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 2.1 m-20 -52.39 -13.69 0.39 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 111.235 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.39 -43.77 9.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.511 -1.368 . . . . 0.0 108.683 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -76.06 -6.96 53.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.534 -0.729 . . . . 0.0 109.053 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.538 HG12 ' CD2' ' A' ' 7' ' ' LEU . 19.0 mt -111.85 -50.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 0.0 109.998 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 23.7 t-160 -59.15 -23.67 62.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.12 -0.988 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.429 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.3 49.43 0.36 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -80.6 123.3 28.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -1.071 . . . . 0.0 110.299 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 55' ' ' VAL . 6.5 ptpp? -86.69 59.99 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.509 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 43.9 mt -96.94 169.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.579 0.704 . . . . 0.0 111.033 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 55.9 m-85 -149.79 110.13 4.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 42' ' ' LEU . 6.9 mp -85.08 135.65 33.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.48 HG23 ' ND2' ' A' ' 45' ' ' ASN . 3.2 m -101.34 104.3 15.28 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.481 ' CD1' ' CZ ' ' A' ' 10' ' ' TYR . 53.8 mt -93.56 44.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.073 -1.017 . . . . 0.0 111.246 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.48 ' ND2' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -87.58 -127.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.94 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 43.28 27.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.955 -1.09 . . . . 0.0 109.81 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 73.69 69.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.313 0.578 . . . . 0.0 111.797 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.28 0.23 35.95 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.471 ' OG ' ' HB1' ' A' ' 46' ' ' ALA . 1.1 p -58.76 -165.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.283 . . . . 0.0 110.369 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 49' ' ' SER . 14.1 t -146.28 124.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -135.49 164.09 28.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.32 -0.863 . . . . 0.0 109.989 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -141.8 132.43 25.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.462 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -159.76 116.07 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 110.003 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HB3' HG12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -95.5 178.45 5.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.605 -179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.469 ' O ' ' HD3' ' A' ' 39' ' ' LYS . 6.2 t -140.16 107.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.464 -0.772 . . . . 0.0 109.621 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.01 155.02 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 110.582 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' A ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.24 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 137.71 -53.46 0.73 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.0 171.53 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 110.268 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.462 ' O ' ' HG2' ' A' ' 56' E LYS . 28.0 m -94.17 164.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 56' D VAL . 6.8 mtpt -142.39 168.59 13.0 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -83.61 -173.61 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 121.897 1.731 . . . . 0.0 109.947 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 85.3 t80 179.24 124.77 0.22 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.232 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.9 Cg_endo -87.33 100.2 0.25 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.745 -1.773 . . . . 0.0 110.311 -0.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 53.4 p . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 110.933 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.499 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 50.2 mm-40 . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.417 0.627 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 2.9 ttp180 -78.57 79.72 4.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.44 -0.788 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.525 HG23 ' CB ' ' A' ' 10' ' ' TYR . 69.1 mt -89.56 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.854 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.553 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -48.91 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.439 1.114 . . . . 0.0 111.94 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.546 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . 2.0 tp -94.01 -38.17 11.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.445 ' HG3' HG23 ' A' ' 34' ' ' ILE . 11.7 tmtt? -90.28 -56.67 3.12 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.386 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 25.7 t70 -50.89 -42.01 58.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.605 ' CE1' ' CZ ' ' A' ' 14' ' ' PHE . 14.6 t80 -58.17 -61.27 2.68 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.793 0.806 . . . . 0.0 109.887 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.462 ' CB ' ' OG1' ' A' ' 19' ' ' THR . . . -56.3 -18.03 9.45 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.396 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -38.99 50.42 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.583 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -52.45 -42.84 64.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.555 -0.715 . . . . 0.0 109.173 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -114.46 -99.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.265 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.65 155.12 20.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -28.2 57.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 110.266 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -74.97 -12.33 60.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.423 ' HG2' ' CE2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -81.32 -58.19 3.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.219 -0.926 . . . . 0.0 108.617 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.462 ' OG1' ' CB ' ' A' ' 11' ' ' ALA . 15.5 m -50.68 -34.18 25.55 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.39 -38.62 55.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 110.898 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -35.01 79.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 110.327 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.7 -50.14 65.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.447 ' HB3' HG22 ' A' ' 25' ' ' VAL . 47.8 mt -80.66 -7.63 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.78 38.13 95.2 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 23' ' ' LEU . 3.0 t -112.88 178.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.087 -1.243 . . . . 0.0 109.917 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.465 ' O ' HD13 ' A' ' 30' ' ' ILE . 90.9 m-85 -100.65 141.03 34.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.193 -0.942 . . . . 0.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.455 ' HA ' HD11 ' A' ' 30' ' ' ILE . 5.2 mt-30 -46.95 -23.19 0.41 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t -72.38 -51.71 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.487 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.25 -26.13 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.066 -1.021 . . . . 0.0 110.053 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.52 HG21 ' CD1' ' A' ' 34' ' ' ILE . 1.3 mp -76.46 -55.8 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 2.6 m-80 -57.88 -14.12 5.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 110.545 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 -48.38 6.12 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.733 -1.229 . . . . 0.0 108.832 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -72.31 -3.1 21.84 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.132 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.546 ' CD1' ' HG ' ' A' ' 7' ' ' LEU . 9.5 mt -120.06 -49.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.272 -0.892 . . . . 0.0 110.547 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.566 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t60 -69.48 -7.75 40.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.967 -1.083 . . . . 0.0 110.098 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.96 -28.71 49.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.123 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.54 31.28 1.84 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -90.53 -176.97 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 82.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.273 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.568 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 4.1 mt -102.95 160.26 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 41.0 m-85 -153.35 160.71 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.078 -1.014 . . . . 0.0 110.529 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.546 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 3.7 mp -134.82 155.45 50.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 110.534 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 20.6 m -127.8 105.29 8.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 109.618 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.441 ' CG2' ' H ' ' A' ' 45' ' ' ASN . 0.7 OUTLIER -84.93 -148.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.087 -1.008 . . . . 0.0 110.974 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.499 ' OD1' ' HB2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER 38.37 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.252 0.549 . . . . 0.0 110.628 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.658 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 62.01 12.02 4.65 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.658 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 3.8 t70 135.47 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 124.147 0.979 . . . . 0.0 109.325 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.85 11.59 81.25 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -83.23 121.74 27.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.998 . . . . 0.0 110.232 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.2 118.4 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 110.375 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 3.7 m-85 -98.39 155.85 17.03 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.928 . . . . 0.0 108.541 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.467 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -142.31 86.74 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 110.419 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' O ' HG21 ' A' ' 40' ' ' ILE . 1.3 pt-20 -101.56 -177.12 3.34 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 110.192 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 56' E LYS . 0.3 OUTLIER -152.67 173.48 15.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.272 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.414 HG21 HG13 ' A' ' 56' D VAL . 86.7 t -142.95 151.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.987 -1.07 . . . . 0.0 110.515 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 158.41 30.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.5 t0 -57.55 -11.62 2.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.08 -1.013 . . . . 0.0 110.633 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 56' C GLU . . . -100.83 -38.62 3.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' C GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 56' B GLY . 0.6 OUTLIER 174.58 179.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 110.288 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.414 HG13 HG21 ' A' ' 55' ' ' VAL . 35.6 m -102.64 148.16 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.288 -0.882 . . . . 0.0 109.862 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -144.58 166.7 17.41 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 0.0 110.474 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.8 Cg_exo -80.81 179.79 5.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.457 1.767 . . . . 0.0 110.287 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 3.1 t80 -159.99 125.61 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.003 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 71.2 Cg_endo -88.82 47.78 1.05 Allowed 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.802 -1.749 . . . . 0.0 110.87 0.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 110.49 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 8.4 ttm180 -76.97 83.05 3.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.692 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.558 HG23 ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -77.43 -174.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.547 -0.721 . . . . 0.0 109.721 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.83 -178.78 5.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 111.45 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . 9.4 tp -92.33 -46.14 7.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.514 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.58 -65.71 0.99 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.881 -0.512 . . . . 0.0 110.07 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 10.3 t70 -45.03 -46.92 11.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 108.89 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.558 ' CG ' HG23 ' A' ' 5' ' ' ILE . 8.6 t80 -53.59 -62.44 1.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' CB ' HG23 ' A' ' 19' ' ' THR . . . -51.82 -20.73 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.501 -0.749 . . . . 0.0 109.722 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.9 ttm -72.62 -49.6 30.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.65 76.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.091 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.59 -83.13 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 110.356 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.58 150.05 12.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -31.0 69.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -1.172 . . . . 0.0 110.087 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 t -83.75 -14.61 51.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -82.43 -52.94 6.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.461 HG23 ' CB ' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -61.8 -31.39 71.61 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -47.1 55.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.657 -0.652 . . . . 0.0 110.02 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -69.72 -17.0 63.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.531 -0.731 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' HB3' ' CB ' ' A' ' 50' ' ' VAL . 1.3 m-20 -79.79 -34.86 39.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.173 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 19' ' ' THR . 7.0 mt -80.75 -25.77 37.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 110.144 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 86.34 63.88 1.48 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.465 ' CG2' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -154.04 147.45 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.225 -1.162 . . . . 0.0 109.766 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -47.56 167.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 110.136 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -87.62 -19.07 28.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.373 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 m -79.63 -63.57 1.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.091 -1.006 . . . . 0.0 109.94 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.48 -24.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.986 . . . . 0.0 109.262 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -68.45 -62.34 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.569 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 3.9 t-20 -55.76 -13.55 1.79 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.601 -0.687 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 4.6 mttp -93.96 -34.43 13.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 108.408 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.86 -8.15 59.66 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.518 ' CD1' HD11 ' A' ' 30' ' ' ILE . 21.9 mt -113.66 -49.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.753 . . . . 0.0 109.747 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 13.1 t60 -60.22 -39.79 87.86 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.741 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -49.64 -23.95 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.61 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.46 31.18 8.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -59.04 -177.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.116 . . . . 0.0 110.498 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -128.47 76.08 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.7 mt -113.16 167.73 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 111.047 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.412 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 79.3 m-85 -147.4 122.99 10.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 6.7 mp -90.84 142.41 27.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.978 -1.076 . . . . 0.0 111.56 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 1.2 m -110.15 103.88 12.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.509 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 56.5 mt -84.15 60.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.832 -1.167 . . . . 0.0 111.51 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -88.48 -146.16 0.15 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.836 -1.165 . . . . 0.0 110.28 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.597 ' HB2' ' CB ' ' A' ' 49' ' ' SER . . . 56.2 14.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.459 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 26.4 t70 88.98 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 123.164 0.585 . . . . 0.0 110.115 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.07 14.48 0.57 Allowed Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.048 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.597 ' CB ' ' HB2' ' A' ' 46' ' ' ALA . 8.1 t -84.65 159.29 20.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.898 -1.354 . . . . 0.0 109.62 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.434 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 21.7 t -112.46 122.18 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 0.0 110.83 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -113.12 -171.09 1.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.853 . . . . 0.0 109.627 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -146.53 154.24 41.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.49 106.75 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 110.091 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' D VAL . 5.6 mt-10 -83.57 165.5 19.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 t -144.97 129.23 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.088 -1.008 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 56' A ASP . 5.4 ttpp -146.83 94.53 2.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 65.1 t0 61.06 41.38 13.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.54 -0.725 . . . . 0.0 110.505 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 86.99 -11.15 65.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.9 tt0 -89.42 87.18 6.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 4.9 m -94.23 170.77 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.224 -0.923 . . . . 0.0 110.234 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' E LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.0 170.51 2.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 0.0 110.518 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 5.8 Cg_exo -80.53 166.39 19.88 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.474 1.776 . . . . 0.0 110.288 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.498 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 15.8 t80 -169.84 117.71 0.53 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -84.04 100.89 0.32 Allowed 'Cis proline' 0 C--N 1.316 -1.165 0 C-N-CA 122.758 -1.767 . . . . 0.0 110.285 -0.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 97.6 p . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 110.053 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.491 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 8.4 mm-40 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.308 0.575 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -83.88 65.16 8.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.591 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 30.6 mm -90.74 135.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.7 p -46.96 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.202 1.001 . . . . 0.0 111.254 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.537 ' CD2' ' CG1' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -91.81 -34.8 14.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.344 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -82.74 -69.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.844 -0.535 . . . . 0.0 110.174 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -44.39 -45.9 9.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 109.246 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.591 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 8.6 t80 -49.14 -59.47 3.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -46.81 -30.9 2.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 110.17 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -46.06 70.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -25.57 63.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 0.0 110.423 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -111.97 -64.34 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.309 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 155.58 160.44 9.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -75.07 -32.33 61.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -1.206 . . . . 0.0 109.903 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -9.67 59.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.751 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.61 -41.3 12.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.142 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 m -70.01 -24.53 63.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.517 -0.739 . . . . 0.0 109.615 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.67 20.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 0.0 110.393 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -75.99 -16.11 60.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -90.6 -44.35 9.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.499 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 mt -79.65 -31.06 41.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 110.322 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.36 16.03 36.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -116.02 147.71 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 109.938 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -64.62 153.08 40.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.612 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.465 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 2.5 mt-30 -47.97 -25.97 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.341 -0.85 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.0 -54.59 31.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.761 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . . . -46.08 -36.06 5.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.788 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.4 mp -63.24 -47.67 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 109.868 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 71.3 m-80 -66.35 -6.44 14.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -88.57 -44.02 10.95 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.722 -1.236 . . . . 0.0 108.982 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -72.66 -28.08 62.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.569 ' O ' ' CD ' ' A' ' 38' ' ' ARG . 49.3 mt -87.2 -51.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.477 -0.765 . . . . 0.0 109.91 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 20.5 t60 -68.46 -4.69 15.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.838 -1.164 . . . . 0.0 110.492 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -90.68 -59.37 2.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.032 -1.042 . . . . 0.0 111.411 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . -155.18 99.29 0.19 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.569 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -51.47 -164.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.868 -0.784 . . . . 0.0 111.523 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 1.1 tttt 73.03 48.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.584 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 17.0 mt -97.06 166.48 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.316 0.579 . . . . 0.0 110.316 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.6 m-85 -158.54 117.42 3.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -110.36 132.96 53.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.91 100.56 11.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.491 ' HB ' ' CB ' ' A' ' 3' ' ' GLN . 57.2 mt -84.39 55.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.707 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 46' ' ' ALA . 24.0 p30 -104.74 -122.08 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.059 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 42.48 30.42 0.21 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.975 -1.078 . . . . 0.0 109.839 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.7 t70 80.95 50.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.553 0.692 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 82.11 -9.53 56.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 46' ' ' ALA . 7.2 m -52.7 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.041 -1.27 . . . . 0.0 109.747 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.28 116.75 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 52' ' ' ALA . 5.5 t80 -120.55 140.48 51.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -96.1 150.97 19.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.033 -1.042 . . . . 0.0 110.07 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -159.73 85.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 110.138 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 56' D VAL . 6.0 mt-10 -84.69 169.65 14.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.093 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 56' D VAL . 1.5 p -161.39 148.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.117 -0.99 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.425 ' N ' HG21 ' A' ' 55' ' ' VAL . 8.2 tptp -157.4 112.95 2.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 110.235 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' A ASP . . . . . . . . . . . . . 31.4 t70 45.77 49.0 11.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.873 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 78.1 35.52 34.19 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 20.2 tt0 -137.85 84.16 2.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -1.169 . . . . 0.0 109.887 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 3.2 m -96.39 153.98 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.168 -0.957 . . . . 0.0 111.015 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' E LYS . . . . . . . . . . . . . 3.4 pttt -148.13 168.67 10.65 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.852 . . . . 0.0 110.107 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -82.81 -82.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.35 1.71 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER 56.92 107.36 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 0.0 109.951 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.41 140.23 54.94 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.082 -2.049 . . . . 0.0 110.381 -0.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.335 179.89 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.582 ' CB ' ' ND2' ' A' ' 45' ' ' ASN . 4.6 mm-40 . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.606 0.717 . . . . 0.0 109.221 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.55 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 2.7 ttm180 -78.95 82.5 5.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.62 -0.675 . . . . 0.0 109.634 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 10' ' ' TYR . 12.5 mt -85.67 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.07 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.4 p -46.95 178.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.157 0.98 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.533 ' CD2' HG12 ' A' ' 34' ' ' ILE . 1.5 tp -91.58 -35.26 14.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' ASP . 2.3 tmtt? -79.77 -68.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 6' ' ' THR . 5.6 t0 -45.28 -55.12 6.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.655 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CZ ' HD11 ' A' ' 44' ' ' ILE . 50.2 t80 -42.9 -60.05 1.75 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.418 -0.801 . . . . 0.0 111.219 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 14' ' ' PHE . . . -60.38 -29.07 68.71 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.161 -0.962 . . . . 0.0 110.424 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -24.21 61.72 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -71.86 -47.82 50.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.518 -0.739 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 10' ' ' TYR . 26.9 p90 -111.42 -43.52 3.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.586 -1.321 . . . . 0.0 111.434 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 14' ' ' PHE . . . 168.24 162.92 21.28 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.033 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -90.6 -25.22 20.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.449 -1.03 . . . . 0.0 110.672 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.468 HG21 ' N ' ' A' ' 18' ' ' LYS . 13.5 t -73.39 -18.28 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.982 . . . . 0.0 110.236 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 7.8 mttt -90.62 -34.52 15.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.482 ' OG1' ' CZ ' ' A' ' 14' ' ' PHE . 18.4 m -67.58 -32.09 72.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.68 -27.06 29.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.65 -0.656 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -83.75 -18.38 38.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 110.141 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -84.04 -41.55 17.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.058 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.485 ' HB3' ' HG2' ' A' ' 59' ' ' PRO . 90.1 mt -79.91 -60.02 2.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 110.037 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' HG11 ' A' ' 25' ' ' VAL . . . 130.48 43.98 0.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 24' ' ' GLY . 3.7 m -142.3 152.96 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -67.96 169.67 9.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.337 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.462 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 33.3 mt-30 -65.16 -35.36 80.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.912 . . . . 0.0 110.27 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.9 p -63.78 -54.44 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.767 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . . . -52.79 -23.2 6.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.131 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -71.2 -62.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.579 -0.701 . . . . 0.0 109.29 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.545 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -62.15 -8.03 4.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 110.447 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 15.1 mtpp -90.46 -38.21 13.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.808 -1.183 . . . . 0.0 108.37 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.58 -9.03 56.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.533 HG12 ' CD2' ' A' ' 7' ' ' LEU . 19.3 mt -101.15 -46.18 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 5.2 t60 -68.67 -56.85 6.81 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.238 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.98 40.46 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.281 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' HD13 ' A' ' 40' ' ' ILE . . . -176.19 79.12 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.526 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 23.0 mmm-85 -84.52 -173.43 4.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -1.068 . . . . 0.0 110.53 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 4.3 mtmt 57.63 79.38 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.525 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 7.1 mt -135.04 160.19 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.0 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.55 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 70.5 m-85 -153.67 154.38 34.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 110.349 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.489 HD22 ' CB ' ' A' ' 52' ' ' ALA . 4.1 mp -144.92 129.96 18.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.163 -0.961 . . . . 0.0 111.102 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.539 ' CG2' ' HA2' ' A' ' 48' ' ' GLY . 2.1 m -83.51 107.18 15.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 108.442 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.576 HD11 ' CZ ' ' A' ' 10' ' ' TYR . 2.6 mt -129.15 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.048 -1.032 . . . . 0.0 111.689 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.582 ' ND2' ' CB ' ' A' ' 3' ' ' GLN . 11.5 m-80 64.22 -165.06 0.24 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.8 0.81 . . . . 0.0 112.122 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.76 0.96 3.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -136.77 41.46 2.52 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.539 ' HA2' ' CG2' ' A' ' 43' ' ' THR . . . -169.02 -27.17 0.02 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 120.038 -1.077 . . . . 0.0 110.633 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.575 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 0.4 OUTLIER 59.77 -92.74 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.855 -1.379 . . . . 0.0 107.715 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.575 ' CG2' ' O ' ' A' ' 49' ' ' SER . 5.5 t -161.2 77.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.299 -0.876 . . . . 0.0 110.455 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.98 137.92 43.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.504 -0.748 . . . . 0.0 109.042 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -129.59 113.91 15.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 110.836 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.72 121.58 23.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.789 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 56' D VAL . 7.9 pt-20 -91.21 159.0 16.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.43 139.9 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.266 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 56' C GLU . 0.7 OUTLIER -157.4 78.1 0.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.948 -1.095 . . . . 0.0 110.932 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 56' ' ' LYS . 31.0 t70 40.35 76.78 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.804 . . . . 0.0 111.279 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 83.51 -5.88 75.72 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.66 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' C GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 1.1 tt0 -117.68 83.37 1.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.894 -1.356 . . . . 0.0 110.342 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 56' E LYS . 1.0 OUTLIER -124.02 124.12 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.488 -0.758 . . . . 0.0 109.702 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.31 164.13 40.94 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.482 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 3.8 Cg_exo -82.8 97.37 0.85 Allowed 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.015 1.81 . . . . 0.0 110.762 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -133.07 140.59 37.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 110.068 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.485 ' HG2' ' HB3' ' A' ' 23' ' ' LEU . 59.9 Cg_endo -92.97 52.48 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.495 -1.877 . . . . 0.0 110.028 -0.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 36.7 t . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 110.719 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.471 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 2.7 mt-30 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.512 0.672 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -79.89 85.04 5.57 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.822 0.82 . . . . 0.0 111.869 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 4.6 mm -89.59 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.57 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 2.6 p -65.46 -178.89 0.56 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 111.405 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.572 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -87.29 -26.7 23.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.47 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HG2' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -79.52 -77.93 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.271 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 8' ' ' LYS . 7.9 t70 -42.87 -59.23 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.995 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 8.6 t80 -41.96 -54.65 3.41 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.246 -0.909 . . . . 0.0 110.555 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.45 -38.25 71.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.181 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.5 ttt -63.54 -30.11 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.502 -0.749 . . . . 0.0 109.998 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.38 -41.01 28.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -109.37 -57.26 2.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.322 -0.861 . . . . 0.0 109.902 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 154.68 156.96 7.95 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 110.147 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 31.1 p -67.76 -11.5 58.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.919 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -85.91 -46.79 10.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.323 -0.861 . . . . 0.0 108.917 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -27.57 63.24 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.27 -32.41 22.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.669 -0.644 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.1 tmtp? -74.29 -18.63 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.908 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.94 -46.76 10.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 0.0 110.069 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.43 HD23 ' HD3' ' A' ' 59' ' ' PRO . 41.8 mt -80.87 -19.14 45.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.08 39.81 94.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.79 179.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -1.186 . . . . 0.0 110.206 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.64 142.41 49.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.297 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -11.5 56.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.92 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -72.43 -54.78 8.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.975 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.66 -25.15 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.59 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 30' ' ' ILE . 50.0 mt -78.57 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.586 -0.696 . . . . 0.0 109.797 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -58.52 -9.14 1.48 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 110.63 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -93.39 -42.22 9.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.699 -1.251 . . . . 0.0 108.228 178.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -75.24 -11.11 60.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG23 ' HG2' ' A' ' 8' ' ' LYS . 65.2 mt -105.83 -54.17 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 31.6 t60 -54.97 -23.47 19.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.77 85.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.53 37.93 1.39 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.64 -164.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -1.129 . . . . 0.0 110.633 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HE2' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -145.45 87.64 1.81 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.581 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 27.3 mt -114.91 172.09 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.426 -0.797 . . . . 0.0 110.879 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 38.5 m-85 -160.01 141.67 12.78 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.572 ' CD1' ' CD1' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -114.89 109.29 17.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.906 -1.121 . . . . 0.0 109.642 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.486 ' OG1' ' HB3' ' A' ' 4' ' ' ARG . 1.4 m -75.93 102.12 5.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 108.746 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.507 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.9 mt -78.17 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 0.0 110.471 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 9.1 p-10 34.28 -140.29 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.964 -0.46 . . . . 0.0 111.309 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.639 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 49.1 26.35 1.4 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 50.7 t0 97.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 123.697 0.799 . . . . 0.0 108.87 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.09 9.78 43.19 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.93 113.58 3.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.794 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.1 t -86.29 100.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 110.334 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 28.5 m-85 -104.73 92.77 4.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.1 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 58' ' ' PHE . . . -88.48 135.47 33.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.05 -1.031 . . . . 0.0 109.361 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' A' ' 56' E LYS . 0.8 OUTLIER -156.76 135.17 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.15 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.439 ' O ' HG21 ' A' ' 55' ' ' VAL . 3.2 tm-20 -83.73 171.39 13.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.492 -0.755 . . . . 0.0 109.447 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 54' ' ' GLU . 10.4 t -140.28 141.61 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 110.441 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 56' A ASP . 0.8 OUTLIER -157.02 120.4 4.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 28.3 t70 57.74 -90.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . -146.35 43.76 0.87 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.7 tt0 -156.65 123.81 5.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -1.155 . . . . 0.0 110.35 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.401 ' HB ' ' OE1' ' A' ' 53' ' ' GLU . 10.0 m -109.97 155.99 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 11.9 mttm -135.78 164.47 43.11 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.863 . . . . 0.0 109.486 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -82.6 150.71 14.82 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.917 1.745 . . . . 0.0 111.006 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.9 t80 -146.16 128.87 8.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.435 ' C ' ' OG ' ' A' ' 60' ' ' SER . 9.6 Cg_endo -89.16 52.92 0.66 Allowed 'Cis proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.98 -1.675 . . . . 0.0 110.648 0.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.4 mm-40 . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 121.298 0.57 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -79.51 74.9 6.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.713 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.56 HD11 ' CD1' ' A' ' 10' ' ' TYR . 10.2 mt -90.67 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -70.65 -173.45 0.76 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.069 0.938 . . . . 0.0 111.491 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . 1.6 tp -93.99 -38.61 11.07 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.516 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 1.3 tmtt? -90.11 -67.39 0.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.51 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 9.5 m-20 -43.9 -44.11 6.83 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.566 ' CB ' ' O ' ' A' ' 6' ' ' THR . 8.4 t80 -57.96 -54.29 48.56 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.975 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -59.08 -20.73 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -21.6 21.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.969 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.31 -12.95 25.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.25 -27.76 4.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.965 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.69 130.92 3.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.77 72.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -1.165 . . . . 0.0 109.813 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 15.5 p -82.07 -14.08 56.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -55.37 4.8 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.42 -0.8 . . . . 0.0 108.87 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.529 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 66.7 m -57.18 -32.08 66.09 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.41 -44.97 63.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.9 tmtt? -80.25 1.63 27.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.843 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 50' ' ' VAL . 53.1 m-20 -89.9 -43.07 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER -115.25 -8.55 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.677 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.97 67.95 1.26 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.58 ' CG1' ' CD1' ' A' ' 30' ' ' ILE . 60.8 t -142.88 140.0 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 110.34 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' O ' HG12 ' A' ' 30' ' ' ILE . 4.3 m-85 -75.0 139.63 43.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 0.0 110.184 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -46.82 -23.84 0.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -69.92 -58.8 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' N ' ' OG ' ' A' ' 28' ' ' SER . . . -46.96 -25.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.671 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.58 ' CD1' ' CG1' ' A' ' 25' ' ' VAL . 2.7 mm -71.29 -56.27 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.765 . . . . 0.0 109.986 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -62.81 -8.96 7.87 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 1.9 mttp -94.74 -40.48 9.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.748 -1.22 . . . . 0.0 108.612 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -79.86 -9.45 59.67 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' A' ' 8' ' ' LYS . 76.5 mt -108.8 -49.12 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.53 -0.731 . . . . 0.0 110.067 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.579 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 16.8 t-160 -63.39 -33.41 75.48 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.947 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -59.0 -21.59 59.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.64 30.3 13.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -78.3 -173.5 3.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.227 -1.161 . . . . 0.0 110.256 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.76 75.36 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.174 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.544 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 62.1 mt -106.17 169.25 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 50.9 m-85 -156.56 158.83 37.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 3.1 mp -134.4 114.96 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.0 110.492 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.531 ' O ' ' CG2' ' A' ' 43' ' ' THR . 13.0 t -93.55 102.95 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 109.848 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.518 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 1.9 mp -91.68 130.23 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.055 . . . . 0.0 110.453 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.65 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 8.2 m-20 -50.53 -19.52 0.91 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.65 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 91.09 -19.52 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.66 -11.96 57.97 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.34 -22.86 5.85 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.482 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 5.0 t -60.04 148.63 34.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 109.583 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 22' ' ' ASP . 52.9 t -133.4 123.32 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.991 -1.068 . . . . 0.0 111.047 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.517 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 15.0 t80 -120.64 119.18 32.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 108.933 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -93.61 154.28 17.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.921 -1.112 . . . . 0.0 111.241 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -160.35 142.53 12.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.563 -0.711 . . . . 0.0 109.844 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 56' D VAL . 11.7 tm-20 -121.47 167.18 13.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.4 116.49 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.463 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' B GLY . 11.3 ttmt -143.2 153.86 43.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 110.156 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' LYS . 28.9 t0 -43.73 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.465 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.66 -64.34 0.42 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -170.29 171.78 6.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.471 -1.017 . . . . 0.0 110.237 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 21.4 m -93.22 133.26 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 110.16 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 mmtp -116.87 132.61 23.33 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.978 . . . . 0.0 110.747 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.9 Cg_exo -80.23 125.81 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.218 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.511 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -140.88 144.54 35.93 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HG3' HG23 ' A' ' 25' ' ' VAL . 60.3 Cg_endo -91.47 48.53 1.27 Allowed 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.275 -1.969 . . . . 0.0 110.578 0.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.627 ' CG ' ' O ' ' A' ' 3' ' ' GLN 0.257 0.7 OUTLIER . . . . . 0 C--O 1.211 -0.927 0 CA-C-O 122.637 1.208 . . . . 0.0 108.882 . . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -78.59 73.55 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.922 -1.111 . . . . 0.0 111.375 -178.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.557 HD11 ' CD1' ' A' ' 10' ' ' TYR . 5.1 mt -88.28 145.73 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.145 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 2.3 p -66.53 -173.02 0.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.753 0.787 . . . . 0.0 111.246 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.585 HD13 ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -90.44 -26.62 19.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HG2' HG22 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -81.94 -73.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.071 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.7 -56.29 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.045 -1.034 . . . . 0.0 109.709 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CB ' ' O ' ' A' ' 6' ' ' THR . 6.1 t80 -46.74 -53.81 11.02 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 7' ' ' LEU . . . -56.21 -33.16 65.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ttm -63.79 -40.19 96.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.258 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 -28.37 50.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.55 -74.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 110.171 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.16 148.19 5.83 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.457 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 12.9 tp60 -58.17 -39.0 77.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -1.102 . . . . 0.0 109.845 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.51 -14.21 59.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 0.0 110.364 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -79.49 -56.31 4.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.199 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.436 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 2.1 m -62.51 -29.25 70.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -75.58 -29.82 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 110.259 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -82.72 -14.57 54.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -90.14 -25.39 20.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 109.949 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 19' ' ' THR . 95.6 mt -79.96 -35.85 37.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 110.358 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.97 23.17 30.77 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -132.81 157.16 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -1.095 . . . . 0.0 110.074 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 25' ' ' VAL . 49.5 m-85 -46.6 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 110.437 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -85.11 -13.78 49.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 110.559 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 t -76.91 -56.39 4.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.955 . . . . 0.0 110.315 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.81 -25.3 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 109.966 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -76.27 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.846 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -58.82 -7.91 1.17 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.427 -0.796 . . . . 0.0 111.132 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -91.39 -40.37 11.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.514 -1.366 . . . . 0.0 108.169 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.442 ' O ' ' HD2' ' A' ' 38' ' ' ARG . . . -75.29 -18.84 59.96 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 7' ' ' LEU . 37.7 mt -96.71 -52.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.423 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 72.3 t60 -52.06 -23.03 4.65 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.295 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.42 -55.5 13.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.814 . . . . 0.0 110.464 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . 124.57 8.96 5.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -51.34 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.401 -1.058 . . . . 0.0 111.835 -179.489 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.86 81.18 1.86 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.492 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.518 ' CG1' ' HG2' ' A' ' 38' ' ' ARG . 1.8 mt -97.07 157.5 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.174 -0.954 . . . . 0.0 110.78 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.448 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 97.9 m-85 -150.13 98.16 2.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.453 -0.779 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.585 ' CD2' HD13 ' A' ' 7' ' ' LEU . 7.8 mp -85.13 101.82 12.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.139 -0.976 . . . . 0.0 111.251 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 4' ' ' ARG . 2.3 m -77.78 100.73 6.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.166 -0.958 . . . . 0.0 108.842 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 49' ' ' SER . 5.4 mt -96.5 132.47 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.987 . . . . 0.0 111.453 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.644 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 14.2 m-20 -54.66 -17.86 3.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.701 -0.624 . . . . 0.0 110.597 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.644 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 90.92 -15.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.33 -17.01 28.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.88 -27.06 3.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -57.09 112.04 1.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.243 . . . . 0.0 109.392 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.449 HG21 HG22 ' A' ' 44' ' ' ILE . 29.2 t -109.18 126.31 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.463 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 7.1 m-85 -116.64 108.79 16.36 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -88.06 119.0 28.01 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.034 -1.042 . . . . 0.0 110.615 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 56' E LYS . 0.0 OUTLIER -148.18 121.33 8.9 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.358 -0.839 . . . . 0.0 110.567 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 56' D VAL . 9.3 mt-10 -81.25 154.76 26.43 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.05 115.01 2.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.685 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -148.99 121.91 8.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 109.624 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 26.1 t70 58.42 16.78 4.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 100.81 -27.68 19.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 111.57 3.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -1.196 . . . . 0.0 110.505 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 3.3 m -111.71 146.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 110.324 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 7.3 mtpt -145.46 157.89 51.61 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.136 -0.978 . . . . 0.0 110.523 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -83.4 174.5 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.776 1.651 . . . . 0.0 110.222 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 84.4 t80 176.98 113.35 0.13 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 110.303 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 5.6 Cg_exo -78.05 108.21 1.15 Allowed 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.589 -1.838 . . . . 0.0 110.53 0.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 14.1 p . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 110.56 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.3 mt-30 . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 121.264 0.554 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -79.13 81.89 5.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.896 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.593 HD11 ' CE1' ' A' ' 10' ' ' TYR . 2.0 mt -90.46 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.477 -0.764 . . . . 0.0 110.063 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -74.52 -169.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.059 0.933 . . . . 0.0 111.7 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 33' ' ' ALA . 5.2 tp -91.44 -42.48 10.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.541 ' CG ' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -91.11 -58.05 2.6 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.479 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -46.19 -49.33 17.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CE1' HD11 ' A' ' 5' ' ' ILE . 3.6 t80 -56.32 -57.04 13.95 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.818 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.42 -20.21 2.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.536 -0.727 . . . . 0.0 109.926 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.47 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 1.5 ttp -71.65 -44.84 63.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 110.362 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -21.95 62.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.199 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 13.2 m-85 -112.02 -89.91 0.51 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.64 151.76 14.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.54 -35.98 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -1.107 . . . . 0.0 109.942 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.9 t -78.48 -11.84 59.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -47.75 9.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.23 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.426 HG21 HD13 ' A' ' 23' ' ' LEU . 2.5 m -67.7 -26.99 66.44 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.441 -0.787 . . . . 0.0 109.341 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.48 -37.98 50.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -0.757 . . . . 0.0 110.271 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.76 68.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.532 ' OD2' ' CG1' ' A' ' 50' ' ' VAL . 3.3 t70 -73.9 -38.48 64.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HB2' HG21 ' A' ' 25' ' ' VAL . 24.4 mt -84.99 -12.41 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.03 49.9 37.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -128.27 176.93 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.194 -1.18 . . . . 0.0 109.902 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 1.4 m-85 -93.48 148.02 22.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.88 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.459 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.4 tt0 -44.9 -47.73 11.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.848 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -53.47 -56.58 15.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.762 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.57 -32.03 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.502 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 3.1 mm -66.34 -54.48 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.789 0.804 . . . . 0.0 109.856 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -52.41 -17.16 1.08 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.546 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -95.69 -36.59 11.14 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.439 -1.413 . . . . 0.0 108.924 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -78.64 2.95 17.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.53 -0.731 . . . . 0.0 109.178 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.541 ' CG2' ' CG ' ' A' ' 8' ' ' LYS . 20.3 mt -135.55 -46.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.591 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 3.4 t60 -79.62 -11.61 59.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.209 -0.932 . . . . 0.0 110.512 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -90.27 -24.2 20.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.131 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.65 51.13 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -90.78 130.38 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.331 -1.1 . . . . 0.0 110.592 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.35 65.49 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 109.02 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.516 ' CG1' ' HG3' ' A' ' 38' ' ' ARG . 1.1 mt -94.28 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.509 -0.744 . . . . 0.0 110.74 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 95.7 m-85 -142.75 121.63 12.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.413 -0.804 . . . . 0.0 110.161 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 7' ' ' LEU . 5.4 mp -105.38 113.52 27.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.898 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 0.5 OUTLIER -90.05 103.06 15.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.12 -0.988 . . . . 0.0 108.82 179.094 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 6.6 mt -101.11 125.61 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.081 -1.012 . . . . 0.0 110.737 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -91.88 -178.08 4.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.342 -0.848 . . . . 0.0 110.334 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.86 -2.77 7.9 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.68 -2.16 57.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.438 -0.789 . . . . 0.0 110.436 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -6.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.411 ' O ' HG21 ' A' ' 44' ' ' ILE . 3.8 t -56.16 160.59 2.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.862 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.532 ' CG1' ' OD2' ' A' ' 22' ' ' ASP . 95.5 t -137.31 106.04 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.469 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 9.9 m-85 -88.92 84.41 6.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.68 110.55 9.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 109.049 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 56' E LYS . 0.4 OUTLIER -146.39 122.63 10.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.094 -1.004 . . . . 0.0 111.65 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 56' D VAL . 0.0 OUTLIER -78.73 159.56 27.88 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -154.36 132.84 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.568 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 56' C GLU . 0.2 OUTLIER -160.22 78.77 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.402 ' O ' ' CG ' ' A' ' 56' A ASP . 15.4 t0 51.08 46.01 27.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.528 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 114.44 -30.8 6.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' C GLU . . . . . 0.509 ' CB ' ' HB3' ' A' ' 56' ' ' LYS . 4.3 mt-10 -79.06 103.61 9.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.171 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -145.73 153.88 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pttt -171.3 161.37 5.24 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.131 -0.981 . . . . 0.0 110.483 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 58' ' ' PHE . 5.9 Cg_exo -81.29 48.46 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.747 1.631 . . . . 0.0 111.556 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.471 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 15.7 t80 -41.42 122.54 2.18 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.144 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' SER . 2.4 Cg_endo -82.38 103.38 0.51 Allowed 'Cis proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.517 -1.868 . . . . 0.0 110.48 -0.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' PRO . 8.0 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.231 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.0 mm-40 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.377 0.608 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 33.6 ttt-85 -79.68 84.03 5.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.559 HD11 ' CD1' ' A' ' 10' ' ' TYR . 5.9 mt -88.62 169.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.571 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -77.64 -174.12 3.29 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.04 0.924 . . . . 0.0 111.898 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.535 HD23 ' CD1' ' A' ' 40' ' ' ILE . 3.5 tp -91.78 -41.02 10.9 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.508 ' CG ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.31 -53.29 4.52 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.528 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -53.51 -50.92 64.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.571 ' CB ' ' O ' ' A' ' 6' ' ' THR . 7.2 t80 -54.8 -54.69 38.89 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.641 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.486 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -53.03 -25.93 13.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.493 -0.754 . . . . 0.0 109.845 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 17.9 tpp -73.97 -36.84 64.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.852 . . . . 0.0 109.96 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.06 -30.03 60.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.93 -66.34 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.74 160.68 11.91 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.487 ' NE2' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.81 -35.14 67.26 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 0.0 109.67 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.423 HG21 ' N ' ' A' ' 18' ' ' LYS . 7.3 t -83.66 -14.14 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' HG21 ' A' ' 17' ' ' THR . 0.2 OUTLIER -84.43 -47.04 11.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 108.976 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m -64.24 -30.69 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.87 -30.16 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.539 -0.726 . . . . 0.0 109.713 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -76.3 -34.84 59.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.522 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 3.2 m-20 -66.39 -35.32 80.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.786 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.433 HD21 ' HD3' ' A' ' 59' ' ' PRO . 74.9 mt -81.28 -34.64 31.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 0.0 110.196 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.97 48.0 5.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.48 -179.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -1.121 . . . . 0.0 110.132 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -70.18 171.54 9.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.766 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.465 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.7 tt0 -87.94 -21.02 25.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -0.808 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 p -66.24 -45.38 80.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 109.968 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -21.48 16.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.741 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.487 HG23 ' NE2' ' A' ' 16' ' ' GLN . 1.7 mp -80.01 -50.93 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.42 -0.8 . . . . 0.0 109.724 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -71.18 -2.34 15.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -101.47 -42.22 6.34 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.909 -1.12 . . . . 0.0 108.155 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -74.65 -18.16 60.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.529 HG12 ' CD2' ' A' ' 7' ' ' LEU . 45.5 mt -102.11 -50.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.442 -0.786 . . . . 0.0 110.246 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 2.2 t60 -60.56 -16.46 37.96 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.9 -1.125 . . . . 0.0 109.817 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 -46.08 17.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.6 7.22 5.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -51.58 161.96 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -1.182 . . . . 0.0 110.172 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 5.4 mmtt -115.88 70.27 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.1 mt -90.55 161.3 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.816 . . . . 0.0 110.15 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 48.6 m-85 -151.26 114.03 4.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 42' ' ' LEU . 7.3 mp -80.52 141.69 34.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 2.8 m -116.71 103.28 10.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.38 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 49' ' ' SER . 1.2 mt -105.12 130.66 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.731 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER -105.25 -172.22 2.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.925 179.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.26 -2.2 18.09 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -161.67 21.53 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -90.7 -5.36 68.9 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.538 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 0.5 OUTLIER 60.09 -94.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.522 ' CG1' ' HB3' ' A' ' 22' ' ' ASP . 1.7 t -162.3 112.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 0.0 110.867 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 20.0 m-85 -101.69 151.99 21.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 108.995 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . -127.03 99.62 5.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.873 -1.142 . . . . 0.0 111.051 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 40' ' ' ILE . 1.8 mt-10 -101.86 169.95 8.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.611 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -150.51 153.56 36.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.927 -1.108 . . . . 0.0 110.587 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 5.8 t -150.94 118.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 110.114 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 0.2 OUTLIER -146.37 -168.8 3.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 56' B GLY . 15.3 t0 -41.25 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.462 -0.774 . . . . 0.0 110.306 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 42.32 57.21 3.79 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 mt-10 -160.42 84.87 0.71 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.244 . . . . 0.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.451 ' O ' HG21 ' A' ' 56' D VAL . 4.5 m -102.07 148.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.0 pttt -172.62 166.19 3.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 110.345 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.0 Cg_endo -88.1 -83.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.867 1.712 . . . . 0.0 110.558 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.542 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 59.19 109.57 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.367 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 5.8 Cg_exo -77.39 140.4 63.45 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.456 -1.893 . . . . 0.0 109.923 -0.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.425 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 33.2 t . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.054 -1.029 . . . . 0.0 110.358 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -79.4 75.77 6.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 10' ' ' TYR . 54.4 mt -90.82 177.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -87.52 -171.03 3.27 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.453 1.12 . . . . 0.0 112.496 -178.761 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.565 HD21 ' CD1' ' A' ' 40' ' ' ILE . 3.5 tp -92.14 -52.42 4.7 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 123.307 1.527 . . . . 0.0 107.203 176.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.453 ' HB2' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.45 -57.54 3.2 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.229 179.618 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.539 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -47.67 -47.87 29.28 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 6' ' ' THR . 27.0 t80 -52.44 -60.19 3.53 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.396 -0.922 . . . . 0.0 109.659 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.7 -26.57 2.38 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.557 0.694 . . . . 0.0 109.577 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.461 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.42 -52.65 44.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.995 179.931 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 -64.36 -31.85 73.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.698 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.45 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 7.5 m-30 -109.75 -80.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 110.152 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 173.75 39.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.441 ' HG3' ' HG2' ' A' ' 27' ' ' GLN . 9.1 tp60 -79.1 -32.3 44.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -1.14 . . . . 0.0 110.075 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -67.96 -21.6 65.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.853 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 14' ' ' PHE . 6.5 mttt -79.74 -38.33 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.867 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.18 -14.18 61.31 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.15 -47.07 16.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 0.0 109.669 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -12.13 60.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.731 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.566 ' OD1' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -77.3 -55.35 5.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HG ' ' OD2' ' A' ' 22' ' ' ASP . 10.9 mt -86.22 -14.37 44.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.292 -0.88 . . . . 0.0 110.151 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.58 31.06 46.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.02 178.5 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -1.075 . . . . 0.0 109.75 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' O ' HD13 ' A' ' 30' ' ' ILE . 57.0 m-85 -89.01 132.95 34.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -0.992 . . . . 0.0 110.2 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.474 ' HA ' HD11 ' A' ' 30' ' ' ILE . 17.1 mt-30 -41.71 -29.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 110.264 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.65 -18.87 8.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.452 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.535 HG21 ' CD1' ' A' ' 34' ' ' ILE . 1.6 mp -86.2 -43.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.044 -1.035 . . . . 0.0 110.315 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.3 t-20 -67.16 -9.92 44.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.235 -0.915 . . . . 0.0 110.206 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -94.52 -48.85 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 108.186 178.482 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -67.83 -16.39 64.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.557 ' O ' ' CD ' ' A' ' 38' ' ' ARG . 7.3 mt -95.93 -64.18 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 19.2 t-160 -49.71 -19.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.651 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -76.56 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.588 -0.695 . . . . 0.0 111.78 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 39' ' ' LYS . . . -132.59 87.83 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 15.6 mmm-85 -57.19 108.1 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.941 . . . . 0.0 111.049 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.497 ' HD2' ' HD2' ' A' ' 56' ' ' LYS . 11.7 pttm 179.21 42.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.582 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 15.8 mt -102.24 164.18 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.996 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 58.6 m-85 -156.74 110.54 2.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.546 ' CD2' HD13 ' A' ' 7' ' ' LEU . 5.3 mp -99.44 144.1 28.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 112.183 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 49' ' ' SER . 1.5 m -96.1 110.92 23.09 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 176.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -89.12 175.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 113.048 -176.369 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.578 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 36.8 p30 -60.87 -133.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.246 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.592 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 57.35 43.38 23.45 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 35.5 t70 69.22 26.33 5.46 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -176.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.535 ' O ' ' CG2' ' A' ' 43' ' ' THR . . . -124.61 -13.9 3.67 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 43' ' ' THR . 11.9 m 61.2 133.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -1.057 . . . . 0.0 108.441 -178.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.601 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 23.1 t -78.41 136.54 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.701 -1.249 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 50' ' ' VAL . 20.9 m-85 -165.61 177.84 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.742 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -144.97 133.82 22.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 109.981 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 56' E LYS . 18.2 tt0 -154.46 117.05 4.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 0.0 110.916 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' CG ' HG12 ' A' ' 40' ' ' ILE . 15.2 mt-10 -80.77 153.54 27.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 8.7 t -146.67 123.37 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.94 -1.1 . . . . 0.0 110.979 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -147.35 141.02 25.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.706 . . . . 0.0 109.208 179.403 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -40.53 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 110.42 -179.357 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.41 -48.51 0.53 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 tt0 -179.33 163.92 1.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.257 -1.143 . . . . 0.0 110.718 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 56' E LYS . 15.2 m -112.88 170.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 15.8 mttt -143.11 160.34 52.78 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 110.477 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 1.3 Cg_endo -85.26 -65.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.887 1.725 . . . . 0.0 110.2 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.55 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 28.4 t80 57.09 99.63 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.519 -0.738 . . . . 0.0 110.611 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.3 152.38 81.21 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.827 -2.155 . . . . 0.0 110.427 0.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.9 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.053 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 121.322 0.582 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 5.8 ttp180 -77.82 82.15 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.432 -0.793 . . . . 0.0 109.927 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 10' ' ' TYR . 11.2 mm -90.73 163.78 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -77.1 -171.88 2.18 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.121 0.962 . . . . 0.0 111.952 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.566 ' CD1' ' CD1' ' A' ' 23' ' ' LEU . 4.9 tp -91.62 -40.04 11.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.542 ' HG3' ' CG2' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -90.79 -51.43 5.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.431 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.452 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 1.6 t0 -54.91 -43.57 73.39 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.549 ' HB2' HG21 ' A' ' 5' ' ' ILE . 2.3 t80 -62.94 -55.07 29.1 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.196 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.26 -26.57 18.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.637 -0.664 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ttm -71.79 -36.25 70.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.828 . . . . 0.0 110.053 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.76 -39.21 57.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.675 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.74 -100.9 0.23 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.254 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.7 176.02 32.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -88.28 -30.5 19.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -1.068 . . . . 0.0 110.134 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -84.34 -28.25 27.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -62.16 1.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -53.29 -35.46 60.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.349 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.534 ' CA ' ' O ' ' A' ' 24' ' ' GLY . . . -58.24 -41.47 84.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -57.47 -45.08 85.19 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.8 m-20 -92.19 -5.19 53.01 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.432 -0.792 . . . . 0.0 112.791 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.566 ' CD1' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -164.39 62.74 0.14 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.47 -1.394 . . . . 0.0 109.92 -179.645 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.534 ' O ' ' CA ' ' A' ' 20' ' ' ALA . . . 127.53 74.45 0.19 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.348 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.583 HG21 ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.58 -11.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.92 -0.753 . . . . 0.0 109.842 -177.198 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' SER . 8.1 m-85 -101.71 98.23 8.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -37.12 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 111.53 -178.691 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' TYR . 67.8 m -82.63 -61.12 1.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.79 -1.194 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.92 -22.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.077 -1.015 . . . . 0.0 109.109 179.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.65 -64.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.523 -0.736 . . . . 0.0 109.933 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.7 OUTLIER -52.07 -15.67 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.484 -0.76 . . . . 0.0 111.252 -179.612 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -93.08 -39.8 10.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.435 -1.416 . . . . 0.0 109.028 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.498 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -76.31 -9.71 58.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.462 -0.774 . . . . 0.0 108.942 178.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.542 ' CG2' ' HG3' ' A' ' 8' ' ' LYS . 16.5 mt -111.98 -52.36 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 7.5 t-160 -57.63 -31.76 66.57 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.204 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 38' ' ' ARG . . . -90.05 -45.97 8.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.472 -0.768 . . . . 0.0 109.673 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.02 85.44 1.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 38' ' ' ARG . 2.5 mpt_? -90.1 49.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.266 . . . . 0.0 109.27 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER 42.46 53.96 4.5 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.854 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.549 ' C ' ' CD1' ' A' ' 41' ' ' PHE . 4.2 mt -105.23 154.8 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 110.082 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 70.8 m-85 -149.89 167.58 26.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.29 -0.881 . . . . 0.0 110.066 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.528 HD23 ' CD1' ' A' ' 23' ' ' LEU . 4.2 mp -143.93 149.01 36.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.953 -1.092 . . . . 0.0 110.965 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.2 m -127.62 97.36 4.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.602 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.464 HG12 HG23 ' A' ' 50' ' ' VAL . 3.8 mt -81.03 93.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 110.348 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 27.0 p-10 -54.52 172.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.339 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -5.72 7.01 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.912 178.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.44 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 3.9 t70 -79.23 1.23 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.096 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.3 1.06 73.8 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 43.6 m -83.27 -170.94 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.464 HG23 HG12 ' A' ' 44' ' ' ILE . 10.6 t -144.01 127.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.029 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 13.9 m-85 -104.77 94.96 5.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 109.683 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 58' ' ' PHE . . . -80.41 142.8 33.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.306 -0.871 . . . . 0.0 109.73 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 56' E LYS . 10.2 tt0 -153.86 110.39 3.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.266 -0.896 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' D VAL . 39.6 tt0 -81.31 167.17 19.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.18 126.93 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.037 -1.039 . . . . 0.0 110.583 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' O ' ' C ' ' A' ' 56' A ASP . 6.0 ttpt -158.76 135.07 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.867 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.3 m-20 29.52 65.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.868 -0.52 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 47.7 56.79 8.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.46 96.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -1.164 . . . . 0.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 17.3 m -93.83 161.48 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 56' D VAL . 2.5 mtmt -143.71 167.38 15.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.127 -0.983 . . . . 0.0 111.291 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.6 Cg_endo -85.98 173.47 6.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.415 2.077 . . . . 0.0 110.165 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.555 ' CZ ' ' C ' ' A' ' 23' ' ' LEU . 10.1 t80 174.22 126.34 0.11 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.964 . . . . 0.0 110.913 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HG3' HG21 ' A' ' 25' ' ' VAL . 48.1 Cg_endo -90.12 97.99 0.17 OUTLIER 'Cis proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.782 -1.758 . . . . 0.0 110.297 0.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 57' ' ' PRO . 6.3 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 120.724 -1.235 . . . . 0.0 110.671 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.434 0.635 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -78.45 76.46 4.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.515 -0.741 . . . . 0.0 110.677 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.579 HD11 ' CD1' ' A' ' 10' ' ' TYR . 3.8 mt -89.88 135.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.552 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -45.89 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.172 0.987 . . . . 0.0 112.015 -178.856 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.532 ' CD1' HG12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -92.03 -40.43 11.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.892 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.56 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.79 -60.47 1.95 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.392 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 12' ' ' MET . 11.6 t0 -45.09 -45.1 10.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CD1' HD11 ' A' ' 5' ' ' ILE . 32.1 t80 -61.52 -53.61 54.19 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.47 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.57 -21.52 3.94 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.499 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.9 -47.89 49.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.462 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -65.25 -23.72 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.524 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 5.3 m-85 -114.19 -78.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.143 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 156.41 162.49 11.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.586 ' NE2' ' CG2' ' A' ' 30' ' ' ILE . 22.7 tp60 -57.54 -41.31 80.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -1.1 . . . . 0.0 109.973 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -65.48 -30.26 71.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CB ' ' HB3' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -71.01 -63.53 1.08 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.344 179.488 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.2 m -57.4 -22.67 44.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.272 -0.892 . . . . 0.0 109.19 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.07 -45.7 59.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.431 -0.793 . . . . 0.0 110.228 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 14.0 mmtt -76.84 -13.04 60.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.892 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.46 -48.94 46.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.699 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.507 ' CD2' HG13 ' A' ' 50' ' ' VAL . 23.7 mt -82.61 -10.22 59.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 110.243 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 24.86 76.29 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.464 HG22 ' CB ' ' A' ' 23' ' ' LEU . 2.6 t -109.03 163.97 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -1.096 . . . . 0.0 110.163 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -62.68 147.6 49.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.093 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.78 -24.72 3.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.991 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 t -65.09 -51.3 62.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.842 . . . . 0.0 109.791 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.462 ' CB ' ' CG1' ' A' ' 25' ' ' VAL . . . -53.69 -19.36 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.805 . . . . 0.0 109.953 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.586 ' CG2' ' NE2' ' A' ' 16' ' ' GLN . 3.3 mm -80.88 -50.82 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.5 OUTLIER -70.63 -7.24 42.79 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.603 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -92.4 -44.61 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 108.758 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.556 ' O ' ' CD1' ' A' ' 40' ' ' ILE . . . -80.71 -13.41 59.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.56 ' CG2' ' HG2' ' A' ' 8' ' ' LYS . 9.5 mt -102.49 -42.37 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 42.9 t60 -61.69 -53.82 50.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.955 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 38' ' ' ARG . . . -93.12 -122.16 0.09 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . -1.73 68.38 0.0 OUTLIER Glycine 0 N--CA 1.504 3.223 0 C-N-CA 123.288 0.47 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 36' ' ' ALA . 23.3 mmm-85 -85.28 61.72 7.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.297 -1.119 . . . . 0.0 110.512 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 64.7 pttt -154.22 38.27 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 108.974 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.58 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 10.3 mt -101.65 165.36 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 110.825 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 56.2 m-85 -156.66 103.41 2.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.604 -0.685 . . . . 0.0 109.241 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.492 HD12 ' CB ' ' A' ' 7' ' ' LEU . 5.3 mp -89.33 130.18 35.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.905 . . . . 0.0 111.136 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 m -101.2 103.32 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.163 179.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.499 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 18.6 mt -89.25 74.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.062 -1.024 . . . . 0.0 110.576 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.564 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -44.7 174.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 110.705 179.413 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.95 -2.8 8.17 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.613 -0.835 . . . . 0.0 108.979 178.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.42 -2.1 57.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.885 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.81 -3.55 55.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -72.21 149.93 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -1.227 . . . . 0.0 109.773 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' A' ' 23' ' ' LEU . 13.1 t -111.5 105.87 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 110.668 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 1.9 m-85 -88.95 96.21 10.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.95 . . . . 0.0 109.007 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 58' ' ' PHE . . . -84.87 92.21 8.22 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 110.707 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.444 ' OE1' ' CG2' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.44 165.18 11.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.567 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 56' D VAL . 54.6 mt-10 -134.13 163.08 30.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.479 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 3.3 t -150.33 133.76 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 56' A ASP . 7.1 tptp -148.83 78.54 1.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.401 -0.812 . . . . 0.0 109.497 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 16.0 t0 60.24 50.47 6.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.592 -0.692 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 102.75 -30.43 10.42 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.499 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' C GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 56' ' ' LYS . 9.7 mt-10 -74.26 95.66 2.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.098 -1.237 . . . . 0.0 110.715 -179.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 18.8 m -117.05 147.48 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.214 -0.929 . . . . 0.0 110.393 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' E LYS . . . . . . . . . . . . . 3.6 pttm -175.1 165.73 2.1 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.191 -0.943 . . . . 0.0 110.576 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.49 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 4.7 Cg_exo -78.93 -176.41 3.27 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.872 1.714 . . . . 0.0 110.53 -178.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 1.8 t80 178.63 126.99 0.21 Allowed Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.29 -0.881 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 60.3 Cg_endo -90.11 96.59 0.16 OUTLIER 'Cis proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.913 -1.703 . . . . 0.0 110.514 -0.033 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 12.0 p . . . . . 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.456 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.226 0.536 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 3.2 ttm180 -79.34 74.56 5.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.382 -0.824 . . . . 0.0 110.098 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.581 HG23 ' CD1' ' A' ' 10' ' ' TYR . 3.9 mm -90.08 148.12 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.443 -0.786 . . . . 0.0 109.851 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.589 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -44.54 -179.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 122.486 1.136 . . . . 0.0 112.109 -178.822 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 40' ' ' ILE . 5.7 tp -94.28 -39.35 10.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -88.62 -61.9 1.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.185 179.583 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' LYS . 8.1 t0 -44.76 -42.39 7.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 6' ' ' THR . 12.0 t80 -55.76 -59.5 4.77 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.705 0.764 . . . . 0.0 109.345 178.281 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.9 -15.58 9.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.803 -0.561 . . . . 0.0 110.156 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ttt -83.43 -34.11 25.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.814 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.36 -10.45 49.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.809 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 -51.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.002 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.69 142.1 3.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.461 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -72.82 -27.74 62.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -1.185 . . . . 0.0 110.203 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.405 HG21 ' N ' ' A' ' 18' ' ' LYS . 3.3 t -79.88 -21.78 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' N ' HG21 ' A' ' 17' ' ' THR . 3.1 tttp -82.4 -46.98 12.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.113 179.31 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.477 HG21 ' CD1' ' A' ' 23' ' ' LEU . 11.6 m -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.319 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -82.62 -28.53 30.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 110.092 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -80.59 -36.96 32.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.467 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.4 -36.28 68.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.318 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.477 ' CD1' HG21 ' A' ' 19' ' ' THR . 83.3 mt -82.6 -9.94 59.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.26 40.03 97.58 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 23' ' ' LEU . 3.9 t -124.07 146.71 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.446 -1.032 . . . . 0.0 109.97 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -72.03 150.87 43.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.879 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -61.46 -20.38 63.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.4 p -84.65 -55.76 3.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.0 110.229 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.73 -23.28 1.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.525 HG21 ' CD1' ' A' ' 34' ' ' ILE . 95.0 mt -76.88 -63.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.891 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 11.5 m120 -49.9 -15.67 0.21 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.332 -0.855 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -91.58 -38.61 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.558 -1.339 . . . . 0.0 108.597 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.88 56.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.528 -0.732 . . . . 0.0 109.185 178.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.535 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 10.1 mt -114.57 -48.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.54 -0.725 . . . . 0.0 109.714 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t-160 -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.512 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.44 5.73 49.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 111.615 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' HD13 ' A' ' 40' ' ' ILE . . . -149.29 90.28 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.535 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 20.3 mmm-85 -83.69 -173.57 4.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -1.075 . . . . 0.0 110.157 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER 66.31 58.87 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.199 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.572 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 9.2 mt -116.18 157.65 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.163 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 39.8 m-85 -155.06 144.89 21.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 110.873 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.532 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 4.1 mp -135.57 131.05 35.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.462 -0.774 . . . . 0.0 109.743 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 3.2 m -99.18 101.04 12.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.005 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.587 ' CG2' ' O ' ' A' ' 49' ' ' SER . 15.0 mt -101.1 148.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.982 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 46' ' ' ALA 0.252 2.4 m-20 -65.31 -11.75 44.91 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.531 0.682 . . . . 0.0 110.076 178.113 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 81.49 1.22 1.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -175.166 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.19 38.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.554 ' N ' ' HB2' ' A' ' 45' ' ' ASN . . . -140.13 -63.36 0.04 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -177.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.587 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 0.9 OUTLIER 179.45 -168.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 109.445 -179.045 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 42' ' ' LEU . 11.9 t -125.52 110.93 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.571 -1.331 . . . . 0.0 111.583 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 43' ' ' THR . 4.4 m-85 -81.4 77.69 8.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.515 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -52.47 145.75 10.92 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.708 0.766 . . . . 0.0 111.398 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 78.94 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' D VAL . 3.8 pt-20 -79.41 163.49 24.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.253 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.456 HG21 HG13 ' A' ' 56' D VAL . 3.2 t -132.77 139.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 0.5 OUTLIER -159.76 160.85 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 -179.889 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.4 m-20 -39.21 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.471 -0.768 . . . . 0.0 110.438 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 144.99 -71.41 0.37 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.7 tt0 -174.4 -172.45 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.491 -1.005 . . . . 0.0 109.926 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 34.6 m -104.6 143.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.95 . . . . 0.0 110.434 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' E LYS . . . . . . . . . . . . . 4.9 mmtt -128.09 161.04 58.49 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.393 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.4 Cg_exo -82.9 39.95 0.9 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.825 1.683 . . . . 0.0 111.063 -178.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.459 ' C ' ' O ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -39.56 118.58 1.26 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.409 -0.807 . . . . 0.0 109.817 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -81.86 104.89 0.64 Allowed 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.305 -1.956 . . . . 0.0 110.724 0.2 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.506 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 73.3 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.08 -1.013 . . . . 0.0 110.184 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.122 0.487 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.87 74.89 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.573 HG23 ' CD1' ' A' ' 10' ' ' TYR . 8.4 mt -91.66 141.68 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.305 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 18.8 p -59.47 -175.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 110.848 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.587 ' CD1' ' CG2' ' A' ' 19' ' ' THR . 1.2 tp -92.45 -34.43 14.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.57 ' CG ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -81.84 -69.52 0.61 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.855 -0.528 . . . . 0.0 110.002 179.375 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 41.4 t0 -46.66 -58.09 4.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.219 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.627 ' CZ ' ' CZ ' ' A' ' 14' ' ' PHE . 3.4 t80 -41.9 -51.65 4.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.331 -0.855 . . . . 0.0 110.368 179.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HB3' ' OG1' ' A' ' 19' ' ' THR . . . -56.13 -42.41 76.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 30.1 ttp -60.17 -29.94 69.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.058 179.048 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -55.84 28.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.492 -0.755 . . . . 0.0 110.125 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CZ ' ' CZ ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -123.52 67.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.974 -1.079 . . . . 0.0 111.659 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.28 156.87 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.29 -29.92 30.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -1.03 . . . . 0.0 109.841 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.4 m -60.63 -21.61 62.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.414 -0.804 . . . . 0.0 109.884 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.576 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.0 mmtp -69.76 -54.86 11.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.02 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.587 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 90.3 m -59.37 -19.01 43.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.21 72.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.594 -0.691 . . . . 0.0 109.825 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -81.76 -18.69 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.743 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 3.0 t0 -65.43 -53.84 37.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.033 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.414 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 3.0 mt -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.364 -0.835 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.77 29.78 20.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -122.08 151.26 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -1.115 . . . . 0.0 109.676 -179.751 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 25' ' ' VAL . 47.8 m-85 -47.09 173.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.461 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -77.0 -28.25 54.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -67.56 -57.95 5.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.16 -28.53 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.365 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -62.85 -61.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.524 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 48.9 m-80 -57.28 -9.65 1.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.597 -0.69 . . . . 0.0 110.888 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -88.98 -35.32 16.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.648 -1.283 . . . . 0.0 107.766 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -85.62 -11.11 54.73 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.57 ' CG2' ' CG ' ' A' ' 8' ' ' LYS . 14.9 mt -100.68 -48.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.405 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -74.99 -58.43 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.894 179.661 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.85 11.08 23.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 110.755 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -137.63 69.66 0.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.479 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 15.0 mmm-85 -75.85 -171.85 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.899 -1.353 . . . . 0.0 110.214 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 9.2 mptt 58.73 46.72 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.198 -0.939 . . . . 0.0 110.52 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.589 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 16.7 mt -97.89 161.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 110.353 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 43.9 m-85 -161.32 114.37 1.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 110.267 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 7' ' ' LEU . 2.4 mp -107.24 131.88 53.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.099 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -96.99 100.54 12.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 44' ' ' ILE . 9.6 mt -94.73 43.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -91.97 -131.49 0.12 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 109.85 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 49' ' ' SER . . . 48.75 24.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.957 -1.089 . . . . 0.0 109.127 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.1 t0 75.13 63.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.317 0.579 . . . . 0.0 111.036 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 81.78 -8.43 59.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.554 ' HB2' ' CB ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -51.11 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.317 . . . . 0.0 110.506 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.71 123.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.47 135.68 37.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.576 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 57' ' ' PRO . . . -103.57 149.9 24.46 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.944 -1.098 . . . . 0.0 109.461 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 2.4 tt0 -159.78 151.43 20.12 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 110.651 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 56' D VAL . 2.1 tt0 -135.92 151.1 49.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.55 ' CA ' ' HA ' ' A' ' 56' D VAL . 7.2 p -124.33 -26.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.394 -0.923 . . . . 0.0 112.525 -177.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 3.2 ttmt -160.14 -171.37 3.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.705 -1.247 . . . . 0.0 111.091 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 29.5 t0 47.37 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.693 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -58.76 -51.88 56.44 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 178.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' C GLU . . . . . 0.532 ' CB ' ' OE1' ' A' ' 54' ' ' GLU . 2.5 tt0 174.97 179.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.628 -0.924 . . . . 0.0 110.096 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 4.1 m -122.0 46.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 56' D VAL . 13.9 mttt -149.81 174.95 3.06 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.375 -0.828 . . . . 0.0 112.302 -177.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.533 ' CD ' ' HB3' ' A' ' 56' E LYS . 3.9 Cg_exo -80.04 56.16 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.661 2.24 . . . . 0.0 111.497 -179.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.414 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 5.0 p90 -44.06 146.53 1.08 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.714 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -91.11 50.01 1.08 Allowed 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.221 -1.991 . . . . 0.0 110.31 -0.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 110.021 179.96 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.6 mt-30 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.373 0.606 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.8 ttp180 -79.0 79.71 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.51 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.421 HG23 ' CD1' ' A' ' 10' ' ' TYR . 32.7 mt -89.32 154.17 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.062 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.08 179.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.049 0.928 . . . . 0.0 111.38 -179.262 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.528 ' CD2' HG12 ' A' ' 34' ' ' ILE . 3.7 tp -92.8 -40.08 10.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.077 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.455 ' CG ' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.96 -63.97 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.434 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 3.1 m-20 -45.03 -44.57 10.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.1 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.559 ' CB ' ' O ' ' A' ' 6' ' ' THR . 9.4 t80 -57.24 -56.43 21.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.143 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 19' ' ' THR . . . -57.74 -15.27 7.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.8 -0.562 . . . . 0.0 110.388 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.2 ttt -82.79 -35.34 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -0.976 . . . . 0.0 110.062 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -77.04 -32.17 56.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.664 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 12.1 m-85 -96.64 -54.22 3.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.12 137.92 2.74 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -33.43 66.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -1.18 . . . . 0.0 110.275 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 m -77.5 -23.34 50.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -76.28 -56.66 4.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.071 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 11' ' ' ALA . 2.1 m -57.81 -23.81 54.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.491 -0.756 . . . . 0.0 109.123 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.52 -47.13 43.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.913 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -9.14 57.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 110.053 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.98 -30.84 18.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 110.141 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.444 HD22 ' CD2' ' A' ' 42' ' ' LEU . 75.3 mt -91.37 -5.62 54.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.15 35.3 91.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.523 HG13 ' CB ' ' A' ' 29' ' ' ALA . 2.8 t -119.72 174.46 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -1.128 . . . . 0.0 109.926 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 27' ' ' GLN . 60.1 m-85 -81.96 136.41 35.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 0.0 110.0 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -44.24 -29.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.953 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -74.54 -52.55 11.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.523 ' CB ' HG13 ' A' ' 25' ' ' VAL . . . -50.76 -27.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.597 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.561 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.3 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 109.677 179.672 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 7.0 m-80 -57.7 -10.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.658 -0.651 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.88 -42.8 9.31 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.507 -1.37 . . . . 0.0 108.51 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.89 -9.63 58.73 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.528 HG12 ' CD2' ' A' ' 7' ' ' LEU . 24.6 mt -110.86 -51.1 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.765 . . . . 0.0 110.088 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.582 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 21.3 t-160 -53.86 -26.59 25.31 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.407 179.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.22 -75.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.989 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.07 57.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.562 ' O ' ' C ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -90.48 31.72 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.129 -1.218 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER 19.72 70.15 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.318 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 6.3 mt -105.51 159.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.387 -0.821 . . . . 0.0 110.931 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -143.54 161.56 38.14 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.106 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 4.0 mp -137.47 118.57 14.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.667 -1.271 . . . . 0.0 110.888 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 51' ' ' TYR . 2.8 p -85.32 97.63 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.538 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 45' ' ' ASN . 4.4 mt -89.52 80.79 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.314 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 44' ' ' ILE . 51.6 p30 -44.02 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.464 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -3.74 8.84 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.706 -0.797 . . . . 0.0 109.041 178.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.62 -3.16 58.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.4 -5.13 74.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -70.4 122.41 19.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.32 112.2 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.512 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.497 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 3.5 t80 -102.96 105.69 16.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -82.5 143.54 31.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.205 -0.935 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 56' E LYS . 0.7 OUTLIER -151.01 96.35 2.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.54 -0.725 . . . . 0.0 109.63 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 40.1 tt0 -78.97 161.65 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' HG2' ' A' ' 54' ' ' GLU . 73.3 t -135.44 138.58 48.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.672 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 56' A ASP . 22.3 ttpp -156.06 141.74 17.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -0.76 . . . . 0.0 109.239 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 56' ' ' LYS . 7.6 t0 -37.15 102.94 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.511 -0.743 . . . . 0.0 110.828 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 56' C GLU . . . 139.72 -53.54 0.68 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' C GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 56' B GLY . 11.0 tt0 179.48 171.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 110.042 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 56' E LYS . 23.4 m -98.54 173.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.176 -0.952 . . . . 0.0 110.005 179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 5.3 mtmt -144.7 170.45 8.19 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 110.176 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 58' ' ' PHE . 4.4 Cg_exo -79.53 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.297 -2.138 0 O-C-N 124.42 1.747 . . . . 0.0 109.966 -179.196 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.504 ' O ' ' O ' ' A' ' 57' ' ' PRO . 28.1 t80 57.69 125.86 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.516 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.39 122.47 8.51 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.169 -2.013 . . . . 0.0 110.305 0.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.975 . . . . 0.0 110.591 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 6.4 mt-30 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.412 0.625 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 6.5 ttt180 -78.26 81.48 4.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' A' ' 10' ' ' TYR . 3.9 mt -90.77 -179.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.424 -0.798 . . . . 0.0 109.571 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.61 -173.11 3.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.026 0.917 . . . . 0.0 111.375 -179.313 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.465 HD13 HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -92.91 -46.5 7.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.347 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.506 ' CB ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -84.33 -57.0 3.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.083 178.766 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.519 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -51.98 -51.78 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.393 -0.817 . . . . 0.0 109.127 179.269 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CB ' ' O ' ' A' ' 6' ' ' THR . 1.6 t80 -49.91 -56.78 9.22 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.685 179.115 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.39 -32.67 18.17 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.646 0.736 . . . . 0.0 109.41 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.424 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -58.28 -51.61 69.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -20.74 65.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.616 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -111.58 -84.54 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.805 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 174.32 159.57 20.93 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.702 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -39.01 93.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.594 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -78.38 -3.18 41.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.907 179.768 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -90.15 -50.39 6.02 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.341 -0.849 . . . . 0.0 108.729 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.49 ' OG1' ' CB ' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -54.96 -37.96 67.16 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.271 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 -48.66 55.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.492 0.663 . . . . 0.0 109.905 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.9 mmtp -76.62 3.82 10.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 109.834 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.54 ' OD1' ' CG2' ' A' ' 50' ' ' VAL . 0.9 OUTLIER -88.06 -60.62 1.92 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.84 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' HG ' ' N ' ' A' ' 24' ' ' GLY . 0.5 OUTLIER -99.81 -25.44 14.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.957 -1.089 . . . . 0.0 110.939 -179.408 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.556 ' N ' ' HG ' ' A' ' 23' ' ' LEU . . . 119.84 62.15 0.26 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.779 179.208 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.532 HG22 ' HG ' ' A' ' 23' ' ' LEU . 2.2 t -142.82 -172.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.133 -1.216 . . . . 0.0 109.521 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' O ' HD11 ' A' ' 30' ' ' ILE . 31.4 m-85 -109.48 -170.2 1.61 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.933 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -87.71 -29.52 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.152 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -68.15 -46.66 70.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.02 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HB1' HG13 ' A' ' 25' ' ' VAL . . . -56.97 -22.92 41.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.982 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.3 mp -81.51 -45.8 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 109.57 179.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 26.2 m-20 -72.75 -8.17 54.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 179.357 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -95.5 -44.57 7.46 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.52 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 40' ' ' ILE . . . -71.29 -16.38 62.46 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.766 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.552 ' O ' ' CD ' ' A' ' 38' ' ' ARG . 88.2 mt -103.76 -53.65 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 110.704 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.569 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 8.8 t-80 -62.13 -10.42 10.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.72 -1.237 . . . . 0.0 109.941 179.783 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -81.86 -103.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.921 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' ARG . . . -123.11 78.63 0.35 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.552 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 16.5 mmm-85 -34.14 119.31 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.911 0.863 . . . . 0.0 111.833 -178.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 41.7 pttt -174.88 31.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.652 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.574 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 14.9 mt -105.88 161.16 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.688 . . . . 0.0 110.157 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 45.3 m-85 -155.3 114.37 3.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.299 -0.876 . . . . 0.0 109.897 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 42' ' ' LEU . 5.0 mp -98.27 107.24 19.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.097 -1.002 . . . . 0.0 110.5 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 11.0 t -83.7 105.11 14.35 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.735 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.543 ' CG2' ' O ' ' A' ' 49' ' ' SER . 3.5 mt -97.95 135.29 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.181 -179.751 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -114.2 -168.09 1.31 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.791 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.94 0.31 11.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -165.6 24.6 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.858 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -96.94 -12.35 50.09 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 1.1 m 59.08 -90.41 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.541 -0.976 . . . . 0.0 108.575 -178.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.54 ' CG2' ' OD1' ' A' ' 22' ' ' ASP . 1.3 t -160.95 98.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.113 -0.992 . . . . 0.0 110.401 179.06 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.484 ' HB3' HG21 ' A' ' 43' ' ' THR . 2.3 t80 -95.98 105.53 17.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.255 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -67.5 148.9 50.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.624 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 41' ' ' PHE . 41.1 mt-10 -149.2 102.44 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 110.183 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' C ' ' CG2' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -89.89 148.73 22.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -0.957 . . . . 0.0 109.129 179.423 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 2.4 t -148.62 105.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.879 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 1.7 tptp -125.23 170.02 11.68 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 56' ' ' LYS . 2.7 t70 -42.26 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.171 -0.956 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 60.31 56.7 23.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -167.18 74.55 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.019 -1.283 . . . . 0.0 110.974 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.436 ' O ' HG21 ' A' ' 56' D VAL . 2.6 m -103.82 150.76 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.462 179.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' E LYS . . . . . . . . . . . . . 0.9 OUTLIER -162.77 160.31 19.55 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.765 -1.209 . . . . 0.0 111.154 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 58' ' ' PHE . 5.3 Cg_endo -89.52 37.66 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.049 1.832 . . . . 0.0 110.815 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -41.62 137.55 1.8 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.903 . . . . 0.0 109.922 179.778 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 60' ' ' SER . 53.2 Cg_endo -93.5 66.9 0.25 Allowed 'Cis proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.714 -1.786 . . . . 0.0 110.887 0.164 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 120.875 -1.14 . . . . 0.0 110.689 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.491 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.077 0.465 . . . . 0.0 110.157 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -79.64 73.15 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.365 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 10' ' ' TYR . 9.0 mt -90.33 141.27 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 110.821 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -51.75 -174.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 112.159 -179.31 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.519 HD21 ' CD1' ' A' ' 40' ' ' ILE . 3.4 tp -93.41 -38.39 11.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 176.134 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.568 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -82.2 -60.03 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.787 178.997 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 12' ' ' MET . 9.1 t0 -53.28 -44.35 68.19 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.165 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.632 ' CE1' ' CD1' ' A' ' 44' ' ' ILE . 88.4 t80 -58.9 -63.75 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.495 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.21 -23.54 1.37 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.382 -0.824 . . . . 0.0 109.62 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.43 -54.18 11.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.113 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -88.35 13.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.659 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -161.5 97.27 1.09 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.707 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 14' ' ' PHE . . . -8.72 123.52 0.01 OUTLIER Glycine 0 N--CA 1.506 3.338 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 17' ' ' THR . 6.2 pt20 -59.95 -36.39 76.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.411 -1.052 . . . . 0.0 109.582 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.522 ' N ' ' CG ' ' A' ' 16' ' ' GLN . 2.8 m -51.49 -22.45 3.13 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.242 -179.229 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -82.57 -44.69 15.55 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.109 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.423 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -64.5 -23.37 67.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.205 179.104 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.426 ' HB1' HG13 ' A' ' 30' ' ' ILE . . . -86.04 -28.5 24.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 110.518 -179.543 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -71.73 -28.31 63.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.898 179.788 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' CB ' HG22 ' A' ' 50' ' ' VAL . 68.7 m-20 -89.91 -26.41 20.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 19' ' ' THR . 25.5 mt -79.41 -40.72 29.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.369 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.29 40.45 1.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 -177.75 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.269 -1.136 . . . . 0.0 109.83 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -97.98 -163.76 1.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.31 -50.08 7.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.041 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 29' ' ' ALA . 7.9 t -64.82 -62.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 109.881 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.9 -28.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.57 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -69.22 -58.18 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.506 -0.746 . . . . 0.0 109.278 179.28 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.646 ' O ' ' HB2' ' A' ' 35' ' ' HIS . 0.7 OUTLIER -57.41 -6.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.813 -0.555 . . . . 0.0 111.645 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -91.95 -40.73 10.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.793 -1.192 . . . . 0.0 108.18 178.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -22.3 55.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.568 ' CG2' ' HG2' ' A' ' 8' ' ' LYS . 47.6 mt -87.34 -51.37 12.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -43.6 -35.88 1.91 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.786 0.803 . . . . 0.0 108.976 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.93 -87.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.96 39.75 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HD3' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -84.05 48.33 1.45 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.427 -1.043 . . . . 0.0 111.423 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 2.5 mppt? 64.85 98.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.508 -0.745 . . . . 0.0 110.369 179.191 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.578 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 2.7 mt -129.84 153.78 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 72.8 m-85 -156.57 124.03 5.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.496 HD12 ' CA ' ' A' ' 7' ' ' LEU . 5.1 mp -118.13 132.06 56.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 111.063 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.4 m -108.65 103.27 12.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.421 -0.799 . . . . 0.0 108.983 178.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 10' ' ' TYR . 1.5 mt -94.13 -149.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 111.199 -178.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.622 ' C ' ' H ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER 37.6 -164.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.453 0.644 . . . . 0.0 110.804 -178.847 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 45' ' ' ASN . . . 63.97 -5.49 0.3 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -176.833 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER 174.73 -27.37 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.149 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.88 40.68 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.432 ' OG ' ' CE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -100.2 133.37 44.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.649 -0.913 . . . . 0.0 109.771 179.939 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 22' ' ' ASP . 39.8 t -88.31 97.53 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 110.48 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 55.3 m-85 -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 108.674 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.76 127.52 34.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.198 -0.939 . . . . 0.0 110.867 -178.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.39 161.21 25.2 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 25.7 tt0 -136.07 147.06 47.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.371 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 2.5 t -146.54 104.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.503 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 3.5 ttpt -132.34 153.93 50.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 109.509 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 18.0 t70 -43.06 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.072 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 151.73 -55.74 0.45 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.28 -172.62 0.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.338 -1.095 . . . . 0.0 110.506 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 56' E LYS . 5.0 m -116.3 161.08 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -179.672 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 56' D VAL . 19.2 mttm -146.33 163.65 28.89 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 110.375 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.503 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -83.99 -61.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.016 1.81 . . . . 0.0 110.873 -178.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 4.4 t80 59.89 123.74 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.34 -0.85 . . . . 0.0 110.009 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.4 126.85 13.82 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 122.16 -2.017 . . . . 0.0 110.258 0.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 -179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -78.99 85.78 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 0.0 110.721 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.525 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 11.3 mt -90.44 149.71 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.827 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -48.13 -178.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.248 1.023 . . . . 0.0 111.647 -179.266 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.53 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . 2.6 tp -92.42 -40.21 11.0 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.678 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.442 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -91.32 -59.54 2.12 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 12' ' ' MET . 0.8 OUTLIER -45.83 -39.6 8.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.83 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 6' ' ' THR . 5.5 t80 -62.52 -53.38 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.505 178.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.477 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -51.87 -26.09 9.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 14.4 tpp -72.25 -47.01 53.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.871 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -23.88 65.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.968 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.48 -79.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.65 156.23 14.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.424 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -70.41 -30.52 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 109.994 179.932 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 p -82.58 -20.57 36.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 110.208 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -81.23 -51.42 8.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.329 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 11' ' ' ALA . 2.8 m -63.11 -25.97 68.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 178.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -74.4 -34.8 63.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 0.0 110.529 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 2.2 mmtp -89.6 -14.17 35.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.286 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' OD2' ' O ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -76.25 -40.46 51.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.67 179.737 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.468 ' HG ' ' OD1' ' A' ' 22' ' ' ASP . 4.7 mt -83.51 0.41 46.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.16 56.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.558 ' CG1' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -144.71 -175.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.464 ' O ' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -110.25 155.99 21.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.217 -0.927 . . . . 0.0 109.924 -179.949 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 26' ' ' TYR . 1.1 mt-30 -40.46 -28.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.374 -0.829 . . . . 0.0 110.728 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -61.98 -64.68 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.126 -0.984 . . . . 0.0 110.507 -179.775 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.558 ' CB ' ' CG1' ' A' ' 25' ' ' VAL . . . -44.99 -26.11 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.7 mp -75.84 -43.61 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.2 t30 -73.51 -1.57 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.042 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -104.82 -43.38 5.11 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.999 -1.063 . . . . 0.0 108.879 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -82.1 -0.9 46.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.589 -0.695 . . . . 0.0 109.204 178.576 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.474 HG12 ' CD2' ' A' ' 7' ' ' LEU . 13.6 mt -124.33 -40.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.86 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.548 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 5.7 t-80 -74.06 -26.09 60.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.0 110.019 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 -32.76 71.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.82 45.59 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.7 mmm180 -85.68 -173.45 4.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -1.147 . . . . 0.0 110.401 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.48 79.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 40' ' ' ILE . 10.0 mt -109.82 162.99 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.905 . . . . 0.0 110.452 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CG ' ' NH1' ' A' ' 4' ' ' ARG . 76.2 m-85 -151.09 113.58 4.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 0.0 109.831 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 7.3 mp -80.12 134.58 36.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 17.8 m -106.38 100.3 9.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.474 ' CG2' ' O ' ' A' ' 49' ' ' SER . 10.6 mt -92.65 131.32 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.653 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 3.5 m120 -52.75 -19.09 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.568 -0.708 . . . . 0.0 110.59 179.02 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.653 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 91.96 -21.02 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -176.329 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.1 -2.04 57.55 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.367 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.17 -20.2 11.5 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.474 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -63.32 147.52 50.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -1.198 . . . . 0.0 109.989 179.862 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 22' ' ' ASP . 22.1 t -122.11 141.86 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.448 ' O ' ' C ' ' A' ' 52' ' ' ALA . 18.7 t80 -143.09 76.54 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.479 -0.763 . . . . 0.0 109.636 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 51' ' ' TYR . . . -38.31 143.4 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.616 -0.678 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' PHE . 2.9 tt0 -140.41 86.99 2.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 110.724 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' D VAL . 1.3 tp10 -79.38 147.91 32.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.84 137.38 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 110.496 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 56' C GLU . 11.4 ttpt -160.07 -172.76 3.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.841 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' A ASP . . . . . . . . . . . . . 13.2 m-20 -57.24 105.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.029 -1.044 . . . . 0.0 110.189 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 51.49 29.97 25.38 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' C GLU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -143.77 86.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.175 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 1.2 p -125.44 102.02 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 109.719 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 56' D VAL . 9.0 mtmm -143.81 160.25 50.86 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.215 -0.928 . . . . 0.0 110.383 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.21 128.64 12.31 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.359 1.715 . . . . 0.0 111.166 -178.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.93 144.39 39.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.481 -0.762 . . . . 0.0 109.714 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -90.94 47.48 1.35 Allowed 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.108 -2.039 . . . . 0.0 110.485 0.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.278 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 12.8 mm100 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.374 0.607 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.7 80.11 6.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.365 -0.835 . . . . 0.0 109.977 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.547 HD11 ' CD1' ' A' ' 10' ' ' TYR . 5.3 mt -89.31 141.47 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 110.609 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.581 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -47.17 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.996 0.903 . . . . 0.0 111.139 -179.917 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 34' ' ' ILE . 3.8 tp -93.19 -39.9 10.77 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -86.66 -61.11 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.042 178.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.44 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 1.6 t70 -50.33 -47.56 55.79 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.342 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.581 ' CB ' ' O ' ' A' ' 6' ' ' THR . 4.0 t80 -53.92 -61.31 2.38 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.885 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 19' ' ' THR . . . -57.01 -16.6 7.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.141 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -86.16 -30.67 22.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.511 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -3.93 38.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -126.96 32.72 5.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 -179.994 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 14' ' ' PHE . . . 60.93 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.422 ' OE1' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -79.64 -26.53 41.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 110.375 -179.962 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -75.89 -23.66 55.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 2.7 tptt -76.63 -56.66 4.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.202 -0.936 . . . . 0.0 109.022 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.446 HG22 ' HB3' ' A' ' 11' ' ' ALA . 1.7 m -55.35 -27.95 50.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 178.581 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.44 -30.35 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -82.8 -8.46 59.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -90.41 -48.93 6.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 110.251 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.92 -36.63 36.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.58 33.11 4.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.22 161.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.204 -1.174 . . . . 0.0 109.908 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -76.26 156.06 33.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -35.66 75.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.45 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -62.42 -51.22 68.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.96 -24.8 1.63 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.2 mp -82.92 -56.2 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.949 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 3.3 m120 -49.78 -16.91 0.29 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.709 . . . . 0.0 111.374 -179.32 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -99.87 -51.64 3.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.436 -1.415 . . . . 0.0 109.039 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -80.08 11.46 3.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.653 178.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.551 ' CG2' ' HG2' ' A' ' 8' ' ' LYS . 26.4 mm -135.32 -41.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 110.305 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -70.1 -30.6 67.85 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.947 179.724 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.19 -78.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.12 69.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.5 tpt180 -90.7 123.59 34.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 111.267 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -98.94 63.35 1.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.359 -0.838 . . . . 0.0 109.319 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.524 HD13 ' CD2' ' A' ' 7' ' ' LEU . 5.5 mt -113.29 161.1 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.284 -179.255 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 32.4 m-85 -137.93 150.42 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.948 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 5.0 mp -126.94 140.71 52.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.437 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -103.37 103.68 13.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.58 HD12 ' CE2' ' A' ' 10' ' ' TYR . 3.8 mt -98.89 75.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.131 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 49' ' ' SER . 4.5 p30 -41.87 166.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.686 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.44 -7.67 3.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.555 -0.715 . . . . 0.0 109.323 178.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.15 6.41 11.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.57 0.32 30.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.471 ' O ' HG21 ' A' ' 44' ' ' ILE . 4.6 t -59.17 -176.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.049 -1.265 . . . . 0.0 109.493 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.2 t -149.65 115.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.612 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.482 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 6.6 m-85 -113.45 154.58 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.76 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -131.53 147.26 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.94 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' C ' HG21 ' A' ' 40' ' ' ILE . 15.6 mt-10 -154.43 99.05 2.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HG3' HG12 ' A' ' 40' ' ' ILE . 12.8 tt0 -79.89 147.94 31.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.051 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.25 97.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.931 -1.106 . . . . 0.0 110.46 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' B GLY . 6.7 ttpt -117.64 148.75 41.66 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.838 . . . . 0.0 109.75 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' LYS . 9.7 t70 -43.23 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 110.237 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 152.27 -55.87 0.45 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -174.75 166.11 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.866 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 16.0 m -107.43 160.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -0.839 . . . . 0.0 109.493 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.524 ' HB2' ' CD ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.56 178.12 1.59 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.018 -1.051 . . . . 0.0 110.694 -179.953 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.524 ' CD ' ' HB2' ' A' ' 56' E LYS . 4.8 Cg_exo -77.72 -64.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.296 -2.193 0 O-C-N 124.39 1.732 . . . . 0.0 110.529 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.481 ' HB2' ' HD2' ' A' ' 56' E LYS . 9.5 t80 57.93 117.92 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.57 130.74 20.33 Favored 'Cis proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.178 -2.009 . . . . 0.0 110.308 -0.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.5 179.949 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 36.4 mm-40 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.338 0.589 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 1.4 ttt180 -81.52 69.73 8.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 111.03 -179.309 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.58 ' HB ' ' CD1' ' A' ' 10' ' ' TYR . 6.0 mm -90.66 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 109.904 179.342 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -91.37 164.88 13.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.052 -1.03 . . . . 0.0 112.409 -178.503 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -59.82 -26.55 65.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.375 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 8' ' ' LYS . 5.6 tmtm? -80.21 -79.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.19 -54.4 16.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.784 -1.198 . . . . 0.0 110.228 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.596 ' CB ' ' O ' ' A' ' 6' ' ' THR . 17.7 t80 -46.95 -53.28 12.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.943 -1.098 . . . . 0.0 110.12 -179.75 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.31 -34.97 67.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 110.194 -179.575 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -34.91 78.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -32.61 47.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CD2' ' HD3' ' A' ' 18' ' ' LYS . 5.6 m-30 -107.88 -63.59 1.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 152.62 143.77 3.76 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.588 ' NE2' ' CG2' ' A' ' 30' ' ' ILE . 6.4 tp60 -53.32 -33.23 52.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -28.14 54.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 110.493 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HD3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -73.79 -56.01 5.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 179.66 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.41 ' CG2' HD11 ' A' ' 7' ' ' LEU . 8.1 m -62.96 -17.99 62.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.466 -0.771 . . . . 0.0 109.396 179.286 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -80.32 -36.67 33.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 110.399 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.93 -23.25 48.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.889 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.35 -27.5 32.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.071 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.2 mt -81.96 -40.49 22.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.72 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.12 18.11 10.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.425 HG12 ' CG ' ' A' ' 59' ' ' PRO . 3.4 m -137.35 158.98 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 109.916 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 15.1 m-30 -67.82 178.72 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.34 -179.744 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.451 ' HA ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -70.39 -22.57 62.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -0.903 . . . . 0.0 110.207 179.868 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 m -59.1 -49.69 76.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.47 -19.45 5.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.588 ' CG2' ' NE2' ' A' ' 16' ' ' GLN . 3.0 mm -80.63 -57.85 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.854 0.835 . . . . 0.0 110.003 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -54.3 -15.53 1.65 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.558 -179.444 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -40.96 10.85 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.496 -1.378 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . . . -78.09 -4.55 47.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 109.204 178.717 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 30' ' ' ILE . 15.2 mt -120.02 -47.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.449 -0.782 . . . . 0.0 110.666 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.564 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 12.1 t60 -69.58 -22.22 63.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.006 -1.059 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.38 33.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.194 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.86 46.35 1.04 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.47 148.54 24.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -90.35 55.55 3.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.994 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 7.0 mt -81.3 163.0 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.768 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 53.2 m-85 -157.38 142.1 16.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.55 -0.719 . . . . 0.0 109.26 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.54 ' CD2' HD13 ' A' ' 7' ' ' LEU . 5.3 mp -129.05 113.56 15.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.931 -1.105 . . . . 0.0 111.725 -179.17 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.8 m -97.72 101.68 13.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.396 -0.815 . . . . 0.0 108.918 178.472 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.503 HD11 ' CZ ' ' A' ' 10' ' ' TYR . 8.5 mt -96.56 136.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 111.081 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.639 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.9 m120 -51.83 -18.91 1.45 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 110.653 178.768 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.639 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 90.06 -17.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -176.11 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.05 -13.4 41.63 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.3 -26.42 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.563 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 107.36 0.78 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -1.226 . . . . 0.0 109.682 179.97 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.436 HG21 HG21 ' A' ' 44' ' ' ILE . 40.3 t -100.16 117.95 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.067 . . . . 0.0 111.317 -179.19 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 23.3 m-30 -104.04 111.07 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 108.933 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -87.8 76.51 8.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 0.0 111.072 -179.013 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -84.86 147.03 27.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 109.432 179.102 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 56' D VAL . 7.8 mt-10 -127.73 173.07 10.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.015 -179.993 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.6 119.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.048 -1.033 . . . . 0.0 110.592 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' B GLY . 9.3 tptp -138.31 143.75 40.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 179.534 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' A ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.6 OUTLIER -42.11 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 110.352 -179.762 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 143.34 -54.21 0.59 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.34 162.06 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 110.516 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 56' E LYS . 33.9 m -79.78 161.18 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 179.754 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.93 163.23 45.9 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.142 -0.974 . . . . 0.0 110.767 -179.828 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.3 Cg_endo -83.41 179.18 5.17 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.813 1.675 . . . . 0.0 110.148 -179.29 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.545 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 31.4 t80 179.11 121.68 0.21 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 110.311 -179.645 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.425 ' CG ' HG12 ' A' ' 25' ' ' VAL . 10.1 Cg_endo -85.78 101.4 0.33 Allowed 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.728 -1.78 . . . . 0.0 110.433 -0.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 59' ' ' PRO . 20.2 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 110.147 179.772 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 20.7 mt-30 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -78.75 83.86 4.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.297 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.523 HD11 ' CE1' ' A' ' 10' ' ' TYR . 9.7 mt -90.2 -173.63 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.551 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.12 -179.36 5.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.087 -1.008 . . . . 0.0 111.993 -179.047 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.544 ' CG ' HG12 ' A' ' 34' ' ' ILE . 6.1 tp -92.3 -41.54 10.32 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.778 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HD3' ' CG2' ' A' ' 34' ' ' ILE . 1.3 mmtt -86.27 -64.1 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.333 179.17 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.444 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.7 OUTLIER -46.77 -52.14 14.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.516 179.475 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.551 ' CB ' ' O ' ' A' ' 6' ' ' THR . 4.7 t80 -52.54 -55.13 24.24 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.232 179.79 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -18.72 60.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.951 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -22.11 22.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.041 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -12.26 29.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.777 179.864 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -123.64 -65.85 1.04 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.24 162.19 12.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.68 -30.79 52.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -1.143 . . . . 0.0 110.271 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.0 p -72.52 -33.22 66.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 179.678 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.9 -54.76 11.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.45 -0.781 . . . . 0.0 109.161 179.33 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.436 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 21.7 m -62.23 -20.01 63.78 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.733 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -72.16 -47.53 50.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -70.16 -25.05 63.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.595 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.534 ' CB ' HG13 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -61.86 -47.62 84.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.431 -0.793 . . . . 0.0 109.962 179.675 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.522 ' CD2' HG12 ' A' ' 50' ' ' VAL . 3.4 mt -90.4 -6.54 54.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.852 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.39 22.23 71.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.521 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 23' ' ' LEU . 3.2 t -107.93 153.07 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -1.019 . . . . 0.0 110.23 -179.683 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 12.0 m-85 -59.12 176.29 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.833 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -83.68 -10.89 57.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.005 179.761 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -83.26 -61.78 1.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.92 179.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.42 -40.59 8.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 109.714 179.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 26' ' ' TYR . 72.8 mt -65.0 -55.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.766 . . . . 0.0 109.946 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -50.33 -13.91 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.358 -0.839 . . . . 0.0 111.096 179.792 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -89.56 -37.82 14.42 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.408 -1.432 . . . . 0.0 108.869 178.809 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.439 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -80.03 -10.94 59.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.154 178.488 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.544 ' CG2' ' HD3' ' A' ' 8' ' ' LYS . 7.1 mt -108.8 -47.92 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.845 179.731 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 9.9 t-80 -65.78 -24.21 66.89 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.152 -0.967 . . . . 0.0 110.305 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -73.18 -28.52 62.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -0.945 . . . . 0.0 110.658 -179.626 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.456 ' HA2' ' CE ' ' A' ' 8' ' ' LYS . . . 92.54 47.63 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.0 172.0 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.55 -179.723 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.571 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -103.8 64.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.821 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.568 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 4.2 mm -87.83 169.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 111.036 -179.323 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 84.5 m-85 -156.88 115.73 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.215 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.515 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 6.8 mp -92.56 114.36 26.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 111.375 -178.851 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 3.9 m -90.81 102.9 15.66 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.409 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 6.6 mt -99.9 102.01 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.909 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.51 173.02 9.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 0.0 109.689 179.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -9.25 3.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.092 179.004 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 10.65 7.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.293 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.84 10.14 23.94 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t -89.62 99.63 12.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -1.224 . . . . 0.0 109.591 179.628 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.534 HG13 ' CB ' ' A' ' 22' ' ' ASP . 5.8 p -79.75 137.06 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.84 . . . . 0.0 110.549 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 8.5 m-85 -112.18 95.38 5.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 109.696 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -83.47 111.43 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' OE1' ' CG2' ' A' ' 56' D VAL . 0.1 OUTLIER -147.18 131.73 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 111.088 -179.408 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . 1.7 tt0 -79.77 134.33 36.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.178 179.098 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.468 ' HA ' ' HB ' ' A' ' 56' D VAL . 11.2 t -123.11 134.74 65.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.992 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 56' B GLY . 11.8 tptp -158.08 144.54 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' A ASP . . . . . . . . . . . . . 1.5 t70 -46.07 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 109.872 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' B GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 150.15 -48.71 0.58 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -172.47 156.15 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -1.104 . . . . 0.0 110.636 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' D VAL . . . . . 0.51 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -138.54 125.74 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.76 . . . . 0.0 109.398 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 56' E LYS . . . . . 0.494 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.6 158.84 60.57 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.572 -179.409 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 1.8 Cg_endo -87.61 74.49 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.855 1.703 . . . . 0.0 112.442 -177.814 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -42.98 128.31 3.25 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.049 -1.032 . . . . 0.0 109.162 178.519 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -88.9 93.83 0.14 OUTLIER 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.763 -1.766 . . . . 0.0 110.698 0.058 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 1.2 m . . . . . 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.646 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 35.3 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.154 0.502 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.3 mm-40 55.32 -154.37 0.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.021 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.8 mm-40 -95.72 58.9 2.02 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.144 . . . . 0.0 109.16 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 4.7 ttt180 -79.4 72.12 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.541 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 10.7 mm -84.86 157.73 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.382 -0.824 . . . . 0.0 109.168 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 10.9 p -65.32 -174.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 111.216 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.507 ' CD1' HD12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -91.35 -35.3 14.49 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.527 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.2 tmtp? -81.78 -69.63 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.684 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -42.53 -55.57 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.563 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.541 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 10.1 t80 -44.0 -56.22 4.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . . . -54.91 -35.67 64.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.466 -0.771 . . . . 0.0 110.382 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ttp -66.8 -35.11 79.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.881 . . . . 0.0 110.586 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -78.45 -24.73 45.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.184 -0.947 . . . . 0.0 110.343 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -111.09 -77.36 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.014 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.35 158.85 19.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.429 ' OE1' ' HA ' ' A' ' 16' ' ' GLN . 2.4 tp60 -74.03 -30.62 62.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -24.23 41.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -52.15 8.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.175 -0.953 . . . . 0.0 108.758 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.459 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.5 m -58.31 -27.17 63.85 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.47 -53.81 8.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -9.19 45.44 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.774 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.87 -44.81 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' A' ' 42' ' ' LEU . 14.3 mt -79.57 -28.97 41.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 42.02 4.45 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.2 t -129.96 179.44 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -1.161 . . . . 0.0 109.696 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -75.15 154.8 37.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.326 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -26.59 64.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 m -71.26 -50.57 31.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.905 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.58 -17.89 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.181 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -78.25 -61.3 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.699 0.761 . . . . 0.0 109.214 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.584 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.8 OUTLIER -54.71 -14.28 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.664 -0.648 . . . . 0.0 110.501 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.511 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 10.6 tttt -93.57 -39.98 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.576 -1.327 . . . . 0.0 108.964 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.24 -8.66 57.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.185 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.527 ' CG2' ' HG2' ' A' ' 8' ' ' LYS . 8.3 mt -118.56 -47.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.424 -0.798 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.584 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.8 t-80 -72.95 -11.17 60.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.957 -1.089 . . . . 0.0 110.01 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -76.34 -88.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.962 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.04 46.45 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.69 -170.03 2.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.526 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 13.8 ptpt -148.64 87.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.686 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.584 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 22.8 mt -118.21 171.83 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.86 . . . . 0.0 110.739 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 28.2 m-85 -154.02 110.03 3.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.484 -0.76 . . . . 0.0 109.701 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.502 ' CD2' HD22 ' A' ' 23' ' ' LEU . 3.8 mp -86.14 128.71 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 111.327 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 1.6 m -93.74 105.87 17.88 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.496 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 7.2 mt -91.61 134.22 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 110.916 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.651 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.8 m-20 -53.85 -18.66 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.66 -0.65 . . . . 0.0 110.512 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.651 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 91.01 -19.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -2.33 56.44 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.34 0.52 25.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 50' ' ' VAL . 2.1 t -72.46 -175.18 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -1.138 . . . . 0.0 110.139 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.473 HG12 HD21 ' A' ' 23' ' ' LEU . 19.8 t -156.11 130.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.457 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 8.0 t80 -128.0 76.16 1.67 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 109.345 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -48.54 130.29 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 110.998 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.81 84.94 2.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 109.758 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.511 ' CB ' HG12 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -79.0 147.12 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.333 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.0 t -138.71 86.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.82 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 56' A ASP . 7.2 ttpp -97.12 91.48 5.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 110.106 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.556 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -4.38 73.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.28 0.562 . . . . 0.0 112.373 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 157.0 -23.94 0.47 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.3 tt0 -178.92 128.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.109 -1.23 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.44 ' O ' ' CG2' ' A' ' 56' D VAL . 3.6 m -100.21 129.33 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.655 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.431 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -134.72 158.45 75.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 110.517 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 58' ' ' PHE . 11.2 Cg_exo -72.71 -59.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.263 1.665 . . . . 0.0 110.327 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER 56.35 109.99 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 110.072 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.423 ' C ' ' HA ' ' A' ' 58' ' ' PHE . 20.2 Cg_exo -62.94 133.61 14.05 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.497 0.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.88 170.14 8.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.9 p30 -119.02 165.38 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 3.3 ttmt 178.99 64.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 0.0 110.244 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 1.2 pttp -80.26 77.29 7.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -77.27 0.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.933 . . . . 0.0 110.214 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 p -83.68 6.03 22.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.378 -0.826 . . . . 0.0 110.243 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.231 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.264 0.554 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 57.84 -156.42 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.013 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.6 mm100 -103.35 65.16 0.84 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.11 -0.993 . . . . 0.0 110.05 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 18.6 ttt180 -79.53 74.54 6.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 109.626 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.591 HG23 ' CD1' ' A' ' 10' ' ' TYR . 2.9 mt -90.87 146.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.676 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.06 -178.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.768 0.794 . . . . 0.0 111.3 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . 13.1 tp -92.34 -49.97 5.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.16 -64.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.598 -0.688 . . . . 0.0 109.306 178.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -43.72 -53.26 5.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.108 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.591 ' CD1' HG23 ' A' ' 5' ' ' ILE . 1.9 t80 -46.46 -55.18 7.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 109.707 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.85 -37.34 42.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.612 0.72 . . . . 0.0 109.584 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.468 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -55.35 -41.14 72.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 110.415 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -38.77 54.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.52 -67.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 110.007 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 168.65 155.08 9.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.29 -33.85 70.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -1.156 . . . . 0.0 109.878 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -85.23 -7.55 58.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.151 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -53.9 5.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.472 HG21 ' N ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -66.71 -34.1 77.1 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.421 -0.8 . . . . 0.0 109.051 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' N ' HG21 ' A' ' 19' ' ' THR . . . -76.44 -23.55 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 17' ' ' THR . 2.3 mmtt -71.04 -43.79 67.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.002 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 3.8 m-20 -70.09 -28.79 65.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' CD2' HG13 ' A' ' 50' ' ' VAL . 22.0 mt -79.45 -27.51 41.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 26.96 31.45 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 23' ' ' LEU . 7.0 m -135.82 156.13 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.475 ' O ' HD11 ' A' ' 30' ' ' ILE . 96.1 m-85 -64.93 172.18 3.04 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 110.073 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -75.72 -23.37 56.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.172 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -62.85 -46.52 87.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.844 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.69 66.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.853 . . . . 0.0 109.949 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.549 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.5 mp -67.03 -49.88 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' LYS . 25.5 m-20 -57.22 -58.94 6.02 Favored 'General case' 0 C--O 1.194 -1.833 0 O-C-N 121.358 -0.839 . . . . 0.0 110.007 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -49.76 -23.87 2.04 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 119.588 -1.945 . . . . 0.0 109.107 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' O ' HD12 ' A' ' 40' ' ' ILE . . . -76.7 -40.19 49.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.558 -0.714 . . . . 0.0 109.935 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.582 ' CD1' ' HB2' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -95.12 -40.47 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.405 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -60.69 -58.27 9.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.917 -1.115 . . . . 0.0 108.407 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.45 15.1 16.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.932 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 40' ' ' ILE . . . -152.12 93.39 0.14 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 9.8 mmm-85 -86.77 168.86 13.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -1.064 . . . . 0.0 110.82 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER 71.29 66.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.303 -0.873 . . . . 0.0 110.439 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.614 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 17.2 mt -125.45 163.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.5 m-85 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 4.4 mp -140.88 116.87 10.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.534 ' OG1' ' CB ' ' A' ' 51' ' ' TYR . 2.3 p -88.01 101.67 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.555 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.584 HD12 ' CE2' ' A' ' 10' ' ' TYR . 5.5 mt -94.78 124.44 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.047 -1.033 . . . . 0.0 110.314 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.476 ' ND2' ' CB ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -85.43 -177.25 6.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -0.969 . . . . 0.0 110.26 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.36 0.16 17.79 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -101.14 -4.45 27.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.692 . . . . 0.0 110.166 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.84 -15.06 61.55 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.476 ' CB ' ' ND2' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -48.86 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -1.193 . . . . 0.0 109.589 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.458 HG13 ' CD2' ' A' ' 23' ' ' LEU . 45.7 t -80.8 105.78 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 111.063 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CB ' ' OG1' ' A' ' 43' ' ' THR . 0.2 OUTLIER -88.26 90.71 8.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 109.083 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 58' ' ' PHE . . . -89.08 140.48 29.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 110.124 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 56' E LYS . 0.2 OUTLIER -152.61 136.73 16.47 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.889 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' D VAL . 8.7 mt-10 -98.1 111.83 24.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 56' C GLU . 2.6 p -109.82 132.69 57.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.245 -0.91 . . . . 0.0 110.186 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 56' A ASP . 13.8 ttpp -160.24 110.41 1.82 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.677 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.479 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 38.6 t70 61.26 11.42 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.609 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 128.91 -44.92 1.18 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.455 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' C GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.8 mt-10 -60.9 98.2 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.241 -1.152 . . . . 0.0 110.93 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.532 ' O ' ' CG2' ' A' ' 56' D VAL . 4.8 m -107.19 61.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.833 . . . . 0.0 110.088 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -58.93 174.9 0.36 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.97 -1.081 . . . . 0.0 110.557 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 56' E LYS . 2.0 Cg_endo -88.98 -79.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.35 2.033 . . . . 0.0 110.215 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 0.6 OUTLIER 59.91 122.31 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.282 -0.886 . . . . 0.0 109.865 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -77.78 128.91 17.52 Favored 'Cis proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.326 -0.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.56 -170.49 2.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.383 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -144.09 138.95 28.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.355 -0.841 . . . . 0.0 109.917 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -168.75 55.82 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 110.422 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.7 ptmm? -58.82 -161.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 110.097 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -165.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.13 -0.981 . . . . 0.0 109.735 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ALA . 3.8 t -91.3 -16.07 28.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.372 0.606 . . . . 0.0 110.089 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 45' ' ' ASN . 14.7 mm-40 -47.14 94.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 4.3 mm-40 -139.6 -129.11 0.12 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.029 -1.044 . . . . 0.0 108.992 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 40.0 ttp180 -125.16 79.84 1.83 Allowed 'General case' 0 C--N 1.283 -2.292 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.573 HG23 ' CD1' ' A' ' 10' ' ' TYR . 24.2 mt -84.75 135.59 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.383 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -49.46 -176.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.068 0.937 . . . . 0.0 111.833 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.591 HD23 ' CE2' ' A' ' 58' ' ' PHE . 2.8 tp -94.4 -37.21 11.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.506 ' HD2' ' N ' ' A' ' 9' ' ' ASP . 1.4 tmtt? -83.84 -65.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.278 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.506 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 8.3 m-20 -46.84 -45.58 20.31 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.585 ' HB2' ' O ' ' A' ' 6' ' ' THR . 13.3 t80 -55.4 -50.98 68.33 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.719 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -26.14 63.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.767 -0.583 . . . . 0.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -21.63 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -101.32 -6.15 24.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -77.52 0.59 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.1 143.25 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -65.1 -31.99 73.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 110.097 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -80.4 -10.82 59.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.118 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -90.97 -36.65 13.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.342 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -26.94 60.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.42 -39.09 23.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.813 . . . . 0.0 110.699 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.6 tmtt? -65.08 -34.68 79.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 109.956 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 7.7 m-20 -71.46 -38.38 71.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 110.023 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.478 HD12 ' CE2' ' A' ' 58' ' ' PHE . 21.1 mt -80.7 -7.59 59.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 110.407 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 35.42 90.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -134.44 175.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.22 -1.165 . . . . 0.0 109.9 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -82.36 146.19 29.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 110.378 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.545 ' HA ' ' CD1' ' A' ' 30' ' ' ILE . 2.2 mt-30 -53.35 -24.6 12.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.364 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -64.16 -57.54 9.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.93 -30.9 4.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.135 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.545 ' CD1' ' HA ' ' A' ' 27' ' ' GLN . 45.2 mt -70.0 -55.48 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.035 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.0 OUTLIER -59.99 -7.76 1.94 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 111.378 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -91.26 -34.45 14.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.574 -1.329 . . . . 0.0 108.266 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.472 ' O ' HD12 ' A' ' 40' ' ' ILE . . . -86.16 -15.84 39.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.543 HD13 ' CG2' ' A' ' 30' ' ' ILE . 10.6 mt -95.46 -48.11 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.513 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 18.8 t60 -68.09 -55.9 10.81 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.229 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.11 13.44 18.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.492 ' O ' HD13 ' A' ' 40' ' ' ILE . . . -141.63 83.78 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 8.0 mmm-85 -90.43 77.14 6.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.524 ' CE ' ' HB2' ' A' ' 56' ' ' LYS . 2.9 pttm 177.18 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.568 -0.708 . . . . 0.0 109.126 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.603 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 5.4 mt -103.17 161.66 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.748 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.603 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 37.6 m-85 -157.47 131.31 8.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.397 -0.814 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.532 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 2.0 mp -124.54 118.3 26.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 0.0 110.353 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.516 ' OG1' ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -89.27 102.65 15.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.064 -1.022 . . . . 0.0 109.429 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.3 mt -89.29 43.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.962 -1.086 . . . . 0.0 109.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 49.4 p-10 -105.45 -151.53 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.704 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 68.92 6.34 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.143 -0.973 . . . . 0.0 108.799 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.704 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 120.61 -53.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.47 29.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 33.6 t -78.01 156.37 30.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.541 -0.976 . . . . 0.0 110.181 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.439 ' O ' HG11 ' A' ' 50' ' ' VAL . 24.8 t -110.82 98.35 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 110.484 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.516 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 5.5 m-85 -96.9 89.85 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.467 ' HB3' HD22 ' A' ' 42' ' ' LEU . . . -89.71 122.73 33.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.181 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 56' E LYS . 0.5 OUTLIER -160.21 137.49 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.937 . . . . 0.0 110.582 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.45 178.52 4.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.835 . . . . 0.0 109.673 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 54' ' ' GLU . 83.9 t -152.06 111.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.965 . . . . 0.0 110.462 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HB2' ' CE ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.49 122.4 41.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.094 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.0 t0 50.98 -90.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -142.52 54.87 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.5 tt0 -162.19 97.03 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.136 . . . . 0.0 110.351 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.412 ' CG1' HG21 ' A' ' 55' ' ' VAL . 11.1 m -92.62 165.29 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 9.5 ptpt -165.68 148.53 6.7 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.076 -1.015 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.0 Cg_exo -76.76 73.76 5.16 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.959 1.505 . . . . 0.0 111.211 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CE2' HD23 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -45.62 132.93 6.39 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.846 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 79.0 Cg_endo -92.61 79.15 0.13 OUTLIER 'Cis proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.827 -1.739 . . . . 0.0 110.816 0.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.555 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 1.1 p -62.62 -167.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 110.645 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 23.0 p30 37.12 55.13 1.28 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.722 -0.612 . . . . 0.0 110.734 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.07 49.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.263 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -136.38 -95.15 0.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 110.09 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.39 -92.28 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.06 -1.025 . . . . 0.0 110.205 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.4 t -132.17 26.15 4.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 110.09 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.231 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' C ' ' CG ' ' A' ' 2' ' ' GLU . 16.5 tpp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.242 0.544 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' CG ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -166.71 109.76 0.72 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 109.907 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -100.4 58.85 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.22 94.77 4.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.993 0.901 . . . . 0.0 111.011 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.582 HD13 ' CE1' ' A' ' 10' ' ' TYR . 2.2 mt -90.3 -173.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.663 -0.648 . . . . 0.0 109.766 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.76 -179.09 5.43 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.288 -0.883 . . . . 0.0 111.608 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -91.4 -43.01 10.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.56 -63.79 1.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.406 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -44.25 -50.77 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.582 ' CE1' HD13 ' A' ' 5' ' ' ILE . 5.3 t80 -57.39 -51.64 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.358 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -49.03 -26.08 2.39 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 109.605 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 tpt -71.83 -52.65 16.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.036 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.94 -21.03 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.636 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.95 -75.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 109.611 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 173.5 142.58 3.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.481 ' NE2' ' HG2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.42 -36.06 75.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -1.232 . . . . 0.0 109.701 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -78.72 -16.5 57.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.76 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -78.59 -51.24 10.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 0.0 109.256 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.3 m -64.7 -23.82 67.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -83.82 -25.82 30.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.285 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.55 -27.27 41.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.74 -27.95 26.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.846 . . . . 0.0 110.218 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.7 mt -80.02 -8.13 59.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.66 29.71 72.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.7 m -151.48 150.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 110.107 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.527 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 9.3 p90 -66.68 169.33 7.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.957 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.481 ' HG2' ' NE2' ' A' ' 16' ' ' GLN . 9.4 mp0 -65.3 -32.07 73.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 111.349 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.527 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -46.6 -48.37 19.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.972 -1.08 . . . . 0.0 110.773 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.44 70.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.55 HG22 HD13 ' A' ' 34' ' ' ILE . 2.8 mp -72.11 -32.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.79 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 6.8 t-20 -65.88 -23.77 66.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -36.84 12.84 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.423 -1.423 . . . . 0.0 108.047 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB3' ' CD1' ' A' ' 40' ' ' ILE . . . -71.14 -14.77 62.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.55 HD13 ' CB ' ' A' ' 7' ' ' LEU . 5.7 mt -112.48 -54.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 5.2 t-160 -56.19 -15.63 4.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -85.23 29.14 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.755 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . 43.52 44.11 6.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.32 -172.0 3.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -1.112 . . . . 0.0 111.07 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' O ' ' CG2' ' A' ' 55' ' ' VAL . 15.3 mttt -135.02 83.87 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.539 -0.725 . . . . 0.0 109.053 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.589 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 27.0 mt -114.4 165.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 111.372 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.2 m-85 -159.67 177.51 10.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.641 . . . . 0.0 109.388 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.41 111.78 5.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.062 . . . . 0.0 109.706 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.52 HG23 ' ND2' ' A' ' 45' ' ' ASN . 9.3 m -75.53 99.42 4.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.448 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.578 HD12 ' CE2' ' A' ' 10' ' ' TYR . 55.7 mt -86.99 59.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 111.364 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.52 ' ND2' HG23 ' A' ' 43' ' ' THR . 39.7 p30 -103.4 -123.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.997 -1.064 . . . . 0.0 109.711 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 40.65 29.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.107 -0.996 . . . . 0.0 109.969 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.561 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 41.8 t0 72.78 64.35 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.384 0.612 . . . . 0.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 -12.21 41.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.545 ' HB2' ' CB ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -59.1 159.47 7.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.955 -1.321 . . . . 0.0 109.068 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 38.2 t -127.69 127.87 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 111.19 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 30.0 m-85 -124.64 159.03 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -143.62 137.2 28.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.802 -1.186 . . . . 0.0 111.112 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 56' E LYS . 1.1 mp0 -142.56 143.91 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 110.165 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE2' ' CD1' ' A' ' 58' ' ' PHE . 1.0 OUTLIER -84.01 167.55 16.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.669 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 39' ' ' LYS . 3.0 t -139.24 128.56 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.994 -1.066 . . . . 0.0 110.216 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 56' A ASP . 0.0 OUTLIER -146.92 170.16 17.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.518 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 60.8 t0 -40.57 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 53.31 59.12 10.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 7.6 tt0 -172.49 88.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.197 -1.178 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' D VAL . . . . . . . . . . . . . 6.2 m -97.07 140.38 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 0.0 109.952 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -119.0 172.6 4.15 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.071 -1.018 . . . . 0.0 110.69 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 58' ' ' PHE . 1.2 Cg_endo -87.6 24.94 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.354 2.036 . . . . 0.0 110.564 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.525 ' CD1' ' OE2' ' A' ' 54' ' ' GLU . 62.4 t80 -30.64 123.62 0.32 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.873 -0.517 . . . . 0.0 111.304 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.8 Cg_endo -80.17 108.03 1.16 Allowed 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.396 -1.918 . . . . 0.0 110.551 0.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -48.5 155.32 0.54 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.016 -1.052 . . . . 0.0 110.063 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -86.88 -171.24 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.077 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -155.47 52.85 0.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 110.464 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -100.18 -18.86 16.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.309 -0.87 . . . . 0.0 109.868 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.522 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 21.6 p 41.3 -150.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.366 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 3.3 t -172.7 55.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.987 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.111 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.488 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.027 0.441 . . . . 0.0 110.221 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER 58.81 136.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.393 -0.817 . . . . 0.0 110.157 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -121.5 72.63 1.01 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.997 -1.064 . . . . 0.0 109.951 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -78.76 92.18 4.78 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.131 0.967 . . . . 0.0 111.029 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.555 HD11 ' CD1' ' A' ' 10' ' ' TYR . 18.3 mt -90.74 154.86 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.983 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.54 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -50.78 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.281 1.039 . . . . 0.0 111.413 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' A' ' 34' ' ' ILE . 4.0 tp -92.91 -39.99 10.85 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 9' ' ' ASP . 1.1 mmmp? -90.64 -63.42 1.27 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.3 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.3 t70 -44.63 -44.89 9.29 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.555 ' CD1' HD11 ' A' ' 5' ' ' ILE . 8.7 t80 -56.46 -57.39 12.52 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.501 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.32 -21.01 4.96 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 ttm -78.43 -46.8 18.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.774 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -78.04 -10.85 59.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -69.42 0.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 133.06 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -58.86 -24.02 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.445 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -78.75 -26.8 44.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.041 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -76.35 -56.39 4.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 108.672 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.408 ' O ' HD13 ' A' ' 23' ' ' LEU . 1.1 t -60.21 -30.75 69.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 16' ' ' GLN . . . -64.2 -43.61 94.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -19.48 56.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -73.7 -26.4 60.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.47 HD23 HD22 ' A' ' 42' ' ' LEU . 9.4 mt -82.93 -52.24 6.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.25 28.89 1.05 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.65 162.46 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -1.155 . . . . 0.0 110.015 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.76 -175.11 0.37 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.399 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -22.87 37.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 110.618 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' ALA . 23.5 t -74.58 -72.1 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 110.279 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.82 -27.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.307 -0.87 . . . . 0.0 109.349 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -68.61 -61.69 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.546 -0.721 . . . . 0.0 109.566 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.569 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 0.5 OUTLIER -46.56 -18.26 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.563 -0.711 . . . . 0.0 111.032 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -89.76 -40.86 12.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.438 -1.414 . . . . 0.0 108.588 178.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -7.04 53.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.517 -0.74 . . . . 0.0 109.136 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.531 ' CD1' HD13 ' A' ' 7' ' ' LEU . 15.8 mt -111.33 -54.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.636 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.538 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 67.2 t60 -61.16 -14.99 28.84 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -64.16 -9.01 14.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.629 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 34.12 60.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 153.69 31.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.55 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.544 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER -86.3 58.97 5.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.506 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 4.9 mt -93.25 167.83 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 111.093 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 68.0 m-85 -155.88 167.75 29.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 4.6 mp -142.79 105.35 4.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.835 -1.166 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 1.3 m -78.59 93.1 4.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.587 -0.695 . . . . 0.0 109.197 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 44' ' ' ILE . 27.8 mt -96.76 117.68 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.303 -0.873 . . . . 0.0 110.509 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.572 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER -81.76 -173.48 4.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.266 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.66 0.34 17.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.72 0.71 52.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.122 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' SER . . . 85.16 -14.11 51.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -45.28 162.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -1.205 . . . . 0.0 109.928 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.51 ' CG2' ' OD2' ' A' ' 22' ' ' ASP . 80.9 t -138.72 114.94 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -101.04 80.39 2.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 109.382 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 41' ' ' PHE . . . -80.42 89.68 5.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.701 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -102.47 167.5 9.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.765 . . . . 0.0 109.687 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 56' D VAL . 0.8 OUTLIER -135.08 156.93 48.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.076 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.58 105.23 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 56' A ASP . 11.3 ttpp -123.65 103.24 8.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 56' A ASP . 51.6 t0 59.09 23.77 12.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.915 . . . . 0.0 110.449 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 109.62 -36.5 4.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 42.5 mt-10 -63.04 104.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 34.0 m -106.4 157.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.122 -0.986 . . . . 0.0 110.46 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' E LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.26 167.54 2.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.962 . . . . 0.0 110.575 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.57 175.97 10.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 121.875 1.716 . . . . 0.0 110.411 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 59' ' ' PRO . 13.4 t80 -167.82 146.04 3.89 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 110.364 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.566 ' HA ' ' CD2' ' A' ' 58' ' ' PHE . 59.1 Cg_endo -91.89 48.41 1.34 Allowed 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.115 -2.035 . . . . 0.0 110.455 0.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 t -65.62 177.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.235 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.61 89.59 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.424 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -166.15 61.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 109.991 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.551 ' CG ' ' HA ' ' A' ' 66' ' ' ALA . 12.4 ptpt -44.2 166.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -0.962 . . . . 0.0 109.976 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.546 ' O ' ' CG2' ' A' ' 65' ' ' THR . 77.9 p -80.87 142.02 34.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 110.7 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 64' ' ' THR . 13.8 t 40.52 28.59 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.745 0.783 . . . . 0.0 109.545 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HA ' ' CG ' ' A' ' 63' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.173 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.26 0.552 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.69 149.97 33.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 110.025 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -125.21 77.16 1.61 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.197 -0.939 . . . . 0.0 109.672 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 9.3 ttt180 -79.18 80.11 5.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.546 ' CD1' HD13 ' A' ' 44' ' ' ILE . 2.6 mt -86.02 164.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.523 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -70.34 -178.6 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.134 0.969 . . . . 0.0 112.367 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.536 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . 3.5 tp -92.55 -40.36 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.547 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.44 -65.92 0.97 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -43.42 -48.54 7.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.564 ' CB ' ' O ' ' A' ' 6' ' ' THR . 12.6 t80 -54.03 -57.32 11.48 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.829 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.6 -27.37 4.47 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 109.912 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.79 77.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -15.04 58.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.229 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.71 -87.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 179.47 48.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.504 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.2 tp60 -90.2 -28.66 18.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -1.096 . . . . 0.0 110.509 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 6.1 t -87.03 -24.93 24.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.242 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -73.71 -59.08 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.955 . . . . 0.0 108.75 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.512 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.1 m -60.0 -32.27 70.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.552 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . . . -76.45 -20.63 56.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.129 -0.982 . . . . 0.0 110.336 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.45 -46.93 68.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.104 -0.997 . . . . 0.0 110.912 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.08 -6.41 53.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.105 -0.997 . . . . 0.0 112.221 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.566 ' CD2' ' CD2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -162.72 36.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.639 -1.288 . . . . 0.0 109.882 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . -160.82 67.25 0.26 Allowed Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 59' ' ' PRO 0.254 38.3 t -75.12 -2.26 3.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.734 0.778 . . . . 0.0 109.5 -178.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -134.32 82.54 1.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 26' ' ' TYR . 1.6 tt0 -36.14 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.617 -0.677 . . . . 0.0 111.369 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 26' ' ' TYR . 36.1 p -76.61 -55.44 5.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.977 -1.077 . . . . 0.0 109.211 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 26' ' ' TYR . . . -57.45 -17.79 15.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.328 -0.857 . . . . 0.0 108.901 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.528 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -74.31 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.623 -0.673 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.6 m-20 -62.24 -9.63 8.45 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.52 -0.737 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 2.3 ttpt -93.25 -38.15 11.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.866 -1.146 . . . . 0.0 108.086 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -82.5 -8.29 59.62 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.547 ' CG2' ' HG2' ' A' ' 8' ' ' LYS . 22.7 mt -108.89 -48.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.573 -0.704 . . . . 0.0 109.585 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 3.5 t60 -70.96 -28.65 64.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.867 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -65.46 -33.43 75.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.52 59.72 0.83 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.33 -176.02 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 26.9 tttt -117.21 71.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 40' ' ' ILE . 10.4 mt -115.95 166.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.472 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 91.8 m-85 -149.39 173.2 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.295 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.566 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 3.6 mp -143.32 147.96 35.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.007 -1.058 . . . . 0.0 111.455 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 94.9 m -112.63 105.52 13.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.583 -0.698 . . . . 0.0 109.191 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.546 HD13 ' CD1' ' A' ' 5' ' ' ILE . 2.5 mt -83.04 -134.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.316 -0.865 . . . . 0.0 111.164 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 2.1 p-10 34.77 -146.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.932 -0.48 . . . . 0.0 111.497 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.655 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 56.27 23.07 6.78 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.655 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 26.8 t70 100.19 35.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 123.752 0.821 . . . . 0.0 109.28 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.62 7.25 57.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -67.63 104.28 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -1.175 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.88 125.78 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.463 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 7.8 m-85 -112.29 158.86 19.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.803 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 23' ' ' LEU . . . -139.34 97.01 3.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 56' E LYS . 29.1 mt-10 -111.99 126.09 54.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.808 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' O ' HG21 ' A' ' 55' ' ' VAL . 1.7 mt-10 -82.04 161.61 22.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 54' ' ' GLU . 5.6 t -142.33 121.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.463 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -147.71 142.72 27.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 15.9 t70 56.21 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.919 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -157.8 36.21 0.54 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.69 132.01 12.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -1.175 . . . . 0.0 110.182 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -101.14 169.71 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.158 -0.964 . . . . 0.0 110.557 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 3.9 mttm -145.24 175.67 2.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 6.2 Cg_exo -81.57 -163.0 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.21 1.94 . . . . 0.0 110.433 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 179.07 113.41 0.19 Allowed Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.305 -0.872 . . . . 0.0 110.329 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.486 ' HG3' HG22 ' A' ' 25' ' ' VAL . 46.0 Cg_endo -77.85 108.18 1.14 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.117 -2.035 . . . . 0.0 110.734 -0.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 63.4 p -47.03 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 59' ' ' PRO . 9.5 t-20 -152.52 62.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.87 . . . . 0.0 110.064 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -173.33 48.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.544 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -107.85 33.58 4.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 110.159 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.527 ' O ' HG21 ' A' ' 65' ' ' THR . 5.3 m -79.05 137.15 37.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.947 . . . . 0.0 110.151 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.527 HG21 ' O ' ' A' ' 64' ' ' THR . 0.5 OUTLIER 57.2 27.47 13.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 110.232 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.193 -179.827 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.356 0.598 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 52.54 94.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 110.2 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -114.08 72.87 0.8 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.213 -0.929 . . . . 0.0 109.633 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.38 68.64 6.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 110.503 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.483 HG23 ' HA ' ' A' ' 10' ' ' TYR . 8.6 mt -91.79 139.35 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 17.7 p -51.22 -174.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.023 -1.048 . . . . 0.0 110.943 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.551 ' CD2' ' CG1' ' A' ' 34' ' ' ILE . 3.6 tp -91.42 -36.48 13.77 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -82.87 -68.79 0.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.725 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.441 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.2 OUTLIER -44.99 -54.2 6.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CB ' ' O ' ' A' ' 6' ' ' THR . 1.2 t80 -47.01 -55.24 8.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.277 -0.889 . . . . 0.0 110.232 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.46 61.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.529 -0.732 . . . . 0.0 110.162 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.3 ttm -67.67 -32.79 73.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' NH1' ' HG2' ' A' ' 13' ' ' ARG . 30.6 mtt-85 -83.52 -27.3 29.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.5 -65.3 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.0 141.34 3.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.441 ' OE1' HG22 ' A' ' 30' ' ' ILE . 1.0 OUTLIER -58.5 -35.79 72.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.019 -1.283 . . . . 0.0 109.998 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -79.72 -16.52 55.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.125 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.93 -57.65 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.452 ' O ' HD22 ' A' ' 23' ' ' LEU . 3.0 m -49.83 -34.45 19.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.85 82.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.743 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -82.06 -4.72 57.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.728 . . . . 0.0 110.041 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' HB3' HG23 ' A' ' 50' ' ' VAL . 7.7 m-20 -84.44 -38.6 19.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.013 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -116.74 14.03 15.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.18 -0.95 . . . . 0.0 110.435 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.88 37.87 91.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.529 HG22 ' CD1' ' A' ' 23' ' ' LEU . 22.1 t -108.88 120.79 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -1.12 . . . . 0.0 110.062 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -45.72 166.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.464 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -71.51 -27.71 63.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.154 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 30' ' ' ILE . 29.3 t -70.66 -61.61 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.724 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -45.32 -26.18 0.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.153 -0.967 . . . . 0.0 109.114 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.555 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -66.06 -66.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.582 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 71.0 m-80 -61.67 -7.25 3.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.545 -0.722 . . . . 0.0 110.468 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -35.93 15.22 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.863 -1.148 . . . . 0.0 108.116 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.98 -10.95 51.93 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.551 ' CG1' ' CD2' ' A' ' 7' ' ' LEU . 35.0 mt -103.66 -43.35 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 52.1 t-80 -74.93 -56.31 4.88 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.901 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.62 -4.17 55.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.955 . . . . 0.0 111.118 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -123.53 69.06 0.46 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.213 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -65.07 -170.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.243 . . . . 0.0 110.266 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 55.15 68.9 0.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 108.872 -179.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.604 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 2.8 mt -120.26 151.01 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.87 . . . . 0.0 110.444 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 90.5 m-85 -158.82 128.0 5.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.651 -0.656 . . . . 0.0 110.203 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.547 ' CD1' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -120.95 133.59 55.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 m -108.04 100.76 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.939 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 5.8 mt -82.05 -173.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.898 . . . . 0.0 110.025 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER 82.7 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.248 0.547 . . . . 0.0 111.927 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.688 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 64.33 17.66 10.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 30.2 t70 110.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.948 0.899 . . . . 0.0 109.067 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.51 79.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -70.85 109.1 4.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.839 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 22' ' ' ASP . 25.3 t -79.5 109.53 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 110.23 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 5.9 m-85 -95.21 143.94 26.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 108.937 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -127.21 86.86 2.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.113 . . . . 0.0 110.916 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.31 151.66 20.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.857 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -130.9 160.1 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 110.168 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 23.3 t -150.24 84.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.416 -0.802 . . . . 0.0 109.9 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 56' A ASP . 5.2 ttmt -94.16 101.76 13.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.141 -0.975 . . . . 0.0 109.609 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 56' ' ' LYS . 38.4 t70 -13.61 80.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.378 0.608 . . . . 0.0 112.049 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.08 -27.44 0.8 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.81 132.42 0.12 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.018 -1.284 . . . . 0.0 110.807 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 56' E LYS . 12.5 m -96.98 165.89 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.425 ' HB2' ' CD ' ' A' ' 57' ' ' PRO . 10.6 ptpt -175.53 171.8 1.15 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.847 -1.158 . . . . 0.0 110.813 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 60' ' ' SER . 3.7 Cg_exo -76.83 -173.18 1.65 Allowed 'Trans proline' 0 C--N 1.299 -2.078 0 O-C-N 124.53 1.805 . . . . 0.0 110.485 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 39.0 t80 178.91 114.79 0.19 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 110.865 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -79.5 107.13 0.99 Allowed 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.372 -1.928 . . . . 0.0 109.886 -0.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 12.5 p -66.85 164.73 16.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.508 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -161.26 119.5 2.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 109.973 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER 179.87 67.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -39.96 -74.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.494 -0.754 . . . . 0.0 110.694 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.55 ' O ' ' CG2' ' A' ' 65' ' ' THR . 91.6 m 59.02 160.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.324 -0.86 . . . . 0.0 110.294 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.55 ' CG2' ' O ' ' A' ' 64' ' ' THR . 8.8 t 41.69 29.07 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.71 0.767 . . . . 0.0 109.508 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 64' ' ' THR . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 1' ' ' MET . 30.8 ttm . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.149 0.499 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.539 ' CB ' ' O ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.05 -161.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.759 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 37.7 mm-40 -145.22 -136.05 0.09 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.057 -1.027 . . . . 0.0 108.288 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -126.55 90.48 3.18 Favored 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.617 -0.677 . . . . 0.0 109.455 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.573 HD11 ' CE1' ' A' ' 10' ' ' TYR . 1.1 mt -90.28 151.57 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.612 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 3.0 p -84.31 -166.16 1.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.767 0.794 . . . . 0.0 111.376 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.541 HD11 ' CD1' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.06 -28.41 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -81.65 -82.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.816 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.1 m-20 -41.69 -56.03 2.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.456 -0.778 . . . . 0.0 110.058 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.573 ' CE1' HD11 ' A' ' 5' ' ' ILE . 1.4 t80 -49.6 -50.63 41.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.409 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 7' ' ' LEU . . . -56.29 -32.49 64.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 110.37 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -36.56 84.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.313 -0.867 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -38.07 44.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.132 -0.98 . . . . 0.0 110.147 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -99.23 -80.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.996 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.59 44.19 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.41 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 14.3 mm100 -88.72 -31.03 18.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.242 -1.151 . . . . 0.0 110.053 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.8 m -83.18 -26.13 31.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -56.55 4.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 108.797 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 2.1 m -55.55 -30.64 61.13 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -64.0 -55.86 19.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.896 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -84.66 11.58 8.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.461 -0.774 . . . . 0.0 109.787 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 3.0 m-20 -90.23 -43.28 10.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.416 -0.802 . . . . 0.0 110.58 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.596 ' CD1' ' CG2' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -94.63 -22.25 18.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.504 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 115.75 58.19 0.34 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.596 ' CG2' ' CD1' ' A' ' 23' ' ' LEU . 3.1 t -152.53 161.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.269 . . . . 0.0 110.166 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -77.8 177.6 8.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.467 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.04 -50.13 30.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 110.272 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.5 p -62.3 -60.32 3.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.59 -29.47 0.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.964 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -65.8 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.603 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.587 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 2.7 m-20 -57.13 -7.45 0.52 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.473 -0.767 . . . . 0.0 111.208 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 -41.87 15.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.73 -1.231 . . . . 0.0 107.762 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.451 ' O ' ' HB1' ' A' ' 36' ' ' ALA . . . -70.44 -45.28 66.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.489 HG12 ' CB ' ' A' ' 7' ' ' LEU . 10.5 mt -66.54 -46.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -42.87 -36.58 1.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.634 178.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 33' ' ' ALA . . . -67.91 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.758 -0.589 . . . . 0.0 109.727 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . 129.14 -16.24 5.77 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.337 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.698 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -39.97 81.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' GLY . 6.6 ptpt 9.69 69.06 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.512 0.672 . . . . 0.0 112.736 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.581 ' O ' ' CD2' ' A' ' 41' ' ' PHE . 29.5 mt -80.77 167.48 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 109.126 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 40' ' ' ILE . 27.6 m-85 -158.29 150.55 21.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.877 -1.14 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.574 HD11 ' N ' ' A' ' 42' ' ' LEU . 4.5 mp -138.97 122.05 16.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.807 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.587 ' O ' ' CG2' ' A' ' 43' ' ' THR . 1.0 OUTLIER -102.27 109.48 21.16 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.475 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.554 ' CG2' ' O ' ' A' ' 49' ' ' SER . 2.0 mt -98.48 152.23 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 110.126 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.426 ' OD1' ' C ' ' A' ' 44' ' ' ILE . 2.9 m-20 -136.09 -171.81 2.97 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.999 -1.063 . . . . 0.0 110.391 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.76 -4.22 30.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -156.67 16.91 0.31 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -93.4 -6.19 62.92 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.351 -1.899 . . . . 0.0 108.351 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.572 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 72.1 m 54.24 -92.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.572 ' CG2' ' O ' ' A' ' 49' ' ' SER . 8.4 t -161.21 98.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.28 -0.888 . . . . 0.0 110.475 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 24.1 t80 -86.8 138.18 31.8 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 58' ' ' PHE . . . -120.8 93.92 4.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.543 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 17.2 pt-20 -111.41 137.45 49.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 110.369 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -89.47 162.84 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.28 -0.888 . . . . 0.0 108.963 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.48 ' O ' ' CG ' ' A' ' 39' ' ' LYS . 6.1 t -135.77 143.41 36.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.892 -1.13 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 56' B GLY . 2.6 tppt? -159.96 169.54 23.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 109.35 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 56' ' ' LYS . 36.9 t70 -29.57 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.379 0.609 . . . . 0.0 111.232 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 46.71 61.6 4.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.21 99.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.123 -1.222 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 56' E LYS . 16.5 m -107.17 153.41 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.132 -0.98 . . . . 0.0 109.681 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.504 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -144.03 175.7 2.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 110.604 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 60' ' ' SER . 1.9 Cg_endo -87.79 -174.21 1.16 Allowed 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.092 1.862 . . . . 0.0 109.611 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 28.5 t80 174.39 113.78 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 110.434 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 61' ' ' ASN . 1.9 Cg_endo -80.06 110.7 1.98 Allowed 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.513 -1.87 . . . . 0.0 110.325 -0.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.524 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 16.3 m -35.23 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.538 -0.726 . . . . 0.0 110.867 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -54.89 -177.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.842 . . . . 0.0 110.453 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -142.46 50.18 1.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.83 . . . . 0.0 109.824 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.63 162.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.539 -0.726 . . . . 0.0 110.388 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 65' ' ' THR . 0.6 OUTLIER -80.91 170.75 15.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.325 -0.859 . . . . 0.0 110.301 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 64' ' ' THR . 5.7 t 41.86 28.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.778 0.799 . . . . 0.0 109.267 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' THR . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.176 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtp . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.214 0.53 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -55.83 177.52 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.074 -1.016 . . . . 0.0 109.452 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 30.1 mm-40 -145.17 -129.54 0.08 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.982 -1.074 . . . . 0.0 108.814 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . 0.255 0.3 OUTLIER -89.53 66.89 7.45 Favored 'General case' 0 C--N 1.282 -2.364 0 O-C-N 121.559 -0.713 . . . . 0.0 109.348 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 22.0 mt -87.24 155.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.221 -0.924 . . . . 0.0 111.242 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 1.1 m -65.99 -173.37 0.18 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.149 0.976 . . . . 0.0 111.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.532 ' CD2' HG12 ' A' ' 34' ' ' ILE . 3.3 tp -93.23 -39.32 11.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.522 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.7 tmtm? -90.22 -61.81 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.113 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 52.2 t0 -46.42 -44.99 17.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.915 . . . . 0.0 108.641 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CE2' HD13 ' A' ' 44' ' ' ILE . 3.0 t80 -55.52 -58.56 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.49 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.04 -14.6 17.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.457 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 tpt -90.52 -24.41 20.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 0.0 110.182 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.73 -21.0 21.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -107.22 -55.41 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.31 140.89 3.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -59.91 -35.68 75.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -11.29 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.486 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -52.47 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.76 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.498 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 3.0 m -60.66 -34.56 74.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.532 ' CB ' ' HG3' ' A' ' 27' ' ' GLN . . . -78.43 -19.66 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -79.78 -51.08 9.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.493 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 57.0 p30 -70.86 -18.13 62.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 29.2 mt -79.81 -31.98 40.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 34.5 22.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.35 169.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.231 -1.159 . . . . 0.0 110.03 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.422 ' O ' HD11 ' A' ' 30' ' ' ILE . 12.8 m-85 -72.2 145.74 47.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.493 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.532 ' HG3' ' CB ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -66.2 -16.77 64.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' ALA . 20.2 m -71.1 -61.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.06 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -41.2 -36.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.606 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.527 ' CG2' HD13 ' A' ' 34' ' ' ILE . 1.3 mp -68.1 -55.11 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.308 -0.87 . . . . 0.0 110.528 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.4 OUTLIER -54.21 -13.65 0.91 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -38.86 11.71 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.563 -1.336 . . . . 0.0 108.253 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -10.89 59.75 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.532 HG12 ' CD2' ' A' ' 7' ' ' LEU . 16.5 mt -111.52 -51.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.0 110.0 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -60.49 -19.72 57.74 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.464 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.69 -84.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 109.883 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.63 38.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 152.28 20.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -1.119 . . . . 0.0 110.889 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -100.51 69.03 1.4 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.825 . . . . 0.0 109.512 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.546 ' C ' ' CD1' ' A' ' 41' ' ' PHE . 15.5 mt -89.64 164.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.864 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 71.7 m-85 -144.62 163.98 32.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 3.2 mp -144.35 141.55 29.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 110.692 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 2.8 m -118.76 102.96 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.785 . . . . 0.0 109.395 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.579 HD13 ' CE2' ' A' ' 10' ' ' TYR . 19.3 mt -118.89 100.01 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 111.167 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -107.81 -167.09 1.21 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.826 -1.171 . . . . 0.0 110.525 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.89 -2.23 7.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' ASN . 11.3 t70 -144.69 7.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.616 -0.678 . . . . 0.0 109.401 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -91.07 -7.83 65.41 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.554 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER 47.81 -92.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' A' ' 48' ' ' GLY . 2.4 t -161.57 95.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.146 -0.971 . . . . 0.0 109.963 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -100.11 134.78 42.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.608 -0.682 . . . . 0.0 109.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.84 130.5 53.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 110.206 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -137.32 104.66 5.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.96 . . . . 0.0 110.692 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -79.36 150.82 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.373 -0.83 . . . . 0.0 109.868 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.34 132.17 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -153.51 151.38 29.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -40.68 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.206 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.32 -65.84 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -171.91 -179.56 2.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -1.051 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -100.48 149.09 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.172 -0.955 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.534 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -122.99 179.4 1.03 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 56' E LYS . 5.6 Cg_endo -90.62 -170.94 0.4 Allowed 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.014 1.809 . . . . 0.0 110.269 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.499 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 40.5 t80 176.49 109.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.207 -0.933 . . . . 0.0 111.03 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -81.68 99.33 0.26 Allowed 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.843 -1.732 . . . . 0.0 109.682 -0.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.53 ' CA ' ' HB2' ' A' ' 57' ' ' PRO . 13.7 m 50.59 -159.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.856 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.417 ' HB3' ' HD3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -107.77 -175.97 2.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.078 -1.014 . . . . 0.0 111.087 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -121.62 40.63 3.56 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.772 0.796 . . . . 0.0 109.429 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 64' ' ' THR . 11.6 mtpt -64.6 -52.23 58.59 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.785 -0.572 . . . . 0.0 110.112 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.528 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 76.56 -73.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.137 0.494 . . . . 0.0 110.435 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -122.39 3.51 9.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.92 . . . . 0.0 110.293 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.318 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.468 ' HA ' HD12 ' A' ' 5' ' ' ILE . 7.8 mtt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.169 0.509 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 5.4 tt0 57.05 29.61 16.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 110.476 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 43' ' ' THR . 5.2 mm-40 -129.56 -133.52 0.22 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.171 -0.955 . . . . 0.0 108.573 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.94 75.8 0.94 Allowed 'General case' 0 C--N 1.281 -2.387 0 O-C-N 121.764 -0.585 . . . . 0.0 109.92 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 10' ' ' TYR . 1.5 mt -90.67 148.51 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.735 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.589 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 1.3 p -90.95 169.23 11.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 112.296 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.572 HD11 ' N ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -61.5 -25.88 67.55 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -81.43 -83.43 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.489 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 8' ' ' LYS . 75.7 m-20 -41.05 -54.6 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.971 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.589 ' CB ' ' O ' ' A' ' 6' ' ' THR . 43.7 t80 -51.12 -58.27 6.56 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.66 -23.36 11.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.522 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -34.19 52.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.635 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -91.67 -12.85 32.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -123.46 -49.95 1.89 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.276 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.18 134.81 2.86 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.42 ' OE1' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -60.9 -32.22 71.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.211 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -84.06 -11.45 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 110.192 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -51.94 7.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.204 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.458 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -65.6 -31.61 72.74 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.425 -0.797 . . . . 0.0 108.893 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -75.68 -26.29 57.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.607 -0.683 . . . . 0.0 109.773 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -27.98 61.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' OD1' ' HG ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -82.94 -27.55 30.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 110.305 -179.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.472 ' HG ' ' OD1' ' A' ' 22' ' ' ASP . 25.9 mt -80.66 -10.8 59.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.965 . . . . 0.0 110.103 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 48.08 75.29 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.22 153.1 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.343 -1.092 . . . . 0.0 110.033 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' O ' HD13 ' A' ' 30' ' ' ILE . 31.8 m-85 -66.75 157.55 32.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.122 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -64.65 -11.66 37.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.26 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.9 t -75.96 -62.31 1.64 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.87 -35.91 4.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.234 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.54 ' CG2' ' CD1' ' A' ' 34' ' ' ILE . 3.7 mt -74.77 -48.15 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -55.11 -13.65 1.3 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.753 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -93.32 -38.94 11.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 108.385 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.32 -7.66 57.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.54 ' CD1' ' CG2' ' A' ' 30' ' ' ILE . 13.1 mt -110.89 -53.35 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.566 -0.709 . . . . 0.0 109.495 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.549 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 83.7 t60 -52.5 -31.3 34.53 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.196 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.17 -43.0 13.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.461 -0.774 . . . . 0.0 109.659 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.52 55.75 16.46 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HD2' ' H ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -85.14 39.86 0.79 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.189 -1.183 . . . . 0.0 111.153 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.5 OUTLIER 72.74 101.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.383 -0.823 . . . . 0.0 111.176 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.564 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 6.6 mt -145.61 159.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 99.4 m-85 -154.08 160.86 42.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.918 -1.114 . . . . 0.0 111.218 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.568 ' CD2' ' CD1' ' A' ' 7' ' ' LEU . 4.7 mp -143.47 114.72 7.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.53 -0.731 . . . . 0.0 110.3 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 51' ' ' TYR . 54.0 m -89.28 100.62 13.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.844 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.483 HD11 ' O ' ' A' ' 49' ' ' SER . 3.7 mm -79.91 74.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 0.0 110.21 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.468 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 3.3 p30 -44.31 167.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 110.397 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -8.97 2.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -78.6 7.0 7.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.02 11.95 46.99 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 44' ' ' ILE . 42.6 m -84.7 -173.06 4.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -1.165 . . . . 0.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 42' ' ' LEU . 70.8 t -138.42 101.34 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.062 -1.024 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CB ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -78.71 77.87 5.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.016 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.46 86.05 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 110.537 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 56' E LYS . 37.1 mt-10 -102.41 108.0 19.18 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' O ' ' CB ' ' A' ' 56' D VAL . 0.0 OUTLIER -79.52 176.01 10.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.39 -0.819 . . . . 0.0 109.705 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 54' ' ' GLU . 15.5 t -142.31 110.49 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.859 . . . . 0.0 110.364 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 27.2 ttmt -128.92 154.64 46.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' A ASP . . . . . . . . . . . . . 48.0 m-20 -47.83 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 146.55 -52.14 0.57 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.95 168.97 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.453 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 27.0 m -81.98 -177.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.8 mttm -148.54 172.07 5.6 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.248 -0.908 . . . . 0.0 110.389 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 1.6 Cg_endo -85.45 -47.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.947 1.764 . . . . 0.0 110.27 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 56.31 95.82 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.249 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 6.4 Cg_exo -70.1 157.21 93.24 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.835 -2.152 . . . . 0.0 110.284 0.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.7 m -65.02 87.09 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.22 37.86 13.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.461 -0.774 . . . . 0.0 110.725 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER 50.34 50.19 19.19 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.528 -0.733 . . . . 0.0 109.381 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 64' ' ' THR . 13.7 mtmt -32.93 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.263 0.554 . . . . 0.0 111.317 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.56 ' N ' ' O ' ' A' ' 62' ' ' LYS . 18.7 m -170.21 -58.62 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.418 -0.801 . . . . 0.0 109.779 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.438 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 9.6 t -175.65 -34.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.448 -0.783 . . . . 0.0 110.222 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.218 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.242 0.544 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.25 163.91 7.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.334 -0.854 . . . . 0.0 110.218 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -113.0 62.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.99 . . . . 0.0 110.016 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -82.95 66.82 8.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 4.8 tp -87.13 173.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 41' ' ' PHE . 5.1 p -77.29 -172.7 2.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.296 1.045 . . . . 0.0 111.108 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.538 ' CD2' HG12 ' A' ' 34' ' ' ILE . 1.4 tp -90.2 -34.65 15.73 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -85.37 -69.78 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.621 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -41.66 -49.17 4.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.247 -0.908 . . . . 0.0 109.111 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 1.6 t80 -50.15 -59.61 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.583 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -48.09 -31.07 5.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 109.449 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.438 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.71 -53.47 55.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.627 -0.67 . . . . 0.0 109.813 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -59.31 -31.19 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.789 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.46 ' CD2' ' HE3' ' A' ' 18' ' ' LYS . 5.0 m-85 -106.76 -81.06 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.253 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 162.87 -176.46 39.15 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.453 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -85.14 -27.5 26.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.096 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 m -85.88 -16.37 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.46 ' HE3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -89.59 -39.92 12.94 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.288 -0.883 . . . . 0.0 108.969 179.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.5 m -71.68 -26.32 62.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.552 -0.718 . . . . 0.0 109.266 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -83.7 -39.21 20.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 110.443 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -62.74 -32.39 73.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -80.67 -31.53 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.041 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.9 mt -89.19 -7.87 54.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.394 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.14 49.79 50.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.43 147.48 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -1.195 . . . . 0.0 109.937 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -59.39 163.54 3.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.262 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -26.11 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 t -83.47 -51.48 7.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.878 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.428 ' O ' ' HB1' ' A' ' 33' ' ' ALA . . . -47.99 -23.74 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -81.01 -68.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.774 . . . . 0.0 109.726 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.573 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 2.1 m-20 -52.39 -13.69 0.39 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 111.235 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.39 -43.77 9.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.511 -1.368 . . . . 0.0 108.683 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -76.06 -6.96 53.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.534 -0.729 . . . . 0.0 109.053 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.538 HG12 ' CD2' ' A' ' 7' ' ' LEU . 19.0 mt -111.85 -50.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 0.0 109.998 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 23.7 t-160 -59.15 -23.67 62.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.12 -0.988 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.429 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.3 49.43 0.36 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -80.6 123.3 28.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -1.071 . . . . 0.0 110.299 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 55' ' ' VAL . 6.5 ptpp? -86.69 59.99 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.509 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 43.9 mt -96.94 169.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.579 0.704 . . . . 0.0 111.033 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 55.9 m-85 -149.79 110.13 4.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 42' ' ' LEU . 6.9 mp -85.08 135.65 33.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.48 HG23 ' ND2' ' A' ' 45' ' ' ASN . 3.2 m -101.34 104.3 15.28 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.481 ' CD1' ' CZ ' ' A' ' 10' ' ' TYR . 53.8 mt -93.56 44.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.073 -1.017 . . . . 0.0 111.246 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.48 ' ND2' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -87.58 -127.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.94 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 43.28 27.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.955 -1.09 . . . . 0.0 109.81 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 73.69 69.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.313 0.578 . . . . 0.0 111.797 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.28 0.23 35.95 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.471 ' OG ' ' HB1' ' A' ' 46' ' ' ALA . 1.1 p -58.76 -165.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.283 . . . . 0.0 110.369 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 49' ' ' SER . 14.1 t -146.28 124.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -135.49 164.09 28.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.32 -0.863 . . . . 0.0 109.989 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -141.8 132.43 25.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.462 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -159.76 116.07 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 110.003 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HB3' HG12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -95.5 178.45 5.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.605 -179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.469 ' O ' ' HD3' ' A' ' 39' ' ' LYS . 6.2 t -140.16 107.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.464 -0.772 . . . . 0.0 109.621 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.01 155.02 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 110.582 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' A ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.24 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 137.71 -53.46 0.73 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.0 171.53 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 110.268 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.462 ' O ' ' HG2' ' A' ' 56' E LYS . 28.0 m -94.17 164.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 56' D VAL . 6.8 mtpt -142.39 168.59 13.0 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -83.61 -173.61 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 121.897 1.731 . . . . 0.0 109.947 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 85.3 t80 179.24 124.77 0.22 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.232 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.9 Cg_endo -87.33 100.2 0.25 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.745 -1.773 . . . . 0.0 110.311 -0.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 61' ' ' ASN . 53.4 p -72.09 80.08 0.95 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 110.933 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 60' ' ' SER . 0.9 OUTLIER 166.0 46.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.214 -0.929 . . . . 0.0 110.089 179.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 5.1 ttmt -179.65 63.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.451 -0.781 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.34 176.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.001 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -78.4 -45.54 22.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.97 . . . . 0.0 110.42 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 t -156.76 19.91 0.32 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.144 179.863 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.209 0.528 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -116.69 -174.79 2.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.363 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 50.2 mm-40 -138.66 85.53 2.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.187 -0.946 . . . . 0.0 109.747 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 2.9 ttp180 -78.57 79.72 4.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.44 -0.788 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.525 HG23 ' CB ' ' A' ' 10' ' ' TYR . 69.1 mt -89.56 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.854 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.553 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -48.91 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.439 1.114 . . . . 0.0 111.94 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.546 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . 2.0 tp -94.01 -38.17 11.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' HG3' HG23 ' A' ' 34' ' ' ILE . 11.7 tmtt? -90.28 -56.67 3.12 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.386 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 25.7 t70 -50.89 -42.01 58.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.605 ' CE1' ' CZ ' ' A' ' 14' ' ' PHE . 14.6 t80 -58.17 -61.27 2.68 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.793 0.806 . . . . 0.0 109.887 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.462 ' CB ' ' OG1' ' A' ' 19' ' ' THR . . . -56.3 -18.03 9.45 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.396 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -38.99 50.42 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.583 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -52.45 -42.84 64.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.555 -0.715 . . . . 0.0 109.173 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -114.46 -99.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.265 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.65 155.12 20.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -28.2 57.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 110.266 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -74.97 -12.33 60.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.423 ' HG2' ' CE2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -81.32 -58.19 3.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.219 -0.926 . . . . 0.0 108.617 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.462 ' OG1' ' CB ' ' A' ' 11' ' ' ALA . 15.5 m -50.68 -34.18 25.55 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.39 -38.62 55.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 110.898 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -35.01 79.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 110.327 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.7 -50.14 65.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.447 ' HB3' HG22 ' A' ' 25' ' ' VAL . 47.8 mt -80.66 -7.63 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.78 38.13 95.2 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 23' ' ' LEU . 3.0 t -112.88 178.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.087 -1.243 . . . . 0.0 109.917 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.465 ' O ' HD13 ' A' ' 30' ' ' ILE . 90.9 m-85 -100.65 141.03 34.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.193 -0.942 . . . . 0.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.455 ' HA ' HD11 ' A' ' 30' ' ' ILE . 5.2 mt-30 -46.95 -23.19 0.41 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t -72.38 -51.71 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.487 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.25 -26.13 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.066 -1.021 . . . . 0.0 110.053 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.52 HG21 ' CD1' ' A' ' 34' ' ' ILE . 1.3 mp -76.46 -55.8 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 2.6 m-80 -57.88 -14.12 5.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 110.545 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 -48.38 6.12 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.733 -1.229 . . . . 0.0 108.832 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -72.31 -3.1 21.84 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.132 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.546 ' CD1' ' HG ' ' A' ' 7' ' ' LEU . 9.5 mt -120.06 -49.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.272 -0.892 . . . . 0.0 110.547 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.566 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t60 -69.48 -7.75 40.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.967 -1.083 . . . . 0.0 110.098 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.96 -28.71 49.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.123 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.54 31.28 1.84 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -90.53 -176.97 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 82.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.273 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.568 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 4.1 mt -102.95 160.26 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 41.0 m-85 -153.35 160.71 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.078 -1.014 . . . . 0.0 110.529 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.546 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 3.7 mp -134.82 155.45 50.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 110.534 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 20.6 m -127.8 105.29 8.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 109.618 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.441 ' CG2' ' H ' ' A' ' 45' ' ' ASN . 0.7 OUTLIER -84.93 -148.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.087 -1.008 . . . . 0.0 110.974 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.499 ' OD1' ' HB2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER 38.37 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.252 0.549 . . . . 0.0 110.628 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.658 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 62.01 12.02 4.65 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.658 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 3.8 t70 135.47 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 124.147 0.979 . . . . 0.0 109.325 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.85 11.59 81.25 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -83.23 121.74 27.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.998 . . . . 0.0 110.232 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.2 118.4 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 110.375 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 3.7 m-85 -98.39 155.85 17.03 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.928 . . . . 0.0 108.541 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.467 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -142.31 86.74 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 110.419 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' O ' HG21 ' A' ' 40' ' ' ILE . 1.3 pt-20 -101.56 -177.12 3.34 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 110.192 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 56' E LYS . 0.3 OUTLIER -152.67 173.48 15.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.272 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.414 HG21 HG13 ' A' ' 56' D VAL . 86.7 t -142.95 151.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.987 -1.07 . . . . 0.0 110.515 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 158.41 30.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.5 t0 -57.55 -11.62 2.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.08 -1.013 . . . . 0.0 110.633 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 56' C GLU . . . -100.83 -38.62 3.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' C GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 56' B GLY . 0.6 OUTLIER 174.58 179.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 110.288 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.414 HG13 HG21 ' A' ' 55' ' ' VAL . 35.6 m -102.64 148.16 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.288 -0.882 . . . . 0.0 109.862 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -144.58 166.7 17.41 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 0.0 110.474 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.8 Cg_exo -80.81 179.79 5.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.457 1.767 . . . . 0.0 110.287 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 3.1 t80 -159.99 125.61 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.003 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 71.2 Cg_endo -88.82 47.78 1.05 Allowed 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.802 -1.749 . . . . 0.0 110.87 0.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 61' ' ' ASN . 0.3 OUTLIER 45.32 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 110.49 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 60' ' ' SER . 14.8 p30 37.74 -162.2 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.619 0.723 . . . . 0.0 111.101 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -146.99 51.12 1.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 0.0 110.228 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 62' ' ' LYS . 1.6 mtmm 32.53 95.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.819 -0.551 . . . . 0.0 111.349 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.5 p -77.83 137.72 38.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.925 . . . . 0.0 110.018 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.459 ' O ' ' OXT' ' A' ' 66' ' ' ALA . 5.6 t -57.15 -22.09 37.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.126 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.459 ' OXT' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.093 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.29 0.567 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.73 163.52 27.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -119.18 75.48 1.05 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.291 -0.88 . . . . 0.0 108.859 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 8.4 ttm180 -76.97 83.05 3.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.692 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.558 HG23 ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -77.43 -174.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.547 -0.721 . . . . 0.0 109.721 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.83 -178.78 5.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 111.45 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . 9.4 tp -92.33 -46.14 7.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.514 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.58 -65.71 0.99 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.881 -0.512 . . . . 0.0 110.07 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 10.3 t70 -45.03 -46.92 11.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 108.89 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.558 ' CG ' HG23 ' A' ' 5' ' ' ILE . 8.6 t80 -53.59 -62.44 1.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' CB ' HG23 ' A' ' 19' ' ' THR . . . -51.82 -20.73 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.501 -0.749 . . . . 0.0 109.722 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.9 ttm -72.62 -49.6 30.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.65 76.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.091 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.59 -83.13 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 110.356 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.58 150.05 12.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -31.0 69.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -1.172 . . . . 0.0 110.087 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 t -83.75 -14.61 51.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -82.43 -52.94 6.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.461 HG23 ' CB ' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -61.8 -31.39 71.61 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -47.1 55.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.657 -0.652 . . . . 0.0 110.02 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -69.72 -17.0 63.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.531 -0.731 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' HB3' ' CB ' ' A' ' 50' ' ' VAL . 1.3 m-20 -79.79 -34.86 39.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.173 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 19' ' ' THR . 7.0 mt -80.75 -25.77 37.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 110.144 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 86.34 63.88 1.48 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.465 ' CG2' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -154.04 147.45 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.225 -1.162 . . . . 0.0 109.766 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -47.56 167.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 110.136 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -87.62 -19.07 28.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.373 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 m -79.63 -63.57 1.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.091 -1.006 . . . . 0.0 109.94 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.48 -24.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.986 . . . . 0.0 109.262 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -68.45 -62.34 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.569 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 3.9 t-20 -55.76 -13.55 1.79 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.601 -0.687 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 4.6 mttp -93.96 -34.43 13.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 108.408 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.86 -8.15 59.66 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.518 ' CD1' HD11 ' A' ' 30' ' ' ILE . 21.9 mt -113.66 -49.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.753 . . . . 0.0 109.747 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 13.1 t60 -60.22 -39.79 87.86 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.741 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -49.64 -23.95 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.61 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.46 31.18 8.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -59.04 -177.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.116 . . . . 0.0 110.498 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -128.47 76.08 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.7 mt -113.16 167.73 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 111.047 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.412 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 79.3 m-85 -147.4 122.99 10.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 6.7 mp -90.84 142.41 27.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.978 -1.076 . . . . 0.0 111.56 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 1.2 m -110.15 103.88 12.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.509 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 56.5 mt -84.15 60.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.832 -1.167 . . . . 0.0 111.51 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -88.48 -146.16 0.15 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.836 -1.165 . . . . 0.0 110.28 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.597 ' HB2' ' CB ' ' A' ' 49' ' ' SER . . . 56.2 14.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.459 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 26.4 t70 88.98 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 123.164 0.585 . . . . 0.0 110.115 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.07 14.48 0.57 Allowed Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.048 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.597 ' CB ' ' HB2' ' A' ' 46' ' ' ALA . 8.1 t -84.65 159.29 20.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.898 -1.354 . . . . 0.0 109.62 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.434 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 21.7 t -112.46 122.18 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 0.0 110.83 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -113.12 -171.09 1.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.853 . . . . 0.0 109.627 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -146.53 154.24 41.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.49 106.75 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 110.091 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' D VAL . 5.6 mt-10 -83.57 165.5 19.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 t -144.97 129.23 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.088 -1.008 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 56' A ASP . 5.4 ttpp -146.83 94.53 2.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 65.1 t0 61.06 41.38 13.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.54 -0.725 . . . . 0.0 110.505 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 86.99 -11.15 65.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.9 tt0 -89.42 87.18 6.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 4.9 m -94.23 170.77 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.224 -0.923 . . . . 0.0 110.234 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' E LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.0 170.51 2.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 0.0 110.518 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 5.8 Cg_exo -80.53 166.39 19.88 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.474 1.776 . . . . 0.0 110.288 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.498 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 15.8 t80 -169.84 117.71 0.53 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -84.04 100.89 0.32 Allowed 'Cis proline' 0 C--N 1.316 -1.165 0 C-N-CA 122.758 -1.767 . . . . 0.0 110.285 -0.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 97.6 p -46.97 106.6 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 110.053 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.81 -172.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.101 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.78 54.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.324 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -117.05 124.82 50.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 110.152 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.7 m -161.68 -39.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 0.0 110.324 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 t -125.11 -25.97 3.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 110.321 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.197 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.287 0.565 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 3' ' ' GLN . 23.7 tp10 -169.8 -77.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.951 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.491 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 8.4 mm-40 -118.14 72.22 0.85 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.358 -0.839 . . . . 0.0 109.839 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -83.88 65.16 8.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.591 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 30.6 mm -90.74 135.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.7 p -46.96 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.202 1.001 . . . . 0.0 111.254 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.537 ' CD2' ' CG1' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -91.81 -34.8 14.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.344 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -82.74 -69.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.844 -0.535 . . . . 0.0 110.174 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -44.39 -45.9 9.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 109.246 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.591 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 8.6 t80 -49.14 -59.47 3.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -46.81 -30.9 2.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 110.17 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -46.06 70.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -25.57 63.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 0.0 110.423 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -111.97 -64.34 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.309 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 155.58 160.44 9.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -75.07 -32.33 61.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -1.206 . . . . 0.0 109.903 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -9.67 59.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.751 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.61 -41.3 12.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.142 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 m -70.01 -24.53 63.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.517 -0.739 . . . . 0.0 109.615 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.67 20.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 0.0 110.393 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -75.99 -16.11 60.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -90.6 -44.35 9.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.499 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 mt -79.65 -31.06 41.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 110.322 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.36 16.03 36.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -116.02 147.71 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 109.938 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -64.62 153.08 40.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.612 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.465 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 2.5 mt-30 -47.97 -25.97 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.341 -0.85 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.0 -54.59 31.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.761 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . . . -46.08 -36.06 5.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.788 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.4 mp -63.24 -47.67 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 109.868 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 71.3 m-80 -66.35 -6.44 14.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -88.57 -44.02 10.95 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.722 -1.236 . . . . 0.0 108.982 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -72.66 -28.08 62.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.569 ' O ' ' CD ' ' A' ' 38' ' ' ARG . 49.3 mt -87.2 -51.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.477 -0.765 . . . . 0.0 109.91 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 20.5 t60 -68.46 -4.69 15.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.838 -1.164 . . . . 0.0 110.492 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -90.68 -59.37 2.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.032 -1.042 . . . . 0.0 111.411 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . -155.18 99.29 0.19 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.569 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -51.47 -164.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.868 -0.784 . . . . 0.0 111.523 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 1.1 tttt 73.03 48.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.584 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 17.0 mt -97.06 166.48 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.316 0.579 . . . . 0.0 110.316 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.6 m-85 -158.54 117.42 3.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -110.36 132.96 53.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.91 100.56 11.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.491 ' HB ' ' CB ' ' A' ' 3' ' ' GLN . 57.2 mt -84.39 55.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.707 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 46' ' ' ALA . 24.0 p30 -104.74 -122.08 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.059 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 42.48 30.42 0.21 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.975 -1.078 . . . . 0.0 109.839 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.7 t70 80.95 50.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.553 0.692 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 82.11 -9.53 56.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 46' ' ' ALA . 7.2 m -52.7 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.041 -1.27 . . . . 0.0 109.747 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.28 116.75 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 52' ' ' ALA . 5.5 t80 -120.55 140.48 51.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -96.1 150.97 19.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.033 -1.042 . . . . 0.0 110.07 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -159.73 85.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 110.138 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 56' D VAL . 6.0 mt-10 -84.69 169.65 14.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.093 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 56' D VAL . 1.5 p -161.39 148.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.117 -0.99 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.425 ' N ' HG21 ' A' ' 55' ' ' VAL . 8.2 tptp -157.4 112.95 2.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 110.235 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' A ASP . . . . . . . . . . . . . 31.4 t70 45.77 49.0 11.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.873 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 78.1 35.52 34.19 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 20.2 tt0 -137.85 84.16 2.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -1.169 . . . . 0.0 109.887 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 3.2 m -96.39 153.98 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.168 -0.957 . . . . 0.0 111.015 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' E LYS . . . . . . . . . . . . . 3.4 pttt -148.13 168.67 10.65 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.852 . . . . 0.0 110.107 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -82.81 -82.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.35 1.71 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER 56.92 107.36 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 0.0 109.951 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.41 140.23 54.94 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.082 -2.049 . . . . 0.0 110.381 -0.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 p -87.12 161.83 17.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.335 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -138.68 -171.58 3.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 110.017 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.86 55.12 0.31 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.91 . . . . 0.0 110.284 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -80.07 120.88 24.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.097 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 p -70.37 -178.0 1.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 110.012 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.4 t -75.14 -26.43 59.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.313 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.101 179.831 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' HG22 ' A' ' 43' ' ' THR . 33.9 mtt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.244 0.545 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.551 ' CB ' ' HB3' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -150.09 -60.61 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.34 -0.85 . . . . 0.0 110.295 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.582 ' CB ' ' ND2' ' A' ' 45' ' ' ASN . 4.6 mm-40 -124.09 77.47 1.55 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.193 -0.942 . . . . 0.0 109.221 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 2.7 ttm180 -78.95 82.5 5.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.62 -0.675 . . . . 0.0 109.634 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 10' ' ' TYR . 12.5 mt -85.67 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.07 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.4 p -46.95 178.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.157 0.98 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.533 ' CD2' HG12 ' A' ' 34' ' ' ILE . 1.5 tp -91.58 -35.26 14.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' ASP . 2.3 tmtt? -79.77 -68.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 6' ' ' THR . 5.6 t0 -45.28 -55.12 6.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.655 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CZ ' HD11 ' A' ' 44' ' ' ILE . 50.2 t80 -42.9 -60.05 1.75 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.418 -0.801 . . . . 0.0 111.219 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 14' ' ' PHE . . . -60.38 -29.07 68.71 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.161 -0.962 . . . . 0.0 110.424 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -24.21 61.72 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -71.86 -47.82 50.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.518 -0.739 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 10' ' ' TYR . 26.9 p90 -111.42 -43.52 3.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.586 -1.321 . . . . 0.0 111.434 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 14' ' ' PHE . . . 168.24 162.92 21.28 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.033 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -90.6 -25.22 20.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.449 -1.03 . . . . 0.0 110.672 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.468 HG21 ' N ' ' A' ' 18' ' ' LYS . 13.5 t -73.39 -18.28 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.982 . . . . 0.0 110.236 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 7.8 mttt -90.62 -34.52 15.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.482 ' OG1' ' CZ ' ' A' ' 14' ' ' PHE . 18.4 m -67.58 -32.09 72.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.68 -27.06 29.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.65 -0.656 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -83.75 -18.38 38.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 110.141 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -84.04 -41.55 17.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.058 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.485 ' HB3' ' HG2' ' A' ' 59' ' ' PRO . 90.1 mt -79.91 -60.02 2.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 110.037 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' HG11 ' A' ' 25' ' ' VAL . . . 130.48 43.98 0.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 24' ' ' GLY . 3.7 m -142.3 152.96 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -67.96 169.67 9.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.337 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.462 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 33.3 mt-30 -65.16 -35.36 80.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.912 . . . . 0.0 110.27 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.9 p -63.78 -54.44 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.767 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . . . -52.79 -23.2 6.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.131 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -71.2 -62.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.579 -0.701 . . . . 0.0 109.29 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -62.15 -8.03 4.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 110.447 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 15.1 mtpp -90.46 -38.21 13.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.808 -1.183 . . . . 0.0 108.37 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.58 -9.03 56.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.533 HG12 ' CD2' ' A' ' 7' ' ' LEU . 19.3 mt -101.15 -46.18 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 5.2 t60 -68.67 -56.85 6.81 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.238 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.98 40.46 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.281 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' HD13 ' A' ' 40' ' ' ILE . . . -176.19 79.12 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.526 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 23.0 mmm-85 -84.52 -173.43 4.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -1.068 . . . . 0.0 110.53 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 4.3 mtmt 57.63 79.38 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.525 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 7.1 mt -135.04 160.19 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.0 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.55 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 70.5 m-85 -153.67 154.38 34.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 110.349 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.489 HD22 ' CB ' ' A' ' 52' ' ' ALA . 4.1 mp -144.92 129.96 18.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.163 -0.961 . . . . 0.0 111.102 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.539 ' CG2' ' HA2' ' A' ' 48' ' ' GLY . 2.1 m -83.51 107.18 15.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 108.442 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.576 HD11 ' CZ ' ' A' ' 10' ' ' TYR . 2.6 mt -129.15 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.048 -1.032 . . . . 0.0 111.689 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.582 ' ND2' ' CB ' ' A' ' 3' ' ' GLN . 11.5 m-80 64.22 -165.06 0.24 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.8 0.81 . . . . 0.0 112.122 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.76 0.96 3.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.551 ' HB3' ' CB ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -136.77 41.46 2.52 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.539 ' HA2' ' CG2' ' A' ' 43' ' ' THR . . . -169.02 -27.17 0.02 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 120.038 -1.077 . . . . 0.0 110.633 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.575 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 0.4 OUTLIER 59.77 -92.74 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.855 -1.379 . . . . 0.0 107.715 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.575 ' CG2' ' O ' ' A' ' 49' ' ' SER . 5.5 t -161.2 77.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.299 -0.876 . . . . 0.0 110.455 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.98 137.92 43.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.504 -0.748 . . . . 0.0 109.042 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -129.59 113.91 15.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 110.836 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.72 121.58 23.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.789 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 56' D VAL . 7.9 pt-20 -91.21 159.0 16.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.43 139.9 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.266 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 56' C GLU . 0.7 OUTLIER -157.4 78.1 0.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.948 -1.095 . . . . 0.0 110.932 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 56' ' ' LYS . 31.0 t70 40.35 76.78 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.804 . . . . 0.0 111.279 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 83.51 -5.88 75.72 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.66 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' C GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 1.1 tt0 -117.68 83.37 1.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.894 -1.356 . . . . 0.0 110.342 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 56' E LYS . 1.0 OUTLIER -124.02 124.12 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.488 -0.758 . . . . 0.0 109.702 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.31 164.13 40.94 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.482 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 3.8 Cg_exo -82.8 97.37 0.85 Allowed 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.015 1.81 . . . . 0.0 110.762 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -133.07 140.59 37.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 110.068 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.485 ' HG2' ' HB3' ' A' ' 23' ' ' LEU . 59.9 Cg_endo -92.97 52.48 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.495 -1.877 . . . . 0.0 110.028 -0.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 36.7 t -66.3 -12.77 58.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 110.719 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 60' ' ' SER . 6.8 t-20 63.77 175.81 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.781 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 52.17 0.93 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.012 . . . . 0.0 110.438 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.532 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 20.3 mttt -63.74 -160.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.817 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.1 m -157.2 -34.8 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.98 -1.075 . . . . 0.0 110.98 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -131.99 41.91 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.115 -0.99 . . . . 0.0 110.598 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.532 ' CB ' ' HD3' ' A' ' 63' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.266 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 mtm . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.26 0.552 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.511 ' O ' ' NH1' ' A' ' 4' ' ' ARG . 23.2 mt-10 -140.53 139.34 35.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.471 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 2.7 mt-30 -101.97 49.7 0.85 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.484 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -79.89 85.04 5.57 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.822 0.82 . . . . 0.0 111.869 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 4.6 mm -89.59 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.57 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 2.6 p -65.46 -178.89 0.56 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 111.405 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.572 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -87.29 -26.7 23.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.47 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HG2' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -79.52 -77.93 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.271 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 8' ' ' LYS . 7.9 t70 -42.87 -59.23 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.995 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 8.6 t80 -41.96 -54.65 3.41 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.246 -0.909 . . . . 0.0 110.555 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.45 -38.25 71.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.181 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.5 ttt -63.54 -30.11 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.502 -0.749 . . . . 0.0 109.998 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.38 -41.01 28.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -109.37 -57.26 2.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.322 -0.861 . . . . 0.0 109.902 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 154.68 156.96 7.95 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 110.147 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 31.1 p -67.76 -11.5 58.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.919 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -85.91 -46.79 10.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.323 -0.861 . . . . 0.0 108.917 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -27.57 63.24 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.27 -32.41 22.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.669 -0.644 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.1 tmtp? -74.29 -18.63 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.908 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.94 -46.76 10.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 0.0 110.069 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.43 HD23 ' HD3' ' A' ' 59' ' ' PRO . 41.8 mt -80.87 -19.14 45.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.08 39.81 94.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.79 179.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -1.186 . . . . 0.0 110.206 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.64 142.41 49.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.297 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -11.5 56.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.92 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -72.43 -54.78 8.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.975 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.66 -25.15 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.59 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 30' ' ' ILE . 50.0 mt -78.57 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.586 -0.696 . . . . 0.0 109.797 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -58.52 -9.14 1.48 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 110.63 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -93.39 -42.22 9.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.699 -1.251 . . . . 0.0 108.228 178.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -75.24 -11.11 60.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 HG23 ' HG2' ' A' ' 8' ' ' LYS . 65.2 mt -105.83 -54.17 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 31.6 t60 -54.97 -23.47 19.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.77 85.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.53 37.93 1.39 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.64 -164.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -1.129 . . . . 0.0 110.633 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HE2' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -145.45 87.64 1.81 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.581 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 27.3 mt -114.91 172.09 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.426 -0.797 . . . . 0.0 110.879 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 38.5 m-85 -160.01 141.67 12.78 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.572 ' CD1' ' CD1' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -114.89 109.29 17.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.906 -1.121 . . . . 0.0 109.642 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.486 ' OG1' ' HB3' ' A' ' 4' ' ' ARG . 1.4 m -75.93 102.12 5.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 108.746 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.507 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.9 mt -78.17 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 0.0 110.471 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 9.1 p-10 34.28 -140.29 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.964 -0.46 . . . . 0.0 111.309 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.639 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 49.1 26.35 1.4 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 50.7 t0 97.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 123.697 0.799 . . . . 0.0 108.87 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.09 9.78 43.19 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.93 113.58 3.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.794 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.1 t -86.29 100.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 110.334 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 28.5 m-85 -104.73 92.77 4.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.1 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 58' ' ' PHE . . . -88.48 135.47 33.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.05 -1.031 . . . . 0.0 109.361 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' A' ' 56' E LYS . 0.8 OUTLIER -156.76 135.17 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.15 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' O ' HG21 ' A' ' 55' ' ' VAL . 3.2 tm-20 -83.73 171.39 13.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.492 -0.755 . . . . 0.0 109.447 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 54' ' ' GLU . 10.4 t -140.28 141.61 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 110.441 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 56' A ASP . 0.8 OUTLIER -157.02 120.4 4.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 28.3 t70 57.74 -90.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . -146.35 43.76 0.87 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.7 tt0 -156.65 123.81 5.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -1.155 . . . . 0.0 110.35 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.401 ' HB ' ' OE1' ' A' ' 53' ' ' GLU . 10.0 m -109.97 155.99 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 11.9 mttm -135.78 164.47 43.11 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.863 . . . . 0.0 109.486 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -82.6 150.71 14.82 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.917 1.745 . . . . 0.0 111.006 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.9 t80 -146.16 128.87 8.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.435 ' C ' ' OG ' ' A' ' 60' ' ' SER . 9.6 Cg_endo -89.16 52.92 0.66 Allowed 'Cis proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.98 -1.675 . . . . 0.0 110.648 0.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER 41.86 68.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 2.7 m120 -98.38 47.38 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 109.812 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 3.7 tttt 175.15 53.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 109.745 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 64' ' ' THR . 0.3 OUTLIER -48.84 167.08 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.431 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 63' ' ' LYS . 65.5 p 42.17 -153.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 110.299 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 t -168.87 -34.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.848 . . . . 0.0 110.487 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.232 -179.871 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.246 0.546 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.443 ' OE2' ' HB2' ' A' ' 4' ' ' ARG . 2.7 pt-20 -139.63 156.93 46.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.968 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.4 mm-40 -116.31 70.11 0.76 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.085 -1.009 . . . . 0.0 109.886 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -79.51 74.9 6.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.713 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.56 HD11 ' CD1' ' A' ' 10' ' ' TYR . 10.2 mt -90.67 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -70.65 -173.45 0.76 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.069 0.938 . . . . 0.0 111.491 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . 1.6 tp -93.99 -38.61 11.07 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.516 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 1.3 tmtt? -90.11 -67.39 0.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.51 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 9.5 m-20 -43.9 -44.11 6.83 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.566 ' CB ' ' O ' ' A' ' 6' ' ' THR . 8.4 t80 -57.96 -54.29 48.56 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.975 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -59.08 -20.73 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -21.6 21.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.969 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.31 -12.95 25.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.25 -27.76 4.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.965 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.69 130.92 3.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.77 72.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -1.165 . . . . 0.0 109.813 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 15.5 p -82.07 -14.08 56.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -55.37 4.8 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.42 -0.8 . . . . 0.0 108.87 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.529 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 66.7 m -57.18 -32.08 66.09 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.41 -44.97 63.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.9 tmtt? -80.25 1.63 27.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.843 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 50' ' ' VAL . 53.1 m-20 -89.9 -43.07 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER -115.25 -8.55 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.677 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.97 67.95 1.26 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.58 ' CG1' ' CD1' ' A' ' 30' ' ' ILE . 60.8 t -142.88 140.0 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 110.34 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' O ' HG12 ' A' ' 30' ' ' ILE . 4.3 m-85 -75.0 139.63 43.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 0.0 110.184 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -46.82 -23.84 0.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -69.92 -58.8 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' N ' ' OG ' ' A' ' 28' ' ' SER . . . -46.96 -25.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.671 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.58 ' CD1' ' CG1' ' A' ' 25' ' ' VAL . 2.7 mm -71.29 -56.27 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.765 . . . . 0.0 109.986 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -62.81 -8.96 7.87 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 1.9 mttp -94.74 -40.48 9.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.748 -1.22 . . . . 0.0 108.612 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -79.86 -9.45 59.67 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' A' ' 8' ' ' LYS . 76.5 mt -108.8 -49.12 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.53 -0.731 . . . . 0.0 110.067 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.579 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 16.8 t-160 -63.39 -33.41 75.48 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.947 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -59.0 -21.59 59.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.64 30.3 13.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -78.3 -173.5 3.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.227 -1.161 . . . . 0.0 110.256 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.76 75.36 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.174 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.544 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 62.1 mt -106.17 169.25 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 50.9 m-85 -156.56 158.83 37.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 3.1 mp -134.4 114.96 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.0 110.492 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.531 ' O ' ' CG2' ' A' ' 43' ' ' THR . 13.0 t -93.55 102.95 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 109.848 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.518 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 1.9 mp -91.68 130.23 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.055 . . . . 0.0 110.453 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.65 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 8.2 m-20 -50.53 -19.52 0.91 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.65 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 91.09 -19.52 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.66 -11.96 57.97 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.34 -22.86 5.85 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.482 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 5.0 t -60.04 148.63 34.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 109.583 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 22' ' ' ASP . 52.9 t -133.4 123.32 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.991 -1.068 . . . . 0.0 111.047 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.517 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 15.0 t80 -120.64 119.18 32.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 108.933 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -93.61 154.28 17.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.921 -1.112 . . . . 0.0 111.241 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -160.35 142.53 12.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.563 -0.711 . . . . 0.0 109.844 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 56' D VAL . 11.7 tm-20 -121.47 167.18 13.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.4 116.49 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.463 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' B GLY . 11.3 ttmt -143.2 153.86 43.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 110.156 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' LYS . 28.9 t0 -43.73 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.465 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.66 -64.34 0.42 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -170.29 171.78 6.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.471 -1.017 . . . . 0.0 110.237 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 21.4 m -93.22 133.26 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 110.16 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 mmtp -116.87 132.61 23.33 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.978 . . . . 0.0 110.747 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.9 Cg_exo -80.23 125.81 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.218 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.511 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -140.88 144.54 35.93 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HG3' HG23 ' A' ' 25' ' ' VAL . 60.3 Cg_endo -91.47 48.53 1.27 Allowed 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.275 -1.969 . . . . 0.0 110.578 0.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.86 165.52 5.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -154.03 -173.53 4.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.238 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.57 52.34 1.0 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 109.678 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -104.52 95.67 6.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.423 -0.798 . . . . 0.0 110.413 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.451 ' O ' ' HB ' ' A' ' 65' ' ' THR . 30.0 p 42.62 -140.45 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.872 . . . . 0.0 110.392 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 64' ' ' THR . 9.5 t -178.25 57.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 110.228 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.249 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 mtm . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.248 0.547 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.37 65.77 0.73 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 110.528 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.627 ' CG ' ' O ' ' A' ' 3' ' ' GLN 0.257 0.7 OUTLIER -86.29 63.13 7.83 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.637 1.208 . . . . 0.0 108.882 179.905 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -78.59 73.55 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.922 -1.111 . . . . 0.0 111.375 -178.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.557 HD11 ' CD1' ' A' ' 10' ' ' TYR . 5.1 mt -88.28 145.73 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.145 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 2.3 p -66.53 -173.02 0.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.753 0.787 . . . . 0.0 111.246 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.585 HD13 ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -90.44 -26.62 19.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HG2' HG22 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -81.94 -73.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.071 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.7 -56.29 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.045 -1.034 . . . . 0.0 109.709 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CB ' ' O ' ' A' ' 6' ' ' THR . 6.1 t80 -46.74 -53.81 11.02 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 7' ' ' LEU . . . -56.21 -33.16 65.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ttm -63.79 -40.19 96.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.258 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 -28.37 50.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.55 -74.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 110.171 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.16 148.19 5.83 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.457 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 12.9 tp60 -58.17 -39.0 77.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -1.102 . . . . 0.0 109.845 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.51 -14.21 59.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 0.0 110.364 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -79.49 -56.31 4.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.199 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.436 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 2.1 m -62.51 -29.25 70.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -75.58 -29.82 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 110.259 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -82.72 -14.57 54.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -90.14 -25.39 20.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 109.949 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 19' ' ' THR . 95.6 mt -79.96 -35.85 37.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 110.358 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.97 23.17 30.77 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -132.81 157.16 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -1.095 . . . . 0.0 110.074 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 25' ' ' VAL . 49.5 m-85 -46.6 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 110.437 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -85.11 -13.78 49.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 110.559 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 t -76.91 -56.39 4.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.955 . . . . 0.0 110.315 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.81 -25.3 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 109.966 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -76.27 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.846 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -58.82 -7.91 1.17 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.427 -0.796 . . . . 0.0 111.132 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -91.39 -40.37 11.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.514 -1.366 . . . . 0.0 108.169 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.442 ' O ' ' HD2' ' A' ' 38' ' ' ARG . . . -75.29 -18.84 59.96 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 7' ' ' LEU . 37.7 mt -96.71 -52.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.423 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 72.3 t60 -52.06 -23.03 4.65 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.295 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.42 -55.5 13.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.814 . . . . 0.0 110.464 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . 124.57 8.96 5.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -51.34 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.401 -1.058 . . . . 0.0 111.835 -179.489 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.86 81.18 1.86 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.492 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.518 ' CG1' ' HG2' ' A' ' 38' ' ' ARG . 1.8 mt -97.07 157.5 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.174 -0.954 . . . . 0.0 110.78 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.448 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 97.9 m-85 -150.13 98.16 2.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.453 -0.779 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.585 ' CD2' HD13 ' A' ' 7' ' ' LEU . 7.8 mp -85.13 101.82 12.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.139 -0.976 . . . . 0.0 111.251 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 4' ' ' ARG . 2.3 m -77.78 100.73 6.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.166 -0.958 . . . . 0.0 108.842 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 49' ' ' SER . 5.4 mt -96.5 132.47 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.987 . . . . 0.0 111.453 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.644 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 14.2 m-20 -54.66 -17.86 3.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.701 -0.624 . . . . 0.0 110.597 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.644 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 90.92 -15.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.33 -17.01 28.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.88 -27.06 3.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -57.09 112.04 1.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.243 . . . . 0.0 109.392 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.449 HG21 HG22 ' A' ' 44' ' ' ILE . 29.2 t -109.18 126.31 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.463 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 7.1 m-85 -116.64 108.79 16.36 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -88.06 119.0 28.01 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.034 -1.042 . . . . 0.0 110.615 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 56' E LYS . 0.0 OUTLIER -148.18 121.33 8.9 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.358 -0.839 . . . . 0.0 110.567 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 56' D VAL . 9.3 mt-10 -81.25 154.76 26.43 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.05 115.01 2.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.685 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -148.99 121.91 8.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 109.624 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 26.1 t70 58.42 16.78 4.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 100.81 -27.68 19.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 111.57 3.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -1.196 . . . . 0.0 110.505 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 3.3 m -111.71 146.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 110.324 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 7.3 mtpt -145.46 157.89 51.61 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.136 -0.978 . . . . 0.0 110.523 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -83.4 174.5 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.776 1.651 . . . . 0.0 110.222 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 84.4 t80 176.98 113.35 0.13 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 110.303 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 5.6 Cg_exo -78.05 108.21 1.15 Allowed 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.589 -1.838 . . . . 0.0 110.53 0.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 14.1 p -55.54 -167.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 110.56 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -55.45 -167.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.0 110.531 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' O ' ' C ' ' A' ' 63' ' ' LYS . 2.9 mttm -132.87 45.29 2.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.366 -0.834 . . . . 0.0 109.996 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' C ' ' O ' ' A' ' 62' ' ' LYS . 3.7 mmmt 30.01 -138.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.117 0.484 . . . . 0.0 111.134 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 p -96.78 -139.79 0.27 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.424 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 9.7 t -65.03 -12.54 51.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.242 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.076 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.163 0.506 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -123.72 136.82 54.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 0.0 109.972 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.3 mt-30 -127.74 76.78 1.7 Allowed 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.102 -0.998 . . . . 0.0 110.019 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -79.13 81.89 5.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.896 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.593 HD11 ' CE1' ' A' ' 10' ' ' TYR . 2.0 mt -90.46 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.477 -0.764 . . . . 0.0 110.063 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -74.52 -169.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.059 0.933 . . . . 0.0 111.7 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 33' ' ' ALA . 5.2 tp -91.44 -42.48 10.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.541 ' CG ' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -91.11 -58.05 2.6 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.479 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -46.19 -49.33 17.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CE1' HD11 ' A' ' 5' ' ' ILE . 3.6 t80 -56.32 -57.04 13.95 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.818 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.42 -20.21 2.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.536 -0.727 . . . . 0.0 109.926 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.47 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 1.5 ttp -71.65 -44.84 63.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 110.362 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -21.95 62.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.199 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 13.2 m-85 -112.02 -89.91 0.51 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.64 151.76 14.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.54 -35.98 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -1.107 . . . . 0.0 109.942 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.9 t -78.48 -11.84 59.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -47.75 9.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.23 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.426 HG21 HD13 ' A' ' 23' ' ' LEU . 2.5 m -67.7 -26.99 66.44 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.441 -0.787 . . . . 0.0 109.341 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.48 -37.98 50.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -0.757 . . . . 0.0 110.271 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.76 68.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.532 ' OD2' ' CG1' ' A' ' 50' ' ' VAL . 3.3 t70 -73.9 -38.48 64.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HB2' HG21 ' A' ' 25' ' ' VAL . 24.4 mt -84.99 -12.41 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.03 49.9 37.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -128.27 176.93 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.194 -1.18 . . . . 0.0 109.902 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 1.4 m-85 -93.48 148.02 22.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.88 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.459 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.4 tt0 -44.9 -47.73 11.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.848 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -53.47 -56.58 15.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.762 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.57 -32.03 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.502 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 3.1 mm -66.34 -54.48 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.789 0.804 . . . . 0.0 109.856 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -52.41 -17.16 1.08 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.546 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -95.69 -36.59 11.14 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.439 -1.413 . . . . 0.0 108.924 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -78.64 2.95 17.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.53 -0.731 . . . . 0.0 109.178 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.541 ' CG2' ' CG ' ' A' ' 8' ' ' LYS . 20.3 mt -135.55 -46.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.591 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 3.4 t60 -79.62 -11.61 59.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.209 -0.932 . . . . 0.0 110.512 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -90.27 -24.2 20.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.131 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.65 51.13 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -90.78 130.38 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.331 -1.1 . . . . 0.0 110.592 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.35 65.49 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 109.02 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.516 ' CG1' ' HG3' ' A' ' 38' ' ' ARG . 1.1 mt -94.28 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.509 -0.744 . . . . 0.0 110.74 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 95.7 m-85 -142.75 121.63 12.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.413 -0.804 . . . . 0.0 110.161 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 7' ' ' LEU . 5.4 mp -105.38 113.52 27.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.898 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 0.5 OUTLIER -90.05 103.06 15.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.12 -0.988 . . . . 0.0 108.82 179.094 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 6.6 mt -101.11 125.61 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.081 -1.012 . . . . 0.0 110.737 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -91.88 -178.08 4.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.342 -0.848 . . . . 0.0 110.334 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.86 -2.77 7.9 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.68 -2.16 57.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.438 -0.789 . . . . 0.0 110.436 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -6.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.411 ' O ' HG21 ' A' ' 44' ' ' ILE . 3.8 t -56.16 160.59 2.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.862 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.532 ' CG1' ' OD2' ' A' ' 22' ' ' ASP . 95.5 t -137.31 106.04 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.469 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 9.9 m-85 -88.92 84.41 6.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.68 110.55 9.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 109.049 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 56' E LYS . 0.4 OUTLIER -146.39 122.63 10.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.094 -1.004 . . . . 0.0 111.65 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 56' D VAL . 0.0 OUTLIER -78.73 159.56 27.88 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -154.36 132.84 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.568 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 56' C GLU . 0.2 OUTLIER -160.22 78.77 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.402 ' O ' ' CG ' ' A' ' 56' A ASP . 15.4 t0 51.08 46.01 27.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.528 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 114.44 -30.8 6.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' C GLU . . . . . 0.509 ' CB ' ' HB3' ' A' ' 56' ' ' LYS . 4.3 mt-10 -79.06 103.61 9.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.171 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -145.73 153.88 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pttt -171.3 161.37 5.24 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.131 -0.981 . . . . 0.0 110.483 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 58' ' ' PHE . 5.9 Cg_exo -81.29 48.46 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.747 1.631 . . . . 0.0 111.556 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.471 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 15.7 t80 -41.42 122.54 2.18 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.144 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' SER . 2.4 Cg_endo -82.38 103.38 0.51 Allowed 'Cis proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.517 -1.868 . . . . 0.0 110.48 -0.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' PRO . 8.0 p -40.91 153.49 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.231 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -159.58 -170.84 3.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.62 53.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 109.767 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.62 56.37 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.41 -0.807 . . . . 0.0 110.336 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.524 ' C ' ' CG2' ' A' ' 65' ' ' THR . 18.8 p -66.78 130.36 42.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.344 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.524 ' CG2' ' C ' ' A' ' 64' ' ' THR . 0.0 OUTLIER 37.87 29.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.829 0.823 . . . . 0.0 109.536 -179.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 64' ' ' THR . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.161 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.473 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 1.2 ttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.24 0.543 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.2 mt-10 57.12 -87.2 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.389 -0.819 . . . . 0.0 110.586 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.0 mm-40 -124.47 74.47 1.33 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.902 -1.124 . . . . 0.0 110.315 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 33.6 ttt-85 -79.68 84.03 5.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.559 HD11 ' CD1' ' A' ' 10' ' ' TYR . 5.9 mt -88.62 169.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.571 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -77.64 -174.12 3.29 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.04 0.924 . . . . 0.0 111.898 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.535 HD23 ' CD1' ' A' ' 40' ' ' ILE . 3.5 tp -91.78 -41.02 10.9 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.508 ' CG ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.31 -53.29 4.52 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.528 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -53.51 -50.92 64.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.571 ' CB ' ' O ' ' A' ' 6' ' ' THR . 7.2 t80 -54.8 -54.69 38.89 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.641 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.486 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -53.03 -25.93 13.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.493 -0.754 . . . . 0.0 109.845 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 17.9 tpp -73.97 -36.84 64.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.852 . . . . 0.0 109.96 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.06 -30.03 60.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.93 -66.34 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.74 160.68 11.91 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.487 ' NE2' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.81 -35.14 67.26 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 0.0 109.67 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.423 HG21 ' N ' ' A' ' 18' ' ' LYS . 7.3 t -83.66 -14.14 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' HG21 ' A' ' 17' ' ' THR . 0.2 OUTLIER -84.43 -47.04 11.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 108.976 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m -64.24 -30.69 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.87 -30.16 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.539 -0.726 . . . . 0.0 109.713 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -76.3 -34.84 59.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.522 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 3.2 m-20 -66.39 -35.32 80.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.786 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.433 HD21 ' HD3' ' A' ' 59' ' ' PRO . 74.9 mt -81.28 -34.64 31.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 0.0 110.196 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.97 48.0 5.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.48 -179.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -1.121 . . . . 0.0 110.132 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -70.18 171.54 9.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.766 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.465 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.7 tt0 -87.94 -21.02 25.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -0.808 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 p -66.24 -45.38 80.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 109.968 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -21.48 16.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.741 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.487 HG23 ' NE2' ' A' ' 16' ' ' GLN . 1.7 mp -80.01 -50.93 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.42 -0.8 . . . . 0.0 109.724 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -71.18 -2.34 15.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -101.47 -42.22 6.34 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.909 -1.12 . . . . 0.0 108.155 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -74.65 -18.16 60.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.529 HG12 ' CD2' ' A' ' 7' ' ' LEU . 45.5 mt -102.11 -50.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.442 -0.786 . . . . 0.0 110.246 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 2.2 t60 -60.56 -16.46 37.96 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.9 -1.125 . . . . 0.0 109.817 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 -46.08 17.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.6 7.22 5.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -51.58 161.96 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -1.182 . . . . 0.0 110.172 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 5.4 mmtt -115.88 70.27 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.1 mt -90.55 161.3 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.816 . . . . 0.0 110.15 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 48.6 m-85 -151.26 114.03 4.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 42' ' ' LEU . 7.3 mp -80.52 141.69 34.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 2.8 m -116.71 103.28 10.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.38 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 49' ' ' SER . 1.2 mt -105.12 130.66 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.731 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER -105.25 -172.22 2.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.925 179.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.26 -2.2 18.09 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -161.67 21.53 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -90.7 -5.36 68.9 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.538 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 0.5 OUTLIER 60.09 -94.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.522 ' CG1' ' HB3' ' A' ' 22' ' ' ASP . 1.7 t -162.3 112.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 0.0 110.867 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 20.0 m-85 -101.69 151.99 21.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 108.995 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . -127.03 99.62 5.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.873 -1.142 . . . . 0.0 111.051 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 40' ' ' ILE . 1.8 mt-10 -101.86 169.95 8.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.611 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -150.51 153.56 36.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.927 -1.108 . . . . 0.0 110.587 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 5.8 t -150.94 118.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 110.114 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 0.2 OUTLIER -146.37 -168.8 3.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 56' B GLY . 15.3 t0 -41.25 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.462 -0.774 . . . . 0.0 110.306 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 42.32 57.21 3.79 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 mt-10 -160.42 84.87 0.71 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.244 . . . . 0.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.451 ' O ' HG21 ' A' ' 56' D VAL . 4.5 m -102.07 148.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.0 pttt -172.62 166.19 3.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 110.345 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.0 Cg_endo -88.1 -83.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.867 1.712 . . . . 0.0 110.558 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.542 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 59.19 109.57 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.367 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 5.8 Cg_exo -77.39 140.4 63.45 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.456 -1.893 . . . . 0.0 109.923 -0.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.425 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 33.2 t -127.78 -56.7 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.054 -1.029 . . . . 0.0 110.358 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -150.87 67.33 0.93 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.421 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.424 ' O ' ' HD2' ' A' ' 63' ' ' LYS . 3.9 ptmt -114.51 38.29 3.13 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.177 -0.952 . . . . 0.0 109.299 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -169.91 156.57 6.26 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.134 0.492 . . . . 0.0 109.846 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.3 -170.52 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -137.96 4.75 2.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 110.287 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.219 -179.872 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.204 0.526 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.88 -162.98 0.31 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.221 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -112.53 70.4 0.71 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -79.4 75.77 6.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 10' ' ' TYR . 54.4 mt -90.82 177.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -87.52 -171.03 3.27 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.453 1.12 . . . . 0.0 112.496 -178.761 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.565 HD21 ' CD1' ' A' ' 40' ' ' ILE . 3.5 tp -92.14 -52.42 4.7 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 123.307 1.527 . . . . 0.0 107.203 176.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.453 ' HB2' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.45 -57.54 3.2 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.229 179.618 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.539 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -47.67 -47.87 29.28 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 6' ' ' THR . 27.0 t80 -52.44 -60.19 3.53 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.396 -0.922 . . . . 0.0 109.659 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.7 -26.57 2.38 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.557 0.694 . . . . 0.0 109.577 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.461 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.42 -52.65 44.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.995 179.931 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 -64.36 -31.85 73.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.698 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.45 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 7.5 m-30 -109.75 -80.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 110.152 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 173.75 39.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.441 ' HG3' ' HG2' ' A' ' 27' ' ' GLN . 9.1 tp60 -79.1 -32.3 44.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -1.14 . . . . 0.0 110.075 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -67.96 -21.6 65.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.853 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 14' ' ' PHE . 6.5 mttt -79.74 -38.33 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.867 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.18 -14.18 61.31 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.15 -47.07 16.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 0.0 109.669 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -12.13 60.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.731 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.566 ' OD1' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -77.3 -55.35 5.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HG ' ' OD2' ' A' ' 22' ' ' ASP . 10.9 mt -86.22 -14.37 44.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.292 -0.88 . . . . 0.0 110.151 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.58 31.06 46.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.02 178.5 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -1.075 . . . . 0.0 109.75 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' O ' HD13 ' A' ' 30' ' ' ILE . 57.0 m-85 -89.01 132.95 34.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -0.992 . . . . 0.0 110.2 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.474 ' HA ' HD11 ' A' ' 30' ' ' ILE . 17.1 mt-30 -41.71 -29.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 110.264 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.65 -18.87 8.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.452 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.535 HG21 ' CD1' ' A' ' 34' ' ' ILE . 1.6 mp -86.2 -43.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.044 -1.035 . . . . 0.0 110.315 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.3 t-20 -67.16 -9.92 44.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.235 -0.915 . . . . 0.0 110.206 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -94.52 -48.85 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 108.186 178.482 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -67.83 -16.39 64.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.557 ' O ' ' CD ' ' A' ' 38' ' ' ARG . 7.3 mt -95.93 -64.18 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 19.2 t-160 -49.71 -19.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.651 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -76.56 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.588 -0.695 . . . . 0.0 111.78 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 39' ' ' LYS . . . -132.59 87.83 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 15.6 mmm-85 -57.19 108.1 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.941 . . . . 0.0 111.049 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.497 ' HD2' ' HD2' ' A' ' 56' ' ' LYS . 11.7 pttm 179.21 42.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.582 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 15.8 mt -102.24 164.18 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.996 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 58.6 m-85 -156.74 110.54 2.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.546 ' CD2' HD13 ' A' ' 7' ' ' LEU . 5.3 mp -99.44 144.1 28.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 112.183 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 49' ' ' SER . 1.5 m -96.1 110.92 23.09 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 176.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -89.12 175.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 113.048 -176.369 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.578 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 36.8 p30 -60.87 -133.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.246 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.592 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 57.35 43.38 23.45 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 35.5 t70 69.22 26.33 5.46 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -176.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.535 ' O ' ' CG2' ' A' ' 43' ' ' THR . . . -124.61 -13.9 3.67 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 43' ' ' THR . 11.9 m 61.2 133.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -1.057 . . . . 0.0 108.441 -178.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.601 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 23.1 t -78.41 136.54 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.701 -1.249 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 50' ' ' VAL . 20.9 m-85 -165.61 177.84 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.742 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -144.97 133.82 22.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 109.981 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 56' E LYS . 18.2 tt0 -154.46 117.05 4.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 0.0 110.916 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' CG ' HG12 ' A' ' 40' ' ' ILE . 15.2 mt-10 -80.77 153.54 27.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 8.7 t -146.67 123.37 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.94 -1.1 . . . . 0.0 110.979 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -147.35 141.02 25.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.706 . . . . 0.0 109.208 179.403 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -40.53 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 110.42 -179.357 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.41 -48.51 0.53 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 tt0 -179.33 163.92 1.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.257 -1.143 . . . . 0.0 110.718 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 56' E LYS . 15.2 m -112.88 170.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 15.8 mttt -143.11 160.34 52.78 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 110.477 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 1.3 Cg_endo -85.26 -65.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.887 1.725 . . . . 0.0 110.2 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.55 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 28.4 t80 57.09 99.63 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.519 -0.738 . . . . 0.0 110.611 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.3 152.38 81.21 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.827 -2.155 . . . . 0.0 110.427 0.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.9 m -95.61 11.89 31.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.053 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -102.44 138.64 39.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 110.2 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -174.15 57.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 110.303 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.64 174.61 11.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 110.038 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.6 p -121.39 175.96 5.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.234 -0.916 . . . . 0.0 109.789 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.451 ' O ' ' OXT' ' A' ' 66' ' ' ALA . 15.3 t -63.49 -22.27 66.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' OXT' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.147 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.25 0.548 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 16.1 mt-10 -46.67 150.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 0.9 OUTLIER -140.97 86.98 2.07 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.259 -0.901 . . . . 0.0 109.59 -179.863 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 5.8 ttp180 -77.82 82.15 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.432 -0.793 . . . . 0.0 109.927 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 10' ' ' TYR . 11.2 mm -90.73 163.78 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -77.1 -171.88 2.18 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.121 0.962 . . . . 0.0 111.952 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.566 ' CD1' ' CD1' ' A' ' 23' ' ' LEU . 4.9 tp -91.62 -40.04 11.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.542 ' HG3' ' CG2' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -90.79 -51.43 5.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.431 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 1.6 t0 -54.91 -43.57 73.39 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.549 ' HB2' HG21 ' A' ' 5' ' ' ILE . 2.3 t80 -62.94 -55.07 29.1 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.196 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.26 -26.57 18.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.637 -0.664 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ttm -71.79 -36.25 70.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.828 . . . . 0.0 110.053 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.76 -39.21 57.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.675 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.74 -100.9 0.23 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.254 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.7 176.02 32.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -88.28 -30.5 19.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -1.068 . . . . 0.0 110.134 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -84.34 -28.25 27.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -62.16 1.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -53.29 -35.46 60.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.349 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.534 ' CA ' ' O ' ' A' ' 24' ' ' GLY . . . -58.24 -41.47 84.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -57.47 -45.08 85.19 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.8 m-20 -92.19 -5.19 53.01 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.432 -0.792 . . . . 0.0 112.791 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.566 ' CD1' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -164.39 62.74 0.14 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.47 -1.394 . . . . 0.0 109.92 -179.645 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.534 ' O ' ' CA ' ' A' ' 20' ' ' ALA . . . 127.53 74.45 0.19 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.348 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.583 HG21 ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.58 -11.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.92 -0.753 . . . . 0.0 109.842 -177.198 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' SER . 8.1 m-85 -101.71 98.23 8.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -37.12 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 111.53 -178.691 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' TYR . 67.8 m -82.63 -61.12 1.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.79 -1.194 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.92 -22.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.077 -1.015 . . . . 0.0 109.109 179.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.65 -64.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.523 -0.736 . . . . 0.0 109.933 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.7 OUTLIER -52.07 -15.67 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.484 -0.76 . . . . 0.0 111.252 -179.612 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -93.08 -39.8 10.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.435 -1.416 . . . . 0.0 109.028 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.498 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -76.31 -9.71 58.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.462 -0.774 . . . . 0.0 108.942 178.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.542 ' CG2' ' HG3' ' A' ' 8' ' ' LYS . 16.5 mt -111.98 -52.36 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 7.5 t-160 -57.63 -31.76 66.57 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.204 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 38' ' ' ARG . . . -90.05 -45.97 8.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.472 -0.768 . . . . 0.0 109.673 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.02 85.44 1.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 38' ' ' ARG . 2.5 mpt_? -90.1 49.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.266 . . . . 0.0 109.27 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER 42.46 53.96 4.5 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.854 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.549 ' C ' ' CD1' ' A' ' 41' ' ' PHE . 4.2 mt -105.23 154.8 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 110.082 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 70.8 m-85 -149.89 167.58 26.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.29 -0.881 . . . . 0.0 110.066 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.528 HD23 ' CD1' ' A' ' 23' ' ' LEU . 4.2 mp -143.93 149.01 36.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.953 -1.092 . . . . 0.0 110.965 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.2 m -127.62 97.36 4.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.602 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.464 HG12 HG23 ' A' ' 50' ' ' VAL . 3.8 mt -81.03 93.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 110.348 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 27.0 p-10 -54.52 172.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.339 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -5.72 7.01 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.912 178.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.44 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 3.9 t70 -79.23 1.23 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.096 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.3 1.06 73.8 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 43.6 m -83.27 -170.94 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.464 HG23 HG12 ' A' ' 44' ' ' ILE . 10.6 t -144.01 127.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.029 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 13.9 m-85 -104.77 94.96 5.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 109.683 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 58' ' ' PHE . . . -80.41 142.8 33.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.306 -0.871 . . . . 0.0 109.73 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 56' E LYS . 10.2 tt0 -153.86 110.39 3.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.266 -0.896 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' D VAL . 39.6 tt0 -81.31 167.17 19.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.18 126.93 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.037 -1.039 . . . . 0.0 110.583 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' O ' ' C ' ' A' ' 56' A ASP . 6.0 ttpt -158.76 135.07 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.867 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.3 m-20 29.52 65.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.868 -0.52 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 47.7 56.79 8.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.46 96.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -1.164 . . . . 0.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 17.3 m -93.83 161.48 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 56' D VAL . 2.5 mtmt -143.71 167.38 15.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.127 -0.983 . . . . 0.0 111.291 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.6 Cg_endo -85.98 173.47 6.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.415 2.077 . . . . 0.0 110.165 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.555 ' CZ ' ' C ' ' A' ' 23' ' ' LEU . 10.1 t80 174.22 126.34 0.11 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.964 . . . . 0.0 110.913 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HG3' HG21 ' A' ' 25' ' ' VAL . 48.1 Cg_endo -90.12 97.99 0.17 OUTLIER 'Cis proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.782 -1.758 . . . . 0.0 110.297 0.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 57' ' ' PRO . 6.3 m -143.45 -109.51 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.724 -1.235 . . . . 0.0 110.671 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 62' ' ' LYS . 3.4 t-20 63.13 172.86 0.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.786 -1.196 . . . . 0.0 109.852 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 19.3 tttt 59.72 47.72 10.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.935 . . . . 0.0 109.687 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.03 -35.1 8.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.697 -0.627 . . . . 0.0 110.572 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.58 -165.89 2.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 110.574 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 t -80.45 -24.52 39.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 110.202 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.188 -179.998 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.108 0.48 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.45 -163.33 1.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.145 -0.972 . . . . 0.0 110.381 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -120.93 75.61 1.16 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.312 -0.867 . . . . 0.0 109.443 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -78.45 76.46 4.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.515 -0.741 . . . . 0.0 110.677 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.579 HD11 ' CD1' ' A' ' 10' ' ' TYR . 3.8 mt -89.88 135.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.552 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -45.89 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.172 0.987 . . . . 0.0 112.015 -178.856 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.532 ' CD1' HG12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -92.03 -40.43 11.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.892 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.56 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.79 -60.47 1.95 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.392 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 12' ' ' MET . 11.6 t0 -45.09 -45.1 10.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CD1' HD11 ' A' ' 5' ' ' ILE . 32.1 t80 -61.52 -53.61 54.19 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.47 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.57 -21.52 3.94 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.499 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.9 -47.89 49.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.462 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -65.25 -23.72 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.524 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 5.3 m-85 -114.19 -78.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.143 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 156.41 162.49 11.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.586 ' NE2' ' CG2' ' A' ' 30' ' ' ILE . 22.7 tp60 -57.54 -41.31 80.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -1.1 . . . . 0.0 109.973 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -65.48 -30.26 71.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CB ' ' HB3' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -71.01 -63.53 1.08 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.344 179.488 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.2 m -57.4 -22.67 44.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.272 -0.892 . . . . 0.0 109.19 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.07 -45.7 59.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.431 -0.793 . . . . 0.0 110.228 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 14.0 mmtt -76.84 -13.04 60.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.892 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.46 -48.94 46.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.699 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.507 ' CD2' HG13 ' A' ' 50' ' ' VAL . 23.7 mt -82.61 -10.22 59.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 110.243 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 24.86 76.29 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.464 HG22 ' CB ' ' A' ' 23' ' ' LEU . 2.6 t -109.03 163.97 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -1.096 . . . . 0.0 110.163 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -62.68 147.6 49.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.093 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.78 -24.72 3.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.991 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 t -65.09 -51.3 62.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.842 . . . . 0.0 109.791 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.462 ' CB ' ' CG1' ' A' ' 25' ' ' VAL . . . -53.69 -19.36 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.805 . . . . 0.0 109.953 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.586 ' CG2' ' NE2' ' A' ' 16' ' ' GLN . 3.3 mm -80.88 -50.82 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.5 OUTLIER -70.63 -7.24 42.79 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.603 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -92.4 -44.61 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 108.758 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.556 ' O ' ' CD1' ' A' ' 40' ' ' ILE . . . -80.71 -13.41 59.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.56 ' CG2' ' HG2' ' A' ' 8' ' ' LYS . 9.5 mt -102.49 -42.37 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 42.9 t60 -61.69 -53.82 50.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.955 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 38' ' ' ARG . . . -93.12 -122.16 0.09 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . -1.73 68.38 0.0 OUTLIER Glycine 0 N--CA 1.504 3.223 0 C-N-CA 123.288 0.47 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 36' ' ' ALA . 23.3 mmm-85 -85.28 61.72 7.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.297 -1.119 . . . . 0.0 110.512 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 64.7 pttt -154.22 38.27 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 108.974 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.58 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 10.3 mt -101.65 165.36 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 110.825 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 56.2 m-85 -156.66 103.41 2.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.604 -0.685 . . . . 0.0 109.241 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.492 HD12 ' CB ' ' A' ' 7' ' ' LEU . 5.3 mp -89.33 130.18 35.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.905 . . . . 0.0 111.136 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 m -101.2 103.32 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.163 179.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.499 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 18.6 mt -89.25 74.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.062 -1.024 . . . . 0.0 110.576 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.564 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -44.7 174.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 110.705 179.413 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.95 -2.8 8.17 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.613 -0.835 . . . . 0.0 108.979 178.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.42 -2.1 57.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.885 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.81 -3.55 55.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -72.21 149.93 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -1.227 . . . . 0.0 109.773 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' A' ' 23' ' ' LEU . 13.1 t -111.5 105.87 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 110.668 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 1.9 m-85 -88.95 96.21 10.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.95 . . . . 0.0 109.007 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 58' ' ' PHE . . . -84.87 92.21 8.22 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 110.707 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.444 ' OE1' ' CG2' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.44 165.18 11.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.567 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 56' D VAL . 54.6 mt-10 -134.13 163.08 30.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.479 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 3.3 t -150.33 133.76 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 56' A ASP . 7.1 tptp -148.83 78.54 1.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.401 -0.812 . . . . 0.0 109.497 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 16.0 t0 60.24 50.47 6.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.592 -0.692 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 102.75 -30.43 10.42 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.499 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' C GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 56' ' ' LYS . 9.7 mt-10 -74.26 95.66 2.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.098 -1.237 . . . . 0.0 110.715 -179.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 18.8 m -117.05 147.48 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.214 -0.929 . . . . 0.0 110.393 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' E LYS . . . . . . . . . . . . . 3.6 pttm -175.1 165.73 2.1 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.191 -0.943 . . . . 0.0 110.576 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.49 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 4.7 Cg_exo -78.93 -176.41 3.27 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.872 1.714 . . . . 0.0 110.53 -178.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 1.8 t80 178.63 126.99 0.21 Allowed Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.29 -0.881 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 60.3 Cg_endo -90.11 96.59 0.16 OUTLIER 'Cis proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.913 -1.703 . . . . 0.0 110.514 -0.033 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 12.0 p -65.05 90.36 0.09 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.456 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 60' ' ' SER . 23.0 m-20 41.11 -163.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -134.2 46.21 2.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.747 . . . . 0.0 110.172 -179.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.569 ' C ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 6.63 109.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.817 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.46 -154.97 0.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.13 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -120.07 25.1 10.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 110.329 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.279 -179.939 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' GLU . 1.4 ttt . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.268 0.556 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 1' ' ' MET . 4.1 tt0 -43.15 125.65 3.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.965 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -125.75 76.73 1.6 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.343 -0.848 . . . . 0.0 109.934 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 3.2 ttm180 -79.34 74.56 5.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.382 -0.824 . . . . 0.0 110.098 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.581 HG23 ' CD1' ' A' ' 10' ' ' TYR . 3.9 mm -90.08 148.12 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.443 -0.786 . . . . 0.0 109.851 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.589 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -44.54 -179.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 122.486 1.136 . . . . 0.0 112.109 -178.822 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 40' ' ' ILE . 5.7 tp -94.28 -39.35 10.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -88.62 -61.9 1.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.185 179.583 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' LYS . 8.1 t0 -44.76 -42.39 7.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 6' ' ' THR . 12.0 t80 -55.76 -59.5 4.77 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.705 0.764 . . . . 0.0 109.345 178.281 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.9 -15.58 9.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.803 -0.561 . . . . 0.0 110.156 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ttt -83.43 -34.11 25.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.814 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.36 -10.45 49.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.809 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 -51.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.002 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.69 142.1 3.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -72.82 -27.74 62.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -1.185 . . . . 0.0 110.203 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.405 HG21 ' N ' ' A' ' 18' ' ' LYS . 3.3 t -79.88 -21.78 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' N ' HG21 ' A' ' 17' ' ' THR . 3.1 tttp -82.4 -46.98 12.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.113 179.31 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.477 HG21 ' CD1' ' A' ' 23' ' ' LEU . 11.6 m -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.319 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -82.62 -28.53 30.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 110.092 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -80.59 -36.96 32.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.467 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.4 -36.28 68.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.318 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.477 ' CD1' HG21 ' A' ' 19' ' ' THR . 83.3 mt -82.6 -9.94 59.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.26 40.03 97.58 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 23' ' ' LEU . 3.9 t -124.07 146.71 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.446 -1.032 . . . . 0.0 109.97 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -72.03 150.87 43.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.879 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -61.46 -20.38 63.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.4 p -84.65 -55.76 3.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.0 110.229 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.73 -23.28 1.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.525 HG21 ' CD1' ' A' ' 34' ' ' ILE . 95.0 mt -76.88 -63.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.891 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 11.5 m120 -49.9 -15.67 0.21 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.332 -0.855 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -91.58 -38.61 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.558 -1.339 . . . . 0.0 108.597 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.88 56.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.528 -0.732 . . . . 0.0 109.185 178.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.535 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 10.1 mt -114.57 -48.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.54 -0.725 . . . . 0.0 109.714 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t-160 -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.512 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.44 5.73 49.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 111.615 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' HD13 ' A' ' 40' ' ' ILE . . . -149.29 90.28 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.535 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 20.3 mmm-85 -83.69 -173.57 4.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -1.075 . . . . 0.0 110.157 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER 66.31 58.87 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.199 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.572 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 9.2 mt -116.18 157.65 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.163 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 39.8 m-85 -155.06 144.89 21.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 110.873 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.532 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 4.1 mp -135.57 131.05 35.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.462 -0.774 . . . . 0.0 109.743 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 3.2 m -99.18 101.04 12.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.005 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.587 ' CG2' ' O ' ' A' ' 49' ' ' SER . 15.0 mt -101.1 148.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.982 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 46' ' ' ALA 0.252 2.4 m-20 -65.31 -11.75 44.91 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.531 0.682 . . . . 0.0 110.076 178.113 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 81.49 1.22 1.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -175.166 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.19 38.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.554 ' N ' ' HB2' ' A' ' 45' ' ' ASN . . . -140.13 -63.36 0.04 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -177.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.587 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 0.9 OUTLIER 179.45 -168.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 109.445 -179.045 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 42' ' ' LEU . 11.9 t -125.52 110.93 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.571 -1.331 . . . . 0.0 111.583 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 43' ' ' THR . 4.4 m-85 -81.4 77.69 8.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.515 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -52.47 145.75 10.92 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.708 0.766 . . . . 0.0 111.398 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 78.94 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' D VAL . 3.8 pt-20 -79.41 163.49 24.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.253 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.456 HG21 HG13 ' A' ' 56' D VAL . 3.2 t -132.77 139.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 0.5 OUTLIER -159.76 160.85 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 -179.889 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.4 m-20 -39.21 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.471 -0.768 . . . . 0.0 110.438 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 144.99 -71.41 0.37 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.7 tt0 -174.4 -172.45 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.491 -1.005 . . . . 0.0 109.926 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 34.6 m -104.6 143.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.95 . . . . 0.0 110.434 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' E LYS . . . . . . . . . . . . . 4.9 mmtt -128.09 161.04 58.49 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.393 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.4 Cg_exo -82.9 39.95 0.9 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.825 1.683 . . . . 0.0 111.063 -178.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.459 ' C ' ' O ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -39.56 118.58 1.26 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.409 -0.807 . . . . 0.0 109.817 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -81.86 104.89 0.64 Allowed 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.305 -1.956 . . . . 0.0 110.724 0.2 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.506 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 73.3 p -49.4 106.23 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.08 -1.013 . . . . 0.0 110.184 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 110.416 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 63' ' ' LYS . 9.1 tptt -158.5 57.9 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.701 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -39.05 144.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.599 -0.688 . . . . 0.0 110.645 -179.732 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -104.2 38.87 1.76 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 110.046 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 t -159.48 56.66 0.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.046 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.246 -179.908 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttm . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.18 0.515 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -139.39 113.38 8.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.403 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.52 71.11 1.07 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.314 -0.866 . . . . 0.0 109.782 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.87 74.89 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.573 HG23 ' CD1' ' A' ' 10' ' ' TYR . 8.4 mt -91.66 141.68 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.305 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 18.8 p -59.47 -175.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 110.848 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.587 ' CD1' ' CG2' ' A' ' 19' ' ' THR . 1.2 tp -92.45 -34.43 14.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' CG ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -81.84 -69.52 0.61 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.855 -0.528 . . . . 0.0 110.002 179.375 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 41.4 t0 -46.66 -58.09 4.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.219 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.627 ' CZ ' ' CZ ' ' A' ' 14' ' ' PHE . 3.4 t80 -41.9 -51.65 4.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.331 -0.855 . . . . 0.0 110.368 179.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HB3' ' OG1' ' A' ' 19' ' ' THR . . . -56.13 -42.41 76.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 30.1 ttp -60.17 -29.94 69.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.058 179.048 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -55.84 28.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.492 -0.755 . . . . 0.0 110.125 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CZ ' ' CZ ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -123.52 67.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.974 -1.079 . . . . 0.0 111.659 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.28 156.87 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.29 -29.92 30.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -1.03 . . . . 0.0 109.841 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.4 m -60.63 -21.61 62.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.414 -0.804 . . . . 0.0 109.884 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.576 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.0 mmtp -69.76 -54.86 11.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.02 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.587 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 90.3 m -59.37 -19.01 43.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.21 72.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.594 -0.691 . . . . 0.0 109.825 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -81.76 -18.69 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.743 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 3.0 t0 -65.43 -53.84 37.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.033 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.414 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 3.0 mt -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.364 -0.835 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.77 29.78 20.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -122.08 151.26 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -1.115 . . . . 0.0 109.676 -179.751 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 25' ' ' VAL . 47.8 m-85 -47.09 173.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.461 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -77.0 -28.25 54.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -67.56 -57.95 5.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.16 -28.53 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.365 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -62.85 -61.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.524 ' N ' ' CG2' ' A' ' 30' ' ' ILE . 48.9 m-80 -57.28 -9.65 1.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.597 -0.69 . . . . 0.0 110.888 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -88.98 -35.32 16.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.648 -1.283 . . . . 0.0 107.766 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -85.62 -11.11 54.73 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.57 ' CG2' ' CG ' ' A' ' 8' ' ' LYS . 14.9 mt -100.68 -48.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.405 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -74.99 -58.43 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.894 179.661 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.85 11.08 23.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 110.755 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -137.63 69.66 0.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.479 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 15.0 mmm-85 -75.85 -171.85 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.899 -1.353 . . . . 0.0 110.214 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 9.2 mptt 58.73 46.72 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.198 -0.939 . . . . 0.0 110.52 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.589 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 16.7 mt -97.89 161.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 110.353 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 43.9 m-85 -161.32 114.37 1.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 110.267 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 7' ' ' LEU . 2.4 mp -107.24 131.88 53.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.099 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -96.99 100.54 12.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 44' ' ' ILE . 9.6 mt -94.73 43.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -91.97 -131.49 0.12 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 109.85 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 49' ' ' SER . . . 48.75 24.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.957 -1.089 . . . . 0.0 109.127 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.1 t0 75.13 63.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.317 0.579 . . . . 0.0 111.036 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 81.78 -8.43 59.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.554 ' HB2' ' CB ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -51.11 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.317 . . . . 0.0 110.506 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.71 123.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.47 135.68 37.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.576 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 57' ' ' PRO . . . -103.57 149.9 24.46 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.944 -1.098 . . . . 0.0 109.461 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 2.4 tt0 -159.78 151.43 20.12 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 110.651 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 56' D VAL . 2.1 tt0 -135.92 151.1 49.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.55 ' CA ' ' HA ' ' A' ' 56' D VAL . 7.2 p -124.33 -26.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.394 -0.923 . . . . 0.0 112.525 -177.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 3.2 ttmt -160.14 -171.37 3.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.705 -1.247 . . . . 0.0 111.091 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 29.5 t0 47.37 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.693 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -58.76 -51.88 56.44 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 178.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' C GLU . . . . . 0.532 ' CB ' ' OE1' ' A' ' 54' ' ' GLU . 2.5 tt0 174.97 179.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.628 -0.924 . . . . 0.0 110.096 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 4.1 m -122.0 46.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 56' D VAL . 13.9 mttt -149.81 174.95 3.06 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.375 -0.828 . . . . 0.0 112.302 -177.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.533 ' CD ' ' HB3' ' A' ' 56' E LYS . 3.9 Cg_exo -80.04 56.16 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.661 2.24 . . . . 0.0 111.497 -179.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.414 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 5.0 p90 -44.06 146.53 1.08 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.714 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -91.11 50.01 1.08 Allowed 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.221 -1.991 . . . . 0.0 110.31 -0.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 p -44.75 141.52 2.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 110.021 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -138.92 83.05 1.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.977 . . . . 0.0 110.485 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -129.93 43.55 3.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.833 179.611 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -118.38 -88.24 0.61 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 110.08 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.456 ' O ' ' HB ' ' A' ' 65' ' ' THR . 2.8 m 53.87 43.7 30.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.25 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 64' ' ' THR . 6.7 t -179.02 -33.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.244 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.284 -179.988 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.244 0.545 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.28 129.53 37.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.6 mt-30 -105.38 63.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.8 ttp180 -79.0 79.71 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.51 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.421 HG23 ' CD1' ' A' ' 10' ' ' TYR . 32.7 mt -89.32 154.17 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.062 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.08 179.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.049 0.928 . . . . 0.0 111.38 -179.262 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.528 ' CD2' HG12 ' A' ' 34' ' ' ILE . 3.7 tp -92.8 -40.08 10.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.077 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.455 ' CG ' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.96 -63.97 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.434 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 3.1 m-20 -45.03 -44.57 10.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.1 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.559 ' CB ' ' O ' ' A' ' 6' ' ' THR . 9.4 t80 -57.24 -56.43 21.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.143 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 19' ' ' THR . . . -57.74 -15.27 7.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.8 -0.562 . . . . 0.0 110.388 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.2 ttt -82.79 -35.34 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -0.976 . . . . 0.0 110.062 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -77.04 -32.17 56.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.664 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 12.1 m-85 -96.64 -54.22 3.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.12 137.92 2.74 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -33.43 66.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -1.18 . . . . 0.0 110.275 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 m -77.5 -23.34 50.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -76.28 -56.66 4.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.071 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 11' ' ' ALA . 2.1 m -57.81 -23.81 54.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.491 -0.756 . . . . 0.0 109.123 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.52 -47.13 43.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.913 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -9.14 57.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 110.053 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.98 -30.84 18.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 110.141 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.444 HD22 ' CD2' ' A' ' 42' ' ' LEU . 75.3 mt -91.37 -5.62 54.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.15 35.3 91.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.523 HG13 ' CB ' ' A' ' 29' ' ' ALA . 2.8 t -119.72 174.46 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -1.128 . . . . 0.0 109.926 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 27' ' ' GLN . 60.1 m-85 -81.96 136.41 35.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 0.0 110.0 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -44.24 -29.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.953 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -74.54 -52.55 11.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.523 ' CB ' HG13 ' A' ' 25' ' ' VAL . . . -50.76 -27.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.597 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.561 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.3 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 109.677 179.672 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 7.0 m-80 -57.7 -10.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.658 -0.651 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.88 -42.8 9.31 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.507 -1.37 . . . . 0.0 108.51 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.89 -9.63 58.73 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 HG12 ' CD2' ' A' ' 7' ' ' LEU . 24.6 mt -110.86 -51.1 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.765 . . . . 0.0 110.088 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.582 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 21.3 t-160 -53.86 -26.59 25.31 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.407 179.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.22 -75.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.989 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.07 57.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.562 ' O ' ' C ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -90.48 31.72 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.129 -1.218 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER 19.72 70.15 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.318 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 6.3 mt -105.51 159.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.387 -0.821 . . . . 0.0 110.931 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -143.54 161.56 38.14 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.106 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 4.0 mp -137.47 118.57 14.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.667 -1.271 . . . . 0.0 110.888 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 51' ' ' TYR . 2.8 p -85.32 97.63 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.538 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 45' ' ' ASN . 4.4 mt -89.52 80.79 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.314 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 44' ' ' ILE . 51.6 p30 -44.02 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.464 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -3.74 8.84 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.706 -0.797 . . . . 0.0 109.041 178.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.62 -3.16 58.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.4 -5.13 74.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -70.4 122.41 19.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.32 112.2 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.512 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.497 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 3.5 t80 -102.96 105.69 16.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -82.5 143.54 31.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.205 -0.935 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 56' E LYS . 0.7 OUTLIER -151.01 96.35 2.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.54 -0.725 . . . . 0.0 109.63 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 40.1 tt0 -78.97 161.65 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' HG2' ' A' ' 54' ' ' GLU . 73.3 t -135.44 138.58 48.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.672 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 56' A ASP . 22.3 ttpp -156.06 141.74 17.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -0.76 . . . . 0.0 109.239 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 56' ' ' LYS . 7.6 t0 -37.15 102.94 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.511 -0.743 . . . . 0.0 110.828 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 56' C GLU . . . 139.72 -53.54 0.68 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' C GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 56' B GLY . 11.0 tt0 179.48 171.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 110.042 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 56' E LYS . 23.4 m -98.54 173.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.176 -0.952 . . . . 0.0 110.005 179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 5.3 mtmt -144.7 170.45 8.19 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 110.176 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 58' ' ' PHE . 4.4 Cg_exo -79.53 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.297 -2.138 0 O-C-N 124.42 1.747 . . . . 0.0 109.966 -179.196 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.504 ' O ' ' O ' ' A' ' 57' ' ' PRO . 28.1 t80 57.69 125.86 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.516 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.39 122.47 8.51 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.169 -2.013 . . . . 0.0 110.305 0.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.63 53.68 0.37 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.975 . . . . 0.0 110.591 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 14.8 t-20 -127.44 50.64 1.99 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.142 -0.974 . . . . 0.0 109.871 179.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 0.4 OUTLIER 178.38 58.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.446 -0.784 . . . . 0.0 110.02 179.986 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -113.19 -88.1 0.55 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 0.0 110.219 -179.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.74 -58.44 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.215 -0.928 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.78 -10.35 14.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 110.48 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.207 -179.917 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.316 0.579 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 105.78 16.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 6.4 mt-30 -118.44 73.22 0.9 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.084 -1.01 . . . . 0.0 109.655 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 6.5 ttt180 -78.26 81.48 4.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' A' ' 10' ' ' TYR . 3.9 mt -90.77 -179.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.424 -0.798 . . . . 0.0 109.571 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.61 -173.11 3.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.026 0.917 . . . . 0.0 111.375 -179.313 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.465 HD13 HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -92.91 -46.5 7.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.347 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.506 ' CB ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -84.33 -57.0 3.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.083 178.766 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.519 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -51.98 -51.78 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.393 -0.817 . . . . 0.0 109.127 179.269 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CB ' ' O ' ' A' ' 6' ' ' THR . 1.6 t80 -49.91 -56.78 9.22 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.685 179.115 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.39 -32.67 18.17 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.646 0.736 . . . . 0.0 109.41 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.424 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -58.28 -51.61 69.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -20.74 65.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.616 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -111.58 -84.54 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.805 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 174.32 159.57 20.93 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.702 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -39.01 93.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.594 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -78.38 -3.18 41.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.907 179.768 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -90.15 -50.39 6.02 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.341 -0.849 . . . . 0.0 108.729 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.49 ' OG1' ' CB ' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -54.96 -37.96 67.16 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.271 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 -48.66 55.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.492 0.663 . . . . 0.0 109.905 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.9 mmtp -76.62 3.82 10.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 109.834 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.54 ' OD1' ' CG2' ' A' ' 50' ' ' VAL . 0.9 OUTLIER -88.06 -60.62 1.92 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.84 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' HG ' ' N ' ' A' ' 24' ' ' GLY . 0.5 OUTLIER -99.81 -25.44 14.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.957 -1.089 . . . . 0.0 110.939 -179.408 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.556 ' N ' ' HG ' ' A' ' 23' ' ' LEU . . . 119.84 62.15 0.26 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.779 179.208 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.532 HG22 ' HG ' ' A' ' 23' ' ' LEU . 2.2 t -142.82 -172.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.133 -1.216 . . . . 0.0 109.521 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' O ' HD11 ' A' ' 30' ' ' ILE . 31.4 m-85 -109.48 -170.2 1.61 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.933 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -87.71 -29.52 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.152 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -68.15 -46.66 70.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.02 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HB1' HG13 ' A' ' 25' ' ' VAL . . . -56.97 -22.92 41.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.982 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.3 mp -81.51 -45.8 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 109.57 179.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 26.2 m-20 -72.75 -8.17 54.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 179.357 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -95.5 -44.57 7.46 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.52 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 40' ' ' ILE . . . -71.29 -16.38 62.46 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.766 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.552 ' O ' ' CD ' ' A' ' 38' ' ' ARG . 88.2 mt -103.76 -53.65 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 110.704 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.569 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 8.8 t-80 -62.13 -10.42 10.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.72 -1.237 . . . . 0.0 109.941 179.783 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -81.86 -103.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.921 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' ARG . . . -123.11 78.63 0.35 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 16.5 mmm-85 -34.14 119.31 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.911 0.863 . . . . 0.0 111.833 -178.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 41.7 pttt -174.88 31.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.652 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.574 ' C ' ' CG ' ' A' ' 41' ' ' PHE . 14.9 mt -105.88 161.16 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.688 . . . . 0.0 110.157 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 45.3 m-85 -155.3 114.37 3.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.299 -0.876 . . . . 0.0 109.897 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 42' ' ' LEU . 5.0 mp -98.27 107.24 19.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.097 -1.002 . . . . 0.0 110.5 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 11.0 t -83.7 105.11 14.35 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.735 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.543 ' CG2' ' O ' ' A' ' 49' ' ' SER . 3.5 mt -97.95 135.29 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.181 -179.751 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -114.2 -168.09 1.31 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.791 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.94 0.31 11.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -165.6 24.6 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.858 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -96.94 -12.35 50.09 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 1.1 m 59.08 -90.41 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.541 -0.976 . . . . 0.0 108.575 -178.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.54 ' CG2' ' OD1' ' A' ' 22' ' ' ASP . 1.3 t -160.95 98.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.113 -0.992 . . . . 0.0 110.401 179.06 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.484 ' HB3' HG21 ' A' ' 43' ' ' THR . 2.3 t80 -95.98 105.53 17.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.255 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -67.5 148.9 50.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.624 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 41' ' ' PHE . 41.1 mt-10 -149.2 102.44 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 110.183 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' C ' ' CG2' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -89.89 148.73 22.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -0.957 . . . . 0.0 109.129 179.423 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 2.4 t -148.62 105.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.879 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 1.7 tptp -125.23 170.02 11.68 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 56' ' ' LYS . 2.7 t70 -42.26 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.171 -0.956 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 60.31 56.7 23.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -167.18 74.55 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.019 -1.283 . . . . 0.0 110.974 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.436 ' O ' HG21 ' A' ' 56' D VAL . 2.6 m -103.82 150.76 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.462 179.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' E LYS . . . . . . . . . . . . . 0.9 OUTLIER -162.77 160.31 19.55 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.765 -1.209 . . . . 0.0 111.154 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 58' ' ' PHE . 5.3 Cg_endo -89.52 37.66 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.049 1.832 . . . . 0.0 110.815 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -41.62 137.55 1.8 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.903 . . . . 0.0 109.922 179.778 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 60' ' ' SER . 53.2 Cg_endo -93.5 66.9 0.25 Allowed 'Cis proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.714 -1.786 . . . . 0.0 110.887 0.164 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -57.19 -155.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.875 -1.14 . . . . 0.0 110.689 -179.774 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -54.83 148.72 12.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.855 -179.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.3 tttp 178.82 62.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.729 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 64' ' ' THR . 4.7 mtpt -82.92 70.71 9.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.936 . . . . 0.0 111.106 -179.186 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 40.9 -148.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.86 . . . . 0.0 110.519 179.229 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 66' ' ' ALA . 9.8 t -85.92 -17.91 34.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 110.316 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' N ' HG21 ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.182 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 1' ' ' MET . 1.8 ttm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.993 0.425 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 1' ' ' MET . 1.9 tp10 -41.77 126.61 3.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 109.907 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.491 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -138.48 86.09 2.13 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.086 -1.009 . . . . 0.0 110.157 -179.418 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -79.64 73.15 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.365 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 10' ' ' TYR . 9.0 mt -90.33 141.27 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 110.821 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -51.75 -174.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 112.159 -179.31 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.519 HD21 ' CD1' ' A' ' 40' ' ' ILE . 3.4 tp -93.41 -38.39 11.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 176.134 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.568 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -82.2 -60.03 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.787 178.997 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 12' ' ' MET . 9.1 t0 -53.28 -44.35 68.19 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.165 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.632 ' CE1' ' CD1' ' A' ' 44' ' ' ILE . 88.4 t80 -58.9 -63.75 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.495 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.21 -23.54 1.37 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.382 -0.824 . . . . 0.0 109.62 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.43 -54.18 11.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.113 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -88.35 13.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.659 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -161.5 97.27 1.09 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.707 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 14' ' ' PHE . . . -8.72 123.52 0.01 OUTLIER Glycine 0 N--CA 1.506 3.338 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 17' ' ' THR . 6.2 pt20 -59.95 -36.39 76.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.411 -1.052 . . . . 0.0 109.582 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.522 ' N ' ' CG ' ' A' ' 16' ' ' GLN . 2.8 m -51.49 -22.45 3.13 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.242 -179.229 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -82.57 -44.69 15.55 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.109 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.423 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -64.5 -23.37 67.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.205 179.104 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.426 ' HB1' HG13 ' A' ' 30' ' ' ILE . . . -86.04 -28.5 24.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 110.518 -179.543 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -71.73 -28.31 63.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.898 179.788 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' CB ' HG22 ' A' ' 50' ' ' VAL . 68.7 m-20 -89.91 -26.41 20.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 19' ' ' THR . 25.5 mt -79.41 -40.72 29.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.369 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.29 40.45 1.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 -177.75 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.269 -1.136 . . . . 0.0 109.83 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -97.98 -163.76 1.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.31 -50.08 7.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.041 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 29' ' ' ALA . 7.9 t -64.82 -62.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 109.881 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.9 -28.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.57 ' CG2' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -69.22 -58.18 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.506 -0.746 . . . . 0.0 109.278 179.28 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.646 ' O ' ' HB2' ' A' ' 35' ' ' HIS . 0.7 OUTLIER -57.41 -6.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.813 -0.555 . . . . 0.0 111.645 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -91.95 -40.73 10.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.793 -1.192 . . . . 0.0 108.18 178.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -22.3 55.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.568 ' CG2' ' HG2' ' A' ' 8' ' ' LYS . 47.6 mt -87.34 -51.37 12.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -43.6 -35.88 1.91 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.786 0.803 . . . . 0.0 108.976 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.93 -87.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.96 39.75 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HD3' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -84.05 48.33 1.45 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.427 -1.043 . . . . 0.0 111.423 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 2.5 mppt? 64.85 98.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.508 -0.745 . . . . 0.0 110.369 179.191 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.578 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 2.7 mt -129.84 153.78 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 72.8 m-85 -156.57 124.03 5.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.496 HD12 ' CA ' ' A' ' 7' ' ' LEU . 5.1 mp -118.13 132.06 56.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 111.063 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.4 m -108.65 103.27 12.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.421 -0.799 . . . . 0.0 108.983 178.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 10' ' ' TYR . 1.5 mt -94.13 -149.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 111.199 -178.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.622 ' C ' ' H ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER 37.6 -164.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.453 0.644 . . . . 0.0 110.804 -178.847 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 45' ' ' ASN . . . 63.97 -5.49 0.3 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -176.833 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER 174.73 -27.37 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.149 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.88 40.68 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.432 ' OG ' ' CE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -100.2 133.37 44.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.649 -0.913 . . . . 0.0 109.771 179.939 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 22' ' ' ASP . 39.8 t -88.31 97.53 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 110.48 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 55.3 m-85 -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 108.674 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.76 127.52 34.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.198 -0.939 . . . . 0.0 110.867 -178.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.39 161.21 25.2 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 25.7 tt0 -136.07 147.06 47.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.371 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 2.5 t -146.54 104.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.503 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 3.5 ttpt -132.34 153.93 50.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 109.509 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 18.0 t70 -43.06 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.072 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 151.73 -55.74 0.45 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.28 -172.62 0.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.338 -1.095 . . . . 0.0 110.506 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 56' E LYS . 5.0 m -116.3 161.08 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -179.672 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 56' D VAL . 19.2 mttm -146.33 163.65 28.89 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 110.375 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.503 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -83.99 -61.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.016 1.81 . . . . 0.0 110.873 -178.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 4.4 t80 59.89 123.74 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.34 -0.85 . . . . 0.0 110.009 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.4 126.85 13.82 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 122.16 -2.017 . . . . 0.0 110.258 0.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.48 31.59 5.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -127.73 63.52 1.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.363 -0.835 . . . . 0.0 110.35 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.79 48.61 2.0 Allowed 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.116 -0.99 . . . . 0.0 109.92 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -44.93 -91.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.468 -0.77 . . . . 0.0 110.269 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.7 p -81.78 -140.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.031 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 t -86.0 -28.86 23.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.0 110.466 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.208 179.985 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.203 0.525 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.18 150.86 51.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 110.505 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -125.48 77.6 1.66 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.332 -0.855 . . . . 0.0 109.39 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -78.99 85.78 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 0.0 110.721 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.525 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 11.3 mt -90.44 149.71 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.827 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -48.13 -178.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.248 1.023 . . . . 0.0 111.647 -179.266 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.53 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . 2.6 tp -92.42 -40.21 11.0 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.678 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.442 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -91.32 -59.54 2.12 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 12' ' ' MET . 0.8 OUTLIER -45.83 -39.6 8.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.83 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 6' ' ' THR . 5.5 t80 -62.52 -53.38 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.505 178.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.477 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -51.87 -26.09 9.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 14.4 tpp -72.25 -47.01 53.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.871 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -23.88 65.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.968 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.48 -79.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.65 156.23 14.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.424 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -70.41 -30.52 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 109.994 179.932 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 p -82.58 -20.57 36.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 110.208 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -81.23 -51.42 8.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.329 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 11' ' ' ALA . 2.8 m -63.11 -25.97 68.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 178.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -74.4 -34.8 63.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 0.0 110.529 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 2.2 mmtp -89.6 -14.17 35.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.286 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' OD2' ' O ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -76.25 -40.46 51.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.67 179.737 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.468 ' HG ' ' OD1' ' A' ' 22' ' ' ASP . 4.7 mt -83.51 0.41 46.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.16 56.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.558 ' CG1' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -144.71 -175.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.464 ' O ' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -110.25 155.99 21.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.217 -0.927 . . . . 0.0 109.924 -179.949 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 26' ' ' TYR . 1.1 mt-30 -40.46 -28.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.374 -0.829 . . . . 0.0 110.728 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -61.98 -64.68 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.126 -0.984 . . . . 0.0 110.507 -179.775 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.558 ' CB ' ' CG1' ' A' ' 25' ' ' VAL . . . -44.99 -26.11 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.7 mp -75.84 -43.61 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.2 t30 -73.51 -1.57 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.042 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -104.82 -43.38 5.11 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.999 -1.063 . . . . 0.0 108.879 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -82.1 -0.9 46.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.589 -0.695 . . . . 0.0 109.204 178.576 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.474 HG12 ' CD2' ' A' ' 7' ' ' LEU . 13.6 mt -124.33 -40.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.86 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.548 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 5.7 t-80 -74.06 -26.09 60.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.0 110.019 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 -32.76 71.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.82 45.59 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.7 mmm180 -85.68 -173.45 4.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -1.147 . . . . 0.0 110.401 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.48 79.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 40' ' ' ILE . 10.0 mt -109.82 162.99 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.905 . . . . 0.0 110.452 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CG ' ' NH1' ' A' ' 4' ' ' ARG . 76.2 m-85 -151.09 113.58 4.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 0.0 109.831 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 7.3 mp -80.12 134.58 36.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 17.8 m -106.38 100.3 9.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.474 ' CG2' ' O ' ' A' ' 49' ' ' SER . 10.6 mt -92.65 131.32 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.653 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 3.5 m120 -52.75 -19.09 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.568 -0.708 . . . . 0.0 110.59 179.02 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.653 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 91.96 -21.02 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -176.329 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.1 -2.04 57.55 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.367 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.17 -20.2 11.5 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.474 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -63.32 147.52 50.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -1.198 . . . . 0.0 109.989 179.862 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 22' ' ' ASP . 22.1 t -122.11 141.86 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.448 ' O ' ' C ' ' A' ' 52' ' ' ALA . 18.7 t80 -143.09 76.54 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.479 -0.763 . . . . 0.0 109.636 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 51' ' ' TYR . . . -38.31 143.4 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.616 -0.678 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' PHE . 2.9 tt0 -140.41 86.99 2.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 110.724 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' D VAL . 1.3 tp10 -79.38 147.91 32.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.84 137.38 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 110.496 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 56' C GLU . 11.4 ttpt -160.07 -172.76 3.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.841 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' A ASP . . . . . . . . . . . . . 13.2 m-20 -57.24 105.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.029 -1.044 . . . . 0.0 110.189 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 51.49 29.97 25.38 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' C GLU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -143.77 86.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.175 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 1.2 p -125.44 102.02 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 109.719 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 56' D VAL . 9.0 mtmm -143.81 160.25 50.86 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.215 -0.928 . . . . 0.0 110.383 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.21 128.64 12.31 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.359 1.715 . . . . 0.0 111.166 -178.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.93 144.39 39.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.481 -0.762 . . . . 0.0 109.714 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -90.94 47.48 1.35 Allowed 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.108 -2.039 . . . . 0.0 110.485 0.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.67 67.26 6.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.278 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -166.18 98.44 0.62 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.129 -0.982 . . . . 0.0 110.417 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.505 ' O ' ' C ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -151.34 50.66 0.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.065 179.717 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' A' ' 62' ' ' LYS . 17.8 mttp 28.4 -139.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.188 0.518 . . . . 0.0 111.282 179.446 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -159.56 -69.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.231 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.27 21.42 0.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 110.447 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.129 179.907 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.233 0.539 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.12 150.76 30.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.164 -0.96 . . . . 0.0 110.436 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 12.8 mm100 -117.4 70.93 0.79 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 109.859 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.7 80.11 6.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.365 -0.835 . . . . 0.0 109.977 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.547 HD11 ' CD1' ' A' ' 10' ' ' TYR . 5.3 mt -89.31 141.47 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 110.609 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.581 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -47.17 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.996 0.903 . . . . 0.0 111.139 -179.917 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 34' ' ' ILE . 3.8 tp -93.19 -39.9 10.77 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -86.66 -61.11 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.042 178.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.44 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 1.6 t70 -50.33 -47.56 55.79 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.342 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.581 ' CB ' ' O ' ' A' ' 6' ' ' THR . 4.0 t80 -53.92 -61.31 2.38 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.885 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 19' ' ' THR . . . -57.01 -16.6 7.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.141 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -86.16 -30.67 22.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.511 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -3.93 38.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -126.96 32.72 5.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 -179.994 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 14' ' ' PHE . . . 60.93 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.422 ' OE1' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -79.64 -26.53 41.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 110.375 -179.962 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -75.89 -23.66 55.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 2.7 tptt -76.63 -56.66 4.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.202 -0.936 . . . . 0.0 109.022 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.446 HG22 ' HB3' ' A' ' 11' ' ' ALA . 1.7 m -55.35 -27.95 50.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 178.581 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.44 -30.35 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -82.8 -8.46 59.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -90.41 -48.93 6.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 110.251 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.92 -36.63 36.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.58 33.11 4.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.22 161.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.204 -1.174 . . . . 0.0 109.908 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -76.26 156.06 33.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -35.66 75.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.45 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -62.42 -51.22 68.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.96 -24.8 1.63 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.2 mp -82.92 -56.2 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.949 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 3.3 m120 -49.78 -16.91 0.29 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.709 . . . . 0.0 111.374 -179.32 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -99.87 -51.64 3.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.436 -1.415 . . . . 0.0 109.039 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -80.08 11.46 3.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.653 178.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.551 ' CG2' ' HG2' ' A' ' 8' ' ' LYS . 26.4 mm -135.32 -41.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 110.305 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -70.1 -30.6 67.85 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.947 179.724 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.19 -78.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.12 69.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.5 tpt180 -90.7 123.59 34.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 111.267 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -98.94 63.35 1.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.359 -0.838 . . . . 0.0 109.319 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.524 HD13 ' CD2' ' A' ' 7' ' ' LEU . 5.5 mt -113.29 161.1 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.284 -179.255 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 32.4 m-85 -137.93 150.42 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.948 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 5.0 mp -126.94 140.71 52.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.437 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -103.37 103.68 13.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.58 HD12 ' CE2' ' A' ' 10' ' ' TYR . 3.8 mt -98.89 75.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.131 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 49' ' ' SER . 4.5 p30 -41.87 166.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.686 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.44 -7.67 3.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.555 -0.715 . . . . 0.0 109.323 178.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.15 6.41 11.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.57 0.32 30.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.471 ' O ' HG21 ' A' ' 44' ' ' ILE . 4.6 t -59.17 -176.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.049 -1.265 . . . . 0.0 109.493 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.2 t -149.65 115.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.612 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.482 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 6.6 m-85 -113.45 154.58 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.76 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -131.53 147.26 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.94 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' C ' HG21 ' A' ' 40' ' ' ILE . 15.6 mt-10 -154.43 99.05 2.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HG3' HG12 ' A' ' 40' ' ' ILE . 12.8 tt0 -79.89 147.94 31.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.051 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.25 97.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.931 -1.106 . . . . 0.0 110.46 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' B GLY . 6.7 ttpt -117.64 148.75 41.66 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.838 . . . . 0.0 109.75 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' LYS . 9.7 t70 -43.23 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 110.237 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 152.27 -55.87 0.45 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -174.75 166.11 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.866 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 16.0 m -107.43 160.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -0.839 . . . . 0.0 109.493 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.524 ' HB2' ' CD ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.56 178.12 1.59 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.018 -1.051 . . . . 0.0 110.694 -179.953 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.524 ' CD ' ' HB2' ' A' ' 56' E LYS . 4.8 Cg_exo -77.72 -64.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.296 -2.193 0 O-C-N 124.39 1.732 . . . . 0.0 110.529 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.481 ' HB2' ' HD2' ' A' ' 56' E LYS . 9.5 t80 57.93 117.92 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.57 130.74 20.33 Favored 'Cis proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.178 -2.009 . . . . 0.0 110.308 -0.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 t -170.97 53.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.5 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -97.4 54.51 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 110.16 179.849 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -176.42 55.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 109.934 -179.82 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -47.39 -69.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.352 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -140.09 -62.19 0.51 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.249 -0.907 . . . . 0.0 110.24 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.8 t -132.56 9.09 4.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.856 . . . . 0.0 110.216 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.181 179.968 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' HG3' ' HG3' ' A' ' 2' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.012 0.434 . . . . 0.0 110.173 . . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -44.04 137.87 3.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.05 -1.031 . . . . 0.0 110.668 -179.712 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 36.4 mm-40 -122.13 68.85 0.94 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.805 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 1.4 ttt180 -81.52 69.73 8.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 111.03 -179.309 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.58 ' HB ' ' CD1' ' A' ' 10' ' ' TYR . 6.0 mm -90.66 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 109.904 179.342 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -91.37 164.88 13.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.052 -1.03 . . . . 0.0 112.409 -178.503 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -59.82 -26.55 65.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.375 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 8' ' ' LYS . 5.6 tmtm? -80.21 -79.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.19 -54.4 16.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.784 -1.198 . . . . 0.0 110.228 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.596 ' CB ' ' O ' ' A' ' 6' ' ' THR . 17.7 t80 -46.95 -53.28 12.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.943 -1.098 . . . . 0.0 110.12 -179.75 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.31 -34.97 67.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 110.194 -179.575 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -34.91 78.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -32.61 47.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CD2' ' HD3' ' A' ' 18' ' ' LYS . 5.6 m-30 -107.88 -63.59 1.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 152.62 143.77 3.76 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.588 ' NE2' ' CG2' ' A' ' 30' ' ' ILE . 6.4 tp60 -53.32 -33.23 52.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -28.14 54.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 110.493 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HD3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -73.79 -56.01 5.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 179.66 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.41 ' CG2' HD11 ' A' ' 7' ' ' LEU . 8.1 m -62.96 -17.99 62.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.466 -0.771 . . . . 0.0 109.396 179.286 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 16' ' ' GLN . . . -80.32 -36.67 33.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 110.399 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.93 -23.25 48.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.889 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.35 -27.5 32.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.071 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.2 mt -81.96 -40.49 22.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.72 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.12 18.11 10.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.425 HG12 ' CG ' ' A' ' 59' ' ' PRO . 3.4 m -137.35 158.98 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 109.916 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 15.1 m-30 -67.82 178.72 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.34 -179.744 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.451 ' HA ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -70.39 -22.57 62.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -0.903 . . . . 0.0 110.207 179.868 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 m -59.1 -49.69 76.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.47 -19.45 5.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.588 ' CG2' ' NE2' ' A' ' 16' ' ' GLN . 3.0 mm -80.63 -57.85 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.854 0.835 . . . . 0.0 110.003 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -54.3 -15.53 1.65 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.558 -179.444 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -40.96 10.85 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.496 -1.378 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . . . -78.09 -4.55 47.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 109.204 178.717 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 30' ' ' ILE . 15.2 mt -120.02 -47.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.449 -0.782 . . . . 0.0 110.666 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.564 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 12.1 t60 -69.58 -22.22 63.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.006 -1.059 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.38 33.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.194 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.86 46.35 1.04 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.47 148.54 24.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -90.35 55.55 3.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.994 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 7.0 mt -81.3 163.0 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.768 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 53.2 m-85 -157.38 142.1 16.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.55 -0.719 . . . . 0.0 109.26 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.54 ' CD2' HD13 ' A' ' 7' ' ' LEU . 5.3 mp -129.05 113.56 15.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.931 -1.105 . . . . 0.0 111.725 -179.17 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.8 m -97.72 101.68 13.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.396 -0.815 . . . . 0.0 108.918 178.472 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.503 HD11 ' CZ ' ' A' ' 10' ' ' TYR . 8.5 mt -96.56 136.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 111.081 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.639 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.9 m120 -51.83 -18.91 1.45 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 110.653 178.768 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.639 ' CB ' ' O ' ' A' ' 45' ' ' ASN . . . 90.06 -17.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -176.11 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.05 -13.4 41.63 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.3 -26.42 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.563 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 107.36 0.78 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -1.226 . . . . 0.0 109.682 179.97 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.436 HG21 HG21 ' A' ' 44' ' ' ILE . 40.3 t -100.16 117.95 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.067 . . . . 0.0 111.317 -179.19 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 23.3 m-30 -104.04 111.07 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 108.933 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -87.8 76.51 8.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 0.0 111.072 -179.013 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -84.86 147.03 27.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 109.432 179.102 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 56' D VAL . 7.8 mt-10 -127.73 173.07 10.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.015 -179.993 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.6 119.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.048 -1.033 . . . . 0.0 110.592 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' B GLY . 9.3 tptp -138.31 143.75 40.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 179.534 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' A ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.6 OUTLIER -42.11 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 110.352 -179.762 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 143.34 -54.21 0.59 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.34 162.06 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 110.516 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 56' E LYS . 33.9 m -79.78 161.18 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 179.754 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.93 163.23 45.9 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.142 -0.974 . . . . 0.0 110.767 -179.828 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.3 Cg_endo -83.41 179.18 5.17 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.813 1.675 . . . . 0.0 110.148 -179.29 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.545 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 31.4 t80 179.11 121.68 0.21 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 110.311 -179.645 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.425 ' CG ' HG12 ' A' ' 25' ' ' VAL . 10.1 Cg_endo -85.78 101.4 0.33 Allowed 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.728 -1.78 . . . . 0.0 110.433 -0.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 59' ' ' PRO . 20.2 m -44.02 144.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 110.147 179.772 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -134.69 146.96 49.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 110.083 -179.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 47.23 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 0.0 110.549 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 17.9 pttp -116.35 120.22 38.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -142.73 -90.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -0.991 . . . . 0.0 110.357 -179.851 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 2.0 p 43.89 33.78 0.8 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.268 -0.895 . . . . 0.0 109.44 179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.284 179.83 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.209 0.528 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.48 111.44 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.456 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 20.7 mt-30 -104.16 64.43 0.77 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.218 -0.927 . . . . 0.0 109.302 179.715 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -78.75 83.86 4.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.297 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.523 HD11 ' CE1' ' A' ' 10' ' ' TYR . 9.7 mt -90.2 -173.63 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.551 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.12 -179.36 5.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.087 -1.008 . . . . 0.0 111.993 -179.047 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.544 ' CG ' HG12 ' A' ' 34' ' ' ILE . 6.1 tp -92.3 -41.54 10.32 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.778 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HD3' ' CG2' ' A' ' 34' ' ' ILE . 1.3 mmtt -86.27 -64.1 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.333 179.17 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.444 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.7 OUTLIER -46.77 -52.14 14.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.516 179.475 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.551 ' CB ' ' O ' ' A' ' 6' ' ' THR . 4.7 t80 -52.54 -55.13 24.24 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.232 179.79 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -18.72 60.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.951 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -22.11 22.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.041 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -12.26 29.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.777 179.864 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -123.64 -65.85 1.04 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.24 162.19 12.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.68 -30.79 52.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -1.143 . . . . 0.0 110.271 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.0 p -72.52 -33.22 66.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 179.678 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.9 -54.76 11.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.45 -0.781 . . . . 0.0 109.161 179.33 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.436 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 21.7 m -62.23 -20.01 63.78 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.733 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -72.16 -47.53 50.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -70.16 -25.05 63.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.595 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.534 ' CB ' HG13 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -61.86 -47.62 84.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.431 -0.793 . . . . 0.0 109.962 179.675 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.522 ' CD2' HG12 ' A' ' 50' ' ' VAL . 3.4 mt -90.4 -6.54 54.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.852 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.39 22.23 71.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.521 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 23' ' ' LEU . 3.2 t -107.93 153.07 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -1.019 . . . . 0.0 110.23 -179.683 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 12.0 m-85 -59.12 176.29 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.833 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -83.68 -10.89 57.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.005 179.761 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -83.26 -61.78 1.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.92 179.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.42 -40.59 8.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 109.714 179.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 26' ' ' TYR . 72.8 mt -65.0 -55.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.766 . . . . 0.0 109.946 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -50.33 -13.91 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.358 -0.839 . . . . 0.0 111.096 179.792 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -89.56 -37.82 14.42 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.408 -1.432 . . . . 0.0 108.869 178.809 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.439 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -80.03 -10.94 59.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.154 178.488 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.544 ' CG2' ' HD3' ' A' ' 8' ' ' LYS . 7.1 mt -108.8 -47.92 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.845 179.731 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 9.9 t-80 -65.78 -24.21 66.89 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.152 -0.967 . . . . 0.0 110.305 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -73.18 -28.52 62.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -0.945 . . . . 0.0 110.658 -179.626 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.456 ' HA2' ' CE ' ' A' ' 8' ' ' LYS . . . 92.54 47.63 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.0 172.0 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.55 -179.723 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.571 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -103.8 64.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.821 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.568 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 4.2 mm -87.83 169.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 111.036 -179.323 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 84.5 m-85 -156.88 115.73 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.215 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.515 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 6.8 mp -92.56 114.36 26.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 111.375 -178.851 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 3.9 m -90.81 102.9 15.66 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.409 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 6.6 mt -99.9 102.01 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.909 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.51 173.02 9.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 0.0 109.689 179.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -9.25 3.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.092 179.004 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 10.65 7.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.293 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.84 10.14 23.94 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t -89.62 99.63 12.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -1.224 . . . . 0.0 109.591 179.628 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.534 HG13 ' CB ' ' A' ' 22' ' ' ASP . 5.8 p -79.75 137.06 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.84 . . . . 0.0 110.549 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 8.5 m-85 -112.18 95.38 5.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 109.696 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -83.47 111.43 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' OE1' ' CG2' ' A' ' 56' D VAL . 0.1 OUTLIER -147.18 131.73 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 111.088 -179.408 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . 1.7 tt0 -79.77 134.33 36.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.178 179.098 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.468 ' HA ' ' HB ' ' A' ' 56' D VAL . 11.2 t -123.11 134.74 65.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.992 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 56' B GLY . 11.8 tptp -158.08 144.54 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' A ASP . . . . . . . . . . . . . 1.5 t70 -46.07 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 109.872 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' B GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 150.15 -48.71 0.58 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -172.47 156.15 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -1.104 . . . . 0.0 110.636 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' D VAL . . . . . 0.51 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -138.54 125.74 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.76 . . . . 0.0 109.398 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 56' E LYS . . . . . 0.494 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.6 158.84 60.57 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.572 -179.409 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 1.8 Cg_endo -87.61 74.49 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.855 1.703 . . . . 0.0 112.442 -177.814 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -42.98 128.31 3.25 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.049 -1.032 . . . . 0.0 109.162 178.519 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -88.9 93.83 0.14 OUTLIER 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.763 -1.766 . . . . 0.0 110.698 0.058 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 1.2 m -61.84 -153.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.646 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 60' ' ' SER . 8.9 m120 57.53 112.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.287 -0.883 . . . . 0.0 110.496 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 tptp -170.54 56.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 110.155 179.893 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 64' ' ' THR . 31.4 tttm -77.67 -24.74 49.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.492 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 1.5 m 69.01 -134.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.207 -0.933 . . . . 0.0 110.106 -179.866 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 t -104.71 -18.35 14.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.034 -1.041 . . . . 0.0 110.474 -179.784 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.386 -179.769 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.8 mm-40 . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 4.7 ttt180 -79.4 72.12 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.793 HG22 ' HB2' ' A' ' 10' ' ' TYR . 10.7 mm -84.86 157.73 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.382 -0.824 . . . . 0.0 109.168 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 10.9 p -65.32 -174.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 111.216 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -91.35 -35.3 14.49 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.2 tmtp? -81.78 -69.63 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.684 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -42.53 -55.57 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.563 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.793 ' HB2' HG22 ' A' ' 5' ' ' ILE . 10.1 t80 -44.0 -56.22 4.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HB1' ' OE1' ' A' ' 16' ' ' GLN . . . -54.91 -35.67 64.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.466 -0.771 . . . . 0.0 110.382 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ttp -66.8 -35.11 79.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.881 . . . . 0.0 110.586 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -78.45 -24.73 45.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.184 -0.947 . . . . 0.0 110.343 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -111.09 -77.36 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.014 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.35 158.85 19.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.465 ' OE1' ' HB1' ' A' ' 11' ' ' ALA . 2.4 tp60 -74.03 -30.62 62.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -24.23 41.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -52.15 8.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.175 -0.953 . . . . 0.0 108.758 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.47 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.5 m -58.31 -27.17 63.85 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.47 -53.81 8.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -9.19 45.44 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.774 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.87 -44.81 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.607 HD21 ' CD2' ' A' ' 42' ' ' LEU . 14.3 mt -79.57 -28.97 41.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 42.02 4.45 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 23' ' ' LEU . 1.2 t -129.96 179.44 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -1.161 . . . . 0.0 109.696 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' H ' HG12 ' A' ' 25' ' ' VAL . 93.9 m-85 -75.15 154.8 37.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.326 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -26.59 64.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 m -71.26 -50.57 31.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.905 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.58 -17.89 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.181 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -78.25 -61.3 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.699 0.761 . . . . 0.0 109.214 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.749 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -54.71 -14.28 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.664 -0.648 . . . . 0.0 110.501 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 10.6 tttt -93.57 -39.98 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.576 -1.327 . . . . 0.0 108.964 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.24 -8.66 57.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.185 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.804 HD11 HD11 ' A' ' 7' ' ' LEU . 8.3 mt -118.56 -47.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.424 -0.798 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.584 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.8 t-80 -72.95 -11.17 60.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.957 -1.089 . . . . 0.0 110.01 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -76.34 -88.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.962 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.04 46.45 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.69 -170.03 2.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.526 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 13.8 ptpt -148.64 87.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.686 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.584 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 22.8 mt -118.21 171.83 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.86 . . . . 0.0 110.739 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 28.2 m-85 -154.02 110.03 3.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.484 -0.76 . . . . 0.0 109.701 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.607 ' CD2' HD21 ' A' ' 23' ' ' LEU . 3.8 mp -86.14 128.71 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 111.327 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 51' ' ' TYR . 1.6 m -93.74 105.87 17.88 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.989 HG23 ' O ' ' A' ' 49' ' ' SER . 7.2 mt -91.61 134.22 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 110.916 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.762 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.8 m-20 -53.85 -18.66 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.66 -0.65 . . . . 0.0 110.512 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.01 -19.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -2.33 56.44 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.34 0.52 25.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.989 ' O ' HG23 ' A' ' 44' ' ' ILE . 2.1 t -72.46 -175.18 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -1.138 . . . . 0.0 110.139 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 49' ' ' SER . 19.8 t -156.11 130.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 8.0 t80 -128.0 76.16 1.67 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 109.345 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -48.54 130.29 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 110.998 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -132.81 84.94 2.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 109.758 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.523 ' CB ' HG12 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -79.0 147.12 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.333 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.58 HG13 HG12 ' A' ' 56' D VAL . 5.0 t -138.71 86.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.82 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 56' A ASP . 7.2 ttpp -97.12 91.48 5.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 110.106 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' A ASP . . . . . 0.556 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -4.38 73.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.28 0.562 . . . . 0.0 112.373 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 157.0 -23.94 0.47 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.3 tt0 -178.92 128.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.109 -1.23 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' D VAL . . . . . 0.58 HG12 HG13 ' A' ' 55' ' ' VAL . 3.6 m -100.21 129.33 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.655 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' E LYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -134.72 158.45 75.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 110.517 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 56' E LYS . 11.2 Cg_exo -72.71 -59.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.263 1.665 . . . . 0.0 110.327 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER 56.35 109.99 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 110.072 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 58' ' ' PHE . 20.2 Cg_exo -62.94 133.61 14.05 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.497 0.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 110.169 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.6 mm100 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.25 0.548 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 18.6 ttt180 -79.53 74.54 6.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 109.626 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' A' ' 10' ' ' TYR . 2.9 mt -90.87 146.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.676 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.06 -178.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.768 0.794 . . . . 0.0 111.3 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.704 ' HB3' HD12 ' A' ' 34' ' ' ILE . 13.1 tp -92.34 -49.97 5.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.918 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.16 -64.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.598 -0.688 . . . . 0.0 109.306 178.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -43.72 -53.26 5.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.108 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.635 ' HB2' HG22 ' A' ' 5' ' ' ILE . 1.9 t80 -46.46 -55.18 7.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 109.707 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.85 -37.34 42.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.612 0.72 . . . . 0.0 109.584 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -55.35 -41.14 72.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 110.415 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -38.77 54.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.52 -67.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 110.007 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 168.65 155.08 9.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.452 ' HB3' ' HG2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.29 -33.85 70.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -1.156 . . . . 0.0 109.878 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.873 HG23 ' OE1' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -85.23 -7.55 58.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.151 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -53.9 5.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -34.1 77.1 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.421 -0.8 . . . . 0.0 109.051 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.44 -23.55 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 17' ' ' THR . 2.3 mmtt -71.04 -43.79 67.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.002 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.508 ' CB ' HG21 ' A' ' 50' ' ' VAL . 3.8 m-20 -70.09 -28.79 65.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 23' ' ' LEU . 22.0 mt -79.45 -27.51 41.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 26.96 31.45 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.0 m -135.82 156.13 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.549 ' O ' HD13 ' A' ' 30' ' ' ILE . 96.1 m-85 -64.93 172.18 3.04 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 110.073 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.873 ' OE1' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER -75.72 -23.37 56.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.172 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -62.85 -46.52 87.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.844 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.69 66.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.853 . . . . 0.0 109.949 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.746 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.5 mp -67.03 -49.88 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' LYS . 25.5 m-20 -57.22 -58.94 6.02 Favored 'General case' 0 C--O 1.194 -1.833 0 O-C-N 121.358 -0.839 . . . . 0.0 110.007 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -49.76 -23.87 2.04 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 119.588 -1.945 . . . . 0.0 109.107 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 30' ' ' ILE . . . -76.7 -40.19 49.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.558 -0.714 . . . . 0.0 109.935 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.918 HD13 ' HB2' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -95.12 -40.47 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.405 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -60.69 -58.27 9.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.917 -1.115 . . . . 0.0 108.407 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.45 15.1 16.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.932 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.955 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -152.12 93.39 0.14 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 9.8 mmm-85 -86.77 168.86 13.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -1.064 . . . . 0.0 110.82 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER 71.29 66.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.303 -0.873 . . . . 0.0 110.439 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.955 HD11 ' O ' ' A' ' 37' ' ' GLY . 17.2 mt -125.45 163.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.5 m-85 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 6' ' ' THR . 4.4 mp -140.88 116.87 10.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.534 ' OG1' ' CB ' ' A' ' 51' ' ' TYR . 2.3 p -88.01 101.67 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.555 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.5 mt -94.78 124.44 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.047 -1.033 . . . . 0.0 110.314 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.561 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -85.43 -177.25 6.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -0.969 . . . . 0.0 110.26 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.36 0.16 17.79 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -101.14 -4.45 27.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.692 . . . . 0.0 110.166 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 90.84 -15.06 61.55 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.86 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -1.193 . . . . 0.0 109.589 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG21 ' CB ' ' A' ' 22' ' ' ASP . 45.7 t -80.8 105.78 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 111.063 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CB ' ' OG1' ' A' ' 43' ' ' THR . 0.2 OUTLIER -88.26 90.71 8.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 109.083 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -89.08 140.48 29.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 110.124 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 56' E LYS . 0.2 OUTLIER -152.61 136.73 16.47 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.889 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 56' D VAL . 8.7 mt-10 -98.1 111.83 24.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG23 HG12 ' A' ' 56' D VAL . 2.6 p -109.82 132.69 57.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.245 -0.91 . . . . 0.0 110.186 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 56' A ASP . 13.8 ttpp -160.24 110.41 1.82 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.677 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' A ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 38.6 t70 61.26 11.42 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.609 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' B GLY . . . . . 0.846 ' O ' HG13 ' A' ' 56' D VAL . . . 128.91 -44.92 1.18 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.455 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' C GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.8 mt-10 -60.9 98.2 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.241 -1.152 . . . . 0.0 110.93 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' D VAL . . . . . 0.846 HG13 ' O ' ' A' ' 56' B GLY . 4.8 m -107.19 61.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.833 . . . . 0.0 110.088 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' E LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -58.93 174.9 0.36 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.97 -1.081 . . . . 0.0 110.557 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.473 ' CD ' ' HB3' ' A' ' 56' E LYS . 2.0 Cg_endo -88.98 -79.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.35 2.033 . . . . 0.0 110.215 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.515 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.6 OUTLIER 59.91 122.31 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.282 -0.886 . . . . 0.0 109.865 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -77.78 128.91 17.52 Favored 'Cis proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.326 -0.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.383 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 C--O 1.216 -0.694 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 40.0 ttp180 -125.16 79.84 1.83 Allowed 'General case' 0 C--N 1.283 -2.292 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.814 HG22 ' HB2' ' A' ' 10' ' ' TYR . 24.2 mt -84.75 135.59 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.383 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -49.46 -176.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.068 0.937 . . . . 0.0 111.833 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.033 HD23 HD13 ' A' ' 40' ' ' ILE . 2.8 tp -94.4 -37.21 11.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.647 ' HB2' HG23 ' A' ' 34' ' ' ILE . 1.4 tmtt? -83.84 -65.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.278 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.523 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 8.3 m-20 -46.84 -45.58 20.31 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.814 ' HB2' HG22 ' A' ' 5' ' ' ILE . 13.3 t80 -55.4 -50.98 68.33 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.719 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -26.14 63.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.767 -0.583 . . . . 0.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -21.63 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -101.32 -6.15 24.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -77.52 0.59 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.1 143.25 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -65.1 -31.99 73.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 110.097 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -80.4 -10.82 59.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.118 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -90.97 -36.65 13.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.342 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.699 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -74.89 -26.94 60.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.288 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HA ' HD11 ' A' ' 30' ' ' ILE . . . -82.42 -39.09 23.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.813 . . . . 0.0 110.699 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.6 tmtt? -65.08 -34.68 79.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 109.956 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 7.7 m-20 -71.46 -38.38 71.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 110.023 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 19' ' ' THR . 21.1 mt -80.7 -7.59 59.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 110.407 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 35.42 90.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -134.44 175.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.22 -1.165 . . . . 0.0 109.9 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -82.36 146.19 29.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 110.378 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 1.055 ' HA ' HD12 ' A' ' 30' ' ' ILE . 2.2 mt-30 -53.35 -24.6 12.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.364 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -64.16 -57.54 9.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.93 -30.9 4.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.135 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.055 HD12 ' HA ' ' A' ' 27' ' ' GLN . 45.2 mt -70.0 -55.48 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.035 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.0 OUTLIER -59.99 -7.76 1.94 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 111.378 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -91.26 -34.45 14.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.574 -1.329 . . . . 0.0 108.266 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.76 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -86.16 -15.84 39.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.647 HG23 ' HB2' ' A' ' 8' ' ' LYS . 10.6 mt -95.46 -48.11 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.513 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 18.8 t60 -68.09 -55.9 10.81 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.229 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.11 13.44 18.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.63 83.78 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 8.0 mmm-85 -90.43 77.14 6.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.538 ' CE ' ' HB2' ' A' ' 56' ' ' LYS . 2.9 pttm 177.18 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.568 -0.708 . . . . 0.0 109.126 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.033 HD13 HD23 ' A' ' 7' ' ' LEU . 5.4 mt -103.17 161.66 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.748 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.603 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 37.6 m-85 -157.47 131.31 8.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.397 -0.814 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 7' ' ' LEU . 2.0 mp -124.54 118.3 26.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 0.0 110.353 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -89.27 102.65 15.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.064 -1.022 . . . . 0.0 109.429 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.3 mt -89.29 43.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.962 -1.086 . . . . 0.0 109.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.71 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 49.4 p-10 -105.45 -151.53 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 68.92 6.34 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.143 -0.973 . . . . 0.0 108.799 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.704 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 120.61 -53.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.47 29.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 33.6 t -78.01 156.37 30.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.541 -0.976 . . . . 0.0 110.181 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 50' ' ' VAL . 24.8 t -110.82 98.35 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 110.484 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.54 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 5.5 m-85 -96.9 89.85 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . -89.71 122.73 33.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.181 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 56' E LYS . 0.5 OUTLIER -160.21 137.49 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.937 . . . . 0.0 110.582 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.539 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.45 178.52 4.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.835 . . . . 0.0 109.673 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.676 HG22 HG12 ' A' ' 56' D VAL . 83.9 t -152.06 111.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.965 . . . . 0.0 110.462 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HB2' ' CE ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.49 122.4 41.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.094 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.0 t0 50.98 -90.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' B GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -142.52 54.87 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.5 tt0 -162.19 97.03 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.136 . . . . 0.0 110.351 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' D VAL . . . . . 0.676 HG12 HG22 ' A' ' 55' ' ' VAL . 11.1 m -92.62 165.29 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' E LYS . . . . . 0.501 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 9.5 ptpt -165.68 148.53 6.7 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.076 -1.015 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.0 Cg_exo -76.76 73.76 5.16 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.959 1.505 . . . . 0.0 111.211 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -45.62 132.93 6.39 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.846 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 79.0 Cg_endo -92.61 79.15 0.13 OUTLIER 'Cis proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.827 -1.739 . . . . 0.0 110.816 0.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.555 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 1.1 p . . . . . 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 110.645 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.233 0.539 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.646 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.22 94.77 4.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.993 0.901 . . . . 0.0 111.011 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.754 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.2 mt -90.3 -173.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.663 -0.648 . . . . 0.0 109.766 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.627 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.76 -179.09 5.43 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.288 -0.883 . . . . 0.0 111.608 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.06 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -91.4 -43.01 10.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.835 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.56 -63.79 1.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.406 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -44.25 -50.77 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.643 ' CE1' HD12 ' A' ' 5' ' ' ILE . 5.3 t80 -57.39 -51.64 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.358 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.648 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -49.03 -26.08 2.39 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 109.605 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 tpt -71.83 -52.65 16.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.036 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.94 -21.03 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.636 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.95 -75.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 109.611 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 173.5 142.58 3.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.648 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -59.42 -36.06 75.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -1.232 . . . . 0.0 109.701 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -78.72 -16.5 57.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.76 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -78.59 -51.24 10.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 0.0 109.256 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.3 m -64.7 -23.82 67.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.82 -25.82 30.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.285 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.55 -27.27 41.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.74 -27.95 26.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.846 . . . . 0.0 110.218 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.875 HD21 HD23 ' A' ' 42' ' ' LEU . 29.7 mt -80.02 -8.13 59.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' O ' HG13 ' A' ' 25' ' ' VAL . . . 68.66 29.71 72.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 24' ' ' GLY . 5.7 m -151.48 150.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 110.107 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.555 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 9.3 p90 -66.68 169.33 7.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.957 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.572 ' HA ' HD13 ' A' ' 30' ' ' ILE . 9.4 mp0 -65.3 -32.07 73.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 111.349 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.555 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -46.6 -48.37 19.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.972 -1.08 . . . . 0.0 110.773 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.44 70.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 27' ' ' GLN . 2.8 mp -72.11 -32.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.79 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 6.8 t-20 -65.88 -23.77 66.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -36.84 12.84 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.423 -1.423 . . . . 0.0 108.047 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.725 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -71.14 -14.77 62.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.017 HD11 ' HB2' ' A' ' 7' ' ' LEU . 5.7 mt -112.48 -54.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.4 t-80 -56.19 -15.63 4.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -85.23 29.14 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.755 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . 43.52 44.11 6.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.32 -172.0 3.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -1.112 . . . . 0.0 111.07 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 55' ' ' VAL . 15.3 mttt -135.02 83.87 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.539 -0.725 . . . . 0.0 109.053 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.725 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 27.0 mt -114.4 165.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 111.372 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.2 m-85 -159.67 177.51 10.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.641 . . . . 0.0 109.388 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.06 HD11 ' CD1' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.41 111.78 5.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.062 . . . . 0.0 109.706 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.497 ' CG2' ' ND2' ' A' ' 45' ' ' ASN . 9.3 m -75.53 99.42 4.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.448 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' A' ' 10' ' ' TYR . 55.7 mt -86.99 59.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 111.364 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.497 ' ND2' ' CG2' ' A' ' 43' ' ' THR . 39.7 p30 -103.4 -123.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.997 -1.064 . . . . 0.0 109.711 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.895 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 40.65 29.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.107 -0.996 . . . . 0.0 109.969 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.578 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 41.8 t0 72.78 64.35 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.384 0.612 . . . . 0.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 -12.21 41.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.895 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -59.1 159.47 7.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.955 -1.321 . . . . 0.0 109.068 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.538 HG22 HG23 ' A' ' 44' ' ' ILE . 38.2 t -127.69 127.87 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 111.19 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 30.0 m-85 -124.64 159.03 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -143.62 137.2 28.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.802 -1.186 . . . . 0.0 111.112 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 56' E LYS . 1.1 mp0 -142.56 143.91 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 110.165 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE2' ' CD1' ' A' ' 58' ' ' PHE . 1.0 OUTLIER -84.01 167.55 16.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.669 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 39' ' ' LYS . 3.0 t -139.24 128.56 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.994 -1.066 . . . . 0.0 110.216 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -146.92 170.16 17.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' A ASP . . . . . 0.504 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 60.8 t0 -40.57 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' B GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 53.31 59.12 10.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 7.6 tt0 -172.49 88.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.197 -1.178 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' D VAL . . . . . . . . . . . . . 6.2 m -97.07 140.38 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 0.0 109.952 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' E LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -119.0 172.6 4.15 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.071 -1.018 . . . . 0.0 110.69 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 58' ' ' PHE . 1.2 Cg_endo -87.6 24.94 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.354 2.036 . . . . 0.0 110.564 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.525 ' CD1' ' OE2' ' A' ' 54' ' ' GLU . 62.4 t80 -30.64 123.62 0.32 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.873 -0.517 . . . . 0.0 111.304 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.8 Cg_endo -80.17 108.03 1.16 Allowed 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.396 -1.918 . . . . 0.0 110.551 0.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.422 ' N ' ' HA ' ' A' ' 58' ' ' PHE . 2.4 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.016 -1.052 . . . . 0.0 110.063 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.293 0.568 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.76 92.18 4.78 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.131 0.967 . . . . 0.0 111.029 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.557 HG22 ' HB2' ' A' ' 10' ' ' TYR . 18.3 mt -90.74 154.86 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.983 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.673 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -50.78 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.281 1.039 . . . . 0.0 111.413 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.673 ' H ' HG22 ' A' ' 6' ' ' THR . 4.0 tp -92.91 -39.99 10.85 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HD3' HG22 ' A' ' 34' ' ' ILE . 1.1 mmmp? -90.64 -63.42 1.27 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.3 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.3 t70 -44.63 -44.89 9.29 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.7 t80 -56.46 -57.39 12.52 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.501 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.32 -21.01 4.96 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 ttm -78.43 -46.8 18.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.774 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -78.04 -10.85 59.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -69.42 0.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 133.06 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -58.86 -24.02 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.445 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 17' ' ' THR . 3.4 t -78.75 -26.8 44.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.041 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -76.35 -56.39 4.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 108.672 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -60.21 -30.75 69.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -64.2 -43.61 94.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -19.48 56.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -73.7 -26.4 60.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 30' ' ' ILE . 9.4 mt -82.93 -52.24 6.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.25 28.89 1.05 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG23 HG12 ' A' ' 30' ' ' ILE . 1.3 m -137.65 162.46 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -1.155 . . . . 0.0 110.015 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.76 -175.11 0.37 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.399 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -22.87 37.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 110.618 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' ALA . 23.5 t -74.58 -72.1 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 110.279 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.82 -27.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.307 -0.87 . . . . 0.0 109.349 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.879 HD12 HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -68.61 -61.69 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.546 -0.721 . . . . 0.0 109.566 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.751 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -46.56 -18.26 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.563 -0.711 . . . . 0.0 111.032 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -89.76 -40.86 12.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.438 -1.414 . . . . 0.0 108.588 178.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -7.04 53.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.517 -0.74 . . . . 0.0 109.136 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.879 HD11 HD12 ' A' ' 30' ' ' ILE . 15.8 mt -111.33 -54.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.636 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.57 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 67.2 t60 -61.16 -14.99 28.84 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -64.16 -9.01 14.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.629 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 34.12 60.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 153.69 31.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.55 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.544 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER -86.3 58.97 5.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.637 HD12 HD22 ' A' ' 7' ' ' LEU . 4.9 mt -93.25 167.83 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 111.093 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 68.0 m-85 -155.88 167.75 29.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 4.6 mp -142.79 105.35 4.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.835 -1.166 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 1.3 m -78.59 93.1 4.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.587 -0.695 . . . . 0.0 109.197 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 10' ' ' TYR . 27.8 mt -96.76 117.68 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.303 -0.873 . . . . 0.0 110.509 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 45' ' ' ASN . 1.1 m-20 -81.76 -173.48 4.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.266 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.66 0.34 17.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.72 0.71 52.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.122 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' SER . . . 85.16 -14.11 51.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -45.28 162.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -1.205 . . . . 0.0 109.928 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.51 ' CG2' ' OD2' ' A' ' 22' ' ' ASP . 80.9 t -138.72 114.94 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -101.04 80.39 2.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 109.382 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -80.42 89.68 5.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.701 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 56' E LYS . 27.3 tt0 -102.47 167.5 9.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.765 . . . . 0.0 109.687 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 56' D VAL . 0.8 OUTLIER -135.08 156.93 48.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.076 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.49 HG13 HG12 ' A' ' 56' D VAL . 2.4 t -141.58 105.23 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 56' A ASP . 11.3 ttpp -123.65 103.24 8.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' A ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 56' A ASP . 51.6 t0 59.09 23.77 12.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.915 . . . . 0.0 110.449 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' B GLY . . . . . 0.619 ' O ' HG13 ' A' ' 56' D VAL . . . 109.62 -36.5 4.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 42.5 mt-10 -63.04 104.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' D VAL . . . . . 0.619 HG13 ' O ' ' A' ' 56' B GLY . 34.0 m -106.4 157.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.122 -0.986 . . . . 0.0 110.46 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' E LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -174.26 167.54 2.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.962 . . . . 0.0 110.575 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.57 175.97 10.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 121.875 1.716 . . . . 0.0 110.411 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CE1' HD22 ' A' ' 23' ' ' LEU . 13.4 t80 -167.82 146.04 3.89 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 110.364 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HA ' ' CD2' ' A' ' 58' ' ' PHE . 59.1 Cg_endo -91.89 48.41 1.34 Allowed 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.115 -2.035 . . . . 0.0 110.455 0.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.235 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.422 0.629 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 9.3 ttt180 -79.18 80.11 5.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.61 HG22 ' HB2' ' A' ' 10' ' ' TYR . 2.6 mt -86.02 164.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.523 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -70.34 -178.6 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.134 0.969 . . . . 0.0 112.367 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.669 HD21 HG12 ' A' ' 34' ' ' ILE . 3.5 tp -92.55 -40.36 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.546 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.44 -65.92 0.97 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.501 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -43.42 -48.54 7.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.61 ' HB2' HG22 ' A' ' 5' ' ' ILE . 12.6 t80 -54.03 -57.32 11.48 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.829 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.6 -27.37 4.47 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 109.912 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.79 77.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -15.04 58.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.229 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.71 -87.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 179.47 48.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 2.2 tp60 -90.2 -28.66 18.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -1.096 . . . . 0.0 110.509 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 6.1 t -87.03 -24.93 24.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.242 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -73.71 -59.08 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.955 . . . . 0.0 108.75 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.1 m -60.0 -32.27 70.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.581 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . . . -76.45 -20.63 56.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.129 -0.982 . . . . 0.0 110.336 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.45 -46.93 68.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.104 -0.997 . . . . 0.0 110.912 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.08 -6.41 53.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.105 -0.997 . . . . 0.0 112.221 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.838 HD13 HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -162.72 36.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.639 -1.288 . . . . 0.0 109.882 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . -160.82 67.25 0.26 Allowed Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.254 38.3 t -75.12 -2.26 3.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.734 0.778 . . . . 0.0 109.5 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.573 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -134.32 82.54 1.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 26' ' ' TYR . 1.6 tt0 -36.14 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.617 -0.677 . . . . 0.0 111.369 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 26' ' ' TYR . 36.1 p -76.61 -55.44 5.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.977 -1.077 . . . . 0.0 109.211 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . . . -57.45 -17.79 15.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.328 -0.857 . . . . 0.0 108.901 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.728 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -74.31 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.623 -0.673 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.728 ' N ' HG22 ' A' ' 30' ' ' ILE . 1.6 m-20 -62.24 -9.63 8.45 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.52 -0.737 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 2.3 ttpt -93.25 -38.15 11.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.866 -1.146 . . . . 0.0 108.086 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.5 -8.29 59.62 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.669 HG12 HD21 ' A' ' 7' ' ' LEU . 22.7 mt -108.89 -48.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.573 -0.704 . . . . 0.0 109.585 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 18.8 t-80 -70.96 -28.65 64.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.867 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -65.46 -33.43 75.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.52 59.72 0.83 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.33 -176.02 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 26.9 tttt -117.21 71.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.557 HD12 HD22 ' A' ' 7' ' ' LEU . 10.4 mt -115.95 166.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 91.8 m-85 -149.39 173.2 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.295 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.838 HD21 HD13 ' A' ' 23' ' ' LEU . 3.6 mp -143.32 147.96 35.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.007 -1.058 . . . . 0.0 111.455 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 94.9 m -112.63 105.52 13.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.583 -0.698 . . . . 0.0 109.191 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 45' ' ' ASN . 2.5 mt -83.04 -134.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.316 -0.865 . . . . 0.0 111.164 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.549 ' H ' HG22 ' A' ' 44' ' ' ILE . 2.1 p-10 34.77 -146.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.932 -0.48 . . . . 0.0 111.497 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.655 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 56.27 23.07 6.78 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.655 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 26.8 t70 100.19 35.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 123.752 0.821 . . . . 0.0 109.28 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.62 7.25 57.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -67.63 104.28 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -1.175 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.88 125.78 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.49 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 7.8 m-85 -112.29 158.86 19.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.803 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . . . -139.34 97.01 3.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 56' E LYS . 29.1 mt-10 -111.99 126.09 54.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.808 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 56' D VAL . 1.7 mt-10 -82.04 161.61 22.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 t -142.33 121.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.463 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -147.71 142.72 27.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' A ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 15.9 t70 56.21 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.919 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' B GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -157.8 36.21 0.54 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.69 132.01 12.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -1.175 . . . . 0.0 110.182 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' D VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -101.14 169.71 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.158 -0.964 . . . . 0.0 110.557 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' E LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 3.9 mttm -145.24 175.67 2.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 6.2 Cg_exo -81.57 -163.0 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.21 1.94 . . . . 0.0 110.433 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 179.07 113.41 0.19 Allowed Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.305 -0.872 . . . . 0.0 110.329 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -77.85 108.18 1.14 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.117 -2.035 . . . . 0.0 110.734 -0.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.49 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 63.4 p . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 121.412 0.625 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -80.38 68.64 6.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 110.503 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 10' ' ' TYR . 8.6 mt -91.79 139.35 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 17.7 p -51.22 -174.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.023 -1.048 . . . . 0.0 110.943 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.878 ' HB2' HD11 ' A' ' 42' ' ' LEU . 3.6 tp -91.42 -36.48 13.77 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HG3' ' CG2' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -82.87 -68.79 0.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.725 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.456 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.2 OUTLIER -44.99 -54.2 6.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.688 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.2 t80 -47.01 -55.24 8.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.277 -0.889 . . . . 0.0 110.232 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.46 61.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.529 -0.732 . . . . 0.0 110.162 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.3 ttm -67.67 -32.79 73.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HG2' ' NH1' ' A' ' 13' ' ' ARG . 30.6 mtt-85 -83.52 -27.3 29.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.5 -65.3 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.0 141.34 3.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.63 ' OE1' HG21 ' A' ' 30' ' ' ILE . 1.0 OUTLIER -58.5 -35.79 72.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.019 -1.283 . . . . 0.0 109.998 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -79.72 -16.52 55.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.125 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.93 -57.65 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m -49.83 -34.45 19.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.85 82.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.743 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -82.06 -4.72 57.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.728 . . . . 0.0 110.041 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' CB ' HD23 ' A' ' 23' ' ' LEU . 7.7 m-20 -84.44 -38.6 19.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.013 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.992 HD12 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -116.74 14.03 15.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.18 -0.95 . . . . 0.0 110.435 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.88 37.87 91.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.992 HG21 HD12 ' A' ' 23' ' ' LEU . 22.1 t -108.88 120.79 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -1.12 . . . . 0.0 110.062 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -45.72 166.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.492 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -71.51 -27.71 63.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.154 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 30' ' ' ILE . 29.3 t -70.66 -61.61 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.724 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -45.32 -26.18 0.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.153 -0.967 . . . . 0.0 109.114 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.77 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -66.06 -66.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.582 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.77 ' N ' HG22 ' A' ' 30' ' ' ILE . 71.0 m-80 -61.67 -7.25 3.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.545 -0.722 . . . . 0.0 110.468 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -35.93 15.22 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.863 -1.148 . . . . 0.0 108.116 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.98 -10.95 51.93 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.688 ' HA ' HD11 ' A' ' 40' ' ' ILE . 35.0 mt -103.66 -43.35 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 52.1 t-80 -74.93 -56.31 4.88 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.901 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.62 -4.17 55.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.955 . . . . 0.0 111.118 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -123.53 69.06 0.46 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.213 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -65.07 -170.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.243 . . . . 0.0 110.266 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 55.15 68.9 0.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 108.872 -179.059 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.755 HD13 HD23 ' A' ' 7' ' ' LEU . 2.8 mt -120.26 151.01 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.87 . . . . 0.0 110.444 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 90.5 m-85 -158.82 128.0 5.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.651 -0.656 . . . . 0.0 110.203 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -120.95 133.59 55.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 m -108.04 100.76 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.939 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.773 HG22 ' H ' ' A' ' 45' ' ' ASN . 5.8 mt -82.05 -173.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.898 . . . . 0.0 110.025 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.773 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.5 OUTLIER 82.7 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.248 0.547 . . . . 0.0 111.927 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.688 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 64.33 17.66 10.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 30.2 t70 110.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.948 0.899 . . . . 0.0 109.067 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.51 79.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -70.85 109.1 4.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.839 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.442 HG11 HD22 ' A' ' 23' ' ' LEU . 25.3 t -79.5 109.53 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 110.23 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 5.9 m-85 -95.21 143.94 26.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 108.937 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -127.21 86.86 2.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.113 . . . . 0.0 110.916 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.31 151.66 20.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.857 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.507 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -130.9 160.1 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 110.168 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 56' D VAL . 23.3 t -150.24 84.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.416 -0.802 . . . . 0.0 109.9 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 56' A ASP . 5.2 ttmt -94.16 101.76 13.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.141 -0.975 . . . . 0.0 109.609 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' A ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 56' ' ' LYS . 38.4 t70 -13.61 80.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.378 0.608 . . . . 0.0 112.049 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' B GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.08 -27.44 0.8 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.81 132.42 0.12 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.018 -1.284 . . . . 0.0 110.807 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' D VAL . . . . . 0.587 HG12 HG13 ' A' ' 55' ' ' VAL . 12.5 m -96.98 165.89 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' E LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 56' D VAL . 10.6 ptpt -175.53 171.8 1.15 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.847 -1.158 . . . . 0.0 110.813 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 60' ' ' SER . 3.7 Cg_exo -76.83 -173.18 1.65 Allowed 'Trans proline' 0 C--N 1.299 -2.078 0 O-C-N 124.53 1.805 . . . . 0.0 110.485 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 39.0 t80 178.91 114.79 0.19 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 110.865 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -79.5 107.13 0.99 Allowed 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.372 -1.928 . . . . 0.0 109.886 -0.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.474 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 12.5 p . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.508 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 . . . . . 0 C--O 1.214 -0.764 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -126.55 90.48 3.18 Favored 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.617 -0.677 . . . . 0.0 109.455 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.745 HG22 ' HB2' ' A' ' 10' ' ' TYR . 1.1 mt -90.28 151.57 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.612 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 3.0 p -84.31 -166.16 1.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.767 0.794 . . . . 0.0 111.376 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.06 -28.41 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.51 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -81.65 -82.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.816 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.1 m-20 -41.69 -56.03 2.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.456 -0.778 . . . . 0.0 110.058 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.745 ' HB2' HG22 ' A' ' 5' ' ' ILE . 1.4 t80 -49.6 -50.63 41.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.409 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 7' ' ' LEU . . . -56.29 -32.49 64.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 110.37 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -36.56 84.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.313 -0.867 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -38.07 44.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.132 -0.98 . . . . 0.0 110.147 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -99.23 -80.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.996 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.59 44.19 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 14.3 mm100 -88.72 -31.03 18.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.242 -1.151 . . . . 0.0 110.053 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.8 m -83.18 -26.13 31.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -56.55 4.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 108.797 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 2.1 m -55.55 -30.64 61.13 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -64.0 -55.86 19.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.896 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -84.66 11.58 8.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.461 -0.774 . . . . 0.0 109.787 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 3.0 m-20 -90.23 -43.28 10.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.416 -0.802 . . . . 0.0 110.58 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.961 HD11 ' CG2' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -94.63 -22.25 18.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.504 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 115.75 58.19 0.34 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.961 ' CG2' HD11 ' A' ' 23' ' ' LEU . 3.1 t -152.53 161.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.269 . . . . 0.0 110.166 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -77.8 177.6 8.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.499 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.5 OUTLIER -72.04 -50.13 30.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 110.272 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.5 p -62.3 -60.32 3.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.59 -29.47 0.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.964 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.743 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -65.8 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.603 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.743 ' N ' HG22 ' A' ' 30' ' ' ILE . 2.7 m-20 -57.13 -7.45 0.52 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.473 -0.767 . . . . 0.0 111.208 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 -41.87 15.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.73 -1.231 . . . . 0.0 107.762 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' ALA . . . -70.44 -45.28 66.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 7' ' ' LEU . 10.5 mt -66.54 -46.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -42.87 -36.58 1.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.634 178.659 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 33' ' ' ALA . . . -67.91 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.758 -0.589 . . . . 0.0 109.727 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . 129.14 -16.24 5.77 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.337 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.697 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -39.97 81.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' GLY . 6.6 ptpt 9.69 69.06 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.512 0.672 . . . . 0.0 112.736 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.829 ' CG2' HD21 ' A' ' 7' ' ' LEU . 29.5 mt -80.77 167.48 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 109.126 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 40' ' ' ILE . 27.6 m-85 -158.29 150.55 21.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.877 -1.14 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 7' ' ' LEU . 4.5 mp -138.97 122.05 16.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.807 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.587 ' O ' ' CG2' ' A' ' 43' ' ' THR . 1.0 OUTLIER -102.27 109.48 21.16 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.475 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.023 HG23 ' O ' ' A' ' 49' ' ' SER . 2.0 mt -98.48 152.23 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 110.126 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.454 ' ND2' ' HA3' ' A' ' 48' ' ' GLY . 2.9 m-20 -136.09 -171.81 2.97 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.999 -1.063 . . . . 0.0 110.391 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.76 -4.22 30.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -156.67 16.91 0.31 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -93.4 -6.19 62.92 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.351 -1.899 . . . . 0.0 108.351 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.023 ' O ' HG23 ' A' ' 44' ' ' ILE . 72.1 m 54.24 -92.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' SER . 8.4 t -161.21 98.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.28 -0.888 . . . . 0.0 110.475 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 24.1 t80 -86.8 138.18 31.8 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.607 ' HB1' ' HD2' ' A' ' 58' ' ' PHE . . . -120.8 93.92 4.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.543 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 17.2 pt-20 -111.41 137.45 49.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 110.369 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -89.47 162.84 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.28 -0.888 . . . . 0.0 108.963 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 6.1 t -135.77 143.41 36.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.892 -1.13 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 56' B GLY . 2.6 tppt? -159.96 169.54 23.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 109.35 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' A ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 56' ' ' LYS . 36.9 t70 -29.57 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.379 0.609 . . . . 0.0 111.232 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' B GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 46.71 61.6 4.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.21 99.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.123 -1.222 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' D VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 56' E LYS . 16.5 m -107.17 153.41 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.132 -0.98 . . . . 0.0 109.681 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' E LYS . . . . . 0.506 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -144.03 175.7 2.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 110.604 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -87.79 -174.21 1.16 Allowed 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.092 1.862 . . . . 0.0 109.611 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.607 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 28.5 t80 174.39 113.78 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 110.434 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -80.06 110.7 1.98 Allowed 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.513 -1.87 . . . . 0.0 110.325 -0.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 16.3 m . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.538 -0.726 . . . . 0.0 110.867 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' THR . 30.1 mm-40 . . . . . 0 C--O 1.214 -0.786 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . 0.255 0.3 OUTLIER -89.53 66.89 7.45 Favored 'General case' 0 C--N 1.282 -2.364 0 O-C-N 121.559 -0.713 . . . . 0.0 109.348 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.76 HG22 ' HB2' ' A' ' 10' ' ' TYR . 22.0 mt -87.24 155.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.221 -0.924 . . . . 0.0 111.242 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.682 HG22 ' H ' ' A' ' 7' ' ' LEU . 1.1 m -65.99 -173.37 0.18 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.149 0.976 . . . . 0.0 111.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.854 HD22 HD12 ' A' ' 40' ' ' ILE . 3.3 tp -93.23 -39.32 11.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.535 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.7 tmtm? -90.22 -61.81 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.113 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.501 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 52.2 t0 -46.42 -44.99 17.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.915 . . . . 0.0 108.641 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.76 ' HB2' HG22 ' A' ' 5' ' ' ILE . 3.0 t80 -55.52 -58.56 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.49 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.04 -14.6 17.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.457 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 tpt -90.52 -24.41 20.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 0.0 110.182 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.73 -21.0 21.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -107.22 -55.41 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.31 140.89 3.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -59.91 -35.68 75.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -11.29 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.486 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -52.47 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.76 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.723 ' O ' HD12 ' A' ' 23' ' ' LEU . 3.0 m -60.66 -34.56 74.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.533 ' CB ' ' HG3' ' A' ' 27' ' ' GLN . . . -78.43 -19.66 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -79.78 -51.08 9.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.493 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 57.0 p30 -70.86 -18.13 62.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 19' ' ' THR . 29.2 mt -79.81 -31.98 40.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 34.5 22.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.35 169.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.231 -1.159 . . . . 0.0 110.03 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.634 ' O ' HD12 ' A' ' 30' ' ' ILE . 12.8 m-85 -72.2 145.74 47.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.493 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.533 ' HG3' ' CB ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -66.2 -16.77 64.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' ALA . 20.2 m -71.1 -61.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.06 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -41.2 -36.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.606 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 26' ' ' TYR . 1.3 mp -68.1 -55.11 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.308 -0.87 . . . . 0.0 110.528 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.4 OUTLIER -54.21 -13.65 0.91 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -92.5 -38.86 11.71 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.563 -1.336 . . . . 0.0 108.253 178.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -10.89 59.75 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.669 HG12 HD21 ' A' ' 7' ' ' LEU . 16.5 mt -111.52 -51.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.0 110.0 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -60.49 -19.72 57.74 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.464 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -66.69 -84.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 109.883 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.63 38.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 152.28 20.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -1.119 . . . . 0.0 110.889 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -100.51 69.03 1.4 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.825 . . . . 0.0 109.512 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.854 HD12 HD22 ' A' ' 7' ' ' LEU . 15.5 mt -89.64 164.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.864 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 71.7 m-85 -144.62 163.98 32.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 3.2 mp -144.35 141.55 29.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 110.692 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 2.8 m -118.76 102.96 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.785 . . . . 0.0 109.395 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.028 HG23 ' O ' ' A' ' 49' ' ' SER . 19.3 mt -118.89 100.01 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 111.167 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -107.81 -167.09 1.21 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.826 -1.171 . . . . 0.0 110.525 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.89 -2.23 7.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -144.69 7.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.616 -0.678 . . . . 0.0 109.401 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -91.07 -7.83 65.41 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.028 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 47.81 -92.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 49' ' ' SER . 2.4 t -161.57 95.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.146 -0.971 . . . . 0.0 109.963 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -100.11 134.78 42.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.608 -0.682 . . . . 0.0 109.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 58' ' ' PHE . . . -121.84 130.5 53.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -137.32 104.66 5.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.96 . . . . 0.0 110.692 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -79.36 150.82 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.373 -0.83 . . . . 0.0 109.868 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.34 132.17 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -153.51 151.38 29.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -40.68 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.206 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' B GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.32 -65.84 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -171.91 -179.56 2.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -1.051 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' D VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -100.48 149.09 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.172 -0.955 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' E LYS . . . . . 0.538 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -122.99 179.4 1.03 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.538 ' CD ' ' HB3' ' A' ' 56' E LYS . 5.6 Cg_endo -90.62 -170.94 0.4 Allowed 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.014 1.809 . . . . 0.0 110.269 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 40.5 t80 176.49 109.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.207 -0.933 . . . . 0.0 111.03 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.0 OUTLIER -81.68 99.33 0.26 Allowed 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.843 -1.732 . . . . 0.0 109.682 -0.675 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.534 ' CA ' ' HB2' ' A' ' 57' ' ' PRO . 13.7 m . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.856 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 43' ' ' THR . 5.2 mm-40 . . . . . 0 C--O 1.213 -0.857 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.94 75.8 0.94 Allowed 'General case' 0 C--N 1.281 -2.387 0 O-C-N 121.764 -0.585 . . . . 0.0 109.92 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.555 HG22 ' HB2' ' A' ' 10' ' ' TYR . 1.5 mt -90.67 148.51 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.735 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.589 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 1.3 p -90.95 169.23 11.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 112.296 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.915 HD11 HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -61.5 -25.88 67.55 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.738 ' HG2' HG23 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -81.43 -83.43 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.489 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 8' ' ' LYS . 75.7 m-20 -41.05 -54.6 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.971 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.589 ' CB ' ' O ' ' A' ' 6' ' ' THR . 43.7 t80 -51.12 -58.27 6.56 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -53.66 -23.36 11.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.522 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -34.19 52.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.635 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -91.67 -12.85 32.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -123.46 -49.95 1.89 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.276 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.18 134.81 2.86 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.413 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -60.9 -32.22 71.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.211 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -84.06 -11.45 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 110.192 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -51.94 7.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.204 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.493 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -65.6 -31.61 72.74 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.425 -0.797 . . . . 0.0 108.893 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.637 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -75.68 -26.29 57.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.607 -0.683 . . . . 0.0 109.773 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -27.98 61.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -82.94 -27.55 30.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 110.305 -179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HG ' ' OD1' ' A' ' 22' ' ' ASP . 25.9 mt -80.66 -10.8 59.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.965 . . . . 0.0 110.103 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 48.08 75.29 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 23' ' ' LEU . 1.5 t -141.22 153.1 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.343 -1.092 . . . . 0.0 110.033 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.814 ' O ' HD12 ' A' ' 30' ' ' ILE . 31.8 m-85 -66.75 157.55 32.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.122 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -64.65 -11.66 37.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.26 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.9 t -75.96 -62.31 1.64 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.87 -35.91 4.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.234 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.814 HD12 ' O ' ' A' ' 26' ' ' TYR . 3.7 mt -74.77 -48.15 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -55.11 -13.65 1.3 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.753 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -93.32 -38.94 11.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 108.385 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.32 -7.66 57.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.738 HG23 ' HG2' ' A' ' 8' ' ' LYS . 13.1 mt -110.89 -53.35 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.566 -0.709 . . . . 0.0 109.495 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.549 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 83.7 t60 -52.5 -31.3 34.53 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.196 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.17 -43.0 13.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.461 -0.774 . . . . 0.0 109.659 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.52 55.75 16.46 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HD2' ' H ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -85.14 39.86 0.79 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.189 -1.183 . . . . 0.0 111.153 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.5 OUTLIER 72.74 101.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.383 -0.823 . . . . 0.0 111.176 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.708 ' CG2' HD21 ' A' ' 7' ' ' LEU . 6.6 mt -145.61 159.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 99.4 m-85 -154.08 160.86 42.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.918 -1.114 . . . . 0.0 111.218 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.915 HD21 HD11 ' A' ' 7' ' ' LEU . 4.7 mp -143.47 114.72 7.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.53 -0.731 . . . . 0.0 110.3 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 54.0 m -89.28 100.62 13.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.844 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.722 ' CD1' HG22 ' A' ' 50' ' ' VAL . 3.7 mm -79.91 74.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 0.0 110.21 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.468 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 3.3 p30 -44.31 167.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 110.397 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -8.97 2.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -78.6 7.0 7.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.02 11.95 46.99 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.417 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 42.6 m -84.7 -173.06 4.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -1.165 . . . . 0.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 44' ' ' ILE . 70.8 t -138.42 101.34 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.062 -1.024 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -78.71 77.87 5.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.016 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.46 86.05 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 110.537 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 56' E LYS . 37.1 mt-10 -102.41 108.0 19.18 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' O ' ' CB ' ' A' ' 56' D VAL . 0.0 OUTLIER -79.52 176.01 10.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.39 -0.819 . . . . 0.0 109.705 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -142.31 110.49 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.859 . . . . 0.0 110.364 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 27.2 ttmt -128.92 154.64 46.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' A ASP . . . . . . . . . . . . . 48.0 m-20 -47.83 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 146.55 -52.14 0.57 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.95 168.97 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' D VAL . . . . . 0.453 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 27.0 m -81.98 -177.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' E LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.8 mttm -148.54 172.07 5.6 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.248 -0.908 . . . . 0.0 110.389 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.484 ' HG2' ' HA ' ' A' ' 60' ' ' SER . 1.6 Cg_endo -85.45 -47.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.947 1.764 . . . . 0.0 110.27 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 56.31 95.82 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.249 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 6.4 Cg_exo -70.1 157.21 93.24 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.835 -2.152 . . . . 0.0 110.284 0.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.7 m . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 110.281 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.154 0.502 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -82.95 66.82 8.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.672 HG23 ' HB2' ' A' ' 10' ' ' TYR . 4.8 tp -87.13 173.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 41' ' ' PHE . 5.1 p -77.29 -172.7 2.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.296 1.045 . . . . 0.0 111.108 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.857 HD22 HD12 ' A' ' 40' ' ' ILE . 1.4 tp -90.2 -34.65 15.73 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -85.37 -69.78 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.621 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -41.66 -49.17 4.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.247 -0.908 . . . . 0.0 109.111 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.71 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.6 t80 -50.15 -59.61 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.583 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -48.09 -31.07 5.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 109.449 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.438 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.71 -53.47 55.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.627 -0.67 . . . . 0.0 109.813 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -59.31 -31.19 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.789 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CD2' ' HE3' ' A' ' 18' ' ' LYS . 5.0 m-85 -106.76 -81.06 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.253 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 162.87 -176.46 39.15 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.418 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.5 OUTLIER -85.14 -27.5 26.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.096 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 m -85.88 -16.37 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HE3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -89.59 -39.92 12.94 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.288 -0.883 . . . . 0.0 108.969 179.143 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.5 m -71.68 -26.32 62.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.552 -0.718 . . . . 0.0 109.266 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.643 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -83.7 -39.21 20.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 110.443 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -62.74 -32.39 73.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.728 ' OD1' HG21 ' A' ' 50' ' ' VAL . 1.3 t0 -80.67 -31.53 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.041 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.9 mt -89.19 -7.87 54.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.394 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.14 49.79 50.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -133.43 147.48 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -1.195 . . . . 0.0 109.937 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -59.39 163.54 3.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.262 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -26.11 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 t -83.47 -51.48 7.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.878 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -47.99 -23.74 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.79 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -81.01 -68.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.774 . . . . 0.0 109.726 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.79 ' N ' HG22 ' A' ' 30' ' ' ILE . 2.1 m-20 -52.39 -13.69 0.39 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 111.235 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.39 -43.77 9.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.511 -1.368 . . . . 0.0 108.683 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -76.06 -6.96 53.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.534 -0.729 . . . . 0.0 109.053 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.855 HG12 HD21 ' A' ' 7' ' ' LEU . 19.0 mt -111.85 -50.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 0.0 109.998 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.5 t60 -59.15 -23.67 62.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.12 -0.988 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.429 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.3 49.43 0.36 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.696 ' HG3' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.6 123.3 28.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -1.071 . . . . 0.0 110.299 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 55' ' ' VAL . 6.5 ptpp? -86.69 59.99 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.857 HD12 HD22 ' A' ' 7' ' ' LEU . 43.9 mt -96.94 169.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.579 0.704 . . . . 0.0 111.033 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 55.9 m-85 -149.79 110.13 4.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.786 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.9 mp -85.08 135.65 33.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.2 m -101.34 104.3 15.28 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.717 HG23 ' O ' ' A' ' 49' ' ' SER . 53.8 mt -93.56 44.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.073 -1.017 . . . . 0.0 111.246 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 46' ' ' ALA . 38.4 p30 -87.58 -127.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.94 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.78 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 43.28 27.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.955 -1.09 . . . . 0.0 109.81 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.557 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 73.69 69.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.313 0.578 . . . . 0.0 111.797 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.28 0.23 35.95 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.78 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 1.1 p -58.76 -165.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.283 . . . . 0.0 110.369 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.728 HG21 ' OD1' ' A' ' 22' ' ' ASP . 14.1 t -146.28 124.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -135.49 164.09 28.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.32 -0.863 . . . . 0.0 109.989 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -141.8 132.43 25.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.462 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' E LYS . 39.1 tt0 -159.76 116.07 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 110.003 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HB3' HG12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -95.5 178.45 5.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.605 -179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.499 ' O ' ' HD3' ' A' ' 39' ' ' LYS . 6.2 t -140.16 107.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.464 -0.772 . . . . 0.0 109.621 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.01 155.02 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 110.582 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' A ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.24 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 137.71 -53.46 0.73 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.0 171.53 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 110.268 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' D VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 56' E LYS . 28.0 m -94.17 164.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' E LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 56' D VAL . 6.8 mtpt -142.39 168.59 13.0 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -83.61 -173.61 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 121.897 1.731 . . . . 0.0 109.947 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 85.3 t80 179.24 124.77 0.22 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.232 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.9 Cg_endo -87.33 100.2 0.25 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.745 -1.773 . . . . 0.0 110.311 -0.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 53.4 p . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 110.933 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.498 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 50.2 mm-40 . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.417 0.627 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 2.9 ttp180 -78.57 79.72 4.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.44 -0.788 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.657 HG22 ' HB2' ' A' ' 10' ' ' TYR . 69.1 mt -89.56 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.854 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -48.91 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.439 1.114 . . . . 0.0 111.94 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.744 ' HG ' HD11 ' A' ' 34' ' ' ILE . 2.0 tp -94.01 -38.17 11.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HB2' HD13 ' A' ' 34' ' ' ILE . 11.7 tmtt? -90.28 -56.67 3.12 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.386 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 25.7 t70 -50.89 -42.01 58.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.657 ' HB2' HG22 ' A' ' 5' ' ' ILE . 14.6 t80 -58.17 -61.27 2.68 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.793 0.806 . . . . 0.0 109.887 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.661 ' HB2' ' OG1' ' A' ' 19' ' ' THR . . . -56.3 -18.03 9.45 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.396 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -38.99 50.42 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -52.45 -42.84 64.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.555 -0.715 . . . . 0.0 109.173 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -114.46 -99.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.265 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.65 155.12 20.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.509 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -75.99 -28.2 57.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 110.266 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -74.97 -12.33 60.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -81.32 -58.19 3.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.219 -0.926 . . . . 0.0 108.617 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.661 ' OG1' ' HB2' ' A' ' 11' ' ' ALA . 15.5 m -50.68 -34.18 25.55 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.39 -38.62 55.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 110.898 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -35.01 79.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 110.327 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.7 -50.14 65.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.8 mt -80.66 -7.63 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.78 38.13 95.2 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 26' ' ' TYR . 3.0 t -112.88 178.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.087 -1.243 . . . . 0.0 109.917 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.575 ' O ' HD12 ' A' ' 30' ' ' ILE . 90.9 m-85 -100.65 141.03 34.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.193 -0.942 . . . . 0.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -46.95 -23.19 0.41 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t -72.38 -51.71 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.487 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.46 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -54.25 -26.13 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.066 -1.021 . . . . 0.0 110.053 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.668 HG23 HD12 ' A' ' 34' ' ' ILE . 1.3 mp -76.46 -55.8 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 2.6 m-80 -57.88 -14.12 5.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 110.545 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -94.56 -48.38 6.12 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.733 -1.229 . . . . 0.0 108.832 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -72.31 -3.1 21.84 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.132 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.744 HD11 ' HG ' ' A' ' 7' ' ' LEU . 9.5 mt -120.06 -49.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.272 -0.892 . . . . 0.0 110.547 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.566 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t60 -69.48 -7.75 40.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.967 -1.083 . . . . 0.0 110.098 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -77.96 -28.71 49.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.123 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.54 31.28 1.84 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -90.53 -176.97 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 82.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.273 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.616 HD12 ' CD2' ' A' ' 7' ' ' LEU . 4.1 mt -102.95 160.26 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 41.0 m-85 -153.35 160.71 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.078 -1.014 . . . . 0.0 110.529 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 3.7 mp -134.82 155.45 50.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 110.534 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 20.6 m -127.8 105.29 8.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 109.618 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.664 HG22 ' H ' ' A' ' 45' ' ' ASN . 0.7 OUTLIER -84.93 -148.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.087 -1.008 . . . . 0.0 110.974 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.664 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 38.37 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.252 0.549 . . . . 0.0 110.628 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.658 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 62.01 12.02 4.65 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.658 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 3.8 t70 135.47 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 124.147 0.979 . . . . 0.0 109.325 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.85 11.59 81.25 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -83.23 121.74 27.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.998 . . . . 0.0 110.232 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.2 118.4 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 110.375 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 3.7 m-85 -98.39 155.85 17.03 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.928 . . . . 0.0 108.541 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -142.31 86.74 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 110.419 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -101.56 -177.12 3.34 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 110.192 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 56' E LYS . 0.3 OUTLIER -152.67 173.48 15.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.272 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.442 HG22 HG12 ' A' ' 56' D VAL . 86.7 t -142.95 151.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.987 -1.07 . . . . 0.0 110.515 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 158.41 30.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.5 t0 -57.55 -11.62 2.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.08 -1.013 . . . . 0.0 110.633 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' B GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 56' C GLU . . . -100.83 -38.62 3.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' C GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' B GLY . 0.6 OUTLIER 174.58 179.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 110.288 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' D VAL . . . . . 0.442 HG12 HG22 ' A' ' 55' ' ' VAL . 35.6 m -102.64 148.16 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.288 -0.882 . . . . 0.0 109.862 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' E LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -144.58 166.7 17.41 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 0.0 110.474 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.8 Cg_exo -80.81 179.79 5.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.457 1.767 . . . . 0.0 110.287 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 3.1 t80 -159.99 125.61 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.003 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 71.2 Cg_endo -88.82 47.78 1.05 Allowed 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.802 -1.749 . . . . 0.0 110.87 0.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 110.49 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 8.4 ttm180 -76.97 83.05 3.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.692 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.659 HG21 ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -77.43 -174.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.547 -0.721 . . . . 0.0 109.721 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.83 -178.78 5.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 111.45 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.929 HD21 HG12 ' A' ' 34' ' ' ILE . 9.4 tp -92.33 -46.14 7.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.58 -65.71 0.99 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.881 -0.512 . . . . 0.0 110.07 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.489 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 10.3 t70 -45.03 -46.92 11.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 108.89 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.659 ' CG ' HG21 ' A' ' 5' ' ' ILE . 8.6 t80 -53.59 -62.44 1.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.779 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -51.82 -20.73 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.501 -0.749 . . . . 0.0 109.722 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.9 ttm -72.62 -49.6 30.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.65 76.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.091 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.59 -83.13 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 110.356 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.58 150.05 12.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -31.0 69.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -1.172 . . . . 0.0 110.087 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 t -83.75 -14.61 51.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -82.43 -52.94 6.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.779 HG21 ' HB2' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -61.8 -31.39 71.61 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -47.1 55.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.657 -0.652 . . . . 0.0 110.02 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -69.72 -17.0 63.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.531 -0.731 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 50' ' ' VAL . 1.3 m-20 -79.79 -34.86 39.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.173 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.66 HD11 HD21 ' A' ' 42' ' ' LEU . 7.0 mt -80.75 -25.77 37.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 110.144 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 86.34 63.88 1.48 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.465 ' CG2' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -154.04 147.45 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.225 -1.162 . . . . 0.0 109.766 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -47.56 167.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 110.136 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -87.62 -19.07 28.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.373 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 m -79.63 -63.57 1.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.091 -1.006 . . . . 0.0 109.94 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.48 -24.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.986 . . . . 0.0 109.262 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -68.45 -62.34 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.749 ' N ' HG22 ' A' ' 30' ' ' ILE . 3.9 t-20 -55.76 -13.55 1.79 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.601 -0.687 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -93.96 -34.43 13.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 108.408 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.86 -8.15 59.66 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.929 HG12 HD21 ' A' ' 7' ' ' LEU . 21.9 mt -113.66 -49.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.753 . . . . 0.0 109.747 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 50.2 t-80 -60.22 -39.79 87.86 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.741 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.64 -23.95 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.61 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.46 31.18 8.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -59.04 -177.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.116 . . . . 0.0 110.498 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -128.47 76.08 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.933 HG23 ' HG3' ' A' ' 54' ' ' GLU . 5.7 mt -113.16 167.73 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 111.047 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 79.3 m-85 -147.4 122.99 10.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.7 mp -90.84 142.41 27.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.978 -1.076 . . . . 0.0 111.56 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 1.2 m -110.15 103.88 12.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 49' ' ' SER . 56.5 mt -84.15 60.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.832 -1.167 . . . . 0.0 111.51 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 16.7 p-10 -88.48 -146.16 0.15 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.836 -1.165 . . . . 0.0 110.28 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 49' ' ' SER . . . 56.2 14.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.459 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 26.4 t70 88.98 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 123.164 0.585 . . . . 0.0 110.115 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.07 14.48 0.57 Allowed Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.048 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.659 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 8.1 t -84.65 159.29 20.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.898 -1.354 . . . . 0.0 109.62 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.439 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 21.7 t -112.46 122.18 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 0.0 110.83 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -113.12 -171.09 1.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.853 . . . . 0.0 109.627 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -146.53 154.24 41.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 56' E LYS . 0.0 OUTLIER -159.49 106.75 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 110.091 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.933 ' HG3' HG23 ' A' ' 40' ' ' ILE . 5.6 mt-10 -83.57 165.5 19.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.504 HG13 HG12 ' A' ' 56' D VAL . 16.7 t -144.97 129.23 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.088 -1.008 . . . . 0.0 110.46 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 56' A ASP . 5.4 ttpp -146.83 94.53 2.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' A ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 65.1 t0 61.06 41.38 13.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.54 -0.725 . . . . 0.0 110.505 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 86.99 -11.15 65.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.9 tt0 -89.42 87.18 6.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' D VAL . . . . . 0.504 HG12 HG13 ' A' ' 55' ' ' VAL . 4.9 m -94.23 170.77 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.224 -0.923 . . . . 0.0 110.234 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' E LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -173.0 170.51 2.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 0.0 110.518 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 5.8 Cg_exo -80.53 166.39 19.88 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.474 1.776 . . . . 0.0 110.288 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.625 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 15.8 t80 -169.84 117.71 0.53 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 4.9 Cg_endo -84.04 100.89 0.32 Allowed 'Cis proline' 0 C--N 1.316 -1.165 0 C-N-CA 122.758 -1.767 . . . . 0.0 110.285 -0.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 97.6 p . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 110.053 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.501 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 8.4 mm-40 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.308 0.575 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -83.88 65.16 8.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.968 HG22 ' HB2' ' A' ' 10' ' ' TYR . 30.6 mm -90.74 135.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.7 p -46.96 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.202 1.001 . . . . 0.0 111.254 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.698 ' HB3' HG21 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -91.81 -34.8 14.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.344 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -82.74 -69.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.844 -0.535 . . . . 0.0 110.174 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -44.39 -45.9 9.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 109.246 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.968 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.6 t80 -49.14 -59.47 3.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -46.81 -30.9 2.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 110.17 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -46.06 70.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -25.57 63.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 0.0 110.423 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -111.97 -64.34 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.309 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 155.58 160.44 9.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -75.07 -32.33 61.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -1.206 . . . . 0.0 109.903 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -9.67 59.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.751 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.61 -41.3 12.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.142 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 m -70.01 -24.53 63.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.517 -0.739 . . . . 0.0 109.615 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.67 20.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 0.0 110.393 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -75.99 -16.11 60.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' HB3' HG21 ' A' ' 50' ' ' VAL . 36.5 m-20 -90.6 -44.35 9.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.499 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.6 HD22 ' HD3' ' A' ' 59' ' ' PRO . 25.3 mt -79.65 -31.06 41.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 110.322 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.36 16.03 36.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -116.02 147.71 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 109.938 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -64.62 153.08 40.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.612 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.477 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 2.5 mt-30 -47.97 -25.97 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.341 -0.85 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.0 -54.59 31.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.761 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . . . -46.08 -36.06 5.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.788 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.627 HG23 HD11 ' A' ' 34' ' ' ILE . 1.4 mp -63.24 -47.67 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 109.868 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 35.8 m120 -66.35 -6.44 14.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -88.57 -44.02 10.95 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.722 -1.236 . . . . 0.0 108.982 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -72.66 -28.08 62.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.674 HG13 HD21 ' A' ' 7' ' ' LEU . 49.3 mt -87.2 -51.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.477 -0.765 . . . . 0.0 109.91 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 20.5 t60 -68.46 -4.69 15.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.838 -1.164 . . . . 0.0 110.492 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -90.68 -59.37 2.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.032 -1.042 . . . . 0.0 111.411 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . -155.18 99.29 0.19 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.589 ' HE ' HG22 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -51.47 -164.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.868 -0.784 . . . . 0.0 111.523 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 1.1 tttt 73.03 48.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.698 HG21 ' HB3' ' A' ' 7' ' ' LEU . 17.0 mt -97.06 166.48 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.316 0.579 . . . . 0.0 110.316 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.6 m-85 -158.54 117.42 3.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -110.36 132.96 53.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.721 ' HG1' ' HD2' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -97.91 100.56 11.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 44' ' ' ILE . 57.2 mt -84.39 55.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.707 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 46' ' ' ALA . 24.0 p30 -104.74 -122.08 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.059 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.939 ' HB3' ' HB2' ' A' ' 49' ' ' SER . . . 42.48 30.42 0.21 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.975 -1.078 . . . . 0.0 109.839 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.7 t70 80.95 50.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.553 0.692 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 82.11 -9.53 56.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.939 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 7.2 m -52.7 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.041 -1.27 . . . . 0.0 109.747 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 22' ' ' ASP . 46.0 t -131.28 116.75 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.721 ' HD2' ' HG1' ' A' ' 43' ' ' THR . 5.5 t80 -120.55 140.48 51.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -96.1 150.97 19.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.033 -1.042 . . . . 0.0 110.07 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -159.73 85.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 110.138 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 56' D VAL . 6.0 mt-10 -84.69 169.65 14.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.093 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' A' ' 56' D VAL . 1.5 p -161.39 148.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.117 -0.99 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -157.4 112.95 2.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 110.235 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' A ASP . . . . . . . . . . . . . 31.4 t70 45.77 49.0 11.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.873 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 78.1 35.52 34.19 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 20.2 tt0 -137.85 84.16 2.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -1.169 . . . . 0.0 109.887 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' D VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 3.2 m -96.39 153.98 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.168 -0.957 . . . . 0.0 111.015 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' E LYS . . . . . . . . . . . . . 3.4 pttt -148.13 168.67 10.65 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.852 . . . . 0.0 110.107 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -82.81 -82.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.35 1.71 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER 56.92 107.36 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 0.0 109.951 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.6 ' HD3' HD22 ' A' ' 23' ' ' LEU . 13.5 Cg_exo -68.41 140.23 54.94 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.082 -2.049 . . . . 0.0 110.381 -0.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.335 179.89 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.438 ' CB ' ' OD1' ' A' ' 45' ' ' ASN . 4.6 mm-40 . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.606 0.717 . . . . 0.0 109.221 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 2.7 ttm180 -78.95 82.5 5.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.62 -0.675 . . . . 0.0 109.634 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.597 HG21 ' HD1' ' A' ' 10' ' ' TYR . 12.5 mt -85.67 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.07 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.4 p -46.95 178.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.157 0.98 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.749 HD11 ' CD1' ' A' ' 30' ' ' ILE . 1.5 tp -91.58 -35.26 14.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.472 ' HG2' HG21 ' A' ' 34' ' ' ILE . 2.3 tmtt? -79.77 -68.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 6' ' ' THR . 5.6 t0 -45.28 -55.12 6.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.655 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.597 ' HD1' HG21 ' A' ' 5' ' ' ILE . 50.2 t80 -42.9 -60.05 1.75 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.418 -0.801 . . . . 0.0 111.219 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -60.38 -29.07 68.71 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.161 -0.962 . . . . 0.0 110.424 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -24.21 61.72 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -71.86 -47.82 50.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.518 -0.739 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 10' ' ' TYR . 26.9 p90 -111.42 -43.52 3.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.586 -1.321 . . . . 0.0 111.434 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 14' ' ' PHE . . . 168.24 162.92 21.28 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.033 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.6 -25.22 20.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.449 -1.03 . . . . 0.0 110.672 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.543 HG23 ' HG2' ' A' ' 18' ' ' LYS . 13.5 t -73.39 -18.28 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.982 . . . . 0.0 110.236 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HG2' HG23 ' A' ' 17' ' ' THR . 7.8 mttt -90.62 -34.52 15.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 11' ' ' ALA . 18.4 m -67.58 -32.09 72.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.68 -27.06 29.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.65 -0.656 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -83.75 -18.38 38.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 110.141 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.438 ' O ' HG11 ' A' ' 50' ' ' VAL . 50.9 m-20 -84.04 -41.55 17.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.058 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 59' ' ' PRO . 90.1 mt -79.91 -60.02 2.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 110.037 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.48 43.98 0.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.3 152.96 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -67.96 169.67 9.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.337 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 33.3 mt-30 -65.16 -35.36 80.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.912 . . . . 0.0 110.27 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.9 p -63.78 -54.44 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.767 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . . . -52.79 -23.2 6.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.131 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.749 ' CD1' HD11 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -71.2 -62.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.579 -0.701 . . . . 0.0 109.29 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.746 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -62.15 -8.03 4.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 110.447 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 15.1 mtpp -90.46 -38.21 13.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.808 -1.183 . . . . 0.0 108.37 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.58 -9.03 56.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 30' ' ' ILE . 19.3 mt -101.15 -46.18 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 9.0 t-80 -68.67 -56.85 6.81 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.238 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.98 40.46 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.281 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.806 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -176.19 79.12 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 23.0 mmm-85 -84.52 -173.43 4.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -1.068 . . . . 0.0 110.53 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 4.3 mtmt 57.63 79.38 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 37' ' ' GLY . 7.1 mt -135.04 160.19 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.0 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.572 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 70.5 m-85 -153.67 154.38 34.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 110.349 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' A' ' 52' ' ' ALA . 4.1 mp -144.92 129.96 18.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.163 -0.961 . . . . 0.0 111.102 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.854 HG22 ' HA2' ' A' ' 48' ' ' GLY . 2.1 m -83.51 107.18 15.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 108.442 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.697 HG23 ' O ' ' A' ' 49' ' ' SER . 2.6 mt -129.15 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.048 -1.032 . . . . 0.0 111.689 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.612 ' H ' HG22 ' A' ' 44' ' ' ILE . 8.1 m120 64.22 -165.06 0.24 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.8 0.81 . . . . 0.0 112.122 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.76 0.96 3.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.77 41.46 2.52 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.854 ' HA2' HG22 ' A' ' 43' ' ' THR . . . -169.02 -27.17 0.02 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 120.038 -1.077 . . . . 0.0 110.633 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.4 OUTLIER 59.77 -92.74 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.855 -1.379 . . . . 0.0 107.715 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 49' ' ' SER . 5.5 t -161.2 77.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.299 -0.876 . . . . 0.0 110.455 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.98 137.92 43.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.504 -0.748 . . . . 0.0 109.042 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -129.59 113.91 15.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 110.836 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.72 121.58 23.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.789 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' D VAL . 7.9 pt-20 -91.21 159.0 16.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.43 139.9 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.266 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 56' C GLU . 0.7 OUTLIER -157.4 78.1 0.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.948 -1.095 . . . . 0.0 110.932 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' A ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 56' ' ' LYS . 31.0 t70 40.35 76.78 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.804 . . . . 0.0 111.279 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 83.51 -5.88 75.72 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.66 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' C GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 1.1 tt0 -117.68 83.37 1.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.894 -1.356 . . . . 0.0 110.342 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' D VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -124.02 124.12 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.488 -0.758 . . . . 0.0 109.702 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' E LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.31 164.13 40.94 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.513 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 3.8 Cg_exo -82.8 97.37 0.85 Allowed 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.015 1.81 . . . . 0.0 110.762 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CZ ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -133.07 140.59 37.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 110.068 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HG2' ' HB3' ' A' ' 23' ' ' LEU . 59.9 Cg_endo -92.97 52.48 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.495 -1.877 . . . . 0.0 110.028 -0.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.513 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 36.7 t . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 110.719 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.469 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 2.3 mt-30 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.512 0.672 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.578 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -79.89 85.04 5.57 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.822 0.82 . . . . 0.0 111.869 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.014 ' O ' HD12 ' A' ' 42' ' ' LEU . 4.6 mm -89.59 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.599 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 2.6 p -65.46 -178.89 0.56 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 111.405 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.944 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -87.29 -26.7 23.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.47 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.71 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -79.52 -77.93 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.271 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 8' ' ' LYS . 7.9 t70 -42.87 -59.23 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.995 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.829 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.6 t80 -41.96 -54.65 3.41 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.246 -0.909 . . . . 0.0 110.555 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.45 -38.25 71.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.181 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.5 ttt -63.54 -30.11 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.502 -0.749 . . . . 0.0 109.998 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.38 -41.01 28.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -109.37 -57.26 2.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.322 -0.861 . . . . 0.0 109.902 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 154.68 156.96 7.95 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 110.147 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 31.1 p -67.76 -11.5 58.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.919 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -85.91 -46.79 10.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.323 -0.861 . . . . 0.0 108.917 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -27.57 63.24 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.27 -32.41 22.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.669 -0.644 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.1 tmtp? -74.29 -18.63 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.908 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.94 -46.76 10.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 0.0 110.069 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.514 HD22 ' HD3' ' A' ' 59' ' ' PRO . 41.8 mt -80.87 -19.14 45.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.08 39.81 94.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.675 HG11 ' HG2' ' A' ' 59' ' ' PRO . 35.9 m -127.79 179.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -1.186 . . . . 0.0 110.206 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.64 142.41 49.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.297 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.445 ' HA ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -66.95 -11.5 56.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.92 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -72.43 -54.78 8.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.975 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.66 -25.15 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.59 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 34' ' ' ILE . 50.0 mt -78.57 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.586 -0.696 . . . . 0.0 109.797 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -58.52 -9.14 1.48 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 110.63 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -93.39 -42.22 9.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.699 -1.251 . . . . 0.0 108.228 178.553 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -75.24 -11.11 60.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.88 HD11 ' HB3' ' A' ' 7' ' ' LEU . 65.2 mt -105.83 -54.17 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 31.6 t60 -54.97 -23.47 19.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.77 85.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.53 37.93 1.39 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.64 -164.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -1.129 . . . . 0.0 110.633 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.447 ' HE2' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -145.45 87.64 1.81 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.649 ' CG2' HD21 ' A' ' 7' ' ' LEU . 27.3 mt -114.91 172.09 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.426 -0.797 . . . . 0.0 110.879 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.583 ' N ' HG22 ' A' ' 40' ' ' ILE . 38.5 m-85 -160.01 141.67 12.78 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.014 HD12 ' O ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -114.89 109.29 17.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.906 -1.121 . . . . 0.0 109.642 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 4' ' ' ARG . 1.4 m -75.93 102.12 5.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 108.746 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.507 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.9 mt -78.17 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 0.0 110.471 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 9.1 p-10 34.28 -140.29 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.964 -0.46 . . . . 0.0 111.309 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.639 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 49.1 26.35 1.4 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 50.7 t0 97.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 123.697 0.799 . . . . 0.0 108.87 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.09 9.78 43.19 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.93 113.58 3.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.794 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.1 t -86.29 100.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 110.334 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 28.5 m-85 -104.73 92.77 4.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.1 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.675 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -88.48 135.47 33.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.05 -1.031 . . . . 0.0 109.361 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 56' E LYS . 0.8 OUTLIER -156.76 135.17 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.15 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -83.73 171.39 13.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.492 -0.755 . . . . 0.0 109.447 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 56' D VAL . 10.4 t -140.28 141.61 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 110.441 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 56' A ASP . 0.8 OUTLIER -157.02 120.4 4.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' A ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 28.3 t70 57.74 -90.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . -146.35 43.76 0.87 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.7 tt0 -156.65 123.81 5.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -1.155 . . . . 0.0 110.35 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' D VAL . . . . . 0.456 HG12 HG13 ' A' ' 55' ' ' VAL . 10.0 m -109.97 155.99 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' E LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 11.9 mttm -135.78 164.47 43.11 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.863 . . . . 0.0 109.486 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 56' E LYS . 4.6 Cg_exo -82.6 150.71 14.82 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.917 1.745 . . . . 0.0 111.006 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 1.9 t80 -146.16 128.87 8.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HG2' HG11 ' A' ' 25' ' ' VAL . 9.6 Cg_endo -89.16 52.92 0.66 Allowed 'Cis proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.98 -1.675 . . . . 0.0 110.648 0.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.4 mm-40 . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 121.298 0.57 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -79.51 74.9 6.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.713 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.722 HD12 ' CE1' ' A' ' 10' ' ' TYR . 10.2 mt -90.67 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.641 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -70.65 -173.45 0.76 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.069 0.938 . . . . 0.0 111.491 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.641 ' H ' HG22 ' A' ' 6' ' ' THR . 1.6 tp -93.99 -38.61 11.07 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.521 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 1.3 tmtt? -90.11 -67.39 0.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.51 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 9.5 m-20 -43.9 -44.11 6.83 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.722 ' CE1' HD12 ' A' ' 5' ' ' ILE . 8.4 t80 -57.96 -54.29 48.56 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.975 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.08 -20.73 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -21.6 21.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.969 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.31 -12.95 25.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.25 -27.76 4.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.965 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.69 130.92 3.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.77 72.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -1.165 . . . . 0.0 109.813 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 15.5 p -82.07 -14.08 56.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -55.37 4.8 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.42 -0.8 . . . . 0.0 108.87 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' HD21 ' A' ' 23' ' ' LEU . 66.7 m -57.18 -32.08 66.09 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 25' ' ' VAL . . . -71.41 -44.97 63.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.9 tmtt? -80.25 1.63 27.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.843 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.525 ' HB3' HG21 ' A' ' 50' ' ' VAL . 53.1 m-20 -89.9 -43.07 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.803 HD12 HG21 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -115.25 -8.55 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.677 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.97 67.95 1.26 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.81 ' CG1' HD11 ' A' ' 30' ' ' ILE . 60.8 t -142.88 140.0 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 110.34 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' O ' HG12 ' A' ' 30' ' ' ILE . 4.3 m-85 -75.0 139.63 43.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 0.0 110.184 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -46.82 -23.84 0.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -69.92 -58.8 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' N ' ' OG ' ' A' ' 28' ' ' SER . . . -46.96 -25.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.671 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.878 HG22 HD12 ' A' ' 34' ' ' ILE . 2.7 mm -71.29 -56.27 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.765 . . . . 0.0 109.986 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -62.81 -8.96 7.87 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -94.74 -40.48 9.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.748 -1.22 . . . . 0.0 108.612 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -79.86 -9.45 59.67 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 HG22 ' A' ' 30' ' ' ILE . 76.5 mt -108.8 -49.12 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.53 -0.731 . . . . 0.0 110.067 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.579 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -63.39 -33.41 75.48 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.947 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.0 -21.59 59.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.64 30.3 13.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -78.3 -173.5 3.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.227 -1.161 . . . . 0.0 110.256 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.76 75.36 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.174 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 58' ' ' PHE . 62.1 mt -106.17 169.25 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 50.9 m-85 -156.56 158.83 37.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 3.1 mp -134.4 114.96 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.0 110.492 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.769 HG23 ' O ' ' A' ' 43' ' ' THR . 13.0 t -93.55 102.95 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 109.848 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' SER . 1.9 mp -91.68 130.23 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.055 . . . . 0.0 110.453 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.763 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 8.2 m-20 -50.53 -19.52 0.91 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.09 -19.52 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.66 -11.96 57.97 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.34 -22.86 5.85 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.822 ' O ' HG23 ' A' ' 44' ' ' ILE . 5.0 t -60.04 148.63 34.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 109.583 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 22' ' ' ASP . 52.9 t -133.4 123.32 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.991 -1.068 . . . . 0.0 111.047 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 15.0 t80 -120.64 119.18 32.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 108.933 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 58' ' ' PHE . . . -93.61 154.28 17.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.921 -1.112 . . . . 0.0 111.241 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -160.35 142.53 12.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.563 -0.711 . . . . 0.0 109.844 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 56' D VAL . 11.7 tm-20 -121.47 167.18 13.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.4 116.49 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.463 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' B GLY . 11.3 ttmt -143.2 153.86 43.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 110.156 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' A ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' LYS . 28.9 t0 -43.73 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.465 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' B GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.66 -64.34 0.42 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -170.29 171.78 6.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.471 -1.017 . . . . 0.0 110.237 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' D VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 21.4 m -93.22 133.26 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 110.16 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' E LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 mmtp -116.87 132.61 23.33 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.978 . . . . 0.0 110.747 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.9 Cg_exo -80.23 125.81 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.218 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -140.88 144.54 35.93 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -91.47 48.53 1.27 Allowed 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.275 -1.969 . . . . 0.0 110.578 0.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.627 ' CG ' ' O ' ' A' ' 3' ' ' GLN 0.257 0.7 OUTLIER . . . . . 0 C--O 1.211 -0.927 0 CA-C-O 122.637 1.208 . . . . 0.0 108.882 . . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.561 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -78.59 73.55 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.922 -1.111 . . . . 0.0 111.375 -178.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.692 HG22 ' HB2' ' A' ' 10' ' ' TYR . 5.1 mt -88.28 145.73 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.145 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 2.3 p -66.53 -173.02 0.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.753 0.787 . . . . 0.0 111.246 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.076 HD23 HD12 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -90.44 -26.62 19.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.506 ' HG2' HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -81.94 -73.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.071 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.7 -56.29 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.045 -1.034 . . . . 0.0 109.709 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' A' ' 5' ' ' ILE . 6.1 t80 -46.74 -53.81 11.02 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.21 -33.16 65.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ttm -63.79 -40.19 96.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.258 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 -28.37 50.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.55 -74.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 110.171 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.16 148.19 5.83 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -58.17 -39.0 77.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -1.102 . . . . 0.0 109.845 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.51 -14.21 59.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 0.0 110.364 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -79.49 -56.31 4.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.199 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 2.1 m -62.51 -29.25 70.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.58 -29.82 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 110.259 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -82.72 -14.57 54.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.798 ' OD1' HG21 ' A' ' 50' ' ' VAL . 4.1 t70 -90.14 -25.39 20.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 109.949 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 30' ' ' ILE . 95.6 mt -79.96 -35.85 37.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 110.358 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.97 23.17 30.77 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -132.81 157.16 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -1.095 . . . . 0.0 110.074 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 25' ' ' VAL . 49.5 m-85 -46.6 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 110.437 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -85.11 -13.78 49.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 110.559 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 t -76.91 -56.39 4.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.955 . . . . 0.0 110.315 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.81 -25.3 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 109.966 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.757 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -76.27 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.846 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.757 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.6 OUTLIER -58.82 -7.91 1.17 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.427 -0.796 . . . . 0.0 111.132 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -91.39 -40.37 11.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.514 -1.366 . . . . 0.0 108.169 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.432 ' O ' ' CD ' ' A' ' 38' ' ' ARG . . . -75.29 -18.84 59.96 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.854 HD11 ' HB3' ' A' ' 7' ' ' LEU . 37.7 mt -96.71 -52.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.423 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 72.3 t60 -52.06 -23.03 4.65 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.295 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.42 -55.5 13.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.814 . . . . 0.0 110.464 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . 124.57 8.96 5.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -51.34 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.401 -1.058 . . . . 0.0 111.835 -179.489 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.86 81.18 1.86 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.492 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.076 HD12 HD23 ' A' ' 7' ' ' LEU . 1.8 mt -97.07 157.5 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.174 -0.954 . . . . 0.0 110.78 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 97.9 m-85 -150.13 98.16 2.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.453 -0.779 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.756 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.8 mp -85.13 101.82 12.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.139 -0.976 . . . . 0.0 111.251 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 43' ' ' THR . 2.3 m -77.78 100.73 6.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.166 -0.958 . . . . 0.0 108.842 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 49' ' ' SER . 5.4 mt -96.5 132.47 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.987 . . . . 0.0 111.453 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 14.2 m-20 -54.66 -17.86 3.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.701 -0.624 . . . . 0.0 110.597 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 90.92 -15.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.33 -17.01 28.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.785 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 135.88 -27.06 3.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -57.09 112.04 1.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.243 . . . . 0.0 109.392 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.798 HG21 ' OD1' ' A' ' 22' ' ' ASP . 29.2 t -109.18 126.31 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.463 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 7.1 m-85 -116.64 108.79 16.36 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -88.06 119.0 28.01 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.034 -1.042 . . . . 0.0 110.615 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 56' E LYS . 0.0 OUTLIER -148.18 121.33 8.9 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.358 -0.839 . . . . 0.0 110.567 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' D VAL . 9.3 mt-10 -81.25 154.76 26.43 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.05 115.01 2.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.685 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -148.99 121.91 8.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 109.624 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' A ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 26.1 t70 58.42 16.78 4.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' B GLY . . . . . 0.623 ' O ' HG13 ' A' ' 56' D VAL . . . 100.81 -27.68 19.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 111.57 3.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -1.196 . . . . 0.0 110.505 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' D VAL . . . . . 0.623 HG13 ' O ' ' A' ' 56' B GLY . 3.3 m -111.71 146.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 110.324 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' E LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 7.3 mtpt -145.46 157.89 51.61 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.136 -0.978 . . . . 0.0 110.523 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -83.4 174.5 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.776 1.651 . . . . 0.0 110.222 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 84.4 t80 176.98 113.35 0.13 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 110.303 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 5.6 Cg_exo -78.05 108.21 1.15 Allowed 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.589 -1.838 . . . . 0.0 110.53 0.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 14.1 p . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 110.56 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.3 mt-30 . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 121.264 0.554 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.565 ' HD2' HG22 ' A' ' 43' ' ' THR . 0.4 OUTLIER -79.13 81.89 5.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.896 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.601 HD12 ' CE1' ' A' ' 10' ' ' TYR . 2.0 mt -90.46 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.477 -0.764 . . . . 0.0 110.063 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -74.52 -169.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.059 0.933 . . . . 0.0 111.7 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 40' ' ' ILE . 5.2 tp -91.44 -42.48 10.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.737 ' HB2' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -91.11 -58.05 2.6 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.502 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -46.19 -49.33 17.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.614 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.601 ' CE1' HD12 ' A' ' 5' ' ' ILE . 3.6 t80 -56.32 -57.04 13.95 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.818 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.42 -20.21 2.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.536 -0.727 . . . . 0.0 109.926 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 1.5 ttp -71.65 -44.84 63.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 110.362 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -70.46 -21.95 62.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.199 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 13.2 m-85 -112.02 -89.91 0.51 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.64 151.76 14.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -35.98 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -1.107 . . . . 0.0 109.942 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.9 t -78.48 -11.84 59.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -47.75 9.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.23 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.5 m -67.7 -26.99 66.44 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.441 -0.787 . . . . 0.0 109.341 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.48 -37.98 50.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -0.757 . . . . 0.0 110.271 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.76 68.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.065 ' OD2' HG11 ' A' ' 50' ' ' VAL . 3.3 t70 -73.9 -38.48 64.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.486 ' HB2' HG23 ' A' ' 25' ' ' VAL . 24.4 mt -84.99 -12.41 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.03 49.9 37.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -128.27 176.93 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.194 -1.18 . . . . 0.0 109.902 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 1.4 m-85 -93.48 148.02 22.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.88 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.475 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.4 tt0 -44.9 -47.73 11.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.848 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -53.47 -56.58 15.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.762 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.57 -32.03 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.502 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.74 HG22 HD12 ' A' ' 34' ' ' ILE . 3.1 mm -66.34 -54.48 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.789 0.804 . . . . 0.0 109.856 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -52.41 -17.16 1.08 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.546 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.766 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -95.69 -36.59 11.14 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.439 -1.413 . . . . 0.0 108.924 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -78.64 2.95 17.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.53 -0.731 . . . . 0.0 109.178 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 30' ' ' ILE . 20.3 mt -135.55 -46.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.591 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 3.4 t60 -79.62 -11.61 59.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.209 -0.932 . . . . 0.0 110.512 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -90.27 -24.2 20.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.131 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.65 51.13 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.604 ' CG ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -90.78 130.38 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.331 -1.1 . . . . 0.0 110.592 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.35 65.49 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 109.02 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 7' ' ' LEU . 1.1 mt -94.28 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.509 -0.744 . . . . 0.0 110.74 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 95.7 m-85 -142.75 121.63 12.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.413 -0.804 . . . . 0.0 110.161 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.648 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.4 mp -105.38 113.52 27.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.898 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.565 HG22 ' HD2' ' A' ' 4' ' ' ARG . 0.5 OUTLIER -90.05 103.06 15.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.12 -0.988 . . . . 0.0 108.82 179.094 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 6.6 mt -101.11 125.61 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.081 -1.012 . . . . 0.0 110.737 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -91.88 -178.08 4.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.342 -0.848 . . . . 0.0 110.334 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.86 -2.77 7.9 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.68 -2.16 57.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.438 -0.789 . . . . 0.0 110.436 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -6.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.413 ' O ' HG23 ' A' ' 44' ' ' ILE . 3.8 t -56.16 160.59 2.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.862 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.065 HG11 ' OD2' ' A' ' 22' ' ' ASP . 95.5 t -137.31 106.04 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.483 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 9.9 m-85 -88.92 84.41 6.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.68 110.55 9.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 109.049 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 56' E LYS . 0.4 OUTLIER -146.39 122.63 10.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.094 -1.004 . . . . 0.0 111.65 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' D VAL . 0.0 OUTLIER -78.73 159.56 27.88 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -154.36 132.84 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.568 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 56' C GLU . 0.2 OUTLIER -160.22 78.77 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' A ASP . . . . . 0.402 ' O ' ' CG ' ' A' ' 56' A ASP . 15.4 t0 51.08 46.01 27.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.528 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' B GLY . . . . . 0.42 ' O ' HG12 ' A' ' 56' D VAL . . . 114.44 -30.8 6.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' C GLU . . . . . 0.515 ' CB ' ' HB3' ' A' ' 56' ' ' LYS . 4.3 mt-10 -79.06 103.61 9.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.171 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' D VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -145.73 153.88 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' E LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pttt -171.3 161.37 5.24 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.131 -0.981 . . . . 0.0 110.483 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 58' ' ' PHE . 5.9 Cg_exo -81.29 48.46 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.747 1.631 . . . . 0.0 111.556 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.492 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 15.7 t80 -41.42 122.54 2.18 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.144 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' SER . 2.4 Cg_endo -82.38 103.38 0.51 Allowed 'Cis proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.517 -1.868 . . . . 0.0 110.48 -0.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' PRO . 8.0 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.231 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.0 mm-40 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.377 0.608 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 33.6 ttt-85 -79.68 84.03 5.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.714 HD12 ' CE1' ' A' ' 10' ' ' TYR . 5.9 mt -88.62 169.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -77.64 -174.12 3.29 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.04 0.924 . . . . 0.0 111.898 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.029 HD22 HD12 ' A' ' 40' ' ' ILE . 3.5 tp -91.78 -41.02 10.9 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.477 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.31 -53.29 4.52 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.554 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -53.51 -50.92 64.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.714 ' CE1' HD12 ' A' ' 5' ' ' ILE . 7.2 t80 -54.8 -54.69 38.89 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.641 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -53.03 -25.93 13.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.493 -0.754 . . . . 0.0 109.845 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.446 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 17.9 tpp -73.97 -36.84 64.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.852 . . . . 0.0 109.96 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.06 -30.03 60.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.93 -66.34 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.74 160.68 11.91 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -35.14 67.26 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 0.0 109.67 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -83.66 -14.14 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.43 -47.04 11.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 108.976 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m -64.24 -30.69 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.87 -30.16 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.539 -0.726 . . . . 0.0 109.713 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -76.3 -34.84 59.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.785 ' HB3' HG11 ' A' ' 50' ' ' VAL . 3.2 m-20 -66.39 -35.32 80.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.786 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' A' ' 59' ' ' PRO . 74.9 mt -81.28 -34.64 31.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 0.0 110.196 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.97 48.0 5.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.48 -179.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -1.121 . . . . 0.0 110.132 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.518 ' O ' HD13 ' A' ' 30' ' ' ILE . 29.2 m-85 -70.18 171.54 9.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.766 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.7 tt0 -87.94 -21.02 25.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -0.808 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 p -66.24 -45.38 80.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 109.968 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -21.48 16.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.741 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.7 mp -80.01 -50.93 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.42 -0.8 . . . . 0.0 109.724 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -71.18 -2.34 15.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -101.47 -42.22 6.34 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.909 -1.12 . . . . 0.0 108.155 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -74.65 -18.16 60.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 7' ' ' LEU . 45.5 mt -102.11 -50.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.442 -0.786 . . . . 0.0 110.246 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 2.2 t60 -60.56 -16.46 37.96 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.9 -1.125 . . . . 0.0 109.817 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 -46.08 17.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.6 7.22 5.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -51.58 161.96 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -1.182 . . . . 0.0 110.172 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 5.4 mmtt -115.88 70.27 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.029 HD12 HD22 ' A' ' 7' ' ' LEU . 6.1 mt -90.55 161.3 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.816 . . . . 0.0 110.15 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 48.6 m-85 -151.26 114.03 4.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.715 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.3 mp -80.52 141.69 34.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 2.8 m -116.71 103.28 10.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.38 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.969 HG23 ' O ' ' A' ' 49' ' ' SER . 1.2 mt -105.12 130.66 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.731 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -105.25 -172.22 2.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.925 179.489 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.26 -2.2 18.09 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -161.67 21.53 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -90.7 -5.36 68.9 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.5 OUTLIER 60.09 -94.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 49' ' ' SER . 1.7 t -162.3 112.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 0.0 110.867 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 20.0 m-85 -101.69 151.99 21.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 108.995 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . -127.03 99.62 5.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.873 -1.142 . . . . 0.0 111.051 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 40' ' ' ILE . 1.8 mt-10 -101.86 169.95 8.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.611 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -150.51 153.56 36.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.927 -1.108 . . . . 0.0 110.587 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 54' ' ' GLU . 5.8 t -150.94 118.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 110.114 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 0.2 OUTLIER -146.37 -168.8 3.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' A ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 56' B GLY . 15.3 t0 -41.25 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.462 -0.774 . . . . 0.0 110.306 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 42.32 57.21 3.79 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 mt-10 -160.42 84.87 0.71 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.244 . . . . 0.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' D VAL . . . . . . . . . . . . . 4.5 m -102.07 148.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' E LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.0 pttt -172.62 166.19 3.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 110.345 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.0 Cg_endo -88.1 -83.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.867 1.712 . . . . 0.0 110.558 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.542 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 59.19 109.57 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.367 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.503 ' HD3' HD22 ' A' ' 23' ' ' LEU . 5.8 Cg_exo -77.39 140.4 63.45 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.456 -1.893 . . . . 0.0 109.923 -0.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 33.2 t . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.054 -1.029 . . . . 0.0 110.358 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 46' ' ' ALA . 1.9 mm100 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -79.4 75.77 6.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 6' ' ' THR . 54.4 mt -90.82 177.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -87.52 -171.03 3.27 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.453 1.12 . . . . 0.0 112.496 -178.761 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.106 HD22 HD13 ' A' ' 40' ' ' ILE . 3.5 tp -92.14 -52.42 4.7 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 123.307 1.527 . . . . 0.0 107.203 176.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.45 -57.54 3.2 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.229 179.618 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.539 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -47.67 -47.87 29.28 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 6' ' ' THR . 27.0 t80 -52.44 -60.19 3.53 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.396 -0.922 . . . . 0.0 109.659 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.7 -26.57 2.38 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.557 0.694 . . . . 0.0 109.577 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.486 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.42 -52.65 44.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.995 179.931 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 -64.36 -31.85 73.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.698 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.469 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 7.5 m-30 -109.75 -80.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 110.152 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 173.75 39.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.445 ' HG3' ' HG2' ' A' ' 27' ' ' GLN . 9.1 tp60 -79.1 -32.3 44.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -1.14 . . . . 0.0 110.075 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -67.96 -21.6 65.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.853 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 14' ' ' PHE . 6.5 mttt -79.74 -38.33 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.867 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.18 -14.18 61.31 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.519 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.696 ' HB2' ' HG3' ' A' ' 27' ' ' GLN . . . -79.15 -47.07 16.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 0.0 109.669 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -12.13 60.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.731 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.566 ' OD1' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -77.3 -55.35 5.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.86 HD21 ' HB2' ' A' ' 52' ' ' ALA . 10.9 mt -86.22 -14.37 44.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.292 -0.88 . . . . 0.0 110.151 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.58 31.06 46.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 26' ' ' TYR . 1.5 t -127.02 178.5 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -1.075 . . . . 0.0 109.75 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.475 ' O ' HD12 ' A' ' 30' ' ' ILE . 57.0 m-85 -89.01 132.95 34.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -0.992 . . . . 0.0 110.2 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.696 ' HG3' ' HB2' ' A' ' 20' ' ' ALA . 17.1 mt-30 -41.71 -29.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 110.264 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.65 -18.87 8.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.452 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.601 HG22 HD12 ' A' ' 34' ' ' ILE . 1.6 mp -86.2 -43.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.044 -1.035 . . . . 0.0 110.315 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.3 t-20 -67.16 -9.92 44.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.235 -0.915 . . . . 0.0 110.206 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -94.52 -48.85 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 108.186 178.482 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -67.83 -16.39 64.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CG1' HD23 ' A' ' 7' ' ' LEU . 7.3 mt -95.93 -64.18 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -49.71 -19.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.651 179.279 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -76.56 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.588 -0.695 . . . . 0.0 111.78 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 39' ' ' LYS . . . -132.59 87.83 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 15.6 mmm-85 -57.19 108.1 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.941 . . . . 0.0 111.049 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HD2' ' HD2' ' A' ' 56' ' ' LYS . 11.7 pttm 179.21 42.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.106 HD13 HD22 ' A' ' 7' ' ' LEU . 15.8 mt -102.24 164.18 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.996 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 58.6 m-85 -156.74 110.54 2.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.952 HD11 HD12 ' A' ' 7' ' ' LEU . 5.3 mp -99.44 144.1 28.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 112.183 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 48' ' ' GLY . 1.5 m -96.1 110.92 23.09 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 176.099 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -89.12 175.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 113.048 -176.369 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.578 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 36.8 p30 -60.87 -133.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.246 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 57.35 43.38 23.45 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.605 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 35.5 t70 69.22 26.33 5.46 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -176.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.581 ' O ' HG22 ' A' ' 43' ' ' THR . . . -124.61 -13.9 3.67 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 43' ' ' THR . 11.9 m 61.2 133.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -1.057 . . . . 0.0 108.441 -178.375 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.601 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 23.1 t -78.41 136.54 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.701 -1.249 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 50' ' ' VAL . 20.9 m-85 -165.61 177.84 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.742 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.86 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -144.97 133.82 22.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 109.981 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 56' E LYS . 18.2 tt0 -154.46 117.05 4.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 0.0 110.916 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.597 ' HG3' HG23 ' A' ' 40' ' ' ILE . 15.2 mt-10 -80.77 153.54 27.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 56' D VAL . 8.7 t -146.67 123.37 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.94 -1.1 . . . . 0.0 110.979 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -147.35 141.02 25.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.706 . . . . 0.0 109.208 179.403 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' A ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -40.53 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 110.42 -179.357 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' B GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.41 -48.51 0.53 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 tt0 -179.33 163.92 1.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.257 -1.143 . . . . 0.0 110.718 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' D VAL . . . . . 0.545 HG12 HG13 ' A' ' 55' ' ' VAL . 15.2 m -112.88 170.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' E LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 15.8 mttt -143.11 160.34 52.78 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 110.477 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 1.3 Cg_endo -85.26 -65.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.887 1.725 . . . . 0.0 110.2 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.55 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 28.4 t80 57.09 99.63 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.519 -0.738 . . . . 0.0 110.611 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 15.0 Cg_exo -66.3 152.38 81.21 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.827 -2.155 . . . . 0.0 110.427 0.065 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.9 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.053 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 121.322 0.582 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 5.8 ttp180 -77.82 82.15 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.432 -0.793 . . . . 0.0 109.927 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.722 HG22 ' HB2' ' A' ' 10' ' ' TYR . 11.2 mm -90.73 163.78 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -77.1 -171.88 2.18 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.121 0.962 . . . . 0.0 111.952 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.705 ' H ' HG22 ' A' ' 6' ' ' THR . 4.9 tp -91.62 -40.04 11.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.565 ' CD ' HG22 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -90.79 -51.43 5.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.431 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.473 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 1.6 t0 -54.91 -43.57 73.39 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.722 ' HB2' HG22 ' A' ' 5' ' ' ILE . 2.3 t80 -62.94 -55.07 29.1 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.196 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.26 -26.57 18.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.637 -0.664 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ttm -71.79 -36.25 70.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.828 . . . . 0.0 110.053 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.76 -39.21 57.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.675 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.74 -100.9 0.23 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.254 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.7 176.02 32.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.715 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 11.2 tp60 -88.28 -30.5 19.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -1.068 . . . . 0.0 110.134 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -84.34 -28.25 27.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -62.16 1.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.67 HG23 HD21 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -53.29 -35.46 60.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.349 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -58.24 -41.47 84.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.56 ' HA ' HG13 ' A' ' 25' ' ' VAL . 6.7 mmtt -57.47 -45.08 85.19 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.8 m-20 -92.19 -5.19 53.01 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.432 -0.792 . . . . 0.0 112.791 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.117 HD22 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -164.39 62.74 0.14 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.47 -1.394 . . . . 0.0 109.92 -179.645 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.714 ' O ' ' HB1' ' A' ' 20' ' ' ALA . . . 127.53 74.45 0.19 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.348 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.706 HG22 ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.58 -11.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.92 -0.753 . . . . 0.0 109.842 -177.198 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' SER . 8.1 m-85 -101.71 98.23 8.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -37.12 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 111.53 -178.691 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' TYR . 67.8 m -82.63 -61.12 1.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.79 -1.194 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . . . -48.92 -22.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.077 -1.015 . . . . 0.0 109.109 179.165 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.743 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.65 -64.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.523 -0.736 . . . . 0.0 109.933 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.743 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -52.07 -15.67 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.484 -0.76 . . . . 0.0 111.252 -179.612 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 4.9 mttt -93.08 -39.8 10.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.435 -1.416 . . . . 0.0 109.028 179.116 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . -76.31 -9.71 58.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.462 -0.774 . . . . 0.0 108.942 178.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 30' ' ' ILE . 16.5 mt -111.98 -52.36 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 7.5 t-160 -57.63 -31.76 66.57 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.204 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 38' ' ' ARG . . . -90.05 -45.97 8.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.472 -0.768 . . . . 0.0 109.673 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.02 85.44 1.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.829 ' HB2' HD11 ' A' ' 40' ' ' ILE . 2.5 mpt_? -90.1 49.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.266 . . . . 0.0 109.27 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER 42.46 53.96 4.5 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.854 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 38' ' ' ARG . 4.2 mt -105.23 154.8 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 110.082 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 70.8 m-85 -149.89 167.58 26.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.29 -0.881 . . . . 0.0 110.066 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.117 HD22 HD22 ' A' ' 23' ' ' LEU . 4.2 mp -143.93 149.01 36.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.953 -1.092 . . . . 0.0 110.965 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.2 m -127.62 97.36 4.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.602 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.714 HG23 ' O ' ' A' ' 49' ' ' SER . 3.8 mt -81.03 93.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 110.348 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 27.0 p-10 -54.52 172.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.339 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -5.72 7.01 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.912 178.551 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 3.9 t70 -79.23 1.23 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.096 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.3 1.06 73.8 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 44' ' ' ILE . 43.6 m -83.27 -170.94 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 44' ' ' ILE . 10.6 t -144.01 127.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.029 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 13.9 m-85 -104.77 94.96 5.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 109.683 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -80.41 142.8 33.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.306 -0.871 . . . . 0.0 109.73 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' E LYS . 10.2 tt0 -153.86 110.39 3.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.266 -0.896 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 56' D VAL . 39.6 tt0 -81.31 167.17 19.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.18 126.93 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.037 -1.039 . . . . 0.0 110.583 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' O ' ' C ' ' A' ' 56' A ASP . 6.0 ttpt -158.76 135.07 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.867 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' A ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.3 m-20 29.52 65.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.868 -0.52 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 47.7 56.79 8.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.46 96.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -1.164 . . . . 0.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' D VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 17.3 m -93.83 161.48 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' E LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 56' D VAL . 2.5 mtmt -143.71 167.38 15.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.127 -0.983 . . . . 0.0 111.291 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 60' ' ' SER . 1.6 Cg_endo -85.98 173.47 6.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.415 2.077 . . . . 0.0 110.165 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.555 ' CZ ' ' C ' ' A' ' 23' ' ' LEU . 10.1 t80 174.22 126.34 0.11 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.964 . . . . 0.0 110.913 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.706 ' HG3' HG22 ' A' ' 25' ' ' VAL . 48.1 Cg_endo -90.12 97.99 0.17 OUTLIER 'Cis proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.782 -1.758 . . . . 0.0 110.297 0.102 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 57' ' ' PRO . 6.3 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 120.724 -1.235 . . . . 0.0 110.671 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.434 0.635 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -78.45 76.46 4.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.515 -0.741 . . . . 0.0 110.677 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.581 HG21 ' HD1' ' A' ' 10' ' ' TYR . 3.8 mt -89.88 135.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -45.89 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.172 0.987 . . . . 0.0 112.015 -178.856 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.041 HD12 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -92.03 -40.43 11.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.892 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.79 -60.47 1.95 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.392 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 12' ' ' MET . 11.6 t0 -45.09 -45.1 10.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.581 ' HD1' HG21 ' A' ' 5' ' ' ILE . 32.1 t80 -61.52 -53.61 54.19 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.47 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.57 -21.52 3.94 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.52 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.9 -47.89 49.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.462 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -65.25 -23.72 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.536 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 5.3 m-85 -114.19 -78.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.143 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 156.41 162.49 11.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.579 ' OE1' HG22 ' A' ' 30' ' ' ILE . 2.9 tp-100 -57.54 -41.31 80.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -1.1 . . . . 0.0 109.973 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -65.48 -30.26 71.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -71.01 -63.53 1.08 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.344 179.488 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 7' ' ' LEU . 4.2 m -57.4 -22.67 44.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.272 -0.892 . . . . 0.0 109.19 179.051 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -72.07 -45.7 59.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.431 -0.793 . . . . 0.0 110.228 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 14.0 mmtt -76.84 -13.04 60.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.892 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB3' HG21 ' A' ' 50' ' ' VAL . 3.5 m-20 -71.46 -48.94 46.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.699 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.402 ' CB ' HG23 ' A' ' 25' ' ' VAL . 23.7 mt -82.61 -10.22 59.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 110.243 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 24.86 76.29 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.462 ' CG1' ' CB ' ' A' ' 29' ' ' ALA . 2.6 t -109.03 163.97 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -1.096 . . . . 0.0 110.163 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -62.68 147.6 49.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.093 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.4 ' HA ' HG12 ' A' ' 30' ' ' ILE . 2.0 mt-30 -50.78 -24.72 3.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.991 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 t -65.09 -51.3 62.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.842 . . . . 0.0 109.791 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.462 ' CB ' ' CG1' ' A' ' 25' ' ' VAL . . . -53.69 -19.36 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.805 . . . . 0.0 109.953 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.7 HG22 HD12 ' A' ' 34' ' ' ILE . 3.3 mm -80.88 -50.82 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.5 OUTLIER -70.63 -7.24 42.79 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.603 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -92.4 -44.61 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 108.758 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.711 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -80.71 -13.41 59.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.012 HG12 HD13 ' A' ' 7' ' ' LEU . 9.5 mt -102.49 -42.37 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 42.9 t60 -61.69 -53.82 50.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.955 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 38' ' ' ARG . . . -93.12 -122.16 0.09 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . -1.73 68.38 0.0 OUTLIER Glycine 0 N--CA 1.504 3.223 0 C-N-CA 123.288 0.47 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 36' ' ' ALA . 23.3 mmm-85 -85.28 61.72 7.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.297 -1.119 . . . . 0.0 110.512 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 64.7 pttt -154.22 38.27 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 108.974 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.041 HD13 HD12 ' A' ' 7' ' ' LEU . 10.3 mt -101.65 165.36 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 110.825 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 56.2 m-85 -156.66 103.41 2.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.604 -0.685 . . . . 0.0 109.241 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.687 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.3 mp -89.33 130.18 35.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.905 . . . . 0.0 111.136 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 43' ' ' THR . 2.1 m -101.2 103.32 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.163 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 45' ' ' ASN . 18.6 mt -89.25 74.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.062 -1.024 . . . . 0.0 110.576 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 44' ' ' ILE . 1.7 p30 -44.7 174.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 110.705 179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.95 -2.8 8.17 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.613 -0.835 . . . . 0.0 108.979 178.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.42 -2.1 57.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.885 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.81 -3.55 55.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -72.21 149.93 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -1.227 . . . . 0.0 109.773 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 22' ' ' ASP . 13.1 t -111.5 105.87 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 110.668 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 1.9 m-85 -88.95 96.21 10.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.95 . . . . 0.0 109.007 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -84.87 92.21 8.22 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 110.707 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.444 ' OE1' ' CG2' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.44 165.18 11.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.567 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 56' D VAL . 54.6 mt-10 -134.13 163.08 30.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.714 HG13 HG12 ' A' ' 56' D VAL . 3.3 t -150.33 133.76 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 56' A ASP . 7.1 tptp -148.83 78.54 1.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.401 -0.812 . . . . 0.0 109.497 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' A ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 16.0 t0 60.24 50.47 6.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.592 -0.692 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 102.75 -30.43 10.42 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.499 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' C GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 56' ' ' LYS . 9.7 mt-10 -74.26 95.66 2.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.098 -1.237 . . . . 0.0 110.715 -179.508 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' D VAL . . . . . 0.714 HG12 HG13 ' A' ' 55' ' ' VAL . 18.8 m -117.05 147.48 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.214 -0.929 . . . . 0.0 110.393 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' E LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 3.6 pttm -175.1 165.73 2.1 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.191 -0.943 . . . . 0.0 110.576 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 4.7 Cg_exo -78.93 -176.41 3.27 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.872 1.714 . . . . 0.0 110.53 -178.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.598 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 1.8 t80 178.63 126.99 0.21 Allowed Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.29 -0.881 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 60.3 Cg_endo -90.11 96.59 0.16 OUTLIER 'Cis proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.913 -1.703 . . . . 0.0 110.514 -0.033 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 12.0 p . . . . . 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.456 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.226 0.536 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 3.2 ttm180 -79.34 74.56 5.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.382 -0.824 . . . . 0.0 110.098 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.996 HG22 ' HB2' ' A' ' 10' ' ' TYR . 3.9 mm -90.08 148.12 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.443 -0.786 . . . . 0.0 109.851 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -44.54 -179.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 122.486 1.136 . . . . 0.0 112.109 -178.822 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.865 ' HB2' HD11 ' A' ' 42' ' ' LEU . 5.7 tp -94.28 -39.35 10.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.411 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -88.62 -61.9 1.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.185 179.583 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' LYS . 8.1 t0 -44.76 -42.39 7.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.996 ' HB2' HG22 ' A' ' 5' ' ' ILE . 12.0 t80 -55.76 -59.5 4.77 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.705 0.764 . . . . 0.0 109.345 178.281 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -57.9 -15.58 9.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.803 -0.561 . . . . 0.0 110.156 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ttt -83.43 -34.11 25.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.814 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.36 -10.45 49.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.809 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 -51.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.002 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.69 142.1 3.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.507 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -72.82 -27.74 62.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -1.185 . . . . 0.0 110.203 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 17' ' ' THR . 3.3 t -79.88 -21.78 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -82.4 -46.98 12.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.113 179.31 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.535 ' O ' HD12 ' A' ' 23' ' ' LEU . 11.6 m -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.319 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.62 -28.53 30.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 110.092 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -80.59 -36.96 32.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.467 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.4 -36.28 68.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.318 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 19' ' ' THR . 83.3 mt -82.6 -9.94 59.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.26 40.03 97.58 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 59' ' ' PRO . 3.9 t -124.07 146.71 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.446 -1.032 . . . . 0.0 109.97 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -72.03 150.87 43.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.879 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.62 ' HA ' HD12 ' A' ' 30' ' ' ILE . 1.9 tt0 -61.46 -20.38 63.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.4 p -84.65 -55.76 3.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.0 110.229 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.73 -23.28 1.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' GLN . 95.0 mt -76.88 -63.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.891 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 31.8 m-80 -49.9 -15.67 0.21 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.332 -0.855 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -91.58 -38.61 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.558 -1.339 . . . . 0.0 108.597 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.88 56.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.528 -0.732 . . . . 0.0 109.185 178.356 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.597 HD11 HD21 ' A' ' 7' ' ' LEU . 10.1 mt -114.57 -48.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.54 -0.725 . . . . 0.0 109.714 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t-160 -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.512 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.44 5.73 49.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 111.615 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.559 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -149.29 90.28 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 20.3 mmm-85 -83.69 -173.57 4.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -1.075 . . . . 0.0 110.157 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER 66.31 58.87 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.199 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.679 HD13 HD23 ' A' ' 7' ' ' LEU . 9.2 mt -116.18 157.65 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.163 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 39.8 m-85 -155.06 144.89 21.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 110.873 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 7' ' ' LEU . 4.1 mp -135.57 131.05 35.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.462 -0.774 . . . . 0.0 109.743 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.432 ' OG1' ' HG3' ' A' ' 4' ' ' ARG . 3.2 m -99.18 101.04 12.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.005 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.011 HG23 ' O ' ' A' ' 49' ' ' SER . 15.0 mt -101.1 148.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.982 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 46' ' ' ALA 0.252 2.4 m-20 -65.31 -11.75 44.91 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.531 0.682 . . . . 0.0 110.076 178.113 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.948 ' H ' HG22 ' A' ' 44' ' ' ILE . . . 81.49 1.22 1.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -175.166 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.19 38.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.575 ' N ' ' HB2' ' A' ' 45' ' ' ASN . . . -140.13 -63.36 0.04 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -177.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.011 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER 179.45 -168.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 109.445 -179.045 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.875 HG22 HG12 ' A' ' 44' ' ' ILE . 11.9 t -125.52 110.93 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.571 -1.331 . . . . 0.0 111.583 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -81.4 77.69 8.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.537 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -52.47 145.75 10.92 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.708 0.766 . . . . 0.0 111.398 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 78.94 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.566 ' CB ' HG23 ' A' ' 40' ' ' ILE . 3.8 pt-20 -79.41 163.49 24.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.253 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 56' D VAL . 3.2 t -132.77 139.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 0.5 OUTLIER -159.76 160.85 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 -179.889 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.4 m-20 -39.21 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.471 -0.768 . . . . 0.0 110.438 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 144.99 -71.41 0.37 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.7 tt0 -174.4 -172.45 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.491 -1.005 . . . . 0.0 109.926 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' D VAL . . . . . 0.611 HG12 HG22 ' A' ' 55' ' ' VAL . 34.6 m -104.6 143.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.95 . . . . 0.0 110.434 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' E LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 4.9 mmtt -128.09 161.04 58.49 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.393 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.4 Cg_exo -82.9 39.95 0.9 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.825 1.683 . . . . 0.0 111.063 -178.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.56 118.58 1.26 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.409 -0.807 . . . . 0.0 109.817 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -81.86 104.89 0.64 Allowed 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.305 -1.956 . . . . 0.0 110.724 0.2 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 73.3 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.08 -1.013 . . . . 0.0 110.184 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.122 0.487 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.87 74.89 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.377 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.801 HG22 ' HB2' ' A' ' 10' ' ' TYR . 8.4 mt -91.66 141.68 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.305 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 18.8 p -59.47 -175.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 110.848 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.964 HD12 HG21 ' A' ' 19' ' ' THR . 1.2 tp -92.45 -34.43 14.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.57 ' CG ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -81.84 -69.52 0.61 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.855 -0.528 . . . . 0.0 110.002 179.375 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 41.4 t0 -46.66 -58.09 4.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.219 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.801 ' HB2' HG22 ' A' ' 5' ' ' ILE . 3.4 t80 -41.9 -51.65 4.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.331 -0.855 . . . . 0.0 110.368 179.282 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -56.13 -42.41 76.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.422 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 30.1 ttp -60.17 -29.94 69.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.058 179.048 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -55.84 28.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.492 -0.755 . . . . 0.0 110.125 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CZ ' ' CZ ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -123.52 67.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.974 -1.079 . . . . 0.0 111.659 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.28 156.87 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.465 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -82.29 -29.92 30.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -1.03 . . . . 0.0 109.841 179.611 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 26.4 m -60.63 -21.61 62.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.414 -0.804 . . . . 0.0 109.884 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.606 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.0 mmtp -69.76 -54.86 11.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.02 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.964 HG21 HD12 ' A' ' 7' ' ' LEU . 90.3 m -59.37 -19.01 43.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.897 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 17' ' ' THR . . . -71.12 -38.21 72.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.594 -0.691 . . . . 0.0 109.825 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -81.76 -18.69 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.743 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 3.0 t0 -65.43 -53.84 37.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.033 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.498 HD11 HD13 ' A' ' 7' ' ' LEU . 3.0 mt -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.364 -0.835 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.77 29.78 20.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -122.08 151.26 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -1.115 . . . . 0.0 109.676 -179.751 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 25' ' ' VAL . 47.8 m-85 -47.09 173.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.488 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -77.0 -28.25 54.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -67.56 -57.95 5.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.16 -28.53 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.365 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.813 ' CD1' HD11 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -62.85 -61.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.727 ' N ' HG22 ' A' ' 30' ' ' ILE . 15.8 m120 -57.28 -9.65 1.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.597 -0.69 . . . . 0.0 110.888 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -88.98 -35.32 16.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.648 -1.283 . . . . 0.0 107.766 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.513 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -85.62 -11.11 54.73 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.57 ' CG2' ' CG ' ' A' ' 8' ' ' LYS . 14.9 mt -100.68 -48.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.405 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -74.99 -58.43 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.894 179.661 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.85 11.08 23.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 110.755 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -137.63 69.66 0.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 15.0 mmm-85 -75.85 -171.85 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.899 -1.353 . . . . 0.0 110.214 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 56' A ASP . 9.2 mptt 58.73 46.72 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.198 -0.939 . . . . 0.0 110.52 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.945 HD13 HD23 ' A' ' 7' ' ' LEU . 16.7 mt -97.89 161.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 110.353 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 43.9 m-85 -161.32 114.37 1.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 110.267 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 7' ' ' LEU . 2.4 mp -107.24 131.88 53.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.099 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 43' ' ' THR . 1.7 m -96.99 100.54 12.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 44' ' ' ILE . 9.6 mt -94.73 43.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.431 ' OD1' HG22 ' A' ' 43' ' ' THR . 45.8 p-10 -91.97 -131.49 0.12 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 109.85 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.929 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 48.75 24.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.957 -1.089 . . . . 0.0 109.127 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.566 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.1 t0 75.13 63.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.317 0.579 . . . . 0.0 111.036 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 81.78 -8.43 59.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.929 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -51.11 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.317 . . . . 0.0 110.506 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.71 123.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.47 135.68 37.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.576 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' PRO . . . -103.57 149.9 24.46 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.944 -1.098 . . . . 0.0 109.461 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 2.4 tt0 -159.78 151.43 20.12 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 110.651 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.715 ' O ' ' HA ' ' A' ' 56' D VAL . 2.1 tt0 -135.92 151.1 49.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.389 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.99 ' O ' HG12 ' A' ' 56' D VAL . 7.2 p -124.33 -26.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.394 -0.923 . . . . 0.0 112.525 -177.254 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 3.2 ttmt -160.14 -171.37 3.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.705 -1.247 . . . . 0.0 111.091 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' A ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 29.5 t0 47.37 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.693 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -58.76 -51.88 56.44 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 178.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' C GLU . . . . . 0.532 ' CB ' ' OE1' ' A' ' 54' ' ' GLU . 2.5 tt0 174.97 179.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.628 -0.924 . . . . 0.0 110.096 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' D VAL . . . . . 0.99 HG12 ' O ' ' A' ' 55' ' ' VAL . 4.1 m -122.0 46.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' E LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 56' D VAL . 13.9 mttt -149.81 174.95 3.06 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.375 -0.828 . . . . 0.0 112.302 -177.743 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 56' E LYS . 3.9 Cg_exo -80.04 56.16 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.661 2.24 . . . . 0.0 111.497 -179.118 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.444 ' HZ ' HD22 ' A' ' 7' ' ' LEU . 5.0 p90 -44.06 146.53 1.08 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.714 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -91.11 50.01 1.08 Allowed 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.221 -1.991 . . . . 0.0 110.31 -0.131 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 110.021 179.96 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.6 mt-30 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.373 0.606 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.8 ttp180 -79.0 79.71 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.51 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 10' ' ' TYR . 32.7 mt -89.32 154.17 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.062 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.08 179.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.049 0.928 . . . . 0.0 111.38 -179.262 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.676 ' CD2' HD12 ' A' ' 40' ' ' ILE . 3.7 tp -92.8 -40.08 10.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.077 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HB2' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.96 -63.97 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.434 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 3.1 m-20 -45.03 -44.57 10.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.1 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.62 ' HB2' HG22 ' A' ' 5' ' ' ILE . 9.4 t80 -57.24 -56.43 21.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.143 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -57.74 -15.27 7.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.8 -0.562 . . . . 0.0 110.388 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.2 ttt -82.79 -35.34 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -0.976 . . . . 0.0 110.062 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -77.04 -32.17 56.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.664 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 12.1 m-85 -96.64 -54.22 3.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.12 137.92 2.74 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -33.43 66.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -1.18 . . . . 0.0 110.275 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 m -77.5 -23.34 50.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -76.28 -56.66 4.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.071 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 ' HB2' ' A' ' 11' ' ' ALA . 2.1 m -57.81 -23.81 54.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.491 -0.756 . . . . 0.0 109.123 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.52 -47.13 43.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.913 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -9.14 57.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 110.053 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.98 -30.84 18.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 110.141 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 42' ' ' LEU . 75.3 mt -91.37 -5.62 54.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.15 35.3 91.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' A' ' 29' ' ' ALA . 2.8 t -119.72 174.46 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -1.128 . . . . 0.0 109.926 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.459 ' H ' HG12 ' A' ' 25' ' ' VAL . 60.1 m-85 -81.96 136.41 35.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 0.0 110.0 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -44.24 -29.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.953 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -74.54 -52.55 11.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.654 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -50.76 -27.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.597 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.744 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.3 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 109.677 179.672 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.744 ' N ' HG22 ' A' ' 30' ' ' ILE . 2.3 m120 -57.7 -10.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.658 -0.651 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.88 -42.8 9.31 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.507 -1.37 . . . . 0.0 108.51 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.89 -9.63 58.73 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.303 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.55 HG12 ' CD2' ' A' ' 7' ' ' LEU . 24.6 mt -110.86 -51.1 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.765 . . . . 0.0 110.088 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.582 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.0 OUTLIER -53.86 -26.59 25.31 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.407 179.588 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.22 -75.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.989 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.07 57.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.562 ' O ' ' C ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -90.48 31.72 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.129 -1.218 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER 19.72 70.15 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.318 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 7' ' ' LEU . 6.3 mt -105.51 159.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.387 -0.821 . . . . 0.0 110.931 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -143.54 161.56 38.14 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.106 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 23' ' ' LEU . 4.0 mp -137.47 118.57 14.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.667 -1.271 . . . . 0.0 110.888 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 51' ' ' TYR . 2.8 p -85.32 97.63 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.538 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 45' ' ' ASN . 4.4 mt -89.52 80.79 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.314 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 44' ' ' ILE . 51.6 p30 -44.02 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.464 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -3.74 8.84 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.706 -0.797 . . . . 0.0 109.041 178.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -85.62 -3.16 58.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.4 -5.13 74.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -70.4 122.41 19.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.32 112.2 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.512 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.513 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 3.5 t80 -102.96 105.69 16.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -82.5 143.54 31.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.205 -0.935 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 56' E LYS . 0.7 OUTLIER -151.01 96.35 2.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.54 -0.725 . . . . 0.0 109.63 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 40.1 tt0 -78.97 161.65 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.741 HG22 HG12 ' A' ' 56' D VAL . 73.3 t -135.44 138.58 48.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.672 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 56' A ASP . 22.3 ttpp -156.06 141.74 17.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -0.76 . . . . 0.0 109.239 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' A ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 56' ' ' LYS . 7.6 t0 -37.15 102.94 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.511 -0.743 . . . . 0.0 110.828 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' B GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 56' C GLU . . . 139.72 -53.54 0.68 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' C GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 56' B GLY . 11.0 tt0 179.48 171.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 110.042 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' D VAL . . . . . 0.741 HG12 HG22 ' A' ' 55' ' ' VAL . 23.4 m -98.54 173.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.176 -0.952 . . . . 0.0 110.005 179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' E LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 5.3 mtmt -144.7 170.45 8.19 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 110.176 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 58' ' ' PHE . 4.4 Cg_exo -79.53 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.297 -2.138 0 O-C-N 124.42 1.747 . . . . 0.0 109.966 -179.196 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.504 ' O ' ' O ' ' A' ' 57' ' ' PRO . 28.1 t80 57.69 125.86 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.516 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.39 122.47 8.51 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.169 -2.013 . . . . 0.0 110.305 0.09 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.975 . . . . 0.0 110.591 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 6.4 mt-30 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.412 0.625 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 6.5 ttt180 -78.26 81.48 4.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 6' ' ' THR . 3.9 mt -90.77 -179.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.424 -0.798 . . . . 0.0 109.571 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.61 -173.11 3.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.026 0.917 . . . . 0.0 111.375 -179.313 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.948 HD12 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -92.91 -46.5 7.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.347 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.559 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -84.33 -57.0 3.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.083 178.766 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.519 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -51.98 -51.78 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.393 -0.817 . . . . 0.0 109.127 179.269 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.6 t80 -49.91 -56.78 9.22 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.685 179.115 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.39 -32.67 18.17 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.646 0.736 . . . . 0.0 109.41 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -58.28 -51.61 69.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -20.74 65.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.616 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -111.58 -84.54 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.805 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 174.32 159.57 20.93 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.702 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -39.01 93.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.594 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -78.38 -3.18 41.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.907 179.768 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -90.15 -50.39 6.02 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.341 -0.849 . . . . 0.0 108.729 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.545 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -54.96 -37.96 67.16 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.271 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 -48.66 55.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.492 0.663 . . . . 0.0 109.905 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.9 mmtp -76.62 3.82 10.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 109.834 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.679 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -88.06 -60.62 1.92 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.84 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.621 ' HG ' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -99.81 -25.44 14.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.957 -1.089 . . . . 0.0 110.939 -179.408 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.57 ' N ' ' HG ' ' A' ' 23' ' ' LEU . . . 119.84 62.15 0.26 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.779 179.208 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 26' ' ' TYR . 2.2 t -142.82 -172.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.133 -1.216 . . . . 0.0 109.521 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.693 ' H ' HG12 ' A' ' 25' ' ' VAL . 31.4 m-85 -109.48 -170.2 1.61 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.933 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -87.71 -29.52 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.152 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -68.15 -46.66 70.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.02 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.97 -22.92 41.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.982 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 26' ' ' TYR . 1.3 mp -81.51 -45.8 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 109.57 179.72 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 26.2 m-20 -72.75 -8.17 54.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 179.357 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -95.5 -44.57 7.46 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.52 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -71.29 -16.38 62.46 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.766 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.603 ' HA ' ' CD ' ' A' ' 38' ' ' ARG . 88.2 mt -103.76 -53.65 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 110.704 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.569 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 8.8 t-80 -62.13 -10.42 10.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.72 -1.237 . . . . 0.0 109.941 179.783 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -81.86 -103.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.921 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' ARG . . . -123.11 78.63 0.35 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.603 ' CD ' ' HA ' ' A' ' 34' ' ' ILE . 16.5 mmm-85 -34.14 119.31 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.911 0.863 . . . . 0.0 111.833 -178.944 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 41.7 pttt -174.88 31.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.652 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.948 HD13 HD12 ' A' ' 7' ' ' LEU . 14.9 mt -105.88 161.16 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.688 . . . . 0.0 110.157 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 45.3 m-85 -155.3 114.37 3.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.299 -0.876 . . . . 0.0 109.897 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.0 mp -98.27 107.24 19.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.097 -1.002 . . . . 0.0 110.5 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 43' ' ' THR . 11.0 t -83.7 105.11 14.35 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.735 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.987 HG23 ' O ' ' A' ' 49' ' ' SER . 3.5 mt -97.95 135.29 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.181 -179.751 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -114.2 -168.09 1.31 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.791 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.94 0.31 11.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.6 24.6 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -96.94 -12.35 50.09 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 44' ' ' ILE . 1.1 m 59.08 -90.41 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.541 -0.976 . . . . 0.0 108.575 -178.8 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.711 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.3 t -160.95 98.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.113 -0.992 . . . . 0.0 110.401 179.06 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.421 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 2.3 t80 -95.98 105.53 17.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.255 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -67.5 148.9 50.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.624 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 41' ' ' PHE . 41.1 mt-10 -149.2 102.44 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 110.183 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' C ' ' CG2' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -89.89 148.73 22.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -0.957 . . . . 0.0 109.129 179.423 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 2.4 t -148.62 105.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.879 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 1.7 tptp -125.23 170.02 11.68 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' A ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 56' ' ' LYS . 2.7 t70 -42.26 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.171 -0.956 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 60.31 56.7 23.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -167.18 74.55 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.019 -1.283 . . . . 0.0 110.974 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' D VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 2.6 m -103.82 150.76 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.462 179.524 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' E LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -162.77 160.31 19.55 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.765 -1.209 . . . . 0.0 111.154 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.3 Cg_endo -89.52 37.66 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.049 1.832 . . . . 0.0 110.815 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -41.62 137.55 1.8 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.903 . . . . 0.0 109.922 179.778 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 60' ' ' SER . 53.2 Cg_endo -93.5 66.9 0.25 Allowed 'Cis proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.714 -1.786 . . . . 0.0 110.887 0.164 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 120.875 -1.14 . . . . 0.0 110.689 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.488 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 2.0 mt-30 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.077 0.465 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -79.64 73.15 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.365 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.734 HG22 ' HB2' ' A' ' 10' ' ' TYR . 9.0 mt -90.33 141.27 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 110.821 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -51.75 -174.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 112.159 -179.31 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.928 HD23 ' CD1' ' A' ' 40' ' ' ILE . 3.4 tp -93.41 -38.39 11.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 176.134 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.569 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -82.2 -60.03 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.787 178.997 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 12' ' ' MET . 9.1 t0 -53.28 -44.35 68.19 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.165 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.734 ' HB2' HG22 ' A' ' 5' ' ' ILE . 88.4 t80 -58.9 -63.75 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.495 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.21 -23.54 1.37 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.382 -0.824 . . . . 0.0 109.62 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.43 -54.18 11.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.113 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -88.35 13.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.659 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -161.5 97.27 1.09 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.707 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 14' ' ' PHE . . . -8.72 123.52 0.01 OUTLIER Glycine 0 N--CA 1.506 3.338 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 17' ' ' THR . 6.2 pt20 -59.95 -36.39 76.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.411 -1.052 . . . . 0.0 109.582 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 2.8 m -51.49 -22.45 3.13 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.242 -179.229 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -82.57 -44.69 15.55 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.109 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.739 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -64.5 -23.37 67.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.205 179.104 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -86.04 -28.5 24.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 110.518 -179.543 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -71.73 -28.31 63.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.898 179.788 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -89.91 -26.41 20.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 19' ' ' THR . 25.5 mt -79.41 -40.72 29.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.369 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.29 40.45 1.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 -177.75 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.269 -1.136 . . . . 0.0 109.83 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -97.98 -163.76 1.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -85.31 -50.08 7.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.041 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 29' ' ' ALA . 7.9 t -64.82 -62.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 109.881 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.9 -28.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.704 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -69.22 -58.18 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.506 -0.746 . . . . 0.0 109.278 179.28 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.704 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -57.41 -6.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.813 -0.555 . . . . 0.0 111.645 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -91.95 -40.73 10.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.793 -1.192 . . . . 0.0 108.18 178.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -22.3 55.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.163 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.618 HD12 HG23 ' A' ' 30' ' ' ILE . 47.6 mt -87.34 -51.37 12.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.552 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.651 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -43.6 -35.88 1.91 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.786 0.803 . . . . 0.0 108.976 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.93 -87.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.96 39.75 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -84.05 48.33 1.45 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.427 -1.043 . . . . 0.0 111.423 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 2.5 mppt? 64.85 98.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.508 -0.745 . . . . 0.0 110.369 179.191 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.928 ' CD1' HD23 ' A' ' 7' ' ' LEU . 2.7 mt -129.84 153.78 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 72.8 m-85 -156.57 124.03 5.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.1 mp -118.13 132.06 56.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 111.063 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.4 m -108.65 103.27 12.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.421 -0.799 . . . . 0.0 108.983 178.854 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 10' ' ' TYR . 1.5 mt -94.13 -149.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 111.199 -178.827 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.632 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 37.6 -164.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.453 0.644 . . . . 0.0 110.804 -178.847 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 63.97 -5.49 0.3 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -176.833 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.606 ' H ' ' C ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER 174.73 -27.37 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.149 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.88 40.68 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.419 ' OG ' ' CE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -100.2 133.37 44.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.649 -0.913 . . . . 0.0 109.771 179.939 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' CG1' HD23 ' A' ' 42' ' ' LEU . 39.8 t -88.31 97.53 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 110.48 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 55.3 m-85 -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 108.674 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.76 127.52 34.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.198 -0.939 . . . . 0.0 110.867 -178.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.39 161.21 25.2 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 25.7 tt0 -136.07 147.06 47.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.371 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 2.5 t -146.54 104.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.503 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 3.5 ttpt -132.34 153.93 50.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 109.509 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' A ASP . . . . . 0.481 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 18.0 t70 -43.06 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.072 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 151.73 -55.74 0.45 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.28 -172.62 0.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.338 -1.095 . . . . 0.0 110.506 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' D VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 56' E LYS . 5.0 m -116.3 161.08 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -179.672 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' E LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 56' D VAL . 19.2 mttm -146.33 163.65 28.89 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 110.375 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -83.99 -61.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.016 1.81 . . . . 0.0 110.873 -178.874 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 4.4 t80 59.89 123.74 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.34 -0.85 . . . . 0.0 110.009 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' HD22 ' A' ' 23' ' ' LEU . 4.4 Cg_exo -76.4 126.85 13.82 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 122.16 -2.017 . . . . 0.0 110.258 0.042 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 -179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -78.99 85.78 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 0.0 110.721 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.887 HG22 ' HB2' ' A' ' 10' ' ' TYR . 11.3 mt -90.44 149.71 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.827 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -48.13 -178.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.248 1.023 . . . . 0.0 111.647 -179.266 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.799 ' HA ' HD13 ' A' ' 42' ' ' LEU . 2.6 tp -92.42 -40.21 11.0 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.678 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.548 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -91.32 -59.54 2.12 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 12' ' ' MET . 0.8 OUTLIER -45.83 -39.6 8.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.83 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.887 ' HB2' HG22 ' A' ' 5' ' ' ILE . 5.5 t80 -62.52 -53.38 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.505 178.766 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -51.87 -26.09 9.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.499 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 14.4 tpp -72.25 -47.01 53.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.871 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -23.88 65.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.968 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.48 -79.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.65 156.23 14.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.488 ' OE1' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -70.41 -30.52 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 109.994 179.932 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 p -82.58 -20.57 36.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 110.208 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -81.23 -51.42 8.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.329 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.622 ' O ' HD12 ' A' ' 23' ' ' LEU . 2.8 m -63.11 -25.97 68.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 178.96 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.4 -34.8 63.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 0.0 110.529 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 2.2 mmtp -89.6 -14.17 35.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.286 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD1' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -76.25 -40.46 51.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.67 179.737 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 19' ' ' THR . 4.7 mt -83.51 0.41 46.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.16 56.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG11 ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -144.71 -175.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.46 ' O ' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -110.25 155.99 21.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.217 -0.927 . . . . 0.0 109.924 -179.949 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.42 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.1 mt-30 -40.46 -28.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.374 -0.829 . . . . 0.0 110.728 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -61.98 -64.68 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.126 -0.984 . . . . 0.0 110.507 -179.775 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.617 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -44.99 -26.11 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.867 HG23 HD12 ' A' ' 34' ' ' ILE . 1.7 mp -75.84 -43.61 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.2 t30 -73.51 -1.57 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.042 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -104.82 -43.38 5.11 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.999 -1.063 . . . . 0.0 108.879 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -82.1 -0.9 46.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.589 -0.695 . . . . 0.0 109.204 178.576 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.867 HD12 HG23 ' A' ' 30' ' ' ILE . 13.6 mt -124.33 -40.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.86 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.548 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 5.7 t-80 -74.06 -26.09 60.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.0 110.019 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 -32.76 71.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.82 45.59 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.7 mmm180 -85.68 -173.45 4.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -1.147 . . . . 0.0 110.401 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.48 79.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 7' ' ' LEU . 10.0 mt -109.82 162.99 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.905 . . . . 0.0 110.452 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CG ' ' NH1' ' A' ' 4' ' ' ARG . 76.2 m-85 -151.09 113.58 4.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 0.0 109.831 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 7' ' ' LEU . 7.3 mp -80.12 134.58 36.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 17.8 m -106.38 100.3 9.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 49' ' ' SER . 10.6 mt -92.65 131.32 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.761 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 3.5 m120 -52.75 -19.09 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.568 -0.708 . . . . 0.0 110.59 179.02 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.96 -21.02 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -176.329 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.1 -2.04 57.55 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.367 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.17 -20.2 11.5 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -63.32 147.52 50.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -1.198 . . . . 0.0 109.989 179.862 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.531 HG11 ' OD1' ' A' ' 22' ' ' ASP . 22.1 t -122.11 141.86 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.448 ' O ' ' C ' ' A' ' 52' ' ' ALA . 18.7 t80 -143.09 76.54 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.479 -0.763 . . . . 0.0 109.636 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 51' ' ' TYR . . . -38.31 143.4 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.616 -0.678 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' PHE . 2.9 tt0 -140.41 86.99 2.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 110.724 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 56' D VAL . 1.3 tp10 -79.38 147.91 32.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.84 137.38 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 110.496 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 56' C GLU . 11.4 ttpt -160.07 -172.76 3.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.841 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' A ASP . . . . . . . . . . . . . 13.2 m-20 -57.24 105.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.029 -1.044 . . . . 0.0 110.189 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 51.49 29.97 25.38 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' C GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -143.77 86.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.175 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' D VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 1.2 p -125.44 102.02 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 109.719 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' E LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 56' D VAL . 9.0 mtmm -143.81 160.25 50.86 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.215 -0.928 . . . . 0.0 110.383 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 56' E LYS . 8.0 Cg_exo -74.21 128.64 12.31 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.359 1.715 . . . . 0.0 111.166 -178.744 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.93 144.39 39.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.481 -0.762 . . . . 0.0 109.714 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -90.94 47.48 1.35 Allowed 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.108 -2.039 . . . . 0.0 110.485 0.198 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.278 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 47.1 mm-40 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.374 0.607 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.7 80.11 6.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.365 -0.835 . . . . 0.0 109.977 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.621 HG22 ' HB2' ' A' ' 10' ' ' TYR . 5.3 mt -89.31 141.47 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 110.609 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.581 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -47.17 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.996 0.903 . . . . 0.0 111.139 -179.917 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.801 HD22 HD12 ' A' ' 40' ' ' ILE . 3.8 tp -93.19 -39.9 10.77 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -86.66 -61.11 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.042 178.831 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 1.6 t70 -50.33 -47.56 55.79 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.342 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.621 ' HB2' HG22 ' A' ' 5' ' ' ILE . 4.0 t80 -53.92 -61.31 2.38 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.885 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -57.01 -16.6 7.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.141 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -86.16 -30.67 22.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.511 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -3.93 38.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -126.96 32.72 5.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 -179.994 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 14' ' ' PHE . . . 60.93 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.572 ' NE2' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -79.64 -26.53 41.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 110.375 -179.962 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -75.89 -23.66 55.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 2.7 tptt -76.63 -56.66 4.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.202 -0.936 . . . . 0.0 109.022 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 11' ' ' ALA . 1.7 m -55.35 -27.95 50.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 178.581 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.44 -30.35 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -82.8 -8.46 59.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -90.41 -48.93 6.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 110.251 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.92 -36.63 36.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.58 33.11 4.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.22 161.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.204 -1.174 . . . . 0.0 109.908 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -76.26 156.06 33.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -35.66 75.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.45 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -62.42 -51.22 68.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.96 -24.8 1.63 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.652 HG23 HG13 ' A' ' 34' ' ' ILE . 1.2 mp -82.92 -56.2 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.949 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.572 ' OD1' ' NE2' ' A' ' 16' ' ' GLN . 3.3 m120 -49.78 -16.91 0.29 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.709 . . . . 0.0 111.374 -179.32 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -99.87 -51.64 3.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.436 -1.415 . . . . 0.0 109.039 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.599 ' O ' HD13 ' A' ' 34' ' ' ILE . . . -80.08 11.46 3.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.653 178.697 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.688 HD11 HD11 ' A' ' 7' ' ' LEU . 26.4 mm -135.32 -41.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 110.305 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -70.1 -30.6 67.85 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.947 179.724 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.19 -78.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.12 69.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.539 ' HB3' HD23 ' A' ' 7' ' ' LEU . 1.5 tpt180 -90.7 123.59 34.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 111.267 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -98.94 63.35 1.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.359 -0.838 . . . . 0.0 109.319 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.86 HG23 ' CA ' ' A' ' 54' ' ' GLU . 5.5 mt -113.29 161.1 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.284 -179.255 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 32.4 m-85 -137.93 150.42 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.948 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.0 mp -126.94 140.71 52.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.437 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -103.37 103.68 13.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 49' ' ' SER . 3.8 mt -98.89 75.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.131 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 49' ' ' SER . 4.5 p30 -41.87 166.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.686 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.44 -7.67 3.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.555 -0.715 . . . . 0.0 109.323 178.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.15 6.41 11.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.57 0.32 30.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 44' ' ' ILE . 4.6 t -59.17 -176.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.049 -1.265 . . . . 0.0 109.493 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 49' ' ' SER . 94.2 t -149.65 115.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.612 -179.638 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.501 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 6.6 m-85 -113.45 154.58 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.76 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -131.53 147.26 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.94 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 52' ' ' ALA . 15.6 mt-10 -154.43 99.05 2.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.86 ' CA ' HG23 ' A' ' 40' ' ' ILE . 12.8 tt0 -79.89 147.94 31.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.051 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 56' D VAL . 2.3 t -137.25 97.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.931 -1.106 . . . . 0.0 110.46 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' B GLY . 6.7 ttpt -117.64 148.75 41.66 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.838 . . . . 0.0 109.75 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' A ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' LYS . 9.7 t70 -43.23 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 110.237 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' B GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 152.27 -55.87 0.45 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -174.75 166.11 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.866 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' D VAL . . . . . 0.644 ' CG1' HG13 ' A' ' 55' ' ' VAL . 16.0 m -107.43 160.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -0.839 . . . . 0.0 109.493 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' E LYS . . . . . 0.515 ' HB2' ' CD ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.56 178.12 1.59 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.018 -1.051 . . . . 0.0 110.694 -179.953 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 56' E LYS . 4.8 Cg_exo -77.72 -64.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.296 -2.193 0 O-C-N 124.39 1.732 . . . . 0.0 110.529 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.493 ' HB2' ' HD2' ' A' ' 56' E LYS . 9.5 t80 57.93 117.92 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 2.8 Cg_exo -72.57 130.74 20.33 Favored 'Cis proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.178 -2.009 . . . . 0.0 110.308 -0.053 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.5 179.949 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 36.4 mm-40 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.338 0.589 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 1.4 ttt180 -81.52 69.73 8.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 111.03 -179.309 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.588 ' HB ' ' CD1' ' A' ' 10' ' ' TYR . 6.0 mm -90.66 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 109.904 179.342 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -91.37 164.88 13.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.052 -1.03 . . . . 0.0 112.409 -178.503 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.782 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -59.82 -26.55 65.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.375 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HG2' HG21 ' A' ' 34' ' ' ILE . 5.6 tmtm? -80.21 -79.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.19 -54.4 16.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.784 -1.198 . . . . 0.0 110.228 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.596 ' CB ' ' O ' ' A' ' 6' ' ' THR . 17.7 t80 -46.95 -53.28 12.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.943 -1.098 . . . . 0.0 110.12 -179.75 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.31 -34.97 67.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 110.194 -179.575 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -34.91 78.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -32.61 47.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD2' ' HD3' ' A' ' 18' ' ' LYS . 5.6 m-30 -107.88 -63.59 1.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 152.62 143.77 3.76 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.751 ' NE2' HG21 ' A' ' 30' ' ' ILE . 6.4 tp60 -53.32 -33.23 52.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -28.14 54.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 110.493 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HD3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -73.79 -56.01 5.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 179.66 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.428 ' HG1' ' HD2' ' A' ' 10' ' ' TYR . 8.1 m -62.96 -17.99 62.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.466 -0.771 . . . . 0.0 109.396 179.286 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -80.32 -36.67 33.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 110.399 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.93 -23.25 48.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.889 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.35 -27.5 32.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.071 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.782 HD11 ' CD1' ' A' ' 7' ' ' LEU . 30.2 mt -81.96 -40.49 22.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.72 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.12 18.11 10.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.35 158.98 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 109.916 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 15.1 m-30 -67.82 178.72 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.34 -179.744 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.537 ' HA ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -70.39 -22.57 62.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -0.903 . . . . 0.0 110.207 179.868 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 m -59.1 -49.69 76.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.47 -19.45 5.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.751 HG21 ' NE2' ' A' ' 16' ' ' GLN . 3.0 mm -80.63 -57.85 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.854 0.835 . . . . 0.0 110.003 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 6.5 t-20 -54.3 -15.53 1.65 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.558 -179.444 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -40.96 10.85 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.496 -1.378 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -78.09 -4.55 47.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 109.204 178.717 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.745 HD12 HG22 ' A' ' 30' ' ' ILE . 15.2 mt -120.02 -47.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.449 -0.782 . . . . 0.0 110.666 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.564 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 12.1 t60 -69.58 -22.22 63.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.006 -1.059 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.38 33.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.194 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.86 46.35 1.04 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.47 148.54 24.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -90.35 55.55 3.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.994 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.847 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 7.0 mt -81.3 163.0 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.768 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.658 ' C ' HD12 ' A' ' 42' ' ' LEU . 53.2 m-85 -157.38 142.1 16.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.55 -0.719 . . . . 0.0 109.26 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.76 HD21 HD11 ' A' ' 7' ' ' LEU . 5.3 mp -129.05 113.56 15.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.931 -1.105 . . . . 0.0 111.725 -179.17 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.8 m -97.72 101.68 13.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.396 -0.815 . . . . 0.0 108.918 178.472 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.565 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 8.5 mt -96.56 136.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 111.081 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.9 m120 -51.83 -18.91 1.45 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 110.653 178.768 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.775 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 90.06 -17.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -176.11 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.05 -13.4 41.63 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.996 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.644 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 134.3 -26.42 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.563 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 107.36 0.78 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -1.226 . . . . 0.0 109.682 179.97 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 48' ' ' GLY . 40.3 t -100.16 117.95 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.067 . . . . 0.0 111.317 -179.19 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 23.3 m-30 -104.04 111.07 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 108.933 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -87.8 76.51 8.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 0.0 111.072 -179.013 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -84.86 147.03 27.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 109.432 179.102 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 56' D VAL . 7.8 mt-10 -127.73 173.07 10.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.015 -179.993 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.6 119.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.048 -1.033 . . . . 0.0 110.592 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' B GLY . 9.3 tptp -138.31 143.75 40.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 179.534 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' A ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.6 OUTLIER -42.11 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 110.352 -179.762 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 56' B GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 143.34 -54.21 0.59 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.34 162.06 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 110.516 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' D VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 56' E LYS . 33.9 m -79.78 161.18 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 179.754 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' E LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.93 163.23 45.9 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.142 -0.974 . . . . 0.0 110.767 -179.828 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.3 Cg_endo -83.41 179.18 5.17 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.813 1.675 . . . . 0.0 110.148 -179.29 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.545 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 31.4 t80 179.11 121.68 0.21 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 110.311 -179.645 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 10.1 Cg_endo -85.78 101.4 0.33 Allowed 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.728 -1.78 . . . . 0.0 110.433 -0.055 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 59' ' ' PRO . 20.2 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 110.147 179.772 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.498 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 20.7 mt-30 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -78.75 83.86 4.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.297 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.728 HG22 ' H ' ' A' ' 6' ' ' THR . 9.7 mt -90.2 -173.63 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.728 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.12 -179.36 5.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.087 -1.008 . . . . 0.0 111.993 -179.047 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.708 HD11 ' CD1' ' A' ' 34' ' ' ILE . 6.1 tp -92.3 -41.54 10.32 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.778 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.565 ' HD3' ' CG2' ' A' ' 34' ' ' ILE . 1.3 mmtt -86.27 -64.1 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.333 179.17 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.7 OUTLIER -46.77 -52.14 14.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.516 179.475 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.693 ' CE2' HD11 ' A' ' 44' ' ' ILE . 4.7 t80 -52.54 -55.13 24.24 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.232 179.79 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -18.72 60.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.951 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -22.11 22.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.041 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -12.26 29.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.777 179.864 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -123.64 -65.85 1.04 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.24 162.19 12.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -77.68 -30.79 52.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -1.143 . . . . 0.0 110.271 -179.988 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 26.0 p -72.52 -33.22 66.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 179.678 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.9 -54.76 11.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.45 -0.781 . . . . 0.0 109.161 179.33 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.445 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 21.7 m -62.23 -20.01 63.78 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.733 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -72.16 -47.53 50.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -70.16 -25.05 63.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.595 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.003 ' HB3' HG11 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -61.86 -47.62 84.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.431 -0.793 . . . . 0.0 109.962 179.675 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 23' ' ' LEU . 3.4 mt -90.4 -6.54 54.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.852 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.39 22.23 71.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.521 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.55 HG23 ' HB2' ' A' ' 23' ' ' LEU . 3.2 t -107.93 153.07 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -1.019 . . . . 0.0 110.23 -179.683 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 12.0 m-85 -59.12 176.29 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.833 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.458 ' HA ' HD12 ' A' ' 30' ' ' ILE . 2.1 mt-30 -83.68 -10.89 57.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.005 179.761 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -83.26 -61.78 1.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.92 179.792 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -45.42 -40.59 8.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 109.714 179.572 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.558 HG22 ' CD1' ' A' ' 34' ' ' ILE . 72.8 mt -65.0 -55.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.766 . . . . 0.0 109.946 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -50.33 -13.91 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.358 -0.839 . . . . 0.0 111.096 179.792 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 -37.82 14.42 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.408 -1.432 . . . . 0.0 108.869 178.809 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.03 -10.94 59.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.154 178.488 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.708 ' CD1' HD11 ' A' ' 7' ' ' LEU . 7.1 mt -108.8 -47.92 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.845 179.731 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 9.9 t-80 -65.78 -24.21 66.89 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.152 -0.967 . . . . 0.0 110.305 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.18 -28.52 62.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -0.945 . . . . 0.0 110.658 -179.626 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 8' ' ' LYS . . . 92.54 47.63 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.0 172.0 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.55 -179.723 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.571 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -103.8 64.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.821 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.711 HD13 ' HB2' ' A' ' 54' ' ' GLU . 4.2 mm -87.83 169.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 111.036 -179.323 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 84.5 m-85 -156.88 115.73 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.215 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.71 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.8 mp -92.56 114.36 26.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 111.375 -178.851 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.9 m -90.81 102.9 15.66 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.409 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.693 HD11 ' CE2' ' A' ' 10' ' ' TYR . 6.6 mt -99.9 102.01 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.909 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.51 173.02 9.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 0.0 109.689 179.128 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -9.25 3.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.092 179.004 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 10.65 7.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.293 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.84 10.14 23.94 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t -89.62 99.63 12.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -1.224 . . . . 0.0 109.591 179.628 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.003 HG11 ' HB3' ' A' ' 22' ' ' ASP . 5.8 p -79.75 137.06 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.84 . . . . 0.0 110.549 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 8.5 m-85 -112.18 95.38 5.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 109.696 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -83.47 111.43 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' OE1' ' CG2' ' A' ' 56' D VAL . 0.1 OUTLIER -147.18 131.73 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 111.088 -179.408 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.711 ' HB2' HD13 ' A' ' 40' ' ' ILE . 1.7 tt0 -79.77 134.33 36.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.178 179.098 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.669 HG22 ' CG2' ' A' ' 56' D VAL . 11.2 t -123.11 134.74 65.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.992 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 56' B GLY . 11.8 tptp -158.08 144.54 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' A ASP . . . . . . . . . . . . . 1.5 t70 -46.07 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 109.872 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' B GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 150.15 -48.71 0.58 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -172.47 156.15 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -1.104 . . . . 0.0 110.636 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' D VAL . . . . . 0.669 ' CG2' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -138.54 125.74 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.76 . . . . 0.0 109.398 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 56' E LYS . . . . . 0.49 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.6 158.84 60.57 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.572 -179.409 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 1.8 Cg_endo -87.61 74.49 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.855 1.703 . . . . 0.0 112.442 -177.814 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -42.98 128.31 3.25 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.049 -1.032 . . . . 0.0 109.162 178.519 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 36.9 Cg_endo -88.9 93.83 0.14 OUTLIER 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.763 -1.766 . . . . 0.0 110.698 0.058 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.541 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 1.2 m . . . . . 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.646 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 35.3 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.154 0.502 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.3 mm-40 55.32 -154.37 0.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.021 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.8 mm-40 -95.72 58.9 2.02 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.144 . . . . 0.0 109.16 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 4.7 ttt180 -79.4 72.12 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.793 HG22 ' HB2' ' A' ' 10' ' ' TYR . 10.7 mm -84.86 157.73 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.382 -0.824 . . . . 0.0 109.168 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 10.9 p -65.32 -174.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 111.216 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -91.35 -35.3 14.49 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.2 tmtp? -81.78 -69.63 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.684 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -42.53 -55.57 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.563 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.793 ' HB2' HG22 ' A' ' 5' ' ' ILE . 10.1 t80 -44.0 -56.22 4.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HB1' ' OE1' ' A' ' 16' ' ' GLN . . . -54.91 -35.67 64.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.466 -0.771 . . . . 0.0 110.382 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ttp -66.8 -35.11 79.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.881 . . . . 0.0 110.586 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -78.45 -24.73 45.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.184 -0.947 . . . . 0.0 110.343 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -111.09 -77.36 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.014 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.35 158.85 19.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.465 ' OE1' ' HB1' ' A' ' 11' ' ' ALA . 2.4 tp60 -74.03 -30.62 62.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -24.23 41.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -52.15 8.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.175 -0.953 . . . . 0.0 108.758 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.47 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.5 m -58.31 -27.17 63.85 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.47 -53.81 8.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -9.19 45.44 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.774 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.87 -44.81 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.607 HD21 ' CD2' ' A' ' 42' ' ' LEU . 14.3 mt -79.57 -28.97 41.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 42.02 4.45 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 23' ' ' LEU . 1.2 t -129.96 179.44 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -1.161 . . . . 0.0 109.696 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' H ' HG12 ' A' ' 25' ' ' VAL . 93.9 m-85 -75.15 154.8 37.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.326 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -26.59 64.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 m -71.26 -50.57 31.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.905 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.58 -17.89 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.181 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -78.25 -61.3 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.699 0.761 . . . . 0.0 109.214 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.749 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -54.71 -14.28 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.664 -0.648 . . . . 0.0 110.501 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 10.6 tttt -93.57 -39.98 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.576 -1.327 . . . . 0.0 108.964 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.24 -8.66 57.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.185 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.804 HD11 HD11 ' A' ' 7' ' ' LEU . 8.3 mt -118.56 -47.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.424 -0.798 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.584 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.8 t-80 -72.95 -11.17 60.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.957 -1.089 . . . . 0.0 110.01 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -76.34 -88.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.962 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.04 46.45 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.69 -170.03 2.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.526 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 13.8 ptpt -148.64 87.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.686 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.584 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 22.8 mt -118.21 171.83 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.86 . . . . 0.0 110.739 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 28.2 m-85 -154.02 110.03 3.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.484 -0.76 . . . . 0.0 109.701 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.607 ' CD2' HD21 ' A' ' 23' ' ' LEU . 3.8 mp -86.14 128.71 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 111.327 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 51' ' ' TYR . 1.6 m -93.74 105.87 17.88 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.989 HG23 ' O ' ' A' ' 49' ' ' SER . 7.2 mt -91.61 134.22 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 110.916 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.762 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.8 m-20 -53.85 -18.66 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.66 -0.65 . . . . 0.0 110.512 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.01 -19.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -2.33 56.44 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.34 0.52 25.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.989 ' O ' HG23 ' A' ' 44' ' ' ILE . 2.1 t -72.46 -175.18 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -1.138 . . . . 0.0 110.139 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 49' ' ' SER . 19.8 t -156.11 130.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 8.0 t80 -128.0 76.16 1.67 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 109.345 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -48.54 130.29 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 110.998 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -132.81 84.94 2.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 109.758 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.523 ' CB ' HG12 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -79.0 147.12 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.333 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.58 HG13 HG12 ' A' ' 56' D VAL . 5.0 t -138.71 86.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.82 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 56' A ASP . 7.2 ttpp -97.12 91.48 5.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 110.106 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' A ASP . . . . . 0.556 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -4.38 73.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.28 0.562 . . . . 0.0 112.373 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 157.0 -23.94 0.47 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.3 tt0 -178.92 128.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.109 -1.23 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' D VAL . . . . . 0.58 HG12 HG13 ' A' ' 55' ' ' VAL . 3.6 m -100.21 129.33 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.655 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' E LYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -134.72 158.45 75.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 110.517 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 56' E LYS . 11.2 Cg_exo -72.71 -59.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.263 1.665 . . . . 0.0 110.327 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER 56.35 109.99 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 110.072 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 58' ' ' PHE . 20.2 Cg_exo -62.94 133.61 14.05 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.497 0.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.88 170.14 8.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.9 p30 -119.02 165.38 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 3.3 ttmt 178.99 64.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 0.0 110.244 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 1.2 pttp -80.26 77.29 7.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -77.27 0.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.933 . . . . 0.0 110.214 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 p -83.68 6.03 22.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.378 -0.826 . . . . 0.0 110.243 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.231 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.264 0.554 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 57.84 -156.42 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.013 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.6 mm100 -103.35 65.16 0.84 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.11 -0.993 . . . . 0.0 110.05 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 18.6 ttt180 -79.53 74.54 6.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 109.626 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' A' ' 10' ' ' TYR . 2.9 mt -90.87 146.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.676 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.06 -178.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.768 0.794 . . . . 0.0 111.3 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.704 ' HB3' HD12 ' A' ' 34' ' ' ILE . 13.1 tp -92.34 -49.97 5.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.918 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.16 -64.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.598 -0.688 . . . . 0.0 109.306 178.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -43.72 -53.26 5.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.108 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.635 ' HB2' HG22 ' A' ' 5' ' ' ILE . 1.9 t80 -46.46 -55.18 7.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 109.707 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.85 -37.34 42.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.612 0.72 . . . . 0.0 109.584 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -55.35 -41.14 72.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 110.415 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -38.77 54.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.52 -67.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 110.007 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 168.65 155.08 9.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.452 ' HB3' ' HG2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.29 -33.85 70.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -1.156 . . . . 0.0 109.878 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.873 HG23 ' OE1' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -85.23 -7.55 58.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.151 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -53.9 5.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -34.1 77.1 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.421 -0.8 . . . . 0.0 109.051 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.44 -23.55 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 17' ' ' THR . 2.3 mmtt -71.04 -43.79 67.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.002 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.508 ' CB ' HG21 ' A' ' 50' ' ' VAL . 3.8 m-20 -70.09 -28.79 65.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 23' ' ' LEU . 22.0 mt -79.45 -27.51 41.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 26.96 31.45 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.0 m -135.82 156.13 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.549 ' O ' HD13 ' A' ' 30' ' ' ILE . 96.1 m-85 -64.93 172.18 3.04 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 110.073 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.873 ' OE1' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER -75.72 -23.37 56.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.172 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -62.85 -46.52 87.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.844 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.69 66.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.853 . . . . 0.0 109.949 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.746 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.5 mp -67.03 -49.88 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' LYS . 25.5 m-20 -57.22 -58.94 6.02 Favored 'General case' 0 C--O 1.194 -1.833 0 O-C-N 121.358 -0.839 . . . . 0.0 110.007 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -49.76 -23.87 2.04 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 119.588 -1.945 . . . . 0.0 109.107 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 30' ' ' ILE . . . -76.7 -40.19 49.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.558 -0.714 . . . . 0.0 109.935 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.918 HD13 ' HB2' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -95.12 -40.47 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.405 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -60.69 -58.27 9.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.917 -1.115 . . . . 0.0 108.407 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.45 15.1 16.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.932 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.955 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -152.12 93.39 0.14 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 9.8 mmm-85 -86.77 168.86 13.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -1.064 . . . . 0.0 110.82 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER 71.29 66.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.303 -0.873 . . . . 0.0 110.439 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.955 HD11 ' O ' ' A' ' 37' ' ' GLY . 17.2 mt -125.45 163.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.5 m-85 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 6' ' ' THR . 4.4 mp -140.88 116.87 10.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.534 ' OG1' ' CB ' ' A' ' 51' ' ' TYR . 2.3 p -88.01 101.67 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.555 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.5 mt -94.78 124.44 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.047 -1.033 . . . . 0.0 110.314 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.561 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -85.43 -177.25 6.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -0.969 . . . . 0.0 110.26 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.36 0.16 17.79 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -101.14 -4.45 27.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.692 . . . . 0.0 110.166 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 90.84 -15.06 61.55 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.86 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -1.193 . . . . 0.0 109.589 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG21 ' CB ' ' A' ' 22' ' ' ASP . 45.7 t -80.8 105.78 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 111.063 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CB ' ' OG1' ' A' ' 43' ' ' THR . 0.2 OUTLIER -88.26 90.71 8.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 109.083 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -89.08 140.48 29.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 110.124 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 56' E LYS . 0.2 OUTLIER -152.61 136.73 16.47 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.889 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 56' D VAL . 8.7 mt-10 -98.1 111.83 24.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG23 HG12 ' A' ' 56' D VAL . 2.6 p -109.82 132.69 57.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.245 -0.91 . . . . 0.0 110.186 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 56' A ASP . 13.8 ttpp -160.24 110.41 1.82 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.677 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' A ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 38.6 t70 61.26 11.42 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.609 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' B GLY . . . . . 0.846 ' O ' HG13 ' A' ' 56' D VAL . . . 128.91 -44.92 1.18 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.455 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' C GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.8 mt-10 -60.9 98.2 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.241 -1.152 . . . . 0.0 110.93 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' D VAL . . . . . 0.846 HG13 ' O ' ' A' ' 56' B GLY . 4.8 m -107.19 61.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.833 . . . . 0.0 110.088 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' E LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -58.93 174.9 0.36 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.97 -1.081 . . . . 0.0 110.557 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.473 ' CD ' ' HB3' ' A' ' 56' E LYS . 2.0 Cg_endo -88.98 -79.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.35 2.033 . . . . 0.0 110.215 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.515 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.6 OUTLIER 59.91 122.31 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.282 -0.886 . . . . 0.0 109.865 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -77.78 128.91 17.52 Favored 'Cis proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.326 -0.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.56 -170.49 2.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.383 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -144.09 138.95 28.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.355 -0.841 . . . . 0.0 109.917 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -168.75 55.82 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 110.422 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.7 ptmm? -58.82 -161.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 110.097 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -165.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.13 -0.981 . . . . 0.0 109.735 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ALA . 3.8 t -91.3 -16.07 28.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.372 0.606 . . . . 0.0 110.089 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 45' ' ' ASN . 14.7 mm-40 -47.14 94.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 4.3 mm-40 -139.6 -129.11 0.12 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.029 -1.044 . . . . 0.0 108.992 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 40.0 ttp180 -125.16 79.84 1.83 Allowed 'General case' 0 C--N 1.283 -2.292 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.814 HG22 ' HB2' ' A' ' 10' ' ' TYR . 24.2 mt -84.75 135.59 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.383 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -49.46 -176.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.068 0.937 . . . . 0.0 111.833 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.033 HD23 HD13 ' A' ' 40' ' ' ILE . 2.8 tp -94.4 -37.21 11.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.647 ' HB2' HG23 ' A' ' 34' ' ' ILE . 1.4 tmtt? -83.84 -65.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.278 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 8.3 m-20 -46.84 -45.58 20.31 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.814 ' HB2' HG22 ' A' ' 5' ' ' ILE . 13.3 t80 -55.4 -50.98 68.33 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.719 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -26.14 63.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.767 -0.583 . . . . 0.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -21.63 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -101.32 -6.15 24.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -77.52 0.59 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.1 143.25 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -65.1 -31.99 73.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 110.097 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -80.4 -10.82 59.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.118 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -90.97 -36.65 13.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.342 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.699 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -74.89 -26.94 60.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.288 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HA ' HD11 ' A' ' 30' ' ' ILE . . . -82.42 -39.09 23.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.813 . . . . 0.0 110.699 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.6 tmtt? -65.08 -34.68 79.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 109.956 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 7.7 m-20 -71.46 -38.38 71.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 110.023 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 19' ' ' THR . 21.1 mt -80.7 -7.59 59.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 110.407 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 35.42 90.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -134.44 175.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.22 -1.165 . . . . 0.0 109.9 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -82.36 146.19 29.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 110.378 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 1.055 ' HA ' HD12 ' A' ' 30' ' ' ILE . 2.2 mt-30 -53.35 -24.6 12.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.364 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -64.16 -57.54 9.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.93 -30.9 4.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.135 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.055 HD12 ' HA ' ' A' ' 27' ' ' GLN . 45.2 mt -70.0 -55.48 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.035 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.0 OUTLIER -59.99 -7.76 1.94 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 111.378 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -91.26 -34.45 14.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.574 -1.329 . . . . 0.0 108.266 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.76 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -86.16 -15.84 39.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.647 HG23 ' HB2' ' A' ' 8' ' ' LYS . 10.6 mt -95.46 -48.11 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.513 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 18.8 t60 -68.09 -55.9 10.81 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.229 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.11 13.44 18.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.63 83.78 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 8.0 mmm-85 -90.43 77.14 6.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.538 ' CE ' ' HB2' ' A' ' 56' ' ' LYS . 2.9 pttm 177.18 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.568 -0.708 . . . . 0.0 109.126 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.033 HD13 HD23 ' A' ' 7' ' ' LEU . 5.4 mt -103.17 161.66 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.748 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.603 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 37.6 m-85 -157.47 131.31 8.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.397 -0.814 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 7' ' ' LEU . 2.0 mp -124.54 118.3 26.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 0.0 110.353 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -89.27 102.65 15.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.064 -1.022 . . . . 0.0 109.429 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.3 mt -89.29 43.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.962 -1.086 . . . . 0.0 109.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.71 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 49.4 p-10 -105.45 -151.53 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 68.92 6.34 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.143 -0.973 . . . . 0.0 108.799 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.704 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 120.61 -53.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.47 29.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 33.6 t -78.01 156.37 30.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.541 -0.976 . . . . 0.0 110.181 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 50' ' ' VAL . 24.8 t -110.82 98.35 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 110.484 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.54 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 5.5 m-85 -96.9 89.85 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . -89.71 122.73 33.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.181 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 56' E LYS . 0.5 OUTLIER -160.21 137.49 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.937 . . . . 0.0 110.582 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.539 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.45 178.52 4.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.835 . . . . 0.0 109.673 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.676 HG22 HG12 ' A' ' 56' D VAL . 83.9 t -152.06 111.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.965 . . . . 0.0 110.462 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HB2' ' CE ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.49 122.4 41.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.094 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.0 t0 50.98 -90.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' B GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -142.52 54.87 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.5 tt0 -162.19 97.03 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.136 . . . . 0.0 110.351 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' D VAL . . . . . 0.676 HG12 HG22 ' A' ' 55' ' ' VAL . 11.1 m -92.62 165.29 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' E LYS . . . . . 0.501 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 9.5 ptpt -165.68 148.53 6.7 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.076 -1.015 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.0 Cg_exo -76.76 73.76 5.16 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.959 1.505 . . . . 0.0 111.211 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -45.62 132.93 6.39 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.846 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 79.0 Cg_endo -92.61 79.15 0.13 OUTLIER 'Cis proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.827 -1.739 . . . . 0.0 110.816 0.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.576 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 1.1 p -62.62 -167.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 110.645 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.616 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 0.5 OUTLIER 37.12 55.13 1.28 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.722 -0.612 . . . . 0.0 110.734 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.07 49.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.263 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -136.38 -95.15 0.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 110.09 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.39 -92.28 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.06 -1.025 . . . . 0.0 110.205 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 11.4 t -132.17 26.15 4.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 110.09 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.231 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' C ' ' CG ' ' A' ' 2' ' ' GLU . 16.5 tpp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.242 0.544 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' CG ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -166.71 109.76 0.72 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 109.907 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -100.4 58.85 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.646 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.22 94.77 4.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.993 0.901 . . . . 0.0 111.011 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.754 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.2 mt -90.3 -173.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.663 -0.648 . . . . 0.0 109.766 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.627 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.76 -179.09 5.43 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.288 -0.883 . . . . 0.0 111.608 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.06 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -91.4 -43.01 10.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.835 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.56 -63.79 1.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.406 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -44.25 -50.77 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.643 ' CE1' HD12 ' A' ' 5' ' ' ILE . 5.3 t80 -57.39 -51.64 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.358 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.648 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -49.03 -26.08 2.39 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 109.605 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 tpt -71.83 -52.65 16.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.036 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.94 -21.03 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.636 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.95 -75.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 109.611 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 173.5 142.58 3.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.648 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -59.42 -36.06 75.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -1.232 . . . . 0.0 109.701 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -78.72 -16.5 57.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.76 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -78.59 -51.24 10.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 0.0 109.256 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.3 m -64.7 -23.82 67.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.82 -25.82 30.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.285 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.55 -27.27 41.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.74 -27.95 26.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.846 . . . . 0.0 110.218 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.875 HD21 HD23 ' A' ' 42' ' ' LEU . 29.7 mt -80.02 -8.13 59.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' O ' HG13 ' A' ' 25' ' ' VAL . . . 68.66 29.71 72.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 24' ' ' GLY . 5.7 m -151.48 150.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 110.107 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.555 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 9.3 p90 -66.68 169.33 7.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.957 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.572 ' HA ' HD13 ' A' ' 30' ' ' ILE . 9.4 mp0 -65.3 -32.07 73.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 111.349 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.555 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -46.6 -48.37 19.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.972 -1.08 . . . . 0.0 110.773 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.44 70.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 27' ' ' GLN . 2.8 mp -72.11 -32.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.79 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 6.8 t-20 -65.88 -23.77 66.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -36.84 12.84 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.423 -1.423 . . . . 0.0 108.047 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.725 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -71.14 -14.77 62.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.017 HD11 ' HB2' ' A' ' 7' ' ' LEU . 5.7 mt -112.48 -54.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.4 t-80 -56.19 -15.63 4.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -85.23 29.14 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.755 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . 43.52 44.11 6.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.32 -172.0 3.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -1.112 . . . . 0.0 111.07 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 55' ' ' VAL . 15.3 mttt -135.02 83.87 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.539 -0.725 . . . . 0.0 109.053 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.725 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 27.0 mt -114.4 165.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 111.372 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.2 m-85 -159.67 177.51 10.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.641 . . . . 0.0 109.388 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.06 HD11 ' CD1' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.41 111.78 5.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.062 . . . . 0.0 109.706 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.497 ' CG2' ' ND2' ' A' ' 45' ' ' ASN . 9.3 m -75.53 99.42 4.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.448 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' A' ' 10' ' ' TYR . 55.7 mt -86.99 59.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 111.364 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.497 ' ND2' ' CG2' ' A' ' 43' ' ' THR . 39.7 p30 -103.4 -123.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.997 -1.064 . . . . 0.0 109.711 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.895 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 40.65 29.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.107 -0.996 . . . . 0.0 109.969 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.578 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 41.8 t0 72.78 64.35 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.384 0.612 . . . . 0.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 -12.21 41.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.895 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -59.1 159.47 7.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.955 -1.321 . . . . 0.0 109.068 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.538 HG22 HG23 ' A' ' 44' ' ' ILE . 38.2 t -127.69 127.87 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 111.19 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 30.0 m-85 -124.64 159.03 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -143.62 137.2 28.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.802 -1.186 . . . . 0.0 111.112 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 56' E LYS . 1.1 mp0 -142.56 143.91 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 110.165 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE2' ' CD1' ' A' ' 58' ' ' PHE . 1.0 OUTLIER -84.01 167.55 16.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.669 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 39' ' ' LYS . 3.0 t -139.24 128.56 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.994 -1.066 . . . . 0.0 110.216 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -146.92 170.16 17.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' A ASP . . . . . 0.504 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 60.8 t0 -40.57 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' B GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 53.31 59.12 10.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 7.6 tt0 -172.49 88.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.197 -1.178 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' D VAL . . . . . . . . . . . . . 6.2 m -97.07 140.38 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 0.0 109.952 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' E LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -119.0 172.6 4.15 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.071 -1.018 . . . . 0.0 110.69 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 58' ' ' PHE . 1.2 Cg_endo -87.6 24.94 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.354 2.036 . . . . 0.0 110.564 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.525 ' CD1' ' OE2' ' A' ' 54' ' ' GLU . 62.4 t80 -30.64 123.62 0.32 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.873 -0.517 . . . . 0.0 111.304 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.8 Cg_endo -80.17 108.03 1.16 Allowed 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.396 -1.918 . . . . 0.0 110.551 0.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.422 ' N ' ' HA ' ' A' ' 58' ' ' PHE . 2.4 m -48.5 155.32 0.54 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.016 -1.052 . . . . 0.0 110.063 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -86.88 -171.24 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.077 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -155.47 52.85 0.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 110.464 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -100.18 -18.86 16.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.309 -0.87 . . . . 0.0 109.868 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.522 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 21.6 p 41.3 -150.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.366 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.68 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 3.3 t -172.7 55.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.987 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.111 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.027 0.441 . . . . 0.0 110.221 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER 58.81 136.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.393 -0.817 . . . . 0.0 110.157 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -121.5 72.63 1.01 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.997 -1.064 . . . . 0.0 109.951 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.76 92.18 4.78 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.131 0.967 . . . . 0.0 111.029 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.557 HG22 ' HB2' ' A' ' 10' ' ' TYR . 18.3 mt -90.74 154.86 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.983 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.673 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -50.78 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.281 1.039 . . . . 0.0 111.413 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.673 ' H ' HG22 ' A' ' 6' ' ' THR . 4.0 tp -92.91 -39.99 10.85 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HD3' HG22 ' A' ' 34' ' ' ILE . 1.1 mmmp? -90.64 -63.42 1.27 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.3 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.3 t70 -44.63 -44.89 9.29 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.7 t80 -56.46 -57.39 12.52 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.501 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.32 -21.01 4.96 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 ttm -78.43 -46.8 18.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.774 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -78.04 -10.85 59.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -69.42 0.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 133.06 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -58.86 -24.02 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.445 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 17' ' ' THR . 3.4 t -78.75 -26.8 44.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.041 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -76.35 -56.39 4.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 108.672 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -60.21 -30.75 69.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -64.2 -43.61 94.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -19.48 56.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -73.7 -26.4 60.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 30' ' ' ILE . 9.4 mt -82.93 -52.24 6.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.25 28.89 1.05 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG23 HG12 ' A' ' 30' ' ' ILE . 1.3 m -137.65 162.46 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -1.155 . . . . 0.0 110.015 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.76 -175.11 0.37 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.399 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -22.87 37.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 110.618 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' ALA . 23.5 t -74.58 -72.1 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 110.279 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.82 -27.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.307 -0.87 . . . . 0.0 109.349 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.879 HD12 HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -68.61 -61.69 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.546 -0.721 . . . . 0.0 109.566 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.751 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -46.56 -18.26 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.563 -0.711 . . . . 0.0 111.032 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -89.76 -40.86 12.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.438 -1.414 . . . . 0.0 108.588 178.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -7.04 53.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.517 -0.74 . . . . 0.0 109.136 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.879 HD11 HD12 ' A' ' 30' ' ' ILE . 15.8 mt -111.33 -54.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.636 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.57 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 67.2 t60 -61.16 -14.99 28.84 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -64.16 -9.01 14.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.629 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 34.12 60.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 153.69 31.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.55 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.544 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER -86.3 58.97 5.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.637 HD12 HD22 ' A' ' 7' ' ' LEU . 4.9 mt -93.25 167.83 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 111.093 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 68.0 m-85 -155.88 167.75 29.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 4.6 mp -142.79 105.35 4.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.835 -1.166 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 1.3 m -78.59 93.1 4.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.587 -0.695 . . . . 0.0 109.197 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 10' ' ' TYR . 27.8 mt -96.76 117.68 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.303 -0.873 . . . . 0.0 110.509 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 45' ' ' ASN . 1.1 m-20 -81.76 -173.48 4.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.266 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.66 0.34 17.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.72 0.71 52.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.122 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' SER . . . 85.16 -14.11 51.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -45.28 162.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -1.205 . . . . 0.0 109.928 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.51 ' CG2' ' OD2' ' A' ' 22' ' ' ASP . 80.9 t -138.72 114.94 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -101.04 80.39 2.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 109.382 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -80.42 89.68 5.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.701 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 56' E LYS . 27.3 tt0 -102.47 167.5 9.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.765 . . . . 0.0 109.687 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 56' D VAL . 0.8 OUTLIER -135.08 156.93 48.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.076 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.49 HG13 HG12 ' A' ' 56' D VAL . 2.4 t -141.58 105.23 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 56' A ASP . 11.3 ttpp -123.65 103.24 8.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' A ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 56' A ASP . 51.6 t0 59.09 23.77 12.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.915 . . . . 0.0 110.449 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' B GLY . . . . . 0.619 ' O ' HG13 ' A' ' 56' D VAL . . . 109.62 -36.5 4.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 42.5 mt-10 -63.04 104.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' D VAL . . . . . 0.619 HG13 ' O ' ' A' ' 56' B GLY . 34.0 m -106.4 157.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.122 -0.986 . . . . 0.0 110.46 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' E LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -174.26 167.54 2.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.962 . . . . 0.0 110.575 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.57 175.97 10.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 121.875 1.716 . . . . 0.0 110.411 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CE1' HD22 ' A' ' 23' ' ' LEU . 13.4 t80 -167.82 146.04 3.89 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 110.364 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HA ' ' CD2' ' A' ' 58' ' ' PHE . 59.1 Cg_endo -91.89 48.41 1.34 Allowed 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.115 -2.035 . . . . 0.0 110.455 0.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 t -65.62 177.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.235 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.61 89.59 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.424 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -166.15 61.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 109.991 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.597 ' CG ' ' HA ' ' A' ' 66' ' ' ALA . 12.4 ptpt -44.2 166.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -0.962 . . . . 0.0 109.976 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.7 ' O ' HG22 ' A' ' 65' ' ' THR . 77.9 p -80.87 142.02 34.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 110.7 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 64' ' ' THR . 13.8 t 40.52 28.59 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.745 0.783 . . . . 0.0 109.545 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HA ' ' CG ' ' A' ' 63' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.173 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.26 0.552 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.69 149.97 33.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 110.025 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -125.21 77.16 1.61 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.197 -0.939 . . . . 0.0 109.672 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 9.3 ttt180 -79.18 80.11 5.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.61 HG22 ' HB2' ' A' ' 10' ' ' TYR . 2.6 mt -86.02 164.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.523 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -70.34 -178.6 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.134 0.969 . . . . 0.0 112.367 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.669 HD21 HG12 ' A' ' 34' ' ' ILE . 3.5 tp -92.55 -40.36 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.546 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.44 -65.92 0.97 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.501 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -43.42 -48.54 7.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.61 ' HB2' HG22 ' A' ' 5' ' ' ILE . 12.6 t80 -54.03 -57.32 11.48 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.829 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.6 -27.37 4.47 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 109.912 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.79 77.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -15.04 58.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.229 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.71 -87.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 179.47 48.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 2.2 tp60 -90.2 -28.66 18.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -1.096 . . . . 0.0 110.509 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 6.1 t -87.03 -24.93 24.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.242 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -73.71 -59.08 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.955 . . . . 0.0 108.75 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.1 m -60.0 -32.27 70.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.581 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . . . -76.45 -20.63 56.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.129 -0.982 . . . . 0.0 110.336 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.45 -46.93 68.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.104 -0.997 . . . . 0.0 110.912 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.08 -6.41 53.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.105 -0.997 . . . . 0.0 112.221 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.838 HD13 HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -162.72 36.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.639 -1.288 . . . . 0.0 109.882 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . -160.82 67.25 0.26 Allowed Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.254 38.3 t -75.12 -2.26 3.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.734 0.778 . . . . 0.0 109.5 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.573 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -134.32 82.54 1.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 26' ' ' TYR . 1.6 tt0 -36.14 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.617 -0.677 . . . . 0.0 111.369 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 26' ' ' TYR . 36.1 p -76.61 -55.44 5.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.977 -1.077 . . . . 0.0 109.211 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . . . -57.45 -17.79 15.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.328 -0.857 . . . . 0.0 108.901 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.728 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -74.31 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.623 -0.673 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.728 ' N ' HG22 ' A' ' 30' ' ' ILE . 1.6 m-20 -62.24 -9.63 8.45 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.52 -0.737 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 2.3 ttpt -93.25 -38.15 11.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.866 -1.146 . . . . 0.0 108.086 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.5 -8.29 59.62 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.669 HG12 HD21 ' A' ' 7' ' ' LEU . 22.7 mt -108.89 -48.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.573 -0.704 . . . . 0.0 109.585 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 18.8 t-80 -70.96 -28.65 64.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.867 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -65.46 -33.43 75.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.52 59.72 0.83 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.33 -176.02 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 26.9 tttt -117.21 71.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.557 HD12 HD22 ' A' ' 7' ' ' LEU . 10.4 mt -115.95 166.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 91.8 m-85 -149.39 173.2 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.295 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.838 HD21 HD13 ' A' ' 23' ' ' LEU . 3.6 mp -143.32 147.96 35.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.007 -1.058 . . . . 0.0 111.455 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 94.9 m -112.63 105.52 13.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.583 -0.698 . . . . 0.0 109.191 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 45' ' ' ASN . 2.5 mt -83.04 -134.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.316 -0.865 . . . . 0.0 111.164 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.549 ' H ' HG22 ' A' ' 44' ' ' ILE . 2.1 p-10 34.77 -146.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.932 -0.48 . . . . 0.0 111.497 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.655 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 56.27 23.07 6.78 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.655 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 26.8 t70 100.19 35.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 123.752 0.821 . . . . 0.0 109.28 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.62 7.25 57.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -67.63 104.28 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -1.175 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.88 125.78 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.49 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 7.8 m-85 -112.29 158.86 19.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.803 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . . . -139.34 97.01 3.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 56' E LYS . 29.1 mt-10 -111.99 126.09 54.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.808 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 56' D VAL . 1.7 mt-10 -82.04 161.61 22.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 t -142.33 121.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.463 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -147.71 142.72 27.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' A ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 15.9 t70 56.21 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.919 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' B GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -157.8 36.21 0.54 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.69 132.01 12.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -1.175 . . . . 0.0 110.182 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' D VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -101.14 169.71 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.158 -0.964 . . . . 0.0 110.557 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' E LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 3.9 mttm -145.24 175.67 2.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 6.2 Cg_exo -81.57 -163.0 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.21 1.94 . . . . 0.0 110.433 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 179.07 113.41 0.19 Allowed Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.305 -0.872 . . . . 0.0 110.329 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 61' ' ' ASN . 46.0 Cg_endo -77.85 108.18 1.14 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.117 -2.035 . . . . 0.0 110.734 -0.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.49 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 63.4 p -47.03 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 59' ' ' PRO . 9.5 t-20 -152.52 62.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.87 . . . . 0.0 110.064 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -173.33 48.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.544 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -107.85 33.58 4.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 110.159 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.797 ' O ' HG22 ' A' ' 65' ' ' THR . 5.3 m -79.05 137.15 37.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.947 . . . . 0.0 110.151 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 64' ' ' THR . 0.5 OUTLIER 57.2 27.47 13.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 110.232 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.193 -179.827 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.356 0.598 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 52.54 94.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 110.2 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -114.08 72.87 0.8 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.213 -0.929 . . . . 0.0 109.633 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -80.38 68.64 6.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 110.503 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 10' ' ' TYR . 8.6 mt -91.79 139.35 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 17.7 p -51.22 -174.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.023 -1.048 . . . . 0.0 110.943 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.878 ' HB2' HD11 ' A' ' 42' ' ' LEU . 3.6 tp -91.42 -36.48 13.77 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HG3' ' CG2' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -82.87 -68.79 0.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.725 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.456 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.2 OUTLIER -44.99 -54.2 6.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.688 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.2 t80 -47.01 -55.24 8.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.277 -0.889 . . . . 0.0 110.232 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.46 61.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.529 -0.732 . . . . 0.0 110.162 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.3 ttm -67.67 -32.79 73.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HG2' ' NH1' ' A' ' 13' ' ' ARG . 30.6 mtt-85 -83.52 -27.3 29.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.5 -65.3 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.0 141.34 3.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.63 ' OE1' HG21 ' A' ' 30' ' ' ILE . 1.0 OUTLIER -58.5 -35.79 72.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.019 -1.283 . . . . 0.0 109.998 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -79.72 -16.52 55.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.125 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.93 -57.65 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m -49.83 -34.45 19.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.85 82.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.743 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -82.06 -4.72 57.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.728 . . . . 0.0 110.041 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' CB ' HD23 ' A' ' 23' ' ' LEU . 7.7 m-20 -84.44 -38.6 19.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.013 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.992 HD12 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -116.74 14.03 15.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.18 -0.95 . . . . 0.0 110.435 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.88 37.87 91.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.992 HG21 HD12 ' A' ' 23' ' ' LEU . 22.1 t -108.88 120.79 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -1.12 . . . . 0.0 110.062 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -45.72 166.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.492 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -71.51 -27.71 63.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.154 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 30' ' ' ILE . 29.3 t -70.66 -61.61 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.724 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -45.32 -26.18 0.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.153 -0.967 . . . . 0.0 109.114 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.77 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -66.06 -66.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.582 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.77 ' N ' HG22 ' A' ' 30' ' ' ILE . 71.0 m-80 -61.67 -7.25 3.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.545 -0.722 . . . . 0.0 110.468 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -35.93 15.22 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.863 -1.148 . . . . 0.0 108.116 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.98 -10.95 51.93 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.688 ' HA ' HD11 ' A' ' 40' ' ' ILE . 35.0 mt -103.66 -43.35 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 52.1 t-80 -74.93 -56.31 4.88 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.901 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.62 -4.17 55.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.955 . . . . 0.0 111.118 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -123.53 69.06 0.46 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.213 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -65.07 -170.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.243 . . . . 0.0 110.266 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 55.15 68.9 0.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 108.872 -179.059 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.755 HD13 HD23 ' A' ' 7' ' ' LEU . 2.8 mt -120.26 151.01 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.87 . . . . 0.0 110.444 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 90.5 m-85 -158.82 128.0 5.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.651 -0.656 . . . . 0.0 110.203 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -120.95 133.59 55.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 m -108.04 100.76 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.939 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.773 HG22 ' H ' ' A' ' 45' ' ' ASN . 5.8 mt -82.05 -173.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.898 . . . . 0.0 110.025 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.773 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.5 OUTLIER 82.7 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.248 0.547 . . . . 0.0 111.927 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.688 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 64.33 17.66 10.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 30.2 t70 110.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.948 0.899 . . . . 0.0 109.067 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.51 79.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -70.85 109.1 4.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.839 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.442 HG11 HD22 ' A' ' 23' ' ' LEU . 25.3 t -79.5 109.53 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 110.23 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 5.9 m-85 -95.21 143.94 26.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 108.937 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -127.21 86.86 2.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.113 . . . . 0.0 110.916 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.31 151.66 20.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.857 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.507 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -130.9 160.1 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 110.168 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 56' D VAL . 23.3 t -150.24 84.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.416 -0.802 . . . . 0.0 109.9 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 56' A ASP . 5.2 ttmt -94.16 101.76 13.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.141 -0.975 . . . . 0.0 109.609 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' A ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 56' ' ' LYS . 38.4 t70 -13.61 80.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.378 0.608 . . . . 0.0 112.049 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' B GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.08 -27.44 0.8 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.81 132.42 0.12 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.018 -1.284 . . . . 0.0 110.807 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' D VAL . . . . . 0.587 HG12 HG13 ' A' ' 55' ' ' VAL . 12.5 m -96.98 165.89 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' E LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 56' D VAL . 10.6 ptpt -175.53 171.8 1.15 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.847 -1.158 . . . . 0.0 110.813 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 60' ' ' SER . 3.7 Cg_exo -76.83 -173.18 1.65 Allowed 'Trans proline' 0 C--N 1.299 -2.078 0 O-C-N 124.53 1.805 . . . . 0.0 110.485 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 39.0 t80 178.91 114.79 0.19 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 110.865 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -79.5 107.13 0.99 Allowed 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.372 -1.928 . . . . 0.0 109.886 -0.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.474 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 12.5 p -66.85 164.73 16.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.508 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -161.26 119.5 2.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 109.973 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER 179.87 67.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.486 ' O ' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -39.96 -74.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.494 -0.754 . . . . 0.0 110.694 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.735 ' O ' HG22 ' A' ' 65' ' ' THR . 91.6 m 59.02 160.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.324 -0.86 . . . . 0.0 110.294 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.735 HG22 ' O ' ' A' ' 64' ' ' THR . 8.8 t 41.69 29.07 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.71 0.767 . . . . 0.0 109.508 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 1' ' ' MET . 30.8 ttm . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.149 0.499 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.539 ' CB ' ' O ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.05 -161.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.759 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 37.7 mm-40 -145.22 -136.05 0.09 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.057 -1.027 . . . . 0.0 108.288 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -126.55 90.48 3.18 Favored 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.617 -0.677 . . . . 0.0 109.455 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.745 HG22 ' HB2' ' A' ' 10' ' ' TYR . 1.1 mt -90.28 151.57 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.612 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 3.0 p -84.31 -166.16 1.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.767 0.794 . . . . 0.0 111.376 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.06 -28.41 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.51 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -81.65 -82.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.816 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.1 m-20 -41.69 -56.03 2.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.456 -0.778 . . . . 0.0 110.058 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.745 ' HB2' HG22 ' A' ' 5' ' ' ILE . 1.4 t80 -49.6 -50.63 41.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.409 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 7' ' ' LEU . . . -56.29 -32.49 64.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 110.37 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -36.56 84.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.313 -0.867 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -38.07 44.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.132 -0.98 . . . . 0.0 110.147 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -99.23 -80.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.996 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.59 44.19 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 14.3 mm100 -88.72 -31.03 18.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.242 -1.151 . . . . 0.0 110.053 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.8 m -83.18 -26.13 31.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -56.55 4.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 108.797 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 2.1 m -55.55 -30.64 61.13 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -64.0 -55.86 19.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.896 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -84.66 11.58 8.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.461 -0.774 . . . . 0.0 109.787 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 3.0 m-20 -90.23 -43.28 10.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.416 -0.802 . . . . 0.0 110.58 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.961 HD11 ' CG2' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -94.63 -22.25 18.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.504 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 115.75 58.19 0.34 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.961 ' CG2' HD11 ' A' ' 23' ' ' LEU . 3.1 t -152.53 161.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.269 . . . . 0.0 110.166 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -77.8 177.6 8.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.499 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.5 OUTLIER -72.04 -50.13 30.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 110.272 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.5 p -62.3 -60.32 3.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.59 -29.47 0.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.964 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.743 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -65.8 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.603 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.743 ' N ' HG22 ' A' ' 30' ' ' ILE . 2.7 m-20 -57.13 -7.45 0.52 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.473 -0.767 . . . . 0.0 111.208 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 -41.87 15.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.73 -1.231 . . . . 0.0 107.762 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' ALA . . . -70.44 -45.28 66.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 7' ' ' LEU . 10.5 mt -66.54 -46.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -42.87 -36.58 1.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.634 178.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 33' ' ' ALA . . . -67.91 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.758 -0.589 . . . . 0.0 109.727 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . 129.14 -16.24 5.77 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.337 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.697 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -39.97 81.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' GLY . 6.6 ptpt 9.69 69.06 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.512 0.672 . . . . 0.0 112.736 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.829 ' CG2' HD21 ' A' ' 7' ' ' LEU . 29.5 mt -80.77 167.48 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 109.126 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 40' ' ' ILE . 27.6 m-85 -158.29 150.55 21.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.877 -1.14 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 7' ' ' LEU . 4.5 mp -138.97 122.05 16.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.807 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.587 ' O ' ' CG2' ' A' ' 43' ' ' THR . 1.0 OUTLIER -102.27 109.48 21.16 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.475 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.023 HG23 ' O ' ' A' ' 49' ' ' SER . 2.0 mt -98.48 152.23 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 110.126 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.454 ' ND2' ' HA3' ' A' ' 48' ' ' GLY . 2.9 m-20 -136.09 -171.81 2.97 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.999 -1.063 . . . . 0.0 110.391 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.76 -4.22 30.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -156.67 16.91 0.31 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -93.4 -6.19 62.92 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.351 -1.899 . . . . 0.0 108.351 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.023 ' O ' HG23 ' A' ' 44' ' ' ILE . 72.1 m 54.24 -92.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' SER . 8.4 t -161.21 98.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.28 -0.888 . . . . 0.0 110.475 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 24.1 t80 -86.8 138.18 31.8 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.607 ' HB1' ' HD2' ' A' ' 58' ' ' PHE . . . -120.8 93.92 4.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.543 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 17.2 pt-20 -111.41 137.45 49.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 110.369 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -89.47 162.84 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.28 -0.888 . . . . 0.0 108.963 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 6.1 t -135.77 143.41 36.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.892 -1.13 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 56' B GLY . 2.6 tppt? -159.96 169.54 23.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 109.35 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' A ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 56' ' ' LYS . 36.9 t70 -29.57 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.379 0.609 . . . . 0.0 111.232 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' B GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 46.71 61.6 4.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.21 99.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.123 -1.222 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' D VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 56' E LYS . 16.5 m -107.17 153.41 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.132 -0.98 . . . . 0.0 109.681 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' E LYS . . . . . 0.506 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -144.03 175.7 2.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 110.604 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -87.79 -174.21 1.16 Allowed 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.092 1.862 . . . . 0.0 109.611 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.607 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 28.5 t80 174.39 113.78 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 110.434 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 61' ' ' ASN . 1.9 Cg_endo -80.06 110.7 1.98 Allowed 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.513 -1.87 . . . . 0.0 110.325 -0.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 16.3 m -35.23 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.538 -0.726 . . . . 0.0 110.867 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -54.89 -177.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.842 . . . . 0.0 110.453 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -142.46 50.18 1.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.83 . . . . 0.0 109.824 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.63 162.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.539 -0.726 . . . . 0.0 110.388 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.756 ' O ' HG22 ' A' ' 65' ' ' THR . 0.6 OUTLIER -80.91 170.75 15.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.325 -0.859 . . . . 0.0 110.301 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 64' ' ' THR . 5.7 t 41.86 28.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.778 0.799 . . . . 0.0 109.267 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' THR . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.176 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtp . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.214 0.53 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -55.83 177.52 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.074 -1.016 . . . . 0.0 109.452 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' THR . 30.1 mm-40 -145.17 -129.54 0.08 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.982 -1.074 . . . . 0.0 108.814 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . 0.255 0.3 OUTLIER -89.53 66.89 7.45 Favored 'General case' 0 C--N 1.282 -2.364 0 O-C-N 121.559 -0.713 . . . . 0.0 109.348 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.76 HG22 ' HB2' ' A' ' 10' ' ' TYR . 22.0 mt -87.24 155.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.221 -0.924 . . . . 0.0 111.242 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.682 HG22 ' H ' ' A' ' 7' ' ' LEU . 1.1 m -65.99 -173.37 0.18 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.149 0.976 . . . . 0.0 111.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.854 HD22 HD12 ' A' ' 40' ' ' ILE . 3.3 tp -93.23 -39.32 11.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.535 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.7 tmtm? -90.22 -61.81 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.113 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.501 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 52.2 t0 -46.42 -44.99 17.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.915 . . . . 0.0 108.641 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.76 ' HB2' HG22 ' A' ' 5' ' ' ILE . 3.0 t80 -55.52 -58.56 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.49 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.04 -14.6 17.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.457 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 tpt -90.52 -24.41 20.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 0.0 110.182 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.73 -21.0 21.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -107.22 -55.41 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.31 140.89 3.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -59.91 -35.68 75.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -11.29 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.486 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -52.47 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.76 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.723 ' O ' HD12 ' A' ' 23' ' ' LEU . 3.0 m -60.66 -34.56 74.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.533 ' CB ' ' HG3' ' A' ' 27' ' ' GLN . . . -78.43 -19.66 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -79.78 -51.08 9.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.493 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 57.0 p30 -70.86 -18.13 62.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 19' ' ' THR . 29.2 mt -79.81 -31.98 40.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 34.5 22.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.35 169.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.231 -1.159 . . . . 0.0 110.03 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.634 ' O ' HD12 ' A' ' 30' ' ' ILE . 12.8 m-85 -72.2 145.74 47.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.493 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.533 ' HG3' ' CB ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -66.2 -16.77 64.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' ALA . 20.2 m -71.1 -61.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.06 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -41.2 -36.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.606 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 26' ' ' TYR . 1.3 mp -68.1 -55.11 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.308 -0.87 . . . . 0.0 110.528 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.4 OUTLIER -54.21 -13.65 0.91 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -92.5 -38.86 11.71 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.563 -1.336 . . . . 0.0 108.253 178.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -10.89 59.75 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.669 HG12 HD21 ' A' ' 7' ' ' LEU . 16.5 mt -111.52 -51.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.0 110.0 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -60.49 -19.72 57.74 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.464 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -66.69 -84.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 109.883 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.63 38.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 152.28 20.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -1.119 . . . . 0.0 110.889 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -100.51 69.03 1.4 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.825 . . . . 0.0 109.512 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.854 HD12 HD22 ' A' ' 7' ' ' LEU . 15.5 mt -89.64 164.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.864 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 71.7 m-85 -144.62 163.98 32.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 3.2 mp -144.35 141.55 29.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 110.692 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 2.8 m -118.76 102.96 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.785 . . . . 0.0 109.395 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.028 HG23 ' O ' ' A' ' 49' ' ' SER . 19.3 mt -118.89 100.01 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 111.167 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -107.81 -167.09 1.21 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.826 -1.171 . . . . 0.0 110.525 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.89 -2.23 7.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -144.69 7.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.616 -0.678 . . . . 0.0 109.401 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -91.07 -7.83 65.41 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.028 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 47.81 -92.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 49' ' ' SER . 2.4 t -161.57 95.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.146 -0.971 . . . . 0.0 109.963 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -100.11 134.78 42.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.608 -0.682 . . . . 0.0 109.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 58' ' ' PHE . . . -121.84 130.5 53.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -137.32 104.66 5.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.96 . . . . 0.0 110.692 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -79.36 150.82 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.373 -0.83 . . . . 0.0 109.868 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.34 132.17 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -153.51 151.38 29.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -40.68 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.206 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' B GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.32 -65.84 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -171.91 -179.56 2.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -1.051 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' D VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -100.48 149.09 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.172 -0.955 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' E LYS . . . . . 0.538 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -122.99 179.4 1.03 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.538 ' CD ' ' HB3' ' A' ' 56' E LYS . 5.6 Cg_endo -90.62 -170.94 0.4 Allowed 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.014 1.809 . . . . 0.0 110.269 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 40.5 t80 176.49 109.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.207 -0.933 . . . . 0.0 111.03 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.0 OUTLIER -81.68 99.33 0.26 Allowed 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.843 -1.732 . . . . 0.0 109.682 -0.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.534 ' CA ' ' HB2' ' A' ' 57' ' ' PRO . 13.7 m 50.59 -159.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.856 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.458 ' HB3' ' HD3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -107.77 -175.97 2.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.078 -1.014 . . . . 0.0 111.087 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -121.62 40.63 3.56 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.772 0.796 . . . . 0.0 109.429 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 64' ' ' THR . 11.6 mtpt -64.6 -52.23 58.59 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.785 -0.572 . . . . 0.0 110.112 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.528 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 76.56 -73.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.137 0.494 . . . . 0.0 110.435 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -122.39 3.51 9.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.92 . . . . 0.0 110.293 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.318 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.537 ' HA ' HD11 ' A' ' 5' ' ' ILE . 7.8 mtt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.169 0.509 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 5.4 tt0 57.05 29.61 16.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 110.476 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 43' ' ' THR . 5.2 mm-40 -129.56 -133.52 0.22 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.171 -0.955 . . . . 0.0 108.573 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.94 75.8 0.94 Allowed 'General case' 0 C--N 1.281 -2.387 0 O-C-N 121.764 -0.585 . . . . 0.0 109.92 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.555 HG22 ' HB2' ' A' ' 10' ' ' TYR . 1.5 mt -90.67 148.51 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.735 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.589 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 1.3 p -90.95 169.23 11.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 112.296 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.915 HD11 HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -61.5 -25.88 67.55 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.738 ' HG2' HG23 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -81.43 -83.43 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.489 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 8' ' ' LYS . 75.7 m-20 -41.05 -54.6 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.971 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.589 ' CB ' ' O ' ' A' ' 6' ' ' THR . 43.7 t80 -51.12 -58.27 6.56 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -53.66 -23.36 11.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.522 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -34.19 52.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.635 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -91.67 -12.85 32.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -123.46 -49.95 1.89 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.276 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.18 134.81 2.86 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.413 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -60.9 -32.22 71.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.211 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -84.06 -11.45 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 110.192 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -51.94 7.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.204 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.493 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -65.6 -31.61 72.74 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.425 -0.797 . . . . 0.0 108.893 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.637 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -75.68 -26.29 57.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.607 -0.683 . . . . 0.0 109.773 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -27.98 61.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -82.94 -27.55 30.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 110.305 -179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HG ' ' OD1' ' A' ' 22' ' ' ASP . 25.9 mt -80.66 -10.8 59.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.965 . . . . 0.0 110.103 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 48.08 75.29 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 23' ' ' LEU . 1.5 t -141.22 153.1 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.343 -1.092 . . . . 0.0 110.033 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.814 ' O ' HD12 ' A' ' 30' ' ' ILE . 31.8 m-85 -66.75 157.55 32.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.122 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -64.65 -11.66 37.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.26 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.9 t -75.96 -62.31 1.64 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.87 -35.91 4.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.234 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.814 HD12 ' O ' ' A' ' 26' ' ' TYR . 3.7 mt -74.77 -48.15 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -55.11 -13.65 1.3 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.753 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -93.32 -38.94 11.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 108.385 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.32 -7.66 57.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.738 HG23 ' HG2' ' A' ' 8' ' ' LYS . 13.1 mt -110.89 -53.35 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.566 -0.709 . . . . 0.0 109.495 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.549 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 83.7 t60 -52.5 -31.3 34.53 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.196 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.17 -43.0 13.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.461 -0.774 . . . . 0.0 109.659 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.52 55.75 16.46 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HD2' ' H ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -85.14 39.86 0.79 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.189 -1.183 . . . . 0.0 111.153 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.5 OUTLIER 72.74 101.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.383 -0.823 . . . . 0.0 111.176 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.708 ' CG2' HD21 ' A' ' 7' ' ' LEU . 6.6 mt -145.61 159.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 99.4 m-85 -154.08 160.86 42.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.918 -1.114 . . . . 0.0 111.218 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.915 HD21 HD11 ' A' ' 7' ' ' LEU . 4.7 mp -143.47 114.72 7.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.53 -0.731 . . . . 0.0 110.3 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 54.0 m -89.28 100.62 13.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.844 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.722 ' CD1' HG22 ' A' ' 50' ' ' VAL . 3.7 mm -79.91 74.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 0.0 110.21 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.468 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 3.3 p30 -44.31 167.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 110.397 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -8.97 2.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -78.6 7.0 7.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.02 11.95 46.99 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.417 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 42.6 m -84.7 -173.06 4.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -1.165 . . . . 0.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 44' ' ' ILE . 70.8 t -138.42 101.34 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.062 -1.024 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -78.71 77.87 5.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.016 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.46 86.05 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 110.537 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 56' E LYS . 37.1 mt-10 -102.41 108.0 19.18 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' O ' ' CB ' ' A' ' 56' D VAL . 0.0 OUTLIER -79.52 176.01 10.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.39 -0.819 . . . . 0.0 109.705 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -142.31 110.49 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.859 . . . . 0.0 110.364 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 27.2 ttmt -128.92 154.64 46.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' A ASP . . . . . . . . . . . . . 48.0 m-20 -47.83 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 146.55 -52.14 0.57 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.95 168.97 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' D VAL . . . . . 0.453 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 27.0 m -81.98 -177.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' E LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.8 mttm -148.54 172.07 5.6 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.248 -0.908 . . . . 0.0 110.389 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.484 ' HG2' ' HA ' ' A' ' 60' ' ' SER . 1.6 Cg_endo -85.45 -47.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.947 1.764 . . . . 0.0 110.27 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 56.31 95.82 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.249 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 6.4 Cg_exo -70.1 157.21 93.24 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.835 -2.152 . . . . 0.0 110.284 0.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.7 m -65.02 87.09 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.22 37.86 13.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.461 -0.774 . . . . 0.0 110.725 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER 50.34 50.19 19.19 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.528 -0.733 . . . . 0.0 109.381 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 62' ' ' LYS . 13.7 mtmt -32.93 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.263 0.554 . . . . 0.0 111.317 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.56 ' N ' ' O ' ' A' ' 62' ' ' LYS . 18.7 m -170.21 -58.62 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.418 -0.801 . . . . 0.0 109.779 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.539 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 9.6 t -175.65 -34.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.448 -0.783 . . . . 0.0 110.222 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.218 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.242 0.544 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.25 163.91 7.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.334 -0.854 . . . . 0.0 110.218 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -113.0 62.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.99 . . . . 0.0 110.016 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -82.95 66.82 8.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.672 HG23 ' HB2' ' A' ' 10' ' ' TYR . 4.8 tp -87.13 173.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 41' ' ' PHE . 5.1 p -77.29 -172.7 2.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.296 1.045 . . . . 0.0 111.108 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.857 HD22 HD12 ' A' ' 40' ' ' ILE . 1.4 tp -90.2 -34.65 15.73 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -85.37 -69.78 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.621 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -41.66 -49.17 4.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.247 -0.908 . . . . 0.0 109.111 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.71 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.6 t80 -50.15 -59.61 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.583 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -48.09 -31.07 5.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 109.449 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.438 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.71 -53.47 55.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.627 -0.67 . . . . 0.0 109.813 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -59.31 -31.19 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.789 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CD2' ' HE3' ' A' ' 18' ' ' LYS . 5.0 m-85 -106.76 -81.06 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.253 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 162.87 -176.46 39.15 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.418 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.5 OUTLIER -85.14 -27.5 26.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.096 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 m -85.88 -16.37 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HE3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -89.59 -39.92 12.94 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.288 -0.883 . . . . 0.0 108.969 179.143 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.5 m -71.68 -26.32 62.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.552 -0.718 . . . . 0.0 109.266 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.643 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -83.7 -39.21 20.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 110.443 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -62.74 -32.39 73.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.728 ' OD1' HG21 ' A' ' 50' ' ' VAL . 1.3 t0 -80.67 -31.53 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.041 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.9 mt -89.19 -7.87 54.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.394 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.14 49.79 50.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -133.43 147.48 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -1.195 . . . . 0.0 109.937 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -59.39 163.54 3.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.262 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -26.11 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 t -83.47 -51.48 7.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.878 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -47.99 -23.74 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.79 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -81.01 -68.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.774 . . . . 0.0 109.726 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.79 ' N ' HG22 ' A' ' 30' ' ' ILE . 2.1 m-20 -52.39 -13.69 0.39 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 111.235 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.39 -43.77 9.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.511 -1.368 . . . . 0.0 108.683 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -76.06 -6.96 53.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.534 -0.729 . . . . 0.0 109.053 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.855 HG12 HD21 ' A' ' 7' ' ' LEU . 19.0 mt -111.85 -50.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 0.0 109.998 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.5 t60 -59.15 -23.67 62.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.12 -0.988 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.429 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.3 49.43 0.36 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.696 ' HG3' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.6 123.3 28.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -1.071 . . . . 0.0 110.299 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 55' ' ' VAL . 6.5 ptpp? -86.69 59.99 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.857 HD12 HD22 ' A' ' 7' ' ' LEU . 43.9 mt -96.94 169.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.579 0.704 . . . . 0.0 111.033 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 55.9 m-85 -149.79 110.13 4.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.786 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.9 mp -85.08 135.65 33.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.2 m -101.34 104.3 15.28 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.717 HG23 ' O ' ' A' ' 49' ' ' SER . 53.8 mt -93.56 44.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.073 -1.017 . . . . 0.0 111.246 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 46' ' ' ALA . 38.4 p30 -87.58 -127.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.94 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.78 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 43.28 27.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.955 -1.09 . . . . 0.0 109.81 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.557 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 73.69 69.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.313 0.578 . . . . 0.0 111.797 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.28 0.23 35.95 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.78 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 1.1 p -58.76 -165.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.283 . . . . 0.0 110.369 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.728 HG21 ' OD1' ' A' ' 22' ' ' ASP . 14.1 t -146.28 124.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -135.49 164.09 28.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.32 -0.863 . . . . 0.0 109.989 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -141.8 132.43 25.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.462 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' E LYS . 39.1 tt0 -159.76 116.07 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 110.003 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HB3' HG12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -95.5 178.45 5.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.605 -179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.499 ' O ' ' HD3' ' A' ' 39' ' ' LYS . 6.2 t -140.16 107.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.464 -0.772 . . . . 0.0 109.621 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.01 155.02 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 110.582 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' A ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.24 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 137.71 -53.46 0.73 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.0 171.53 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 110.268 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' D VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 56' E LYS . 28.0 m -94.17 164.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' E LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 56' D VAL . 6.8 mtpt -142.39 168.59 13.0 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -83.61 -173.61 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 121.897 1.731 . . . . 0.0 109.947 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 85.3 t80 179.24 124.77 0.22 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.232 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.9 Cg_endo -87.33 100.2 0.25 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.745 -1.773 . . . . 0.0 110.311 -0.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 61' ' ' ASN . 53.4 p -72.09 80.08 0.95 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 110.933 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 60' ' ' SER . 0.9 OUTLIER 166.0 46.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.214 -0.929 . . . . 0.0 110.089 179.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 5.1 ttmt -179.65 63.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.451 -0.781 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.34 176.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.001 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -78.4 -45.54 22.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.97 . . . . 0.0 110.42 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 t -156.76 19.91 0.32 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.144 179.863 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.209 0.528 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -116.69 -174.79 2.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.363 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.498 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 50.2 mm-40 -138.66 85.53 2.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.187 -0.946 . . . . 0.0 109.747 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 2.9 ttp180 -78.57 79.72 4.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.44 -0.788 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.657 HG22 ' HB2' ' A' ' 10' ' ' TYR . 69.1 mt -89.56 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.854 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -48.91 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.439 1.114 . . . . 0.0 111.94 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.744 ' HG ' HD11 ' A' ' 34' ' ' ILE . 2.0 tp -94.01 -38.17 11.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HB2' HD13 ' A' ' 34' ' ' ILE . 11.7 tmtt? -90.28 -56.67 3.12 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.386 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 25.7 t70 -50.89 -42.01 58.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.657 ' HB2' HG22 ' A' ' 5' ' ' ILE . 14.6 t80 -58.17 -61.27 2.68 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.793 0.806 . . . . 0.0 109.887 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.661 ' HB2' ' OG1' ' A' ' 19' ' ' THR . . . -56.3 -18.03 9.45 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.396 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -38.99 50.42 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -52.45 -42.84 64.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.555 -0.715 . . . . 0.0 109.173 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -114.46 -99.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.265 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.65 155.12 20.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.509 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -75.99 -28.2 57.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 110.266 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -74.97 -12.33 60.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -81.32 -58.19 3.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.219 -0.926 . . . . 0.0 108.617 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.661 ' OG1' ' HB2' ' A' ' 11' ' ' ALA . 15.5 m -50.68 -34.18 25.55 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.39 -38.62 55.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 110.898 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -35.01 79.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 110.327 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.7 -50.14 65.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.8 mt -80.66 -7.63 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.78 38.13 95.2 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 26' ' ' TYR . 3.0 t -112.88 178.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.087 -1.243 . . . . 0.0 109.917 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.575 ' O ' HD12 ' A' ' 30' ' ' ILE . 90.9 m-85 -100.65 141.03 34.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.193 -0.942 . . . . 0.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -46.95 -23.19 0.41 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t -72.38 -51.71 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.487 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.46 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -54.25 -26.13 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.066 -1.021 . . . . 0.0 110.053 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.668 HG23 HD12 ' A' ' 34' ' ' ILE . 1.3 mp -76.46 -55.8 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 2.6 m-80 -57.88 -14.12 5.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 110.545 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -94.56 -48.38 6.12 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.733 -1.229 . . . . 0.0 108.832 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -72.31 -3.1 21.84 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.132 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.744 HD11 ' HG ' ' A' ' 7' ' ' LEU . 9.5 mt -120.06 -49.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.272 -0.892 . . . . 0.0 110.547 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.566 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t60 -69.48 -7.75 40.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.967 -1.083 . . . . 0.0 110.098 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -77.96 -28.71 49.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.123 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.54 31.28 1.84 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -90.53 -176.97 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 82.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.273 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.616 HD12 ' CD2' ' A' ' 7' ' ' LEU . 4.1 mt -102.95 160.26 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 41.0 m-85 -153.35 160.71 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.078 -1.014 . . . . 0.0 110.529 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 3.7 mp -134.82 155.45 50.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 110.534 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 20.6 m -127.8 105.29 8.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 109.618 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.664 HG22 ' H ' ' A' ' 45' ' ' ASN . 0.7 OUTLIER -84.93 -148.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.087 -1.008 . . . . 0.0 110.974 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.664 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 38.37 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.252 0.549 . . . . 0.0 110.628 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.658 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 62.01 12.02 4.65 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.658 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 3.8 t70 135.47 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 124.147 0.979 . . . . 0.0 109.325 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.85 11.59 81.25 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -83.23 121.74 27.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.998 . . . . 0.0 110.232 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.2 118.4 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 110.375 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 3.7 m-85 -98.39 155.85 17.03 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.928 . . . . 0.0 108.541 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -142.31 86.74 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 110.419 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -101.56 -177.12 3.34 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 110.192 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 56' E LYS . 0.3 OUTLIER -152.67 173.48 15.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.272 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.442 HG22 HG12 ' A' ' 56' D VAL . 86.7 t -142.95 151.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.987 -1.07 . . . . 0.0 110.515 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 158.41 30.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.5 t0 -57.55 -11.62 2.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.08 -1.013 . . . . 0.0 110.633 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' B GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 56' C GLU . . . -100.83 -38.62 3.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' C GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' B GLY . 0.6 OUTLIER 174.58 179.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 110.288 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' D VAL . . . . . 0.442 HG12 HG22 ' A' ' 55' ' ' VAL . 35.6 m -102.64 148.16 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.288 -0.882 . . . . 0.0 109.862 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' E LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -144.58 166.7 17.41 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 0.0 110.474 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.8 Cg_exo -80.81 179.79 5.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.457 1.767 . . . . 0.0 110.287 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 3.1 t80 -159.99 125.61 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.003 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 71.2 Cg_endo -88.82 47.78 1.05 Allowed 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.802 -1.749 . . . . 0.0 110.87 0.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 61' ' ' ASN . 0.3 OUTLIER 45.32 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 110.49 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 60' ' ' SER . 14.8 p30 37.74 -162.2 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.619 0.723 . . . . 0.0 111.101 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -146.99 51.12 1.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 0.0 110.228 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 62' ' ' LYS . 1.6 mtmm 32.53 95.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.819 -0.551 . . . . 0.0 111.349 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.5 p -77.83 137.72 38.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.925 . . . . 0.0 110.018 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.584 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 5.6 t -57.15 -22.09 37.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.126 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.093 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.29 0.567 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.643 ' HG2' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -72.73 163.52 27.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 110.271 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -119.18 75.48 1.05 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.291 -0.88 . . . . 0.0 108.859 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 8.4 ttm180 -76.97 83.05 3.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.692 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.659 HG21 ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -77.43 -174.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.547 -0.721 . . . . 0.0 109.721 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.83 -178.78 5.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 111.45 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.929 HD21 HG12 ' A' ' 34' ' ' ILE . 9.4 tp -92.33 -46.14 7.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.58 -65.71 0.99 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.881 -0.512 . . . . 0.0 110.07 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.489 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 10.3 t70 -45.03 -46.92 11.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 108.89 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.659 ' CG ' HG21 ' A' ' 5' ' ' ILE . 8.6 t80 -53.59 -62.44 1.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.779 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -51.82 -20.73 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.501 -0.749 . . . . 0.0 109.722 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.9 ttm -72.62 -49.6 30.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.65 76.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.091 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.59 -83.13 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 110.356 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.58 150.05 12.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -31.0 69.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -1.172 . . . . 0.0 110.087 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 t -83.75 -14.61 51.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -82.43 -52.94 6.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.779 HG21 ' HB2' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -61.8 -31.39 71.61 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -47.1 55.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.657 -0.652 . . . . 0.0 110.02 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -69.72 -17.0 63.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.531 -0.731 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 50' ' ' VAL . 1.3 m-20 -79.79 -34.86 39.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.173 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.66 HD11 HD21 ' A' ' 42' ' ' LEU . 7.0 mt -80.75 -25.77 37.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 110.144 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 86.34 63.88 1.48 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.465 ' CG2' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -154.04 147.45 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.225 -1.162 . . . . 0.0 109.766 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -47.56 167.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 110.136 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -87.62 -19.07 28.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.373 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 m -79.63 -63.57 1.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.091 -1.006 . . . . 0.0 109.94 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.48 -24.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.986 . . . . 0.0 109.262 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -68.45 -62.34 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.749 ' N ' HG22 ' A' ' 30' ' ' ILE . 3.9 t-20 -55.76 -13.55 1.79 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.601 -0.687 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -93.96 -34.43 13.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 108.408 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.86 -8.15 59.66 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.929 HG12 HD21 ' A' ' 7' ' ' LEU . 21.9 mt -113.66 -49.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.753 . . . . 0.0 109.747 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 50.2 t-80 -60.22 -39.79 87.86 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.741 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.64 -23.95 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.61 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.46 31.18 8.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -59.04 -177.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.116 . . . . 0.0 110.498 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -128.47 76.08 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.933 HG23 ' HG3' ' A' ' 54' ' ' GLU . 5.7 mt -113.16 167.73 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 111.047 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 79.3 m-85 -147.4 122.99 10.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.7 mp -90.84 142.41 27.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.978 -1.076 . . . . 0.0 111.56 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.643 HG23 ' HG2' ' A' ' 2' ' ' GLU . 1.2 m -110.15 103.88 12.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 49' ' ' SER . 56.5 mt -84.15 60.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.832 -1.167 . . . . 0.0 111.51 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 16.7 p-10 -88.48 -146.16 0.15 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.836 -1.165 . . . . 0.0 110.28 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 49' ' ' SER . . . 56.2 14.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.459 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 26.4 t70 88.98 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 123.164 0.585 . . . . 0.0 110.115 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.07 14.48 0.57 Allowed Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.048 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.659 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 8.1 t -84.65 159.29 20.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.898 -1.354 . . . . 0.0 109.62 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.439 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 21.7 t -112.46 122.18 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 0.0 110.83 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -113.12 -171.09 1.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.853 . . . . 0.0 109.627 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -146.53 154.24 41.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 56' E LYS . 0.0 OUTLIER -159.49 106.75 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 110.091 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.933 ' HG3' HG23 ' A' ' 40' ' ' ILE . 5.6 mt-10 -83.57 165.5 19.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG13 HG12 ' A' ' 56' D VAL . 16.7 t -144.97 129.23 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.088 -1.008 . . . . 0.0 110.46 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 56' A ASP . 5.4 ttpp -146.83 94.53 2.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' A ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 65.1 t0 61.06 41.38 13.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.54 -0.725 . . . . 0.0 110.505 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 86.99 -11.15 65.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.9 tt0 -89.42 87.18 6.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' D VAL . . . . . 0.504 HG12 HG13 ' A' ' 55' ' ' VAL . 4.9 m -94.23 170.77 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.224 -0.923 . . . . 0.0 110.234 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' E LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -173.0 170.51 2.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 0.0 110.518 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 5.8 Cg_exo -80.53 166.39 19.88 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.474 1.776 . . . . 0.0 110.288 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.625 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 15.8 t80 -169.84 117.71 0.53 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 4.9 Cg_endo -84.04 100.89 0.32 Allowed 'Cis proline' 0 C--N 1.316 -1.165 0 C-N-CA 122.758 -1.767 . . . . 0.0 110.285 -0.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 97.6 p -46.97 106.6 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 110.053 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.81 -172.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.101 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.78 54.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.324 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -117.05 124.82 50.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 110.152 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.7 m -161.68 -39.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 0.0 110.324 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 t -125.11 -25.97 3.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 110.321 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.197 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.287 0.565 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 3' ' ' GLN . 23.7 tp10 -169.8 -77.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.951 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.501 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 8.4 mm-40 -118.14 72.22 0.85 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.358 -0.839 . . . . 0.0 109.839 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -83.88 65.16 8.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.968 HG22 ' HB2' ' A' ' 10' ' ' TYR . 30.6 mm -90.74 135.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.7 p -46.96 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.202 1.001 . . . . 0.0 111.254 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.698 ' HB3' HG21 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -91.81 -34.8 14.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.344 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -82.74 -69.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.844 -0.535 . . . . 0.0 110.174 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -44.39 -45.9 9.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 109.246 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.968 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.6 t80 -49.14 -59.47 3.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -46.81 -30.9 2.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 110.17 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -46.06 70.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -25.57 63.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 0.0 110.423 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -111.97 -64.34 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.309 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 155.58 160.44 9.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -75.07 -32.33 61.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -1.206 . . . . 0.0 109.903 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -9.67 59.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.751 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.61 -41.3 12.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.142 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 m -70.01 -24.53 63.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.517 -0.739 . . . . 0.0 109.615 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.67 20.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 0.0 110.393 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -75.99 -16.11 60.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' HB3' HG21 ' A' ' 50' ' ' VAL . 36.5 m-20 -90.6 -44.35 9.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.499 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD22 ' HD3' ' A' ' 59' ' ' PRO . 25.3 mt -79.65 -31.06 41.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 110.322 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.36 16.03 36.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -116.02 147.71 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 109.938 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -64.62 153.08 40.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.612 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.477 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 2.5 mt-30 -47.97 -25.97 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.341 -0.85 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.0 -54.59 31.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.761 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . . . -46.08 -36.06 5.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.788 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.627 HG23 HD11 ' A' ' 34' ' ' ILE . 1.4 mp -63.24 -47.67 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 109.868 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 35.8 m120 -66.35 -6.44 14.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -88.57 -44.02 10.95 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.722 -1.236 . . . . 0.0 108.982 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -72.66 -28.08 62.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.674 HG13 HD21 ' A' ' 7' ' ' LEU . 49.3 mt -87.2 -51.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.477 -0.765 . . . . 0.0 109.91 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 20.5 t60 -68.46 -4.69 15.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.838 -1.164 . . . . 0.0 110.492 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -90.68 -59.37 2.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.032 -1.042 . . . . 0.0 111.411 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . -155.18 99.29 0.19 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.589 ' HE ' HG22 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -51.47 -164.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.868 -0.784 . . . . 0.0 111.523 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 1.1 tttt 73.03 48.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.698 HG21 ' HB3' ' A' ' 7' ' ' LEU . 17.0 mt -97.06 166.48 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.316 0.579 . . . . 0.0 110.316 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.6 m-85 -158.54 117.42 3.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -110.36 132.96 53.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.721 ' HG1' ' HD2' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -97.91 100.56 11.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 44' ' ' ILE . 57.2 mt -84.39 55.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.707 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 46' ' ' ALA . 24.0 p30 -104.74 -122.08 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.059 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.939 ' HB3' ' HB2' ' A' ' 49' ' ' SER . . . 42.48 30.42 0.21 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.975 -1.078 . . . . 0.0 109.839 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.7 t70 80.95 50.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.553 0.692 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 82.11 -9.53 56.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.939 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 7.2 m -52.7 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.041 -1.27 . . . . 0.0 109.747 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 22' ' ' ASP . 46.0 t -131.28 116.75 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.721 ' HD2' ' HG1' ' A' ' 43' ' ' THR . 5.5 t80 -120.55 140.48 51.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -96.1 150.97 19.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.033 -1.042 . . . . 0.0 110.07 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -159.73 85.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 110.138 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 56' D VAL . 6.0 mt-10 -84.69 169.65 14.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.093 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' A' ' 56' D VAL . 1.5 p -161.39 148.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.117 -0.99 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -157.4 112.95 2.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 110.235 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' A ASP . . . . . . . . . . . . . 31.4 t70 45.77 49.0 11.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.873 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 78.1 35.52 34.19 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 20.2 tt0 -137.85 84.16 2.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -1.169 . . . . 0.0 109.887 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' D VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 3.2 m -96.39 153.98 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.168 -0.957 . . . . 0.0 111.015 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' E LYS . . . . . . . . . . . . . 3.4 pttt -148.13 168.67 10.65 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.852 . . . . 0.0 110.107 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -82.81 -82.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.35 1.71 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER 56.92 107.36 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 0.0 109.951 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.6 ' HD3' HD22 ' A' ' 23' ' ' LEU . 13.5 Cg_exo -68.41 140.23 54.94 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.082 -2.049 . . . . 0.0 110.381 -0.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 p -87.12 161.83 17.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.335 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -138.68 -171.58 3.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 110.017 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.86 55.12 0.31 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.91 . . . . 0.0 110.284 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -80.07 120.88 24.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.097 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 p -70.37 -178.0 1.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 110.012 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.4 t -75.14 -26.43 59.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.313 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.101 179.831 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.9 mtt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.244 0.545 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.565 ' CB ' ' HB3' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -150.09 -60.61 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.34 -0.85 . . . . 0.0 110.295 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.438 ' CB ' ' OD1' ' A' ' 45' ' ' ASN . 4.6 mm-40 -124.09 77.47 1.55 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.193 -0.942 . . . . 0.0 109.221 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 2.7 ttm180 -78.95 82.5 5.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.62 -0.675 . . . . 0.0 109.634 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.597 HG21 ' HD1' ' A' ' 10' ' ' TYR . 12.5 mt -85.67 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.07 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.4 p -46.95 178.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.157 0.98 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.749 HD11 ' CD1' ' A' ' 30' ' ' ILE . 1.5 tp -91.58 -35.26 14.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.472 ' HG2' HG21 ' A' ' 34' ' ' ILE . 2.3 tmtt? -79.77 -68.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 6' ' ' THR . 5.6 t0 -45.28 -55.12 6.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.655 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.597 ' HD1' HG21 ' A' ' 5' ' ' ILE . 50.2 t80 -42.9 -60.05 1.75 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.418 -0.801 . . . . 0.0 111.219 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -60.38 -29.07 68.71 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.161 -0.962 . . . . 0.0 110.424 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -24.21 61.72 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -71.86 -47.82 50.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.518 -0.739 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 10' ' ' TYR . 26.9 p90 -111.42 -43.52 3.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.586 -1.321 . . . . 0.0 111.434 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 14' ' ' PHE . . . 168.24 162.92 21.28 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.033 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.6 -25.22 20.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.449 -1.03 . . . . 0.0 110.672 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.543 HG23 ' HG2' ' A' ' 18' ' ' LYS . 13.5 t -73.39 -18.28 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.982 . . . . 0.0 110.236 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HG2' HG23 ' A' ' 17' ' ' THR . 7.8 mttt -90.62 -34.52 15.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 11' ' ' ALA . 18.4 m -67.58 -32.09 72.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.68 -27.06 29.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.65 -0.656 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -83.75 -18.38 38.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 110.141 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' O ' HG11 ' A' ' 50' ' ' VAL . 50.9 m-20 -84.04 -41.55 17.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.058 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 59' ' ' PRO . 90.1 mt -79.91 -60.02 2.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 110.037 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.48 43.98 0.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.3 152.96 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -67.96 169.67 9.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.337 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 33.3 mt-30 -65.16 -35.36 80.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.912 . . . . 0.0 110.27 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.9 p -63.78 -54.44 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.767 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . . . -52.79 -23.2 6.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.131 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.749 ' CD1' HD11 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -71.2 -62.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.579 -0.701 . . . . 0.0 109.29 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.746 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -62.15 -8.03 4.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 110.447 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 15.1 mtpp -90.46 -38.21 13.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.808 -1.183 . . . . 0.0 108.37 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.58 -9.03 56.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 30' ' ' ILE . 19.3 mt -101.15 -46.18 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 9.0 t-80 -68.67 -56.85 6.81 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.238 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.98 40.46 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.281 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.806 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -176.19 79.12 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 23.0 mmm-85 -84.52 -173.43 4.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -1.068 . . . . 0.0 110.53 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 4.3 mtmt 57.63 79.38 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 37' ' ' GLY . 7.1 mt -135.04 160.19 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.0 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.572 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 70.5 m-85 -153.67 154.38 34.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 110.349 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' A' ' 52' ' ' ALA . 4.1 mp -144.92 129.96 18.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.163 -0.961 . . . . 0.0 111.102 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.854 HG22 ' HA2' ' A' ' 48' ' ' GLY . 2.1 m -83.51 107.18 15.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 108.442 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.697 HG23 ' O ' ' A' ' 49' ' ' SER . 2.6 mt -129.15 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.048 -1.032 . . . . 0.0 111.689 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.612 ' H ' HG22 ' A' ' 44' ' ' ILE . 8.1 m120 64.22 -165.06 0.24 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.8 0.81 . . . . 0.0 112.122 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.76 0.96 3.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.565 ' HB3' ' CB ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -136.77 41.46 2.52 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.854 ' HA2' HG22 ' A' ' 43' ' ' THR . . . -169.02 -27.17 0.02 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 120.038 -1.077 . . . . 0.0 110.633 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.4 OUTLIER 59.77 -92.74 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.855 -1.379 . . . . 0.0 107.715 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 49' ' ' SER . 5.5 t -161.2 77.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.299 -0.876 . . . . 0.0 110.455 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.98 137.92 43.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.504 -0.748 . . . . 0.0 109.042 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -129.59 113.91 15.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 110.836 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.72 121.58 23.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.789 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' D VAL . 7.9 pt-20 -91.21 159.0 16.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.43 139.9 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.266 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 56' C GLU . 0.7 OUTLIER -157.4 78.1 0.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.948 -1.095 . . . . 0.0 110.932 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' A ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 56' ' ' LYS . 31.0 t70 40.35 76.78 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.804 . . . . 0.0 111.279 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 83.51 -5.88 75.72 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.66 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' C GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 1.1 tt0 -117.68 83.37 1.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.894 -1.356 . . . . 0.0 110.342 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' D VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -124.02 124.12 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.488 -0.758 . . . . 0.0 109.702 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' E LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.31 164.13 40.94 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.513 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 3.8 Cg_exo -82.8 97.37 0.85 Allowed 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.015 1.81 . . . . 0.0 110.762 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CZ ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -133.07 140.59 37.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 110.068 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HG2' ' HB3' ' A' ' 23' ' ' LEU . 59.9 Cg_endo -92.97 52.48 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.495 -1.877 . . . . 0.0 110.028 -0.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.513 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 36.7 t -66.3 -12.77 58.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 110.719 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 60' ' ' SER . 6.8 t-20 63.77 175.81 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.781 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 52.17 0.93 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.012 . . . . 0.0 110.438 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 66' ' ' ALA . 20.3 mttt -63.74 -160.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.817 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.1 m -157.2 -34.8 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.98 -1.075 . . . . 0.0 110.98 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.575 ' O ' HG23 ' A' ' 65' ' ' THR . 9.3 t -131.99 41.91 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.115 -0.99 . . . . 0.0 110.598 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.576 ' HB2' ' HD3' ' A' ' 63' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.266 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 mtm . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.26 0.552 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.511 ' O ' ' NH1' ' A' ' 4' ' ' ARG . 23.2 mt-10 -140.53 139.34 35.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.469 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 2.3 mt-30 -101.97 49.7 0.85 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.484 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.578 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -79.89 85.04 5.57 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.822 0.82 . . . . 0.0 111.869 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.014 ' O ' HD12 ' A' ' 42' ' ' LEU . 4.6 mm -89.59 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.599 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 2.6 p -65.46 -178.89 0.56 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 111.405 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.944 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -87.29 -26.7 23.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.47 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.71 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -79.52 -77.93 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.271 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 8' ' ' LYS . 7.9 t70 -42.87 -59.23 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.995 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.829 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.6 t80 -41.96 -54.65 3.41 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.246 -0.909 . . . . 0.0 110.555 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.45 -38.25 71.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.181 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.5 ttt -63.54 -30.11 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.502 -0.749 . . . . 0.0 109.998 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.38 -41.01 28.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -109.37 -57.26 2.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.322 -0.861 . . . . 0.0 109.902 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 154.68 156.96 7.95 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 110.147 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 31.1 p -67.76 -11.5 58.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.919 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -85.91 -46.79 10.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.323 -0.861 . . . . 0.0 108.917 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -27.57 63.24 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.27 -32.41 22.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.669 -0.644 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.1 tmtp? -74.29 -18.63 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.908 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.94 -46.76 10.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 0.0 110.069 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.514 HD22 ' HD3' ' A' ' 59' ' ' PRO . 41.8 mt -80.87 -19.14 45.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.08 39.81 94.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.675 HG11 ' HG2' ' A' ' 59' ' ' PRO . 35.9 m -127.79 179.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -1.186 . . . . 0.0 110.206 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.64 142.41 49.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.297 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.445 ' HA ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -66.95 -11.5 56.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.92 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -72.43 -54.78 8.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.975 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.66 -25.15 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.59 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 34' ' ' ILE . 50.0 mt -78.57 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.586 -0.696 . . . . 0.0 109.797 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -58.52 -9.14 1.48 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 110.63 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -93.39 -42.22 9.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.699 -1.251 . . . . 0.0 108.228 178.553 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -75.24 -11.11 60.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.88 HD11 ' HB3' ' A' ' 7' ' ' LEU . 65.2 mt -105.83 -54.17 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 31.6 t60 -54.97 -23.47 19.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.77 85.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.53 37.93 1.39 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.64 -164.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -1.129 . . . . 0.0 110.633 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.447 ' HE2' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -145.45 87.64 1.81 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.649 ' CG2' HD21 ' A' ' 7' ' ' LEU . 27.3 mt -114.91 172.09 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.426 -0.797 . . . . 0.0 110.879 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.583 ' N ' HG22 ' A' ' 40' ' ' ILE . 38.5 m-85 -160.01 141.67 12.78 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.014 HD12 ' O ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -114.89 109.29 17.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.906 -1.121 . . . . 0.0 109.642 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 4' ' ' ARG . 1.4 m -75.93 102.12 5.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 108.746 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.507 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.9 mt -78.17 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 0.0 110.471 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 9.1 p-10 34.28 -140.29 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.964 -0.46 . . . . 0.0 111.309 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.639 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 49.1 26.35 1.4 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 50.7 t0 97.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 123.697 0.799 . . . . 0.0 108.87 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.09 9.78 43.19 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.93 113.58 3.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.794 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.1 t -86.29 100.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 110.334 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 28.5 m-85 -104.73 92.77 4.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.1 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.675 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -88.48 135.47 33.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.05 -1.031 . . . . 0.0 109.361 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 56' E LYS . 0.8 OUTLIER -156.76 135.17 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.15 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -83.73 171.39 13.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.492 -0.755 . . . . 0.0 109.447 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 56' D VAL . 10.4 t -140.28 141.61 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 110.441 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 56' A ASP . 0.8 OUTLIER -157.02 120.4 4.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' A ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 28.3 t70 57.74 -90.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . -146.35 43.76 0.87 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.7 tt0 -156.65 123.81 5.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -1.155 . . . . 0.0 110.35 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' D VAL . . . . . 0.456 HG12 HG13 ' A' ' 55' ' ' VAL . 10.0 m -109.97 155.99 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' E LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 11.9 mttm -135.78 164.47 43.11 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.863 . . . . 0.0 109.486 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 56' E LYS . 4.6 Cg_exo -82.6 150.71 14.82 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.917 1.745 . . . . 0.0 111.006 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 1.9 t80 -146.16 128.87 8.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HG2' HG11 ' A' ' 25' ' ' VAL . 9.6 Cg_endo -89.16 52.92 0.66 Allowed 'Cis proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.98 -1.675 . . . . 0.0 110.648 0.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER 41.86 68.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 2.7 m120 -98.38 47.38 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 109.812 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 3.7 tttt 175.15 53.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 109.745 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 64' ' ' THR . 0.3 OUTLIER -48.84 167.08 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.431 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 63' ' ' LYS . 65.5 p 42.17 -153.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 110.299 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 1.8 t -168.87 -34.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.848 . . . . 0.0 110.487 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.232 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.246 0.546 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.461 ' OE2' ' HB2' ' A' ' 4' ' ' ARG . 2.7 pt-20 -139.63 156.93 46.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.968 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.4 mm-40 -116.31 70.11 0.76 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.085 -1.009 . . . . 0.0 109.886 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.461 ' HB2' ' OE2' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -79.51 74.9 6.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.713 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.722 HD12 ' CE1' ' A' ' 10' ' ' TYR . 10.2 mt -90.67 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.641 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -70.65 -173.45 0.76 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.069 0.938 . . . . 0.0 111.491 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.641 ' H ' HG22 ' A' ' 6' ' ' THR . 1.6 tp -93.99 -38.61 11.07 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.521 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 1.3 tmtt? -90.11 -67.39 0.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.51 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 9.5 m-20 -43.9 -44.11 6.83 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.722 ' CE1' HD12 ' A' ' 5' ' ' ILE . 8.4 t80 -57.96 -54.29 48.56 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.975 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.08 -20.73 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -21.6 21.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.969 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.31 -12.95 25.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.25 -27.76 4.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.965 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.69 130.92 3.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.77 72.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -1.165 . . . . 0.0 109.813 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 15.5 p -82.07 -14.08 56.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -55.37 4.8 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.42 -0.8 . . . . 0.0 108.87 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' HD21 ' A' ' 23' ' ' LEU . 66.7 m -57.18 -32.08 66.09 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 25' ' ' VAL . . . -71.41 -44.97 63.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.9 tmtt? -80.25 1.63 27.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.843 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.525 ' HB3' HG21 ' A' ' 50' ' ' VAL . 53.1 m-20 -89.9 -43.07 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.803 HD12 HG21 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -115.25 -8.55 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.677 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.97 67.95 1.26 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.81 ' CG1' HD11 ' A' ' 30' ' ' ILE . 60.8 t -142.88 140.0 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 110.34 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' O ' HG12 ' A' ' 30' ' ' ILE . 4.3 m-85 -75.0 139.63 43.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 0.0 110.184 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -46.82 -23.84 0.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -69.92 -58.8 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' N ' ' OG ' ' A' ' 28' ' ' SER . . . -46.96 -25.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.671 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.878 HG22 HD12 ' A' ' 34' ' ' ILE . 2.7 mm -71.29 -56.27 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.765 . . . . 0.0 109.986 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -62.81 -8.96 7.87 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -94.74 -40.48 9.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.748 -1.22 . . . . 0.0 108.612 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -79.86 -9.45 59.67 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 HG22 ' A' ' 30' ' ' ILE . 76.5 mt -108.8 -49.12 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.53 -0.731 . . . . 0.0 110.067 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.579 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -63.39 -33.41 75.48 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.947 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.0 -21.59 59.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.64 30.3 13.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -78.3 -173.5 3.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.227 -1.161 . . . . 0.0 110.256 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.76 75.36 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.174 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 58' ' ' PHE . 62.1 mt -106.17 169.25 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 50.9 m-85 -156.56 158.83 37.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 3.1 mp -134.4 114.96 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.0 110.492 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.769 HG23 ' O ' ' A' ' 43' ' ' THR . 13.0 t -93.55 102.95 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 109.848 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' SER . 1.9 mp -91.68 130.23 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.055 . . . . 0.0 110.453 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.763 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 8.2 m-20 -50.53 -19.52 0.91 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.09 -19.52 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.66 -11.96 57.97 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.34 -22.86 5.85 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.822 ' O ' HG23 ' A' ' 44' ' ' ILE . 5.0 t -60.04 148.63 34.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 109.583 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 22' ' ' ASP . 52.9 t -133.4 123.32 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.991 -1.068 . . . . 0.0 111.047 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 15.0 t80 -120.64 119.18 32.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 108.933 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 58' ' ' PHE . . . -93.61 154.28 17.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.921 -1.112 . . . . 0.0 111.241 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -160.35 142.53 12.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.563 -0.711 . . . . 0.0 109.844 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 56' D VAL . 11.7 tm-20 -121.47 167.18 13.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.4 116.49 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.463 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' B GLY . 11.3 ttmt -143.2 153.86 43.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 110.156 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' A ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' LYS . 28.9 t0 -43.73 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.465 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' B GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.66 -64.34 0.42 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -170.29 171.78 6.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.471 -1.017 . . . . 0.0 110.237 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' D VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 21.4 m -93.22 133.26 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 110.16 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' E LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 mmtp -116.87 132.61 23.33 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.978 . . . . 0.0 110.747 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.9 Cg_exo -80.23 125.81 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.218 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -140.88 144.54 35.93 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -91.47 48.53 1.27 Allowed 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.275 -1.969 . . . . 0.0 110.578 0.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.86 165.52 5.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -154.03 -173.53 4.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.238 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.57 52.34 1.0 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 109.678 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -104.52 95.67 6.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.423 -0.798 . . . . 0.0 110.413 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.458 ' O ' ' HB ' ' A' ' 65' ' ' THR . 30.0 p 42.62 -140.45 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.872 . . . . 0.0 110.392 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.675 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 9.5 t -178.25 57.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 110.228 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.249 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 mtm . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.248 0.547 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.37 65.77 0.73 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 110.528 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.627 ' CG ' ' O ' ' A' ' 3' ' ' GLN 0.257 0.7 OUTLIER -86.29 63.13 7.83 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.637 1.208 . . . . 0.0 108.882 179.905 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.561 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -78.59 73.55 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.922 -1.111 . . . . 0.0 111.375 -178.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.692 HG22 ' HB2' ' A' ' 10' ' ' TYR . 5.1 mt -88.28 145.73 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.145 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 2.3 p -66.53 -173.02 0.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.753 0.787 . . . . 0.0 111.246 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.076 HD23 HD12 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -90.44 -26.62 19.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.506 ' HG2' HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -81.94 -73.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.071 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.7 -56.29 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.045 -1.034 . . . . 0.0 109.709 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' A' ' 5' ' ' ILE . 6.1 t80 -46.74 -53.81 11.02 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.21 -33.16 65.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ttm -63.79 -40.19 96.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.258 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 -28.37 50.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.55 -74.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 110.171 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.16 148.19 5.83 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -58.17 -39.0 77.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -1.102 . . . . 0.0 109.845 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.51 -14.21 59.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 0.0 110.364 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -79.49 -56.31 4.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.199 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 2.1 m -62.51 -29.25 70.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.58 -29.82 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 110.259 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -82.72 -14.57 54.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.798 ' OD1' HG21 ' A' ' 50' ' ' VAL . 4.1 t70 -90.14 -25.39 20.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 109.949 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 30' ' ' ILE . 95.6 mt -79.96 -35.85 37.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 110.358 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.97 23.17 30.77 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -132.81 157.16 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -1.095 . . . . 0.0 110.074 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 25' ' ' VAL . 49.5 m-85 -46.6 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 110.437 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -85.11 -13.78 49.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 110.559 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 t -76.91 -56.39 4.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.955 . . . . 0.0 110.315 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.81 -25.3 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 109.966 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.757 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -76.27 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.846 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.757 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.6 OUTLIER -58.82 -7.91 1.17 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.427 -0.796 . . . . 0.0 111.132 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -91.39 -40.37 11.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.514 -1.366 . . . . 0.0 108.169 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.432 ' O ' ' CD ' ' A' ' 38' ' ' ARG . . . -75.29 -18.84 59.96 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.854 HD11 ' HB3' ' A' ' 7' ' ' LEU . 37.7 mt -96.71 -52.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.423 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 72.3 t60 -52.06 -23.03 4.65 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.295 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.42 -55.5 13.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.814 . . . . 0.0 110.464 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . 124.57 8.96 5.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -51.34 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.401 -1.058 . . . . 0.0 111.835 -179.489 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.86 81.18 1.86 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.492 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.076 HD12 HD23 ' A' ' 7' ' ' LEU . 1.8 mt -97.07 157.5 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.174 -0.954 . . . . 0.0 110.78 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 97.9 m-85 -150.13 98.16 2.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.453 -0.779 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.756 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.8 mp -85.13 101.82 12.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.139 -0.976 . . . . 0.0 111.251 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 43' ' ' THR . 2.3 m -77.78 100.73 6.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.166 -0.958 . . . . 0.0 108.842 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 49' ' ' SER . 5.4 mt -96.5 132.47 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.987 . . . . 0.0 111.453 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 14.2 m-20 -54.66 -17.86 3.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.701 -0.624 . . . . 0.0 110.597 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 90.92 -15.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.33 -17.01 28.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.785 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 135.88 -27.06 3.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -57.09 112.04 1.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.243 . . . . 0.0 109.392 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.798 HG21 ' OD1' ' A' ' 22' ' ' ASP . 29.2 t -109.18 126.31 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.463 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 7.1 m-85 -116.64 108.79 16.36 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -88.06 119.0 28.01 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.034 -1.042 . . . . 0.0 110.615 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 56' E LYS . 0.0 OUTLIER -148.18 121.33 8.9 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.358 -0.839 . . . . 0.0 110.567 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' D VAL . 9.3 mt-10 -81.25 154.76 26.43 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.05 115.01 2.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.685 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -148.99 121.91 8.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 109.624 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' A ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 26.1 t70 58.42 16.78 4.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' B GLY . . . . . 0.623 ' O ' HG13 ' A' ' 56' D VAL . . . 100.81 -27.68 19.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 111.57 3.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -1.196 . . . . 0.0 110.505 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' D VAL . . . . . 0.623 HG13 ' O ' ' A' ' 56' B GLY . 3.3 m -111.71 146.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 110.324 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' E LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 7.3 mtpt -145.46 157.89 51.61 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.136 -0.978 . . . . 0.0 110.523 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -83.4 174.5 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.776 1.651 . . . . 0.0 110.222 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 84.4 t80 176.98 113.35 0.13 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 110.303 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 5.6 Cg_exo -78.05 108.21 1.15 Allowed 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.589 -1.838 . . . . 0.0 110.53 0.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 14.1 p -55.54 -167.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 110.56 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -55.45 -167.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.0 110.531 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' O ' ' C ' ' A' ' 63' ' ' LYS . 2.9 mttm -132.87 45.29 2.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.366 -0.834 . . . . 0.0 109.996 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' C ' ' O ' ' A' ' 62' ' ' LYS . 3.7 mmmt 30.01 -138.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.117 0.484 . . . . 0.0 111.134 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 p -96.78 -139.79 0.27 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.668 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 9.7 t -65.03 -12.54 51.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.242 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.076 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.163 0.506 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -123.72 136.82 54.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 0.0 109.972 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.3 mt-30 -127.74 76.78 1.7 Allowed 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.102 -0.998 . . . . 0.0 110.019 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.565 ' HD2' HG22 ' A' ' 43' ' ' THR . 0.4 OUTLIER -79.13 81.89 5.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.896 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.601 HD12 ' CE1' ' A' ' 10' ' ' TYR . 2.0 mt -90.46 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.477 -0.764 . . . . 0.0 110.063 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -74.52 -169.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.059 0.933 . . . . 0.0 111.7 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 40' ' ' ILE . 5.2 tp -91.44 -42.48 10.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.737 ' HB2' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -91.11 -58.05 2.6 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -46.19 -49.33 17.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.601 ' CE1' HD12 ' A' ' 5' ' ' ILE . 3.6 t80 -56.32 -57.04 13.95 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.818 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.42 -20.21 2.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.536 -0.727 . . . . 0.0 109.926 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 1.5 ttp -71.65 -44.84 63.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 110.362 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -70.46 -21.95 62.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.199 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 13.2 m-85 -112.02 -89.91 0.51 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.64 151.76 14.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -35.98 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -1.107 . . . . 0.0 109.942 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.9 t -78.48 -11.84 59.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -47.75 9.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.23 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.5 m -67.7 -26.99 66.44 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.441 -0.787 . . . . 0.0 109.341 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.48 -37.98 50.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -0.757 . . . . 0.0 110.271 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.76 68.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.065 ' OD2' HG11 ' A' ' 50' ' ' VAL . 3.3 t70 -73.9 -38.48 64.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.486 ' HB2' HG23 ' A' ' 25' ' ' VAL . 24.4 mt -84.99 -12.41 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.03 49.9 37.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -128.27 176.93 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.194 -1.18 . . . . 0.0 109.902 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 1.4 m-85 -93.48 148.02 22.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.88 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.475 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.4 tt0 -44.9 -47.73 11.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.848 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -53.47 -56.58 15.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.762 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.57 -32.03 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.502 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.74 HG22 HD12 ' A' ' 34' ' ' ILE . 3.1 mm -66.34 -54.48 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.789 0.804 . . . . 0.0 109.856 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -52.41 -17.16 1.08 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.546 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.766 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -95.69 -36.59 11.14 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.439 -1.413 . . . . 0.0 108.924 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -78.64 2.95 17.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.53 -0.731 . . . . 0.0 109.178 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 30' ' ' ILE . 20.3 mt -135.55 -46.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.591 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 3.4 t60 -79.62 -11.61 59.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.209 -0.932 . . . . 0.0 110.512 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -90.27 -24.2 20.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.131 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.65 51.13 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.604 ' CG ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -90.78 130.38 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.331 -1.1 . . . . 0.0 110.592 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.35 65.49 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 109.02 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 7' ' ' LEU . 1.1 mt -94.28 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.509 -0.744 . . . . 0.0 110.74 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 95.7 m-85 -142.75 121.63 12.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.413 -0.804 . . . . 0.0 110.161 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.648 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.4 mp -105.38 113.52 27.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.898 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.565 HG22 ' HD2' ' A' ' 4' ' ' ARG . 0.5 OUTLIER -90.05 103.06 15.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.12 -0.988 . . . . 0.0 108.82 179.094 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 6.6 mt -101.11 125.61 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.081 -1.012 . . . . 0.0 110.737 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -91.88 -178.08 4.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.342 -0.848 . . . . 0.0 110.334 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.86 -2.77 7.9 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.68 -2.16 57.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.438 -0.789 . . . . 0.0 110.436 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -6.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.413 ' O ' HG23 ' A' ' 44' ' ' ILE . 3.8 t -56.16 160.59 2.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.862 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.065 HG11 ' OD2' ' A' ' 22' ' ' ASP . 95.5 t -137.31 106.04 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.483 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 9.9 m-85 -88.92 84.41 6.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.68 110.55 9.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 109.049 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 56' E LYS . 0.4 OUTLIER -146.39 122.63 10.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.094 -1.004 . . . . 0.0 111.65 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' D VAL . 0.0 OUTLIER -78.73 159.56 27.88 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -154.36 132.84 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.568 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 56' C GLU . 0.2 OUTLIER -160.22 78.77 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' A ASP . . . . . 0.402 ' O ' ' CG ' ' A' ' 56' A ASP . 15.4 t0 51.08 46.01 27.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.528 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' B GLY . . . . . 0.42 ' O ' HG12 ' A' ' 56' D VAL . . . 114.44 -30.8 6.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' C GLU . . . . . 0.515 ' CB ' ' HB3' ' A' ' 56' ' ' LYS . 4.3 mt-10 -79.06 103.61 9.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.171 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' D VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -145.73 153.88 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' E LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pttt -171.3 161.37 5.24 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.131 -0.981 . . . . 0.0 110.483 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 58' ' ' PHE . 5.9 Cg_exo -81.29 48.46 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.747 1.631 . . . . 0.0 111.556 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.492 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 15.7 t80 -41.42 122.54 2.18 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.144 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' SER . 2.4 Cg_endo -82.38 103.38 0.51 Allowed 'Cis proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.517 -1.868 . . . . 0.0 110.48 -0.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' PRO . 8.0 p -40.91 153.49 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.231 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -159.58 -170.84 3.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.62 53.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 109.767 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.62 56.37 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.41 -0.807 . . . . 0.0 110.336 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.524 ' C ' ' CG2' ' A' ' 65' ' ' THR . 18.8 p -66.78 130.36 42.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.344 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.524 ' CG2' ' C ' ' A' ' 64' ' ' THR . 0.0 OUTLIER 37.87 29.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.829 0.823 . . . . 0.0 109.536 -179.367 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 64' ' ' THR . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.161 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 1.2 ttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.24 0.543 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.2 mt-10 57.12 -87.2 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.389 -0.819 . . . . 0.0 110.586 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.0 mm-40 -124.47 74.47 1.33 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.902 -1.124 . . . . 0.0 110.315 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 33.6 ttt-85 -79.68 84.03 5.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.714 HD12 ' CE1' ' A' ' 10' ' ' TYR . 5.9 mt -88.62 169.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -77.64 -174.12 3.29 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.04 0.924 . . . . 0.0 111.898 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.029 HD22 HD12 ' A' ' 40' ' ' ILE . 3.5 tp -91.78 -41.02 10.9 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.477 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.31 -53.29 4.52 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.554 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -53.51 -50.92 64.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.714 ' CE1' HD12 ' A' ' 5' ' ' ILE . 7.2 t80 -54.8 -54.69 38.89 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.641 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -53.03 -25.93 13.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.493 -0.754 . . . . 0.0 109.845 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.446 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 17.9 tpp -73.97 -36.84 64.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.852 . . . . 0.0 109.96 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.06 -30.03 60.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.93 -66.34 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.74 160.68 11.91 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -35.14 67.26 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 0.0 109.67 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -83.66 -14.14 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.43 -47.04 11.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 108.976 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m -64.24 -30.69 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.87 -30.16 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.539 -0.726 . . . . 0.0 109.713 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -76.3 -34.84 59.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.785 ' HB3' HG11 ' A' ' 50' ' ' VAL . 3.2 m-20 -66.39 -35.32 80.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.786 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' A' ' 59' ' ' PRO . 74.9 mt -81.28 -34.64 31.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 0.0 110.196 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.97 48.0 5.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.48 -179.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -1.121 . . . . 0.0 110.132 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.518 ' O ' HD13 ' A' ' 30' ' ' ILE . 29.2 m-85 -70.18 171.54 9.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.766 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.7 tt0 -87.94 -21.02 25.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -0.808 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 p -66.24 -45.38 80.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 109.968 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -21.48 16.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.741 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.7 mp -80.01 -50.93 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.42 -0.8 . . . . 0.0 109.724 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -71.18 -2.34 15.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -101.47 -42.22 6.34 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.909 -1.12 . . . . 0.0 108.155 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -74.65 -18.16 60.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 7' ' ' LEU . 45.5 mt -102.11 -50.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.442 -0.786 . . . . 0.0 110.246 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 2.2 t60 -60.56 -16.46 37.96 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.9 -1.125 . . . . 0.0 109.817 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 -46.08 17.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.6 7.22 5.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -51.58 161.96 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -1.182 . . . . 0.0 110.172 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 5.4 mmtt -115.88 70.27 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.029 HD12 HD22 ' A' ' 7' ' ' LEU . 6.1 mt -90.55 161.3 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.816 . . . . 0.0 110.15 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 48.6 m-85 -151.26 114.03 4.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.715 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.3 mp -80.52 141.69 34.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 2.8 m -116.71 103.28 10.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.38 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.969 HG23 ' O ' ' A' ' 49' ' ' SER . 1.2 mt -105.12 130.66 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.731 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -105.25 -172.22 2.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.925 179.489 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.26 -2.2 18.09 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -161.67 21.53 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -90.7 -5.36 68.9 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.5 OUTLIER 60.09 -94.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 49' ' ' SER . 1.7 t -162.3 112.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 0.0 110.867 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 20.0 m-85 -101.69 151.99 21.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 108.995 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . -127.03 99.62 5.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.873 -1.142 . . . . 0.0 111.051 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 40' ' ' ILE . 1.8 mt-10 -101.86 169.95 8.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.611 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -150.51 153.56 36.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.927 -1.108 . . . . 0.0 110.587 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 54' ' ' GLU . 5.8 t -150.94 118.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 110.114 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 0.2 OUTLIER -146.37 -168.8 3.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' A ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 56' B GLY . 15.3 t0 -41.25 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.462 -0.774 . . . . 0.0 110.306 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 42.32 57.21 3.79 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 mt-10 -160.42 84.87 0.71 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.244 . . . . 0.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' D VAL . . . . . . . . . . . . . 4.5 m -102.07 148.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' E LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.0 pttt -172.62 166.19 3.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 110.345 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.0 Cg_endo -88.1 -83.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.867 1.712 . . . . 0.0 110.558 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.542 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 59.19 109.57 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.367 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.503 ' HD3' HD22 ' A' ' 23' ' ' LEU . 5.8 Cg_exo -77.39 140.4 63.45 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.456 -1.893 . . . . 0.0 109.923 -0.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 33.2 t -127.78 -56.7 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.054 -1.029 . . . . 0.0 110.358 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -150.87 67.33 0.93 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.421 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 63' ' ' LYS . 3.9 ptmt -114.51 38.29 3.13 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.177 -0.952 . . . . 0.0 109.299 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -169.91 156.57 6.26 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.134 0.492 . . . . 0.0 109.846 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.3 -170.52 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -137.96 4.75 2.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 110.287 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.219 -179.872 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.204 0.526 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.88 -162.98 0.31 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.221 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 46' ' ' ALA . 1.9 mm100 -112.53 70.4 0.71 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -79.4 75.77 6.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 6' ' ' THR . 54.4 mt -90.82 177.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -87.52 -171.03 3.27 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.453 1.12 . . . . 0.0 112.496 -178.761 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.106 HD22 HD13 ' A' ' 40' ' ' ILE . 3.5 tp -92.14 -52.42 4.7 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 123.307 1.527 . . . . 0.0 107.203 176.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.45 -57.54 3.2 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.229 179.618 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.539 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -47.67 -47.87 29.28 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 6' ' ' THR . 27.0 t80 -52.44 -60.19 3.53 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.396 -0.922 . . . . 0.0 109.659 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.7 -26.57 2.38 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.557 0.694 . . . . 0.0 109.577 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.486 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.42 -52.65 44.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.995 179.931 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 -64.36 -31.85 73.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.698 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.469 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 7.5 m-30 -109.75 -80.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 110.152 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 173.75 39.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.445 ' HG3' ' HG2' ' A' ' 27' ' ' GLN . 9.1 tp60 -79.1 -32.3 44.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -1.14 . . . . 0.0 110.075 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -67.96 -21.6 65.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.853 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 14' ' ' PHE . 6.5 mttt -79.74 -38.33 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.867 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.18 -14.18 61.31 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.519 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.696 ' HB2' ' HG3' ' A' ' 27' ' ' GLN . . . -79.15 -47.07 16.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 0.0 109.669 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -12.13 60.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.731 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.566 ' OD1' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -77.3 -55.35 5.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.86 HD21 ' HB2' ' A' ' 52' ' ' ALA . 10.9 mt -86.22 -14.37 44.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.292 -0.88 . . . . 0.0 110.151 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.58 31.06 46.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 26' ' ' TYR . 1.5 t -127.02 178.5 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -1.075 . . . . 0.0 109.75 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.475 ' O ' HD12 ' A' ' 30' ' ' ILE . 57.0 m-85 -89.01 132.95 34.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -0.992 . . . . 0.0 110.2 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.696 ' HG3' ' HB2' ' A' ' 20' ' ' ALA . 17.1 mt-30 -41.71 -29.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 110.264 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.65 -18.87 8.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.452 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.601 HG22 HD12 ' A' ' 34' ' ' ILE . 1.6 mp -86.2 -43.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.044 -1.035 . . . . 0.0 110.315 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.3 t-20 -67.16 -9.92 44.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.235 -0.915 . . . . 0.0 110.206 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -94.52 -48.85 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 108.186 178.482 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -67.83 -16.39 64.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CG1' HD23 ' A' ' 7' ' ' LEU . 7.3 mt -95.93 -64.18 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -49.71 -19.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.651 179.279 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -76.56 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.588 -0.695 . . . . 0.0 111.78 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 39' ' ' LYS . . . -132.59 87.83 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 15.6 mmm-85 -57.19 108.1 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.941 . . . . 0.0 111.049 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HD2' ' HD2' ' A' ' 56' ' ' LYS . 11.7 pttm 179.21 42.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.106 HD13 HD22 ' A' ' 7' ' ' LEU . 15.8 mt -102.24 164.18 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.996 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 58.6 m-85 -156.74 110.54 2.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.952 HD11 HD12 ' A' ' 7' ' ' LEU . 5.3 mp -99.44 144.1 28.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 112.183 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 48' ' ' GLY . 1.5 m -96.1 110.92 23.09 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 176.099 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -89.12 175.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 113.048 -176.369 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.578 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 36.8 p30 -60.87 -133.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.246 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 57.35 43.38 23.45 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.605 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 35.5 t70 69.22 26.33 5.46 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -176.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' O ' HG22 ' A' ' 43' ' ' THR . . . -124.61 -13.9 3.67 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 43' ' ' THR . 11.9 m 61.2 133.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -1.057 . . . . 0.0 108.441 -178.375 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.601 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 23.1 t -78.41 136.54 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.701 -1.249 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 50' ' ' VAL . 20.9 m-85 -165.61 177.84 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.742 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.86 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -144.97 133.82 22.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 109.981 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 56' E LYS . 18.2 tt0 -154.46 117.05 4.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 0.0 110.916 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.597 ' HG3' HG23 ' A' ' 40' ' ' ILE . 15.2 mt-10 -80.77 153.54 27.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 56' D VAL . 8.7 t -146.67 123.37 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.94 -1.1 . . . . 0.0 110.979 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -147.35 141.02 25.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.706 . . . . 0.0 109.208 179.403 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' A ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -40.53 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 110.42 -179.357 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' B GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.41 -48.51 0.53 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 tt0 -179.33 163.92 1.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.257 -1.143 . . . . 0.0 110.718 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' D VAL . . . . . 0.545 HG12 HG13 ' A' ' 55' ' ' VAL . 15.2 m -112.88 170.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' E LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 15.8 mttt -143.11 160.34 52.78 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 110.477 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 1.3 Cg_endo -85.26 -65.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.887 1.725 . . . . 0.0 110.2 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.55 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 28.4 t80 57.09 99.63 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.519 -0.738 . . . . 0.0 110.611 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 15.0 Cg_exo -66.3 152.38 81.21 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.827 -2.155 . . . . 0.0 110.427 0.065 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.9 m -95.61 11.89 31.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.053 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -102.44 138.64 39.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 110.2 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -174.15 57.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 110.303 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.64 174.61 11.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 110.038 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.6 p -121.39 175.96 5.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.234 -0.916 . . . . 0.0 109.789 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.451 ' O ' ' OXT' ' A' ' 66' ' ' ALA . 15.3 t -63.49 -22.27 66.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' OXT' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.147 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.25 0.548 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 16.1 mt-10 -46.67 150.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 0.9 OUTLIER -140.97 86.98 2.07 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.259 -0.901 . . . . 0.0 109.59 -179.863 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 5.8 ttp180 -77.82 82.15 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.432 -0.793 . . . . 0.0 109.927 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.722 HG22 ' HB2' ' A' ' 10' ' ' TYR . 11.2 mm -90.73 163.78 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -77.1 -171.88 2.18 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.121 0.962 . . . . 0.0 111.952 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.705 ' H ' HG22 ' A' ' 6' ' ' THR . 4.9 tp -91.62 -40.04 11.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.565 ' CD ' HG22 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -90.79 -51.43 5.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.431 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.473 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 1.6 t0 -54.91 -43.57 73.39 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.722 ' HB2' HG22 ' A' ' 5' ' ' ILE . 2.3 t80 -62.94 -55.07 29.1 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.196 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.26 -26.57 18.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.637 -0.664 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ttm -71.79 -36.25 70.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.828 . . . . 0.0 110.053 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.76 -39.21 57.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.675 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.74 -100.9 0.23 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.254 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.7 176.02 32.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.715 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 11.2 tp60 -88.28 -30.5 19.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -1.068 . . . . 0.0 110.134 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -84.34 -28.25 27.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -62.16 1.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.67 HG23 HD21 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -53.29 -35.46 60.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.349 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -58.24 -41.47 84.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.56 ' HA ' HG13 ' A' ' 25' ' ' VAL . 6.7 mmtt -57.47 -45.08 85.19 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.8 m-20 -92.19 -5.19 53.01 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.432 -0.792 . . . . 0.0 112.791 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.117 HD22 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -164.39 62.74 0.14 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.47 -1.394 . . . . 0.0 109.92 -179.645 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.714 ' O ' ' HB1' ' A' ' 20' ' ' ALA . . . 127.53 74.45 0.19 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.348 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.706 HG22 ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.58 -11.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.92 -0.753 . . . . 0.0 109.842 -177.198 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' SER . 8.1 m-85 -101.71 98.23 8.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -37.12 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 111.53 -178.691 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' TYR . 67.8 m -82.63 -61.12 1.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.79 -1.194 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . . . -48.92 -22.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.077 -1.015 . . . . 0.0 109.109 179.165 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.743 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.65 -64.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.523 -0.736 . . . . 0.0 109.933 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.743 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -52.07 -15.67 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.484 -0.76 . . . . 0.0 111.252 -179.612 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 4.9 mttt -93.08 -39.8 10.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.435 -1.416 . . . . 0.0 109.028 179.116 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . -76.31 -9.71 58.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.462 -0.774 . . . . 0.0 108.942 178.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 30' ' ' ILE . 16.5 mt -111.98 -52.36 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 7.5 t-160 -57.63 -31.76 66.57 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.204 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 38' ' ' ARG . . . -90.05 -45.97 8.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.472 -0.768 . . . . 0.0 109.673 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.02 85.44 1.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.829 ' HB2' HD11 ' A' ' 40' ' ' ILE . 2.5 mpt_? -90.1 49.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.266 . . . . 0.0 109.27 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER 42.46 53.96 4.5 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.854 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 38' ' ' ARG . 4.2 mt -105.23 154.8 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 110.082 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 70.8 m-85 -149.89 167.58 26.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.29 -0.881 . . . . 0.0 110.066 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.117 HD22 HD22 ' A' ' 23' ' ' LEU . 4.2 mp -143.93 149.01 36.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.953 -1.092 . . . . 0.0 110.965 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.2 m -127.62 97.36 4.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.602 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.714 HG23 ' O ' ' A' ' 49' ' ' SER . 3.8 mt -81.03 93.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 110.348 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 27.0 p-10 -54.52 172.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.339 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -5.72 7.01 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.912 178.551 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 3.9 t70 -79.23 1.23 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.096 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.3 1.06 73.8 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 44' ' ' ILE . 43.6 m -83.27 -170.94 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 44' ' ' ILE . 10.6 t -144.01 127.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.029 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 13.9 m-85 -104.77 94.96 5.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 109.683 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -80.41 142.8 33.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.306 -0.871 . . . . 0.0 109.73 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' E LYS . 10.2 tt0 -153.86 110.39 3.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.266 -0.896 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 56' D VAL . 39.6 tt0 -81.31 167.17 19.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.18 126.93 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.037 -1.039 . . . . 0.0 110.583 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' O ' ' C ' ' A' ' 56' A ASP . 6.0 ttpt -158.76 135.07 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.867 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' A ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.3 m-20 29.52 65.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.868 -0.52 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 47.7 56.79 8.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.46 96.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -1.164 . . . . 0.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' D VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 17.3 m -93.83 161.48 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' E LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 56' D VAL . 2.5 mtmt -143.71 167.38 15.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.127 -0.983 . . . . 0.0 111.291 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 60' ' ' SER . 1.6 Cg_endo -85.98 173.47 6.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.415 2.077 . . . . 0.0 110.165 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.555 ' CZ ' ' C ' ' A' ' 23' ' ' LEU . 10.1 t80 174.22 126.34 0.11 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.964 . . . . 0.0 110.913 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.706 ' HG3' HG22 ' A' ' 25' ' ' VAL . 48.1 Cg_endo -90.12 97.99 0.17 OUTLIER 'Cis proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.782 -1.758 . . . . 0.0 110.297 0.102 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 57' ' ' PRO . 6.3 m -143.45 -109.51 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.724 -1.235 . . . . 0.0 110.671 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 62' ' ' LYS . 3.4 t-20 63.13 172.86 0.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.786 -1.196 . . . . 0.0 109.852 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 19.3 tttt 59.72 47.72 10.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.935 . . . . 0.0 109.687 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.03 -35.1 8.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.697 -0.627 . . . . 0.0 110.572 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.58 -165.89 2.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 110.574 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 65' ' ' THR . 5.4 t -80.45 -24.52 39.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 110.202 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.188 -179.998 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.108 0.48 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.45 -163.33 1.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.145 -0.972 . . . . 0.0 110.381 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -120.93 75.61 1.16 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.312 -0.867 . . . . 0.0 109.443 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -78.45 76.46 4.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.515 -0.741 . . . . 0.0 110.677 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.581 HG21 ' HD1' ' A' ' 10' ' ' TYR . 3.8 mt -89.88 135.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -45.89 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.172 0.987 . . . . 0.0 112.015 -178.856 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.041 HD12 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -92.03 -40.43 11.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.892 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.79 -60.47 1.95 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.392 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 12' ' ' MET . 11.6 t0 -45.09 -45.1 10.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.581 ' HD1' HG21 ' A' ' 5' ' ' ILE . 32.1 t80 -61.52 -53.61 54.19 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.47 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.57 -21.52 3.94 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.52 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.9 -47.89 49.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.462 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -65.25 -23.72 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.536 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 5.3 m-85 -114.19 -78.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.143 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 156.41 162.49 11.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.579 ' OE1' HG22 ' A' ' 30' ' ' ILE . 2.9 tp-100 -57.54 -41.31 80.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -1.1 . . . . 0.0 109.973 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -65.48 -30.26 71.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -71.01 -63.53 1.08 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.344 179.488 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 7' ' ' LEU . 4.2 m -57.4 -22.67 44.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.272 -0.892 . . . . 0.0 109.19 179.051 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -72.07 -45.7 59.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.431 -0.793 . . . . 0.0 110.228 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 14.0 mmtt -76.84 -13.04 60.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.892 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB3' HG21 ' A' ' 50' ' ' VAL . 3.5 m-20 -71.46 -48.94 46.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.699 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.402 ' CB ' HG23 ' A' ' 25' ' ' VAL . 23.7 mt -82.61 -10.22 59.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 110.243 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 24.86 76.29 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.462 ' CG1' ' CB ' ' A' ' 29' ' ' ALA . 2.6 t -109.03 163.97 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -1.096 . . . . 0.0 110.163 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -62.68 147.6 49.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.093 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.4 ' HA ' HG12 ' A' ' 30' ' ' ILE . 2.0 mt-30 -50.78 -24.72 3.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.991 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 t -65.09 -51.3 62.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.842 . . . . 0.0 109.791 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.462 ' CB ' ' CG1' ' A' ' 25' ' ' VAL . . . -53.69 -19.36 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.805 . . . . 0.0 109.953 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.7 HG22 HD12 ' A' ' 34' ' ' ILE . 3.3 mm -80.88 -50.82 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.5 OUTLIER -70.63 -7.24 42.79 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.603 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -92.4 -44.61 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 108.758 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.711 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -80.71 -13.41 59.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.012 HG12 HD13 ' A' ' 7' ' ' LEU . 9.5 mt -102.49 -42.37 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 42.9 t60 -61.69 -53.82 50.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.955 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 38' ' ' ARG . . . -93.12 -122.16 0.09 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . -1.73 68.38 0.0 OUTLIER Glycine 0 N--CA 1.504 3.223 0 C-N-CA 123.288 0.47 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 36' ' ' ALA . 23.3 mmm-85 -85.28 61.72 7.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.297 -1.119 . . . . 0.0 110.512 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 64.7 pttt -154.22 38.27 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 108.974 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.041 HD13 HD12 ' A' ' 7' ' ' LEU . 10.3 mt -101.65 165.36 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 110.825 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 56.2 m-85 -156.66 103.41 2.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.604 -0.685 . . . . 0.0 109.241 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.687 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.3 mp -89.33 130.18 35.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.905 . . . . 0.0 111.136 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 43' ' ' THR . 2.1 m -101.2 103.32 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.163 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 45' ' ' ASN . 18.6 mt -89.25 74.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.062 -1.024 . . . . 0.0 110.576 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 44' ' ' ILE . 1.7 p30 -44.7 174.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 110.705 179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.95 -2.8 8.17 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.613 -0.835 . . . . 0.0 108.979 178.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.42 -2.1 57.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.885 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.81 -3.55 55.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -72.21 149.93 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -1.227 . . . . 0.0 109.773 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 22' ' ' ASP . 13.1 t -111.5 105.87 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 110.668 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 1.9 m-85 -88.95 96.21 10.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.95 . . . . 0.0 109.007 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -84.87 92.21 8.22 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 110.707 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.444 ' OE1' ' CG2' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.44 165.18 11.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.567 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 56' D VAL . 54.6 mt-10 -134.13 163.08 30.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.714 HG13 HG12 ' A' ' 56' D VAL . 3.3 t -150.33 133.76 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 56' A ASP . 7.1 tptp -148.83 78.54 1.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.401 -0.812 . . . . 0.0 109.497 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' A ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 16.0 t0 60.24 50.47 6.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.592 -0.692 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 102.75 -30.43 10.42 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.499 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' C GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 56' ' ' LYS . 9.7 mt-10 -74.26 95.66 2.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.098 -1.237 . . . . 0.0 110.715 -179.508 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' D VAL . . . . . 0.714 HG12 HG13 ' A' ' 55' ' ' VAL . 18.8 m -117.05 147.48 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.214 -0.929 . . . . 0.0 110.393 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' E LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 3.6 pttm -175.1 165.73 2.1 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.191 -0.943 . . . . 0.0 110.576 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 4.7 Cg_exo -78.93 -176.41 3.27 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.872 1.714 . . . . 0.0 110.53 -178.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.598 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 1.8 t80 178.63 126.99 0.21 Allowed Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.29 -0.881 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 60.3 Cg_endo -90.11 96.59 0.16 OUTLIER 'Cis proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.913 -1.703 . . . . 0.0 110.514 -0.033 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 12.0 p -65.05 90.36 0.09 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.456 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 60' ' ' SER . 23.0 m-20 41.11 -163.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -134.2 46.21 2.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.747 . . . . 0.0 110.172 -179.952 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.569 ' C ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 6.63 109.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.817 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.46 -154.97 0.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.13 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -120.07 25.1 10.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 110.329 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.279 -179.939 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' GLU . 1.4 ttt . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.268 0.556 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 1' ' ' MET . 4.1 tt0 -43.15 125.65 3.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.965 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -125.75 76.73 1.6 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.343 -0.848 . . . . 0.0 109.934 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 3.2 ttm180 -79.34 74.56 5.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.382 -0.824 . . . . 0.0 110.098 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.996 HG22 ' HB2' ' A' ' 10' ' ' TYR . 3.9 mm -90.08 148.12 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.443 -0.786 . . . . 0.0 109.851 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -44.54 -179.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 122.486 1.136 . . . . 0.0 112.109 -178.822 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.865 ' HB2' HD11 ' A' ' 42' ' ' LEU . 5.7 tp -94.28 -39.35 10.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.411 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -88.62 -61.9 1.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.185 179.583 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' LYS . 8.1 t0 -44.76 -42.39 7.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.996 ' HB2' HG22 ' A' ' 5' ' ' ILE . 12.0 t80 -55.76 -59.5 4.77 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.705 0.764 . . . . 0.0 109.345 178.281 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -57.9 -15.58 9.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.803 -0.561 . . . . 0.0 110.156 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ttt -83.43 -34.11 25.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.814 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.36 -10.45 49.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.809 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 -51.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.002 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.69 142.1 3.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.507 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -72.82 -27.74 62.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -1.185 . . . . 0.0 110.203 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 17' ' ' THR . 3.3 t -79.88 -21.78 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -82.4 -46.98 12.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.113 179.31 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.535 ' O ' HD12 ' A' ' 23' ' ' LEU . 11.6 m -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.319 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.62 -28.53 30.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 110.092 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -80.59 -36.96 32.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.467 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.4 -36.28 68.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.318 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 19' ' ' THR . 83.3 mt -82.6 -9.94 59.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.26 40.03 97.58 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 59' ' ' PRO . 3.9 t -124.07 146.71 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.446 -1.032 . . . . 0.0 109.97 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -72.03 150.87 43.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.879 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.62 ' HA ' HD12 ' A' ' 30' ' ' ILE . 1.9 tt0 -61.46 -20.38 63.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.4 p -84.65 -55.76 3.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.0 110.229 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.73 -23.28 1.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' GLN . 95.0 mt -76.88 -63.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.891 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 31.8 m-80 -49.9 -15.67 0.21 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.332 -0.855 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -91.58 -38.61 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.558 -1.339 . . . . 0.0 108.597 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.88 56.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.528 -0.732 . . . . 0.0 109.185 178.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.597 HD11 HD21 ' A' ' 7' ' ' LEU . 10.1 mt -114.57 -48.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.54 -0.725 . . . . 0.0 109.714 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t-160 -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.512 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.44 5.73 49.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 111.615 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.559 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -149.29 90.28 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 20.3 mmm-85 -83.69 -173.57 4.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -1.075 . . . . 0.0 110.157 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER 66.31 58.87 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.199 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.679 HD13 HD23 ' A' ' 7' ' ' LEU . 9.2 mt -116.18 157.65 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.163 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 39.8 m-85 -155.06 144.89 21.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 110.873 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 7' ' ' LEU . 4.1 mp -135.57 131.05 35.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.462 -0.774 . . . . 0.0 109.743 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.432 ' OG1' ' HG3' ' A' ' 4' ' ' ARG . 3.2 m -99.18 101.04 12.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.005 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.011 HG23 ' O ' ' A' ' 49' ' ' SER . 15.0 mt -101.1 148.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.982 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 46' ' ' ALA 0.252 2.4 m-20 -65.31 -11.75 44.91 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.531 0.682 . . . . 0.0 110.076 178.113 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.948 ' H ' HG22 ' A' ' 44' ' ' ILE . . . 81.49 1.22 1.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -175.166 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.19 38.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.575 ' N ' ' HB2' ' A' ' 45' ' ' ASN . . . -140.13 -63.36 0.04 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -177.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.011 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER 179.45 -168.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 109.445 -179.045 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.875 HG22 HG12 ' A' ' 44' ' ' ILE . 11.9 t -125.52 110.93 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.571 -1.331 . . . . 0.0 111.583 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -81.4 77.69 8.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.537 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -52.47 145.75 10.92 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.708 0.766 . . . . 0.0 111.398 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 78.94 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.566 ' CB ' HG23 ' A' ' 40' ' ' ILE . 3.8 pt-20 -79.41 163.49 24.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.253 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 56' D VAL . 3.2 t -132.77 139.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 0.5 OUTLIER -159.76 160.85 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 -179.889 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.4 m-20 -39.21 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.471 -0.768 . . . . 0.0 110.438 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 144.99 -71.41 0.37 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.7 tt0 -174.4 -172.45 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.491 -1.005 . . . . 0.0 109.926 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' D VAL . . . . . 0.611 HG12 HG22 ' A' ' 55' ' ' VAL . 34.6 m -104.6 143.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.95 . . . . 0.0 110.434 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' E LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 4.9 mmtt -128.09 161.04 58.49 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.393 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.4 Cg_exo -82.9 39.95 0.9 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.825 1.683 . . . . 0.0 111.063 -178.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.56 118.58 1.26 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.409 -0.807 . . . . 0.0 109.817 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -81.86 104.89 0.64 Allowed 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.305 -1.956 . . . . 0.0 110.724 0.2 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 73.3 p -49.4 106.23 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.08 -1.013 . . . . 0.0 110.184 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 110.416 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 63' ' ' LYS . 9.1 tptt -158.5 57.9 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.701 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -39.05 144.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.599 -0.688 . . . . 0.0 110.645 -179.732 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -104.2 38.87 1.76 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 110.046 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 t -159.48 56.66 0.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.046 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.246 -179.908 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttm . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.18 0.515 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -139.39 113.38 8.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.403 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.52 71.11 1.07 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.314 -0.866 . . . . 0.0 109.782 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.87 74.89 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.377 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.801 HG22 ' HB2' ' A' ' 10' ' ' TYR . 8.4 mt -91.66 141.68 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.305 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 18.8 p -59.47 -175.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 110.848 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.964 HD12 HG21 ' A' ' 19' ' ' THR . 1.2 tp -92.45 -34.43 14.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' CG ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -81.84 -69.52 0.61 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.855 -0.528 . . . . 0.0 110.002 179.375 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 41.4 t0 -46.66 -58.09 4.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.219 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.801 ' HB2' HG22 ' A' ' 5' ' ' ILE . 3.4 t80 -41.9 -51.65 4.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.331 -0.855 . . . . 0.0 110.368 179.282 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -56.13 -42.41 76.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.422 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 30.1 ttp -60.17 -29.94 69.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.058 179.048 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -55.84 28.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.492 -0.755 . . . . 0.0 110.125 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CZ ' ' CZ ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -123.52 67.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.974 -1.079 . . . . 0.0 111.659 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.28 156.87 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.465 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -82.29 -29.92 30.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -1.03 . . . . 0.0 109.841 179.611 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 26.4 m -60.63 -21.61 62.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.414 -0.804 . . . . 0.0 109.884 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.606 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.0 mmtp -69.76 -54.86 11.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.02 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.964 HG21 HD12 ' A' ' 7' ' ' LEU . 90.3 m -59.37 -19.01 43.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 17' ' ' THR . . . -71.12 -38.21 72.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.594 -0.691 . . . . 0.0 109.825 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -81.76 -18.69 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.743 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 3.0 t0 -65.43 -53.84 37.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.033 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.498 HD11 HD13 ' A' ' 7' ' ' LEU . 3.0 mt -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.364 -0.835 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.77 29.78 20.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -122.08 151.26 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -1.115 . . . . 0.0 109.676 -179.751 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 25' ' ' VAL . 47.8 m-85 -47.09 173.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.488 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -77.0 -28.25 54.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -67.56 -57.95 5.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.16 -28.53 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.365 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.813 ' CD1' HD11 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -62.85 -61.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.727 ' N ' HG22 ' A' ' 30' ' ' ILE . 15.8 m120 -57.28 -9.65 1.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.597 -0.69 . . . . 0.0 110.888 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -88.98 -35.32 16.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.648 -1.283 . . . . 0.0 107.766 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.513 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -85.62 -11.11 54.73 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.57 ' CG2' ' CG ' ' A' ' 8' ' ' LYS . 14.9 mt -100.68 -48.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.405 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -74.99 -58.43 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.894 179.661 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.85 11.08 23.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 110.755 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -137.63 69.66 0.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 15.0 mmm-85 -75.85 -171.85 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.899 -1.353 . . . . 0.0 110.214 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 56' A ASP . 9.2 mptt 58.73 46.72 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.198 -0.939 . . . . 0.0 110.52 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.945 HD13 HD23 ' A' ' 7' ' ' LEU . 16.7 mt -97.89 161.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 110.353 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 43.9 m-85 -161.32 114.37 1.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 110.267 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 7' ' ' LEU . 2.4 mp -107.24 131.88 53.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.099 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 43' ' ' THR . 1.7 m -96.99 100.54 12.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 44' ' ' ILE . 9.6 mt -94.73 43.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.431 ' OD1' HG22 ' A' ' 43' ' ' THR . 45.8 p-10 -91.97 -131.49 0.12 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 109.85 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.929 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 48.75 24.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.957 -1.089 . . . . 0.0 109.127 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.566 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.1 t0 75.13 63.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.317 0.579 . . . . 0.0 111.036 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 81.78 -8.43 59.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.929 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -51.11 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.317 . . . . 0.0 110.506 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.71 123.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.47 135.68 37.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.576 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' PRO . . . -103.57 149.9 24.46 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.944 -1.098 . . . . 0.0 109.461 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 2.4 tt0 -159.78 151.43 20.12 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 110.651 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.715 ' O ' ' HA ' ' A' ' 56' D VAL . 2.1 tt0 -135.92 151.1 49.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.389 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.99 ' O ' HG12 ' A' ' 56' D VAL . 7.2 p -124.33 -26.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.394 -0.923 . . . . 0.0 112.525 -177.254 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 3.2 ttmt -160.14 -171.37 3.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.705 -1.247 . . . . 0.0 111.091 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' A ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 29.5 t0 47.37 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.693 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -58.76 -51.88 56.44 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 178.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' C GLU . . . . . 0.532 ' CB ' ' OE1' ' A' ' 54' ' ' GLU . 2.5 tt0 174.97 179.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.628 -0.924 . . . . 0.0 110.096 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' D VAL . . . . . 0.99 HG12 ' O ' ' A' ' 55' ' ' VAL . 4.1 m -122.0 46.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' E LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 56' D VAL . 13.9 mttt -149.81 174.95 3.06 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.375 -0.828 . . . . 0.0 112.302 -177.743 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 56' E LYS . 3.9 Cg_exo -80.04 56.16 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.661 2.24 . . . . 0.0 111.497 -179.118 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.444 ' HZ ' HD22 ' A' ' 7' ' ' LEU . 5.0 p90 -44.06 146.53 1.08 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.714 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -91.11 50.01 1.08 Allowed 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.221 -1.991 . . . . 0.0 110.31 -0.131 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 p -44.75 141.52 2.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 110.021 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -138.92 83.05 1.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.977 . . . . 0.0 110.485 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -129.93 43.55 3.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.833 179.611 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.586 ' O ' HG22 ' A' ' 65' ' ' THR . 7.8 mtmt -118.38 -88.24 0.61 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 110.08 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.46 ' O ' ' HB ' ' A' ' 65' ' ' THR . 2.8 m 53.87 43.7 30.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.25 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 63' ' ' LYS . 6.7 t -179.02 -33.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.244 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.284 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.244 0.545 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.28 129.53 37.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.6 mt-30 -105.38 63.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.8 ttp180 -79.0 79.71 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.51 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 10' ' ' TYR . 32.7 mt -89.32 154.17 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.062 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.08 179.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.049 0.928 . . . . 0.0 111.38 -179.262 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.676 ' CD2' HD12 ' A' ' 40' ' ' ILE . 3.7 tp -92.8 -40.08 10.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.077 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HB2' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.96 -63.97 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.434 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 3.1 m-20 -45.03 -44.57 10.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.1 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.62 ' HB2' HG22 ' A' ' 5' ' ' ILE . 9.4 t80 -57.24 -56.43 21.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.143 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -57.74 -15.27 7.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.8 -0.562 . . . . 0.0 110.388 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.2 ttt -82.79 -35.34 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -0.976 . . . . 0.0 110.062 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -77.04 -32.17 56.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.664 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 12.1 m-85 -96.64 -54.22 3.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.12 137.92 2.74 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -33.43 66.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -1.18 . . . . 0.0 110.275 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 m -77.5 -23.34 50.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -76.28 -56.66 4.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.071 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 ' HB2' ' A' ' 11' ' ' ALA . 2.1 m -57.81 -23.81 54.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.491 -0.756 . . . . 0.0 109.123 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.52 -47.13 43.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.913 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -9.14 57.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 110.053 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.98 -30.84 18.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 110.141 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 42' ' ' LEU . 75.3 mt -91.37 -5.62 54.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.15 35.3 91.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' A' ' 29' ' ' ALA . 2.8 t -119.72 174.46 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -1.128 . . . . 0.0 109.926 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.459 ' H ' HG12 ' A' ' 25' ' ' VAL . 60.1 m-85 -81.96 136.41 35.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 0.0 110.0 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -44.24 -29.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.953 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -74.54 -52.55 11.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.654 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -50.76 -27.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.597 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.744 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.3 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 109.677 179.672 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.744 ' N ' HG22 ' A' ' 30' ' ' ILE . 2.3 m120 -57.7 -10.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.658 -0.651 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.88 -42.8 9.31 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.507 -1.37 . . . . 0.0 108.51 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.89 -9.63 58.73 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.303 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.55 HG12 ' CD2' ' A' ' 7' ' ' LEU . 24.6 mt -110.86 -51.1 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.765 . . . . 0.0 110.088 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.582 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.0 OUTLIER -53.86 -26.59 25.31 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.407 179.588 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.22 -75.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.989 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.07 57.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.562 ' O ' ' C ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -90.48 31.72 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.129 -1.218 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER 19.72 70.15 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.318 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 7' ' ' LEU . 6.3 mt -105.51 159.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.387 -0.821 . . . . 0.0 110.931 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -143.54 161.56 38.14 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.106 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 23' ' ' LEU . 4.0 mp -137.47 118.57 14.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.667 -1.271 . . . . 0.0 110.888 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 51' ' ' TYR . 2.8 p -85.32 97.63 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.538 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 45' ' ' ASN . 4.4 mt -89.52 80.79 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.314 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 44' ' ' ILE . 51.6 p30 -44.02 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.464 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -3.74 8.84 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.706 -0.797 . . . . 0.0 109.041 178.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -85.62 -3.16 58.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.4 -5.13 74.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -70.4 122.41 19.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.32 112.2 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.512 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.513 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 3.5 t80 -102.96 105.69 16.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -82.5 143.54 31.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.205 -0.935 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 56' E LYS . 0.7 OUTLIER -151.01 96.35 2.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.54 -0.725 . . . . 0.0 109.63 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 40.1 tt0 -78.97 161.65 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.741 HG22 HG12 ' A' ' 56' D VAL . 73.3 t -135.44 138.58 48.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.672 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 56' A ASP . 22.3 ttpp -156.06 141.74 17.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -0.76 . . . . 0.0 109.239 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' A ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 56' ' ' LYS . 7.6 t0 -37.15 102.94 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.511 -0.743 . . . . 0.0 110.828 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' B GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 56' C GLU . . . 139.72 -53.54 0.68 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' C GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 56' B GLY . 11.0 tt0 179.48 171.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 110.042 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' D VAL . . . . . 0.741 HG12 HG22 ' A' ' 55' ' ' VAL . 23.4 m -98.54 173.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.176 -0.952 . . . . 0.0 110.005 179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' E LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 5.3 mtmt -144.7 170.45 8.19 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 110.176 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 58' ' ' PHE . 4.4 Cg_exo -79.53 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.297 -2.138 0 O-C-N 124.42 1.747 . . . . 0.0 109.966 -179.196 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.504 ' O ' ' O ' ' A' ' 57' ' ' PRO . 28.1 t80 57.69 125.86 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.516 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.39 122.47 8.51 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.169 -2.013 . . . . 0.0 110.305 0.09 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.63 53.68 0.37 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.975 . . . . 0.0 110.591 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 14.8 t-20 -127.44 50.64 1.99 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.142 -0.974 . . . . 0.0 109.871 179.53 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 0.4 OUTLIER 178.38 58.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.446 -0.784 . . . . 0.0 110.02 179.986 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -113.19 -88.1 0.55 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 0.0 110.219 -179.881 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.74 -58.44 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.215 -0.928 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.78 -10.35 14.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 110.48 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.207 -179.917 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.316 0.579 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 105.78 16.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 6.4 mt-30 -118.44 73.22 0.9 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.084 -1.01 . . . . 0.0 109.655 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 6.5 ttt180 -78.26 81.48 4.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 6' ' ' THR . 3.9 mt -90.77 -179.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.424 -0.798 . . . . 0.0 109.571 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.61 -173.11 3.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.026 0.917 . . . . 0.0 111.375 -179.313 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.948 HD12 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -92.91 -46.5 7.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.347 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.559 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -84.33 -57.0 3.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.083 178.766 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.519 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -51.98 -51.78 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.393 -0.817 . . . . 0.0 109.127 179.269 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.6 t80 -49.91 -56.78 9.22 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.685 179.115 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.39 -32.67 18.17 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.646 0.736 . . . . 0.0 109.41 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -58.28 -51.61 69.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -20.74 65.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.616 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -111.58 -84.54 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.805 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 174.32 159.57 20.93 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.702 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -39.01 93.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.594 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -78.38 -3.18 41.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.907 179.768 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -90.15 -50.39 6.02 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.341 -0.849 . . . . 0.0 108.729 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.545 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -54.96 -37.96 67.16 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.271 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 -48.66 55.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.492 0.663 . . . . 0.0 109.905 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.9 mmtp -76.62 3.82 10.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 109.834 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.679 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -88.06 -60.62 1.92 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.84 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.621 ' HG ' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -99.81 -25.44 14.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.957 -1.089 . . . . 0.0 110.939 -179.408 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.57 ' N ' ' HG ' ' A' ' 23' ' ' LEU . . . 119.84 62.15 0.26 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.779 179.208 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 26' ' ' TYR . 2.2 t -142.82 -172.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.133 -1.216 . . . . 0.0 109.521 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.693 ' H ' HG12 ' A' ' 25' ' ' VAL . 31.4 m-85 -109.48 -170.2 1.61 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.933 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -87.71 -29.52 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.152 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -68.15 -46.66 70.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.02 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.97 -22.92 41.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.982 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 26' ' ' TYR . 1.3 mp -81.51 -45.8 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 109.57 179.72 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 26.2 m-20 -72.75 -8.17 54.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 179.357 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -95.5 -44.57 7.46 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.52 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -71.29 -16.38 62.46 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.766 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.603 ' HA ' ' CD ' ' A' ' 38' ' ' ARG . 88.2 mt -103.76 -53.65 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 110.704 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.569 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 8.8 t-80 -62.13 -10.42 10.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.72 -1.237 . . . . 0.0 109.941 179.783 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -81.86 -103.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.921 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' ARG . . . -123.11 78.63 0.35 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.603 ' CD ' ' HA ' ' A' ' 34' ' ' ILE . 16.5 mmm-85 -34.14 119.31 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.911 0.863 . . . . 0.0 111.833 -178.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 41.7 pttt -174.88 31.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.652 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.948 HD13 HD12 ' A' ' 7' ' ' LEU . 14.9 mt -105.88 161.16 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.688 . . . . 0.0 110.157 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 45.3 m-85 -155.3 114.37 3.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.299 -0.876 . . . . 0.0 109.897 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.0 mp -98.27 107.24 19.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.097 -1.002 . . . . 0.0 110.5 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 43' ' ' THR . 11.0 t -83.7 105.11 14.35 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.735 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.987 HG23 ' O ' ' A' ' 49' ' ' SER . 3.5 mt -97.95 135.29 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.181 -179.751 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -114.2 -168.09 1.31 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.791 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.94 0.31 11.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.6 24.6 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -96.94 -12.35 50.09 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 44' ' ' ILE . 1.1 m 59.08 -90.41 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.541 -0.976 . . . . 0.0 108.575 -178.8 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.711 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.3 t -160.95 98.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.113 -0.992 . . . . 0.0 110.401 179.06 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.421 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 2.3 t80 -95.98 105.53 17.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.255 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -67.5 148.9 50.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.624 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 41' ' ' PHE . 41.1 mt-10 -149.2 102.44 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 110.183 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' C ' ' CG2' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -89.89 148.73 22.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -0.957 . . . . 0.0 109.129 179.423 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 2.4 t -148.62 105.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.879 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 1.7 tptp -125.23 170.02 11.68 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' A ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 56' ' ' LYS . 2.7 t70 -42.26 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.171 -0.956 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 60.31 56.7 23.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -167.18 74.55 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.019 -1.283 . . . . 0.0 110.974 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' D VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 2.6 m -103.82 150.76 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.462 179.524 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' E LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -162.77 160.31 19.55 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.765 -1.209 . . . . 0.0 111.154 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.3 Cg_endo -89.52 37.66 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.049 1.832 . . . . 0.0 110.815 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -41.62 137.55 1.8 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.903 . . . . 0.0 109.922 179.778 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 60' ' ' SER . 53.2 Cg_endo -93.5 66.9 0.25 Allowed 'Cis proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.714 -1.786 . . . . 0.0 110.887 0.164 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -57.19 -155.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.875 -1.14 . . . . 0.0 110.689 -179.774 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -54.83 148.72 12.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.855 -179.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.3 tttp 178.82 62.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.729 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 64' ' ' THR . 4.7 mtpt -82.92 70.71 9.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.936 . . . . 0.0 111.106 -179.186 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 40.9 -148.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.86 . . . . 0.0 110.519 179.229 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -85.92 -17.91 34.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 110.316 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.182 179.972 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' ' HG3' ' A' ' 3' ' ' GLN . 1.8 ttm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.993 0.425 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 1' ' ' MET . 1.9 tp10 -41.77 126.61 3.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 109.907 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.488 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 2.0 mt-30 -138.48 86.09 2.13 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.086 -1.009 . . . . 0.0 110.157 -179.418 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -79.64 73.15 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.365 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.734 HG22 ' HB2' ' A' ' 10' ' ' TYR . 9.0 mt -90.33 141.27 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 110.821 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -51.75 -174.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 112.159 -179.31 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.928 HD23 ' CD1' ' A' ' 40' ' ' ILE . 3.4 tp -93.41 -38.39 11.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 176.134 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.569 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -82.2 -60.03 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.787 178.997 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 12' ' ' MET . 9.1 t0 -53.28 -44.35 68.19 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.165 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.734 ' HB2' HG22 ' A' ' 5' ' ' ILE . 88.4 t80 -58.9 -63.75 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.495 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.21 -23.54 1.37 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.382 -0.824 . . . . 0.0 109.62 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.43 -54.18 11.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.113 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -88.35 13.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.659 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -161.5 97.27 1.09 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.707 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 14' ' ' PHE . . . -8.72 123.52 0.01 OUTLIER Glycine 0 N--CA 1.506 3.338 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 17' ' ' THR . 6.2 pt20 -59.95 -36.39 76.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.411 -1.052 . . . . 0.0 109.582 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 2.8 m -51.49 -22.45 3.13 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.242 -179.229 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -82.57 -44.69 15.55 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.109 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.739 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -64.5 -23.37 67.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.205 179.104 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -86.04 -28.5 24.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 110.518 -179.543 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -71.73 -28.31 63.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.898 179.788 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -89.91 -26.41 20.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 19' ' ' THR . 25.5 mt -79.41 -40.72 29.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.369 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.29 40.45 1.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 -177.75 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.269 -1.136 . . . . 0.0 109.83 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -97.98 -163.76 1.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -85.31 -50.08 7.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.041 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 29' ' ' ALA . 7.9 t -64.82 -62.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 109.881 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.9 -28.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.704 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -69.22 -58.18 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.506 -0.746 . . . . 0.0 109.278 179.28 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.704 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -57.41 -6.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.813 -0.555 . . . . 0.0 111.645 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -91.95 -40.73 10.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.793 -1.192 . . . . 0.0 108.18 178.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -22.3 55.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.163 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.618 HD12 HG23 ' A' ' 30' ' ' ILE . 47.6 mt -87.34 -51.37 12.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.552 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.651 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -43.6 -35.88 1.91 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.786 0.803 . . . . 0.0 108.976 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.93 -87.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.96 39.75 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -84.05 48.33 1.45 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.427 -1.043 . . . . 0.0 111.423 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 2.5 mppt? 64.85 98.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.508 -0.745 . . . . 0.0 110.369 179.191 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.928 ' CD1' HD23 ' A' ' 7' ' ' LEU . 2.7 mt -129.84 153.78 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 72.8 m-85 -156.57 124.03 5.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.1 mp -118.13 132.06 56.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 111.063 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.4 m -108.65 103.27 12.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.421 -0.799 . . . . 0.0 108.983 178.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 10' ' ' TYR . 1.5 mt -94.13 -149.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 111.199 -178.827 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.632 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 37.6 -164.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.453 0.644 . . . . 0.0 110.804 -178.847 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 63.97 -5.49 0.3 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -176.833 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.606 ' H ' ' C ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER 174.73 -27.37 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.149 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.88 40.68 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.419 ' OG ' ' CE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -100.2 133.37 44.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.649 -0.913 . . . . 0.0 109.771 179.939 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' CG1' HD23 ' A' ' 42' ' ' LEU . 39.8 t -88.31 97.53 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 110.48 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 55.3 m-85 -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 108.674 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.76 127.52 34.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.198 -0.939 . . . . 0.0 110.867 -178.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.39 161.21 25.2 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 25.7 tt0 -136.07 147.06 47.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.371 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 2.5 t -146.54 104.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.503 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 3.5 ttpt -132.34 153.93 50.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 109.509 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' A ASP . . . . . 0.481 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 18.0 t70 -43.06 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.072 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 151.73 -55.74 0.45 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.28 -172.62 0.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.338 -1.095 . . . . 0.0 110.506 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' D VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 56' E LYS . 5.0 m -116.3 161.08 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -179.672 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' E LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 56' D VAL . 19.2 mttm -146.33 163.65 28.89 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 110.375 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -83.99 -61.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.016 1.81 . . . . 0.0 110.873 -178.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 4.4 t80 59.89 123.74 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.34 -0.85 . . . . 0.0 110.009 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' HD22 ' A' ' 23' ' ' LEU . 4.4 Cg_exo -76.4 126.85 13.82 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 122.16 -2.017 . . . . 0.0 110.258 0.042 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.48 31.59 5.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -127.73 63.52 1.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.363 -0.835 . . . . 0.0 110.35 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.79 48.61 2.0 Allowed 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.116 -0.99 . . . . 0.0 109.92 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -44.93 -91.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.468 -0.77 . . . . 0.0 110.269 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.7 p -81.78 -140.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.031 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 t -86.0 -28.86 23.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.0 110.466 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.208 179.985 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.203 0.525 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.18 150.86 51.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 110.505 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -125.48 77.6 1.66 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.332 -0.855 . . . . 0.0 109.39 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -78.99 85.78 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 0.0 110.721 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.887 HG22 ' HB2' ' A' ' 10' ' ' TYR . 11.3 mt -90.44 149.71 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.827 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -48.13 -178.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.248 1.023 . . . . 0.0 111.647 -179.266 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.799 ' HA ' HD13 ' A' ' 42' ' ' LEU . 2.6 tp -92.42 -40.21 11.0 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.678 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.548 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -91.32 -59.54 2.12 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 12' ' ' MET . 0.8 OUTLIER -45.83 -39.6 8.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.83 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.887 ' HB2' HG22 ' A' ' 5' ' ' ILE . 5.5 t80 -62.52 -53.38 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.505 178.766 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -51.87 -26.09 9.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.499 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 14.4 tpp -72.25 -47.01 53.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.871 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -23.88 65.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.968 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.48 -79.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.65 156.23 14.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.488 ' OE1' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -70.41 -30.52 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 109.994 179.932 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 p -82.58 -20.57 36.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 110.208 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -81.23 -51.42 8.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.329 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.622 ' O ' HD12 ' A' ' 23' ' ' LEU . 2.8 m -63.11 -25.97 68.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 178.96 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.4 -34.8 63.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 0.0 110.529 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 2.2 mmtp -89.6 -14.17 35.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.286 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD1' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -76.25 -40.46 51.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.67 179.737 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 19' ' ' THR . 4.7 mt -83.51 0.41 46.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.16 56.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG11 ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -144.71 -175.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.46 ' O ' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -110.25 155.99 21.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.217 -0.927 . . . . 0.0 109.924 -179.949 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.42 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.1 mt-30 -40.46 -28.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.374 -0.829 . . . . 0.0 110.728 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -61.98 -64.68 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.126 -0.984 . . . . 0.0 110.507 -179.775 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.617 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -44.99 -26.11 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.867 HG23 HD12 ' A' ' 34' ' ' ILE . 1.7 mp -75.84 -43.61 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.2 t30 -73.51 -1.57 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.042 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -104.82 -43.38 5.11 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.999 -1.063 . . . . 0.0 108.879 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -82.1 -0.9 46.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.589 -0.695 . . . . 0.0 109.204 178.576 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.867 HD12 HG23 ' A' ' 30' ' ' ILE . 13.6 mt -124.33 -40.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.86 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.548 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 5.7 t-80 -74.06 -26.09 60.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.0 110.019 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 -32.76 71.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.82 45.59 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.7 mmm180 -85.68 -173.45 4.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -1.147 . . . . 0.0 110.401 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.48 79.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 7' ' ' LEU . 10.0 mt -109.82 162.99 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.905 . . . . 0.0 110.452 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CG ' ' NH1' ' A' ' 4' ' ' ARG . 76.2 m-85 -151.09 113.58 4.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 0.0 109.831 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 7' ' ' LEU . 7.3 mp -80.12 134.58 36.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 17.8 m -106.38 100.3 9.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 49' ' ' SER . 10.6 mt -92.65 131.32 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.761 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 3.5 m120 -52.75 -19.09 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.568 -0.708 . . . . 0.0 110.59 179.02 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.96 -21.02 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -176.329 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.1 -2.04 57.55 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.367 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.17 -20.2 11.5 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -63.32 147.52 50.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -1.198 . . . . 0.0 109.989 179.862 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.531 HG11 ' OD1' ' A' ' 22' ' ' ASP . 22.1 t -122.11 141.86 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.448 ' O ' ' C ' ' A' ' 52' ' ' ALA . 18.7 t80 -143.09 76.54 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.479 -0.763 . . . . 0.0 109.636 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 51' ' ' TYR . . . -38.31 143.4 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.616 -0.678 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' PHE . 2.9 tt0 -140.41 86.99 2.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 110.724 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 56' D VAL . 1.3 tp10 -79.38 147.91 32.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.84 137.38 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 110.496 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 56' C GLU . 11.4 ttpt -160.07 -172.76 3.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.841 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' A ASP . . . . . . . . . . . . . 13.2 m-20 -57.24 105.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.029 -1.044 . . . . 0.0 110.189 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 51.49 29.97 25.38 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' C GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -143.77 86.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.175 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' D VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 1.2 p -125.44 102.02 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 109.719 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' E LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 56' D VAL . 9.0 mtmm -143.81 160.25 50.86 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.215 -0.928 . . . . 0.0 110.383 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 56' E LYS . 8.0 Cg_exo -74.21 128.64 12.31 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.359 1.715 . . . . 0.0 111.166 -178.744 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.93 144.39 39.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.481 -0.762 . . . . 0.0 109.714 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -90.94 47.48 1.35 Allowed 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.108 -2.039 . . . . 0.0 110.485 0.198 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.67 67.26 6.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.278 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -166.18 98.44 0.62 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.129 -0.982 . . . . 0.0 110.417 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.505 ' O ' ' C ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -151.34 50.66 0.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.065 179.717 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' A' ' 62' ' ' LYS . 17.8 mttp 28.4 -139.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.188 0.518 . . . . 0.0 111.282 179.446 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 63' ' ' LYS . 3.1 m -159.56 -69.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.231 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.27 21.42 0.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 110.447 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.129 179.907 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.233 0.539 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.12 150.76 30.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.164 -0.96 . . . . 0.0 110.436 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 47.1 mm-40 -117.4 70.93 0.79 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 109.859 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.7 80.11 6.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.365 -0.835 . . . . 0.0 109.977 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.621 HG22 ' HB2' ' A' ' 10' ' ' TYR . 5.3 mt -89.31 141.47 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 110.609 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.581 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -47.17 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.996 0.903 . . . . 0.0 111.139 -179.917 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.801 HD22 HD12 ' A' ' 40' ' ' ILE . 3.8 tp -93.19 -39.9 10.77 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -86.66 -61.11 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.042 178.831 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 1.6 t70 -50.33 -47.56 55.79 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.342 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.621 ' HB2' HG22 ' A' ' 5' ' ' ILE . 4.0 t80 -53.92 -61.31 2.38 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.885 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -57.01 -16.6 7.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.141 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -86.16 -30.67 22.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.511 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -3.93 38.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -126.96 32.72 5.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 -179.994 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 14' ' ' PHE . . . 60.93 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.572 ' NE2' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -79.64 -26.53 41.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 110.375 -179.962 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -75.89 -23.66 55.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 2.7 tptt -76.63 -56.66 4.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.202 -0.936 . . . . 0.0 109.022 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 11' ' ' ALA . 1.7 m -55.35 -27.95 50.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 178.581 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.44 -30.35 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -82.8 -8.46 59.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -90.41 -48.93 6.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 110.251 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.92 -36.63 36.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.58 33.11 4.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.22 161.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.204 -1.174 . . . . 0.0 109.908 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -76.26 156.06 33.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -35.66 75.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.45 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -62.42 -51.22 68.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.96 -24.8 1.63 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.652 HG23 HG13 ' A' ' 34' ' ' ILE . 1.2 mp -82.92 -56.2 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.949 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.572 ' OD1' ' NE2' ' A' ' 16' ' ' GLN . 3.3 m120 -49.78 -16.91 0.29 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.709 . . . . 0.0 111.374 -179.32 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -99.87 -51.64 3.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.436 -1.415 . . . . 0.0 109.039 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.599 ' O ' HD13 ' A' ' 34' ' ' ILE . . . -80.08 11.46 3.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.653 178.697 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.688 HD11 HD11 ' A' ' 7' ' ' LEU . 26.4 mm -135.32 -41.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 110.305 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -70.1 -30.6 67.85 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.947 179.724 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.19 -78.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.12 69.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.539 ' HB3' HD23 ' A' ' 7' ' ' LEU . 1.5 tpt180 -90.7 123.59 34.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 111.267 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -98.94 63.35 1.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.359 -0.838 . . . . 0.0 109.319 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.86 HG23 ' CA ' ' A' ' 54' ' ' GLU . 5.5 mt -113.29 161.1 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.284 -179.255 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 32.4 m-85 -137.93 150.42 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.948 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.0 mp -126.94 140.71 52.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.437 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -103.37 103.68 13.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 49' ' ' SER . 3.8 mt -98.89 75.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.131 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 49' ' ' SER . 4.5 p30 -41.87 166.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.686 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.44 -7.67 3.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.555 -0.715 . . . . 0.0 109.323 178.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.15 6.41 11.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.57 0.32 30.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 44' ' ' ILE . 4.6 t -59.17 -176.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.049 -1.265 . . . . 0.0 109.493 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 49' ' ' SER . 94.2 t -149.65 115.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.612 -179.638 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.501 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 6.6 m-85 -113.45 154.58 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.76 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -131.53 147.26 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.94 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 52' ' ' ALA . 15.6 mt-10 -154.43 99.05 2.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.86 ' CA ' HG23 ' A' ' 40' ' ' ILE . 12.8 tt0 -79.89 147.94 31.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.051 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 56' D VAL . 2.3 t -137.25 97.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.931 -1.106 . . . . 0.0 110.46 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' B GLY . 6.7 ttpt -117.64 148.75 41.66 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.838 . . . . 0.0 109.75 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' A ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' LYS . 9.7 t70 -43.23 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 110.237 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' B GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 152.27 -55.87 0.45 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -174.75 166.11 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.866 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' D VAL . . . . . 0.644 ' CG1' HG13 ' A' ' 55' ' ' VAL . 16.0 m -107.43 160.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -0.839 . . . . 0.0 109.493 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' E LYS . . . . . 0.515 ' HB2' ' CD ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.56 178.12 1.59 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.018 -1.051 . . . . 0.0 110.694 -179.953 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 56' E LYS . 4.8 Cg_exo -77.72 -64.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.296 -2.193 0 O-C-N 124.39 1.732 . . . . 0.0 110.529 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.493 ' HB2' ' HD2' ' A' ' 56' E LYS . 9.5 t80 57.93 117.92 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 2.8 Cg_exo -72.57 130.74 20.33 Favored 'Cis proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.178 -2.009 . . . . 0.0 110.308 -0.053 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 t -170.97 53.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.5 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -97.4 54.51 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 110.16 179.849 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -176.42 55.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 109.934 -179.82 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -47.39 -69.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.352 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -140.09 -62.19 0.51 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.249 -0.907 . . . . 0.0 110.24 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.8 t -132.56 9.09 4.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.856 . . . . 0.0 110.216 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.181 179.968 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HG3' ' HG3' ' A' ' 2' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.012 0.434 . . . . 0.0 110.173 . . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.507 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -44.04 137.87 3.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.05 -1.031 . . . . 0.0 110.668 -179.712 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 36.4 mm-40 -122.13 68.85 0.94 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.805 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 1.4 ttt180 -81.52 69.73 8.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 111.03 -179.309 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.588 ' HB ' ' CD1' ' A' ' 10' ' ' TYR . 6.0 mm -90.66 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 109.904 179.342 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -91.37 164.88 13.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.052 -1.03 . . . . 0.0 112.409 -178.503 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.782 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -59.82 -26.55 65.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.375 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HG2' HG21 ' A' ' 34' ' ' ILE . 5.6 tmtm? -80.21 -79.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.19 -54.4 16.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.784 -1.198 . . . . 0.0 110.228 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.596 ' CB ' ' O ' ' A' ' 6' ' ' THR . 17.7 t80 -46.95 -53.28 12.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.943 -1.098 . . . . 0.0 110.12 -179.75 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.31 -34.97 67.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 110.194 -179.575 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -34.91 78.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -32.61 47.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD2' ' HD3' ' A' ' 18' ' ' LYS . 5.6 m-30 -107.88 -63.59 1.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 152.62 143.77 3.76 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.751 ' NE2' HG21 ' A' ' 30' ' ' ILE . 6.4 tp60 -53.32 -33.23 52.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -28.14 54.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 110.493 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HD3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -73.79 -56.01 5.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 179.66 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.428 ' HG1' ' HD2' ' A' ' 10' ' ' TYR . 8.1 m -62.96 -17.99 62.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.466 -0.771 . . . . 0.0 109.396 179.286 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -80.32 -36.67 33.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 110.399 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.93 -23.25 48.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.889 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.35 -27.5 32.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.071 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.782 HD11 ' CD1' ' A' ' 7' ' ' LEU . 30.2 mt -81.96 -40.49 22.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.72 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.12 18.11 10.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.35 158.98 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 109.916 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 15.1 m-30 -67.82 178.72 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.34 -179.744 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.537 ' HA ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -70.39 -22.57 62.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -0.903 . . . . 0.0 110.207 179.868 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 m -59.1 -49.69 76.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.47 -19.45 5.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.751 HG21 ' NE2' ' A' ' 16' ' ' GLN . 3.0 mm -80.63 -57.85 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.854 0.835 . . . . 0.0 110.003 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 6.5 t-20 -54.3 -15.53 1.65 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.558 -179.444 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -40.96 10.85 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.496 -1.378 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -78.09 -4.55 47.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 109.204 178.717 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.745 HD12 HG22 ' A' ' 30' ' ' ILE . 15.2 mt -120.02 -47.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.449 -0.782 . . . . 0.0 110.666 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.564 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 12.1 t60 -69.58 -22.22 63.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.006 -1.059 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.38 33.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.194 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.86 46.35 1.04 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.47 148.54 24.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -90.35 55.55 3.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.994 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.847 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 7.0 mt -81.3 163.0 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.768 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.658 ' C ' HD12 ' A' ' 42' ' ' LEU . 53.2 m-85 -157.38 142.1 16.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.55 -0.719 . . . . 0.0 109.26 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.76 HD21 HD11 ' A' ' 7' ' ' LEU . 5.3 mp -129.05 113.56 15.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.931 -1.105 . . . . 0.0 111.725 -179.17 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.8 m -97.72 101.68 13.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.396 -0.815 . . . . 0.0 108.918 178.472 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.565 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 8.5 mt -96.56 136.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 111.081 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.9 m120 -51.83 -18.91 1.45 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 110.653 178.768 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.775 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 90.06 -17.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -176.11 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.05 -13.4 41.63 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.996 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.644 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 134.3 -26.42 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.563 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 107.36 0.78 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -1.226 . . . . 0.0 109.682 179.97 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 48' ' ' GLY . 40.3 t -100.16 117.95 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.067 . . . . 0.0 111.317 -179.19 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 23.3 m-30 -104.04 111.07 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 108.933 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -87.8 76.51 8.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 0.0 111.072 -179.013 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -84.86 147.03 27.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 109.432 179.102 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 56' D VAL . 7.8 mt-10 -127.73 173.07 10.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.015 -179.993 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.6 119.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.048 -1.033 . . . . 0.0 110.592 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' B GLY . 9.3 tptp -138.31 143.75 40.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 179.534 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' A ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.6 OUTLIER -42.11 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 110.352 -179.762 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 56' B GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 143.34 -54.21 0.59 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.34 162.06 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 110.516 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' D VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 56' E LYS . 33.9 m -79.78 161.18 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 179.754 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' E LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.93 163.23 45.9 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.142 -0.974 . . . . 0.0 110.767 -179.828 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.3 Cg_endo -83.41 179.18 5.17 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.813 1.675 . . . . 0.0 110.148 -179.29 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.545 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 31.4 t80 179.11 121.68 0.21 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 110.311 -179.645 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 10.1 Cg_endo -85.78 101.4 0.33 Allowed 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.728 -1.78 . . . . 0.0 110.433 -0.055 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 59' ' ' PRO . 20.2 m -44.02 144.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 110.147 179.772 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -134.69 146.96 49.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 110.083 -179.961 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 47.23 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 0.0 110.549 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 17.9 pttp -116.35 120.22 38.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -142.73 -90.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -0.991 . . . . 0.0 110.357 -179.851 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.0 p 43.89 33.78 0.8 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.268 -0.895 . . . . 0.0 109.44 179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.284 179.83 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.209 0.528 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.48 111.44 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.456 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.498 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 20.7 mt-30 -104.16 64.43 0.77 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.218 -0.927 . . . . 0.0 109.302 179.715 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -78.75 83.86 4.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.297 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.728 HG22 ' H ' ' A' ' 6' ' ' THR . 9.7 mt -90.2 -173.63 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.728 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.12 -179.36 5.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.087 -1.008 . . . . 0.0 111.993 -179.047 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.708 HD11 ' CD1' ' A' ' 34' ' ' ILE . 6.1 tp -92.3 -41.54 10.32 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.778 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.565 ' HD3' ' CG2' ' A' ' 34' ' ' ILE . 1.3 mmtt -86.27 -64.1 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.333 179.17 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.7 OUTLIER -46.77 -52.14 14.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.516 179.475 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.693 ' CE2' HD11 ' A' ' 44' ' ' ILE . 4.7 t80 -52.54 -55.13 24.24 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.232 179.79 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -18.72 60.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.951 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -22.11 22.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.041 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -12.26 29.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.777 179.864 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -123.64 -65.85 1.04 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.24 162.19 12.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -77.68 -30.79 52.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -1.143 . . . . 0.0 110.271 -179.988 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 26.0 p -72.52 -33.22 66.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 179.678 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.9 -54.76 11.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.45 -0.781 . . . . 0.0 109.161 179.33 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.445 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 21.7 m -62.23 -20.01 63.78 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.733 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -72.16 -47.53 50.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -70.16 -25.05 63.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.595 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.003 ' HB3' HG11 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -61.86 -47.62 84.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.431 -0.793 . . . . 0.0 109.962 179.675 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 23' ' ' LEU . 3.4 mt -90.4 -6.54 54.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.852 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.39 22.23 71.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.521 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.55 HG23 ' HB2' ' A' ' 23' ' ' LEU . 3.2 t -107.93 153.07 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -1.019 . . . . 0.0 110.23 -179.683 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 12.0 m-85 -59.12 176.29 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.833 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.458 ' HA ' HD12 ' A' ' 30' ' ' ILE . 2.1 mt-30 -83.68 -10.89 57.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.005 179.761 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -83.26 -61.78 1.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.92 179.792 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -45.42 -40.59 8.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 109.714 179.572 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.558 HG22 ' CD1' ' A' ' 34' ' ' ILE . 72.8 mt -65.0 -55.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.766 . . . . 0.0 109.946 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -50.33 -13.91 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.358 -0.839 . . . . 0.0 111.096 179.792 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 -37.82 14.42 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.408 -1.432 . . . . 0.0 108.869 178.809 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.03 -10.94 59.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.154 178.488 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.708 ' CD1' HD11 ' A' ' 7' ' ' LEU . 7.1 mt -108.8 -47.92 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.845 179.731 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 9.9 t-80 -65.78 -24.21 66.89 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.152 -0.967 . . . . 0.0 110.305 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.18 -28.52 62.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -0.945 . . . . 0.0 110.658 -179.626 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 8' ' ' LYS . . . 92.54 47.63 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.0 172.0 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.55 -179.723 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.571 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -103.8 64.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.821 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.711 HD13 ' HB2' ' A' ' 54' ' ' GLU . 4.2 mm -87.83 169.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 111.036 -179.323 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 84.5 m-85 -156.88 115.73 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.215 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.71 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.8 mp -92.56 114.36 26.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 111.375 -178.851 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.9 m -90.81 102.9 15.66 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.409 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.693 HD11 ' CE2' ' A' ' 10' ' ' TYR . 6.6 mt -99.9 102.01 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.909 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.51 173.02 9.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 0.0 109.689 179.128 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -9.25 3.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.092 179.004 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 10.65 7.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.293 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.84 10.14 23.94 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t -89.62 99.63 12.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -1.224 . . . . 0.0 109.591 179.628 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.003 HG11 ' HB3' ' A' ' 22' ' ' ASP . 5.8 p -79.75 137.06 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.84 . . . . 0.0 110.549 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 8.5 m-85 -112.18 95.38 5.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 109.696 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -83.47 111.43 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' OE1' ' CG2' ' A' ' 56' D VAL . 0.1 OUTLIER -147.18 131.73 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 111.088 -179.408 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.711 ' HB2' HD13 ' A' ' 40' ' ' ILE . 1.7 tt0 -79.77 134.33 36.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.178 179.098 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.669 HG22 ' CG2' ' A' ' 56' D VAL . 11.2 t -123.11 134.74 65.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.992 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 56' B GLY . 11.8 tptp -158.08 144.54 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' A ASP . . . . . . . . . . . . . 1.5 t70 -46.07 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 109.872 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' B GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 150.15 -48.71 0.58 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -172.47 156.15 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -1.104 . . . . 0.0 110.636 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' D VAL . . . . . 0.669 ' CG2' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -138.54 125.74 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.76 . . . . 0.0 109.398 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 56' E LYS . . . . . 0.49 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.6 158.84 60.57 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.572 -179.409 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 1.8 Cg_endo -87.61 74.49 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.855 1.703 . . . . 0.0 112.442 -177.814 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -42.98 128.31 3.25 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.049 -1.032 . . . . 0.0 109.162 178.519 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 36.9 Cg_endo -88.9 93.83 0.14 OUTLIER 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.763 -1.766 . . . . 0.0 110.698 0.058 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.541 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 1.2 m -61.84 -153.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.646 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 60' ' ' SER . 8.9 m120 57.53 112.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.287 -0.883 . . . . 0.0 110.496 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 tptp -170.54 56.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 110.155 179.893 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 64' ' ' THR . 31.4 tttm -77.67 -24.74 49.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.492 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 1.5 m 69.01 -134.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.207 -0.933 . . . . 0.0 110.106 -179.866 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.427 ' H ' HG22 ' A' ' 65' ' ' THR . 1.8 t -104.71 -18.35 14.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.034 -1.041 . . . . 0.0 110.474 -179.784 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.386 -179.769 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.8 mm-40 . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 4.7 ttt180 -79.4 72.12 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.793 HG22 ' HB2' ' A' ' 10' ' ' TYR . 10.7 mm -84.86 157.73 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.382 -0.824 . . . . 0.0 109.168 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 10.9 p -65.32 -174.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 111.216 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -91.35 -35.3 14.49 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.2 tmtp? -81.78 -69.63 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.684 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -42.53 -55.57 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.563 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.793 ' HB2' HG22 ' A' ' 5' ' ' ILE . 10.1 t80 -44.0 -56.22 4.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HB1' ' OE1' ' A' ' 16' ' ' GLN . . . -54.91 -35.67 64.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.466 -0.771 . . . . 0.0 110.382 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ttp -66.8 -35.11 79.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.881 . . . . 0.0 110.586 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -78.45 -24.73 45.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.184 -0.947 . . . . 0.0 110.343 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -111.09 -77.36 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.014 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.35 158.85 19.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.465 ' OE1' ' HB1' ' A' ' 11' ' ' ALA . 2.4 tp60 -74.03 -30.62 62.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -24.23 41.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -52.15 8.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.175 -0.953 . . . . 0.0 108.758 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.47 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.5 m -58.31 -27.17 63.85 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.47 -53.81 8.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -9.19 45.44 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.774 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.87 -44.81 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.607 HD21 ' CD2' ' A' ' 42' ' ' LEU . 14.3 mt -79.57 -28.97 41.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 42.02 4.45 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 23' ' ' LEU . 1.2 t -129.96 179.44 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -1.161 . . . . 0.0 109.696 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' H ' HG12 ' A' ' 25' ' ' VAL . 93.9 m-85 -75.15 154.8 37.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.326 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -26.59 64.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 m -71.26 -50.57 31.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.905 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.58 -17.89 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.181 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -78.25 -61.3 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.699 0.761 . . . . 0.0 109.214 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.749 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -54.71 -14.28 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.664 -0.648 . . . . 0.0 110.501 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 10.6 tttt -93.57 -39.98 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.576 -1.327 . . . . 0.0 108.964 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.24 -8.66 57.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.185 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.804 HD11 HD11 ' A' ' 7' ' ' LEU . 8.3 mt -118.56 -47.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.424 -0.798 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.584 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.8 t-80 -72.95 -11.17 60.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.957 -1.089 . . . . 0.0 110.01 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -76.34 -88.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.962 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.04 46.45 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.69 -170.03 2.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.526 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 13.8 ptpt -148.64 87.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.686 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.584 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 22.8 mt -118.21 171.83 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.86 . . . . 0.0 110.739 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 28.2 m-85 -154.02 110.03 3.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.484 -0.76 . . . . 0.0 109.701 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.607 ' CD2' HD21 ' A' ' 23' ' ' LEU . 3.8 mp -86.14 128.71 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 111.327 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 51' ' ' TYR . 1.6 m -93.74 105.87 17.88 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.989 HG23 ' O ' ' A' ' 49' ' ' SER . 7.2 mt -91.61 134.22 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 110.916 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.762 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.8 m-20 -53.85 -18.66 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.66 -0.65 . . . . 0.0 110.512 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.01 -19.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -2.33 56.44 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.34 0.52 25.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.989 ' O ' HG23 ' A' ' 44' ' ' ILE . 2.1 t -72.46 -175.18 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -1.138 . . . . 0.0 110.139 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 49' ' ' SER . 19.8 t -156.11 130.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 8.0 t80 -128.0 76.16 1.67 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 109.345 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -48.54 130.29 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 110.998 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -132.81 84.94 2.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 109.758 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.523 ' CB ' HG12 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -79.0 147.12 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.333 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.58 HG13 HG12 ' A' ' 56' D VAL . 5.0 t -138.71 86.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.82 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 56' A ASP . 7.2 ttpp -97.12 91.48 5.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 110.106 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.556 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -4.38 73.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.28 0.562 . . . . 0.0 112.373 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 157.0 -23.94 0.47 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.3 tt0 -178.92 128.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.109 -1.23 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.58 HG12 HG13 ' A' ' 55' ' ' VAL . 3.6 m -100.21 129.33 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.655 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -134.72 158.45 75.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 110.517 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 56' E LYS . 11.2 Cg_exo -72.71 -59.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.263 1.665 . . . . 0.0 110.327 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER 56.35 109.99 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 110.072 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 58' ' ' PHE . 20.2 Cg_exo -62.94 133.61 14.05 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.497 0.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 110.169 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.6 mm100 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.25 0.548 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 18.6 ttt180 -79.53 74.54 6.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 109.626 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' A' ' 10' ' ' TYR . 2.9 mt -90.87 146.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.676 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.06 -178.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.768 0.794 . . . . 0.0 111.3 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.704 ' HB3' HD12 ' A' ' 34' ' ' ILE . 13.1 tp -92.34 -49.97 5.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.918 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.16 -64.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.598 -0.688 . . . . 0.0 109.306 178.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -43.72 -53.26 5.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.108 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.635 ' HB2' HG22 ' A' ' 5' ' ' ILE . 1.9 t80 -46.46 -55.18 7.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 109.707 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.85 -37.34 42.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.612 0.72 . . . . 0.0 109.584 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -55.35 -41.14 72.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 110.415 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -38.77 54.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.52 -67.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 110.007 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 168.65 155.08 9.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.452 ' HB3' ' HG2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.29 -33.85 70.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -1.156 . . . . 0.0 109.878 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.873 HG23 ' OE1' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -85.23 -7.55 58.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.151 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -53.9 5.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -34.1 77.1 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.421 -0.8 . . . . 0.0 109.051 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.44 -23.55 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 17' ' ' THR . 2.3 mmtt -71.04 -43.79 67.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.002 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.508 ' CB ' HG21 ' A' ' 50' ' ' VAL . 3.8 m-20 -70.09 -28.79 65.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 23' ' ' LEU . 22.0 mt -79.45 -27.51 41.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 26.96 31.45 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.0 m -135.82 156.13 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.549 ' O ' HD13 ' A' ' 30' ' ' ILE . 96.1 m-85 -64.93 172.18 3.04 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 110.073 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.873 ' OE1' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER -75.72 -23.37 56.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.172 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -62.85 -46.52 87.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.844 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.69 66.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.853 . . . . 0.0 109.949 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.746 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.5 mp -67.03 -49.88 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' LYS . 25.5 m-20 -57.22 -58.94 6.02 Favored 'General case' 0 C--O 1.194 -1.833 0 O-C-N 121.358 -0.839 . . . . 0.0 110.007 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -49.76 -23.87 2.04 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 119.588 -1.945 . . . . 0.0 109.107 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 30' ' ' ILE . . . -76.7 -40.19 49.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.558 -0.714 . . . . 0.0 109.935 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.918 HD13 ' HB2' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -95.12 -40.47 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.405 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -60.69 -58.27 9.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.917 -1.115 . . . . 0.0 108.407 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.45 15.1 16.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.932 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.955 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -152.12 93.39 0.14 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 9.8 mmm-85 -86.77 168.86 13.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -1.064 . . . . 0.0 110.82 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER 71.29 66.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.303 -0.873 . . . . 0.0 110.439 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.955 HD11 ' O ' ' A' ' 37' ' ' GLY . 17.2 mt -125.45 163.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.5 m-85 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 6' ' ' THR . 4.4 mp -140.88 116.87 10.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.534 ' OG1' ' CB ' ' A' ' 51' ' ' TYR . 2.3 p -88.01 101.67 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.555 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.5 mt -94.78 124.44 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.047 -1.033 . . . . 0.0 110.314 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER -85.43 -177.25 6.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -0.969 . . . . 0.0 110.26 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.36 0.16 17.79 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -101.14 -4.45 27.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.692 . . . . 0.0 110.166 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 90.84 -15.06 61.55 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.489 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -48.86 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -1.193 . . . . 0.0 109.589 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG21 ' CB ' ' A' ' 22' ' ' ASP . 45.7 t -80.8 105.78 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 111.063 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CB ' ' OG1' ' A' ' 43' ' ' THR . 0.2 OUTLIER -88.26 90.71 8.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 109.083 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -89.08 140.48 29.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 110.124 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 56' E LYS . 0.2 OUTLIER -152.61 136.73 16.47 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.889 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 56' D VAL . 8.7 mt-10 -98.1 111.83 24.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG23 HG12 ' A' ' 56' D VAL . 2.6 p -109.82 132.69 57.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.245 -0.91 . . . . 0.0 110.186 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 56' A ASP . 13.8 ttpp -160.24 110.41 1.82 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.677 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 38.6 t70 61.26 11.42 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.609 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.846 ' O ' HG13 ' A' ' 56' D VAL . . . 128.91 -44.92 1.18 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.455 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' C GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.8 mt-10 -60.9 98.2 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.241 -1.152 . . . . 0.0 110.93 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.846 HG13 ' O ' ' A' ' 56' B GLY . 4.8 m -107.19 61.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.833 . . . . 0.0 110.088 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -58.93 174.9 0.36 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.97 -1.081 . . . . 0.0 110.557 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.473 ' CD ' ' HB3' ' A' ' 56' E LYS . 2.0 Cg_endo -88.98 -79.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.35 2.033 . . . . 0.0 110.215 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.515 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.6 OUTLIER 59.91 122.31 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.282 -0.886 . . . . 0.0 109.865 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -77.78 128.91 17.52 Favored 'Cis proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.326 -0.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.383 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 C--O 1.216 -0.694 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 40.0 ttp180 -125.16 79.84 1.83 Allowed 'General case' 0 C--N 1.283 -2.292 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.814 HG22 ' HB2' ' A' ' 10' ' ' TYR . 24.2 mt -84.75 135.59 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.383 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -49.46 -176.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.068 0.937 . . . . 0.0 111.833 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.033 HD23 HD13 ' A' ' 40' ' ' ILE . 2.8 tp -94.4 -37.21 11.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.647 ' HB2' HG23 ' A' ' 34' ' ' ILE . 1.4 tmtt? -83.84 -65.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.278 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.523 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 8.3 m-20 -46.84 -45.58 20.31 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.814 ' HB2' HG22 ' A' ' 5' ' ' ILE . 13.3 t80 -55.4 -50.98 68.33 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.719 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -26.14 63.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.767 -0.583 . . . . 0.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -21.63 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -101.32 -6.15 24.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -77.52 0.59 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.1 143.25 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -65.1 -31.99 73.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 110.097 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -80.4 -10.82 59.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.118 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -90.97 -36.65 13.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.342 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.699 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -74.89 -26.94 60.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.288 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HA ' HD11 ' A' ' 30' ' ' ILE . . . -82.42 -39.09 23.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.813 . . . . 0.0 110.699 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.6 tmtt? -65.08 -34.68 79.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 109.956 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 7.7 m-20 -71.46 -38.38 71.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 110.023 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 19' ' ' THR . 21.1 mt -80.7 -7.59 59.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 110.407 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 35.42 90.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -134.44 175.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.22 -1.165 . . . . 0.0 109.9 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -82.36 146.19 29.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 110.378 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 1.055 ' HA ' HD12 ' A' ' 30' ' ' ILE . 2.2 mt-30 -53.35 -24.6 12.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.364 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -64.16 -57.54 9.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.93 -30.9 4.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.135 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.055 HD12 ' HA ' ' A' ' 27' ' ' GLN . 45.2 mt -70.0 -55.48 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.035 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.0 OUTLIER -59.99 -7.76 1.94 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 111.378 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -91.26 -34.45 14.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.574 -1.329 . . . . 0.0 108.266 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.76 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -86.16 -15.84 39.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.647 HG23 ' HB2' ' A' ' 8' ' ' LYS . 10.6 mt -95.46 -48.11 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.513 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 18.8 t60 -68.09 -55.9 10.81 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.229 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.11 13.44 18.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.63 83.78 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 8.0 mmm-85 -90.43 77.14 6.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.538 ' CE ' ' HB2' ' A' ' 56' ' ' LYS . 2.9 pttm 177.18 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.568 -0.708 . . . . 0.0 109.126 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.033 HD13 HD23 ' A' ' 7' ' ' LEU . 5.4 mt -103.17 161.66 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.748 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.603 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 37.6 m-85 -157.47 131.31 8.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.397 -0.814 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 7' ' ' LEU . 2.0 mp -124.54 118.3 26.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 0.0 110.353 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -89.27 102.65 15.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.064 -1.022 . . . . 0.0 109.429 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.3 mt -89.29 43.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.962 -1.086 . . . . 0.0 109.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.71 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 49.4 p-10 -105.45 -151.53 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 68.92 6.34 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.143 -0.973 . . . . 0.0 108.799 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.704 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 120.61 -53.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.47 29.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 33.6 t -78.01 156.37 30.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.541 -0.976 . . . . 0.0 110.181 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 50' ' ' VAL . 24.8 t -110.82 98.35 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 110.484 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.54 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 5.5 m-85 -96.9 89.85 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . -89.71 122.73 33.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.181 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 56' E LYS . 0.5 OUTLIER -160.21 137.49 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.937 . . . . 0.0 110.582 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.539 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.45 178.52 4.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.835 . . . . 0.0 109.673 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.676 HG22 HG12 ' A' ' 56' D VAL . 83.9 t -152.06 111.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.965 . . . . 0.0 110.462 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HB2' ' CE ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.49 122.4 41.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.094 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.0 t0 50.98 -90.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -142.52 54.87 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.5 tt0 -162.19 97.03 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.136 . . . . 0.0 110.351 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.676 HG12 HG22 ' A' ' 55' ' ' VAL . 11.1 m -92.62 165.29 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.501 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 9.5 ptpt -165.68 148.53 6.7 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.076 -1.015 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.0 Cg_exo -76.76 73.76 5.16 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.959 1.505 . . . . 0.0 111.211 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -45.62 132.93 6.39 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.846 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 79.0 Cg_endo -92.61 79.15 0.13 OUTLIER 'Cis proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.827 -1.739 . . . . 0.0 110.816 0.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.555 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 1.1 p . . . . . 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 110.645 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.233 0.539 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.646 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.22 94.77 4.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.993 0.901 . . . . 0.0 111.011 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.754 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.2 mt -90.3 -173.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.663 -0.648 . . . . 0.0 109.766 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.627 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.76 -179.09 5.43 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.288 -0.883 . . . . 0.0 111.608 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.06 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -91.4 -43.01 10.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.835 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.56 -63.79 1.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.406 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -44.25 -50.77 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.643 ' CE1' HD12 ' A' ' 5' ' ' ILE . 5.3 t80 -57.39 -51.64 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.358 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.648 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -49.03 -26.08 2.39 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 109.605 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 tpt -71.83 -52.65 16.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.036 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.94 -21.03 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.636 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.95 -75.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 109.611 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 173.5 142.58 3.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.648 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -59.42 -36.06 75.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -1.232 . . . . 0.0 109.701 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -78.72 -16.5 57.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.76 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -78.59 -51.24 10.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 0.0 109.256 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.3 m -64.7 -23.82 67.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.82 -25.82 30.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.285 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.55 -27.27 41.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.74 -27.95 26.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.846 . . . . 0.0 110.218 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.875 HD21 HD23 ' A' ' 42' ' ' LEU . 29.7 mt -80.02 -8.13 59.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' O ' HG13 ' A' ' 25' ' ' VAL . . . 68.66 29.71 72.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 24' ' ' GLY . 5.7 m -151.48 150.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 110.107 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.555 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 9.3 p90 -66.68 169.33 7.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.957 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.572 ' HA ' HD13 ' A' ' 30' ' ' ILE . 9.4 mp0 -65.3 -32.07 73.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 111.349 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.555 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -46.6 -48.37 19.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.972 -1.08 . . . . 0.0 110.773 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.44 70.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 27' ' ' GLN . 2.8 mp -72.11 -32.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.79 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 6.8 t-20 -65.88 -23.77 66.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -36.84 12.84 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.423 -1.423 . . . . 0.0 108.047 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.725 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -71.14 -14.77 62.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.017 HD11 ' HB2' ' A' ' 7' ' ' LEU . 5.7 mt -112.48 -54.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 5.2 t-160 -56.19 -15.63 4.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -85.23 29.14 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.755 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . 43.52 44.11 6.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.32 -172.0 3.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -1.112 . . . . 0.0 111.07 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 55' ' ' VAL . 15.3 mttt -135.02 83.87 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.539 -0.725 . . . . 0.0 109.053 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.725 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 27.0 mt -114.4 165.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 111.372 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.2 m-85 -159.67 177.51 10.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.641 . . . . 0.0 109.388 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.06 HD11 ' CD1' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.41 111.78 5.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.062 . . . . 0.0 109.706 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.497 ' CG2' ' ND2' ' A' ' 45' ' ' ASN . 9.3 m -75.53 99.42 4.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.448 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' A' ' 10' ' ' TYR . 55.7 mt -86.99 59.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 111.364 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.497 ' ND2' ' CG2' ' A' ' 43' ' ' THR . 39.7 p30 -103.4 -123.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.997 -1.064 . . . . 0.0 109.711 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.895 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 40.65 29.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.107 -0.996 . . . . 0.0 109.969 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.578 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 41.8 t0 72.78 64.35 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.384 0.612 . . . . 0.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 -12.21 41.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.895 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -59.1 159.47 7.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.955 -1.321 . . . . 0.0 109.068 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.538 HG22 HG23 ' A' ' 44' ' ' ILE . 38.2 t -127.69 127.87 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 111.19 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 30.0 m-85 -124.64 159.03 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -143.62 137.2 28.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.802 -1.186 . . . . 0.0 111.112 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 56' E LYS . 1.1 mp0 -142.56 143.91 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 110.165 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE2' ' CD1' ' A' ' 58' ' ' PHE . 1.0 OUTLIER -84.01 167.55 16.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.669 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 39' ' ' LYS . 3.0 t -139.24 128.56 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.994 -1.066 . . . . 0.0 110.216 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -146.92 170.16 17.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.504 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 60.8 t0 -40.57 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 53.31 59.12 10.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 7.6 tt0 -172.49 88.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.197 -1.178 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' D VAL . . . . . . . . . . . . . 6.2 m -97.07 140.38 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 0.0 109.952 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -119.0 172.6 4.15 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.071 -1.018 . . . . 0.0 110.69 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 58' ' ' PHE . 1.2 Cg_endo -87.6 24.94 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.354 2.036 . . . . 0.0 110.564 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.525 ' CD1' ' OE2' ' A' ' 54' ' ' GLU . 62.4 t80 -30.64 123.62 0.32 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.873 -0.517 . . . . 0.0 111.304 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.8 Cg_endo -80.17 108.03 1.16 Allowed 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.396 -1.918 . . . . 0.0 110.551 0.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.422 ' N ' ' HA ' ' A' ' 58' ' ' PHE . 2.4 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.016 -1.052 . . . . 0.0 110.063 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.293 0.568 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.76 92.18 4.78 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.131 0.967 . . . . 0.0 111.029 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.557 HG22 ' HB2' ' A' ' 10' ' ' TYR . 18.3 mt -90.74 154.86 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.983 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.673 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -50.78 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.281 1.039 . . . . 0.0 111.413 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.673 ' H ' HG22 ' A' ' 6' ' ' THR . 4.0 tp -92.91 -39.99 10.85 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HD3' HG22 ' A' ' 34' ' ' ILE . 1.1 mmmp? -90.64 -63.42 1.27 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.3 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.3 t70 -44.63 -44.89 9.29 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.7 t80 -56.46 -57.39 12.52 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.501 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.32 -21.01 4.96 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 ttm -78.43 -46.8 18.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.774 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -78.04 -10.85 59.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -69.42 0.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 133.06 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -58.86 -24.02 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.445 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 17' ' ' THR . 3.4 t -78.75 -26.8 44.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.041 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -76.35 -56.39 4.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 108.672 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -60.21 -30.75 69.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -64.2 -43.61 94.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -19.48 56.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -73.7 -26.4 60.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 30' ' ' ILE . 9.4 mt -82.93 -52.24 6.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.25 28.89 1.05 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG23 HG12 ' A' ' 30' ' ' ILE . 1.3 m -137.65 162.46 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -1.155 . . . . 0.0 110.015 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.76 -175.11 0.37 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.399 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -22.87 37.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 110.618 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' ALA . 23.5 t -74.58 -72.1 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 110.279 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.82 -27.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.307 -0.87 . . . . 0.0 109.349 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.879 HD12 HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -68.61 -61.69 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.546 -0.721 . . . . 0.0 109.566 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.751 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -46.56 -18.26 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.563 -0.711 . . . . 0.0 111.032 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -89.76 -40.86 12.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.438 -1.414 . . . . 0.0 108.588 178.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -7.04 53.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.517 -0.74 . . . . 0.0 109.136 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.879 HD11 HD12 ' A' ' 30' ' ' ILE . 15.8 mt -111.33 -54.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.636 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.57 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 67.2 t60 -61.16 -14.99 28.84 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -64.16 -9.01 14.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.629 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 34.12 60.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 153.69 31.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.55 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.544 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER -86.3 58.97 5.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.637 HD12 HD22 ' A' ' 7' ' ' LEU . 4.9 mt -93.25 167.83 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 111.093 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 68.0 m-85 -155.88 167.75 29.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 4.6 mp -142.79 105.35 4.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.835 -1.166 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 1.3 m -78.59 93.1 4.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.587 -0.695 . . . . 0.0 109.197 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 10' ' ' TYR . 27.8 mt -96.76 117.68 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.303 -0.873 . . . . 0.0 110.509 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.572 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER -81.76 -173.48 4.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.266 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.66 0.34 17.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.72 0.71 52.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.122 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' SER . . . 85.16 -14.11 51.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -45.28 162.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -1.205 . . . . 0.0 109.928 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.51 ' CG2' ' OD2' ' A' ' 22' ' ' ASP . 80.9 t -138.72 114.94 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -101.04 80.39 2.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 109.382 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -80.42 89.68 5.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.701 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 56' E LYS . 27.3 tt0 -102.47 167.5 9.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.765 . . . . 0.0 109.687 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 56' D VAL . 0.8 OUTLIER -135.08 156.93 48.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.076 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.49 HG13 HG12 ' A' ' 56' D VAL . 2.4 t -141.58 105.23 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 56' A ASP . 11.3 ttpp -123.65 103.24 8.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 56' A ASP . 51.6 t0 59.09 23.77 12.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.915 . . . . 0.0 110.449 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.619 ' O ' HG13 ' A' ' 56' D VAL . . . 109.62 -36.5 4.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 42.5 mt-10 -63.04 104.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.619 HG13 ' O ' ' A' ' 56' B GLY . 34.0 m -106.4 157.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.122 -0.986 . . . . 0.0 110.46 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -174.26 167.54 2.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.962 . . . . 0.0 110.575 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.57 175.97 10.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 121.875 1.716 . . . . 0.0 110.411 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CE1' HD22 ' A' ' 23' ' ' LEU . 13.4 t80 -167.82 146.04 3.89 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 110.364 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HA ' ' CD2' ' A' ' 58' ' ' PHE . 59.1 Cg_endo -91.89 48.41 1.34 Allowed 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.115 -2.035 . . . . 0.0 110.455 0.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.235 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.422 0.629 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 9.3 ttt180 -79.18 80.11 5.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.61 HG22 ' HB2' ' A' ' 10' ' ' TYR . 2.6 mt -86.02 164.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.523 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -70.34 -178.6 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.134 0.969 . . . . 0.0 112.367 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.669 HD21 HG12 ' A' ' 34' ' ' ILE . 3.5 tp -92.55 -40.36 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.546 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.44 -65.92 0.97 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.501 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -43.42 -48.54 7.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.61 ' HB2' HG22 ' A' ' 5' ' ' ILE . 12.6 t80 -54.03 -57.32 11.48 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.829 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.6 -27.37 4.47 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 109.912 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.79 77.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -15.04 58.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.229 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.71 -87.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 179.47 48.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 2.2 tp60 -90.2 -28.66 18.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -1.096 . . . . 0.0 110.509 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 6.1 t -87.03 -24.93 24.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.242 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -73.71 -59.08 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.955 . . . . 0.0 108.75 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.1 m -60.0 -32.27 70.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.581 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . . . -76.45 -20.63 56.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.129 -0.982 . . . . 0.0 110.336 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.45 -46.93 68.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.104 -0.997 . . . . 0.0 110.912 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.08 -6.41 53.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.105 -0.997 . . . . 0.0 112.221 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.838 HD13 HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -162.72 36.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.639 -1.288 . . . . 0.0 109.882 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . -160.82 67.25 0.26 Allowed Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.254 38.3 t -75.12 -2.26 3.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.734 0.778 . . . . 0.0 109.5 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.573 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -134.32 82.54 1.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 26' ' ' TYR . 1.6 tt0 -36.14 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.617 -0.677 . . . . 0.0 111.369 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 26' ' ' TYR . 36.1 p -76.61 -55.44 5.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.977 -1.077 . . . . 0.0 109.211 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . . . -57.45 -17.79 15.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.328 -0.857 . . . . 0.0 108.901 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.728 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -74.31 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.623 -0.673 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.728 ' N ' HG22 ' A' ' 30' ' ' ILE . 1.6 m-20 -62.24 -9.63 8.45 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.52 -0.737 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 2.3 ttpt -93.25 -38.15 11.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.866 -1.146 . . . . 0.0 108.086 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.5 -8.29 59.62 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.669 HG12 HD21 ' A' ' 7' ' ' LEU . 22.7 mt -108.89 -48.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.573 -0.704 . . . . 0.0 109.585 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 3.5 t60 -70.96 -28.65 64.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.867 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -65.46 -33.43 75.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.52 59.72 0.83 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.33 -176.02 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 26.9 tttt -117.21 71.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.557 HD12 HD22 ' A' ' 7' ' ' LEU . 10.4 mt -115.95 166.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 91.8 m-85 -149.39 173.2 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.295 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.838 HD21 HD13 ' A' ' 23' ' ' LEU . 3.6 mp -143.32 147.96 35.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.007 -1.058 . . . . 0.0 111.455 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 94.9 m -112.63 105.52 13.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.583 -0.698 . . . . 0.0 109.191 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 45' ' ' ASN . 2.5 mt -83.04 -134.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.316 -0.865 . . . . 0.0 111.164 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.549 ' H ' HG22 ' A' ' 44' ' ' ILE . 2.1 p-10 34.77 -146.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.932 -0.48 . . . . 0.0 111.497 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.655 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 56.27 23.07 6.78 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.655 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 26.8 t70 100.19 35.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 123.752 0.821 . . . . 0.0 109.28 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.62 7.25 57.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -67.63 104.28 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -1.175 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.88 125.78 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.49 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 7.8 m-85 -112.29 158.86 19.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.803 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . . . -139.34 97.01 3.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 56' E LYS . 29.1 mt-10 -111.99 126.09 54.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.808 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 56' D VAL . 1.7 mt-10 -82.04 161.61 22.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 t -142.33 121.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.463 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -147.71 142.72 27.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 15.9 t70 56.21 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.919 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -157.8 36.21 0.54 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.69 132.01 12.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -1.175 . . . . 0.0 110.182 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -101.14 169.71 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.158 -0.964 . . . . 0.0 110.557 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 3.9 mttm -145.24 175.67 2.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 6.2 Cg_exo -81.57 -163.0 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.21 1.94 . . . . 0.0 110.433 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 179.07 113.41 0.19 Allowed Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.305 -0.872 . . . . 0.0 110.329 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -77.85 108.18 1.14 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.117 -2.035 . . . . 0.0 110.734 -0.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.49 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 63.4 p . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 121.412 0.625 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -80.38 68.64 6.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 110.503 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 10' ' ' TYR . 8.6 mt -91.79 139.35 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 17.7 p -51.22 -174.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.023 -1.048 . . . . 0.0 110.943 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.878 ' HB2' HD11 ' A' ' 42' ' ' LEU . 3.6 tp -91.42 -36.48 13.77 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HG3' ' CG2' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -82.87 -68.79 0.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.725 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.456 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.2 OUTLIER -44.99 -54.2 6.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.688 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.2 t80 -47.01 -55.24 8.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.277 -0.889 . . . . 0.0 110.232 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.46 61.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.529 -0.732 . . . . 0.0 110.162 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.3 ttm -67.67 -32.79 73.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HG2' ' NH1' ' A' ' 13' ' ' ARG . 30.6 mtt-85 -83.52 -27.3 29.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.5 -65.3 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.0 141.34 3.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.63 ' OE1' HG21 ' A' ' 30' ' ' ILE . 1.0 OUTLIER -58.5 -35.79 72.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.019 -1.283 . . . . 0.0 109.998 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -79.72 -16.52 55.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.125 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.93 -57.65 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m -49.83 -34.45 19.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.85 82.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.743 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -82.06 -4.72 57.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.728 . . . . 0.0 110.041 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' CB ' HD23 ' A' ' 23' ' ' LEU . 7.7 m-20 -84.44 -38.6 19.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.013 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.992 HD12 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -116.74 14.03 15.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.18 -0.95 . . . . 0.0 110.435 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.88 37.87 91.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.992 HG21 HD12 ' A' ' 23' ' ' LEU . 22.1 t -108.88 120.79 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -1.12 . . . . 0.0 110.062 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -45.72 166.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.492 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -71.51 -27.71 63.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.154 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 30' ' ' ILE . 29.3 t -70.66 -61.61 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.724 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -45.32 -26.18 0.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.153 -0.967 . . . . 0.0 109.114 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.77 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -66.06 -66.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.582 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.77 ' N ' HG22 ' A' ' 30' ' ' ILE . 71.0 m-80 -61.67 -7.25 3.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.545 -0.722 . . . . 0.0 110.468 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -35.93 15.22 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.863 -1.148 . . . . 0.0 108.116 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.98 -10.95 51.93 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.688 ' HA ' HD11 ' A' ' 40' ' ' ILE . 35.0 mt -103.66 -43.35 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 52.1 t-80 -74.93 -56.31 4.88 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.901 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.62 -4.17 55.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.955 . . . . 0.0 111.118 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -123.53 69.06 0.46 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.213 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -65.07 -170.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.243 . . . . 0.0 110.266 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 55.15 68.9 0.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 108.872 -179.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.755 HD13 HD23 ' A' ' 7' ' ' LEU . 2.8 mt -120.26 151.01 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.87 . . . . 0.0 110.444 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 90.5 m-85 -158.82 128.0 5.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.651 -0.656 . . . . 0.0 110.203 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -120.95 133.59 55.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 m -108.04 100.76 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.939 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.773 HG22 ' H ' ' A' ' 45' ' ' ASN . 5.8 mt -82.05 -173.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.898 . . . . 0.0 110.025 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.773 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.5 OUTLIER 82.7 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.248 0.547 . . . . 0.0 111.927 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.688 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 64.33 17.66 10.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 30.2 t70 110.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.948 0.899 . . . . 0.0 109.067 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.51 79.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -70.85 109.1 4.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.839 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.442 HG11 HD22 ' A' ' 23' ' ' LEU . 25.3 t -79.5 109.53 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 110.23 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 5.9 m-85 -95.21 143.94 26.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 108.937 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -127.21 86.86 2.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.113 . . . . 0.0 110.916 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.31 151.66 20.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.857 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.507 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -130.9 160.1 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 110.168 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 56' D VAL . 23.3 t -150.24 84.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.416 -0.802 . . . . 0.0 109.9 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 56' A ASP . 5.2 ttmt -94.16 101.76 13.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.141 -0.975 . . . . 0.0 109.609 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 56' ' ' LYS . 38.4 t70 -13.61 80.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.378 0.608 . . . . 0.0 112.049 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.08 -27.44 0.8 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.81 132.42 0.12 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.018 -1.284 . . . . 0.0 110.807 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.587 HG12 HG13 ' A' ' 55' ' ' VAL . 12.5 m -96.98 165.89 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 56' D VAL . 10.6 ptpt -175.53 171.8 1.15 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.847 -1.158 . . . . 0.0 110.813 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 60' ' ' SER . 3.7 Cg_exo -76.83 -173.18 1.65 Allowed 'Trans proline' 0 C--N 1.299 -2.078 0 O-C-N 124.53 1.805 . . . . 0.0 110.485 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 39.0 t80 178.91 114.79 0.19 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 110.865 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -79.5 107.13 0.99 Allowed 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.372 -1.928 . . . . 0.0 109.886 -0.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.474 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 12.5 p . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.508 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 . . . . . 0 C--O 1.214 -0.764 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -126.55 90.48 3.18 Favored 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.617 -0.677 . . . . 0.0 109.455 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.745 HG22 ' HB2' ' A' ' 10' ' ' TYR . 1.1 mt -90.28 151.57 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.612 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 3.0 p -84.31 -166.16 1.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.767 0.794 . . . . 0.0 111.376 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.06 -28.41 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -81.65 -82.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.816 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.1 m-20 -41.69 -56.03 2.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.456 -0.778 . . . . 0.0 110.058 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.745 ' HB2' HG22 ' A' ' 5' ' ' ILE . 1.4 t80 -49.6 -50.63 41.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.409 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 7' ' ' LEU . . . -56.29 -32.49 64.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 110.37 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -36.56 84.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.313 -0.867 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -38.07 44.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.132 -0.98 . . . . 0.0 110.147 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -99.23 -80.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.996 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.59 44.19 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 14.3 mm100 -88.72 -31.03 18.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.242 -1.151 . . . . 0.0 110.053 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.8 m -83.18 -26.13 31.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -56.55 4.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 108.797 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 2.1 m -55.55 -30.64 61.13 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -64.0 -55.86 19.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.896 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -84.66 11.58 8.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.461 -0.774 . . . . 0.0 109.787 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 3.0 m-20 -90.23 -43.28 10.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.416 -0.802 . . . . 0.0 110.58 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.961 HD11 ' CG2' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -94.63 -22.25 18.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.504 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 115.75 58.19 0.34 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.961 ' CG2' HD11 ' A' ' 23' ' ' LEU . 3.1 t -152.53 161.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.269 . . . . 0.0 110.166 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -77.8 177.6 8.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.499 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.04 -50.13 30.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 110.272 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.5 p -62.3 -60.32 3.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.59 -29.47 0.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.964 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.743 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -65.8 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.603 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.743 ' N ' HG22 ' A' ' 30' ' ' ILE . 2.7 m-20 -57.13 -7.45 0.52 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.473 -0.767 . . . . 0.0 111.208 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 -41.87 15.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.73 -1.231 . . . . 0.0 107.762 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' ALA . . . -70.44 -45.28 66.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 7' ' ' LEU . 10.5 mt -66.54 -46.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -42.87 -36.58 1.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.634 178.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 33' ' ' ALA . . . -67.91 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.758 -0.589 . . . . 0.0 109.727 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . 129.14 -16.24 5.77 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.337 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.697 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -39.97 81.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' GLY . 6.6 ptpt 9.69 69.06 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.512 0.672 . . . . 0.0 112.736 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.829 ' CG2' HD21 ' A' ' 7' ' ' LEU . 29.5 mt -80.77 167.48 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 109.126 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 40' ' ' ILE . 27.6 m-85 -158.29 150.55 21.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.877 -1.14 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 7' ' ' LEU . 4.5 mp -138.97 122.05 16.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.807 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.587 ' O ' ' CG2' ' A' ' 43' ' ' THR . 1.0 OUTLIER -102.27 109.48 21.16 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.475 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.023 HG23 ' O ' ' A' ' 49' ' ' SER . 2.0 mt -98.48 152.23 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 110.126 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.454 ' ND2' ' HA3' ' A' ' 48' ' ' GLY . 2.9 m-20 -136.09 -171.81 2.97 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.999 -1.063 . . . . 0.0 110.391 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.76 -4.22 30.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -156.67 16.91 0.31 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -93.4 -6.19 62.92 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.351 -1.899 . . . . 0.0 108.351 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.023 ' O ' HG23 ' A' ' 44' ' ' ILE . 72.1 m 54.24 -92.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' SER . 8.4 t -161.21 98.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.28 -0.888 . . . . 0.0 110.475 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 24.1 t80 -86.8 138.18 31.8 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.607 ' HB1' ' HD2' ' A' ' 58' ' ' PHE . . . -120.8 93.92 4.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.543 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 17.2 pt-20 -111.41 137.45 49.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 110.369 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -89.47 162.84 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.28 -0.888 . . . . 0.0 108.963 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 6.1 t -135.77 143.41 36.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.892 -1.13 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 56' B GLY . 2.6 tppt? -159.96 169.54 23.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 109.35 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 56' ' ' LYS . 36.9 t70 -29.57 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.379 0.609 . . . . 0.0 111.232 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 46.71 61.6 4.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.21 99.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.123 -1.222 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 56' E LYS . 16.5 m -107.17 153.41 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.132 -0.98 . . . . 0.0 109.681 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.506 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -144.03 175.7 2.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 110.604 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -87.79 -174.21 1.16 Allowed 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.092 1.862 . . . . 0.0 109.611 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.607 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 28.5 t80 174.39 113.78 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 110.434 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -80.06 110.7 1.98 Allowed 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.513 -1.87 . . . . 0.0 110.325 -0.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 16.3 m . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.538 -0.726 . . . . 0.0 110.867 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' THR . 30.1 mm-40 . . . . . 0 C--O 1.214 -0.786 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . 0.255 0.3 OUTLIER -89.53 66.89 7.45 Favored 'General case' 0 C--N 1.282 -2.364 0 O-C-N 121.559 -0.713 . . . . 0.0 109.348 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.76 HG22 ' HB2' ' A' ' 10' ' ' TYR . 22.0 mt -87.24 155.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.221 -0.924 . . . . 0.0 111.242 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.682 HG22 ' H ' ' A' ' 7' ' ' LEU . 1.1 m -65.99 -173.37 0.18 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.149 0.976 . . . . 0.0 111.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.854 HD22 HD12 ' A' ' 40' ' ' ILE . 3.3 tp -93.23 -39.32 11.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.535 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.7 tmtm? -90.22 -61.81 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.113 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.501 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 52.2 t0 -46.42 -44.99 17.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.915 . . . . 0.0 108.641 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.76 ' HB2' HG22 ' A' ' 5' ' ' ILE . 3.0 t80 -55.52 -58.56 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.49 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.04 -14.6 17.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.457 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 tpt -90.52 -24.41 20.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 0.0 110.182 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.73 -21.0 21.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -107.22 -55.41 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.31 140.89 3.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -59.91 -35.68 75.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -11.29 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.486 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -52.47 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.76 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.723 ' O ' HD12 ' A' ' 23' ' ' LEU . 3.0 m -60.66 -34.56 74.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.533 ' CB ' ' HG3' ' A' ' 27' ' ' GLN . . . -78.43 -19.66 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -79.78 -51.08 9.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.493 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 57.0 p30 -70.86 -18.13 62.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 19' ' ' THR . 29.2 mt -79.81 -31.98 40.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 34.5 22.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.35 169.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.231 -1.159 . . . . 0.0 110.03 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.634 ' O ' HD12 ' A' ' 30' ' ' ILE . 12.8 m-85 -72.2 145.74 47.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.493 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.533 ' HG3' ' CB ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -66.2 -16.77 64.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' ALA . 20.2 m -71.1 -61.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.06 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -41.2 -36.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.606 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 26' ' ' TYR . 1.3 mp -68.1 -55.11 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.308 -0.87 . . . . 0.0 110.528 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.4 OUTLIER -54.21 -13.65 0.91 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -92.5 -38.86 11.71 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.563 -1.336 . . . . 0.0 108.253 178.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -10.89 59.75 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.669 HG12 HD21 ' A' ' 7' ' ' LEU . 16.5 mt -111.52 -51.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.0 110.0 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -60.49 -19.72 57.74 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.464 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -66.69 -84.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 109.883 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.63 38.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 152.28 20.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -1.119 . . . . 0.0 110.889 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -100.51 69.03 1.4 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.825 . . . . 0.0 109.512 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.854 HD12 HD22 ' A' ' 7' ' ' LEU . 15.5 mt -89.64 164.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.864 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 71.7 m-85 -144.62 163.98 32.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 3.2 mp -144.35 141.55 29.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 110.692 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 2.8 m -118.76 102.96 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.785 . . . . 0.0 109.395 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.028 HG23 ' O ' ' A' ' 49' ' ' SER . 19.3 mt -118.89 100.01 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 111.167 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -107.81 -167.09 1.21 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.826 -1.171 . . . . 0.0 110.525 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.89 -2.23 7.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -144.69 7.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.616 -0.678 . . . . 0.0 109.401 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -91.07 -7.83 65.41 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.028 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 47.81 -92.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 49' ' ' SER . 2.4 t -161.57 95.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.146 -0.971 . . . . 0.0 109.963 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -100.11 134.78 42.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.608 -0.682 . . . . 0.0 109.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 58' ' ' PHE . . . -121.84 130.5 53.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -137.32 104.66 5.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.96 . . . . 0.0 110.692 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -79.36 150.82 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.373 -0.83 . . . . 0.0 109.868 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.34 132.17 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -153.51 151.38 29.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -40.68 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.206 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.32 -65.84 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -171.91 -179.56 2.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -1.051 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -100.48 149.09 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.172 -0.955 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.538 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -122.99 179.4 1.03 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.538 ' CD ' ' HB3' ' A' ' 56' E LYS . 5.6 Cg_endo -90.62 -170.94 0.4 Allowed 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.014 1.809 . . . . 0.0 110.269 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 40.5 t80 176.49 109.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.207 -0.933 . . . . 0.0 111.03 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.0 OUTLIER -81.68 99.33 0.26 Allowed 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.843 -1.732 . . . . 0.0 109.682 -0.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.534 ' CA ' ' HB2' ' A' ' 57' ' ' PRO . 13.7 m . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.856 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 43' ' ' THR . 5.2 mm-40 . . . . . 0 C--O 1.213 -0.857 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.94 75.8 0.94 Allowed 'General case' 0 C--N 1.281 -2.387 0 O-C-N 121.764 -0.585 . . . . 0.0 109.92 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.555 HG22 ' HB2' ' A' ' 10' ' ' TYR . 1.5 mt -90.67 148.51 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.735 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.589 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 1.3 p -90.95 169.23 11.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 112.296 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.915 HD11 HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -61.5 -25.88 67.55 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.738 ' HG2' HG23 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -81.43 -83.43 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.489 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 8' ' ' LYS . 75.7 m-20 -41.05 -54.6 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.971 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.589 ' CB ' ' O ' ' A' ' 6' ' ' THR . 43.7 t80 -51.12 -58.27 6.56 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -53.66 -23.36 11.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.522 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -34.19 52.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.635 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -91.67 -12.85 32.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -123.46 -49.95 1.89 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.276 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.18 134.81 2.86 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.413 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -60.9 -32.22 71.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.211 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -84.06 -11.45 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 110.192 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -51.94 7.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.204 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.493 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -65.6 -31.61 72.74 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.425 -0.797 . . . . 0.0 108.893 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.637 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -75.68 -26.29 57.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.607 -0.683 . . . . 0.0 109.773 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -27.98 61.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -82.94 -27.55 30.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 110.305 -179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HG ' ' OD1' ' A' ' 22' ' ' ASP . 25.9 mt -80.66 -10.8 59.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.965 . . . . 0.0 110.103 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 48.08 75.29 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 23' ' ' LEU . 1.5 t -141.22 153.1 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.343 -1.092 . . . . 0.0 110.033 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.814 ' O ' HD12 ' A' ' 30' ' ' ILE . 31.8 m-85 -66.75 157.55 32.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.122 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -64.65 -11.66 37.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.26 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.9 t -75.96 -62.31 1.64 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.87 -35.91 4.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.234 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.814 HD12 ' O ' ' A' ' 26' ' ' TYR . 3.7 mt -74.77 -48.15 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -55.11 -13.65 1.3 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.753 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -93.32 -38.94 11.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 108.385 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.32 -7.66 57.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.738 HG23 ' HG2' ' A' ' 8' ' ' LYS . 13.1 mt -110.89 -53.35 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.566 -0.709 . . . . 0.0 109.495 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.549 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 83.7 t60 -52.5 -31.3 34.53 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.196 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.17 -43.0 13.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.461 -0.774 . . . . 0.0 109.659 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.52 55.75 16.46 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HD2' ' H ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -85.14 39.86 0.79 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.189 -1.183 . . . . 0.0 111.153 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.5 OUTLIER 72.74 101.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.383 -0.823 . . . . 0.0 111.176 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.708 ' CG2' HD21 ' A' ' 7' ' ' LEU . 6.6 mt -145.61 159.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 99.4 m-85 -154.08 160.86 42.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.918 -1.114 . . . . 0.0 111.218 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.915 HD21 HD11 ' A' ' 7' ' ' LEU . 4.7 mp -143.47 114.72 7.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.53 -0.731 . . . . 0.0 110.3 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 54.0 m -89.28 100.62 13.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.844 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.722 ' CD1' HG22 ' A' ' 50' ' ' VAL . 3.7 mm -79.91 74.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 0.0 110.21 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.468 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 3.3 p30 -44.31 167.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 110.397 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -8.97 2.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -78.6 7.0 7.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.02 11.95 46.99 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.417 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 42.6 m -84.7 -173.06 4.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -1.165 . . . . 0.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 44' ' ' ILE . 70.8 t -138.42 101.34 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.062 -1.024 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -78.71 77.87 5.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.016 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.46 86.05 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 110.537 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 56' E LYS . 37.1 mt-10 -102.41 108.0 19.18 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' O ' ' CB ' ' A' ' 56' D VAL . 0.0 OUTLIER -79.52 176.01 10.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.39 -0.819 . . . . 0.0 109.705 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -142.31 110.49 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.859 . . . . 0.0 110.364 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 27.2 ttmt -128.92 154.64 46.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' A ASP . . . . . . . . . . . . . 48.0 m-20 -47.83 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 146.55 -52.14 0.57 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.95 168.97 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.453 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 27.0 m -81.98 -177.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.8 mttm -148.54 172.07 5.6 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.248 -0.908 . . . . 0.0 110.389 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.484 ' HG2' ' HA ' ' A' ' 60' ' ' SER . 1.6 Cg_endo -85.45 -47.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.947 1.764 . . . . 0.0 110.27 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 56.31 95.82 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.249 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 6.4 Cg_exo -70.1 157.21 93.24 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.835 -2.152 . . . . 0.0 110.284 0.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.7 m . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 110.281 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.154 0.502 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -82.95 66.82 8.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.672 HG23 ' HB2' ' A' ' 10' ' ' TYR . 4.8 tp -87.13 173.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 41' ' ' PHE . 5.1 p -77.29 -172.7 2.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.296 1.045 . . . . 0.0 111.108 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.857 HD22 HD12 ' A' ' 40' ' ' ILE . 1.4 tp -90.2 -34.65 15.73 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -85.37 -69.78 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.621 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -41.66 -49.17 4.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.247 -0.908 . . . . 0.0 109.111 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.71 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.6 t80 -50.15 -59.61 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.583 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -48.09 -31.07 5.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 109.449 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.438 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.71 -53.47 55.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.627 -0.67 . . . . 0.0 109.813 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -59.31 -31.19 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.789 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CD2' ' HE3' ' A' ' 18' ' ' LYS . 5.0 m-85 -106.76 -81.06 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.253 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 162.87 -176.46 39.15 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.418 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.9 OUTLIER -85.14 -27.5 26.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.096 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 m -85.88 -16.37 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HE3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -89.59 -39.92 12.94 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.288 -0.883 . . . . 0.0 108.969 179.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.5 m -71.68 -26.32 62.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.552 -0.718 . . . . 0.0 109.266 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.643 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -83.7 -39.21 20.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 110.443 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -62.74 -32.39 73.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.728 ' OD1' HG21 ' A' ' 50' ' ' VAL . 1.3 t0 -80.67 -31.53 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.041 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.9 mt -89.19 -7.87 54.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.394 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.14 49.79 50.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -133.43 147.48 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -1.195 . . . . 0.0 109.937 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -59.39 163.54 3.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.262 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -26.11 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 t -83.47 -51.48 7.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.878 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -47.99 -23.74 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.79 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -81.01 -68.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.774 . . . . 0.0 109.726 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.79 ' N ' HG22 ' A' ' 30' ' ' ILE . 2.1 m-20 -52.39 -13.69 0.39 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 111.235 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.39 -43.77 9.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.511 -1.368 . . . . 0.0 108.683 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -76.06 -6.96 53.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.534 -0.729 . . . . 0.0 109.053 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.855 HG12 HD21 ' A' ' 7' ' ' LEU . 19.0 mt -111.85 -50.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 0.0 109.998 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 23.7 t-160 -59.15 -23.67 62.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.12 -0.988 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.429 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.3 49.43 0.36 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.696 ' HG3' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.6 123.3 28.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -1.071 . . . . 0.0 110.299 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 55' ' ' VAL . 6.5 ptpp? -86.69 59.99 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.857 HD12 HD22 ' A' ' 7' ' ' LEU . 43.9 mt -96.94 169.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.579 0.704 . . . . 0.0 111.033 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 55.9 m-85 -149.79 110.13 4.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.786 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.9 mp -85.08 135.65 33.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.512 HG22 ' ND2' ' A' ' 45' ' ' ASN . 3.2 m -101.34 104.3 15.28 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.717 HG23 ' O ' ' A' ' 49' ' ' SER . 53.8 mt -93.56 44.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.073 -1.017 . . . . 0.0 111.246 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.512 ' ND2' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -87.58 -127.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.94 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.78 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 43.28 27.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.955 -1.09 . . . . 0.0 109.81 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.557 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 73.69 69.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.313 0.578 . . . . 0.0 111.797 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.28 0.23 35.95 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.78 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 1.1 p -58.76 -165.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.283 . . . . 0.0 110.369 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.728 HG21 ' OD1' ' A' ' 22' ' ' ASP . 14.1 t -146.28 124.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -135.49 164.09 28.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.32 -0.863 . . . . 0.0 109.989 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -141.8 132.43 25.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.462 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' E LYS . 39.1 tt0 -159.76 116.07 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 110.003 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HB3' HG12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -95.5 178.45 5.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.605 -179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.499 ' O ' ' HD3' ' A' ' 39' ' ' LYS . 6.2 t -140.16 107.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.464 -0.772 . . . . 0.0 109.621 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.01 155.02 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 110.582 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' A ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.24 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 137.71 -53.46 0.73 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.0 171.53 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 110.268 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 56' E LYS . 28.0 m -94.17 164.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 56' D VAL . 6.8 mtpt -142.39 168.59 13.0 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -83.61 -173.61 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 121.897 1.731 . . . . 0.0 109.947 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 85.3 t80 179.24 124.77 0.22 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.232 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.9 Cg_endo -87.33 100.2 0.25 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.745 -1.773 . . . . 0.0 110.311 -0.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 53.4 p . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 110.933 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.498 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 50.2 mm-40 . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.417 0.627 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 2.9 ttp180 -78.57 79.72 4.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.44 -0.788 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.657 HG22 ' HB2' ' A' ' 10' ' ' TYR . 69.1 mt -89.56 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.854 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -48.91 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.439 1.114 . . . . 0.0 111.94 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.744 ' HG ' HD11 ' A' ' 34' ' ' ILE . 2.0 tp -94.01 -38.17 11.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HB2' HD13 ' A' ' 34' ' ' ILE . 11.7 tmtt? -90.28 -56.67 3.12 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.386 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 25.7 t70 -50.89 -42.01 58.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.657 ' HB2' HG22 ' A' ' 5' ' ' ILE . 14.6 t80 -58.17 -61.27 2.68 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.793 0.806 . . . . 0.0 109.887 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.661 ' HB2' ' OG1' ' A' ' 19' ' ' THR . . . -56.3 -18.03 9.45 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.396 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -38.99 50.42 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -52.45 -42.84 64.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.555 -0.715 . . . . 0.0 109.173 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -114.46 -99.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.265 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.65 155.12 20.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.509 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -75.99 -28.2 57.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 110.266 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -74.97 -12.33 60.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -81.32 -58.19 3.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.219 -0.926 . . . . 0.0 108.617 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.661 ' OG1' ' HB2' ' A' ' 11' ' ' ALA . 15.5 m -50.68 -34.18 25.55 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.39 -38.62 55.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 110.898 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -35.01 79.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 110.327 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.7 -50.14 65.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.8 mt -80.66 -7.63 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.78 38.13 95.2 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 26' ' ' TYR . 3.0 t -112.88 178.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.087 -1.243 . . . . 0.0 109.917 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.575 ' O ' HD12 ' A' ' 30' ' ' ILE . 90.9 m-85 -100.65 141.03 34.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.193 -0.942 . . . . 0.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -46.95 -23.19 0.41 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t -72.38 -51.71 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.487 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.46 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -54.25 -26.13 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.066 -1.021 . . . . 0.0 110.053 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.668 HG23 HD12 ' A' ' 34' ' ' ILE . 1.3 mp -76.46 -55.8 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 2.6 m-80 -57.88 -14.12 5.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 110.545 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -94.56 -48.38 6.12 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.733 -1.229 . . . . 0.0 108.832 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -72.31 -3.1 21.84 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.132 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.744 HD11 ' HG ' ' A' ' 7' ' ' LEU . 9.5 mt -120.06 -49.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.272 -0.892 . . . . 0.0 110.547 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.566 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t60 -69.48 -7.75 40.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.967 -1.083 . . . . 0.0 110.098 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -77.96 -28.71 49.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.123 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.54 31.28 1.84 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -90.53 -176.97 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 82.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.273 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.616 HD12 ' CD2' ' A' ' 7' ' ' LEU . 4.1 mt -102.95 160.26 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 41.0 m-85 -153.35 160.71 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.078 -1.014 . . . . 0.0 110.529 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 3.7 mp -134.82 155.45 50.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 110.534 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 20.6 m -127.8 105.29 8.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 109.618 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.664 HG22 ' H ' ' A' ' 45' ' ' ASN . 0.7 OUTLIER -84.93 -148.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.087 -1.008 . . . . 0.0 110.974 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.664 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 38.37 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.252 0.549 . . . . 0.0 110.628 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.658 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 62.01 12.02 4.65 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.658 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 3.8 t70 135.47 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 124.147 0.979 . . . . 0.0 109.325 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.85 11.59 81.25 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -83.23 121.74 27.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.998 . . . . 0.0 110.232 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.2 118.4 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 110.375 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 3.7 m-85 -98.39 155.85 17.03 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.928 . . . . 0.0 108.541 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -142.31 86.74 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 110.419 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -101.56 -177.12 3.34 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 110.192 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 56' E LYS . 0.3 OUTLIER -152.67 173.48 15.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.272 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.442 HG22 HG12 ' A' ' 56' D VAL . 86.7 t -142.95 151.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.987 -1.07 . . . . 0.0 110.515 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 158.41 30.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.5 t0 -57.55 -11.62 2.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.08 -1.013 . . . . 0.0 110.633 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 56' C GLU . . . -100.83 -38.62 3.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' C GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' B GLY . 0.6 OUTLIER 174.58 179.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 110.288 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.442 HG12 HG22 ' A' ' 55' ' ' VAL . 35.6 m -102.64 148.16 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.288 -0.882 . . . . 0.0 109.862 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -144.58 166.7 17.41 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 0.0 110.474 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.8 Cg_exo -80.81 179.79 5.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.457 1.767 . . . . 0.0 110.287 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 3.1 t80 -159.99 125.61 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.003 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 71.2 Cg_endo -88.82 47.78 1.05 Allowed 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.802 -1.749 . . . . 0.0 110.87 0.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 110.49 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 8.4 ttm180 -76.97 83.05 3.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.692 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.659 HG21 ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -77.43 -174.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.547 -0.721 . . . . 0.0 109.721 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.83 -178.78 5.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 111.45 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.929 HD21 HG12 ' A' ' 34' ' ' ILE . 9.4 tp -92.33 -46.14 7.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.58 -65.71 0.99 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.881 -0.512 . . . . 0.0 110.07 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.489 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 10.3 t70 -45.03 -46.92 11.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 108.89 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.659 ' CG ' HG21 ' A' ' 5' ' ' ILE . 8.6 t80 -53.59 -62.44 1.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.779 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -51.82 -20.73 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.501 -0.749 . . . . 0.0 109.722 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.9 ttm -72.62 -49.6 30.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.65 76.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.091 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.59 -83.13 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 110.356 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.58 150.05 12.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -31.0 69.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -1.172 . . . . 0.0 110.087 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 t -83.75 -14.61 51.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -82.43 -52.94 6.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.779 HG21 ' HB2' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -61.8 -31.39 71.61 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -47.1 55.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.657 -0.652 . . . . 0.0 110.02 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -69.72 -17.0 63.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.531 -0.731 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 50' ' ' VAL . 1.3 m-20 -79.79 -34.86 39.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.173 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.66 HD11 HD21 ' A' ' 42' ' ' LEU . 7.0 mt -80.75 -25.77 37.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 110.144 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 86.34 63.88 1.48 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.465 ' CG2' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -154.04 147.45 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.225 -1.162 . . . . 0.0 109.766 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -47.56 167.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 110.136 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -87.62 -19.07 28.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.373 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 m -79.63 -63.57 1.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.091 -1.006 . . . . 0.0 109.94 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.48 -24.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.986 . . . . 0.0 109.262 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -68.45 -62.34 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.749 ' N ' HG22 ' A' ' 30' ' ' ILE . 3.9 t-20 -55.76 -13.55 1.79 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.601 -0.687 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -93.96 -34.43 13.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 108.408 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.86 -8.15 59.66 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.929 HG12 HD21 ' A' ' 7' ' ' LEU . 21.9 mt -113.66 -49.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.753 . . . . 0.0 109.747 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 13.1 t60 -60.22 -39.79 87.86 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.741 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.64 -23.95 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.61 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.46 31.18 8.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -59.04 -177.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.116 . . . . 0.0 110.498 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -128.47 76.08 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.933 HG23 ' HG3' ' A' ' 54' ' ' GLU . 5.7 mt -113.16 167.73 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 111.047 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 79.3 m-85 -147.4 122.99 10.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.7 mp -90.84 142.41 27.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.978 -1.076 . . . . 0.0 111.56 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 1.2 m -110.15 103.88 12.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 49' ' ' SER . 56.5 mt -84.15 60.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.832 -1.167 . . . . 0.0 111.51 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 16.7 p-10 -88.48 -146.16 0.15 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.836 -1.165 . . . . 0.0 110.28 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 49' ' ' SER . . . 56.2 14.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.459 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 26.4 t70 88.98 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 123.164 0.585 . . . . 0.0 110.115 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.07 14.48 0.57 Allowed Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.048 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.659 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 8.1 t -84.65 159.29 20.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.898 -1.354 . . . . 0.0 109.62 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.439 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 21.7 t -112.46 122.18 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 0.0 110.83 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -113.12 -171.09 1.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.853 . . . . 0.0 109.627 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -146.53 154.24 41.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 56' E LYS . 0.0 OUTLIER -159.49 106.75 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 110.091 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.933 ' HG3' HG23 ' A' ' 40' ' ' ILE . 5.6 mt-10 -83.57 165.5 19.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.504 HG13 HG12 ' A' ' 56' D VAL . 16.7 t -144.97 129.23 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.088 -1.008 . . . . 0.0 110.46 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 56' A ASP . 5.4 ttpp -146.83 94.53 2.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 65.1 t0 61.06 41.38 13.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.54 -0.725 . . . . 0.0 110.505 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 86.99 -11.15 65.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.9 tt0 -89.42 87.18 6.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.504 HG12 HG13 ' A' ' 55' ' ' VAL . 4.9 m -94.23 170.77 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.224 -0.923 . . . . 0.0 110.234 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -173.0 170.51 2.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 0.0 110.518 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 5.8 Cg_exo -80.53 166.39 19.88 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.474 1.776 . . . . 0.0 110.288 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.625 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 15.8 t80 -169.84 117.71 0.53 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 4.9 Cg_endo -84.04 100.89 0.32 Allowed 'Cis proline' 0 C--N 1.316 -1.165 0 C-N-CA 122.758 -1.767 . . . . 0.0 110.285 -0.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 97.6 p . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 110.053 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.501 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 8.4 mm-40 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.308 0.575 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -83.88 65.16 8.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.968 HG22 ' HB2' ' A' ' 10' ' ' TYR . 30.6 mm -90.74 135.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.7 p -46.96 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.202 1.001 . . . . 0.0 111.254 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.698 ' HB3' HG21 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -91.81 -34.8 14.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.344 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -82.74 -69.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.844 -0.535 . . . . 0.0 110.174 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -44.39 -45.9 9.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 109.246 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.968 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.6 t80 -49.14 -59.47 3.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -46.81 -30.9 2.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 110.17 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -46.06 70.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -25.57 63.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 0.0 110.423 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -111.97 -64.34 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.309 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 155.58 160.44 9.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -75.07 -32.33 61.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -1.206 . . . . 0.0 109.903 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -9.67 59.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.751 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.61 -41.3 12.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.142 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 m -70.01 -24.53 63.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.517 -0.739 . . . . 0.0 109.615 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.67 20.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 0.0 110.393 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -75.99 -16.11 60.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' HB3' HG21 ' A' ' 50' ' ' VAL . 36.5 m-20 -90.6 -44.35 9.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.499 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.6 HD22 ' HD3' ' A' ' 59' ' ' PRO . 25.3 mt -79.65 -31.06 41.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 110.322 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.36 16.03 36.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -116.02 147.71 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 109.938 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -64.62 153.08 40.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.612 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.477 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 2.5 mt-30 -47.97 -25.97 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.341 -0.85 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.0 -54.59 31.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.761 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . . . -46.08 -36.06 5.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.788 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.627 HG23 HD11 ' A' ' 34' ' ' ILE . 1.4 mp -63.24 -47.67 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 109.868 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 71.3 m-80 -66.35 -6.44 14.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -88.57 -44.02 10.95 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.722 -1.236 . . . . 0.0 108.982 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -72.66 -28.08 62.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.674 HG13 HD21 ' A' ' 7' ' ' LEU . 49.3 mt -87.2 -51.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.477 -0.765 . . . . 0.0 109.91 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 20.5 t60 -68.46 -4.69 15.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.838 -1.164 . . . . 0.0 110.492 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -90.68 -59.37 2.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.032 -1.042 . . . . 0.0 111.411 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . -155.18 99.29 0.19 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.589 ' HE ' HG22 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -51.47 -164.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.868 -0.784 . . . . 0.0 111.523 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 1.1 tttt 73.03 48.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.698 HG21 ' HB3' ' A' ' 7' ' ' LEU . 17.0 mt -97.06 166.48 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.316 0.579 . . . . 0.0 110.316 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.6 m-85 -158.54 117.42 3.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -110.36 132.96 53.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.721 ' HG1' ' HD2' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -97.91 100.56 11.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 44' ' ' ILE . 57.2 mt -84.39 55.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.707 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 46' ' ' ALA . 24.0 p30 -104.74 -122.08 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.059 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.939 ' HB3' ' HB2' ' A' ' 49' ' ' SER . . . 42.48 30.42 0.21 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.975 -1.078 . . . . 0.0 109.839 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.7 t70 80.95 50.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.553 0.692 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 82.11 -9.53 56.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.939 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 7.2 m -52.7 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.041 -1.27 . . . . 0.0 109.747 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 22' ' ' ASP . 46.0 t -131.28 116.75 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.721 ' HD2' ' HG1' ' A' ' 43' ' ' THR . 5.5 t80 -120.55 140.48 51.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -96.1 150.97 19.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.033 -1.042 . . . . 0.0 110.07 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -159.73 85.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 110.138 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 56' D VAL . 6.0 mt-10 -84.69 169.65 14.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.093 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' A' ' 56' D VAL . 1.5 p -161.39 148.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.117 -0.99 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -157.4 112.95 2.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 110.235 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' A ASP . . . . . . . . . . . . . 31.4 t70 45.77 49.0 11.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.873 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 78.1 35.52 34.19 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 20.2 tt0 -137.85 84.16 2.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -1.169 . . . . 0.0 109.887 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 3.2 m -96.39 153.98 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.168 -0.957 . . . . 0.0 111.015 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' E LYS . . . . . . . . . . . . . 3.4 pttt -148.13 168.67 10.65 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.852 . . . . 0.0 110.107 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -82.81 -82.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.35 1.71 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER 56.92 107.36 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 0.0 109.951 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.6 ' HD3' HD22 ' A' ' 23' ' ' LEU . 13.5 Cg_exo -68.41 140.23 54.94 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.082 -2.049 . . . . 0.0 110.381 -0.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.335 179.89 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.582 ' CB ' ' ND2' ' A' ' 45' ' ' ASN . 4.6 mm-40 . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.606 0.717 . . . . 0.0 109.221 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 2.7 ttm180 -78.95 82.5 5.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.62 -0.675 . . . . 0.0 109.634 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.597 HG21 ' HD1' ' A' ' 10' ' ' TYR . 12.5 mt -85.67 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.07 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.4 p -46.95 178.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.157 0.98 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.749 HD11 ' CD1' ' A' ' 30' ' ' ILE . 1.5 tp -91.58 -35.26 14.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.472 ' HG2' HG21 ' A' ' 34' ' ' ILE . 2.3 tmtt? -79.77 -68.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 6' ' ' THR . 5.6 t0 -45.28 -55.12 6.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.655 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.597 ' HD1' HG21 ' A' ' 5' ' ' ILE . 50.2 t80 -42.9 -60.05 1.75 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.418 -0.801 . . . . 0.0 111.219 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -60.38 -29.07 68.71 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.161 -0.962 . . . . 0.0 110.424 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -24.21 61.72 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -71.86 -47.82 50.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.518 -0.739 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 10' ' ' TYR . 26.9 p90 -111.42 -43.52 3.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.586 -1.321 . . . . 0.0 111.434 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 14' ' ' PHE . . . 168.24 162.92 21.28 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.033 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -90.6 -25.22 20.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.449 -1.03 . . . . 0.0 110.672 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.543 HG23 ' HG2' ' A' ' 18' ' ' LYS . 13.5 t -73.39 -18.28 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.982 . . . . 0.0 110.236 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HG2' HG23 ' A' ' 17' ' ' THR . 7.8 mttt -90.62 -34.52 15.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 11' ' ' ALA . 18.4 m -67.58 -32.09 72.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.68 -27.06 29.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.65 -0.656 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -83.75 -18.38 38.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 110.141 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.438 ' O ' HG11 ' A' ' 50' ' ' VAL . 50.9 m-20 -84.04 -41.55 17.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.058 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 59' ' ' PRO . 90.1 mt -79.91 -60.02 2.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 110.037 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.48 43.98 0.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.3 152.96 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -67.96 169.67 9.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.337 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 33.3 mt-30 -65.16 -35.36 80.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.912 . . . . 0.0 110.27 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.9 p -63.78 -54.44 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.767 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . . . -52.79 -23.2 6.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.131 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.749 ' CD1' HD11 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -71.2 -62.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.579 -0.701 . . . . 0.0 109.29 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.746 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -62.15 -8.03 4.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 110.447 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 15.1 mtpp -90.46 -38.21 13.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.808 -1.183 . . . . 0.0 108.37 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.58 -9.03 56.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 30' ' ' ILE . 19.3 mt -101.15 -46.18 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 5.2 t60 -68.67 -56.85 6.81 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.238 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.98 40.46 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.281 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.806 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -176.19 79.12 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 23.0 mmm-85 -84.52 -173.43 4.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -1.068 . . . . 0.0 110.53 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 4.3 mtmt 57.63 79.38 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 37' ' ' GLY . 7.1 mt -135.04 160.19 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.0 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.572 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 70.5 m-85 -153.67 154.38 34.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 110.349 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' A' ' 52' ' ' ALA . 4.1 mp -144.92 129.96 18.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.163 -0.961 . . . . 0.0 111.102 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.854 HG22 ' HA2' ' A' ' 48' ' ' GLY . 2.1 m -83.51 107.18 15.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 108.442 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.697 HG23 ' O ' ' A' ' 49' ' ' SER . 2.6 mt -129.15 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.048 -1.032 . . . . 0.0 111.689 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.612 ' H ' HG22 ' A' ' 44' ' ' ILE . 11.5 m-80 64.22 -165.06 0.24 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.8 0.81 . . . . 0.0 112.122 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.76 0.96 3.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.77 41.46 2.52 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.854 ' HA2' HG22 ' A' ' 43' ' ' THR . . . -169.02 -27.17 0.02 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 120.038 -1.077 . . . . 0.0 110.633 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.4 OUTLIER 59.77 -92.74 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.855 -1.379 . . . . 0.0 107.715 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 49' ' ' SER . 5.5 t -161.2 77.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.299 -0.876 . . . . 0.0 110.455 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.98 137.92 43.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.504 -0.748 . . . . 0.0 109.042 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -129.59 113.91 15.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 110.836 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.72 121.58 23.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.789 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' D VAL . 7.9 pt-20 -91.21 159.0 16.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.43 139.9 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.266 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 56' C GLU . 0.7 OUTLIER -157.4 78.1 0.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.948 -1.095 . . . . 0.0 110.932 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 56' ' ' LYS . 31.0 t70 40.35 76.78 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.804 . . . . 0.0 111.279 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 83.51 -5.88 75.72 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.66 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' C GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 1.1 tt0 -117.68 83.37 1.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.894 -1.356 . . . . 0.0 110.342 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -124.02 124.12 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.488 -0.758 . . . . 0.0 109.702 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.31 164.13 40.94 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.513 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 3.8 Cg_exo -82.8 97.37 0.85 Allowed 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.015 1.81 . . . . 0.0 110.762 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CZ ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -133.07 140.59 37.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 110.068 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HG2' ' HB3' ' A' ' 23' ' ' LEU . 59.9 Cg_endo -92.97 52.48 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.495 -1.877 . . . . 0.0 110.028 -0.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.513 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 36.7 t . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 110.719 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.469 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 2.7 mt-30 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.512 0.672 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.578 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -79.89 85.04 5.57 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.822 0.82 . . . . 0.0 111.869 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.014 ' O ' HD12 ' A' ' 42' ' ' LEU . 4.6 mm -89.59 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.599 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 2.6 p -65.46 -178.89 0.56 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 111.405 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.944 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -87.29 -26.7 23.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.71 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -79.52 -77.93 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.271 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 8' ' ' LYS . 7.9 t70 -42.87 -59.23 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.995 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.829 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.6 t80 -41.96 -54.65 3.41 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.246 -0.909 . . . . 0.0 110.555 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.45 -38.25 71.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.181 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.5 ttt -63.54 -30.11 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.502 -0.749 . . . . 0.0 109.998 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.38 -41.01 28.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -109.37 -57.26 2.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.322 -0.861 . . . . 0.0 109.902 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 154.68 156.96 7.95 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 110.147 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 31.1 p -67.76 -11.5 58.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.919 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -85.91 -46.79 10.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.323 -0.861 . . . . 0.0 108.917 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -27.57 63.24 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.27 -32.41 22.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.669 -0.644 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.1 tmtp? -74.29 -18.63 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.908 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.94 -46.76 10.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 0.0 110.069 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.514 HD22 ' HD3' ' A' ' 59' ' ' PRO . 41.8 mt -80.87 -19.14 45.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.08 39.81 94.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.675 HG11 ' HG2' ' A' ' 59' ' ' PRO . 35.9 m -127.79 179.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -1.186 . . . . 0.0 110.206 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.64 142.41 49.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.297 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.445 ' HA ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -66.95 -11.5 56.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.92 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -72.43 -54.78 8.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.975 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.66 -25.15 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.59 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 34' ' ' ILE . 50.0 mt -78.57 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.586 -0.696 . . . . 0.0 109.797 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -58.52 -9.14 1.48 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 110.63 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -93.39 -42.22 9.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.699 -1.251 . . . . 0.0 108.228 178.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -75.24 -11.11 60.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.88 HD11 ' HB3' ' A' ' 7' ' ' LEU . 65.2 mt -105.83 -54.17 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 31.6 t60 -54.97 -23.47 19.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.77 85.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.53 37.93 1.39 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.64 -164.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -1.129 . . . . 0.0 110.633 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.447 ' HE2' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -145.45 87.64 1.81 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.649 ' CG2' HD21 ' A' ' 7' ' ' LEU . 27.3 mt -114.91 172.09 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.426 -0.797 . . . . 0.0 110.879 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.583 ' N ' HG22 ' A' ' 40' ' ' ILE . 38.5 m-85 -160.01 141.67 12.78 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.014 HD12 ' O ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -114.89 109.29 17.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.906 -1.121 . . . . 0.0 109.642 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 4' ' ' ARG . 1.4 m -75.93 102.12 5.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 108.746 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.507 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.9 mt -78.17 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 0.0 110.471 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 9.1 p-10 34.28 -140.29 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.964 -0.46 . . . . 0.0 111.309 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.639 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 49.1 26.35 1.4 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 50.7 t0 97.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 123.697 0.799 . . . . 0.0 108.87 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.09 9.78 43.19 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.93 113.58 3.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.794 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.1 t -86.29 100.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 110.334 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 28.5 m-85 -104.73 92.77 4.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.1 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.675 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -88.48 135.47 33.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.05 -1.031 . . . . 0.0 109.361 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 56' E LYS . 0.8 OUTLIER -156.76 135.17 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.15 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -83.73 171.39 13.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.492 -0.755 . . . . 0.0 109.447 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 56' D VAL . 10.4 t -140.28 141.61 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 110.441 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 56' A ASP . 0.8 OUTLIER -157.02 120.4 4.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 28.3 t70 57.74 -90.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . -146.35 43.76 0.87 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.7 tt0 -156.65 123.81 5.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -1.155 . . . . 0.0 110.35 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.456 HG12 HG13 ' A' ' 55' ' ' VAL . 10.0 m -109.97 155.99 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 11.9 mttm -135.78 164.47 43.11 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.863 . . . . 0.0 109.486 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 56' E LYS . 4.6 Cg_exo -82.6 150.71 14.82 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.917 1.745 . . . . 0.0 111.006 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 1.9 t80 -146.16 128.87 8.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HG2' HG11 ' A' ' 25' ' ' VAL . 9.6 Cg_endo -89.16 52.92 0.66 Allowed 'Cis proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.98 -1.675 . . . . 0.0 110.648 0.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.4 mm-40 . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 121.298 0.57 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -79.51 74.9 6.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.713 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.722 HD12 ' CE1' ' A' ' 10' ' ' TYR . 10.2 mt -90.67 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.641 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -70.65 -173.45 0.76 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.069 0.938 . . . . 0.0 111.491 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.641 ' H ' HG22 ' A' ' 6' ' ' THR . 1.6 tp -93.99 -38.61 11.07 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.521 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 1.3 tmtt? -90.11 -67.39 0.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.51 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 9.5 m-20 -43.9 -44.11 6.83 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.722 ' CE1' HD12 ' A' ' 5' ' ' ILE . 8.4 t80 -57.96 -54.29 48.56 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.975 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.08 -20.73 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -21.6 21.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.969 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.31 -12.95 25.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.25 -27.76 4.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.965 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.69 130.92 3.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.77 72.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -1.165 . . . . 0.0 109.813 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 15.5 p -82.07 -14.08 56.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -55.37 4.8 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.42 -0.8 . . . . 0.0 108.87 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' HD21 ' A' ' 23' ' ' LEU . 66.7 m -57.18 -32.08 66.09 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 25' ' ' VAL . . . -71.41 -44.97 63.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.9 tmtt? -80.25 1.63 27.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.843 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.525 ' HB3' HG21 ' A' ' 50' ' ' VAL . 53.1 m-20 -89.9 -43.07 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.803 HD12 HG21 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -115.25 -8.55 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.677 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.97 67.95 1.26 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.81 ' CG1' HD11 ' A' ' 30' ' ' ILE . 60.8 t -142.88 140.0 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 110.34 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' O ' HG12 ' A' ' 30' ' ' ILE . 4.3 m-85 -75.0 139.63 43.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 0.0 110.184 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -46.82 -23.84 0.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -69.92 -58.8 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' N ' ' OG ' ' A' ' 28' ' ' SER . . . -46.96 -25.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.671 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.878 HG22 HD12 ' A' ' 34' ' ' ILE . 2.7 mm -71.29 -56.27 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.765 . . . . 0.0 109.986 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -62.81 -8.96 7.87 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -94.74 -40.48 9.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.748 -1.22 . . . . 0.0 108.612 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -79.86 -9.45 59.67 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 HG22 ' A' ' 30' ' ' ILE . 76.5 mt -108.8 -49.12 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.53 -0.731 . . . . 0.0 110.067 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.579 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 16.8 t-160 -63.39 -33.41 75.48 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.947 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.0 -21.59 59.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.64 30.3 13.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -78.3 -173.5 3.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.227 -1.161 . . . . 0.0 110.256 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.76 75.36 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.174 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 58' ' ' PHE . 62.1 mt -106.17 169.25 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 50.9 m-85 -156.56 158.83 37.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 3.1 mp -134.4 114.96 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.0 110.492 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.769 HG23 ' O ' ' A' ' 43' ' ' THR . 13.0 t -93.55 102.95 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 109.848 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' SER . 1.9 mp -91.68 130.23 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.055 . . . . 0.0 110.453 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.763 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 8.2 m-20 -50.53 -19.52 0.91 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.09 -19.52 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.66 -11.96 57.97 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.34 -22.86 5.85 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.822 ' O ' HG23 ' A' ' 44' ' ' ILE . 5.0 t -60.04 148.63 34.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 109.583 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 22' ' ' ASP . 52.9 t -133.4 123.32 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.991 -1.068 . . . . 0.0 111.047 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 15.0 t80 -120.64 119.18 32.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 108.933 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 58' ' ' PHE . . . -93.61 154.28 17.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.921 -1.112 . . . . 0.0 111.241 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -160.35 142.53 12.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.563 -0.711 . . . . 0.0 109.844 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 56' D VAL . 11.7 tm-20 -121.47 167.18 13.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.4 116.49 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.463 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' B GLY . 11.3 ttmt -143.2 153.86 43.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 110.156 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' LYS . 28.9 t0 -43.73 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.465 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.66 -64.34 0.42 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -170.29 171.78 6.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.471 -1.017 . . . . 0.0 110.237 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 21.4 m -93.22 133.26 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 110.16 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 mmtp -116.87 132.61 23.33 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.978 . . . . 0.0 110.747 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.9 Cg_exo -80.23 125.81 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.218 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -140.88 144.54 35.93 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -91.47 48.53 1.27 Allowed 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.275 -1.969 . . . . 0.0 110.578 0.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.627 ' CG ' ' O ' ' A' ' 3' ' ' GLN 0.257 0.7 OUTLIER . . . . . 0 C--O 1.211 -0.927 0 CA-C-O 122.637 1.208 . . . . 0.0 108.882 . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.561 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -78.59 73.55 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.922 -1.111 . . . . 0.0 111.375 -178.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.692 HG22 ' HB2' ' A' ' 10' ' ' TYR . 5.1 mt -88.28 145.73 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.145 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 2.3 p -66.53 -173.02 0.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.753 0.787 . . . . 0.0 111.246 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.076 HD23 HD12 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -90.44 -26.62 19.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.506 ' HG2' HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -81.94 -73.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.071 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.7 -56.29 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.045 -1.034 . . . . 0.0 109.709 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' A' ' 5' ' ' ILE . 6.1 t80 -46.74 -53.81 11.02 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.21 -33.16 65.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ttm -63.79 -40.19 96.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.258 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 -28.37 50.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.55 -74.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 110.171 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.16 148.19 5.83 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -58.17 -39.0 77.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -1.102 . . . . 0.0 109.845 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.51 -14.21 59.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 0.0 110.364 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -79.49 -56.31 4.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.199 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 2.1 m -62.51 -29.25 70.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.58 -29.82 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 110.259 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -82.72 -14.57 54.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.798 ' OD1' HG21 ' A' ' 50' ' ' VAL . 4.1 t70 -90.14 -25.39 20.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 109.949 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 30' ' ' ILE . 95.6 mt -79.96 -35.85 37.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 110.358 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.97 23.17 30.77 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -132.81 157.16 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -1.095 . . . . 0.0 110.074 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 25' ' ' VAL . 49.5 m-85 -46.6 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 110.437 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -85.11 -13.78 49.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 110.559 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 t -76.91 -56.39 4.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.955 . . . . 0.0 110.315 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.81 -25.3 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 109.966 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.757 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -76.27 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.846 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.757 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.6 OUTLIER -58.82 -7.91 1.17 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.427 -0.796 . . . . 0.0 111.132 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -91.39 -40.37 11.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.514 -1.366 . . . . 0.0 108.169 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.432 ' O ' ' CD ' ' A' ' 38' ' ' ARG . . . -75.29 -18.84 59.96 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.854 HD11 ' HB3' ' A' ' 7' ' ' LEU . 37.7 mt -96.71 -52.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.423 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 72.3 t60 -52.06 -23.03 4.65 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.295 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.42 -55.5 13.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.814 . . . . 0.0 110.464 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . 124.57 8.96 5.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -51.34 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.401 -1.058 . . . . 0.0 111.835 -179.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.86 81.18 1.86 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.492 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.076 HD12 HD23 ' A' ' 7' ' ' LEU . 1.8 mt -97.07 157.5 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.174 -0.954 . . . . 0.0 110.78 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 97.9 m-85 -150.13 98.16 2.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.453 -0.779 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.756 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.8 mp -85.13 101.82 12.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.139 -0.976 . . . . 0.0 111.251 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 43' ' ' THR . 2.3 m -77.78 100.73 6.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.166 -0.958 . . . . 0.0 108.842 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 49' ' ' SER . 5.4 mt -96.5 132.47 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.987 . . . . 0.0 111.453 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 14.2 m-20 -54.66 -17.86 3.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.701 -0.624 . . . . 0.0 110.597 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 90.92 -15.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.33 -17.01 28.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.785 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 135.88 -27.06 3.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -57.09 112.04 1.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.243 . . . . 0.0 109.392 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.798 HG21 ' OD1' ' A' ' 22' ' ' ASP . 29.2 t -109.18 126.31 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.463 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 7.1 m-85 -116.64 108.79 16.36 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -88.06 119.0 28.01 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.034 -1.042 . . . . 0.0 110.615 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 56' E LYS . 0.0 OUTLIER -148.18 121.33 8.9 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.358 -0.839 . . . . 0.0 110.567 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' D VAL . 9.3 mt-10 -81.25 154.76 26.43 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.05 115.01 2.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.685 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -148.99 121.91 8.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 109.624 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 26.1 t70 58.42 16.78 4.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.623 ' O ' HG13 ' A' ' 56' D VAL . . . 100.81 -27.68 19.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 111.57 3.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -1.196 . . . . 0.0 110.505 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.623 HG13 ' O ' ' A' ' 56' B GLY . 3.3 m -111.71 146.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 110.324 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 7.3 mtpt -145.46 157.89 51.61 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.136 -0.978 . . . . 0.0 110.523 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -83.4 174.5 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.776 1.651 . . . . 0.0 110.222 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 84.4 t80 176.98 113.35 0.13 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 110.303 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 5.6 Cg_exo -78.05 108.21 1.15 Allowed 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.589 -1.838 . . . . 0.0 110.53 0.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 14.1 p . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 110.56 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.3 mt-30 . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 121.264 0.554 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.565 ' HD2' HG22 ' A' ' 43' ' ' THR . 0.4 OUTLIER -79.13 81.89 5.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.896 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.601 HD12 ' CE1' ' A' ' 10' ' ' TYR . 2.0 mt -90.46 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.477 -0.764 . . . . 0.0 110.063 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -74.52 -169.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.059 0.933 . . . . 0.0 111.7 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 40' ' ' ILE . 5.2 tp -91.44 -42.48 10.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.737 ' HB2' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -91.11 -58.05 2.6 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.502 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -46.19 -49.33 17.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.601 ' CE1' HD12 ' A' ' 5' ' ' ILE . 3.6 t80 -56.32 -57.04 13.95 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.818 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.42 -20.21 2.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.536 -0.727 . . . . 0.0 109.926 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 1.5 ttp -71.65 -44.84 63.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 110.362 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -70.46 -21.95 62.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.199 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 13.2 m-85 -112.02 -89.91 0.51 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.64 151.76 14.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.54 -35.98 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -1.107 . . . . 0.0 109.942 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.9 t -78.48 -11.84 59.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -47.75 9.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.23 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.5 m -67.7 -26.99 66.44 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.441 -0.787 . . . . 0.0 109.341 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.48 -37.98 50.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -0.757 . . . . 0.0 110.271 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.76 68.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.065 ' OD2' HG11 ' A' ' 50' ' ' VAL . 3.3 t70 -73.9 -38.48 64.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.486 ' HB2' HG23 ' A' ' 25' ' ' VAL . 24.4 mt -84.99 -12.41 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.03 49.9 37.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -128.27 176.93 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.194 -1.18 . . . . 0.0 109.902 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 1.4 m-85 -93.48 148.02 22.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.88 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.475 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.4 tt0 -44.9 -47.73 11.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.848 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -53.47 -56.58 15.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.762 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.57 -32.03 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.502 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.74 HG22 HD12 ' A' ' 34' ' ' ILE . 3.1 mm -66.34 -54.48 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.789 0.804 . . . . 0.0 109.856 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -52.41 -17.16 1.08 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.546 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.766 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -95.69 -36.59 11.14 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.439 -1.413 . . . . 0.0 108.924 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -78.64 2.95 17.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.53 -0.731 . . . . 0.0 109.178 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 30' ' ' ILE . 20.3 mt -135.55 -46.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.591 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 3.4 t60 -79.62 -11.61 59.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.209 -0.932 . . . . 0.0 110.512 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -90.27 -24.2 20.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.131 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.65 51.13 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.604 ' CG ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -90.78 130.38 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.331 -1.1 . . . . 0.0 110.592 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.35 65.49 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 109.02 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 7' ' ' LEU . 1.1 mt -94.28 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.509 -0.744 . . . . 0.0 110.74 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 95.7 m-85 -142.75 121.63 12.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.413 -0.804 . . . . 0.0 110.161 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.648 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.4 mp -105.38 113.52 27.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.898 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.565 HG22 ' HD2' ' A' ' 4' ' ' ARG . 0.5 OUTLIER -90.05 103.06 15.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.12 -0.988 . . . . 0.0 108.82 179.094 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 6.6 mt -101.11 125.61 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.081 -1.012 . . . . 0.0 110.737 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -91.88 -178.08 4.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.342 -0.848 . . . . 0.0 110.334 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.86 -2.77 7.9 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.68 -2.16 57.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.438 -0.789 . . . . 0.0 110.436 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -6.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.413 ' O ' HG23 ' A' ' 44' ' ' ILE . 3.8 t -56.16 160.59 2.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.862 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.065 HG11 ' OD2' ' A' ' 22' ' ' ASP . 95.5 t -137.31 106.04 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.483 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 9.9 m-85 -88.92 84.41 6.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.68 110.55 9.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 109.049 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 56' E LYS . 0.4 OUTLIER -146.39 122.63 10.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.094 -1.004 . . . . 0.0 111.65 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' D VAL . 0.0 OUTLIER -78.73 159.56 27.88 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -154.36 132.84 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.568 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 56' C GLU . 0.2 OUTLIER -160.22 78.77 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.402 ' O ' ' CG ' ' A' ' 56' A ASP . 15.4 t0 51.08 46.01 27.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.528 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.42 ' O ' HG12 ' A' ' 56' D VAL . . . 114.44 -30.8 6.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' C GLU . . . . . 0.515 ' CB ' ' HB3' ' A' ' 56' ' ' LYS . 4.3 mt-10 -79.06 103.61 9.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.171 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -145.73 153.88 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pttt -171.3 161.37 5.24 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.131 -0.981 . . . . 0.0 110.483 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 58' ' ' PHE . 5.9 Cg_exo -81.29 48.46 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.747 1.631 . . . . 0.0 111.556 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.492 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 15.7 t80 -41.42 122.54 2.18 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.144 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' SER . 2.4 Cg_endo -82.38 103.38 0.51 Allowed 'Cis proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.517 -1.868 . . . . 0.0 110.48 -0.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' PRO . 8.0 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.231 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.0 mm-40 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.377 0.608 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 33.6 ttt-85 -79.68 84.03 5.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.714 HD12 ' CE1' ' A' ' 10' ' ' TYR . 5.9 mt -88.62 169.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -77.64 -174.12 3.29 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.04 0.924 . . . . 0.0 111.898 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.029 HD22 HD12 ' A' ' 40' ' ' ILE . 3.5 tp -91.78 -41.02 10.9 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.477 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.31 -53.29 4.52 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.554 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -53.51 -50.92 64.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.714 ' CE1' HD12 ' A' ' 5' ' ' ILE . 7.2 t80 -54.8 -54.69 38.89 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.641 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -53.03 -25.93 13.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.493 -0.754 . . . . 0.0 109.845 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.446 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 17.9 tpp -73.97 -36.84 64.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.852 . . . . 0.0 109.96 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.06 -30.03 60.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.93 -66.34 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.74 160.68 11.91 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.44 ' NE2' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.81 -35.14 67.26 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 0.0 109.67 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -83.66 -14.14 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.43 -47.04 11.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 108.976 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m -64.24 -30.69 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.87 -30.16 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.539 -0.726 . . . . 0.0 109.713 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -76.3 -34.84 59.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.785 ' HB3' HG11 ' A' ' 50' ' ' VAL . 3.2 m-20 -66.39 -35.32 80.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.786 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' A' ' 59' ' ' PRO . 74.9 mt -81.28 -34.64 31.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 0.0 110.196 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.97 48.0 5.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.48 -179.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -1.121 . . . . 0.0 110.132 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.518 ' O ' HD13 ' A' ' 30' ' ' ILE . 29.2 m-85 -70.18 171.54 9.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.766 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.7 tt0 -87.94 -21.02 25.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -0.808 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 p -66.24 -45.38 80.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 109.968 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -21.48 16.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.741 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.7 mp -80.01 -50.93 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.42 -0.8 . . . . 0.0 109.724 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -71.18 -2.34 15.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -101.47 -42.22 6.34 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.909 -1.12 . . . . 0.0 108.155 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -74.65 -18.16 60.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 7' ' ' LEU . 45.5 mt -102.11 -50.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.442 -0.786 . . . . 0.0 110.246 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 2.2 t60 -60.56 -16.46 37.96 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.9 -1.125 . . . . 0.0 109.817 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 -46.08 17.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.6 7.22 5.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -51.58 161.96 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -1.182 . . . . 0.0 110.172 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 5.4 mmtt -115.88 70.27 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.029 HD12 HD22 ' A' ' 7' ' ' LEU . 6.1 mt -90.55 161.3 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.816 . . . . 0.0 110.15 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 48.6 m-85 -151.26 114.03 4.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.715 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.3 mp -80.52 141.69 34.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.407 HG22 HD21 ' A' ' 45' ' ' ASN . 2.8 m -116.71 103.28 10.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.38 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.969 HG23 ' O ' ' A' ' 49' ' ' SER . 1.2 mt -105.12 130.66 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.731 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER -105.25 -172.22 2.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.925 179.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.26 -2.2 18.09 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -161.67 21.53 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -90.7 -5.36 68.9 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.5 OUTLIER 60.09 -94.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 49' ' ' SER . 1.7 t -162.3 112.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 0.0 110.867 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 20.0 m-85 -101.69 151.99 21.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 108.995 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . -127.03 99.62 5.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.873 -1.142 . . . . 0.0 111.051 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 40' ' ' ILE . 1.8 mt-10 -101.86 169.95 8.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.611 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -150.51 153.56 36.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.927 -1.108 . . . . 0.0 110.587 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 54' ' ' GLU . 5.8 t -150.94 118.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 110.114 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 0.2 OUTLIER -146.37 -168.8 3.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 56' B GLY . 15.3 t0 -41.25 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.462 -0.774 . . . . 0.0 110.306 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 42.32 57.21 3.79 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 mt-10 -160.42 84.87 0.71 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.244 . . . . 0.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' D VAL . . . . . . . . . . . . . 4.5 m -102.07 148.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.0 pttt -172.62 166.19 3.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 110.345 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.0 Cg_endo -88.1 -83.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.867 1.712 . . . . 0.0 110.558 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.542 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 59.19 109.57 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.367 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.503 ' HD3' HD22 ' A' ' 23' ' ' LEU . 5.8 Cg_exo -77.39 140.4 63.45 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.456 -1.893 . . . . 0.0 109.923 -0.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 33.2 t . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.054 -1.029 . . . . 0.0 110.358 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 46' ' ' ALA . 1.9 mm100 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -79.4 75.77 6.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 6' ' ' THR . 54.4 mt -90.82 177.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -87.52 -171.03 3.27 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.453 1.12 . . . . 0.0 112.496 -178.761 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.106 HD22 HD13 ' A' ' 40' ' ' ILE . 3.5 tp -92.14 -52.42 4.7 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 123.307 1.527 . . . . 0.0 107.203 176.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.45 -57.54 3.2 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.229 179.618 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.539 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -47.67 -47.87 29.28 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 6' ' ' THR . 27.0 t80 -52.44 -60.19 3.53 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.396 -0.922 . . . . 0.0 109.659 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.7 -26.57 2.38 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.557 0.694 . . . . 0.0 109.577 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.486 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.42 -52.65 44.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.995 179.931 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 -64.36 -31.85 73.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.698 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.469 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 7.5 m-30 -109.75 -80.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 110.152 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 173.75 39.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.445 ' HG3' ' HG2' ' A' ' 27' ' ' GLN . 9.1 tp60 -79.1 -32.3 44.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -1.14 . . . . 0.0 110.075 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -67.96 -21.6 65.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.853 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 14' ' ' PHE . 6.5 mttt -79.74 -38.33 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.867 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.18 -14.18 61.31 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.696 ' HB2' ' HG3' ' A' ' 27' ' ' GLN . . . -79.15 -47.07 16.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 0.0 109.669 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -12.13 60.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.731 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.566 ' OD1' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -77.3 -55.35 5.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.86 HD21 ' HB2' ' A' ' 52' ' ' ALA . 10.9 mt -86.22 -14.37 44.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.292 -0.88 . . . . 0.0 110.151 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.58 31.06 46.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 26' ' ' TYR . 1.5 t -127.02 178.5 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -1.075 . . . . 0.0 109.75 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.475 ' O ' HD12 ' A' ' 30' ' ' ILE . 57.0 m-85 -89.01 132.95 34.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -0.992 . . . . 0.0 110.2 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.696 ' HG3' ' HB2' ' A' ' 20' ' ' ALA . 17.1 mt-30 -41.71 -29.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 110.264 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.65 -18.87 8.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.452 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.601 HG22 HD12 ' A' ' 34' ' ' ILE . 1.6 mp -86.2 -43.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.044 -1.035 . . . . 0.0 110.315 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.3 t-20 -67.16 -9.92 44.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.235 -0.915 . . . . 0.0 110.206 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -94.52 -48.85 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 108.186 178.482 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -67.83 -16.39 64.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CG1' HD23 ' A' ' 7' ' ' LEU . 7.3 mt -95.93 -64.18 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 19.2 t-160 -49.71 -19.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.651 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -76.56 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.588 -0.695 . . . . 0.0 111.78 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 39' ' ' LYS . . . -132.59 87.83 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 15.6 mmm-85 -57.19 108.1 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.941 . . . . 0.0 111.049 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HD2' ' HD2' ' A' ' 56' ' ' LYS . 11.7 pttm 179.21 42.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.106 HD13 HD22 ' A' ' 7' ' ' LEU . 15.8 mt -102.24 164.18 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.996 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 58.6 m-85 -156.74 110.54 2.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.952 HD11 HD12 ' A' ' 7' ' ' LEU . 5.3 mp -99.44 144.1 28.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 112.183 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 48' ' ' GLY . 1.5 m -96.1 110.92 23.09 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 176.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -89.12 175.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 113.048 -176.369 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.578 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 36.8 p30 -60.87 -133.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.246 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 57.35 43.38 23.45 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.605 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 35.5 t70 69.22 26.33 5.46 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -176.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.581 ' O ' HG22 ' A' ' 43' ' ' THR . . . -124.61 -13.9 3.67 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 43' ' ' THR . 11.9 m 61.2 133.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -1.057 . . . . 0.0 108.441 -178.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.601 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 23.1 t -78.41 136.54 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.701 -1.249 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 50' ' ' VAL . 20.9 m-85 -165.61 177.84 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.742 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.86 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -144.97 133.82 22.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 109.981 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 56' E LYS . 18.2 tt0 -154.46 117.05 4.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 0.0 110.916 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.597 ' HG3' HG23 ' A' ' 40' ' ' ILE . 15.2 mt-10 -80.77 153.54 27.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 56' D VAL . 8.7 t -146.67 123.37 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.94 -1.1 . . . . 0.0 110.979 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -147.35 141.02 25.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.706 . . . . 0.0 109.208 179.403 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -40.53 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 110.42 -179.357 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.41 -48.51 0.53 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 tt0 -179.33 163.92 1.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.257 -1.143 . . . . 0.0 110.718 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.545 HG12 HG13 ' A' ' 55' ' ' VAL . 15.2 m -112.88 170.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 15.8 mttt -143.11 160.34 52.78 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 110.477 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 1.3 Cg_endo -85.26 -65.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.887 1.725 . . . . 0.0 110.2 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.55 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 28.4 t80 57.09 99.63 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.519 -0.738 . . . . 0.0 110.611 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 15.0 Cg_exo -66.3 152.38 81.21 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.827 -2.155 . . . . 0.0 110.427 0.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.9 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.053 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 121.322 0.582 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 5.8 ttp180 -77.82 82.15 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.432 -0.793 . . . . 0.0 109.927 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.722 HG22 ' HB2' ' A' ' 10' ' ' TYR . 11.2 mm -90.73 163.78 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -77.1 -171.88 2.18 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.121 0.962 . . . . 0.0 111.952 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.705 ' H ' HG22 ' A' ' 6' ' ' THR . 4.9 tp -91.62 -40.04 11.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.565 ' CD ' HG22 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -90.79 -51.43 5.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.431 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.473 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 1.6 t0 -54.91 -43.57 73.39 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.722 ' HB2' HG22 ' A' ' 5' ' ' ILE . 2.3 t80 -62.94 -55.07 29.1 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.196 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.26 -26.57 18.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.637 -0.664 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ttm -71.79 -36.25 70.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.828 . . . . 0.0 110.053 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.76 -39.21 57.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.675 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.74 -100.9 0.23 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.254 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.7 176.02 32.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.715 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 11.2 tp60 -88.28 -30.5 19.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -1.068 . . . . 0.0 110.134 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -84.34 -28.25 27.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -62.16 1.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.67 HG23 HD21 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -53.29 -35.46 60.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.349 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -58.24 -41.47 84.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.56 ' HA ' HG13 ' A' ' 25' ' ' VAL . 6.7 mmtt -57.47 -45.08 85.19 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.8 m-20 -92.19 -5.19 53.01 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.432 -0.792 . . . . 0.0 112.791 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.117 HD22 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -164.39 62.74 0.14 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.47 -1.394 . . . . 0.0 109.92 -179.645 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.714 ' O ' ' HB1' ' A' ' 20' ' ' ALA . . . 127.53 74.45 0.19 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.348 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.706 HG22 ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.58 -11.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.92 -0.753 . . . . 0.0 109.842 -177.198 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' SER . 8.1 m-85 -101.71 98.23 8.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -37.12 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 111.53 -178.691 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' TYR . 67.8 m -82.63 -61.12 1.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.79 -1.194 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . . . -48.92 -22.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.077 -1.015 . . . . 0.0 109.109 179.165 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.743 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.65 -64.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.523 -0.736 . . . . 0.0 109.933 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.743 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -52.07 -15.67 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.484 -0.76 . . . . 0.0 111.252 -179.612 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 4.9 mttt -93.08 -39.8 10.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.435 -1.416 . . . . 0.0 109.028 179.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . -76.31 -9.71 58.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.462 -0.774 . . . . 0.0 108.942 178.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 30' ' ' ILE . 16.5 mt -111.98 -52.36 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 7.5 t-160 -57.63 -31.76 66.57 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.204 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 38' ' ' ARG . . . -90.05 -45.97 8.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.472 -0.768 . . . . 0.0 109.673 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.02 85.44 1.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.829 ' HB2' HD11 ' A' ' 40' ' ' ILE . 2.5 mpt_? -90.1 49.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.266 . . . . 0.0 109.27 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER 42.46 53.96 4.5 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.854 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 38' ' ' ARG . 4.2 mt -105.23 154.8 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 110.082 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 70.8 m-85 -149.89 167.58 26.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.29 -0.881 . . . . 0.0 110.066 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.117 HD22 HD22 ' A' ' 23' ' ' LEU . 4.2 mp -143.93 149.01 36.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.953 -1.092 . . . . 0.0 110.965 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.2 m -127.62 97.36 4.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.602 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.714 HG23 ' O ' ' A' ' 49' ' ' SER . 3.8 mt -81.03 93.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 110.348 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 27.0 p-10 -54.52 172.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.339 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -5.72 7.01 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.912 178.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 3.9 t70 -79.23 1.23 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.096 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.3 1.06 73.8 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 44' ' ' ILE . 43.6 m -83.27 -170.94 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 44' ' ' ILE . 10.6 t -144.01 127.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.029 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 13.9 m-85 -104.77 94.96 5.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 109.683 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -80.41 142.8 33.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.306 -0.871 . . . . 0.0 109.73 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' E LYS . 10.2 tt0 -153.86 110.39 3.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.266 -0.896 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 56' D VAL . 39.6 tt0 -81.31 167.17 19.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.18 126.93 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.037 -1.039 . . . . 0.0 110.583 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' O ' ' C ' ' A' ' 56' A ASP . 6.0 ttpt -158.76 135.07 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.867 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.3 m-20 29.52 65.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.868 -0.52 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 47.7 56.79 8.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.46 96.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -1.164 . . . . 0.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 17.3 m -93.83 161.48 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 56' D VAL . 2.5 mtmt -143.71 167.38 15.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.127 -0.983 . . . . 0.0 111.291 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 60' ' ' SER . 1.6 Cg_endo -85.98 173.47 6.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.415 2.077 . . . . 0.0 110.165 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.555 ' CZ ' ' C ' ' A' ' 23' ' ' LEU . 10.1 t80 174.22 126.34 0.11 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.964 . . . . 0.0 110.913 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.706 ' HG3' HG22 ' A' ' 25' ' ' VAL . 48.1 Cg_endo -90.12 97.99 0.17 OUTLIER 'Cis proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.782 -1.758 . . . . 0.0 110.297 0.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 57' ' ' PRO . 6.3 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 120.724 -1.235 . . . . 0.0 110.671 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.434 0.635 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -78.45 76.46 4.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.515 -0.741 . . . . 0.0 110.677 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.581 HG21 ' HD1' ' A' ' 10' ' ' TYR . 3.8 mt -89.88 135.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -45.89 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.172 0.987 . . . . 0.0 112.015 -178.856 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.041 HD12 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -92.03 -40.43 11.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.892 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.79 -60.47 1.95 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.392 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 12' ' ' MET . 11.6 t0 -45.09 -45.1 10.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.581 ' HD1' HG21 ' A' ' 5' ' ' ILE . 32.1 t80 -61.52 -53.61 54.19 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.47 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.57 -21.52 3.94 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.52 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.9 -47.89 49.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.462 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -65.25 -23.72 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.536 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 5.3 m-85 -114.19 -78.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.143 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 156.41 162.49 11.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.729 ' NE2' HG22 ' A' ' 30' ' ' ILE . 22.7 tp60 -57.54 -41.31 80.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -1.1 . . . . 0.0 109.973 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -65.48 -30.26 71.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -71.01 -63.53 1.08 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.344 179.488 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 7' ' ' LEU . 4.2 m -57.4 -22.67 44.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.272 -0.892 . . . . 0.0 109.19 179.051 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -72.07 -45.7 59.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.431 -0.793 . . . . 0.0 110.228 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 14.0 mmtt -76.84 -13.04 60.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.892 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB3' HG21 ' A' ' 50' ' ' VAL . 3.5 m-20 -71.46 -48.94 46.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.699 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.402 ' CB ' HG23 ' A' ' 25' ' ' VAL . 23.7 mt -82.61 -10.22 59.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 110.243 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 24.86 76.29 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.462 ' CG1' ' CB ' ' A' ' 29' ' ' ALA . 2.6 t -109.03 163.97 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -1.096 . . . . 0.0 110.163 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -62.68 147.6 49.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.093 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.4 ' HA ' HG12 ' A' ' 30' ' ' ILE . 2.0 mt-30 -50.78 -24.72 3.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.991 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 t -65.09 -51.3 62.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.842 . . . . 0.0 109.791 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.462 ' CB ' ' CG1' ' A' ' 25' ' ' VAL . . . -53.69 -19.36 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.805 . . . . 0.0 109.953 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.729 HG22 ' NE2' ' A' ' 16' ' ' GLN . 3.3 mm -80.88 -50.82 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.5 OUTLIER -70.63 -7.24 42.79 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.603 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -92.4 -44.61 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 108.758 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.711 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -80.71 -13.41 59.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.012 HG12 HD13 ' A' ' 7' ' ' LEU . 9.5 mt -102.49 -42.37 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 42.9 t60 -61.69 -53.82 50.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.955 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 38' ' ' ARG . . . -93.12 -122.16 0.09 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . -1.73 68.38 0.0 OUTLIER Glycine 0 N--CA 1.504 3.223 0 C-N-CA 123.288 0.47 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 36' ' ' ALA . 23.3 mmm-85 -85.28 61.72 7.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.297 -1.119 . . . . 0.0 110.512 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 64.7 pttt -154.22 38.27 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 108.974 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.041 HD13 HD12 ' A' ' 7' ' ' LEU . 10.3 mt -101.65 165.36 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 110.825 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 56.2 m-85 -156.66 103.41 2.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.604 -0.685 . . . . 0.0 109.241 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.687 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.3 mp -89.33 130.18 35.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.905 . . . . 0.0 111.136 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 43' ' ' THR . 2.1 m -101.2 103.32 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.163 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 45' ' ' ASN . 18.6 mt -89.25 74.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.062 -1.024 . . . . 0.0 110.576 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.564 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -44.7 174.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 110.705 179.413 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.95 -2.8 8.17 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.613 -0.835 . . . . 0.0 108.979 178.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.42 -2.1 57.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.885 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.81 -3.55 55.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -72.21 149.93 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -1.227 . . . . 0.0 109.773 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 22' ' ' ASP . 13.1 t -111.5 105.87 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 110.668 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 1.9 m-85 -88.95 96.21 10.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.95 . . . . 0.0 109.007 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -84.87 92.21 8.22 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 110.707 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.444 ' OE1' ' CG2' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.44 165.18 11.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.567 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 56' D VAL . 54.6 mt-10 -134.13 163.08 30.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.714 HG13 HG12 ' A' ' 56' D VAL . 3.3 t -150.33 133.76 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 56' A ASP . 7.1 tptp -148.83 78.54 1.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.401 -0.812 . . . . 0.0 109.497 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 16.0 t0 60.24 50.47 6.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.592 -0.692 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 102.75 -30.43 10.42 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.499 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' C GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 56' ' ' LYS . 9.7 mt-10 -74.26 95.66 2.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.098 -1.237 . . . . 0.0 110.715 -179.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.714 HG12 HG13 ' A' ' 55' ' ' VAL . 18.8 m -117.05 147.48 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.214 -0.929 . . . . 0.0 110.393 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 3.6 pttm -175.1 165.73 2.1 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.191 -0.943 . . . . 0.0 110.576 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 4.7 Cg_exo -78.93 -176.41 3.27 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.872 1.714 . . . . 0.0 110.53 -178.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.598 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 1.8 t80 178.63 126.99 0.21 Allowed Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.29 -0.881 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 60.3 Cg_endo -90.11 96.59 0.16 OUTLIER 'Cis proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.913 -1.703 . . . . 0.0 110.514 -0.033 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 12.0 p . . . . . 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.456 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.226 0.536 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 3.2 ttm180 -79.34 74.56 5.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.382 -0.824 . . . . 0.0 110.098 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.996 HG22 ' HB2' ' A' ' 10' ' ' TYR . 3.9 mm -90.08 148.12 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.443 -0.786 . . . . 0.0 109.851 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -44.54 -179.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 122.486 1.136 . . . . 0.0 112.109 -178.822 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.865 ' HB2' HD11 ' A' ' 42' ' ' LEU . 5.7 tp -94.28 -39.35 10.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.411 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -88.62 -61.9 1.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.185 179.583 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' LYS . 8.1 t0 -44.76 -42.39 7.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.996 ' HB2' HG22 ' A' ' 5' ' ' ILE . 12.0 t80 -55.76 -59.5 4.77 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.705 0.764 . . . . 0.0 109.345 178.281 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -57.9 -15.58 9.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.803 -0.561 . . . . 0.0 110.156 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ttt -83.43 -34.11 25.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.814 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.36 -10.45 49.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.809 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 -51.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.002 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.69 142.1 3.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.507 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -72.82 -27.74 62.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -1.185 . . . . 0.0 110.203 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 17' ' ' THR . 3.3 t -79.88 -21.78 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -82.4 -46.98 12.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.113 179.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.535 ' O ' HD12 ' A' ' 23' ' ' LEU . 11.6 m -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.319 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.62 -28.53 30.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 110.092 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -80.59 -36.96 32.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.467 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.4 -36.28 68.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.318 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 19' ' ' THR . 83.3 mt -82.6 -9.94 59.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.26 40.03 97.58 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 59' ' ' PRO . 3.9 t -124.07 146.71 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.446 -1.032 . . . . 0.0 109.97 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -72.03 150.87 43.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.879 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.62 ' HA ' HD12 ' A' ' 30' ' ' ILE . 1.9 tt0 -61.46 -20.38 63.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.4 p -84.65 -55.76 3.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.0 110.229 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.73 -23.28 1.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' GLN . 95.0 mt -76.88 -63.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.891 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 11.5 m120 -49.9 -15.67 0.21 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.332 -0.855 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -91.58 -38.61 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.558 -1.339 . . . . 0.0 108.597 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.88 56.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.528 -0.732 . . . . 0.0 109.185 178.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.597 HD11 HD21 ' A' ' 7' ' ' LEU . 10.1 mt -114.57 -48.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.54 -0.725 . . . . 0.0 109.714 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t-160 -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.512 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.44 5.73 49.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 111.615 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.559 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -149.29 90.28 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 20.3 mmm-85 -83.69 -173.57 4.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -1.075 . . . . 0.0 110.157 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER 66.31 58.87 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.199 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.679 HD13 HD23 ' A' ' 7' ' ' LEU . 9.2 mt -116.18 157.65 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.163 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 39.8 m-85 -155.06 144.89 21.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 110.873 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 7' ' ' LEU . 4.1 mp -135.57 131.05 35.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.462 -0.774 . . . . 0.0 109.743 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.432 ' OG1' ' HG3' ' A' ' 4' ' ' ARG . 3.2 m -99.18 101.04 12.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.005 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.011 HG23 ' O ' ' A' ' 49' ' ' SER . 15.0 mt -101.1 148.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.982 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 46' ' ' ALA 0.252 2.4 m-20 -65.31 -11.75 44.91 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.531 0.682 . . . . 0.0 110.076 178.113 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.948 ' H ' HG22 ' A' ' 44' ' ' ILE . . . 81.49 1.22 1.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -175.166 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.19 38.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.575 ' N ' ' HB2' ' A' ' 45' ' ' ASN . . . -140.13 -63.36 0.04 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -177.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.011 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER 179.45 -168.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 109.445 -179.045 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.875 HG22 HG12 ' A' ' 44' ' ' ILE . 11.9 t -125.52 110.93 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.571 -1.331 . . . . 0.0 111.583 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -81.4 77.69 8.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.537 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -52.47 145.75 10.92 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.708 0.766 . . . . 0.0 111.398 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 78.94 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.566 ' CB ' HG23 ' A' ' 40' ' ' ILE . 3.8 pt-20 -79.41 163.49 24.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.253 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 56' D VAL . 3.2 t -132.77 139.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 0.5 OUTLIER -159.76 160.85 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 -179.889 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.4 m-20 -39.21 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.471 -0.768 . . . . 0.0 110.438 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 144.99 -71.41 0.37 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.7 tt0 -174.4 -172.45 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.491 -1.005 . . . . 0.0 109.926 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.611 HG12 HG22 ' A' ' 55' ' ' VAL . 34.6 m -104.6 143.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.95 . . . . 0.0 110.434 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 4.9 mmtt -128.09 161.04 58.49 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.393 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.4 Cg_exo -82.9 39.95 0.9 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.825 1.683 . . . . 0.0 111.063 -178.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.56 118.58 1.26 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.409 -0.807 . . . . 0.0 109.817 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -81.86 104.89 0.64 Allowed 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.305 -1.956 . . . . 0.0 110.724 0.2 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 73.3 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.08 -1.013 . . . . 0.0 110.184 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.122 0.487 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.87 74.89 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.377 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.801 HG22 ' HB2' ' A' ' 10' ' ' TYR . 8.4 mt -91.66 141.68 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.305 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 18.8 p -59.47 -175.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 110.848 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.964 HD12 HG21 ' A' ' 19' ' ' THR . 1.2 tp -92.45 -34.43 14.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.57 ' CG ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -81.84 -69.52 0.61 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.855 -0.528 . . . . 0.0 110.002 179.375 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 41.4 t0 -46.66 -58.09 4.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.219 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.801 ' HB2' HG22 ' A' ' 5' ' ' ILE . 3.4 t80 -41.9 -51.65 4.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.331 -0.855 . . . . 0.0 110.368 179.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -56.13 -42.41 76.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.422 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 30.1 ttp -60.17 -29.94 69.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.058 179.048 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -55.84 28.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.492 -0.755 . . . . 0.0 110.125 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CZ ' ' CZ ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -123.52 67.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.974 -1.079 . . . . 0.0 111.659 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.28 156.87 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.465 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -82.29 -29.92 30.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -1.03 . . . . 0.0 109.841 179.611 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 26.4 m -60.63 -21.61 62.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.414 -0.804 . . . . 0.0 109.884 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.606 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.0 mmtp -69.76 -54.86 11.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.02 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.964 HG21 HD12 ' A' ' 7' ' ' LEU . 90.3 m -59.37 -19.01 43.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 17' ' ' THR . . . -71.12 -38.21 72.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.594 -0.691 . . . . 0.0 109.825 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -81.76 -18.69 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.743 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 3.0 t0 -65.43 -53.84 37.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.033 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.498 HD11 HD13 ' A' ' 7' ' ' LEU . 3.0 mt -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.364 -0.835 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.77 29.78 20.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -122.08 151.26 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -1.115 . . . . 0.0 109.676 -179.751 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 25' ' ' VAL . 47.8 m-85 -47.09 173.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.488 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -77.0 -28.25 54.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -67.56 -57.95 5.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.16 -28.53 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.365 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.813 ' CD1' HD11 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -62.85 -61.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.727 ' N ' HG22 ' A' ' 30' ' ' ILE . 48.9 m-80 -57.28 -9.65 1.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.597 -0.69 . . . . 0.0 110.888 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -88.98 -35.32 16.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.648 -1.283 . . . . 0.0 107.766 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.513 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -85.62 -11.11 54.73 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.57 ' CG2' ' CG ' ' A' ' 8' ' ' LYS . 14.9 mt -100.68 -48.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.405 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -74.99 -58.43 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.894 179.661 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.85 11.08 23.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 110.755 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -137.63 69.66 0.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 15.0 mmm-85 -75.85 -171.85 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.899 -1.353 . . . . 0.0 110.214 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 56' A ASP . 9.2 mptt 58.73 46.72 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.198 -0.939 . . . . 0.0 110.52 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.945 HD13 HD23 ' A' ' 7' ' ' LEU . 16.7 mt -97.89 161.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 110.353 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 43.9 m-85 -161.32 114.37 1.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 110.267 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 7' ' ' LEU . 2.4 mp -107.24 131.88 53.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.099 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 43' ' ' THR . 1.7 m -96.99 100.54 12.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 44' ' ' ILE . 9.6 mt -94.73 43.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.431 ' OD1' HG22 ' A' ' 43' ' ' THR . 45.8 p-10 -91.97 -131.49 0.12 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 109.85 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.929 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 48.75 24.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.957 -1.089 . . . . 0.0 109.127 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.566 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.1 t0 75.13 63.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.317 0.579 . . . . 0.0 111.036 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 81.78 -8.43 59.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.929 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -51.11 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.317 . . . . 0.0 110.506 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.71 123.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.47 135.68 37.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.576 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' PRO . . . -103.57 149.9 24.46 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.944 -1.098 . . . . 0.0 109.461 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 2.4 tt0 -159.78 151.43 20.12 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 110.651 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.715 ' O ' ' HA ' ' A' ' 56' D VAL . 2.1 tt0 -135.92 151.1 49.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.389 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.99 ' O ' HG12 ' A' ' 56' D VAL . 7.2 p -124.33 -26.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.394 -0.923 . . . . 0.0 112.525 -177.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 3.2 ttmt -160.14 -171.37 3.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.705 -1.247 . . . . 0.0 111.091 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 29.5 t0 47.37 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.693 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -58.76 -51.88 56.44 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 178.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' C GLU . . . . . 0.532 ' CB ' ' OE1' ' A' ' 54' ' ' GLU . 2.5 tt0 174.97 179.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.628 -0.924 . . . . 0.0 110.096 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.99 HG12 ' O ' ' A' ' 55' ' ' VAL . 4.1 m -122.0 46.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 56' D VAL . 13.9 mttt -149.81 174.95 3.06 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.375 -0.828 . . . . 0.0 112.302 -177.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 56' E LYS . 3.9 Cg_exo -80.04 56.16 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.661 2.24 . . . . 0.0 111.497 -179.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.444 ' HZ ' HD22 ' A' ' 7' ' ' LEU . 5.0 p90 -44.06 146.53 1.08 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.714 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -91.11 50.01 1.08 Allowed 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.221 -1.991 . . . . 0.0 110.31 -0.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 110.021 179.96 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.6 mt-30 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.373 0.606 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.8 ttp180 -79.0 79.71 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.51 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 10' ' ' TYR . 32.7 mt -89.32 154.17 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.062 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.08 179.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.049 0.928 . . . . 0.0 111.38 -179.262 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.676 ' CD2' HD12 ' A' ' 40' ' ' ILE . 3.7 tp -92.8 -40.08 10.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.077 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HB2' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.96 -63.97 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.434 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 3.1 m-20 -45.03 -44.57 10.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.62 ' HB2' HG22 ' A' ' 5' ' ' ILE . 9.4 t80 -57.24 -56.43 21.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.143 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -57.74 -15.27 7.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.8 -0.562 . . . . 0.0 110.388 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.2 ttt -82.79 -35.34 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -0.976 . . . . 0.0 110.062 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -77.04 -32.17 56.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.664 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 12.1 m-85 -96.64 -54.22 3.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.12 137.92 2.74 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -33.43 66.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -1.18 . . . . 0.0 110.275 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 m -77.5 -23.34 50.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -76.28 -56.66 4.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.071 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 ' HB2' ' A' ' 11' ' ' ALA . 2.1 m -57.81 -23.81 54.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.491 -0.756 . . . . 0.0 109.123 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.52 -47.13 43.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.913 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -9.14 57.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 110.053 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.98 -30.84 18.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 110.141 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 42' ' ' LEU . 75.3 mt -91.37 -5.62 54.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.15 35.3 91.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' A' ' 29' ' ' ALA . 2.8 t -119.72 174.46 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -1.128 . . . . 0.0 109.926 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.459 ' H ' HG12 ' A' ' 25' ' ' VAL . 60.1 m-85 -81.96 136.41 35.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 0.0 110.0 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -44.24 -29.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.953 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -74.54 -52.55 11.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.654 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -50.76 -27.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.597 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.744 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.3 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 109.677 179.672 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.744 ' N ' HG22 ' A' ' 30' ' ' ILE . 7.0 m-80 -57.7 -10.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.658 -0.651 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.88 -42.8 9.31 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.507 -1.37 . . . . 0.0 108.51 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.89 -9.63 58.73 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.55 HG12 ' CD2' ' A' ' 7' ' ' LEU . 24.6 mt -110.86 -51.1 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.765 . . . . 0.0 110.088 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.582 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 21.3 t-160 -53.86 -26.59 25.31 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.407 179.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.22 -75.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.989 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.07 57.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.562 ' O ' ' C ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -90.48 31.72 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.129 -1.218 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER 19.72 70.15 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.318 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 7' ' ' LEU . 6.3 mt -105.51 159.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.387 -0.821 . . . . 0.0 110.931 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -143.54 161.56 38.14 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.106 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 23' ' ' LEU . 4.0 mp -137.47 118.57 14.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.667 -1.271 . . . . 0.0 110.888 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 51' ' ' TYR . 2.8 p -85.32 97.63 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.538 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 45' ' ' ASN . 4.4 mt -89.52 80.79 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.314 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 44' ' ' ILE . 51.6 p30 -44.02 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.464 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -3.74 8.84 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.706 -0.797 . . . . 0.0 109.041 178.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -85.62 -3.16 58.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.4 -5.13 74.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -70.4 122.41 19.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.32 112.2 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.512 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.513 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 3.5 t80 -102.96 105.69 16.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -82.5 143.54 31.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.205 -0.935 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 56' E LYS . 0.7 OUTLIER -151.01 96.35 2.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.54 -0.725 . . . . 0.0 109.63 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 40.1 tt0 -78.97 161.65 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.741 HG22 HG12 ' A' ' 56' D VAL . 73.3 t -135.44 138.58 48.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.672 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 56' A ASP . 22.3 ttpp -156.06 141.74 17.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -0.76 . . . . 0.0 109.239 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 56' ' ' LYS . 7.6 t0 -37.15 102.94 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.511 -0.743 . . . . 0.0 110.828 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 56' C GLU . . . 139.72 -53.54 0.68 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' C GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 56' B GLY . 11.0 tt0 179.48 171.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 110.042 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.741 HG12 HG22 ' A' ' 55' ' ' VAL . 23.4 m -98.54 173.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.176 -0.952 . . . . 0.0 110.005 179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 5.3 mtmt -144.7 170.45 8.19 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 110.176 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 58' ' ' PHE . 4.4 Cg_exo -79.53 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.297 -2.138 0 O-C-N 124.42 1.747 . . . . 0.0 109.966 -179.196 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.504 ' O ' ' O ' ' A' ' 57' ' ' PRO . 28.1 t80 57.69 125.86 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.516 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.39 122.47 8.51 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.169 -2.013 . . . . 0.0 110.305 0.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.975 . . . . 0.0 110.591 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 6.4 mt-30 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.412 0.625 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 6.5 ttt180 -78.26 81.48 4.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 6' ' ' THR . 3.9 mt -90.77 -179.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.424 -0.798 . . . . 0.0 109.571 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.61 -173.11 3.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.026 0.917 . . . . 0.0 111.375 -179.313 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.948 HD12 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -92.91 -46.5 7.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.347 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.559 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -84.33 -57.0 3.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.083 178.766 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.519 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -51.98 -51.78 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.393 -0.817 . . . . 0.0 109.127 179.269 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.6 t80 -49.91 -56.78 9.22 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.685 179.115 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.39 -32.67 18.17 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.646 0.736 . . . . 0.0 109.41 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -58.28 -51.61 69.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -20.74 65.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.616 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -111.58 -84.54 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.805 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 174.32 159.57 20.93 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.702 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -39.01 93.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.594 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -78.38 -3.18 41.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.907 179.768 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -90.15 -50.39 6.02 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.341 -0.849 . . . . 0.0 108.729 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.545 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -54.96 -37.96 67.16 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.271 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 -48.66 55.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.492 0.663 . . . . 0.0 109.905 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.9 mmtp -76.62 3.82 10.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 109.834 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.679 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -88.06 -60.62 1.92 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.84 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.621 ' HG ' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -99.81 -25.44 14.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.957 -1.089 . . . . 0.0 110.939 -179.408 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.57 ' N ' ' HG ' ' A' ' 23' ' ' LEU . . . 119.84 62.15 0.26 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.779 179.208 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 26' ' ' TYR . 2.2 t -142.82 -172.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.133 -1.216 . . . . 0.0 109.521 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.693 ' H ' HG12 ' A' ' 25' ' ' VAL . 31.4 m-85 -109.48 -170.2 1.61 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.933 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -87.71 -29.52 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.152 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -68.15 -46.66 70.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.02 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.97 -22.92 41.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.982 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 26' ' ' TYR . 1.3 mp -81.51 -45.8 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 109.57 179.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 26.2 m-20 -72.75 -8.17 54.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 179.357 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -95.5 -44.57 7.46 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.52 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -71.29 -16.38 62.46 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.603 ' HA ' ' CD ' ' A' ' 38' ' ' ARG . 88.2 mt -103.76 -53.65 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 110.704 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.569 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 8.8 t-80 -62.13 -10.42 10.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.72 -1.237 . . . . 0.0 109.941 179.783 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -81.86 -103.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.921 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' ARG . . . -123.11 78.63 0.35 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.603 ' CD ' ' HA ' ' A' ' 34' ' ' ILE . 16.5 mmm-85 -34.14 119.31 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.911 0.863 . . . . 0.0 111.833 -178.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 41.7 pttt -174.88 31.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.652 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.948 HD13 HD12 ' A' ' 7' ' ' LEU . 14.9 mt -105.88 161.16 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.688 . . . . 0.0 110.157 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 45.3 m-85 -155.3 114.37 3.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.299 -0.876 . . . . 0.0 109.897 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.0 mp -98.27 107.24 19.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.097 -1.002 . . . . 0.0 110.5 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 43' ' ' THR . 11.0 t -83.7 105.11 14.35 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.735 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.987 HG23 ' O ' ' A' ' 49' ' ' SER . 3.5 mt -97.95 135.29 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.181 -179.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -114.2 -168.09 1.31 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.791 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.94 0.31 11.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.6 24.6 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -96.94 -12.35 50.09 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 44' ' ' ILE . 1.1 m 59.08 -90.41 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.541 -0.976 . . . . 0.0 108.575 -178.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.711 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.3 t -160.95 98.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.113 -0.992 . . . . 0.0 110.401 179.06 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.421 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 2.3 t80 -95.98 105.53 17.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.255 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -67.5 148.9 50.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.624 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 41' ' ' PHE . 41.1 mt-10 -149.2 102.44 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 110.183 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' C ' ' CG2' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -89.89 148.73 22.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -0.957 . . . . 0.0 109.129 179.423 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 2.4 t -148.62 105.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.879 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 1.7 tptp -125.23 170.02 11.68 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 56' ' ' LYS . 2.7 t70 -42.26 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.171 -0.956 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 60.31 56.7 23.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -167.18 74.55 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.019 -1.283 . . . . 0.0 110.974 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 2.6 m -103.82 150.76 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.462 179.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -162.77 160.31 19.55 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.765 -1.209 . . . . 0.0 111.154 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.3 Cg_endo -89.52 37.66 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.049 1.832 . . . . 0.0 110.815 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -41.62 137.55 1.8 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.903 . . . . 0.0 109.922 179.778 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 60' ' ' SER . 53.2 Cg_endo -93.5 66.9 0.25 Allowed 'Cis proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.714 -1.786 . . . . 0.0 110.887 0.164 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 120.875 -1.14 . . . . 0.0 110.689 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.488 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.077 0.465 . . . . 0.0 110.157 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -79.64 73.15 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.365 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.734 HG22 ' HB2' ' A' ' 10' ' ' TYR . 9.0 mt -90.33 141.27 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 110.821 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -51.75 -174.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 112.159 -179.31 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.928 HD23 ' CD1' ' A' ' 40' ' ' ILE . 3.4 tp -93.41 -38.39 11.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 176.134 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.569 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -82.2 -60.03 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.787 178.997 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 12' ' ' MET . 9.1 t0 -53.28 -44.35 68.19 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.165 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.734 ' HB2' HG22 ' A' ' 5' ' ' ILE . 88.4 t80 -58.9 -63.75 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.495 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.21 -23.54 1.37 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.382 -0.824 . . . . 0.0 109.62 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.43 -54.18 11.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.113 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -88.35 13.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.659 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -161.5 97.27 1.09 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.707 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 14' ' ' PHE . . . -8.72 123.52 0.01 OUTLIER Glycine 0 N--CA 1.506 3.338 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 17' ' ' THR . 6.2 pt20 -59.95 -36.39 76.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.411 -1.052 . . . . 0.0 109.582 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 2.8 m -51.49 -22.45 3.13 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.242 -179.229 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -82.57 -44.69 15.55 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.109 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.739 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -64.5 -23.37 67.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.205 179.104 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -86.04 -28.5 24.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 110.518 -179.543 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -71.73 -28.31 63.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.898 179.788 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -89.91 -26.41 20.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 19' ' ' THR . 25.5 mt -79.41 -40.72 29.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.369 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.29 40.45 1.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 -177.75 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.269 -1.136 . . . . 0.0 109.83 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -97.98 -163.76 1.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.31 -50.08 7.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.041 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 29' ' ' ALA . 7.9 t -64.82 -62.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 109.881 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.9 -28.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.704 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -69.22 -58.18 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.506 -0.746 . . . . 0.0 109.278 179.28 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.704 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -57.41 -6.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.813 -0.555 . . . . 0.0 111.645 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -91.95 -40.73 10.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.793 -1.192 . . . . 0.0 108.18 178.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -22.3 55.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.618 HD12 HG23 ' A' ' 30' ' ' ILE . 47.6 mt -87.34 -51.37 12.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.651 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -43.6 -35.88 1.91 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.786 0.803 . . . . 0.0 108.976 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.93 -87.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.96 39.75 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -84.05 48.33 1.45 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.427 -1.043 . . . . 0.0 111.423 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 2.5 mppt? 64.85 98.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.508 -0.745 . . . . 0.0 110.369 179.191 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.928 ' CD1' HD23 ' A' ' 7' ' ' LEU . 2.7 mt -129.84 153.78 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 72.8 m-85 -156.57 124.03 5.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.1 mp -118.13 132.06 56.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 111.063 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.4 m -108.65 103.27 12.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.421 -0.799 . . . . 0.0 108.983 178.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 10' ' ' TYR . 1.5 mt -94.13 -149.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 111.199 -178.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.632 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 37.6 -164.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.453 0.644 . . . . 0.0 110.804 -178.847 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 63.97 -5.49 0.3 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -176.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.606 ' H ' ' C ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER 174.73 -27.37 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.149 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.88 40.68 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.419 ' OG ' ' CE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -100.2 133.37 44.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.649 -0.913 . . . . 0.0 109.771 179.939 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' CG1' HD23 ' A' ' 42' ' ' LEU . 39.8 t -88.31 97.53 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 110.48 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 55.3 m-85 -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 108.674 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.76 127.52 34.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.198 -0.939 . . . . 0.0 110.867 -178.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.39 161.21 25.2 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 25.7 tt0 -136.07 147.06 47.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.371 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 2.5 t -146.54 104.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.503 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 3.5 ttpt -132.34 153.93 50.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 109.509 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.481 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 18.0 t70 -43.06 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.072 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 151.73 -55.74 0.45 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.28 -172.62 0.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.338 -1.095 . . . . 0.0 110.506 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 56' E LYS . 5.0 m -116.3 161.08 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -179.672 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 56' D VAL . 19.2 mttm -146.33 163.65 28.89 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 110.375 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -83.99 -61.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.016 1.81 . . . . 0.0 110.873 -178.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 4.4 t80 59.89 123.74 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.34 -0.85 . . . . 0.0 110.009 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' HD22 ' A' ' 23' ' ' LEU . 4.4 Cg_exo -76.4 126.85 13.82 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 122.16 -2.017 . . . . 0.0 110.258 0.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 -179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -78.99 85.78 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 0.0 110.721 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.887 HG22 ' HB2' ' A' ' 10' ' ' TYR . 11.3 mt -90.44 149.71 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.827 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -48.13 -178.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.248 1.023 . . . . 0.0 111.647 -179.266 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.799 ' HA ' HD13 ' A' ' 42' ' ' LEU . 2.6 tp -92.42 -40.21 11.0 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.678 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.548 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -91.32 -59.54 2.12 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 12' ' ' MET . 0.8 OUTLIER -45.83 -39.6 8.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.83 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.887 ' HB2' HG22 ' A' ' 5' ' ' ILE . 5.5 t80 -62.52 -53.38 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.505 178.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -51.87 -26.09 9.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.499 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 14.4 tpp -72.25 -47.01 53.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.871 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -23.88 65.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.968 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.48 -79.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.65 156.23 14.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.488 ' OE1' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -70.41 -30.52 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 109.994 179.932 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 p -82.58 -20.57 36.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 110.208 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -81.23 -51.42 8.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.329 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.622 ' O ' HD12 ' A' ' 23' ' ' LEU . 2.8 m -63.11 -25.97 68.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 178.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.4 -34.8 63.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 0.0 110.529 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 2.2 mmtp -89.6 -14.17 35.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.286 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD1' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -76.25 -40.46 51.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.67 179.737 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 19' ' ' THR . 4.7 mt -83.51 0.41 46.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.16 56.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG11 ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -144.71 -175.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.46 ' O ' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -110.25 155.99 21.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.217 -0.927 . . . . 0.0 109.924 -179.949 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.42 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.1 mt-30 -40.46 -28.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.374 -0.829 . . . . 0.0 110.728 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -61.98 -64.68 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.126 -0.984 . . . . 0.0 110.507 -179.775 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.617 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -44.99 -26.11 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.867 HG23 HD12 ' A' ' 34' ' ' ILE . 1.7 mp -75.84 -43.61 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.2 t30 -73.51 -1.57 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.042 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -104.82 -43.38 5.11 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.999 -1.063 . . . . 0.0 108.879 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -82.1 -0.9 46.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.589 -0.695 . . . . 0.0 109.204 178.576 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.867 HD12 HG23 ' A' ' 30' ' ' ILE . 13.6 mt -124.33 -40.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.86 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.548 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 5.7 t-80 -74.06 -26.09 60.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.0 110.019 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 -32.76 71.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.82 45.59 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.7 mmm180 -85.68 -173.45 4.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -1.147 . . . . 0.0 110.401 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.48 79.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 7' ' ' LEU . 10.0 mt -109.82 162.99 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.905 . . . . 0.0 110.452 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CG ' ' NH1' ' A' ' 4' ' ' ARG . 76.2 m-85 -151.09 113.58 4.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 0.0 109.831 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 7' ' ' LEU . 7.3 mp -80.12 134.58 36.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 17.8 m -106.38 100.3 9.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 49' ' ' SER . 10.6 mt -92.65 131.32 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.761 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 3.5 m120 -52.75 -19.09 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.568 -0.708 . . . . 0.0 110.59 179.02 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.96 -21.02 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -176.329 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.1 -2.04 57.55 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.367 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.17 -20.2 11.5 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -63.32 147.52 50.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -1.198 . . . . 0.0 109.989 179.862 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.531 HG11 ' OD1' ' A' ' 22' ' ' ASP . 22.1 t -122.11 141.86 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.448 ' O ' ' C ' ' A' ' 52' ' ' ALA . 18.7 t80 -143.09 76.54 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.479 -0.763 . . . . 0.0 109.636 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 51' ' ' TYR . . . -38.31 143.4 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.616 -0.678 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' PHE . 2.9 tt0 -140.41 86.99 2.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 110.724 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 56' D VAL . 1.3 tp10 -79.38 147.91 32.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.84 137.38 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 110.496 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 56' C GLU . 11.4 ttpt -160.07 -172.76 3.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.841 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' A ASP . . . . . . . . . . . . . 13.2 m-20 -57.24 105.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.029 -1.044 . . . . 0.0 110.189 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 51.49 29.97 25.38 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' C GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -143.77 86.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.175 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 1.2 p -125.44 102.02 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 109.719 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 56' D VAL . 9.0 mtmm -143.81 160.25 50.86 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.215 -0.928 . . . . 0.0 110.383 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 56' E LYS . 8.0 Cg_exo -74.21 128.64 12.31 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.359 1.715 . . . . 0.0 111.166 -178.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.93 144.39 39.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.481 -0.762 . . . . 0.0 109.714 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -90.94 47.48 1.35 Allowed 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.108 -2.039 . . . . 0.0 110.485 0.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.278 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.529 HE21 HD11 ' A' ' 5' ' ' ILE . 12.8 mm100 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.374 0.607 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.7 80.11 6.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.365 -0.835 . . . . 0.0 109.977 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.621 HG22 ' HB2' ' A' ' 10' ' ' TYR . 5.3 mt -89.31 141.47 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 110.609 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.581 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -47.17 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.996 0.903 . . . . 0.0 111.139 -179.917 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.801 HD22 HD12 ' A' ' 40' ' ' ILE . 3.8 tp -93.19 -39.9 10.77 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -86.66 -61.11 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.042 178.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 1.6 t70 -50.33 -47.56 55.79 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.342 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.621 ' HB2' HG22 ' A' ' 5' ' ' ILE . 4.0 t80 -53.92 -61.31 2.38 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.885 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -57.01 -16.6 7.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.141 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -86.16 -30.67 22.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.511 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -3.93 38.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -126.96 32.72 5.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 -179.994 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 14' ' ' PHE . . . 60.93 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.422 ' OE1' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -79.64 -26.53 41.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 110.375 -179.962 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -75.89 -23.66 55.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 2.7 tptt -76.63 -56.66 4.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.202 -0.936 . . . . 0.0 109.022 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 11' ' ' ALA . 1.7 m -55.35 -27.95 50.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 178.581 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.44 -30.35 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -82.8 -8.46 59.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -90.41 -48.93 6.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 110.251 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.92 -36.63 36.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.58 33.11 4.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.22 161.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.204 -1.174 . . . . 0.0 109.908 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -76.26 156.06 33.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -35.66 75.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.45 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -62.42 -51.22 68.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.96 -24.8 1.63 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.652 HG23 HG13 ' A' ' 34' ' ' ILE . 1.2 mp -82.92 -56.2 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.949 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 3.3 m120 -49.78 -16.91 0.29 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.709 . . . . 0.0 111.374 -179.32 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -99.87 -51.64 3.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.436 -1.415 . . . . 0.0 109.039 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.599 ' O ' HD13 ' A' ' 34' ' ' ILE . . . -80.08 11.46 3.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.653 178.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.688 HD11 HD11 ' A' ' 7' ' ' LEU . 26.4 mm -135.32 -41.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 110.305 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -70.1 -30.6 67.85 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.947 179.724 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.19 -78.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.12 69.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.539 ' HB3' HD23 ' A' ' 7' ' ' LEU . 1.5 tpt180 -90.7 123.59 34.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 111.267 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -98.94 63.35 1.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.359 -0.838 . . . . 0.0 109.319 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.86 HG23 ' CA ' ' A' ' 54' ' ' GLU . 5.5 mt -113.29 161.1 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.284 -179.255 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 32.4 m-85 -137.93 150.42 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.948 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.0 mp -126.94 140.71 52.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.437 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -103.37 103.68 13.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 49' ' ' SER . 3.8 mt -98.89 75.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.131 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 49' ' ' SER . 4.5 p30 -41.87 166.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.686 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.44 -7.67 3.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.555 -0.715 . . . . 0.0 109.323 178.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.15 6.41 11.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.57 0.32 30.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 44' ' ' ILE . 4.6 t -59.17 -176.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.049 -1.265 . . . . 0.0 109.493 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 49' ' ' SER . 94.2 t -149.65 115.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.612 -179.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.501 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 6.6 m-85 -113.45 154.58 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.76 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -131.53 147.26 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.94 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 52' ' ' ALA . 15.6 mt-10 -154.43 99.05 2.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.86 ' CA ' HG23 ' A' ' 40' ' ' ILE . 12.8 tt0 -79.89 147.94 31.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.051 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 56' D VAL . 2.3 t -137.25 97.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.931 -1.106 . . . . 0.0 110.46 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' B GLY . 6.7 ttpt -117.64 148.75 41.66 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.838 . . . . 0.0 109.75 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' LYS . 9.7 t70 -43.23 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 110.237 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 152.27 -55.87 0.45 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -174.75 166.11 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.866 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.644 ' CG1' HG13 ' A' ' 55' ' ' VAL . 16.0 m -107.43 160.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -0.839 . . . . 0.0 109.493 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.515 ' HB2' ' CD ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.56 178.12 1.59 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.018 -1.051 . . . . 0.0 110.694 -179.953 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 56' E LYS . 4.8 Cg_exo -77.72 -64.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.296 -2.193 0 O-C-N 124.39 1.732 . . . . 0.0 110.529 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.493 ' HB2' ' HD2' ' A' ' 56' E LYS . 9.5 t80 57.93 117.92 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 2.8 Cg_exo -72.57 130.74 20.33 Favored 'Cis proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.178 -2.009 . . . . 0.0 110.308 -0.053 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.5 179.949 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 36.4 mm-40 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.338 0.589 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 1.4 ttt180 -81.52 69.73 8.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 111.03 -179.309 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.588 ' HB ' ' CD1' ' A' ' 10' ' ' TYR . 6.0 mm -90.66 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 109.904 179.342 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -91.37 164.88 13.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.052 -1.03 . . . . 0.0 112.409 -178.503 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.782 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -59.82 -26.55 65.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.375 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HG2' HG21 ' A' ' 34' ' ' ILE . 5.6 tmtm? -80.21 -79.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.19 -54.4 16.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.784 -1.198 . . . . 0.0 110.228 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.596 ' CB ' ' O ' ' A' ' 6' ' ' THR . 17.7 t80 -46.95 -53.28 12.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.943 -1.098 . . . . 0.0 110.12 -179.75 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.31 -34.97 67.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 110.194 -179.575 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -34.91 78.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -32.61 47.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD2' ' HD3' ' A' ' 18' ' ' LYS . 5.6 m-30 -107.88 -63.59 1.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 152.62 143.77 3.76 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.751 ' NE2' HG21 ' A' ' 30' ' ' ILE . 6.4 tp60 -53.32 -33.23 52.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -28.14 54.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 110.493 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HD3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -73.79 -56.01 5.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 179.66 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.428 ' HG1' ' HD2' ' A' ' 10' ' ' TYR . 8.1 m -62.96 -17.99 62.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.466 -0.771 . . . . 0.0 109.396 179.286 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -80.32 -36.67 33.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 110.399 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.93 -23.25 48.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.889 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.35 -27.5 32.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.071 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.782 HD11 ' CD1' ' A' ' 7' ' ' LEU . 30.2 mt -81.96 -40.49 22.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.72 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.12 18.11 10.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.35 158.98 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 109.916 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 15.1 m-30 -67.82 178.72 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.34 -179.744 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.537 ' HA ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -70.39 -22.57 62.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -0.903 . . . . 0.0 110.207 179.868 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 m -59.1 -49.69 76.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.47 -19.45 5.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.751 HG21 ' NE2' ' A' ' 16' ' ' GLN . 3.0 mm -80.63 -57.85 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.854 0.835 . . . . 0.0 110.003 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -54.3 -15.53 1.65 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.558 -179.444 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -40.96 10.85 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.496 -1.378 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -78.09 -4.55 47.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 109.204 178.717 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.745 HD12 HG22 ' A' ' 30' ' ' ILE . 15.2 mt -120.02 -47.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.449 -0.782 . . . . 0.0 110.666 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.564 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 12.1 t60 -69.58 -22.22 63.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.006 -1.059 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.38 33.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.194 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.86 46.35 1.04 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.47 148.54 24.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -90.35 55.55 3.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.994 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.847 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 7.0 mt -81.3 163.0 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.768 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.658 ' C ' HD12 ' A' ' 42' ' ' LEU . 53.2 m-85 -157.38 142.1 16.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.55 -0.719 . . . . 0.0 109.26 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.76 HD21 HD11 ' A' ' 7' ' ' LEU . 5.3 mp -129.05 113.56 15.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.931 -1.105 . . . . 0.0 111.725 -179.17 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.8 m -97.72 101.68 13.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.396 -0.815 . . . . 0.0 108.918 178.472 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.565 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 8.5 mt -96.56 136.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 111.081 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.9 m120 -51.83 -18.91 1.45 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 110.653 178.768 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.775 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 90.06 -17.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -176.11 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.05 -13.4 41.63 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.644 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 134.3 -26.42 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.563 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 107.36 0.78 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -1.226 . . . . 0.0 109.682 179.97 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 48' ' ' GLY . 40.3 t -100.16 117.95 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.067 . . . . 0.0 111.317 -179.19 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 23.3 m-30 -104.04 111.07 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 108.933 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -87.8 76.51 8.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 0.0 111.072 -179.013 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -84.86 147.03 27.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 109.432 179.102 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 56' D VAL . 7.8 mt-10 -127.73 173.07 10.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.015 -179.993 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.6 119.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.048 -1.033 . . . . 0.0 110.592 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' B GLY . 9.3 tptp -138.31 143.75 40.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 179.534 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' A ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.6 OUTLIER -42.11 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 110.352 -179.762 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 143.34 -54.21 0.59 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.34 162.06 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 110.516 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 56' E LYS . 33.9 m -79.78 161.18 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 179.754 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.93 163.23 45.9 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.142 -0.974 . . . . 0.0 110.767 -179.828 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.3 Cg_endo -83.41 179.18 5.17 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.813 1.675 . . . . 0.0 110.148 -179.29 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.545 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 31.4 t80 179.11 121.68 0.21 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 110.311 -179.645 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 10.1 Cg_endo -85.78 101.4 0.33 Allowed 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.728 -1.78 . . . . 0.0 110.433 -0.055 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 59' ' ' PRO . 20.2 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 110.147 179.772 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.498 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 20.7 mt-30 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -78.75 83.86 4.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.297 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.728 HG22 ' H ' ' A' ' 6' ' ' THR . 9.7 mt -90.2 -173.63 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.728 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.12 -179.36 5.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.087 -1.008 . . . . 0.0 111.993 -179.047 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.708 HD11 ' CD1' ' A' ' 34' ' ' ILE . 6.1 tp -92.3 -41.54 10.32 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.778 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.565 ' HD3' ' CG2' ' A' ' 34' ' ' ILE . 1.3 mmtt -86.27 -64.1 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.333 179.17 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.7 OUTLIER -46.77 -52.14 14.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.516 179.475 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.693 ' CE2' HD11 ' A' ' 44' ' ' ILE . 4.7 t80 -52.54 -55.13 24.24 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.232 179.79 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -18.72 60.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.951 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -22.11 22.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.041 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -12.26 29.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.777 179.864 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -123.64 -65.85 1.04 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.24 162.19 12.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -77.68 -30.79 52.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -1.143 . . . . 0.0 110.271 -179.988 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 26.0 p -72.52 -33.22 66.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 179.678 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.9 -54.76 11.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.45 -0.781 . . . . 0.0 109.161 179.33 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.445 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 21.7 m -62.23 -20.01 63.78 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.733 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -72.16 -47.53 50.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -70.16 -25.05 63.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.595 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.003 ' HB3' HG11 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -61.86 -47.62 84.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.431 -0.793 . . . . 0.0 109.962 179.675 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 23' ' ' LEU . 3.4 mt -90.4 -6.54 54.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.852 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.39 22.23 71.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.521 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.55 HG23 ' HB2' ' A' ' 23' ' ' LEU . 3.2 t -107.93 153.07 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -1.019 . . . . 0.0 110.23 -179.683 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 12.0 m-85 -59.12 176.29 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.833 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.458 ' HA ' HD12 ' A' ' 30' ' ' ILE . 2.1 mt-30 -83.68 -10.89 57.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.005 179.761 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -83.26 -61.78 1.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.92 179.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -45.42 -40.59 8.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 109.714 179.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.558 HG22 ' CD1' ' A' ' 34' ' ' ILE . 72.8 mt -65.0 -55.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.766 . . . . 0.0 109.946 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -50.33 -13.91 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.358 -0.839 . . . . 0.0 111.096 179.792 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 -37.82 14.42 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.408 -1.432 . . . . 0.0 108.869 178.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.03 -10.94 59.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.154 178.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.708 ' CD1' HD11 ' A' ' 7' ' ' LEU . 7.1 mt -108.8 -47.92 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.845 179.731 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 9.9 t-80 -65.78 -24.21 66.89 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.152 -0.967 . . . . 0.0 110.305 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.18 -28.52 62.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -0.945 . . . . 0.0 110.658 -179.626 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 8' ' ' LYS . . . 92.54 47.63 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.0 172.0 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.55 -179.723 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.571 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -103.8 64.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.821 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.711 HD13 ' HB2' ' A' ' 54' ' ' GLU . 4.2 mm -87.83 169.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 111.036 -179.323 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 84.5 m-85 -156.88 115.73 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.215 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.71 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.8 mp -92.56 114.36 26.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 111.375 -178.851 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.9 m -90.81 102.9 15.66 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.409 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.693 HD11 ' CE2' ' A' ' 10' ' ' TYR . 6.6 mt -99.9 102.01 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.909 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.51 173.02 9.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 0.0 109.689 179.128 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -9.25 3.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.092 179.004 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 10.65 7.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.293 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.84 10.14 23.94 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t -89.62 99.63 12.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -1.224 . . . . 0.0 109.591 179.628 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.003 HG11 ' HB3' ' A' ' 22' ' ' ASP . 5.8 p -79.75 137.06 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.84 . . . . 0.0 110.549 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 8.5 m-85 -112.18 95.38 5.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 109.696 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -83.47 111.43 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' OE1' ' CG2' ' A' ' 56' D VAL . 0.1 OUTLIER -147.18 131.73 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 111.088 -179.408 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.711 ' HB2' HD13 ' A' ' 40' ' ' ILE . 1.7 tt0 -79.77 134.33 36.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.178 179.098 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.669 HG22 ' CG2' ' A' ' 56' D VAL . 11.2 t -123.11 134.74 65.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.992 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 56' B GLY . 11.8 tptp -158.08 144.54 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' A ASP . . . . . . . . . . . . . 1.5 t70 -46.07 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 109.872 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' B GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 150.15 -48.71 0.58 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -172.47 156.15 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -1.104 . . . . 0.0 110.636 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' D VAL . . . . . 0.669 ' CG2' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -138.54 125.74 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.76 . . . . 0.0 109.398 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 56' E LYS . . . . . 0.49 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.6 158.84 60.57 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.572 -179.409 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 1.8 Cg_endo -87.61 74.49 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.855 1.703 . . . . 0.0 112.442 -177.814 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -42.98 128.31 3.25 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.049 -1.032 . . . . 0.0 109.162 178.519 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 36.9 Cg_endo -88.9 93.83 0.14 OUTLIER 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.763 -1.766 . . . . 0.0 110.698 0.058 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.541 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 1.2 m . . . . . 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.646 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 35.3 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.154 0.502 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.3 mm-40 55.32 -154.37 0.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.021 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.8 mm-40 -95.72 58.9 2.02 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.144 . . . . 0.0 109.16 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 4.7 ttt180 -79.4 72.12 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.793 HG22 ' HB2' ' A' ' 10' ' ' TYR . 10.7 mm -84.86 157.73 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.382 -0.824 . . . . 0.0 109.168 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 10.9 p -65.32 -174.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 111.216 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -91.35 -35.3 14.49 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.2 tmtp? -81.78 -69.63 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.684 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -42.53 -55.57 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.563 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.793 ' HB2' HG22 ' A' ' 5' ' ' ILE . 10.1 t80 -44.0 -56.22 4.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HB1' ' OE1' ' A' ' 16' ' ' GLN . . . -54.91 -35.67 64.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.466 -0.771 . . . . 0.0 110.382 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ttp -66.8 -35.11 79.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.881 . . . . 0.0 110.586 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -78.45 -24.73 45.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.184 -0.947 . . . . 0.0 110.343 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -111.09 -77.36 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.014 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.35 158.85 19.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.465 ' OE1' ' HB1' ' A' ' 11' ' ' ALA . 2.4 tp60 -74.03 -30.62 62.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -24.23 41.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -52.15 8.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.175 -0.953 . . . . 0.0 108.758 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.47 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.5 m -58.31 -27.17 63.85 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.47 -53.81 8.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -9.19 45.44 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.774 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.87 -44.81 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.607 HD21 ' CD2' ' A' ' 42' ' ' LEU . 14.3 mt -79.57 -28.97 41.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 42.02 4.45 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 23' ' ' LEU . 1.2 t -129.96 179.44 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -1.161 . . . . 0.0 109.696 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' H ' HG12 ' A' ' 25' ' ' VAL . 93.9 m-85 -75.15 154.8 37.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.326 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -26.59 64.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 m -71.26 -50.57 31.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.169 -0.957 . . . . 0.0 109.905 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.58 -17.89 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.181 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -78.25 -61.3 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.699 0.761 . . . . 0.0 109.214 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.749 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -54.71 -14.28 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.664 -0.648 . . . . 0.0 110.501 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 10.6 tttt -93.57 -39.98 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.576 -1.327 . . . . 0.0 108.964 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.24 -8.66 57.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.185 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.804 HD11 HD11 ' A' ' 7' ' ' LEU . 8.3 mt -118.56 -47.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.424 -0.798 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.584 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 1.8 t-80 -72.95 -11.17 60.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.957 -1.089 . . . . 0.0 110.01 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -76.34 -88.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.962 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.04 46.45 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.69 -170.03 2.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.526 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 13.8 ptpt -148.64 87.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.686 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.584 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 22.8 mt -118.21 171.83 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.86 . . . . 0.0 110.739 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 28.2 m-85 -154.02 110.03 3.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.484 -0.76 . . . . 0.0 109.701 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.607 ' CD2' HD21 ' A' ' 23' ' ' LEU . 3.8 mp -86.14 128.71 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 111.327 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 51' ' ' TYR . 1.6 m -93.74 105.87 17.88 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.989 HG23 ' O ' ' A' ' 49' ' ' SER . 7.2 mt -91.61 134.22 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 110.916 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.762 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.8 m-20 -53.85 -18.66 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.66 -0.65 . . . . 0.0 110.512 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.01 -19.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -2.33 56.44 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.34 0.52 25.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.989 ' O ' HG23 ' A' ' 44' ' ' ILE . 2.1 t -72.46 -175.18 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -1.138 . . . . 0.0 110.139 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 49' ' ' SER . 19.8 t -156.11 130.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 8.0 t80 -128.0 76.16 1.67 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 109.345 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -48.54 130.29 16.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 110.998 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -132.81 84.94 2.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 109.758 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.523 ' CB ' HG12 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -79.0 147.12 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.333 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.58 HG13 HG12 ' A' ' 56' D VAL . 5.0 t -138.71 86.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.446 -0.784 . . . . 0.0 109.82 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 56' A ASP . 7.2 ttpp -97.12 91.48 5.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 110.106 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.556 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -4.38 73.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.28 0.562 . . . . 0.0 112.373 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 157.0 -23.94 0.47 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.3 tt0 -178.92 128.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.109 -1.23 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.58 HG12 HG13 ' A' ' 55' ' ' VAL . 3.6 m -100.21 129.33 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.655 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -134.72 158.45 75.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 110.517 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 56' E LYS . 11.2 Cg_exo -72.71 -59.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.263 1.665 . . . . 0.0 110.327 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER 56.35 109.99 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 110.072 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 58' ' ' PHE . 20.2 Cg_exo -62.94 133.61 14.05 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.497 0.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.88 170.14 8.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.9 p30 -119.02 165.38 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 3.3 ttmt 178.99 64.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 0.0 110.244 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 1.2 pttp -80.26 77.29 7.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -77.27 0.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.933 . . . . 0.0 110.214 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 p -83.68 6.03 22.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.378 -0.826 . . . . 0.0 110.243 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.231 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.264 0.554 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 57.84 -156.42 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.013 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.6 mm100 -103.35 65.16 0.84 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.11 -0.993 . . . . 0.0 110.05 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 18.6 ttt180 -79.53 74.54 6.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 109.626 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' A' ' 10' ' ' TYR . 2.9 mt -90.87 146.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.676 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.06 -178.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.768 0.794 . . . . 0.0 111.3 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.704 ' HB3' HD12 ' A' ' 34' ' ' ILE . 13.1 tp -92.34 -49.97 5.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.918 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.16 -64.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.598 -0.688 . . . . 0.0 109.306 178.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -43.72 -53.26 5.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.108 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.635 ' HB2' HG22 ' A' ' 5' ' ' ILE . 1.9 t80 -46.46 -55.18 7.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 109.707 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.85 -37.34 42.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.612 0.72 . . . . 0.0 109.584 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -55.35 -41.14 72.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 110.415 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -38.77 54.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.52 -67.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 110.007 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 168.65 155.08 9.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.452 ' HB3' ' HG2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.29 -33.85 70.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -1.156 . . . . 0.0 109.878 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.873 HG23 ' OE1' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -85.23 -7.55 58.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.151 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -53.9 5.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -34.1 77.1 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.421 -0.8 . . . . 0.0 109.051 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.44 -23.55 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 17' ' ' THR . 2.3 mmtt -71.04 -43.79 67.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.002 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.508 ' CB ' HG21 ' A' ' 50' ' ' VAL . 3.8 m-20 -70.09 -28.79 65.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 23' ' ' LEU . 22.0 mt -79.45 -27.51 41.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 26.96 31.45 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.0 m -135.82 156.13 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.549 ' O ' HD13 ' A' ' 30' ' ' ILE . 96.1 m-85 -64.93 172.18 3.04 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 110.073 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.873 ' OE1' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER -75.72 -23.37 56.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.172 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -62.85 -46.52 87.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.844 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.69 66.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.853 . . . . 0.0 109.949 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.746 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.5 mp -67.03 -49.88 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' LYS . 25.5 m-20 -57.22 -58.94 6.02 Favored 'General case' 0 C--O 1.194 -1.833 0 O-C-N 121.358 -0.839 . . . . 0.0 110.007 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -49.76 -23.87 2.04 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 119.588 -1.945 . . . . 0.0 109.107 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 30' ' ' ILE . . . -76.7 -40.19 49.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.558 -0.714 . . . . 0.0 109.935 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.918 HD13 ' HB2' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -95.12 -40.47 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.405 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -60.69 -58.27 9.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.917 -1.115 . . . . 0.0 108.407 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.45 15.1 16.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.932 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.955 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -152.12 93.39 0.14 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 9.8 mmm-85 -86.77 168.86 13.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -1.064 . . . . 0.0 110.82 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER 71.29 66.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.303 -0.873 . . . . 0.0 110.439 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.955 HD11 ' O ' ' A' ' 37' ' ' GLY . 17.2 mt -125.45 163.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.5 m-85 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 6' ' ' THR . 4.4 mp -140.88 116.87 10.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.534 ' OG1' ' CB ' ' A' ' 51' ' ' TYR . 2.3 p -88.01 101.67 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.555 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.5 mt -94.78 124.44 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.047 -1.033 . . . . 0.0 110.314 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER -85.43 -177.25 6.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -0.969 . . . . 0.0 110.26 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.36 0.16 17.79 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -101.14 -4.45 27.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.592 -0.692 . . . . 0.0 110.166 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 90.84 -15.06 61.55 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.489 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -48.86 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -1.193 . . . . 0.0 109.589 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG21 ' CB ' ' A' ' 22' ' ' ASP . 45.7 t -80.8 105.78 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 111.063 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CB ' ' OG1' ' A' ' 43' ' ' THR . 0.2 OUTLIER -88.26 90.71 8.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 109.083 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -89.08 140.48 29.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 110.124 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 56' E LYS . 0.2 OUTLIER -152.61 136.73 16.47 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.889 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 56' D VAL . 8.7 mt-10 -98.1 111.83 24.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG23 HG12 ' A' ' 56' D VAL . 2.6 p -109.82 132.69 57.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.245 -0.91 . . . . 0.0 110.186 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 56' A ASP . 13.8 ttpp -160.24 110.41 1.82 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.677 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 38.6 t70 61.26 11.42 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.609 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.846 ' O ' HG13 ' A' ' 56' D VAL . . . 128.91 -44.92 1.18 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.455 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' C GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.8 mt-10 -60.9 98.2 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.241 -1.152 . . . . 0.0 110.93 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.846 HG13 ' O ' ' A' ' 56' B GLY . 4.8 m -107.19 61.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.833 . . . . 0.0 110.088 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -58.93 174.9 0.36 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.97 -1.081 . . . . 0.0 110.557 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.473 ' CD ' ' HB3' ' A' ' 56' E LYS . 2.0 Cg_endo -88.98 -79.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.35 2.033 . . . . 0.0 110.215 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.515 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.6 OUTLIER 59.91 122.31 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.282 -0.886 . . . . 0.0 109.865 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -77.78 128.91 17.52 Favored 'Cis proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.326 -0.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.56 -170.49 2.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.383 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -144.09 138.95 28.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.355 -0.841 . . . . 0.0 109.917 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -168.75 55.82 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 110.422 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.7 ptmm? -58.82 -161.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 110.097 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -165.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.13 -0.981 . . . . 0.0 109.735 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ALA . 3.8 t -91.3 -16.07 28.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.372 0.606 . . . . 0.0 110.089 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 45' ' ' ASN . 14.7 mm-40 -47.14 94.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 4.3 mm-40 -139.6 -129.11 0.12 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.029 -1.044 . . . . 0.0 108.992 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 40.0 ttp180 -125.16 79.84 1.83 Allowed 'General case' 0 C--N 1.283 -2.292 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.814 HG22 ' HB2' ' A' ' 10' ' ' TYR . 24.2 mt -84.75 135.59 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.383 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -49.46 -176.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.068 0.937 . . . . 0.0 111.833 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.033 HD23 HD13 ' A' ' 40' ' ' ILE . 2.8 tp -94.4 -37.21 11.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.647 ' HB2' HG23 ' A' ' 34' ' ' ILE . 1.4 tmtt? -83.84 -65.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.278 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 8.3 m-20 -46.84 -45.58 20.31 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.814 ' HB2' HG22 ' A' ' 5' ' ' ILE . 13.3 t80 -55.4 -50.98 68.33 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.719 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -26.14 63.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.767 -0.583 . . . . 0.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -21.63 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -101.32 -6.15 24.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -77.52 0.59 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.1 143.25 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -65.1 -31.99 73.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 110.097 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -80.4 -10.82 59.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.118 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -90.97 -36.65 13.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.342 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.699 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -74.89 -26.94 60.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.288 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HA ' HD11 ' A' ' 30' ' ' ILE . . . -82.42 -39.09 23.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.813 . . . . 0.0 110.699 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.6 tmtt? -65.08 -34.68 79.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 109.956 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 7.7 m-20 -71.46 -38.38 71.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 110.023 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 19' ' ' THR . 21.1 mt -80.7 -7.59 59.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 110.407 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 35.42 90.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -134.44 175.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.22 -1.165 . . . . 0.0 109.9 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -82.36 146.19 29.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 110.378 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 1.055 ' HA ' HD12 ' A' ' 30' ' ' ILE . 2.2 mt-30 -53.35 -24.6 12.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.364 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -64.16 -57.54 9.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.93 -30.9 4.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.135 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.055 HD12 ' HA ' ' A' ' 27' ' ' GLN . 45.2 mt -70.0 -55.48 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.035 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.0 OUTLIER -59.99 -7.76 1.94 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 111.378 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -91.26 -34.45 14.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.574 -1.329 . . . . 0.0 108.266 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.76 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -86.16 -15.84 39.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.647 HG23 ' HB2' ' A' ' 8' ' ' LYS . 10.6 mt -95.46 -48.11 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.513 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 18.8 t60 -68.09 -55.9 10.81 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.229 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.11 13.44 18.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.63 83.78 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 8.0 mmm-85 -90.43 77.14 6.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.538 ' CE ' ' HB2' ' A' ' 56' ' ' LYS . 2.9 pttm 177.18 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.568 -0.708 . . . . 0.0 109.126 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.033 HD13 HD23 ' A' ' 7' ' ' LEU . 5.4 mt -103.17 161.66 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.504 -0.748 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.603 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 37.6 m-85 -157.47 131.31 8.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.397 -0.814 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 7' ' ' LEU . 2.0 mp -124.54 118.3 26.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 0.0 110.353 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -89.27 102.65 15.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.064 -1.022 . . . . 0.0 109.429 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.3 mt -89.29 43.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.962 -1.086 . . . . 0.0 109.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.71 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 49.4 p-10 -105.45 -151.53 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 68.92 6.34 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.143 -0.973 . . . . 0.0 108.799 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.704 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 120.61 -53.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.47 29.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 33.6 t -78.01 156.37 30.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.541 -0.976 . . . . 0.0 110.181 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 50' ' ' VAL . 24.8 t -110.82 98.35 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 110.484 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.54 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 5.5 m-85 -96.9 89.85 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . -89.71 122.73 33.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.181 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 56' E LYS . 0.5 OUTLIER -160.21 137.49 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.937 . . . . 0.0 110.582 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.539 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.45 178.52 4.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.835 . . . . 0.0 109.673 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.676 HG22 HG12 ' A' ' 56' D VAL . 83.9 t -152.06 111.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.965 . . . . 0.0 110.462 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HB2' ' CE ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.49 122.4 41.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.094 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.0 t0 50.98 -90.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -142.52 54.87 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.5 tt0 -162.19 97.03 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.136 . . . . 0.0 110.351 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.676 HG12 HG22 ' A' ' 55' ' ' VAL . 11.1 m -92.62 165.29 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.501 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 9.5 ptpt -165.68 148.53 6.7 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.076 -1.015 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.0 Cg_exo -76.76 73.76 5.16 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.959 1.505 . . . . 0.0 111.211 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -45.62 132.93 6.39 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.846 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 79.0 Cg_endo -92.61 79.15 0.13 OUTLIER 'Cis proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.827 -1.739 . . . . 0.0 110.816 0.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.555 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 1.1 p -62.62 -167.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 110.645 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 23.0 p30 37.12 55.13 1.28 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.722 -0.612 . . . . 0.0 110.734 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.07 49.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.263 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -136.38 -95.15 0.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 110.09 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.39 -92.28 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.06 -1.025 . . . . 0.0 110.205 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 11.4 t -132.17 26.15 4.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 110.09 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.231 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' C ' ' CG ' ' A' ' 2' ' ' GLU . 16.5 tpp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.242 0.544 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' CG ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -166.71 109.76 0.72 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 109.907 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -100.4 58.85 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.646 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.22 94.77 4.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.993 0.901 . . . . 0.0 111.011 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.754 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.2 mt -90.3 -173.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.663 -0.648 . . . . 0.0 109.766 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.627 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.76 -179.09 5.43 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.288 -0.883 . . . . 0.0 111.608 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.06 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -91.4 -43.01 10.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.835 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.56 -63.79 1.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.406 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -44.25 -50.77 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.643 ' CE1' HD12 ' A' ' 5' ' ' ILE . 5.3 t80 -57.39 -51.64 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.358 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.648 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -49.03 -26.08 2.39 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 109.605 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 tpt -71.83 -52.65 16.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.036 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.94 -21.03 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.636 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.95 -75.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 109.611 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 173.5 142.58 3.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.648 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -59.42 -36.06 75.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -1.232 . . . . 0.0 109.701 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -78.72 -16.5 57.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.76 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -78.59 -51.24 10.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 0.0 109.256 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.3 m -64.7 -23.82 67.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.82 -25.82 30.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.285 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.55 -27.27 41.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.74 -27.95 26.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.846 . . . . 0.0 110.218 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.875 HD21 HD23 ' A' ' 42' ' ' LEU . 29.7 mt -80.02 -8.13 59.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' O ' HG13 ' A' ' 25' ' ' VAL . . . 68.66 29.71 72.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 24' ' ' GLY . 5.7 m -151.48 150.54 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 110.107 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.555 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 9.3 p90 -66.68 169.33 7.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.957 . . . . 0.0 110.314 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.572 ' HA ' HD13 ' A' ' 30' ' ' ILE . 9.4 mp0 -65.3 -32.07 73.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 111.349 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.555 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -46.6 -48.37 19.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.972 -1.08 . . . . 0.0 110.773 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.44 70.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 27' ' ' GLN . 2.8 mp -72.11 -32.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.79 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 6.8 t-20 -65.88 -23.77 66.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -36.84 12.84 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.423 -1.423 . . . . 0.0 108.047 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.725 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -71.14 -14.77 62.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.017 HD11 ' HB2' ' A' ' 7' ' ' LEU . 5.7 mt -112.48 -54.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 5.2 t-160 -56.19 -15.63 4.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -85.23 29.14 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.755 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . 43.52 44.11 6.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.32 -172.0 3.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -1.112 . . . . 0.0 111.07 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 55' ' ' VAL . 15.3 mttt -135.02 83.87 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.539 -0.725 . . . . 0.0 109.053 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.725 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 27.0 mt -114.4 165.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 111.372 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.2 m-85 -159.67 177.51 10.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.641 . . . . 0.0 109.388 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.06 HD11 ' CD1' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.41 111.78 5.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.062 . . . . 0.0 109.706 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.497 ' CG2' ' ND2' ' A' ' 45' ' ' ASN . 9.3 m -75.53 99.42 4.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 109.448 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' A' ' 10' ' ' TYR . 55.7 mt -86.99 59.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 111.364 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.497 ' ND2' ' CG2' ' A' ' 43' ' ' THR . 39.7 p30 -103.4 -123.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.997 -1.064 . . . . 0.0 109.711 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.895 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 40.65 29.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.107 -0.996 . . . . 0.0 109.969 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.578 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 41.8 t0 72.78 64.35 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.384 0.612 . . . . 0.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 -12.21 41.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.895 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -59.1 159.47 7.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.955 -1.321 . . . . 0.0 109.068 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.538 HG22 HG23 ' A' ' 44' ' ' ILE . 38.2 t -127.69 127.87 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 111.19 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 30.0 m-85 -124.64 159.03 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -143.62 137.2 28.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.802 -1.186 . . . . 0.0 111.112 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 56' E LYS . 1.1 mp0 -142.56 143.91 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 110.165 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE2' ' CD1' ' A' ' 58' ' ' PHE . 1.0 OUTLIER -84.01 167.55 16.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.669 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 39' ' ' LYS . 3.0 t -139.24 128.56 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.994 -1.066 . . . . 0.0 110.216 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -146.92 170.16 17.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.504 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 60.8 t0 -40.57 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 53.31 59.12 10.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 7.6 tt0 -172.49 88.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.197 -1.178 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' D VAL . . . . . . . . . . . . . 6.2 m -97.07 140.38 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 0.0 109.952 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -119.0 172.6 4.15 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.071 -1.018 . . . . 0.0 110.69 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 58' ' ' PHE . 1.2 Cg_endo -87.6 24.94 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.354 2.036 . . . . 0.0 110.564 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.525 ' CD1' ' OE2' ' A' ' 54' ' ' GLU . 62.4 t80 -30.64 123.62 0.32 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.873 -0.517 . . . . 0.0 111.304 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.8 Cg_endo -80.17 108.03 1.16 Allowed 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.396 -1.918 . . . . 0.0 110.551 0.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.422 ' N ' ' HA ' ' A' ' 58' ' ' PHE . 2.4 m -48.5 155.32 0.54 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.016 -1.052 . . . . 0.0 110.063 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -86.88 -171.24 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.077 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -155.47 52.85 0.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 110.464 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -100.18 -18.86 16.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.309 -0.87 . . . . 0.0 109.868 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.522 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 21.6 p 41.3 -150.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.366 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.68 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 3.3 t -172.7 55.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.987 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.111 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.027 0.441 . . . . 0.0 110.221 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER 58.81 136.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.393 -0.817 . . . . 0.0 110.157 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -121.5 72.63 1.01 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.997 -1.064 . . . . 0.0 109.951 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.76 92.18 4.78 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.131 0.967 . . . . 0.0 111.029 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.557 HG22 ' HB2' ' A' ' 10' ' ' TYR . 18.3 mt -90.74 154.86 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.983 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.673 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -50.78 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.281 1.039 . . . . 0.0 111.413 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.673 ' H ' HG22 ' A' ' 6' ' ' THR . 4.0 tp -92.91 -39.99 10.85 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HD3' HG22 ' A' ' 34' ' ' ILE . 1.1 mmmp? -90.64 -63.42 1.27 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.3 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.3 t70 -44.63 -44.89 9.29 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.7 t80 -56.46 -57.39 12.52 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.501 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.32 -21.01 4.96 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 ttm -78.43 -46.8 18.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.774 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -78.04 -10.85 59.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -69.42 0.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.0 110.214 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 133.06 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -58.86 -24.02 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.445 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 17' ' ' THR . 3.4 t -78.75 -26.8 44.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.041 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -76.35 -56.39 4.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 108.672 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -60.21 -30.75 69.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -64.2 -43.61 94.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -19.48 56.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -73.7 -26.4 60.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 30' ' ' ILE . 9.4 mt -82.93 -52.24 6.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.25 28.89 1.05 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG23 HG12 ' A' ' 30' ' ' ILE . 1.3 m -137.65 162.46 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -1.155 . . . . 0.0 110.015 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.76 -175.11 0.37 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.399 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -22.87 37.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 110.618 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' ALA . 23.5 t -74.58 -72.1 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 110.279 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.82 -27.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.307 -0.87 . . . . 0.0 109.349 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.879 HD12 HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -68.61 -61.69 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.546 -0.721 . . . . 0.0 109.566 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.751 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -46.56 -18.26 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.563 -0.711 . . . . 0.0 111.032 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -89.76 -40.86 12.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.438 -1.414 . . . . 0.0 108.588 178.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -7.04 53.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.517 -0.74 . . . . 0.0 109.136 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.879 HD11 HD12 ' A' ' 30' ' ' ILE . 15.8 mt -111.33 -54.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.636 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.57 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 67.2 t60 -61.16 -14.99 28.84 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -64.16 -9.01 14.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.629 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.52 34.12 60.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.36 153.69 31.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.55 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.544 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER -86.3 58.97 5.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.637 HD12 HD22 ' A' ' 7' ' ' LEU . 4.9 mt -93.25 167.83 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 111.093 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 68.0 m-85 -155.88 167.75 29.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 4.6 mp -142.79 105.35 4.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.835 -1.166 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 1.3 m -78.59 93.1 4.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.587 -0.695 . . . . 0.0 109.197 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 10' ' ' TYR . 27.8 mt -96.76 117.68 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.303 -0.873 . . . . 0.0 110.509 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.572 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER -81.76 -173.48 4.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.266 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.66 0.34 17.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.72 0.71 52.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.122 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' SER . . . 85.16 -14.11 51.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -45.28 162.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -1.205 . . . . 0.0 109.928 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.51 ' CG2' ' OD2' ' A' ' 22' ' ' ASP . 80.9 t -138.72 114.94 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -101.04 80.39 2.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 109.382 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -80.42 89.68 5.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.701 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 56' E LYS . 27.3 tt0 -102.47 167.5 9.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.765 . . . . 0.0 109.687 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 56' D VAL . 0.8 OUTLIER -135.08 156.93 48.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.076 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.49 HG13 HG12 ' A' ' 56' D VAL . 2.4 t -141.58 105.23 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 56' A ASP . 11.3 ttpp -123.65 103.24 8.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 56' A ASP . 51.6 t0 59.09 23.77 12.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.915 . . . . 0.0 110.449 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.619 ' O ' HG13 ' A' ' 56' D VAL . . . 109.62 -36.5 4.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 42.5 mt-10 -63.04 104.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.619 HG13 ' O ' ' A' ' 56' B GLY . 34.0 m -106.4 157.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.122 -0.986 . . . . 0.0 110.46 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -174.26 167.54 2.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.962 . . . . 0.0 110.575 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.57 175.97 10.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 121.875 1.716 . . . . 0.0 110.411 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CE1' HD22 ' A' ' 23' ' ' LEU . 13.4 t80 -167.82 146.04 3.89 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 110.364 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HA ' ' CD2' ' A' ' 58' ' ' PHE . 59.1 Cg_endo -91.89 48.41 1.34 Allowed 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.115 -2.035 . . . . 0.0 110.455 0.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 t -65.62 177.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.235 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.61 89.59 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.424 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -166.15 61.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 109.991 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.597 ' CG ' ' HA ' ' A' ' 66' ' ' ALA . 12.4 ptpt -44.2 166.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -0.962 . . . . 0.0 109.976 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.7 ' O ' HG22 ' A' ' 65' ' ' THR . 77.9 p -80.87 142.02 34.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 110.7 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 64' ' ' THR . 13.8 t 40.52 28.59 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.745 0.783 . . . . 0.0 109.545 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HA ' ' CG ' ' A' ' 63' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.173 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.26 0.552 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.69 149.97 33.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 110.025 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -125.21 77.16 1.61 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.197 -0.939 . . . . 0.0 109.672 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 9.3 ttt180 -79.18 80.11 5.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.61 HG22 ' HB2' ' A' ' 10' ' ' TYR . 2.6 mt -86.02 164.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.523 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -70.34 -178.6 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.134 0.969 . . . . 0.0 112.367 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.669 HD21 HG12 ' A' ' 34' ' ' ILE . 3.5 tp -92.55 -40.36 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.546 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.44 -65.92 0.97 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.501 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -43.42 -48.54 7.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.61 ' HB2' HG22 ' A' ' 5' ' ' ILE . 12.6 t80 -54.03 -57.32 11.48 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.829 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.6 -27.37 4.47 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 109.912 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.79 77.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -15.04 58.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.229 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.71 -87.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 179.47 48.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 2.2 tp60 -90.2 -28.66 18.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -1.096 . . . . 0.0 110.509 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 6.1 t -87.03 -24.93 24.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.242 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -73.71 -59.08 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.955 . . . . 0.0 108.75 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 1.1 m -60.0 -32.27 70.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.581 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . . . -76.45 -20.63 56.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.129 -0.982 . . . . 0.0 110.336 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.45 -46.93 68.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.104 -0.997 . . . . 0.0 110.912 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.08 -6.41 53.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.105 -0.997 . . . . 0.0 112.221 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.838 HD13 HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -162.72 36.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.639 -1.288 . . . . 0.0 109.882 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . -160.82 67.25 0.26 Allowed Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.254 38.3 t -75.12 -2.26 3.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.734 0.778 . . . . 0.0 109.5 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.573 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -134.32 82.54 1.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 26' ' ' TYR . 1.6 tt0 -36.14 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.617 -0.677 . . . . 0.0 111.369 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 26' ' ' TYR . 36.1 p -76.61 -55.44 5.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.977 -1.077 . . . . 0.0 109.211 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . . . -57.45 -17.79 15.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.328 -0.857 . . . . 0.0 108.901 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.728 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -74.31 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.623 -0.673 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.728 ' N ' HG22 ' A' ' 30' ' ' ILE . 1.6 m-20 -62.24 -9.63 8.45 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.52 -0.737 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 2.3 ttpt -93.25 -38.15 11.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.866 -1.146 . . . . 0.0 108.086 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.5 -8.29 59.62 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.669 HG12 HD21 ' A' ' 7' ' ' LEU . 22.7 mt -108.89 -48.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.573 -0.704 . . . . 0.0 109.585 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 3.5 t60 -70.96 -28.65 64.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.867 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -65.46 -33.43 75.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.52 59.72 0.83 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.33 -176.02 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 26.9 tttt -117.21 71.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.557 HD12 HD22 ' A' ' 7' ' ' LEU . 10.4 mt -115.95 166.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 91.8 m-85 -149.39 173.2 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.295 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.838 HD21 HD13 ' A' ' 23' ' ' LEU . 3.6 mp -143.32 147.96 35.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.007 -1.058 . . . . 0.0 111.455 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 94.9 m -112.63 105.52 13.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.583 -0.698 . . . . 0.0 109.191 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 45' ' ' ASN . 2.5 mt -83.04 -134.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.316 -0.865 . . . . 0.0 111.164 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.549 ' H ' HG22 ' A' ' 44' ' ' ILE . 2.1 p-10 34.77 -146.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.932 -0.48 . . . . 0.0 111.497 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.655 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 56.27 23.07 6.78 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.655 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 26.8 t70 100.19 35.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 123.752 0.821 . . . . 0.0 109.28 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.62 7.25 57.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -67.63 104.28 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -1.175 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.88 125.78 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.49 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 7.8 m-85 -112.29 158.86 19.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.803 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . . . -139.34 97.01 3.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 56' E LYS . 29.1 mt-10 -111.99 126.09 54.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.808 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 56' D VAL . 1.7 mt-10 -82.04 161.61 22.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 t -142.33 121.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.463 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -147.71 142.72 27.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 15.9 t70 56.21 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.919 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -157.8 36.21 0.54 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.69 132.01 12.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -1.175 . . . . 0.0 110.182 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -101.14 169.71 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.158 -0.964 . . . . 0.0 110.557 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 3.9 mttm -145.24 175.67 2.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 6.2 Cg_exo -81.57 -163.0 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.21 1.94 . . . . 0.0 110.433 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 179.07 113.41 0.19 Allowed Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.305 -0.872 . . . . 0.0 110.329 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 61' ' ' ASN . 46.0 Cg_endo -77.85 108.18 1.14 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.117 -2.035 . . . . 0.0 110.734 -0.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.49 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 63.4 p -47.03 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 59' ' ' PRO . 9.5 t-20 -152.52 62.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.87 . . . . 0.0 110.064 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -173.33 48.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.544 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -107.85 33.58 4.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 110.159 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.797 ' O ' HG22 ' A' ' 65' ' ' THR . 5.3 m -79.05 137.15 37.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.947 . . . . 0.0 110.151 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 64' ' ' THR . 0.5 OUTLIER 57.2 27.47 13.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 110.232 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.193 -179.827 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.356 0.598 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 52.54 94.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 110.2 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -114.08 72.87 0.8 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.213 -0.929 . . . . 0.0 109.633 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -80.38 68.64 6.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 110.503 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 10' ' ' TYR . 8.6 mt -91.79 139.35 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 17.7 p -51.22 -174.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.023 -1.048 . . . . 0.0 110.943 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.878 ' HB2' HD11 ' A' ' 42' ' ' LEU . 3.6 tp -91.42 -36.48 13.77 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HG3' ' CG2' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -82.87 -68.79 0.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.725 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.456 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.2 OUTLIER -44.99 -54.2 6.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.688 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.2 t80 -47.01 -55.24 8.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.277 -0.889 . . . . 0.0 110.232 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.46 61.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.529 -0.732 . . . . 0.0 110.162 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.3 ttm -67.67 -32.79 73.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HG2' ' NH1' ' A' ' 13' ' ' ARG . 30.6 mtt-85 -83.52 -27.3 29.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.5 -65.3 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.0 141.34 3.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.63 ' OE1' HG21 ' A' ' 30' ' ' ILE . 1.0 OUTLIER -58.5 -35.79 72.78 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.019 -1.283 . . . . 0.0 109.998 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -79.72 -16.52 55.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.125 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.93 -57.65 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m -49.83 -34.45 19.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.85 82.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.743 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -82.06 -4.72 57.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.728 . . . . 0.0 110.041 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' CB ' HD23 ' A' ' 23' ' ' LEU . 7.7 m-20 -84.44 -38.6 19.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.013 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.992 HD12 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -116.74 14.03 15.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.18 -0.95 . . . . 0.0 110.435 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.88 37.87 91.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.992 HG21 HD12 ' A' ' 23' ' ' LEU . 22.1 t -108.88 120.79 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -1.12 . . . . 0.0 110.062 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -45.72 166.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.492 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -71.51 -27.71 63.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.154 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 30' ' ' ILE . 29.3 t -70.66 -61.61 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.724 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -45.32 -26.18 0.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.153 -0.967 . . . . 0.0 109.114 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.77 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -66.06 -66.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.582 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.77 ' N ' HG22 ' A' ' 30' ' ' ILE . 71.0 m-80 -61.67 -7.25 3.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.545 -0.722 . . . . 0.0 110.468 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -35.93 15.22 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.863 -1.148 . . . . 0.0 108.116 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.98 -10.95 51.93 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.688 ' HA ' HD11 ' A' ' 40' ' ' ILE . 35.0 mt -103.66 -43.35 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 52.1 t-80 -74.93 -56.31 4.88 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.901 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.62 -4.17 55.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.955 . . . . 0.0 111.118 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 33' ' ' ALA . . . -123.53 69.06 0.46 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.213 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -65.07 -170.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.243 . . . . 0.0 110.266 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 55.15 68.9 0.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 108.872 -179.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.755 HD13 HD23 ' A' ' 7' ' ' LEU . 2.8 mt -120.26 151.01 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.87 . . . . 0.0 110.444 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 90.5 m-85 -158.82 128.0 5.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.651 -0.656 . . . . 0.0 110.203 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -120.95 133.59 55.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 m -108.04 100.76 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.939 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.773 HG22 ' H ' ' A' ' 45' ' ' ASN . 5.8 mt -82.05 -173.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.898 . . . . 0.0 110.025 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.773 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.5 OUTLIER 82.7 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.248 0.547 . . . . 0.0 111.927 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.688 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 64.33 17.66 10.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 30.2 t70 110.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.948 0.899 . . . . 0.0 109.067 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.51 79.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -70.85 109.1 4.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.839 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.442 HG11 HD22 ' A' ' 23' ' ' LEU . 25.3 t -79.5 109.53 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 110.23 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 5.9 m-85 -95.21 143.94 26.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 108.937 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -127.21 86.86 2.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.113 . . . . 0.0 110.916 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.31 151.66 20.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.857 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.507 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -130.9 160.1 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 110.168 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 56' D VAL . 23.3 t -150.24 84.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.416 -0.802 . . . . 0.0 109.9 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 56' A ASP . 5.2 ttmt -94.16 101.76 13.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.141 -0.975 . . . . 0.0 109.609 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 56' ' ' LYS . 38.4 t70 -13.61 80.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.378 0.608 . . . . 0.0 112.049 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.08 -27.44 0.8 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.81 132.42 0.12 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.018 -1.284 . . . . 0.0 110.807 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.587 HG12 HG13 ' A' ' 55' ' ' VAL . 12.5 m -96.98 165.89 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 56' D VAL . 10.6 ptpt -175.53 171.8 1.15 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.847 -1.158 . . . . 0.0 110.813 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 60' ' ' SER . 3.7 Cg_exo -76.83 -173.18 1.65 Allowed 'Trans proline' 0 C--N 1.299 -2.078 0 O-C-N 124.53 1.805 . . . . 0.0 110.485 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 39.0 t80 178.91 114.79 0.19 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 110.865 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -79.5 107.13 0.99 Allowed 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.372 -1.928 . . . . 0.0 109.886 -0.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.474 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 12.5 p -66.85 164.73 16.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.508 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -161.26 119.5 2.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 109.973 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER 179.87 67.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.486 ' O ' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -39.96 -74.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.494 -0.754 . . . . 0.0 110.694 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.735 ' O ' HG22 ' A' ' 65' ' ' THR . 91.6 m 59.02 160.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.324 -0.86 . . . . 0.0 110.294 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.735 HG22 ' O ' ' A' ' 64' ' ' THR . 8.8 t 41.69 29.07 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.71 0.767 . . . . 0.0 109.508 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 1' ' ' MET . 30.8 ttm . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.149 0.499 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.539 ' CB ' ' O ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.05 -161.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.759 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 37.7 mm-40 -145.22 -136.05 0.09 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.057 -1.027 . . . . 0.0 108.288 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -126.55 90.48 3.18 Favored 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.617 -0.677 . . . . 0.0 109.455 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.745 HG22 ' HB2' ' A' ' 10' ' ' TYR . 1.1 mt -90.28 151.57 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.612 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 3.0 p -84.31 -166.16 1.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.767 0.794 . . . . 0.0 111.376 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.06 -28.41 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -81.65 -82.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.816 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 8' ' ' LYS . 1.1 m-20 -41.69 -56.03 2.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.456 -0.778 . . . . 0.0 110.058 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.745 ' HB2' HG22 ' A' ' 5' ' ' ILE . 1.4 t80 -49.6 -50.63 41.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.409 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 7' ' ' LEU . . . -56.29 -32.49 64.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 110.37 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -36.56 84.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.313 -0.867 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -38.07 44.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.132 -0.98 . . . . 0.0 110.147 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -99.23 -80.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.996 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.59 44.19 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 14.3 mm100 -88.72 -31.03 18.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.242 -1.151 . . . . 0.0 110.053 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.8 m -83.18 -26.13 31.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -56.55 4.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 108.797 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 2.1 m -55.55 -30.64 61.13 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -64.0 -55.86 19.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.896 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -84.66 11.58 8.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.461 -0.774 . . . . 0.0 109.787 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 3.0 m-20 -90.23 -43.28 10.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.416 -0.802 . . . . 0.0 110.58 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.961 HD11 ' CG2' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -94.63 -22.25 18.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.504 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 115.75 58.19 0.34 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.961 ' CG2' HD11 ' A' ' 23' ' ' LEU . 3.1 t -152.53 161.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.269 . . . . 0.0 110.166 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -77.8 177.6 8.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.499 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.04 -50.13 30.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 110.272 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.5 p -62.3 -60.32 3.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -42.59 -29.47 0.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.964 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.743 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -65.8 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.603 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.743 ' N ' HG22 ' A' ' 30' ' ' ILE . 2.7 m-20 -57.13 -7.45 0.52 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.473 -0.767 . . . . 0.0 111.208 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 -41.87 15.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.73 -1.231 . . . . 0.0 107.762 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' ALA . . . -70.44 -45.28 66.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 7' ' ' LEU . 10.5 mt -66.54 -46.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -42.87 -36.58 1.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.634 178.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 33' ' ' ALA . . . -67.91 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.758 -0.589 . . . . 0.0 109.727 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . 129.14 -16.24 5.77 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.337 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.697 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -39.97 81.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' GLY . 6.6 ptpt 9.69 69.06 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.512 0.672 . . . . 0.0 112.736 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.829 ' CG2' HD21 ' A' ' 7' ' ' LEU . 29.5 mt -80.77 167.48 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 109.126 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 40' ' ' ILE . 27.6 m-85 -158.29 150.55 21.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.877 -1.14 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 7' ' ' LEU . 4.5 mp -138.97 122.05 16.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.807 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.587 ' O ' ' CG2' ' A' ' 43' ' ' THR . 1.0 OUTLIER -102.27 109.48 21.16 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.475 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.023 HG23 ' O ' ' A' ' 49' ' ' SER . 2.0 mt -98.48 152.23 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 110.126 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.454 ' ND2' ' HA3' ' A' ' 48' ' ' GLY . 2.9 m-20 -136.09 -171.81 2.97 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.999 -1.063 . . . . 0.0 110.391 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.76 -4.22 30.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -156.67 16.91 0.31 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -93.4 -6.19 62.92 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.351 -1.899 . . . . 0.0 108.351 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.023 ' O ' HG23 ' A' ' 44' ' ' ILE . 72.1 m 54.24 -92.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' SER . 8.4 t -161.21 98.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.28 -0.888 . . . . 0.0 110.475 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 24.1 t80 -86.8 138.18 31.8 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.607 ' HB1' ' HD2' ' A' ' 58' ' ' PHE . . . -120.8 93.92 4.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.543 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 17.2 pt-20 -111.41 137.45 49.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 110.369 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -89.47 162.84 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.28 -0.888 . . . . 0.0 108.963 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 6.1 t -135.77 143.41 36.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.892 -1.13 . . . . 0.0 110.245 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 56' B GLY . 2.6 tppt? -159.96 169.54 23.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 109.35 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 56' ' ' LYS . 36.9 t70 -29.57 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.379 0.609 . . . . 0.0 111.232 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 46.71 61.6 4.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.21 99.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.123 -1.222 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 56' E LYS . 16.5 m -107.17 153.41 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.132 -0.98 . . . . 0.0 109.681 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.506 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -144.03 175.7 2.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 110.604 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -87.79 -174.21 1.16 Allowed 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.092 1.862 . . . . 0.0 109.611 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.607 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 28.5 t80 174.39 113.78 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 110.434 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 61' ' ' ASN . 1.9 Cg_endo -80.06 110.7 1.98 Allowed 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.513 -1.87 . . . . 0.0 110.325 -0.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 16.3 m -35.23 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.538 -0.726 . . . . 0.0 110.867 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -54.89 -177.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.842 . . . . 0.0 110.453 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -142.46 50.18 1.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.83 . . . . 0.0 109.824 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.63 162.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.539 -0.726 . . . . 0.0 110.388 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.756 ' O ' HG22 ' A' ' 65' ' ' THR . 0.6 OUTLIER -80.91 170.75 15.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.325 -0.859 . . . . 0.0 110.301 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 64' ' ' THR . 5.7 t 41.86 28.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.778 0.799 . . . . 0.0 109.267 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' THR . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.176 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtp . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.214 0.53 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -55.83 177.52 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.074 -1.016 . . . . 0.0 109.452 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' THR . 30.1 mm-40 -145.17 -129.54 0.08 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.982 -1.074 . . . . 0.0 108.814 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . 0.255 0.3 OUTLIER -89.53 66.89 7.45 Favored 'General case' 0 C--N 1.282 -2.364 0 O-C-N 121.559 -0.713 . . . . 0.0 109.348 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.76 HG22 ' HB2' ' A' ' 10' ' ' TYR . 22.0 mt -87.24 155.13 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.221 -0.924 . . . . 0.0 111.242 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.682 HG22 ' H ' ' A' ' 7' ' ' LEU . 1.1 m -65.99 -173.37 0.18 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.149 0.976 . . . . 0.0 111.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.854 HD22 HD12 ' A' ' 40' ' ' ILE . 3.3 tp -93.23 -39.32 11.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.535 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 1.7 tmtm? -90.22 -61.81 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.113 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.501 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 52.2 t0 -46.42 -44.99 17.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.915 . . . . 0.0 108.641 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.76 ' HB2' HG22 ' A' ' 5' ' ' ILE . 3.0 t80 -55.52 -58.56 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.49 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.04 -14.6 17.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.457 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 tpt -90.52 -24.41 20.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 0.0 110.182 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.73 -21.0 21.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -107.22 -55.41 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.31 140.89 3.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -59.91 -35.68 75.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -11.29 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.486 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -52.47 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.76 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.723 ' O ' HD12 ' A' ' 23' ' ' LEU . 3.0 m -60.66 -34.56 74.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.533 ' CB ' ' HG3' ' A' ' 27' ' ' GLN . . . -78.43 -19.66 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -79.78 -51.08 9.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.493 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 57.0 p30 -70.86 -18.13 62.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 19' ' ' THR . 29.2 mt -79.81 -31.98 40.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 34.5 22.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.35 169.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.231 -1.159 . . . . 0.0 110.03 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.634 ' O ' HD12 ' A' ' 30' ' ' ILE . 12.8 m-85 -72.2 145.74 47.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.493 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.533 ' HG3' ' CB ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -66.2 -16.77 64.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' ALA . 20.2 m -71.1 -61.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.06 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -41.2 -36.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.606 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 26' ' ' TYR . 1.3 mp -68.1 -55.11 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.308 -0.87 . . . . 0.0 110.528 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.4 OUTLIER -54.21 -13.65 0.91 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -92.5 -38.86 11.71 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.563 -1.336 . . . . 0.0 108.253 178.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -10.89 59.75 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.669 HG12 HD21 ' A' ' 7' ' ' LEU . 16.5 mt -111.52 -51.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.0 110.0 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -60.49 -19.72 57.74 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.464 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -66.69 -84.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 109.883 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.63 38.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 152.28 20.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -1.119 . . . . 0.0 110.889 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -100.51 69.03 1.4 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.825 . . . . 0.0 109.512 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.854 HD12 HD22 ' A' ' 7' ' ' LEU . 15.5 mt -89.64 164.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.864 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 71.7 m-85 -144.62 163.98 32.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 3.2 mp -144.35 141.55 29.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 110.692 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 2.8 m -118.76 102.96 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.785 . . . . 0.0 109.395 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.028 HG23 ' O ' ' A' ' 49' ' ' SER . 19.3 mt -118.89 100.01 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 111.167 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -107.81 -167.09 1.21 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.826 -1.171 . . . . 0.0 110.525 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.89 -2.23 7.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -144.69 7.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.616 -0.678 . . . . 0.0 109.401 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . -91.07 -7.83 65.41 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.028 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 47.81 -92.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 49' ' ' SER . 2.4 t -161.57 95.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.146 -0.971 . . . . 0.0 109.963 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -100.11 134.78 42.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.608 -0.682 . . . . 0.0 109.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 58' ' ' PHE . . . -121.84 130.5 53.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -137.32 104.66 5.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.96 . . . . 0.0 110.692 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -79.36 150.82 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.373 -0.83 . . . . 0.0 109.868 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.34 132.17 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -153.51 151.38 29.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -40.68 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.206 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.32 -65.84 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -171.91 -179.56 2.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -1.051 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 10.5 m -100.48 149.09 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.172 -0.955 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.538 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -122.99 179.4 1.03 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.538 ' CD ' ' HB3' ' A' ' 56' E LYS . 5.6 Cg_endo -90.62 -170.94 0.4 Allowed 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.014 1.809 . . . . 0.0 110.269 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 40.5 t80 176.49 109.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.207 -0.933 . . . . 0.0 111.03 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.0 OUTLIER -81.68 99.33 0.26 Allowed 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.843 -1.732 . . . . 0.0 109.682 -0.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.534 ' CA ' ' HB2' ' A' ' 57' ' ' PRO . 13.7 m 50.59 -159.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.856 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.458 ' HB3' ' HD3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -107.77 -175.97 2.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.078 -1.014 . . . . 0.0 111.087 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -121.62 40.63 3.56 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.772 0.796 . . . . 0.0 109.429 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 64' ' ' THR . 11.6 mtpt -64.6 -52.23 58.59 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.785 -0.572 . . . . 0.0 110.112 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.528 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 76.56 -73.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.137 0.494 . . . . 0.0 110.435 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -122.39 3.51 9.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.92 . . . . 0.0 110.293 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.318 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.537 ' HA ' HD11 ' A' ' 5' ' ' ILE . 7.8 mtt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.169 0.509 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 5.4 tt0 57.05 29.61 16.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 110.476 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 43' ' ' THR . 5.2 mm-40 -129.56 -133.52 0.22 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.171 -0.955 . . . . 0.0 108.573 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.94 75.8 0.94 Allowed 'General case' 0 C--N 1.281 -2.387 0 O-C-N 121.764 -0.585 . . . . 0.0 109.92 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.555 HG22 ' HB2' ' A' ' 10' ' ' TYR . 1.5 mt -90.67 148.51 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.735 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.589 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 1.3 p -90.95 169.23 11.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 112.296 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.915 HD11 HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -61.5 -25.88 67.55 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.738 ' HG2' HG23 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -81.43 -83.43 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.489 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 8' ' ' LYS . 75.7 m-20 -41.05 -54.6 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.971 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.589 ' CB ' ' O ' ' A' ' 6' ' ' THR . 43.7 t80 -51.12 -58.27 6.56 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -53.66 -23.36 11.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.522 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -34.19 52.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.635 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -91.67 -12.85 32.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -123.46 -49.95 1.89 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.276 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.18 134.81 2.86 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.413 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -60.9 -32.22 71.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.211 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -84.06 -11.45 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 110.192 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -51.94 7.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.204 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.493 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -65.6 -31.61 72.74 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.425 -0.797 . . . . 0.0 108.893 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.637 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -75.68 -26.29 57.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.607 -0.683 . . . . 0.0 109.773 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -27.98 61.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -82.94 -27.55 30.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 110.305 -179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HG ' ' OD1' ' A' ' 22' ' ' ASP . 25.9 mt -80.66 -10.8 59.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.965 . . . . 0.0 110.103 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 48.08 75.29 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 23' ' ' LEU . 1.5 t -141.22 153.1 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.343 -1.092 . . . . 0.0 110.033 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.814 ' O ' HD12 ' A' ' 30' ' ' ILE . 31.8 m-85 -66.75 157.55 32.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.122 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -64.65 -11.66 37.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.26 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.9 t -75.96 -62.31 1.64 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.87 -35.91 4.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.234 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.814 HD12 ' O ' ' A' ' 26' ' ' TYR . 3.7 mt -74.77 -48.15 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -55.11 -13.65 1.3 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.311 -0.868 . . . . 0.0 110.753 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -93.32 -38.94 11.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 108.385 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.32 -7.66 57.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.738 HG23 ' HG2' ' A' ' 8' ' ' LYS . 13.1 mt -110.89 -53.35 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.566 -0.709 . . . . 0.0 109.495 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.549 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 83.7 t60 -52.5 -31.3 34.53 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.196 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.17 -43.0 13.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.461 -0.774 . . . . 0.0 109.659 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.52 55.75 16.46 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HD2' ' H ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -85.14 39.86 0.79 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.189 -1.183 . . . . 0.0 111.153 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.5 OUTLIER 72.74 101.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.383 -0.823 . . . . 0.0 111.176 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.708 ' CG2' HD21 ' A' ' 7' ' ' LEU . 6.6 mt -145.61 159.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 99.4 m-85 -154.08 160.86 42.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.918 -1.114 . . . . 0.0 111.218 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.915 HD21 HD11 ' A' ' 7' ' ' LEU . 4.7 mp -143.47 114.72 7.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.53 -0.731 . . . . 0.0 110.3 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 54.0 m -89.28 100.62 13.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.844 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.722 ' CD1' HG22 ' A' ' 50' ' ' VAL . 3.7 mm -79.91 74.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 0.0 110.21 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.468 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 3.3 p30 -44.31 167.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 110.397 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -8.97 2.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -78.6 7.0 7.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.02 11.95 46.99 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.417 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 42.6 m -84.7 -173.06 4.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -1.165 . . . . 0.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 44' ' ' ILE . 70.8 t -138.42 101.34 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.062 -1.024 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -78.71 77.87 5.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.016 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.46 86.05 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 110.537 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 56' E LYS . 37.1 mt-10 -102.41 108.0 19.18 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' O ' ' CB ' ' A' ' 56' D VAL . 0.0 OUTLIER -79.52 176.01 10.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.39 -0.819 . . . . 0.0 109.705 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -142.31 110.49 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.859 . . . . 0.0 110.364 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 27.2 ttmt -128.92 154.64 46.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' A ASP . . . . . . . . . . . . . 48.0 m-20 -47.83 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 146.55 -52.14 0.57 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.95 168.97 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.453 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 27.0 m -81.98 -177.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.8 mttm -148.54 172.07 5.6 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.248 -0.908 . . . . 0.0 110.389 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.484 ' HG2' ' HA ' ' A' ' 60' ' ' SER . 1.6 Cg_endo -85.45 -47.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.947 1.764 . . . . 0.0 110.27 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 3.0 t80 56.31 95.82 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.249 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 6.4 Cg_exo -70.1 157.21 93.24 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.835 -2.152 . . . . 0.0 110.284 0.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.7 m -65.02 87.09 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.22 37.86 13.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.461 -0.774 . . . . 0.0 110.725 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER 50.34 50.19 19.19 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.528 -0.733 . . . . 0.0 109.381 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 62' ' ' LYS . 13.7 mtmt -32.93 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.263 0.554 . . . . 0.0 111.317 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.56 ' N ' ' O ' ' A' ' 62' ' ' LYS . 18.7 m -170.21 -58.62 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.418 -0.801 . . . . 0.0 109.779 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.539 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 9.6 t -175.65 -34.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.448 -0.783 . . . . 0.0 110.222 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.218 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.242 0.544 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.25 163.91 7.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.334 -0.854 . . . . 0.0 110.218 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -113.0 62.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.99 . . . . 0.0 110.016 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -82.95 66.82 8.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.672 HG23 ' HB2' ' A' ' 10' ' ' TYR . 4.8 tp -87.13 173.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 41' ' ' PHE . 5.1 p -77.29 -172.7 2.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.296 1.045 . . . . 0.0 111.108 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.857 HD22 HD12 ' A' ' 40' ' ' ILE . 1.4 tp -90.2 -34.65 15.73 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -85.37 -69.78 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.621 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -41.66 -49.17 4.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.247 -0.908 . . . . 0.0 109.111 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.71 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.6 t80 -50.15 -59.61 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.583 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -48.09 -31.07 5.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 109.449 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.438 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.71 -53.47 55.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.627 -0.67 . . . . 0.0 109.813 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -59.31 -31.19 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.789 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CD2' ' HE3' ' A' ' 18' ' ' LYS . 5.0 m-85 -106.76 -81.06 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.253 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 162.87 -176.46 39.15 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.418 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.9 OUTLIER -85.14 -27.5 26.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.096 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 m -85.88 -16.37 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HE3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -89.59 -39.92 12.94 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.288 -0.883 . . . . 0.0 108.969 179.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.5 m -71.68 -26.32 62.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.552 -0.718 . . . . 0.0 109.266 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.643 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -83.7 -39.21 20.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 110.443 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -62.74 -32.39 73.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.728 ' OD1' HG21 ' A' ' 50' ' ' VAL . 1.3 t0 -80.67 -31.53 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.041 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.9 mt -89.19 -7.87 54.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.394 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.14 49.79 50.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -133.43 147.48 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -1.195 . . . . 0.0 109.937 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -59.39 163.54 3.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.262 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -26.11 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 t -83.47 -51.48 7.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.92 . . . . 0.0 109.878 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -47.99 -23.74 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.79 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -81.01 -68.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.774 . . . . 0.0 109.726 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.79 ' N ' HG22 ' A' ' 30' ' ' ILE . 2.1 m-20 -52.39 -13.69 0.39 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 111.235 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.39 -43.77 9.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.511 -1.368 . . . . 0.0 108.683 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -76.06 -6.96 53.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.534 -0.729 . . . . 0.0 109.053 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.855 HG12 HD21 ' A' ' 7' ' ' LEU . 19.0 mt -111.85 -50.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 0.0 109.998 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 23.7 t-160 -59.15 -23.67 62.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.12 -0.988 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.429 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.3 49.43 0.36 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.696 ' HG3' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.6 123.3 28.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -1.071 . . . . 0.0 110.299 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 55' ' ' VAL . 6.5 ptpp? -86.69 59.99 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.857 HD12 HD22 ' A' ' 7' ' ' LEU . 43.9 mt -96.94 169.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.579 0.704 . . . . 0.0 111.033 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 55.9 m-85 -149.79 110.13 4.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.786 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.9 mp -85.08 135.65 33.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.512 HG22 ' ND2' ' A' ' 45' ' ' ASN . 3.2 m -101.34 104.3 15.28 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.717 HG23 ' O ' ' A' ' 49' ' ' SER . 53.8 mt -93.56 44.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.073 -1.017 . . . . 0.0 111.246 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.512 ' ND2' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -87.58 -127.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.94 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.78 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 43.28 27.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.955 -1.09 . . . . 0.0 109.81 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.557 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 43.5 t0 73.69 69.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.313 0.578 . . . . 0.0 111.797 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.28 0.23 35.95 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.78 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 1.1 p -58.76 -165.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.283 . . . . 0.0 110.369 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.728 HG21 ' OD1' ' A' ' 22' ' ' ASP . 14.1 t -146.28 124.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -135.49 164.09 28.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.32 -0.863 . . . . 0.0 109.989 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -141.8 132.43 25.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.462 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' E LYS . 39.1 tt0 -159.76 116.07 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 110.003 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HB3' HG12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -95.5 178.45 5.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.605 -179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.499 ' O ' ' HD3' ' A' ' 39' ' ' LYS . 6.2 t -140.16 107.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.464 -0.772 . . . . 0.0 109.621 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.01 155.02 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 110.582 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' A ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.24 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 137.71 -53.46 0.73 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -178.0 171.53 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 110.268 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 56' E LYS . 28.0 m -94.17 164.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 56' D VAL . 6.8 mtpt -142.39 168.59 13.0 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 1.9 Cg_endo -83.61 -173.61 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 121.897 1.731 . . . . 0.0 109.947 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 85.3 t80 179.24 124.77 0.22 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.232 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.9 Cg_endo -87.33 100.2 0.25 Allowed 'Cis proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.745 -1.773 . . . . 0.0 110.311 -0.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 61' ' ' ASN . 53.4 p -72.09 80.08 0.95 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 110.933 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 60' ' ' SER . 0.9 OUTLIER 166.0 46.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.214 -0.929 . . . . 0.0 110.089 179.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 5.1 ttmt -179.65 63.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.451 -0.781 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.34 176.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.001 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -78.4 -45.54 22.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.97 . . . . 0.0 110.42 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 t -156.76 19.91 0.32 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.144 179.863 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.209 0.528 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -116.69 -174.79 2.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.363 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.498 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 50.2 mm-40 -138.66 85.53 2.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.187 -0.946 . . . . 0.0 109.747 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 2.9 ttp180 -78.57 79.72 4.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.44 -0.788 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.657 HG22 ' HB2' ' A' ' 10' ' ' TYR . 69.1 mt -89.56 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.854 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -48.91 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.439 1.114 . . . . 0.0 111.94 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.744 ' HG ' HD11 ' A' ' 34' ' ' ILE . 2.0 tp -94.01 -38.17 11.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HB2' HD13 ' A' ' 34' ' ' ILE . 11.7 tmtt? -90.28 -56.67 3.12 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.386 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 25.7 t70 -50.89 -42.01 58.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.657 ' HB2' HG22 ' A' ' 5' ' ' ILE . 14.6 t80 -58.17 -61.27 2.68 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.793 0.806 . . . . 0.0 109.887 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.661 ' HB2' ' OG1' ' A' ' 19' ' ' THR . . . -56.3 -18.03 9.45 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.396 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -38.99 50.42 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -52.45 -42.84 64.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.555 -0.715 . . . . 0.0 109.173 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -114.46 -99.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.265 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.65 155.12 20.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.509 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -75.99 -28.2 57.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 110.266 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -74.97 -12.33 60.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -81.32 -58.19 3.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.219 -0.926 . . . . 0.0 108.617 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.661 ' OG1' ' HB2' ' A' ' 11' ' ' ALA . 15.5 m -50.68 -34.18 25.55 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.39 -38.62 55.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 110.898 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -35.01 79.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 110.327 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.7 -50.14 65.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.8 mt -80.66 -7.63 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.78 38.13 95.2 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 26' ' ' TYR . 3.0 t -112.88 178.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.087 -1.243 . . . . 0.0 109.917 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.575 ' O ' HD12 ' A' ' 30' ' ' ILE . 90.9 m-85 -100.65 141.03 34.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.193 -0.942 . . . . 0.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -46.95 -23.19 0.41 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t -72.38 -51.71 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.487 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.46 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -54.25 -26.13 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.066 -1.021 . . . . 0.0 110.053 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.668 HG23 HD12 ' A' ' 34' ' ' ILE . 1.3 mp -76.46 -55.8 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 2.6 m-80 -57.88 -14.12 5.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 110.545 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -94.56 -48.38 6.12 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.733 -1.229 . . . . 0.0 108.832 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -72.31 -3.1 21.84 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.132 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.744 HD11 ' HG ' ' A' ' 7' ' ' LEU . 9.5 mt -120.06 -49.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.272 -0.892 . . . . 0.0 110.547 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.566 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t60 -69.48 -7.75 40.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.967 -1.083 . . . . 0.0 110.098 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -77.96 -28.71 49.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.123 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.54 31.28 1.84 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -90.53 -176.97 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.52 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 82.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.273 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.616 HD12 ' CD2' ' A' ' 7' ' ' LEU . 4.1 mt -102.95 160.26 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 41.0 m-85 -153.35 160.71 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.078 -1.014 . . . . 0.0 110.529 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 4' ' ' ARG . 3.7 mp -134.82 155.45 50.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 110.534 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 20.6 m -127.8 105.29 8.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 109.618 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.664 HG22 ' H ' ' A' ' 45' ' ' ASN . 0.7 OUTLIER -84.93 -148.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.087 -1.008 . . . . 0.0 110.974 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.664 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 38.37 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.252 0.549 . . . . 0.0 110.628 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.658 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 62.01 12.02 4.65 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.658 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 3.8 t70 135.47 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 124.147 0.979 . . . . 0.0 109.325 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.85 11.59 81.25 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -83.23 121.74 27.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.998 . . . . 0.0 110.232 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.2 118.4 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 110.375 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 3.7 m-85 -98.39 155.85 17.03 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.928 . . . . 0.0 108.541 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -142.31 86.74 1.98 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 110.419 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -101.56 -177.12 3.34 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 110.192 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 56' E LYS . 0.3 OUTLIER -152.67 173.48 15.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.272 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.442 HG22 HG12 ' A' ' 56' D VAL . 86.7 t -142.95 151.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.987 -1.07 . . . . 0.0 110.515 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 158.41 30.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' A ASP . . . . . . . . . . . . . 7.5 t0 -57.55 -11.62 2.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.08 -1.013 . . . . 0.0 110.633 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 56' C GLU . . . -100.83 -38.62 3.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' C GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' B GLY . 0.6 OUTLIER 174.58 179.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 110.288 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.442 HG12 HG22 ' A' ' 55' ' ' VAL . 35.6 m -102.64 148.16 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.288 -0.882 . . . . 0.0 109.862 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -144.58 166.7 17.41 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 0.0 110.474 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.8 Cg_exo -80.81 179.79 5.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.457 1.767 . . . . 0.0 110.287 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 3.1 t80 -159.99 125.61 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.003 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 71.2 Cg_endo -88.82 47.78 1.05 Allowed 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.802 -1.749 . . . . 0.0 110.87 0.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 61' ' ' ASN . 0.3 OUTLIER 45.32 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 110.49 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 60' ' ' SER . 14.8 p30 37.74 -162.2 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.619 0.723 . . . . 0.0 111.101 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -146.99 51.12 1.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 0.0 110.228 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 62' ' ' LYS . 1.6 mtmm 32.53 95.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.819 -0.551 . . . . 0.0 111.349 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.5 p -77.83 137.72 38.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.925 . . . . 0.0 110.018 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.584 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 5.6 t -57.15 -22.09 37.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.126 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.093 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.29 0.567 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.643 ' HG2' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -72.73 163.52 27.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 110.271 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -119.18 75.48 1.05 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.291 -0.88 . . . . 0.0 108.859 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 8.4 ttm180 -76.97 83.05 3.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.692 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.659 HG21 ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -77.43 -174.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.547 -0.721 . . . . 0.0 109.721 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.83 -178.78 5.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 111.45 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.929 HD21 HG12 ' A' ' 34' ' ' ILE . 9.4 tp -92.33 -46.14 7.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.58 -65.71 0.99 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.881 -0.512 . . . . 0.0 110.07 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.489 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 10.3 t70 -45.03 -46.92 11.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 108.89 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.659 ' CG ' HG21 ' A' ' 5' ' ' ILE . 8.6 t80 -53.59 -62.44 1.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.779 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -51.82 -20.73 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.501 -0.749 . . . . 0.0 109.722 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.9 ttm -72.62 -49.6 30.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.65 76.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.091 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.59 -83.13 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 110.356 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.58 150.05 12.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -31.0 69.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -1.172 . . . . 0.0 110.087 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 t -83.75 -14.61 51.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -82.43 -52.94 6.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.779 HG21 ' HB2' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -61.8 -31.39 71.61 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -47.1 55.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.657 -0.652 . . . . 0.0 110.02 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -69.72 -17.0 63.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.531 -0.731 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 50' ' ' VAL . 1.3 m-20 -79.79 -34.86 39.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.173 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.66 HD11 HD21 ' A' ' 42' ' ' LEU . 7.0 mt -80.75 -25.77 37.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 110.144 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' C ' ' CG2' ' A' ' 25' ' ' VAL . . . 86.34 63.88 1.48 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.465 ' CG2' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -154.04 147.45 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.225 -1.162 . . . . 0.0 109.766 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -47.56 167.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 110.136 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -87.62 -19.07 28.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.373 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 m -79.63 -63.57 1.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.091 -1.006 . . . . 0.0 109.94 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.48 -24.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.986 . . . . 0.0 109.262 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -68.45 -62.34 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.749 ' N ' HG22 ' A' ' 30' ' ' ILE . 3.9 t-20 -55.76 -13.55 1.79 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.601 -0.687 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -93.96 -34.43 13.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 108.408 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.86 -8.15 59.66 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.929 HG12 HD21 ' A' ' 7' ' ' LEU . 21.9 mt -113.66 -49.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.753 . . . . 0.0 109.747 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 13.1 t60 -60.22 -39.79 87.86 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.741 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.64 -23.95 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.61 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.46 31.18 8.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -59.04 -177.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.116 . . . . 0.0 110.498 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -128.47 76.08 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.933 HG23 ' HG3' ' A' ' 54' ' ' GLU . 5.7 mt -113.16 167.73 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 111.047 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 79.3 m-85 -147.4 122.99 10.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.7 mp -90.84 142.41 27.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.978 -1.076 . . . . 0.0 111.56 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.643 HG23 ' HG2' ' A' ' 2' ' ' GLU . 1.2 m -110.15 103.88 12.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 49' ' ' SER . 56.5 mt -84.15 60.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.832 -1.167 . . . . 0.0 111.51 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 16.7 p-10 -88.48 -146.16 0.15 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.836 -1.165 . . . . 0.0 110.28 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 49' ' ' SER . . . 56.2 14.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.459 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 26.4 t70 88.98 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 123.164 0.585 . . . . 0.0 110.115 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.07 14.48 0.57 Allowed Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.048 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.659 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 8.1 t -84.65 159.29 20.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.898 -1.354 . . . . 0.0 109.62 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.439 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 21.7 t -112.46 122.18 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 0.0 110.83 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -113.12 -171.09 1.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.853 . . . . 0.0 109.627 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -146.53 154.24 41.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 56' E LYS . 0.0 OUTLIER -159.49 106.75 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 110.091 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.933 ' HG3' HG23 ' A' ' 40' ' ' ILE . 5.6 mt-10 -83.57 165.5 19.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG13 HG12 ' A' ' 56' D VAL . 16.7 t -144.97 129.23 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.088 -1.008 . . . . 0.0 110.46 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 56' A ASP . 5.4 ttpp -146.83 94.53 2.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 65.1 t0 61.06 41.38 13.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.54 -0.725 . . . . 0.0 110.505 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 86.99 -11.15 65.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 4.9 tt0 -89.42 87.18 6.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.504 HG12 HG13 ' A' ' 55' ' ' VAL . 4.9 m -94.23 170.77 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.224 -0.923 . . . . 0.0 110.234 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -173.0 170.51 2.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 0.0 110.518 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 5.8 Cg_exo -80.53 166.39 19.88 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.474 1.776 . . . . 0.0 110.288 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.625 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 15.8 t80 -169.84 117.71 0.53 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 4.9 Cg_endo -84.04 100.89 0.32 Allowed 'Cis proline' 0 C--N 1.316 -1.165 0 C-N-CA 122.758 -1.767 . . . . 0.0 110.285 -0.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 97.6 p -46.97 106.6 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 110.053 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.81 -172.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.101 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.78 54.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.324 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -117.05 124.82 50.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 110.152 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.7 m -161.68 -39.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 0.0 110.324 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 t -125.11 -25.97 3.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 110.321 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.197 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.287 0.565 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 3' ' ' GLN . 23.7 tp10 -169.8 -77.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.951 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.501 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 8.4 mm-40 -118.14 72.22 0.85 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.358 -0.839 . . . . 0.0 109.839 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -83.88 65.16 8.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 110.272 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.968 HG22 ' HB2' ' A' ' 10' ' ' TYR . 30.6 mm -90.74 135.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.7 p -46.96 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.202 1.001 . . . . 0.0 111.254 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.698 ' HB3' HG21 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -91.81 -34.8 14.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.344 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -82.74 -69.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.844 -0.535 . . . . 0.0 110.174 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -44.39 -45.9 9.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 109.246 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.968 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.6 t80 -49.14 -59.47 3.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 110.294 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -46.81 -30.9 2.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 110.17 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -46.06 70.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -25.57 63.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 0.0 110.423 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -111.97 -64.34 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.309 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 155.58 160.44 9.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -75.07 -32.33 61.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -1.206 . . . . 0.0 109.903 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -9.67 59.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.751 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.61 -41.3 12.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.142 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 m -70.01 -24.53 63.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.517 -0.739 . . . . 0.0 109.615 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.67 20.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 0.0 110.393 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -75.99 -16.11 60.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' HB3' HG21 ' A' ' 50' ' ' VAL . 36.5 m-20 -90.6 -44.35 9.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.499 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD22 ' HD3' ' A' ' 59' ' ' PRO . 25.3 mt -79.65 -31.06 41.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 110.322 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.36 16.03 36.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -116.02 147.71 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 109.938 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -64.62 153.08 40.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.612 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.477 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 2.5 mt-30 -47.97 -25.97 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.341 -0.85 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.0 -54.59 31.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.761 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . . . -46.08 -36.06 5.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.788 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.627 HG23 HD11 ' A' ' 34' ' ' ILE . 1.4 mp -63.24 -47.67 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 109.868 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 71.3 m-80 -66.35 -6.44 14.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -88.57 -44.02 10.95 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.722 -1.236 . . . . 0.0 108.982 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -72.66 -28.08 62.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.674 HG13 HD21 ' A' ' 7' ' ' LEU . 49.3 mt -87.2 -51.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.477 -0.765 . . . . 0.0 109.91 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 20.5 t60 -68.46 -4.69 15.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.838 -1.164 . . . . 0.0 110.492 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -90.68 -59.37 2.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.032 -1.042 . . . . 0.0 111.411 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . -155.18 99.29 0.19 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.589 ' HE ' HG22 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -51.47 -164.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.868 -0.784 . . . . 0.0 111.523 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 1.1 tttt 73.03 48.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.698 HG21 ' HB3' ' A' ' 7' ' ' LEU . 17.0 mt -97.06 166.48 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.316 0.579 . . . . 0.0 110.316 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 91.6 m-85 -158.54 117.42 3.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -110.36 132.96 53.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.721 ' HG1' ' HD2' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -97.91 100.56 11.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 44' ' ' ILE . 57.2 mt -84.39 55.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.707 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 46' ' ' ALA . 24.0 p30 -104.74 -122.08 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.059 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.939 ' HB3' ' HB2' ' A' ' 49' ' ' SER . . . 42.48 30.42 0.21 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.975 -1.078 . . . . 0.0 109.839 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.7 t70 80.95 50.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.553 0.692 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 82.11 -9.53 56.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.939 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 7.2 m -52.7 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.041 -1.27 . . . . 0.0 109.747 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 22' ' ' ASP . 46.0 t -131.28 116.75 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.721 ' HD2' ' HG1' ' A' ' 43' ' ' THR . 5.5 t80 -120.55 140.48 51.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -96.1 150.97 19.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.033 -1.042 . . . . 0.0 110.07 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -159.73 85.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 110.138 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 56' D VAL . 6.0 mt-10 -84.69 169.65 14.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.093 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' A' ' 56' D VAL . 1.5 p -161.39 148.79 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.117 -0.99 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -157.4 112.95 2.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 110.235 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' A ASP . . . . . . . . . . . . . 31.4 t70 45.77 49.0 11.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.873 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 78.1 35.52 34.19 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 20.2 tt0 -137.85 84.16 2.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -1.169 . . . . 0.0 109.887 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 3.2 m -96.39 153.98 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.168 -0.957 . . . . 0.0 111.015 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' E LYS . . . . . . . . . . . . . 3.4 pttt -148.13 168.67 10.65 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.852 . . . . 0.0 110.107 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -82.81 -82.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.35 1.71 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER 56.92 107.36 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 0.0 109.951 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.6 ' HD3' HD22 ' A' ' 23' ' ' LEU . 13.5 Cg_exo -68.41 140.23 54.94 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.082 -2.049 . . . . 0.0 110.381 -0.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 p -87.12 161.83 17.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.335 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -138.68 -171.58 3.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 110.017 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.86 55.12 0.31 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.91 . . . . 0.0 110.284 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -80.07 120.88 24.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.097 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 p -70.37 -178.0 1.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 110.012 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.4 t -75.14 -26.43 59.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.313 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.101 179.831 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.9 mtt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.244 0.545 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.565 ' CB ' ' HB3' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -150.09 -60.61 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.34 -0.85 . . . . 0.0 110.295 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.582 ' CB ' ' ND2' ' A' ' 45' ' ' ASN . 4.6 mm-40 -124.09 77.47 1.55 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.193 -0.942 . . . . 0.0 109.221 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 2.7 ttm180 -78.95 82.5 5.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.62 -0.675 . . . . 0.0 109.634 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.597 HG21 ' HD1' ' A' ' 10' ' ' TYR . 12.5 mt -85.67 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.07 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 7.4 p -46.95 178.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.157 0.98 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.749 HD11 ' CD1' ' A' ' 30' ' ' ILE . 1.5 tp -91.58 -35.26 14.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.472 ' HG2' HG21 ' A' ' 34' ' ' ILE . 2.3 tmtt? -79.77 -68.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 6' ' ' THR . 5.6 t0 -45.28 -55.12 6.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.655 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.597 ' HD1' HG21 ' A' ' 5' ' ' ILE . 50.2 t80 -42.9 -60.05 1.75 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.418 -0.801 . . . . 0.0 111.219 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -60.38 -29.07 68.71 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.161 -0.962 . . . . 0.0 110.424 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -24.21 61.72 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -71.86 -47.82 50.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.518 -0.739 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 10' ' ' TYR . 26.9 p90 -111.42 -43.52 3.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.586 -1.321 . . . . 0.0 111.434 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 14' ' ' PHE . . . 168.24 162.92 21.28 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.033 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -90.6 -25.22 20.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.449 -1.03 . . . . 0.0 110.672 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.543 HG23 ' HG2' ' A' ' 18' ' ' LYS . 13.5 t -73.39 -18.28 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.982 . . . . 0.0 110.236 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HG2' HG23 ' A' ' 17' ' ' THR . 7.8 mttt -90.62 -34.52 15.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 11' ' ' ALA . 18.4 m -67.58 -32.09 72.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.68 -27.06 29.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.65 -0.656 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -83.75 -18.38 38.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 110.141 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' O ' HG11 ' A' ' 50' ' ' VAL . 50.9 m-20 -84.04 -41.55 17.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.058 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 59' ' ' PRO . 90.1 mt -79.91 -60.02 2.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 110.037 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.48 43.98 0.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.3 152.96 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -67.96 169.67 9.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.337 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 33.3 mt-30 -65.16 -35.36 80.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.912 . . . . 0.0 110.27 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.9 p -63.78 -54.44 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.767 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . . . -52.79 -23.2 6.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.131 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.749 ' CD1' HD11 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -71.2 -62.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.579 -0.701 . . . . 0.0 109.29 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.746 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -62.15 -8.03 4.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 110.447 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 15.1 mtpp -90.46 -38.21 13.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.808 -1.183 . . . . 0.0 108.37 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -86.58 -9.03 56.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 30' ' ' ILE . 19.3 mt -101.15 -46.18 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 31' ' ' ASN . 5.2 t60 -68.67 -56.85 6.81 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.238 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.98 40.46 1.03 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.281 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.806 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -176.19 79.12 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 38' ' ' ARG . 23.0 mmm-85 -84.52 -173.43 4.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -1.068 . . . . 0.0 110.53 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 4.3 mtmt 57.63 79.38 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 37' ' ' GLY . 7.1 mt -135.04 160.19 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.0 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.572 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 70.5 m-85 -153.67 154.38 34.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 110.349 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' A' ' 52' ' ' ALA . 4.1 mp -144.92 129.96 18.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.163 -0.961 . . . . 0.0 111.102 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.854 HG22 ' HA2' ' A' ' 48' ' ' GLY . 2.1 m -83.51 107.18 15.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 108.442 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.697 HG23 ' O ' ' A' ' 49' ' ' SER . 2.6 mt -129.15 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.048 -1.032 . . . . 0.0 111.689 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.612 ' H ' HG22 ' A' ' 44' ' ' ILE . 11.5 m-80 64.22 -165.06 0.24 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.8 0.81 . . . . 0.0 112.122 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.76 0.96 3.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.565 ' HB3' ' CB ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -136.77 41.46 2.52 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.854 ' HA2' HG22 ' A' ' 43' ' ' THR . . . -169.02 -27.17 0.02 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 120.038 -1.077 . . . . 0.0 110.633 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.4 OUTLIER 59.77 -92.74 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.855 -1.379 . . . . 0.0 107.715 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 49' ' ' SER . 5.5 t -161.2 77.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.299 -0.876 . . . . 0.0 110.455 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.98 137.92 43.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.504 -0.748 . . . . 0.0 109.042 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -129.59 113.91 15.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 110.836 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.72 121.58 23.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.789 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' D VAL . 7.9 pt-20 -91.21 159.0 16.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.43 139.9 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.266 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 56' C GLU . 0.7 OUTLIER -157.4 78.1 0.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.948 -1.095 . . . . 0.0 110.932 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 56' ' ' LYS . 31.0 t70 40.35 76.78 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.804 . . . . 0.0 111.279 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 83.51 -5.88 75.72 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.66 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' C GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 1.1 tt0 -117.68 83.37 1.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.894 -1.356 . . . . 0.0 110.342 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -124.02 124.12 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.488 -0.758 . . . . 0.0 109.702 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.31 164.13 40.94 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.513 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 3.8 Cg_exo -82.8 97.37 0.85 Allowed 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.015 1.81 . . . . 0.0 110.762 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CZ ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -133.07 140.59 37.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 110.068 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HG2' ' HB3' ' A' ' 23' ' ' LEU . 59.9 Cg_endo -92.97 52.48 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.495 -1.877 . . . . 0.0 110.028 -0.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.513 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 36.7 t -66.3 -12.77 58.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 110.719 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 60' ' ' SER . 6.8 t-20 63.77 175.81 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.781 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 52.17 0.93 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.012 . . . . 0.0 110.438 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 66' ' ' ALA . 20.3 mttt -63.74 -160.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.817 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.1 m -157.2 -34.8 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.98 -1.075 . . . . 0.0 110.98 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.575 ' O ' HG23 ' A' ' 65' ' ' THR . 9.3 t -131.99 41.91 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.115 -0.99 . . . . 0.0 110.598 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.576 ' HB2' ' HD3' ' A' ' 63' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.266 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 mtm . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.26 0.552 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.511 ' O ' ' NH1' ' A' ' 4' ' ' ARG . 23.2 mt-10 -140.53 139.34 35.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.469 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 2.7 mt-30 -101.97 49.7 0.85 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.484 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.578 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -79.89 85.04 5.57 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.822 0.82 . . . . 0.0 111.869 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.014 ' O ' HD12 ' A' ' 42' ' ' LEU . 4.6 mm -89.59 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.599 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 2.6 p -65.46 -178.89 0.56 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 111.405 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.944 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -87.29 -26.7 23.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.71 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -79.52 -77.93 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.271 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 8' ' ' LYS . 7.9 t70 -42.87 -59.23 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.995 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.829 ' HB2' HG22 ' A' ' 5' ' ' ILE . 8.6 t80 -41.96 -54.65 3.41 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.246 -0.909 . . . . 0.0 110.555 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.45 -38.25 71.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.181 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.5 ttt -63.54 -30.11 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.502 -0.749 . . . . 0.0 109.998 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.38 -41.01 28.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -109.37 -57.26 2.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.322 -0.861 . . . . 0.0 109.902 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 154.68 156.96 7.95 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 110.147 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 31.1 p -67.76 -11.5 58.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.919 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -85.91 -46.79 10.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.323 -0.861 . . . . 0.0 108.917 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -27.57 63.24 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.27 -32.41 22.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.669 -0.644 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.1 tmtp? -74.29 -18.63 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.908 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.94 -46.76 10.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 0.0 110.069 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.514 HD22 ' HD3' ' A' ' 59' ' ' PRO . 41.8 mt -80.87 -19.14 45.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.08 39.81 94.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.675 HG11 ' HG2' ' A' ' 59' ' ' PRO . 35.9 m -127.79 179.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -1.186 . . . . 0.0 110.206 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.64 142.41 49.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.297 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.445 ' HA ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -66.95 -11.5 56.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.92 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -72.43 -54.78 8.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.975 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.66 -25.15 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.59 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 34' ' ' ILE . 50.0 mt -78.57 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.586 -0.696 . . . . 0.0 109.797 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -58.52 -9.14 1.48 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 110.63 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -93.39 -42.22 9.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.699 -1.251 . . . . 0.0 108.228 178.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -75.24 -11.11 60.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.88 HD11 ' HB3' ' A' ' 7' ' ' LEU . 65.2 mt -105.83 -54.17 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 31.6 t60 -54.97 -23.47 19.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.77 85.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.53 37.93 1.39 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.64 -164.78 1.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -1.129 . . . . 0.0 110.633 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.447 ' HE2' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -145.45 87.64 1.81 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.649 ' CG2' HD21 ' A' ' 7' ' ' LEU . 27.3 mt -114.91 172.09 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.426 -0.797 . . . . 0.0 110.879 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.583 ' N ' HG22 ' A' ' 40' ' ' ILE . 38.5 m-85 -160.01 141.67 12.78 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.014 HD12 ' O ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -114.89 109.29 17.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.906 -1.121 . . . . 0.0 109.642 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 4' ' ' ARG . 1.4 m -75.93 102.12 5.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 108.746 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.507 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.9 mt -78.17 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 0.0 110.471 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 44' ' ' ILE . 9.1 p-10 34.28 -140.29 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.964 -0.46 . . . . 0.0 111.309 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.639 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . 49.1 26.35 1.4 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 46' ' ' ALA . 50.7 t0 97.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 123.697 0.799 . . . . 0.0 108.87 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.09 9.78 43.19 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.93 113.58 3.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.794 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.1 t -86.29 100.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 110.334 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 28.5 m-85 -104.73 92.77 4.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.1 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.675 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -88.48 135.47 33.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.05 -1.031 . . . . 0.0 109.361 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 56' E LYS . 0.8 OUTLIER -156.76 135.17 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.15 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -83.73 171.39 13.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.492 -0.755 . . . . 0.0 109.447 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 56' D VAL . 10.4 t -140.28 141.61 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 110.441 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 56' A ASP . 0.8 OUTLIER -157.02 120.4 4.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 28.3 t70 57.74 -90.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . -146.35 43.76 0.87 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 5.7 tt0 -156.65 123.81 5.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -1.155 . . . . 0.0 110.35 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.456 HG12 HG13 ' A' ' 55' ' ' VAL . 10.0 m -109.97 155.99 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 11.9 mttm -135.78 164.47 43.11 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.863 . . . . 0.0 109.486 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 56' E LYS . 4.6 Cg_exo -82.6 150.71 14.82 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.917 1.745 . . . . 0.0 111.006 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 1.9 t80 -146.16 128.87 8.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HG2' HG11 ' A' ' 25' ' ' VAL . 9.6 Cg_endo -89.16 52.92 0.66 Allowed 'Cis proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.98 -1.675 . . . . 0.0 110.648 0.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER 41.86 68.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 2.7 m120 -98.38 47.38 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 109.812 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 3.7 tttt 175.15 53.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 109.745 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 64' ' ' THR . 0.3 OUTLIER -48.84 167.08 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.431 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 63' ' ' LYS . 65.5 p 42.17 -153.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 110.299 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 1.8 t -168.87 -34.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.848 . . . . 0.0 110.487 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.232 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.246 0.546 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.461 ' OE2' ' HB2' ' A' ' 4' ' ' ARG . 2.7 pt-20 -139.63 156.93 46.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.968 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 3.4 mm-40 -116.31 70.11 0.76 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.085 -1.009 . . . . 0.0 109.886 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.461 ' HB2' ' OE2' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -79.51 74.9 6.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.713 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.722 HD12 ' CE1' ' A' ' 10' ' ' TYR . 10.2 mt -90.67 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.641 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -70.65 -173.45 0.76 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.069 0.938 . . . . 0.0 111.491 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.641 ' H ' HG22 ' A' ' 6' ' ' THR . 1.6 tp -93.99 -38.61 11.07 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.521 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 1.3 tmtt? -90.11 -67.39 0.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.51 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 9.5 m-20 -43.9 -44.11 6.83 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.722 ' CE1' HD12 ' A' ' 5' ' ' ILE . 8.4 t80 -57.96 -54.29 48.56 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.975 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.08 -20.73 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -21.6 21.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.969 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.31 -12.95 25.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.25 -27.76 4.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.965 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.69 130.92 3.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.77 72.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -1.165 . . . . 0.0 109.813 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 15.5 p -82.07 -14.08 56.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -55.37 4.8 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.42 -0.8 . . . . 0.0 108.87 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' HD21 ' A' ' 23' ' ' LEU . 66.7 m -57.18 -32.08 66.09 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 25' ' ' VAL . . . -71.41 -44.97 63.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' THR . 4.9 tmtt? -80.25 1.63 27.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.843 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.525 ' HB3' HG21 ' A' ' 50' ' ' VAL . 53.1 m-20 -89.9 -43.07 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.803 HD12 HG21 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -115.25 -8.55 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.677 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.97 67.95 1.26 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.81 ' CG1' HD11 ' A' ' 30' ' ' ILE . 60.8 t -142.88 140.0 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -1.189 . . . . 0.0 110.34 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' O ' HG12 ' A' ' 30' ' ' ILE . 4.3 m-85 -75.0 139.63 43.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 0.0 110.184 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -46.82 -23.84 0.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -69.92 -58.8 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' N ' ' OG ' ' A' ' 28' ' ' SER . . . -46.96 -25.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.671 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.878 HG22 HD12 ' A' ' 34' ' ' ILE . 2.7 mm -71.29 -56.27 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.765 . . . . 0.0 109.986 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -62.81 -8.96 7.87 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -94.74 -40.48 9.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.748 -1.22 . . . . 0.0 108.612 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -79.86 -9.45 59.67 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 HG22 ' A' ' 30' ' ' ILE . 76.5 mt -108.8 -49.12 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.53 -0.731 . . . . 0.0 110.067 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.579 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 16.8 t-160 -63.39 -33.41 75.48 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.947 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.0 -21.59 59.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.64 30.3 13.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -78.3 -173.5 3.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.227 -1.161 . . . . 0.0 110.256 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.76 75.36 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.174 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 58' ' ' PHE . 62.1 mt -106.17 169.25 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 50.9 m-85 -156.56 158.83 37.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 7' ' ' LEU . 3.1 mp -134.4 114.96 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.0 110.492 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.769 HG23 ' O ' ' A' ' 43' ' ' THR . 13.0 t -93.55 102.95 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 109.848 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' SER . 1.9 mp -91.68 130.23 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.055 . . . . 0.0 110.453 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.763 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 8.2 m-20 -50.53 -19.52 0.91 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.09 -19.52 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.66 -11.96 57.97 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.34 -22.86 5.85 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.822 ' O ' HG23 ' A' ' 44' ' ' ILE . 5.0 t -60.04 148.63 34.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 109.583 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 22' ' ' ASP . 52.9 t -133.4 123.32 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.991 -1.068 . . . . 0.0 111.047 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 15.0 t80 -120.64 119.18 32.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 108.933 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 58' ' ' PHE . . . -93.61 154.28 17.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.921 -1.112 . . . . 0.0 111.241 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -160.35 142.53 12.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.563 -0.711 . . . . 0.0 109.844 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 56' D VAL . 11.7 tm-20 -121.47 167.18 13.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.4 116.49 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.463 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' B GLY . 11.3 ttmt -143.2 153.86 43.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 110.156 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' LYS . 28.9 t0 -43.73 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.465 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 147.66 -64.34 0.42 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -170.29 171.78 6.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.471 -1.017 . . . . 0.0 110.237 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 21.4 m -93.22 133.26 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 110.16 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 mmtp -116.87 132.61 23.33 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.978 . . . . 0.0 110.747 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.9 Cg_exo -80.23 125.81 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.218 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -140.88 144.54 35.93 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -91.47 48.53 1.27 Allowed 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.275 -1.969 . . . . 0.0 110.578 0.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.86 165.52 5.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -154.03 -173.53 4.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.238 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.57 52.34 1.0 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 109.678 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -104.52 95.67 6.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.423 -0.798 . . . . 0.0 110.413 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.458 ' O ' ' HB ' ' A' ' 65' ' ' THR . 30.0 p 42.62 -140.45 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.872 . . . . 0.0 110.392 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.675 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 9.5 t -178.25 57.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 110.228 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.249 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 mtm . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.248 0.547 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.37 65.77 0.73 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 110.528 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.627 ' CG ' ' O ' ' A' ' 3' ' ' GLN 0.257 0.7 OUTLIER -86.29 63.13 7.83 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.637 1.208 . . . . 0.0 108.882 179.905 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.561 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -78.59 73.55 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.922 -1.111 . . . . 0.0 111.375 -178.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.692 HG22 ' HB2' ' A' ' 10' ' ' TYR . 5.1 mt -88.28 145.73 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.145 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 2.3 p -66.53 -173.02 0.19 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.753 0.787 . . . . 0.0 111.246 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.076 HD23 HD12 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -90.44 -26.62 19.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.506 ' HG2' HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -81.94 -73.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.071 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.7 -56.29 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.045 -1.034 . . . . 0.0 109.709 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' A' ' 5' ' ' ILE . 6.1 t80 -46.74 -53.81 11.02 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.21 -33.16 65.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ttm -63.79 -40.19 96.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.258 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 -28.37 50.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.55 -74.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 110.171 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.16 148.19 5.83 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -58.17 -39.0 77.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -1.102 . . . . 0.0 109.845 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.51 -14.21 59.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 0.0 110.364 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -79.49 -56.31 4.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.199 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 2.1 m -62.51 -29.25 70.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.58 -29.82 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 110.259 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -82.72 -14.57 54.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 110.296 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.798 ' OD1' HG21 ' A' ' 50' ' ' VAL . 4.1 t70 -90.14 -25.39 20.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 109.949 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 30' ' ' ILE . 95.6 mt -79.96 -35.85 37.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 110.358 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.97 23.17 30.77 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -132.81 157.16 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -1.095 . . . . 0.0 110.074 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 25' ' ' VAL . 49.5 m-85 -46.6 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 110.437 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -85.11 -13.78 49.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 110.559 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 t -76.91 -56.39 4.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.955 . . . . 0.0 110.315 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.81 -25.3 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 109.966 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.757 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -76.27 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.846 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.757 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.6 OUTLIER -58.82 -7.91 1.17 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.427 -0.796 . . . . 0.0 111.132 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -91.39 -40.37 11.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.514 -1.366 . . . . 0.0 108.169 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.432 ' O ' ' CD ' ' A' ' 38' ' ' ARG . . . -75.29 -18.84 59.96 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.854 HD11 ' HB3' ' A' ' 7' ' ' LEU . 37.7 mt -96.71 -52.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.423 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 72.3 t60 -52.06 -23.03 4.65 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.295 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.42 -55.5 13.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.814 . . . . 0.0 110.464 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 38' ' ' ARG . . . 124.57 8.96 5.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -51.34 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.401 -1.058 . . . . 0.0 111.835 -179.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.86 81.18 1.86 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.492 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.076 HD12 HD23 ' A' ' 7' ' ' LEU . 1.8 mt -97.07 157.5 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.174 -0.954 . . . . 0.0 110.78 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 97.9 m-85 -150.13 98.16 2.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.453 -0.779 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.756 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.8 mp -85.13 101.82 12.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.139 -0.976 . . . . 0.0 111.251 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 43' ' ' THR . 2.3 m -77.78 100.73 6.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.166 -0.958 . . . . 0.0 108.842 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 49' ' ' SER . 5.4 mt -96.5 132.47 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.987 . . . . 0.0 111.453 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 14.2 m-20 -54.66 -17.86 3.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.701 -0.624 . . . . 0.0 110.597 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 90.92 -15.84 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.33 -17.01 28.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.785 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 135.88 -27.06 3.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -57.09 112.04 1.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.243 . . . . 0.0 109.392 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.798 HG21 ' OD1' ' A' ' 22' ' ' ASP . 29.2 t -109.18 126.31 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.463 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 7.1 m-85 -116.64 108.79 16.36 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -88.06 119.0 28.01 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.034 -1.042 . . . . 0.0 110.615 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 56' E LYS . 0.0 OUTLIER -148.18 121.33 8.9 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.358 -0.839 . . . . 0.0 110.567 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' D VAL . 9.3 mt-10 -81.25 154.76 26.43 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.05 115.01 2.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.685 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' A ASP . 0.0 OUTLIER -148.99 121.91 8.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 109.624 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 26.1 t70 58.42 16.78 4.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.623 ' O ' HG13 ' A' ' 56' D VAL . . . 100.81 -27.68 19.44 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 111.57 3.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -1.196 . . . . 0.0 110.505 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.623 HG13 ' O ' ' A' ' 56' B GLY . 3.3 m -111.71 146.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 110.324 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 7.3 mtpt -145.46 157.89 51.61 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.136 -0.978 . . . . 0.0 110.523 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.7 Cg_endo -83.4 174.5 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.776 1.651 . . . . 0.0 110.222 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 84.4 t80 176.98 113.35 0.13 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 110.303 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 5.6 Cg_exo -78.05 108.21 1.15 Allowed 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.589 -1.838 . . . . 0.0 110.53 0.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 57' ' ' PRO . 14.1 p -55.54 -167.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 110.56 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -55.45 -167.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.0 110.531 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' O ' ' C ' ' A' ' 63' ' ' LYS . 2.9 mttm -132.87 45.29 2.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.366 -0.834 . . . . 0.0 109.996 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' C ' ' O ' ' A' ' 62' ' ' LYS . 3.7 mmmt 30.01 -138.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.117 0.484 . . . . 0.0 111.134 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 p -96.78 -139.79 0.27 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.668 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 9.7 t -65.03 -12.54 51.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.242 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.076 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.163 0.506 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -123.72 136.82 54.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 0.0 109.972 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.3 mt-30 -127.74 76.78 1.7 Allowed 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.102 -0.998 . . . . 0.0 110.019 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.565 ' HD2' HG22 ' A' ' 43' ' ' THR . 0.4 OUTLIER -79.13 81.89 5.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.896 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.601 HD12 ' CE1' ' A' ' 10' ' ' TYR . 2.0 mt -90.46 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.477 -0.764 . . . . 0.0 110.063 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -74.52 -169.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.059 0.933 . . . . 0.0 111.7 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 40' ' ' ILE . 5.2 tp -91.44 -42.48 10.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.737 ' HB2' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -91.11 -58.05 2.6 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -46.19 -49.33 17.11 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.601 ' CE1' HD12 ' A' ' 5' ' ' ILE . 3.6 t80 -56.32 -57.04 13.95 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.818 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.42 -20.21 2.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.536 -0.727 . . . . 0.0 109.926 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 1.5 ttp -71.65 -44.84 63.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 110.362 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -70.46 -21.95 62.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.199 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 13.2 m-85 -112.02 -89.91 0.51 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.64 151.76 14.01 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.54 -35.98 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -1.107 . . . . 0.0 109.942 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.9 t -78.48 -11.84 59.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -47.75 9.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.23 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.5 m -67.7 -26.99 66.44 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.441 -0.787 . . . . 0.0 109.341 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.48 -37.98 50.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -0.757 . . . . 0.0 110.271 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.76 68.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.065 ' OD2' HG11 ' A' ' 50' ' ' VAL . 3.3 t70 -73.9 -38.48 64.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.486 ' HB2' HG23 ' A' ' 25' ' ' VAL . 24.4 mt -84.99 -12.41 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.03 49.9 37.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -128.27 176.93 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.194 -1.18 . . . . 0.0 109.902 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 1.4 m-85 -93.48 148.02 22.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.88 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.475 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.4 tt0 -44.9 -47.73 11.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.848 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -53.47 -56.58 15.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.762 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.57 -32.03 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.502 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.74 HG22 HD12 ' A' ' 34' ' ' ILE . 3.1 mm -66.34 -54.48 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.789 0.804 . . . . 0.0 109.856 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -52.41 -17.16 1.08 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.546 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.766 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -95.69 -36.59 11.14 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.439 -1.413 . . . . 0.0 108.924 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -78.64 2.95 17.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.53 -0.731 . . . . 0.0 109.178 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 30' ' ' ILE . 20.3 mt -135.55 -46.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.591 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 3.4 t60 -79.62 -11.61 59.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.209 -0.932 . . . . 0.0 110.512 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -90.27 -24.2 20.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.131 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.65 51.13 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.604 ' CG ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -90.78 130.38 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.331 -1.1 . . . . 0.0 110.592 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.35 65.49 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 109.02 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 7' ' ' LEU . 1.1 mt -94.28 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.509 -0.744 . . . . 0.0 110.74 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 95.7 m-85 -142.75 121.63 12.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.413 -0.804 . . . . 0.0 110.161 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.648 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.4 mp -105.38 113.52 27.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.898 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.565 HG22 ' HD2' ' A' ' 4' ' ' ARG . 0.5 OUTLIER -90.05 103.06 15.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.12 -0.988 . . . . 0.0 108.82 179.094 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 6.6 mt -101.11 125.61 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.081 -1.012 . . . . 0.0 110.737 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -91.88 -178.08 4.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.342 -0.848 . . . . 0.0 110.334 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.86 -2.77 7.9 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.68 -2.16 57.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.438 -0.789 . . . . 0.0 110.436 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -6.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.413 ' O ' HG23 ' A' ' 44' ' ' ILE . 3.8 t -56.16 160.59 2.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.862 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.065 HG11 ' OD2' ' A' ' 22' ' ' ASP . 95.5 t -137.31 106.04 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.483 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 9.9 m-85 -88.92 84.41 6.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.68 110.55 9.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 109.049 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 56' E LYS . 0.4 OUTLIER -146.39 122.63 10.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.094 -1.004 . . . . 0.0 111.65 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' D VAL . 0.0 OUTLIER -78.73 159.56 27.88 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -154.36 132.84 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 110.568 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 56' C GLU . 0.2 OUTLIER -160.22 78.77 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 110.641 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.402 ' O ' ' CG ' ' A' ' 56' A ASP . 15.4 t0 51.08 46.01 27.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.528 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.42 ' O ' HG12 ' A' ' 56' D VAL . . . 114.44 -30.8 6.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' C GLU . . . . . 0.515 ' CB ' ' HB3' ' A' ' 56' ' ' LYS . 4.3 mt-10 -79.06 103.61 9.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.171 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -145.73 153.88 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pttt -171.3 161.37 5.24 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.131 -0.981 . . . . 0.0 110.483 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 58' ' ' PHE . 5.9 Cg_exo -81.29 48.46 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.747 1.631 . . . . 0.0 111.556 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.492 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 15.7 t80 -41.42 122.54 2.18 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.144 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' SER . 2.4 Cg_endo -82.38 103.38 0.51 Allowed 'Cis proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.517 -1.868 . . . . 0.0 110.48 -0.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' PRO . 8.0 p -40.91 153.49 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.231 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -159.58 -170.84 3.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.62 53.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 109.767 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.62 56.37 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.41 -0.807 . . . . 0.0 110.336 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.524 ' C ' ' CG2' ' A' ' 65' ' ' THR . 18.8 p -66.78 130.36 42.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.344 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.524 ' CG2' ' C ' ' A' ' 64' ' ' THR . 0.0 OUTLIER 37.87 29.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.829 0.823 . . . . 0.0 109.536 -179.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 64' ' ' THR . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.161 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 1.2 ttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.24 0.543 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.2 mt-10 57.12 -87.2 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.389 -0.819 . . . . 0.0 110.586 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 10.0 mm-40 -124.47 74.47 1.33 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.902 -1.124 . . . . 0.0 110.315 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 33.6 ttt-85 -79.68 84.03 5.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.714 HD12 ' CE1' ' A' ' 10' ' ' TYR . 5.9 mt -88.62 169.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -77.64 -174.12 3.29 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.04 0.924 . . . . 0.0 111.898 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.029 HD22 HD12 ' A' ' 40' ' ' ILE . 3.5 tp -91.78 -41.02 10.9 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.477 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.31 -53.29 4.52 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.554 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -53.51 -50.92 64.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.714 ' CE1' HD12 ' A' ' 5' ' ' ILE . 7.2 t80 -54.8 -54.69 38.89 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.641 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -53.03 -25.93 13.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.493 -0.754 . . . . 0.0 109.845 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.446 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 17.9 tpp -73.97 -36.84 64.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.852 . . . . 0.0 109.96 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.06 -30.03 60.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.93 -66.34 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.74 160.68 11.91 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.44 ' NE2' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -72.81 -35.14 67.26 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 0.0 109.67 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -83.66 -14.14 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.43 -47.04 11.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 108.976 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m -64.24 -30.69 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.87 -30.16 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.539 -0.726 . . . . 0.0 109.713 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -76.3 -34.84 59.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.785 ' HB3' HG11 ' A' ' 50' ' ' VAL . 3.2 m-20 -66.39 -35.32 80.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.786 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' A' ' 59' ' ' PRO . 74.9 mt -81.28 -34.64 31.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 0.0 110.196 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.97 48.0 5.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.48 -179.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -1.121 . . . . 0.0 110.132 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.518 ' O ' HD13 ' A' ' 30' ' ' ILE . 29.2 m-85 -70.18 171.54 9.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.766 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.7 tt0 -87.94 -21.02 25.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -0.808 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 p -66.24 -45.38 80.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 109.968 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -21.48 16.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.741 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.7 mp -80.01 -50.93 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.42 -0.8 . . . . 0.0 109.724 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -71.18 -2.34 15.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -101.47 -42.22 6.34 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.909 -1.12 . . . . 0.0 108.155 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -74.65 -18.16 60.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 7' ' ' LEU . 45.5 mt -102.11 -50.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.442 -0.786 . . . . 0.0 110.246 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 2.2 t60 -60.56 -16.46 37.96 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.9 -1.125 . . . . 0.0 109.817 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 -46.08 17.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.6 7.22 5.31 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -51.58 161.96 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -1.182 . . . . 0.0 110.172 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 5.4 mmtt -115.88 70.27 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.029 HD12 HD22 ' A' ' 7' ' ' LEU . 6.1 mt -90.55 161.3 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.816 . . . . 0.0 110.15 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 40' ' ' ILE . 48.6 m-85 -151.26 114.03 4.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.715 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.3 mp -80.52 141.69 34.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.407 HG22 HD21 ' A' ' 45' ' ' ASN . 2.8 m -116.71 103.28 10.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.38 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.969 HG23 ' O ' ' A' ' 49' ' ' SER . 1.2 mt -105.12 130.66 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.731 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER -105.25 -172.22 2.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.925 179.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.26 -2.2 18.09 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -161.67 21.53 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -90.7 -5.36 68.9 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.5 OUTLIER 60.09 -94.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 49' ' ' SER . 1.7 t -162.3 112.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 0.0 110.867 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 20.0 m-85 -101.69 151.99 21.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 108.995 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . -127.03 99.62 5.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.873 -1.142 . . . . 0.0 111.051 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 40' ' ' ILE . 1.8 mt-10 -101.86 169.95 8.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.611 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -150.51 153.56 36.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.927 -1.108 . . . . 0.0 110.587 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 54' ' ' GLU . 5.8 t -150.94 118.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 110.114 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 0.2 OUTLIER -146.37 -168.8 3.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 56' B GLY . 15.3 t0 -41.25 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.462 -0.774 . . . . 0.0 110.306 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 42.32 57.21 3.79 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 mt-10 -160.42 84.87 0.71 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.244 . . . . 0.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' D VAL . . . . . . . . . . . . . 4.5 m -102.07 148.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.0 pttt -172.62 166.19 3.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 110.345 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.0 Cg_endo -88.1 -83.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.867 1.712 . . . . 0.0 110.558 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.542 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 59.19 109.57 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.367 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.503 ' HD3' HD22 ' A' ' 23' ' ' LEU . 5.8 Cg_exo -77.39 140.4 63.45 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.456 -1.893 . . . . 0.0 109.923 -0.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 33.2 t -127.78 -56.7 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.054 -1.029 . . . . 0.0 110.358 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -150.87 67.33 0.93 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.421 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 63' ' ' LYS . 3.9 ptmt -114.51 38.29 3.13 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.177 -0.952 . . . . 0.0 109.299 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -169.91 156.57 6.26 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.134 0.492 . . . . 0.0 109.846 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.3 -170.52 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -137.96 4.75 2.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 110.287 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.219 -179.872 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.204 0.526 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.88 -162.98 0.31 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.221 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 46' ' ' ALA . 1.9 mm100 -112.53 70.4 0.71 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -79.4 75.77 6.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 6' ' ' THR . 54.4 mt -90.82 177.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -87.52 -171.03 3.27 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.453 1.12 . . . . 0.0 112.496 -178.761 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.106 HD22 HD13 ' A' ' 40' ' ' ILE . 3.5 tp -92.14 -52.42 4.7 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 123.307 1.527 . . . . 0.0 107.203 176.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -83.45 -57.54 3.2 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.229 179.618 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.539 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -47.67 -47.87 29.28 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 6' ' ' THR . 27.0 t80 -52.44 -60.19 3.53 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.396 -0.922 . . . . 0.0 109.659 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.7 -26.57 2.38 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.557 0.694 . . . . 0.0 109.577 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.486 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.42 -52.65 44.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.995 179.931 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 -64.36 -31.85 73.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.698 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.469 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 7.5 m-30 -109.75 -80.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 110.152 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 173.75 39.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.445 ' HG3' ' HG2' ' A' ' 27' ' ' GLN . 9.1 tp60 -79.1 -32.3 44.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -1.14 . . . . 0.0 110.075 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -67.96 -21.6 65.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.853 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 14' ' ' PHE . 6.5 mttt -79.74 -38.33 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.867 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.18 -14.18 61.31 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.696 ' HB2' ' HG3' ' A' ' 27' ' ' GLN . . . -79.15 -47.07 16.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 0.0 109.669 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -12.13 60.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.731 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.566 ' OD1' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -77.3 -55.35 5.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.86 HD21 ' HB2' ' A' ' 52' ' ' ALA . 10.9 mt -86.22 -14.37 44.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.292 -0.88 . . . . 0.0 110.151 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.58 31.06 46.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 26' ' ' TYR . 1.5 t -127.02 178.5 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -1.075 . . . . 0.0 109.75 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.475 ' O ' HD12 ' A' ' 30' ' ' ILE . 57.0 m-85 -89.01 132.95 34.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -0.992 . . . . 0.0 110.2 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.696 ' HG3' ' HB2' ' A' ' 20' ' ' ALA . 17.1 mt-30 -41.71 -29.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 110.264 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.65 -18.87 8.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 110.452 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.601 HG22 HD12 ' A' ' 34' ' ' ILE . 1.6 mp -86.2 -43.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.044 -1.035 . . . . 0.0 110.315 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.3 t-20 -67.16 -9.92 44.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.235 -0.915 . . . . 0.0 110.206 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -94.52 -48.85 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 108.186 178.482 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -67.83 -16.39 64.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CG1' HD23 ' A' ' 7' ' ' LEU . 7.3 mt -95.93 -64.18 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 19.2 t-160 -49.71 -19.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.651 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -76.56 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.588 -0.695 . . . . 0.0 111.78 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 39' ' ' LYS . . . -132.59 87.83 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 34' ' ' ILE . 15.6 mmm-85 -57.19 108.1 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.941 . . . . 0.0 111.049 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HD2' ' HD2' ' A' ' 56' ' ' LYS . 11.7 pttm 179.21 42.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.106 HD13 HD22 ' A' ' 7' ' ' LEU . 15.8 mt -102.24 164.18 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.996 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 58.6 m-85 -156.74 110.54 2.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.952 HD11 HD12 ' A' ' 7' ' ' LEU . 5.3 mp -99.44 144.1 28.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 112.183 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 48' ' ' GLY . 1.5 m -96.1 110.92 23.09 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 176.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -89.12 175.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 113.048 -176.369 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.578 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 36.8 p30 -60.87 -133.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.246 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 47' ' ' ASP . . . 57.35 43.38 23.45 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.605 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 35.5 t70 69.22 26.33 5.46 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -176.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' O ' HG22 ' A' ' 43' ' ' THR . . . -124.61 -13.9 3.67 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 43' ' ' THR . 11.9 m 61.2 133.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -1.057 . . . . 0.0 108.441 -178.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.601 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 23.1 t -78.41 136.54 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.701 -1.249 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 50' ' ' VAL . 20.9 m-85 -165.61 177.84 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.742 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.86 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -144.97 133.82 22.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 109.981 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 56' E LYS . 18.2 tt0 -154.46 117.05 4.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 0.0 110.916 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.597 ' HG3' HG23 ' A' ' 40' ' ' ILE . 15.2 mt-10 -80.77 153.54 27.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 56' D VAL . 8.7 t -146.67 123.37 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.94 -1.1 . . . . 0.0 110.979 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 56' B GLY . 0.0 OUTLIER -147.35 141.02 25.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.706 . . . . 0.0 109.208 179.403 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -40.53 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 110.42 -179.357 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 153.41 -48.51 0.53 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 1.1 tt0 -179.33 163.92 1.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.257 -1.143 . . . . 0.0 110.718 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.545 HG12 HG13 ' A' ' 55' ' ' VAL . 15.2 m -112.88 170.28 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 15.8 mttt -143.11 160.34 52.78 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 110.477 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 1.3 Cg_endo -85.26 -65.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.887 1.725 . . . . 0.0 110.2 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.55 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 28.4 t80 57.09 99.63 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.519 -0.738 . . . . 0.0 110.611 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 15.0 Cg_exo -66.3 152.38 81.21 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.827 -2.155 . . . . 0.0 110.427 0.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 57' ' ' PRO . 14.9 m -95.61 11.89 31.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.053 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -102.44 138.64 39.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 110.2 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -174.15 57.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 110.303 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.64 174.61 11.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 110.038 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.6 p -121.39 175.96 5.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.234 -0.916 . . . . 0.0 109.789 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.451 ' O ' ' OXT' ' A' ' 66' ' ' ALA . 15.3 t -63.49 -22.27 66.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' OXT' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.147 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.25 0.548 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 16.1 mt-10 -46.67 150.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 0.9 OUTLIER -140.97 86.98 2.07 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.259 -0.901 . . . . 0.0 109.59 -179.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 5.8 ttp180 -77.82 82.15 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.432 -0.793 . . . . 0.0 109.927 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.722 HG22 ' HB2' ' A' ' 10' ' ' TYR . 11.2 mm -90.73 163.78 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -77.1 -171.88 2.18 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.121 0.962 . . . . 0.0 111.952 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.705 ' H ' HG22 ' A' ' 6' ' ' THR . 4.9 tp -91.62 -40.04 11.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.565 ' CD ' HG22 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -90.79 -51.43 5.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.431 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.473 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 1.6 t0 -54.91 -43.57 73.39 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.722 ' HB2' HG22 ' A' ' 5' ' ' ILE . 2.3 t80 -62.94 -55.07 29.1 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.196 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.26 -26.57 18.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.637 -0.664 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ttm -71.79 -36.25 70.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.828 . . . . 0.0 110.053 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.76 -39.21 57.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.675 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.74 -100.9 0.23 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.254 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.7 176.02 32.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.715 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 11.2 tp60 -88.28 -30.5 19.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -1.068 . . . . 0.0 110.134 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -84.34 -28.25 27.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -62.16 1.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.67 HG23 HD21 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -53.29 -35.46 60.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.349 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -58.24 -41.47 84.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.56 ' HA ' HG13 ' A' ' 25' ' ' VAL . 6.7 mmtt -57.47 -45.08 85.19 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.8 m-20 -92.19 -5.19 53.01 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.432 -0.792 . . . . 0.0 112.791 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.117 HD22 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -164.39 62.74 0.14 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.47 -1.394 . . . . 0.0 109.92 -179.645 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.714 ' O ' ' HB1' ' A' ' 20' ' ' ALA . . . 127.53 74.45 0.19 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.348 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.706 HG22 ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.58 -11.12 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.92 -0.753 . . . . 0.0 109.842 -177.198 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' SER . 8.1 m-85 -101.71 98.23 8.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -37.12 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.488 -0.757 . . . . 0.0 111.53 -178.691 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' TYR . 67.8 m -82.63 -61.12 1.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.79 -1.194 . . . . 0.0 110.015 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . . . -48.92 -22.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.077 -1.015 . . . . 0.0 109.109 179.165 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.743 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.65 -64.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.523 -0.736 . . . . 0.0 109.933 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.743 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -52.07 -15.67 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.484 -0.76 . . . . 0.0 111.252 -179.612 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 4.9 mttt -93.08 -39.8 10.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.435 -1.416 . . . . 0.0 109.028 179.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . -76.31 -9.71 58.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.462 -0.774 . . . . 0.0 108.942 178.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 30' ' ' ILE . 16.5 mt -111.98 -52.36 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.563 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 7.5 t-160 -57.63 -31.76 66.57 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.204 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 38' ' ' ARG . . . -90.05 -45.97 8.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.472 -0.768 . . . . 0.0 109.673 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.02 85.44 1.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.829 ' HB2' HD11 ' A' ' 40' ' ' ILE . 2.5 mpt_? -90.1 49.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.266 . . . . 0.0 109.27 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER 42.46 53.96 4.5 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.854 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 38' ' ' ARG . 4.2 mt -105.23 154.8 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 110.082 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 40' ' ' ILE . 70.8 m-85 -149.89 167.58 26.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.29 -0.881 . . . . 0.0 110.066 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.117 HD22 HD22 ' A' ' 23' ' ' LEU . 4.2 mp -143.93 149.01 36.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.953 -1.092 . . . . 0.0 110.965 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.2 m -127.62 97.36 4.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.602 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.714 HG23 ' O ' ' A' ' 49' ' ' SER . 3.8 mt -81.03 93.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 110.348 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 27.0 p-10 -54.52 172.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.339 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -5.72 7.01 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.912 178.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 3.9 t70 -79.23 1.23 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.096 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.3 1.06 73.8 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 44' ' ' ILE . 43.6 m -83.27 -170.94 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.202 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 44' ' ' ILE . 10.6 t -144.01 127.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.029 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 13.9 m-85 -104.77 94.96 5.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 109.683 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -80.41 142.8 33.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.306 -0.871 . . . . 0.0 109.73 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' E LYS . 10.2 tt0 -153.86 110.39 3.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.266 -0.896 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 56' D VAL . 39.6 tt0 -81.31 167.17 19.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.18 126.93 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.037 -1.039 . . . . 0.0 110.583 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' O ' ' C ' ' A' ' 56' A ASP . 6.0 ttpt -158.76 135.07 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.867 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.3 m-20 29.52 65.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.868 -0.52 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 47.7 56.79 8.15 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.46 96.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -1.164 . . . . 0.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 17.3 m -93.83 161.48 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 56' D VAL . 2.5 mtmt -143.71 167.38 15.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.127 -0.983 . . . . 0.0 111.291 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 60' ' ' SER . 1.6 Cg_endo -85.98 173.47 6.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.415 2.077 . . . . 0.0 110.165 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.555 ' CZ ' ' C ' ' A' ' 23' ' ' LEU . 10.1 t80 174.22 126.34 0.11 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.964 . . . . 0.0 110.913 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.706 ' HG3' HG22 ' A' ' 25' ' ' VAL . 48.1 Cg_endo -90.12 97.99 0.17 OUTLIER 'Cis proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.782 -1.758 . . . . 0.0 110.297 0.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 57' ' ' PRO . 6.3 m -143.45 -109.51 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.724 -1.235 . . . . 0.0 110.671 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 62' ' ' LYS . 3.4 t-20 63.13 172.86 0.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.786 -1.196 . . . . 0.0 109.852 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 19.3 tttt 59.72 47.72 10.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.935 . . . . 0.0 109.687 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.03 -35.1 8.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.697 -0.627 . . . . 0.0 110.572 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.58 -165.89 2.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 110.574 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 65' ' ' THR . 5.4 t -80.45 -24.52 39.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 110.202 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.188 -179.998 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.108 0.48 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.45 -163.33 1.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.145 -0.972 . . . . 0.0 110.381 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -120.93 75.61 1.16 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.312 -0.867 . . . . 0.0 109.443 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -78.45 76.46 4.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.515 -0.741 . . . . 0.0 110.677 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.581 HG21 ' HD1' ' A' ' 10' ' ' TYR . 3.8 mt -89.88 135.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -45.89 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.172 0.987 . . . . 0.0 112.015 -178.856 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.041 HD12 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -92.03 -40.43 11.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.892 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.79 -60.47 1.95 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.392 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 12' ' ' MET . 11.6 t0 -45.09 -45.1 10.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.581 ' HD1' HG21 ' A' ' 5' ' ' ILE . 32.1 t80 -61.52 -53.61 54.19 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.47 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.57 -21.52 3.94 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.071 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.52 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.9 -47.89 49.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.462 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -65.25 -23.72 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.536 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 5.3 m-85 -114.19 -78.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.143 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 156.41 162.49 11.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.729 ' NE2' HG22 ' A' ' 30' ' ' ILE . 22.7 tp60 -57.54 -41.31 80.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -1.1 . . . . 0.0 109.973 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.4 p -65.48 -30.26 71.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -71.01 -63.53 1.08 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.344 179.488 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 7' ' ' LEU . 4.2 m -57.4 -22.67 44.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.272 -0.892 . . . . 0.0 109.19 179.051 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -72.07 -45.7 59.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.431 -0.793 . . . . 0.0 110.228 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 14.0 mmtt -76.84 -13.04 60.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.892 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB3' HG21 ' A' ' 50' ' ' VAL . 3.5 m-20 -71.46 -48.94 46.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.699 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.402 ' CB ' HG23 ' A' ' 25' ' ' VAL . 23.7 mt -82.61 -10.22 59.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 110.243 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 24.86 76.29 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.462 ' CG1' ' CB ' ' A' ' 29' ' ' ALA . 2.6 t -109.03 163.97 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -1.096 . . . . 0.0 110.163 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -62.68 147.6 49.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.093 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.4 ' HA ' HG12 ' A' ' 30' ' ' ILE . 2.0 mt-30 -50.78 -24.72 3.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.991 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 t -65.09 -51.3 62.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.842 . . . . 0.0 109.791 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.462 ' CB ' ' CG1' ' A' ' 25' ' ' VAL . . . -53.69 -19.36 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.805 . . . . 0.0 109.953 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.729 HG22 ' NE2' ' A' ' 16' ' ' GLN . 3.3 mm -80.88 -50.82 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.5 OUTLIER -70.63 -7.24 42.79 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.603 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -92.4 -44.61 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 108.758 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.711 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -80.71 -13.41 59.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.012 HG12 HD13 ' A' ' 7' ' ' LEU . 9.5 mt -102.49 -42.37 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 42.9 t60 -61.69 -53.82 50.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.955 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 38' ' ' ARG . . . -93.12 -122.16 0.09 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 36' ' ' ALA . . . -1.73 68.38 0.0 OUTLIER Glycine 0 N--CA 1.504 3.223 0 C-N-CA 123.288 0.47 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 36' ' ' ALA . 23.3 mmm-85 -85.28 61.72 7.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.297 -1.119 . . . . 0.0 110.512 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 64.7 pttt -154.22 38.27 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 108.974 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.041 HD13 HD12 ' A' ' 7' ' ' LEU . 10.3 mt -101.65 165.36 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 110.825 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 56.2 m-85 -156.66 103.41 2.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.604 -0.685 . . . . 0.0 109.241 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.687 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.3 mp -89.33 130.18 35.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.905 . . . . 0.0 111.136 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 43' ' ' THR . 2.1 m -101.2 103.32 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.163 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 45' ' ' ASN . 18.6 mt -89.25 74.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.062 -1.024 . . . . 0.0 110.576 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.564 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -44.7 174.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 110.705 179.413 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.95 -2.8 8.17 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.613 -0.835 . . . . 0.0 108.979 178.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.42 -2.1 57.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.885 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.81 -3.55 55.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -72.21 149.93 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -1.227 . . . . 0.0 109.773 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 22' ' ' ASP . 13.1 t -111.5 105.87 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 110.668 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 1.9 m-85 -88.95 96.21 10.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.95 . . . . 0.0 109.007 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -84.87 92.21 8.22 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 110.707 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.444 ' OE1' ' CG2' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.44 165.18 11.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.567 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 56' D VAL . 54.6 mt-10 -134.13 163.08 30.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.714 HG13 HG12 ' A' ' 56' D VAL . 3.3 t -150.33 133.76 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 56' A ASP . 7.1 tptp -148.83 78.54 1.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.401 -0.812 . . . . 0.0 109.497 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 56' ' ' LYS . 16.0 t0 60.24 50.47 6.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.592 -0.692 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 102.75 -30.43 10.42 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.499 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' C GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 56' ' ' LYS . 9.7 mt-10 -74.26 95.66 2.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.098 -1.237 . . . . 0.0 110.715 -179.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.714 HG12 HG13 ' A' ' 55' ' ' VAL . 18.8 m -117.05 147.48 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.214 -0.929 . . . . 0.0 110.393 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 3.6 pttm -175.1 165.73 2.1 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.191 -0.943 . . . . 0.0 110.576 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 4.7 Cg_exo -78.93 -176.41 3.27 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.872 1.714 . . . . 0.0 110.53 -178.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.598 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 1.8 t80 178.63 126.99 0.21 Allowed Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.29 -0.881 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 60.3 Cg_endo -90.11 96.59 0.16 OUTLIER 'Cis proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.913 -1.703 . . . . 0.0 110.514 -0.033 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 12.0 p -65.05 90.36 0.09 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.456 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 60' ' ' SER . 23.0 m-20 41.11 -163.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -134.2 46.21 2.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.747 . . . . 0.0 110.172 -179.952 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.569 ' C ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 6.63 109.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.817 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.46 -154.97 0.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.13 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -120.07 25.1 10.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 110.329 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.279 -179.939 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' GLU . 1.4 ttt . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.268 0.556 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 1' ' ' MET . 4.1 tt0 -43.15 125.65 3.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.965 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -125.75 76.73 1.6 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.343 -0.848 . . . . 0.0 109.934 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 3.2 ttm180 -79.34 74.56 5.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.382 -0.824 . . . . 0.0 110.098 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.996 HG22 ' HB2' ' A' ' 10' ' ' TYR . 3.9 mm -90.08 148.12 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.443 -0.786 . . . . 0.0 109.851 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -44.54 -179.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 122.486 1.136 . . . . 0.0 112.109 -178.822 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.865 ' HB2' HD11 ' A' ' 42' ' ' LEU . 5.7 tp -94.28 -39.35 10.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.411 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -88.62 -61.9 1.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.185 179.583 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 8' ' ' LYS . 8.1 t0 -44.76 -42.39 7.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.996 ' HB2' HG22 ' A' ' 5' ' ' ILE . 12.0 t80 -55.76 -59.5 4.77 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.705 0.764 . . . . 0.0 109.345 178.281 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -57.9 -15.58 9.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.803 -0.561 . . . . 0.0 110.156 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ttt -83.43 -34.11 25.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.814 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.36 -10.45 49.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.809 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -122.71 -51.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.002 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.69 142.1 3.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.507 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -72.82 -27.74 62.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -1.185 . . . . 0.0 110.203 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 17' ' ' THR . 3.3 t -79.88 -21.78 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -82.4 -46.98 12.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.113 179.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.535 ' O ' HD12 ' A' ' 23' ' ' LEU . 11.6 m -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.319 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.62 -28.53 30.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 110.092 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -80.59 -36.96 32.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.467 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.4 -36.28 68.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.318 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 19' ' ' THR . 83.3 mt -82.6 -9.94 59.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.26 40.03 97.58 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 59' ' ' PRO . 3.9 t -124.07 146.71 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.446 -1.032 . . . . 0.0 109.97 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -72.03 150.87 43.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.879 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.62 ' HA ' HD12 ' A' ' 30' ' ' ILE . 1.9 tt0 -61.46 -20.38 63.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.548 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.4 p -84.65 -55.76 3.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.0 110.229 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.73 -23.28 1.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' GLN . 95.0 mt -76.88 -63.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.891 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 11.5 m120 -49.9 -15.67 0.21 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.332 -0.855 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -91.58 -38.61 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.558 -1.339 . . . . 0.0 108.597 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.88 56.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.528 -0.732 . . . . 0.0 109.185 178.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.597 HD11 HD21 ' A' ' 7' ' ' LEU . 10.1 mt -114.57 -48.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.54 -0.725 . . . . 0.0 109.714 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 10.9 t-160 -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.512 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.44 5.73 49.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 111.615 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.559 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -149.29 90.28 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 20.3 mmm-85 -83.69 -173.57 4.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -1.075 . . . . 0.0 110.157 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER 66.31 58.87 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.199 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.679 HD13 HD23 ' A' ' 7' ' ' LEU . 9.2 mt -116.18 157.65 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.163 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 39.8 m-85 -155.06 144.89 21.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 110.873 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 7' ' ' LEU . 4.1 mp -135.57 131.05 35.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.462 -0.774 . . . . 0.0 109.743 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.432 ' OG1' ' HG3' ' A' ' 4' ' ' ARG . 3.2 m -99.18 101.04 12.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.005 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.011 HG23 ' O ' ' A' ' 49' ' ' SER . 15.0 mt -101.1 148.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.982 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 46' ' ' ALA 0.252 2.4 m-20 -65.31 -11.75 44.91 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.531 0.682 . . . . 0.0 110.076 178.113 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.948 ' H ' HG22 ' A' ' 44' ' ' ILE . . . 81.49 1.22 1.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -175.166 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.19 38.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.575 ' N ' ' HB2' ' A' ' 45' ' ' ASN . . . -140.13 -63.36 0.04 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -177.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.011 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER 179.45 -168.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.694 -0.886 . . . . 0.0 109.445 -179.045 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.875 HG22 HG12 ' A' ' 44' ' ' ILE . 11.9 t -125.52 110.93 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.571 -1.331 . . . . 0.0 111.583 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -81.4 77.69 8.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.537 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -52.47 145.75 10.92 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.708 0.766 . . . . 0.0 111.398 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 78.94 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.566 ' CB ' HG23 ' A' ' 40' ' ' ILE . 3.8 pt-20 -79.41 163.49 24.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.253 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 56' D VAL . 3.2 t -132.77 139.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' B GLY . 0.5 OUTLIER -159.76 160.85 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 -179.889 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 56' ' ' LYS . 1.4 m-20 -39.21 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.471 -0.768 . . . . 0.0 110.438 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 144.99 -71.41 0.37 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.7 tt0 -174.4 -172.45 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.491 -1.005 . . . . 0.0 109.926 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.611 HG12 HG22 ' A' ' 55' ' ' VAL . 34.6 m -104.6 143.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.95 . . . . 0.0 110.434 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 4.9 mmtt -128.09 161.04 58.49 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.393 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 3.4 Cg_exo -82.9 39.95 0.9 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.825 1.683 . . . . 0.0 111.063 -178.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.56 118.58 1.26 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.409 -0.807 . . . . 0.0 109.817 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -81.86 104.89 0.64 Allowed 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.305 -1.956 . . . . 0.0 110.724 0.2 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 73.3 p -49.4 106.23 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.08 -1.013 . . . . 0.0 110.184 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 110.416 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 63' ' ' LYS . 9.1 tptt -158.5 57.9 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.701 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -39.05 144.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.599 -0.688 . . . . 0.0 110.645 -179.732 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -104.2 38.87 1.76 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 110.046 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 t -159.48 56.66 0.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.046 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.246 -179.908 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttm . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.18 0.515 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -139.39 113.38 8.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.403 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.52 71.11 1.07 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.314 -0.866 . . . . 0.0 109.782 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.87 74.89 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.377 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.801 HG22 ' HB2' ' A' ' 10' ' ' TYR . 8.4 mt -91.66 141.68 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.305 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 18.8 p -59.47 -175.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 110.848 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.964 HD12 HG21 ' A' ' 19' ' ' THR . 1.2 tp -92.45 -34.43 14.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' CG ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -81.84 -69.52 0.61 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.855 -0.528 . . . . 0.0 110.002 179.375 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 41.4 t0 -46.66 -58.09 4.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.219 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.801 ' HB2' HG22 ' A' ' 5' ' ' ILE . 3.4 t80 -41.9 -51.65 4.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.331 -0.855 . . . . 0.0 110.368 179.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 16' ' ' GLN . . . -56.13 -42.41 76.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.422 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 30.1 ttp -60.17 -29.94 69.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.058 179.048 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -55.84 28.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.492 -0.755 . . . . 0.0 110.125 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CZ ' ' CZ ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -123.52 67.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.974 -1.079 . . . . 0.0 111.659 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.28 156.87 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.465 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -82.29 -29.92 30.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -1.03 . . . . 0.0 109.841 179.611 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 26.4 m -60.63 -21.61 62.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.414 -0.804 . . . . 0.0 109.884 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.606 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.0 mmtp -69.76 -54.86 11.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.02 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.964 HG21 HD12 ' A' ' 7' ' ' LEU . 90.3 m -59.37 -19.01 43.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 17' ' ' THR . . . -71.12 -38.21 72.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.594 -0.691 . . . . 0.0 109.825 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -81.76 -18.69 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.743 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 3.0 t0 -65.43 -53.84 37.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.033 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.498 HD11 HD13 ' A' ' 7' ' ' LEU . 3.0 mt -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.364 -0.835 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.77 29.78 20.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -122.08 151.26 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -1.115 . . . . 0.0 109.676 -179.751 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 25' ' ' VAL . 47.8 m-85 -47.09 173.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.488 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -77.0 -28.25 54.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -67.56 -57.95 5.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.16 -28.53 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.365 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.813 ' CD1' HD11 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -62.85 -61.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.727 ' N ' HG22 ' A' ' 30' ' ' ILE . 48.9 m-80 -57.28 -9.65 1.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.597 -0.69 . . . . 0.0 110.888 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -88.98 -35.32 16.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.648 -1.283 . . . . 0.0 107.766 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.513 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -85.62 -11.11 54.73 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.57 ' CG2' ' CG ' ' A' ' 8' ' ' LYS . 14.9 mt -100.68 -48.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.405 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -74.99 -58.43 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.894 179.661 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.85 11.08 23.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 110.755 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -137.63 69.66 0.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 15.0 mmm-85 -75.85 -171.85 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.899 -1.353 . . . . 0.0 110.214 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 56' A ASP . 9.2 mptt 58.73 46.72 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.198 -0.939 . . . . 0.0 110.52 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.945 HD13 HD23 ' A' ' 7' ' ' LEU . 16.7 mt -97.89 161.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 110.353 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 43.9 m-85 -161.32 114.37 1.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 110.267 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 7' ' ' LEU . 2.4 mp -107.24 131.88 53.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.099 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 43' ' ' THR . 1.7 m -96.99 100.54 12.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 44' ' ' ILE . 9.6 mt -94.73 43.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.431 ' OD1' HG22 ' A' ' 43' ' ' THR . 45.8 p-10 -91.97 -131.49 0.12 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 109.85 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.929 ' HB3' ' CB ' ' A' ' 49' ' ' SER . . . 48.75 24.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.957 -1.089 . . . . 0.0 109.127 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.566 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 23.1 t0 75.13 63.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.317 0.579 . . . . 0.0 111.036 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 49' ' ' SER . . . 81.78 -8.43 59.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.929 ' CB ' ' HB3' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -51.11 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.317 . . . . 0.0 110.506 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.71 123.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.47 135.68 37.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.576 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' PRO . . . -103.57 149.9 24.46 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.944 -1.098 . . . . 0.0 109.461 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 2.4 tt0 -159.78 151.43 20.12 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 110.651 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.715 ' O ' ' HA ' ' A' ' 56' D VAL . 2.1 tt0 -135.92 151.1 49.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.389 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.99 ' O ' HG12 ' A' ' 56' D VAL . 7.2 p -124.33 -26.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.394 -0.923 . . . . 0.0 112.525 -177.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 3.2 ttmt -160.14 -171.37 3.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.705 -1.247 . . . . 0.0 111.091 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 29.5 t0 47.37 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.693 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . -58.76 -51.88 56.44 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 178.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' C GLU . . . . . 0.532 ' CB ' ' OE1' ' A' ' 54' ' ' GLU . 2.5 tt0 174.97 179.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.628 -0.924 . . . . 0.0 110.096 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.99 HG12 ' O ' ' A' ' 55' ' ' VAL . 4.1 m -122.0 46.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 56' D VAL . 13.9 mttt -149.81 174.95 3.06 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.375 -0.828 . . . . 0.0 112.302 -177.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 56' E LYS . 3.9 Cg_exo -80.04 56.16 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.661 2.24 . . . . 0.0 111.497 -179.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.444 ' HZ ' HD22 ' A' ' 7' ' ' LEU . 5.0 p90 -44.06 146.53 1.08 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.714 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -91.11 50.01 1.08 Allowed 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.221 -1.991 . . . . 0.0 110.31 -0.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 p -44.75 141.52 2.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 110.021 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -138.92 83.05 1.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.977 . . . . 0.0 110.485 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -129.93 43.55 3.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.833 179.611 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.586 ' O ' HG22 ' A' ' 65' ' ' THR . 7.8 mtmt -118.38 -88.24 0.61 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 110.08 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.46 ' O ' ' HB ' ' A' ' 65' ' ' THR . 2.8 m 53.87 43.7 30.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.25 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 63' ' ' LYS . 6.7 t -179.02 -33.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.244 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.284 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.244 0.545 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.28 129.53 37.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 2.6 mt-30 -105.38 63.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 35.8 ttp180 -79.0 79.71 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.51 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 10' ' ' TYR . 32.7 mt -89.32 154.17 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.062 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -51.08 179.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.049 0.928 . . . . 0.0 111.38 -179.262 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.676 ' CD2' HD12 ' A' ' 40' ' ' ILE . 3.7 tp -92.8 -40.08 10.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.077 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HB2' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -90.96 -63.97 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.434 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 3.1 m-20 -45.03 -44.57 10.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.62 ' HB2' HG22 ' A' ' 5' ' ' ILE . 9.4 t80 -57.24 -56.43 21.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.143 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -57.74 -15.27 7.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.8 -0.562 . . . . 0.0 110.388 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.2 ttt -82.79 -35.34 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -0.976 . . . . 0.0 110.062 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -77.04 -32.17 56.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.664 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 12.1 m-85 -96.64 -54.22 3.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.12 137.92 2.74 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -33.43 66.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -1.18 . . . . 0.0 110.275 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 m -77.5 -23.34 50.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 110.271 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -76.28 -56.66 4.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.071 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 ' HB2' ' A' ' 11' ' ' ALA . 2.1 m -57.81 -23.81 54.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.491 -0.756 . . . . 0.0 109.123 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.52 -47.13 43.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.913 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -9.14 57.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 110.053 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.98 -30.84 18.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 110.141 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 42' ' ' LEU . 75.3 mt -91.37 -5.62 54.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.15 35.3 91.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' A' ' 29' ' ' ALA . 2.8 t -119.72 174.46 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -1.128 . . . . 0.0 109.926 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.459 ' H ' HG12 ' A' ' 25' ' ' VAL . 60.1 m-85 -81.96 136.41 35.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.96 . . . . 0.0 110.0 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -44.24 -29.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.953 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -74.54 -52.55 11.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.654 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -50.76 -27.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.597 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.744 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -70.3 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.457 -0.777 . . . . 0.0 109.677 179.672 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.744 ' N ' HG22 ' A' ' 30' ' ' ILE . 7.0 m-80 -57.7 -10.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.658 -0.651 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.88 -42.8 9.31 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.507 -1.37 . . . . 0.0 108.51 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.89 -9.63 58.73 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.55 HG12 ' CD2' ' A' ' 7' ' ' LEU . 24.6 mt -110.86 -51.1 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -0.765 . . . . 0.0 110.088 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.582 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 21.3 t-160 -53.86 -26.59 25.31 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.407 179.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.22 -75.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.989 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.07 57.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.562 ' O ' ' C ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -90.48 31.72 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.129 -1.218 . . . . 0.0 110.517 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER 19.72 70.15 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.318 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 7' ' ' LEU . 6.3 mt -105.51 159.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.387 -0.821 . . . . 0.0 110.931 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -143.54 161.56 38.14 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.106 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 23' ' ' LEU . 4.0 mp -137.47 118.57 14.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.667 -1.271 . . . . 0.0 110.888 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 51' ' ' TYR . 2.8 p -85.32 97.63 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.538 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 45' ' ' ASN . 4.4 mt -89.52 80.79 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.314 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 44' ' ' ILE . 51.6 p30 -44.02 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.464 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -3.74 8.84 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.706 -0.797 . . . . 0.0 109.041 178.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -85.62 -3.16 58.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.4 -5.13 74.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -70.4 122.41 19.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.32 112.2 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.512 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.513 ' HB3' ' OG1' ' A' ' 43' ' ' THR . 3.5 t80 -102.96 105.69 16.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -82.5 143.54 31.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.205 -0.935 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 56' E LYS . 0.7 OUTLIER -151.01 96.35 2.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.54 -0.725 . . . . 0.0 109.63 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 40.1 tt0 -78.97 161.65 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.741 HG22 HG12 ' A' ' 56' D VAL . 73.3 t -135.44 138.58 48.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.672 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 56' A ASP . 22.3 ttpp -156.06 141.74 17.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -0.76 . . . . 0.0 109.239 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 56' ' ' LYS . 7.6 t0 -37.15 102.94 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.511 -0.743 . . . . 0.0 110.828 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 56' C GLU . . . 139.72 -53.54 0.68 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' C GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 56' B GLY . 11.0 tt0 179.48 171.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 110.042 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.741 HG12 HG22 ' A' ' 55' ' ' VAL . 23.4 m -98.54 173.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.176 -0.952 . . . . 0.0 110.005 179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 5.3 mtmt -144.7 170.45 8.19 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 110.176 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 58' ' ' PHE . 4.4 Cg_exo -79.53 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.297 -2.138 0 O-C-N 124.42 1.747 . . . . 0.0 109.966 -179.196 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.504 ' O ' ' O ' ' A' ' 57' ' ' PRO . 28.1 t80 57.69 125.86 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.516 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.39 122.47 8.51 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.169 -2.013 . . . . 0.0 110.305 0.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.63 53.68 0.37 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.975 . . . . 0.0 110.591 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 14.8 t-20 -127.44 50.64 1.99 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.142 -0.974 . . . . 0.0 109.871 179.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 0.4 OUTLIER 178.38 58.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.446 -0.784 . . . . 0.0 110.02 179.986 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -113.19 -88.1 0.55 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 0.0 110.219 -179.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.74 -58.44 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.215 -0.928 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.78 -10.35 14.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 110.48 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.207 -179.917 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.316 0.579 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 105.78 16.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 6.4 mt-30 -118.44 73.22 0.9 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.084 -1.01 . . . . 0.0 109.655 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 6.5 ttt180 -78.26 81.48 4.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 6' ' ' THR . 3.9 mt -90.77 -179.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.424 -0.798 . . . . 0.0 109.571 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -90.61 -173.11 3.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.026 0.917 . . . . 0.0 111.375 -179.313 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.948 HD12 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -92.91 -46.5 7.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.347 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.559 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -84.33 -57.0 3.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.083 178.766 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.519 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -51.98 -51.78 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.393 -0.817 . . . . 0.0 109.127 179.269 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CE2' HD11 ' A' ' 44' ' ' ILE . 1.6 t80 -49.91 -56.78 9.22 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.685 179.115 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -50.39 -32.67 18.17 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.646 0.736 . . . . 0.0 109.41 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -58.28 -51.61 69.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -20.74 65.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.616 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -111.58 -84.54 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.805 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 174.32 159.57 20.93 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.702 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -39.01 93.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.594 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -78.38 -3.18 41.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.907 179.768 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -90.15 -50.39 6.02 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.341 -0.849 . . . . 0.0 108.729 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.545 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -54.96 -37.96 67.16 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.271 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 -48.66 55.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.492 0.663 . . . . 0.0 109.905 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' THR . 1.9 mmtp -76.62 3.82 10.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 109.834 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.679 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -88.06 -60.62 1.92 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.84 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.621 ' HG ' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -99.81 -25.44 14.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.957 -1.089 . . . . 0.0 110.939 -179.408 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.57 ' N ' ' HG ' ' A' ' 23' ' ' LEU . . . 119.84 62.15 0.26 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.779 179.208 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 26' ' ' TYR . 2.2 t -142.82 -172.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.133 -1.216 . . . . 0.0 109.521 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.693 ' H ' HG12 ' A' ' 25' ' ' VAL . 31.4 m-85 -109.48 -170.2 1.61 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.933 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -87.71 -29.52 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.152 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -68.15 -46.66 70.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.02 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.97 -22.92 41.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.982 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 26' ' ' TYR . 1.3 mp -81.51 -45.8 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 109.57 179.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 26.2 m-20 -72.75 -8.17 54.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 179.357 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -95.5 -44.57 7.46 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.52 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' O ' HD11 ' A' ' 40' ' ' ILE . . . -71.29 -16.38 62.46 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.603 ' HA ' ' CD ' ' A' ' 38' ' ' ARG . 88.2 mt -103.76 -53.65 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 110.704 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.569 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 8.8 t-80 -62.13 -10.42 10.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.72 -1.237 . . . . 0.0 109.941 179.783 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -81.86 -103.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.921 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' ARG . . . -123.11 78.63 0.35 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.603 ' CD ' ' HA ' ' A' ' 34' ' ' ILE . 16.5 mmm-85 -34.14 119.31 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.911 0.863 . . . . 0.0 111.833 -178.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 41.7 pttt -174.88 31.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.652 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.948 HD13 HD12 ' A' ' 7' ' ' LEU . 14.9 mt -105.88 161.16 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.688 . . . . 0.0 110.157 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CG ' ' C ' ' A' ' 40' ' ' ILE . 45.3 m-85 -155.3 114.37 3.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.299 -0.876 . . . . 0.0 109.897 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.0 mp -98.27 107.24 19.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.097 -1.002 . . . . 0.0 110.5 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 43' ' ' THR . 11.0 t -83.7 105.11 14.35 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.735 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.987 HG23 ' O ' ' A' ' 49' ' ' SER . 3.5 mt -97.95 135.29 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.745 . . . . 0.0 110.181 -179.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -114.2 -168.09 1.31 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.05 -1.031 . . . . 0.0 110.256 179.791 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.94 0.31 11.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.6 24.6 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' SER . . . -96.94 -12.35 50.09 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 44' ' ' ILE . 1.1 m 59.08 -90.41 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.541 -0.976 . . . . 0.0 108.575 -178.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.711 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.3 t -160.95 98.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.113 -0.992 . . . . 0.0 110.401 179.06 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.421 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 2.3 t80 -95.98 105.53 17.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.255 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 58' ' ' PHE . . . -67.5 148.9 50.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.624 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 41' ' ' PHE . 41.1 mt-10 -149.2 102.44 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 110.183 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' C ' ' CG2' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -89.89 148.73 22.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -0.957 . . . . 0.0 109.129 179.423 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' CG2' ' C ' ' A' ' 54' ' ' GLU . 2.4 t -148.62 105.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.879 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' B GLY . 1.7 tptp -125.23 170.02 11.68 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 56' ' ' LYS . 2.7 t70 -42.26 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.171 -0.956 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 60.31 56.7 23.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 2.3 tt0 -167.18 74.55 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.019 -1.283 . . . . 0.0 110.974 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 2.6 m -103.82 150.76 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.462 179.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -162.77 160.31 19.55 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.765 -1.209 . . . . 0.0 111.154 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 56' E LYS . 5.3 Cg_endo -89.52 37.66 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.049 1.832 . . . . 0.0 110.815 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -41.62 137.55 1.8 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.903 . . . . 0.0 109.922 179.778 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 60' ' ' SER . 53.2 Cg_endo -93.5 66.9 0.25 Allowed 'Cis proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.714 -1.786 . . . . 0.0 110.887 0.164 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -57.19 -155.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.875 -1.14 . . . . 0.0 110.689 -179.774 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -54.83 148.72 12.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.855 -179.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.3 tttp 178.82 62.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.729 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 64' ' ' THR . 4.7 mtpt -82.92 70.71 9.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.936 . . . . 0.0 111.106 -179.186 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 40.9 -148.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.86 . . . . 0.0 110.519 179.229 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -85.92 -17.91 34.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 110.316 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.182 179.972 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' ' HG3' ' A' ' 3' ' ' GLN . 1.8 ttm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.993 0.425 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 1' ' ' MET . 1.9 tp10 -41.77 126.61 3.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 109.907 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.488 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -138.48 86.09 2.13 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.086 -1.009 . . . . 0.0 110.157 -179.418 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -79.64 73.15 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.365 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.734 HG22 ' HB2' ' A' ' 10' ' ' TYR . 9.0 mt -90.33 141.27 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 110.821 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -51.75 -174.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 112.159 -179.31 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.928 HD23 ' CD1' ' A' ' 40' ' ' ILE . 3.4 tp -93.41 -38.39 11.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 176.134 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.569 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -82.2 -60.03 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.787 178.997 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 12' ' ' MET . 9.1 t0 -53.28 -44.35 68.19 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.165 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.734 ' HB2' HG22 ' A' ' 5' ' ' ILE . 88.4 t80 -58.9 -63.75 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.495 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.21 -23.54 1.37 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.382 -0.824 . . . . 0.0 109.62 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.43 -54.18 11.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.113 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -88.35 13.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.659 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -161.5 97.27 1.09 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.707 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 14' ' ' PHE . . . -8.72 123.52 0.01 OUTLIER Glycine 0 N--CA 1.506 3.338 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 17' ' ' THR . 6.2 pt20 -59.95 -36.39 76.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.411 -1.052 . . . . 0.0 109.582 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 2.8 m -51.49 -22.45 3.13 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.242 -179.229 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -82.57 -44.69 15.55 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.109 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.739 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -64.5 -23.37 67.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.205 179.104 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -86.04 -28.5 24.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 110.518 -179.543 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -71.73 -28.31 63.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.898 179.788 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -89.91 -26.41 20.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 19' ' ' THR . 25.5 mt -79.41 -40.72 29.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.369 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.29 40.45 1.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 -177.75 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.269 -1.136 . . . . 0.0 109.83 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -97.98 -163.76 1.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.31 -50.08 7.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.041 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 29' ' ' ALA . 7.9 t -64.82 -62.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 109.881 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' SER . . . -43.9 -28.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.704 HG22 ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -69.22 -58.18 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.506 -0.746 . . . . 0.0 109.278 179.28 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.704 ' N ' HG22 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -57.41 -6.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.813 -0.555 . . . . 0.0 111.645 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -91.95 -40.73 10.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.793 -1.192 . . . . 0.0 108.18 178.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.31 -22.3 55.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.618 HD12 HG23 ' A' ' 30' ' ' ILE . 47.6 mt -87.34 -51.37 12.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.651 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -43.6 -35.88 1.91 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.786 0.803 . . . . 0.0 108.976 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.93 -87.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.96 39.75 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -84.05 48.33 1.45 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.427 -1.043 . . . . 0.0 111.423 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 38' ' ' ARG . 2.5 mppt? 64.85 98.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.508 -0.745 . . . . 0.0 110.369 179.191 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.928 ' CD1' HD23 ' A' ' 7' ' ' LEU . 2.7 mt -129.84 153.78 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 72.8 m-85 -156.57 124.03 5.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.1 mp -118.13 132.06 56.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 111.063 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.4 m -108.65 103.27 12.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.421 -0.799 . . . . 0.0 108.983 178.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 10' ' ' TYR . 1.5 mt -94.13 -149.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 111.199 -178.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.632 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 37.6 -164.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.453 0.644 . . . . 0.0 110.804 -178.847 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 63.97 -5.49 0.3 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -176.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.606 ' H ' ' C ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER 174.73 -27.37 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.149 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.88 40.68 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.419 ' OG ' ' CE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -100.2 133.37 44.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.649 -0.913 . . . . 0.0 109.771 179.939 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' CG1' HD23 ' A' ' 42' ' ' LEU . 39.8 t -88.31 97.53 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 110.48 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 55.3 m-85 -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 108.674 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.76 127.52 34.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.198 -0.939 . . . . 0.0 110.867 -178.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.39 161.21 25.2 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 25.7 tt0 -136.07 147.06 47.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.371 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 2.5 t -146.54 104.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.503 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 56' B GLY . 3.5 ttpt -132.34 153.93 50.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 109.509 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.481 ' N ' ' HG3' ' A' ' 56' ' ' LYS . 18.0 t70 -43.06 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.072 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 151.73 -55.74 0.45 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.28 -172.62 0.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.338 -1.095 . . . . 0.0 110.506 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 56' E LYS . 5.0 m -116.3 161.08 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -179.672 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 56' D VAL . 19.2 mttm -146.33 163.65 28.89 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 110.375 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 2.4 Cg_endo -83.99 -61.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.016 1.81 . . . . 0.0 110.873 -178.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 4.4 t80 59.89 123.74 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.34 -0.85 . . . . 0.0 110.009 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' HD22 ' A' ' 23' ' ' LEU . 4.4 Cg_exo -76.4 126.85 13.82 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 122.16 -2.017 . . . . 0.0 110.258 0.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.48 31.59 5.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -127.73 63.52 1.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.363 -0.835 . . . . 0.0 110.35 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.79 48.61 2.0 Allowed 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.116 -0.99 . . . . 0.0 109.92 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -44.93 -91.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.468 -0.77 . . . . 0.0 110.269 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.7 p -81.78 -140.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.031 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 t -86.0 -28.86 23.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.0 110.466 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.208 179.985 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.203 0.525 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.18 150.86 51.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 110.505 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -125.48 77.6 1.66 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.332 -0.855 . . . . 0.0 109.39 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.581 ' NH1' ' CG ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -78.99 85.78 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 0.0 110.721 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.887 HG22 ' HB2' ' A' ' 10' ' ' TYR . 11.3 mt -90.44 149.71 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.827 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -48.13 -178.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.248 1.023 . . . . 0.0 111.647 -179.266 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.799 ' HA ' HD13 ' A' ' 42' ' ' LEU . 2.6 tp -92.42 -40.21 11.0 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.678 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.548 ' CG ' HG21 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -91.32 -59.54 2.12 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 12' ' ' MET . 0.8 OUTLIER -45.83 -39.6 8.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.83 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.887 ' HB2' HG22 ' A' ' 5' ' ' ILE . 5.5 t80 -62.52 -53.38 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.505 178.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -51.87 -26.09 9.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.499 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 14.4 tpp -72.25 -47.01 53.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.871 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -23.88 65.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.968 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.48 -79.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.65 156.23 14.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.488 ' OE1' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -70.41 -30.52 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 109.994 179.932 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 p -82.58 -20.57 36.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 110.208 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -81.23 -51.42 8.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.057 179.329 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.622 ' O ' HD12 ' A' ' 23' ' ' LEU . 2.8 m -63.11 -25.97 68.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 178.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.4 -34.8 63.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 0.0 110.529 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 2.2 mmtp -89.6 -14.17 35.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.286 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD1' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -76.25 -40.46 51.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.67 179.737 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 19' ' ' THR . 4.7 mt -83.51 0.41 46.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.16 56.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG11 ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -144.71 -175.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.46 ' O ' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -110.25 155.99 21.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.217 -0.927 . . . . 0.0 109.924 -179.949 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.42 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 1.1 mt-30 -40.46 -28.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.374 -0.829 . . . . 0.0 110.728 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -61.98 -64.68 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.126 -0.984 . . . . 0.0 110.507 -179.775 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.617 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -44.99 -26.11 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.867 HG23 HD12 ' A' ' 34' ' ' ILE . 1.7 mp -75.84 -43.61 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 1.2 t30 -73.51 -1.57 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.042 . . . . 0.0 110.118 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -104.82 -43.38 5.11 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.999 -1.063 . . . . 0.0 108.879 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 38' ' ' ARG . . . -82.1 -0.9 46.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.589 -0.695 . . . . 0.0 109.204 178.576 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.867 HD12 HG23 ' A' ' 30' ' ' ILE . 13.6 mt -124.33 -40.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.86 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.548 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 5.7 t-80 -74.06 -26.09 60.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.816 -1.177 . . . . 0.0 110.019 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 -32.76 71.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.82 45.59 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.7 mmm180 -85.68 -173.45 4.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -1.147 . . . . 0.0 110.401 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.48 79.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 7' ' ' LEU . 10.0 mt -109.82 162.99 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.905 . . . . 0.0 110.452 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.581 ' CG ' ' NH1' ' A' ' 4' ' ' ARG . 76.2 m-85 -151.09 113.58 4.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 0.0 109.831 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 7' ' ' LEU . 7.3 mp -80.12 134.58 36.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 4' ' ' ARG . 17.8 m -106.38 100.3 9.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 49' ' ' SER . 10.6 mt -92.65 131.32 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.761 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 3.5 m120 -52.75 -19.09 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.568 -0.708 . . . . 0.0 110.59 179.02 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 91.96 -21.02 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -176.329 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.1 -2.04 57.55 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.367 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.17 -20.2 11.5 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -63.32 147.52 50.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -1.198 . . . . 0.0 109.989 179.862 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.531 HG11 ' OD1' ' A' ' 22' ' ' ASP . 22.1 t -122.11 141.86 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.448 ' O ' ' C ' ' A' ' 52' ' ' ALA . 18.7 t80 -143.09 76.54 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.479 -0.763 . . . . 0.0 109.636 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 51' ' ' TYR . . . -38.31 143.4 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.616 -0.678 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' PHE . 2.9 tt0 -140.41 86.99 2.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 110.724 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 56' D VAL . 1.3 tp10 -79.38 147.91 32.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.84 137.38 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 110.496 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 56' C GLU . 11.4 ttpt -160.07 -172.76 3.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.841 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' A ASP . . . . . . . . . . . . . 13.2 m-20 -57.24 105.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.029 -1.044 . . . . 0.0 110.189 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' B GLY . . . . . . . . . . . . . . . 51.49 29.97 25.38 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' C GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -143.77 86.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.175 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 1.2 p -125.44 102.02 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 109.719 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 56' D VAL . 9.0 mtmm -143.81 160.25 50.86 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.215 -0.928 . . . . 0.0 110.383 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 56' E LYS . 8.0 Cg_exo -74.21 128.64 12.31 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.359 1.715 . . . . 0.0 111.166 -178.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.93 144.39 39.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.481 -0.762 . . . . 0.0 109.714 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -90.94 47.48 1.35 Allowed 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.108 -2.039 . . . . 0.0 110.485 0.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.67 67.26 6.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.278 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -166.18 98.44 0.62 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.129 -0.982 . . . . 0.0 110.417 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.505 ' O ' ' C ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -151.34 50.66 0.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.065 179.717 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' A' ' 62' ' ' LYS . 17.8 mttp 28.4 -139.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.188 0.518 . . . . 0.0 111.282 179.446 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 63' ' ' LYS . 3.1 m -159.56 -69.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.231 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.27 21.42 0.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 110.447 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.129 179.907 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.233 0.539 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.12 150.76 30.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.164 -0.96 . . . . 0.0 110.436 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.529 HE21 HD11 ' A' ' 5' ' ' ILE . 12.8 mm100 -117.4 70.93 0.79 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 109.859 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.7 80.11 6.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.365 -0.835 . . . . 0.0 109.977 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.621 HG22 ' HB2' ' A' ' 10' ' ' TYR . 5.3 mt -89.31 141.47 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 110.609 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.581 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -47.17 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.996 0.903 . . . . 0.0 111.139 -179.917 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.801 HD22 HD12 ' A' ' 40' ' ' ILE . 3.8 tp -93.19 -39.9 10.77 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HG2' ' CG2' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -86.66 -61.11 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.042 178.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 1.6 t70 -50.33 -47.56 55.79 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 179.342 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.621 ' HB2' HG22 ' A' ' 5' ' ' ILE . 4.0 t80 -53.92 -61.31 2.38 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.885 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 19' ' ' THR . . . -57.01 -16.6 7.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.141 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -86.16 -30.67 22.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.511 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -3.93 38.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -126.96 32.72 5.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 -179.994 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 14' ' ' PHE . . . 60.93 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.422 ' OE1' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -79.64 -26.53 41.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 110.375 -179.962 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -75.89 -23.66 55.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 2.7 tptt -76.63 -56.66 4.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.202 -0.936 . . . . 0.0 109.022 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 11' ' ' ALA . 1.7 m -55.35 -27.95 50.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 178.581 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.44 -30.35 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -82.8 -8.46 59.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -90.41 -48.93 6.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 110.251 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.92 -36.63 36.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.58 33.11 4.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.22 161.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.204 -1.174 . . . . 0.0 109.908 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -76.26 156.06 33.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -35.66 75.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.45 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -62.42 -51.22 68.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.96 -24.8 1.63 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.652 HG23 HG13 ' A' ' 34' ' ' ILE . 1.2 mp -82.92 -56.2 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.949 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 3.3 m120 -49.78 -16.91 0.29 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.709 . . . . 0.0 111.374 -179.32 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -99.87 -51.64 3.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.436 -1.415 . . . . 0.0 109.039 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.599 ' O ' HD13 ' A' ' 34' ' ' ILE . . . -80.08 11.46 3.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.653 178.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.688 HD11 HD11 ' A' ' 7' ' ' LEU . 26.4 mm -135.32 -41.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 110.305 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.571 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -70.1 -30.6 67.85 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.947 179.724 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.19 -78.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.12 69.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.539 ' HB3' HD23 ' A' ' 7' ' ' LEU . 1.5 tpt180 -90.7 123.59 34.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 111.267 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -98.94 63.35 1.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.359 -0.838 . . . . 0.0 109.319 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.86 HG23 ' CA ' ' A' ' 54' ' ' GLU . 5.5 mt -113.29 161.1 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.284 -179.255 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 32.4 m-85 -137.93 150.42 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.948 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.0 mp -126.94 140.71 52.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.952 . . . . 0.0 110.437 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -103.37 103.68 13.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 49' ' ' SER . 3.8 mt -98.89 75.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.131 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 49' ' ' SER . 4.5 p30 -41.87 166.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.686 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.44 -7.67 3.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.555 -0.715 . . . . 0.0 109.323 178.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.15 6.41 11.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.57 0.32 30.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 44' ' ' ILE . 4.6 t -59.17 -176.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.049 -1.265 . . . . 0.0 109.493 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 49' ' ' SER . 94.2 t -149.65 115.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.612 -179.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.501 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 6.6 m-85 -113.45 154.58 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.76 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -131.53 147.26 52.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.94 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 52' ' ' ALA . 15.6 mt-10 -154.43 99.05 2.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.86 ' CA ' HG23 ' A' ' 40' ' ' ILE . 12.8 tt0 -79.89 147.94 31.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.051 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 56' D VAL . 2.3 t -137.25 97.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.931 -1.106 . . . . 0.0 110.46 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' B GLY . 6.7 ttpt -117.64 148.75 41.66 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.838 . . . . 0.0 109.75 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' LYS . 9.7 t70 -43.23 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 110.237 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 152.27 -55.87 0.45 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -174.75 166.11 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.866 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.644 ' CG1' HG13 ' A' ' 55' ' ' VAL . 16.0 m -107.43 160.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -0.839 . . . . 0.0 109.493 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.515 ' HB2' ' CD ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.56 178.12 1.59 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.018 -1.051 . . . . 0.0 110.694 -179.953 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 56' E LYS . 4.8 Cg_exo -77.72 -64.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.296 -2.193 0 O-C-N 124.39 1.732 . . . . 0.0 110.529 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.493 ' HB2' ' HD2' ' A' ' 56' E LYS . 9.5 t80 57.93 117.92 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 2.8 Cg_exo -72.57 130.74 20.33 Favored 'Cis proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.178 -2.009 . . . . 0.0 110.308 -0.053 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 t -170.97 53.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.5 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -97.4 54.51 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 110.16 179.849 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -176.42 55.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 109.934 -179.82 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -47.39 -69.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.352 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -140.09 -62.19 0.51 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.249 -0.907 . . . . 0.0 110.24 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.8 t -132.56 9.09 4.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.856 . . . . 0.0 110.216 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.181 179.968 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HG3' ' HG3' ' A' ' 2' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.012 0.434 . . . . 0.0 110.173 . . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.507 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -44.04 137.87 3.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.05 -1.031 . . . . 0.0 110.668 -179.712 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 44' ' ' ILE . 36.4 mm-40 -122.13 68.85 0.94 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.805 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 1.4 ttt180 -81.52 69.73 8.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 111.03 -179.309 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.588 ' HB ' ' CD1' ' A' ' 10' ' ' TYR . 6.0 mm -90.66 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 109.904 179.342 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -91.37 164.88 13.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.052 -1.03 . . . . 0.0 112.409 -178.503 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.782 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -59.82 -26.55 65.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.375 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HG2' HG21 ' A' ' 34' ' ' ILE . 5.6 tmtm? -80.21 -79.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.19 -54.4 16.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.784 -1.198 . . . . 0.0 110.228 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.596 ' CB ' ' O ' ' A' ' 6' ' ' THR . 17.7 t80 -46.95 -53.28 12.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.943 -1.098 . . . . 0.0 110.12 -179.75 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -56.31 -34.97 67.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 110.194 -179.575 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -34.91 78.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -32.61 47.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD2' ' HD3' ' A' ' 18' ' ' LYS . 5.6 m-30 -107.88 -63.59 1.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 152.62 143.77 3.76 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.751 ' NE2' HG21 ' A' ' 30' ' ' ILE . 6.4 tp60 -53.32 -33.23 52.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -28.14 54.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 110.493 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HD3' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -73.79 -56.01 5.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 179.66 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.428 ' HG1' ' HD2' ' A' ' 10' ' ' TYR . 8.1 m -62.96 -17.99 62.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.466 -0.771 . . . . 0.0 109.396 179.286 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -80.32 -36.67 33.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 110.399 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.93 -23.25 48.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.889 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.35 -27.5 32.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.071 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.782 HD11 ' CD1' ' A' ' 7' ' ' LEU . 30.2 mt -81.96 -40.49 22.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.72 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.12 18.11 10.19 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.35 158.98 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 109.916 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 15.1 m-30 -67.82 178.72 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.34 -179.744 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.537 ' HA ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -70.39 -22.57 62.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -0.903 . . . . 0.0 110.207 179.868 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 m -59.1 -49.69 76.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.47 -19.45 5.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.751 HG21 ' NE2' ' A' ' 16' ' ' GLN . 3.0 mm -80.63 -57.85 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.854 0.835 . . . . 0.0 110.003 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.6 OUTLIER -54.3 -15.53 1.65 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.558 -179.444 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -40.96 10.85 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.496 -1.378 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -78.09 -4.55 47.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 109.204 178.717 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.745 HD12 HG22 ' A' ' 30' ' ' ILE . 15.2 mt -120.02 -47.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.449 -0.782 . . . . 0.0 110.666 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.564 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 12.1 t60 -69.58 -22.22 63.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.006 -1.059 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.38 33.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.194 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.86 46.35 1.04 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -87.47 148.54 24.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -90.35 55.55 3.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.994 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.847 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 7.0 mt -81.3 163.0 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 -179.768 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.658 ' C ' HD12 ' A' ' 42' ' ' LEU . 53.2 m-85 -157.38 142.1 16.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.55 -0.719 . . . . 0.0 109.26 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.76 HD21 HD11 ' A' ' 7' ' ' LEU . 5.3 mp -129.05 113.56 15.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.931 -1.105 . . . . 0.0 111.725 -179.17 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.8 m -97.72 101.68 13.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.396 -0.815 . . . . 0.0 108.918 178.472 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.565 HD12 ' CZ ' ' A' ' 10' ' ' TYR . 8.5 mt -96.56 136.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 111.081 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.9 m120 -51.83 -18.91 1.45 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 110.653 178.768 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.775 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . 90.06 -17.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -176.11 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.05 -13.4 41.63 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.644 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 134.3 -26.42 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.563 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 107.36 0.78 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -1.226 . . . . 0.0 109.682 179.97 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 48' ' ' GLY . 40.3 t -100.16 117.95 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.067 . . . . 0.0 111.317 -179.19 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 23.3 m-30 -104.04 111.07 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 108.933 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 58' ' ' PHE . . . -87.8 76.51 8.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 0.0 111.072 -179.013 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -84.86 147.03 27.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 109.432 179.102 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 56' D VAL . 7.8 mt-10 -127.73 173.07 10.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.015 -179.993 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.6 119.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.048 -1.033 . . . . 0.0 110.592 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' B GLY . 9.3 tptp -138.31 143.75 40.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 179.534 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' A ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.6 OUTLIER -42.11 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 110.352 -179.762 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 143.34 -54.21 0.59 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.34 162.06 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 110.516 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 56' E LYS . 33.9 m -79.78 161.18 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 179.754 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 56' D VAL . 0.2 OUTLIER -139.93 163.23 45.9 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.142 -0.974 . . . . 0.0 110.767 -179.828 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 2.3 Cg_endo -83.41 179.18 5.17 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.813 1.675 . . . . 0.0 110.148 -179.29 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.545 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 31.4 t80 179.11 121.68 0.21 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 110.311 -179.645 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 10.1 Cg_endo -85.78 101.4 0.33 Allowed 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.728 -1.78 . . . . 0.0 110.433 -0.055 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 59' ' ' PRO . 20.2 m -44.02 144.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 110.147 179.772 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -134.69 146.96 49.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 110.083 -179.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 47.23 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 0.0 110.549 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 17.9 pttp -116.35 120.22 38.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -142.73 -90.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -0.991 . . . . 0.0 110.357 -179.851 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.0 p 43.89 33.78 0.8 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.268 -0.895 . . . . 0.0 109.44 179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.284 179.83 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.209 0.528 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.48 111.44 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.456 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.498 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 20.7 mt-30 -104.16 64.43 0.77 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.218 -0.927 . . . . 0.0 109.302 179.715 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -78.75 83.86 4.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.297 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.728 HG22 ' H ' ' A' ' 6' ' ' THR . 9.7 mt -90.2 -173.63 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.728 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.12 -179.36 5.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.087 -1.008 . . . . 0.0 111.993 -179.047 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.708 HD11 ' CD1' ' A' ' 34' ' ' ILE . 6.1 tp -92.3 -41.54 10.32 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.778 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.565 ' HD3' ' CG2' ' A' ' 34' ' ' ILE . 1.3 mmtt -86.27 -64.1 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.333 179.17 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 6' ' ' THR . 0.7 OUTLIER -46.77 -52.14 14.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.516 179.475 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.693 ' CE2' HD11 ' A' ' 44' ' ' ILE . 4.7 t80 -52.54 -55.13 24.24 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.232 179.79 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -18.72 60.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.951 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -22.11 22.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.041 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -12.26 29.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.777 179.864 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -123.64 -65.85 1.04 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.24 162.19 12.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -77.68 -30.79 52.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -1.143 . . . . 0.0 110.271 -179.988 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 26.0 p -72.52 -33.22 66.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 179.678 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.9 -54.76 11.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.45 -0.781 . . . . 0.0 109.161 179.33 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.445 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 21.7 m -62.23 -20.01 63.78 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.733 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 16' ' ' GLN . . . -72.16 -47.53 50.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -70.16 -25.05 63.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.595 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.003 ' HB3' HG11 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -61.86 -47.62 84.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.431 -0.793 . . . . 0.0 109.962 179.675 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 23' ' ' LEU . 3.4 mt -90.4 -6.54 54.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.852 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.39 22.23 71.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.521 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.55 HG23 ' HB2' ' A' ' 23' ' ' LEU . 3.2 t -107.93 153.07 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -1.019 . . . . 0.0 110.23 -179.683 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 12.0 m-85 -59.12 176.29 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.833 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.458 ' HA ' HD12 ' A' ' 30' ' ' ILE . 2.1 mt-30 -83.68 -10.89 57.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.005 179.761 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -83.26 -61.78 1.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.92 179.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . -45.42 -40.59 8.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 109.714 179.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.558 HG22 ' CD1' ' A' ' 34' ' ' ILE . 72.8 mt -65.0 -55.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.766 . . . . 0.0 109.946 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -50.33 -13.91 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.358 -0.839 . . . . 0.0 111.096 179.792 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 -37.82 14.42 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.408 -1.432 . . . . 0.0 108.869 178.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.03 -10.94 59.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.154 178.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.708 ' CD1' HD11 ' A' ' 7' ' ' LEU . 7.1 mt -108.8 -47.92 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.845 179.731 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 31' ' ' ASN . 9.9 t-80 -65.78 -24.21 66.89 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.152 -0.967 . . . . 0.0 110.305 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.18 -28.52 62.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -0.945 . . . . 0.0 110.658 -179.626 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 8' ' ' LYS . . . 92.54 47.63 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.0 172.0 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.55 -179.723 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.571 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -103.8 64.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.821 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.711 HD13 ' HB2' ' A' ' 54' ' ' GLU . 4.2 mm -87.83 169.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 111.036 -179.323 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 39' ' ' LYS . 84.5 m-85 -156.88 115.73 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.215 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.71 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.8 mp -92.56 114.36 26.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 111.375 -178.851 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.9 m -90.81 102.9 15.66 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.409 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.693 HD11 ' CE2' ' A' ' 10' ' ' TYR . 6.6 mt -99.9 102.01 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.909 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.51 173.02 9.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 0.0 109.689 179.128 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -9.25 3.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.092 179.004 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 10.65 7.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.293 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.84 10.14 23.94 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t -89.62 99.63 12.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -1.224 . . . . 0.0 109.591 179.628 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.003 HG11 ' HB3' ' A' ' 22' ' ' ASP . 5.8 p -79.75 137.06 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.84 . . . . 0.0 110.549 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 8.5 m-85 -112.18 95.38 5.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 109.696 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -83.47 111.43 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' OE1' ' CG2' ' A' ' 56' D VAL . 0.1 OUTLIER -147.18 131.73 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 111.088 -179.408 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.711 ' HB2' HD13 ' A' ' 40' ' ' ILE . 1.7 tt0 -79.77 134.33 36.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.178 179.098 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.669 HG22 ' CG2' ' A' ' 56' D VAL . 11.2 t -123.11 134.74 65.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.992 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 56' B GLY . 11.8 tptp -158.08 144.54 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' A ASP . . . . . . . . . . . . . 1.5 t70 -46.07 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 109.872 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' B GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 56' ' ' LYS . . . 150.15 -48.71 0.58 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' C GLU . . . . . . . . . . . . . 3.4 tt0 -172.47 156.15 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -1.104 . . . . 0.0 110.636 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' D VAL . . . . . 0.669 ' CG2' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -138.54 125.74 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.76 . . . . 0.0 109.398 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 56' E LYS . . . . . 0.49 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.6 158.84 60.57 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.572 -179.409 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 1.8 Cg_endo -87.61 74.49 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.855 1.703 . . . . 0.0 112.442 -177.814 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -42.98 128.31 3.25 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.049 -1.032 . . . . 0.0 109.162 178.519 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 36.9 Cg_endo -88.9 93.83 0.14 OUTLIER 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.763 -1.766 . . . . 0.0 110.698 0.058 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.541 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 1.2 m -61.84 -153.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.646 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 60' ' ' SER . 8.9 m120 57.53 112.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.287 -0.883 . . . . 0.0 110.496 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 tptp -170.54 56.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 110.155 179.893 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 64' ' ' THR . 31.4 tttm -77.67 -24.74 49.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.492 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 1.5 m 69.01 -134.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.207 -0.933 . . . . 0.0 110.106 -179.866 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.427 ' H ' HG22 ' A' ' 65' ' ' THR . 1.8 t -104.71 -18.35 14.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.034 -1.041 . . . . 0.0 110.474 -179.784 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.386 -179.769 . . . . . . . . 0 0 . 1 stop_ save_